
<html>
	<head>
		<meta http-equiv="Content-Type" content="text/html;charset=utf-8">	
		<style type="text/css">
			table {
			    border-collapse: collapse;
				font-family: arial, helvetica, sans-serif;
			}

			table, th, td {
			    border: 1px solid #C0C0C0;
				font-family: arial, helvetica, sans-serif;
			}
		</style>
	</head>
	<body><table class="tablesorter">
<thead><tr><th>Document Date</th><th>Contributor</th><th>Headline</th><th>Language</th><th>Pages</th><th>Tickers</th><th>Company Names</th><th>Category</th><th>Countries</th><th>Industries</th><th>Regions</th><th>Subjects</th><th>Report Styles</th><th>Author</th></tr>
</thead><tbody><tr class="even"><td class="leftalignment">01/17/2022</td><td class="leftalignment">the Idea!</td><td class="leftalignment">What’s New(s) in Amsterdam: Unilever, GSK/Pfizer</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / GSK.L / ULVR.L</td><td class="leftalignment">Pfizer Inc / GlaxoSmithKline PLC / Unilever PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">MORNING COMMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henk Slotboom</td></tr>
<tr class="odd"><td class="leftalignment">01/15/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/13/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">0925288 / 2126335 / 2486813 / 2050832 / 2219224 / 2270726 / 2542049 / 2317087 / 2670519 / 2455965 / 2689560 / 2684703 / 2048804 / 2799351 / 2900335 / 2857817 / B03PGL4 / B7TL820 / B65SQW4 / B7VD3F2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BK0VHF6 / BJ1FD74 / BKVDFF7 / BFZ1K46 / BLGJ610 / BJJMGL2 / BYXJQG9 / BZ1LFG7 / BD5GSZ4 / BWC52Q6</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Kellogg Co / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / Tractor Supply Co / Netflix Inc / NorthWestern Corp / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / IDEAYA Biosciences Inc / Revolve Group Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Spire Inc / Roku Inc / Infrastructure and Energy Alternatives Inc / Solaredge Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/12/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA - BUY - Mgmt Discussion Provides Color on Upcoming 1H22 IDE397 Data, Near-Term Darvosertib Opportunities, and Increasing Excitement on PARG</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACI / BAC / DHI / DIS / INTC.O / KBH / LEN / LLY.N / NVR / PFE.N / RKT / TOL / AMD.O / MU.O / NFLX.O / BIIB.O / DISCA.O / CCS.N / STAG.K / ABBV.N / PFSI.K / OMF / INSP.K / FTCH.K / RAPT.O / HMPT.O / AOMR.N</td><td class="leftalignment">Albertsons Companies Inc / Bank of America Corp / D R Horton Inc / Walt Disney Co / Intel Corp / KB Home / Lennar Corp / Eli Lilly and Co / NVR Inc / Pfizer Inc / Rocket Companies Inc / Toll Brothers Inc / Advanced Micro Devices Inc / Micron Technology Inc / Netflix Inc / Biogen Inc / Discovery Inc / Century Communities Inc / STAG Industrial Inc / Abbvie Inc / PennyMac Financial Services Inc / OneMain Holdings Inc / Inspire Medical Systems Inc / Farfetch Ltd / Rapt Therapeutics Inc / Home Point Capital Inc / Angel Oak Mortgage Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Health Care Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">US03763A2078 / US81728J1097 / US7170811035 / US2521311074 / US1920051067 / US23335Q1004 / US88033G4073 / US44934S2068 / US29251M1062 / US29428V1044 / US00771V1089 / US46266A1097 / US67576A1007 / CA98420N1050 / US2681582019 / US68235C1071 / US1710774076 / US87357P1003 / US4834971032 / US0327241065 / US52187K1016 / US71639T1060 / US8753722037 / US6837501039 / US98887Q1040 / US59045L1061 / US64131A1051 / US22663K1079 / US53635D2027 / US9842411095 / US46583P1021 / US68236P1075 / US0021202025 / US08862L1035 / US3596161097 / US24984K1051 / US83192H1068 / US70805E1091 / US12233L1070 / US0843101017 / US0051111096 / US45720L1070 / US82024L1035 / US45784A1043 / US45783Q1004</td><td class="leftalignment">Apollo Medical Holdings Inc / Sensus Healthcare Inc / Pfizer Inc / Dexcom Inc / Codexis Inc / DLH Holdings Corp / Tenet Healthcare Corp / ICAD Inc / Enanta Pharmaceuticals Inc / Epizyme Inc / Aerie Pharmaceuticals Inc / IRadimed Corp / Ocular Therapeutix Inc / Xenon Pharmaceuticals Inc / Dynavax Technologies Corp / OncoCyte Corp / Chromadex Corp / Tactile Systems Technology Inc / Kalvista Pharmaceuticals Inc / AnaptysBio Inc / Leap Therapeutics Inc / PetIQ Inc / Tandem Diabetes Care Inc / Opiant Pharmaceuticals Inc / Zai Lab Ltd / Mersana Therapeutics Inc / Neuronetics Inc / Crinetics Pharmaceuticals Inc / Liquidia Corp / Y-mAbs Therapeutics Inc / Iveric Bio Inc / Oncternal Therapeutics Inc / aTyr Pharma Inc / Beyond Air Inc / Fulcrum Therapeutics Inc / DermTech Inc / SmileDirectClub Inc / Pennant Group Inc / Burning Rock Biotech Ltd / Berkeley Lights Inc / Acutus Medical Inc / Inhibrx Inc / Shattuck Labs Inc / InnovAge Holding Corp / Inotiv Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0028241000 / US0576652004 / US5324571083 / US7170811035 / US75886F1075 / US6402681083 / US7665596034 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US03209R1032 / US14167L1035 / US1488061029 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US45781M1018 / US44842L1035 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / CA05156X8843 / US7291391057 / US12233L1070 / US4131971040 / US04683R1068 / KYG7307E1070 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Abbott Laboratories / Balchem Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Rigel Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Amphastar Pharmaceuticals Inc / CareDx Inc / Catalent Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Innoviva Inc / HUTCHMED (China) Ltd / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Aurora Cannabis Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Qilian International Holding Group Ltd / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's A Better Pharmaceutical Pick Over Merck Stock</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">PFE: Read-Across From Moderna Analyst Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—January 11, 2022</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DHI / INTC.O / KBH / LEN / NVR / PFE.N / TOL / AMD.O / MU.O / CCS.N / STAG.K / OMF / INSP.K / FTCH.K</td><td class="leftalignment">D R Horton Inc / Intel Corp / KB Home / Lennar Corp / NVR Inc / Pfizer Inc / Toll Brothers Inc / Advanced Micro Devices Inc / Micron Technology Inc / Century Communities Inc / STAG Industrial Inc / OneMain Holdings Inc / Inspire Medical Systems Inc / Farfetch Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CARS / AN=US / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / MCD=US / WEN=US / AGL=US / BLDP=US / AMZN=US / BLD=US / INCY=US / RUN=US / GILD=US / PLUG=US / NOVA=US / LOW=US / THC=US / TTWO=US / LEG=US / VMC=US / HUM=US / CVS=US / CI=US / MLM=US / UNH=US / KFY=US / AMED=US / AMN=US / SWIM=US / ARRY=US / BMRN=US / CBRL=US / KIDS=US / DRI=US / EXEL=US / FCN=US / GFF=US / ABG=US / IBP=US / MAS=US / MHK=US / ASGN=US / REGI=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / CCRN=US / CNC=US / R=US / CNM=US / JAZZ=US / BE=US / DIN=US / ACVA=US / BCO=US / MOH=US / BIIB=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / SPWR=US / CMG=US / REX=US / PGTI=US / GPRE=US / ICFI=US / AWI=US / OC=US / CPRX=US / TAST=US / QSR=US / PRPL=US / LULU=US / IAA=US / ATSG=US / JACK=US / RCUS=US / TREX=US / GNRC=US / FBHS=US / ZNGA=US / ENPH=US / TILE=US / NDLS=US / PTCT=US / FATE=US / CNCE=US / 00770K202 / LOCO=US / OSH=US / UPLD=US / ANTM=US / SHAK=US / GDDY=US / SEDG=US / WING=US / SPNE=US / NVCR=US / 82982L103 / GXO=US / IRTC=US / CRSP=US / ANAB=US / JELD=US / DCPH=US / ALLO=US / FERG=US / AHCO=US / AZEK=US / SHLS=US / PRVA=US / SNPO=US / ROIV=US</td><td class="leftalignment">Cars.com Inc / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / Ballard Power Systems Inc / Amazon.com Inc / TopBuild Corp / Incyte Corp / Sunrun Inc / Gilead Sciences Inc / Plug Power Inc / Sunnova Energy International Inc / Lowe's Companies Inc / Tenet Healthcare Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / Vulcan Materials Co / Humana Inc / CVS Health Corp / Cigna Corp / Martin Marietta Materials Inc / UnitedHealth Group Inc / Korn Ferry / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Array Technologies Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / OrthoPediatrics Corp / Darden Restaurants Inc / Exelixis Inc / FTI Consulting Inc / Griffon Corp / Asbury Automotive Group Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Cross Country Healthcare Inc / Centene Corp / Ryder System Inc / Core & Main Inc / Jazz Pharmaceuticals PLC / Bloom Energy Corp / Dine Brands Global Inc / ACV Auctions Inc / Brinks Co / Molina Healthcare Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / SunPower Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / ICF International Inc / Armstrong World Industries Inc / Owens Corning / Catalyst Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lululemon Athletica Inc / IAA Inc / Air Transport Services Group Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Generac Holdings Inc / Fortune Brands Home & Security Inc / Zynga Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Upland Software Inc / Anthem Inc / Shake Shack Inc / GoDaddy Inc / Solaredge Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Novocure Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / JELD-WEN Holding Inc / Deciphera Pharmaceuticals Inc / Allogene Therapeutics Inc / Ferguson PLC / Adapthealth Corp / Azek Company Inc / Shoals Technologies Group Inc / Privia Health Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FDA Acceptance Of BI's Spesolimab BLA Sets A Rather Low Bar For Imsidolimab. Reitate BUY</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ANAB=US / LLY=US / PFE=US / CNCE=US</td><td class="leftalignment">AnaptysBio Inc / Eli Lilly and Co / Pfizer Inc / Concert Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="even"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2002305 / 2050832 / 2219224 / 2270726 / 2542049 / 2576941 / 2670519 / 2100920 / 2455965 / 2471950 / 2645409 / 2689560 / 2684703 / 7103065 / B00FWN1 / B19FQ48 / 2713317 / 2969637 / B3D7K31 / B23FN39 / B1XGNW4 / B0796X4 / B7TL820 / B7254K9 / B7VD3F2 / B85KFY9 / B8DPDT7 / BFLR866 / BS7K7C9 / BYZLV46 / BFZNYB7 / BK0VHF6 / BD9GVY0 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BDD1B07 / BMXXBD9 / BNKGXX2 / BJ62Z18 / BL53KF5 / BK6L288 / BMBSNX0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Biogen Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / DICK'S Sporting Goods Inc / Discovery Inc / Lululemon Athletica Inc / Insulet Corp / Dexcom Inc / Meta Platforms Inc / AxoGen Inc / Duke Energy Corp / Five Below Inc / Sarepta Therapeutics Inc / Twitter Inc / Nevro Corp / InflaRx NV / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Evergy Inc / Fox Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Rubius Therapeutics Inc / Figs Inc / Verve Therapeutics Inc / Ultragenyx Pharmaceutical Inc / F45 Training Holdings Inc / Beam Therapeutics Inc / IronNet Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/11/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BMY.N / CNX / CP / DHI / DVN / FOR / HFC / KBH / LEN / MDC / MGY / MPC / MRK.N / MTH / NSC / NVR / PFE.N / PHM.N / PSX / TOL / TPH / VLO / PBF / TTWO.O / AMD.O / ILMN.O / CCS.N / ZNGA.O / TMHC.K / LGIH.O / CYAD.O / NVCR.O / OMF / ADAP.O / EDIT.O / INSP.K / FTCH.K</td><td class="leftalignment">Bristol-Myers Squibb Co / CNX Resources Corp / Canadian Pacific Railway Ltd / D R Horton Inc / Devon Energy Corp / Forestar Group Inc / HollyFrontier Corp / KB Home / Lennar Corp / MDC Holdings Inc / Magnolia Oil & Gas Corp / Marathon Petroleum Corp / Merck & Co Inc / Meritage Homes Corp / Norfolk Southern Corp / NVR Inc / Pfizer Inc / Pultegroup Inc / Phillips 66 / Toll Brothers Inc / Tri Pointe Homes Inc (Delaware) / Valero Energy Corp / PBF Energy Inc / Take-Two Interactive Software Inc / Advanced Micro Devices Inc / Illumina Inc / Century Communities Inc / Zynga Inc / Taylor Morrison Home Corp / LGI Homes Inc / Celyad Oncology SA / Novocure Ltd / OneMain Holdings Inc / Adaptimmune Therapeutics PLC / Editas Medicine Inc / Inspire Medical Systems Inc / Farfetch Ltd</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Cayman Islands / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 31, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Nightcap: Partnerships are good for Pharma/LC biotech but investors looking for M&A</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / INCY=US / GILD=US / BMRN=US / VRTX=US / BIIB=US / RCUS=US / PTCT=US / FATE=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Arcus Biosciences Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Aiming to Maintain Growth Through 2030; Other Key Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Takeaways From JPM; Vaccine and mRNA leadership for Today & Beyond</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ABT / AME / BAC / BSX / CP / IEX / IOT / MDT / NOC.N / NSC / PEN / PFE.N / PNC / ROP / TFC / USB / GILD.O / GD.N / EPC / REGN.O / VRTX.O / NDSN.O / BIIB.O / DXCM.O / TNDM.OQ / FIVE.O / MEIP.O / NVRO.K / SMAR.K / SWAV.O / LHX.N / BEAM.O</td><td class="leftalignment">Abbott Laboratories / AMETEK Inc / Bank of America Corp / Boston Scientific Corp / Canadian Pacific Railway Ltd / IDEX Corp / Samsara Inc / Medtronic PLC / Northrop Grumman Corp / Norfolk Southern Corp / Penumbra Inc / Pfizer Inc / PNC Financial Services Group Inc / Roper Technologies Inc / Truist Financial Corp / US Bancorp / Gilead Sciences Inc / General Dynamics Corp / Edgewell Personal Care Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Nordson Corp / Biogen Inc / Dexcom Inc / Tandem Diabetes Care Inc / Five Below Inc / MEI Pharma Inc / Nevro Corp / Smartsheet Inc / Shockwave Medical Inc / L3harris Technologies Inc / Beam Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Bristol Myers Squibb Stock?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">FINAM</td><td class="leftalignment">Pfizer Poised to Reach New Highs</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zareena Sayedova</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Spending In The U.S. Seems Misguided, But We Still Believe In European Value</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0231112063 / US0463531089 / US7170811035 / US58933Y1055</td><td class="leftalignment">Amarin Corporation PLC / AstraZeneca PLC / Pfizer Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ken C. Cacciatore / Stacy Ku, Ph.D. / Georgi Yordanov, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT / AME / BSX / CP / IEX / IOT / MDT / NOC.N / NSC / PEN / PFE.N / ROP / GD.N / NDSN.O / MEIP.O / SMAR.K / SWAV.O / LHX.N / BEAM.O</td><td class="leftalignment">Abbott Laboratories / AMETEK Inc / Boston Scientific Corp / Canadian Pacific Railway Ltd / IDEX Corp / Samsara Inc / Medtronic PLC / Northrop Grumman Corp / Norfolk Southern Corp / Penumbra Inc / Pfizer Inc / Roper Technologies Inc / General Dynamics Corp / Nordson Corp / MEI Pharma Inc / Smartsheet Inc / Shockwave Medical Inc / L3harris Technologies Inc / Beam Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">01/10/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 10, 2022</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">US0188021085 / US0236081024 / US0255371017 / US0311621009 / US1101221083 / US1258961002 / US1264081035 / US1270971039 / US1475281036 / US22160K1051 / US2333311072 / US25179M1036 / US25746U1097 / US26875P1012 / US29364G1031 / US30161N1019 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US4592001014 / US5010441013 / US5324571083 / US56418H1005 / US6267171022 / US64125C1099 / US65473P1057 / US6558441084 / US6745991058 / US7170811035 / US7237871071 / US7445731067 / US75281A1097 / US75886F1075 / US7703231032 / AN8068571086 / US8168511090 / US8425871071 / US8454671095 / US87612E1064 / US8851601018 / US9078181081 / US92276F1003 / US92532F1003 / US9746371007 / US98389B1008 / CA1363751027 / CA4530384086 / CA5649051078 / CA1363851017 / US1667641005 / US5658491064 / CA0636711016 / US0017441017 / US20825C1045 / US15189T1079 / US2274831047 / US09062X1037 / CA67072Q1046 / CA2265331074 / US6293775085 / US0534841012 / US1011211018 / US2644115055 / CA6993202069 / CA0906971035 / CA4495861060 / US42809H1077 / BMG383271050 / US4219461047 / US49427F1084 / US89785X1019 / US2120151012 / US38500T1016 / US26884L1098 / CA22576C1014 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / CA00829Q1019 / US26441C2044 / CA89156V1067 / US69327R1014 / US72919P2020 / CA4013393042 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA3565001086 / US70509V1008 / CA04682R1073 / US5764852050 / US29355A1079 / US25278X1090 / CA4882951060 / US71943U1043 / US60468T1051 / US03674X1063 / CA14150G4007 / CA7397211086 / US65341B1061 / US29444U7000 / US30040W1080 / US83417M1045 / US4278255009 / US92939U1060 / US86771W1053 / US0130911037 / US2057683029 / US13462K1097 / US15136A1025 / GB00BDSFG982 / CA46016U1084 / US92840M1027 / US05722G1004 / US12653C1080 / CA35905B1076 / US00191U1025 / US83200N1037 / US87484T1088 / US0937121079 / US08579X1019 / CA7241121077 / CA6744822033 / US86745K1043 / US69047Q1022 / CA4220961078 / CA84678A1021 / US5168062058 / US13123X5086 / CA89055A2039 / US0412421085 / US62955J1034 / US1651677353 / US03743Q1085 / CA00791P1071 / US1374041093</td><td class="leftalignment">Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Amgen Inc / Bristol-Myers Squibb Co / CMS Energy Corp / CSX Corp / Coterra Energy Inc / Caseys General Stores Inc / Costco Wholesale Corp / DTE Energy Co / Devon Energy Corp / Dominion Energy Inc / EOG Resources Inc / Entergy Corp / Exelon Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / International Business Machines Corp / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Murphy Oil Corp / Neurocrine Biosciences Inc / NiSource Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Public Service Enterprise Group Inc / Range Resources Corp / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Schlumberger NV / Sempra Energy / Southern Co / Southwestern Energy Co / Target Corp / Thor Industries Inc / Union Pacific Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Xcel Energy Inc / Canadian National Railway Co / Imperial Oil Ltd / Maple Leaf Foods Inc / Canadian Natural Resources Ltd / Chevron Corp / Marathon Oil Corp / Bank of Montreal / AMN Healthcare Services Inc / Conocophillips / CenterPoint Energy Inc / Cross Country Healthcare Inc / Biogen Inc / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Avalonbay Communities Inc / Boston Properties Inc / Duke Realty Corp / Paramount Resources Ltd / Birchcliff Energy Ltd / IGM Financial Inc / Hess Corp / GeoPark Ltd / Healthcare Realty Trust Inc / Kilroy Realty Corp / TrueBlue Inc / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Crescent Point Energy Corp / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Africa Oil Corp / Duke Energy Corp / Tourmaline Oil Corp / PDC Energy Inc / Plug Power Inc / Guardian Capital Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Freehold Royalties Ltd / Pebblebrook Hotel Trust / Athabasca Oil Corp / Matador Resources Co / Enphase Energy Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Physicians Realty Trust / Mirati Therapeutics Inc / Antero Resources Corp / Cardinal Energy Ltd (Alberta) / Prairiesky Royalty Ltd / Nextera Energy Partners LP / Equinix Inc / Eversource Energy / Solaredge Technologies Inc / Hersha Hospitality Trust / WEC Energy Group Inc / Sunrun Inc / Albertsons Companies Inc / Comstock Resources Inc / Camping World Holdings Inc / Centennial Resource Development Inc / TechnipFMC PLC / International Petroleum Corp / Vistra Corp / Baker Hughes Co / CNX Resources Corp / Frontera Energy Corp / ASGN Inc / Smartsheet Inc / Talos Energy Inc / Bloom Energy Corp / Berry Corporation (Bry) / Pipestone Energy Corp / Obsidian Energy Ltd / Sunnova Energy International Inc / Ovintiv Inc / Headwater Exploration Inc / Spartan Delta Corp / Laredo Petroleum Inc / Callon Petroleum Co / Topaz Energy Corp / Arko Corp. / Nov Inc / Chesapeake Energy Corp / APA Corp (US) / Advantage Energy Ltd / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/10/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SRPT: SRP-9001 Study 102 Part 2 Topline Results; Safety Profile Unchanged</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SRPT.OQ / PFE.N / SLDB.OQ</td><td class="leftalignment">Sarepta Therapeutics Inc / Pfizer Inc / Solid Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pipeline Pulse - Total Number Of Drugs Up 3% YoY; PIII Assets At Historic High</td><td class="leftalignment">English</td><td class="rightalignment">140</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 9.2% Above Pre-Pandemic Base- Week 90</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/09/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Equity Strategy: 4Q21 Earnings Preview</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">A.N / ABT.N / AIG.N / BAC.N / BAX.N / BK.N / BMY.N / C.N / CRM.N / CVS.N / DAL.N / ECL.N / EOG.N / GPS.N / HLT.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / PFE.N / PM.N / PNC.N / SO.N / T.N / TMO.N / USB.N / WFC.N / WMT.N / SPG.N / PG.N / DUK.N / DHR.N / DIS.N / UNH.N / DE.N / UNP.N / GS.N / MCD.N / HD.N / LOW.N / UPS.N / KR.N / XOM.N / AMT.N / LIN.N / TGT.N / VZ.N / COO.N / NRG.N / TJX.N / PSA.N / V.N / PLD.N / BLK.N / CVX.N / MCO.N / TDY.N / HPQ.N / INTC.OQ / ABMD.OQ / AAPL.OQ / AMAT.OQ / ADSK.OQ / CSCO.OQ / FRC.N / FISV.OQ / MSFT.OQ / ROST.OQ / SJM.N / SNPS.OQ / SBUX.OQ / QCOM.OQ / INTU.OQ / XRAY.OQ / DLTR.OQ / AMZN.OQ / NVDA.OQ / ISRG.OQ / ILMN.OQ / EQIX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / TFC.N / DXCM.OQ / CDNS.OQ / MS.N / FIS.N / CME.OQ / AVGO.OQ / SCHW.N / NEE.N / TSLA.OQ / ADI.OQ / ABBV.N / ZTS.N / MAR.OQ / GOOGL.OQ / KEYS.N / PYPL.OQ / HPE.N / CSX.OQ / IQV.N / PEP.OQ / BKNG.OQ / FB.PS / AEP.OQ / VTRS.OQ</td><td class="leftalignment">Agilent Technologies Inc / Abbott Laboratories / American International Group Inc / Bank of America Corp / Baxter International Inc / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / Citigroup Inc / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / EOG Resources Inc / Gap Inc / Hilton Worldwide Holdings Inc / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Pfizer Inc / Philip Morris International Inc / PNC Financial Services Group Inc / Southern Co / AT&T Inc / Thermo Fisher Scientific Inc / US Bancorp / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Duke Energy Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Union Pacific Corp / Goldman Sachs Group Inc / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / United Parcel Service Inc / Kroger Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Target Corp / Verizon Communications Inc / Cooper Companies Inc / NRG Energy Inc / TJX Companies Inc / Public Storage / Visa Inc / Prologis Inc / BlackRock Inc / Chevron Corp / Moody's Corp / Teledyne Technologies Inc / HP Inc / Intel Corp / ABIOMED Inc / Apple Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / First Republic Bank / Fiserv Inc / Microsoft Corp / Ross Stores Inc / J M Smucker Co / Synopsys Inc / Starbucks Corp / Qualcomm Inc / Intuit Inc / DENTSPLY SIRONA Inc / Dollar Tree Inc / Amazon.com Inc / NVIDIA Corp / Intuitive Surgical Inc / Illumina Inc / Equinix Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Truist Financial Corp / Dexcom Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / CME Group Inc / Broadcom Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / Analog Devices Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Alphabet Inc / Keysight Technologies Inc / PayPal Holdings Inc / Hewlett Packard Enterprise Co / CSX Corp / IQVIA Holdings Inc / PepsiCo Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / American Electric Power Company Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 07,2022.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMPE-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMPE.K / ABT / JNJ / PFE / RIGL.O / REGN.O / ALIM.O / AERI.O</td><td class="leftalignment">Ampio Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Pfizer Inc / Rigel Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alimera Sciences Inc / Aerie Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SPPI-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SPPI.O / ABT / BMY / JNJ / NVS / PFE / GSK / CRIS.O / SGEN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CBAY-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CBAY.O / BMY / PFE / PTCT.O / XNCR.O</td><td class="leftalignment">Cymabay Therapeutics Inc / Bristol-Myers Squibb Co / Pfizer Inc / PTC Therapeutics Inc / Xencor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Suspending Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">00287Y10 / 03116210 / 71708110 / 92532F10 / 37555810 / 75886F10 / 80105N10 / 40637H10 / 31572Q80 / 75046920 / G3910J11 / 61776010 / G8807B10 / 04539610 / 68386J20 / G7627910</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Sanofi SA / Halozyme Therapeutics Inc / FibroGen Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Theravance Biopharma Inc / Assembly Biosciences Inc / Opthea Ltd / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Jim Kelly</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT / AMAT.O / ARW / CCO / DIS / DVN / INTC.O / IPG / KLAC.O / LRCX.O / MCHP.O / OMC / PFE.N / QCOM.O / RKT / RMBS.O / SWN / T / XLNX.O / HUM.N / GILD.O / ASML.O / AUD.N / CMCSA.O / WWE / AAPL.O / CSCO.O / SBGI.O / NVDA.O / MGM.N / GTN / SIRI.O / SGMO.O / AMD.O / ADI.O / VZ / NTAP.O / ARNA.O / SMTC.O / SLAB.O / SNPS.O / CHTR.O / BYD.N / ARGX.O / AYI / MU.O / NEE / MRVL.O / HPQ / CRK.N / HPE / AVGO.O / FCEL.OQ / BLUE.O / BPOP.O / DIOD.O / MKSI.O / NFLX.O / SWKS.O / NXST.O / VIAC.O / DXCM.O / DISCA.O / CDNS.O / STX.O / CVLT.O / CNK.N / PODD.O / JNPR.K / IMAX.N / NXPI.O / CCXI.O / CZR.O / AMCX.O / WDC.O / AMBA.O / RGLS.O / PFSI.K / FOXA.O / RNA.O / HMTV.O / QURE.O / AGTC.O / ANET.K / AFMD.O / QRVO.O / ON.O / CABO.N / TGNA.K / GBT.O / PSTG.K / TMUS.O / VYGR.O / IONS.O / EDIT.O / AGLE.O / NTLA.O / NTNX.O / CRSP.O / LGFb.N / ATUS.N / BOMN.O / ROKU.O / XEL.O / AVT.O / SPOT.K / SSP.O / AVRO.O / DELL.K / IHRT.O / RAPT.O / BEAM.O / CTRA.K / ALGM.O / CHK.O / HMPT.O / VZIO.N / WOLF.N / ARBE.O / MXL.O</td><td class="leftalignment">Abbott Laboratories / Applied Materials Inc / Arrow Electronics Inc / Clear Channel Outdoor Holdings Inc / Walt Disney Co / Devon Energy Corp / Intel Corp / Interpublic Group of Companies Inc / KLA Corp / Lam Research Corp / Microchip Technology Inc / Omnicom Group Inc / Pfizer Inc / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / Southwestern Energy Co / AT&T Inc / Xilinx Inc / Humana Inc / Gilead Sciences Inc / ASML Holding NV / Audacy Inc / Comcast Corp / World Wrestling Entertainment Inc / Apple Inc / Cisco Systems Inc / Sinclair Broadcast Group Inc / NVIDIA Corp / MGM Resorts International / Gray Television Inc / Sirius XM Holdings Inc / Sangamo Therapeutics Inc / Advanced Micro Devices Inc / Analog Devices Inc / Verizon Communications Inc / NetApp Inc / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Charter Communications Inc / Boyd Gaming Corp / argenx SE / Acuity Brands Inc / Micron Technology Inc / Nextera Energy Inc / Marvell Technology Inc / HP Inc / Comstock Resources Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Fuelcell Energy Inc / bluebird bio Inc / Popular Inc / Diodes Inc / MKS Instruments Inc / Netflix Inc / Skyworks Solutions Inc / Nexstar Media Group Inc / ViacomCBS Inc / Dexcom Inc / Discovery Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Commvault Systems Inc / Cinemark Holdings Inc / Insulet Corp / Juniper Networks Inc / Imax Corp / NXP Semiconductors NV / ChemoCentryx Inc / Caesars Entertainment Inc / AMC Networks Inc / Western Digital Corp / Ambarella Inc / Regulus Therapeutics Inc / PennyMac Financial Services Inc / Fox Corp / Avidity Biosciences Inc / Hemisphere Media Group Inc / Uniqure NV / Applied Genetic Technologies Corp / Arista Networks Inc / Affimed NV / Qorvo Inc / ON Semiconductor Corp / Cable One Inc / Tegna Inc / Global Blood Therapeutics Inc / Pure Storage Inc / T-Mobile US Inc / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Aeglea Bio Therapeutics Inc / Intellia Therapeutics Inc / Nutanix Inc / CRISPR Therapeutics AG / Lions Gate Entertainment Corp / Altice USA Inc / Boston Omaha Corp / Roku Inc / Xcel Energy Inc / Avnet Inc / Spotify Technology SA / E W Scripps Co / AVROBIO Inc / Dell Technologies Inc / iHeartMedia Inc / Rapt Therapeutics Inc / Beam Therapeutics Inc / Coterra Energy Inc / Allegro Microsystems Inc / Chesapeake Energy Corp / Home Point Capital Inc / Vizio Holding Corp / Wolfspeed Inc / Arbe Robotics Ltd / Maxlinear Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Israel / Luxembourg / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">The Cowen Edge - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0028241000 / US00846U1016 / US00971T1016 / US0116591092 / US0231351067 / US0378331005 / US0382221051 / US0463531089 / US0718131099 / US0758871091 / US1011371077 / US1101221083 / US1266501006 / US1727551004 / US22284P1057 / US28176E1082 / US3021301094 / US3156161024 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US5951121038 / US66987V1098 / US6701002056 / US6795801009 / US7140461093 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8168501018 / US8308791024 / US8447411088 / US8610121027 / US8740391003 / US8807701029 / US9029251066 / US91347P1057 / US92343V1044 / US9507551086 / US9581021055 / TW0002330008 / US87157D1090 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US20030N1019 / US6402681083 / US09062X1037 / US1572101053 / US0042251084 / US02043Q1076 / US2538681030 / US19239V3024 / US2090341072 / US12541W2098 / US00206R1023 / ACOR.OQ / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US58933Y1055 / US34959E1091 / US1920051067 / US9100471096 / US03027X1000 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US81762P1021 / US8725901040 / US6974351057 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US22822V1017 / US74736K1016 / US29444U7000 / IE00BTN1Y115 / US00653A1079 / US12685J1051 / US02079K1079 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / CA87241L1094 / US78410G1040 / US83304A1060 / US91325V1089 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US87105L1044 / US57777K1060 / US11135F1012 / US5904791358 / US0197701065 / US0144421072 / US90353T1007 / US18915M1071 / US09203E1055 / CH0499880968 / KYG3902L1095 / US5502411037 / US35909R1086 / US25401T1088 / US20717M1036 / US1920031010 / US02080L1026 / US35909D1090 / US23284C1027 / US2935941078 / KYG393871085 / KYG4701H1092 / US86337R1032 / US10576N1028 / US4181001037 / AU0000185993</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Abbott Laboratories / Agilent Technologies Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amazon.com Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Baxter International Inc / Becton Dickinson and Co / Boston Scientific Corp / Bristol-Myers Squibb Co / CVS Health Corp / Cirrus Logic Inc / Covenant Logistics Group Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PerkinElmer Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Semtech Corp / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Taiwan Semiconductor Manufacturing Co Ltd / Teradyne Inc / USA Truck Inc / Universal Display Corp / Verizon Communications Inc / Werner Enterprises Inc / Western Digital Corp / Taiwan Semiconductor Manufacturing Co Ltd / Synaptics Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Nektar Therapeutics / Biogen Inc / CEVA Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Acorda Therapeutics Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Merck & Co Inc / Fortinet Inc / Codexis Inc / United Airlines Holdings Inc / American Tower Corp / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / ServiceNow Inc / T-Mobile US Inc / Palo Alto Networks Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Qorvo Inc / Equinix Inc / Medtronic PLC / Adaptimmune Therapeutics PLC / Cable One Inc / Alphabet Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TFI International Inc / SBA Communications Corp / Snap Inc / Uniti Group Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Switch Inc / MaxCyte Inc / Broadcom Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Uber Technologies Inc / Cloudflare Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / GDS Holdings Ltd / Lumen Technologies Inc / Frontier Group Holdings Inc / DigitalBridge Group Inc / Confluent Inc / Codex DNA Inc / Alpha Teknova Inc / Frontier Communications Parent Inc / Cyxtera Technologies Inc / Enovix Corp / Globalfoundries Inc / IHS Holding Ltd / Stronghold Digital Mining Inc / Braze Inc / Hashicorp Inc / Iris Energy Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - CMS AD NCD & JPM Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 24, 2021 to January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8336351056 / US0091581068 / US0126531013 / US0234361089 / US0311621009 / US0536111091 / US1101221083 / US2017231034 / US2788651006 / US3755581036 / US3976241071 / US4128221086 / US4180561072 / US4282911084 / US4448591028 / US45337C1027 / US4601461035 / US5324571083 / US5463471053 / US56418H1005 / US5719032022 / US5770811025 / US64125C1099 / US6516391066 / US6703461052 / US6935061076 / US6951561090 / US7170811035 / US7310681025 / US7496851038 / US7549071030 / US75886F1075 / US7703231032 / US7802871084 / US8243481061 / US8581191009 / US9113121068 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA25822C2058 / CA1469001053 / CA0679011084 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US37940X1028 / US2274831047 / US09062X1037 / US46625H1005 / US0605051046 / US20451N1019 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2971781057 / US1331311027 / US1508701034 / US2538681030 / CA8911605092 / CA1360691010 / US1011211018 / US2644115055 / US9290421091 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / US57636Q1040 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US59522J1034 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US5021751020 / US63633D1046 / US5500211090 / US89785X1019 / CA3518581051 / US92826C8394 / US58502B1061 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / CA55903Q1046 / US76131N1019 / US70509V1008 / CA38045Y1025 / US16208T1025 / US78573L1061 / US74965L1017 / US23283R1005 / CA05577W2004 / US71943U1043 / US60468T1051 / US9660842041 / US02665T3068 / US45378A1060 / US11120U1051 / US02005N1000 / US1785871013 / CA45868C1095 / US14174T1079 / BMG0750C1082 / US8621211007 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US9741551033 / US1638511089 / US4278255009 / US96145D1054 / US70450Y1038 / CA8485101031 / US95040Q1040 / US8522341036 / 100607060 / US45688C1071 / US53223X1072 / US0441861046 / CA26829L1076 / US7005171050 / US43300A2033 / US46187W1071 / CA9628791027 / GB00BF3ZNS54 / US87105L1044 / CA53680Q2071 / US46590V1008 / CA2960061091 / US3610081057 / CA8585221051 / US29261A1007 / US00191U1025 / US83200N1037 / US48251W1045 / CA4039254079 / US53814L1089 / IE00BZ12WP82 / CA13000C2058 / US2605571031 / GB00BJT16S69 / US73757R1023 / US26614N1028 / US5012701026 / US42250P1030 / CA92625W5072 / US14316J1088 / US47012E4035 / US69526K1051 / CA67079A1021 / US15202L1070 / CA00076T1057 / US11135E2037 / US00848J1043 / BMG6964L1072 / US0708301041 / US71844V2016 / US27923Q1094 / AU0000193666 / US4576791085</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Air Products and Chemicals Inc / Albemarle Corp / Amedisys Inc / Amgen Inc / Avery Dennison Corp / Bristol-Myers Squibb Co / Commercial Metals Co / Ecolab Inc / Gilead Sciences Inc / Greif Inc / Harley-Davidson Inc / Hasbro Inc / Hexcel Corp / Humana Inc / Incyte Corp / International Paper Co / Eli Lilly and Co / Louisiana-Pacific Corp / ManpowerGroup Inc / Marriott International Inc / Mattel Inc / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / PPG Industries Inc / Packaging Corp of America / Pfizer Inc / Polaris Inc / RPM International Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Royal Gold Inc / Sherwin-Williams Co / Steel Dynamics Inc / United Parcel Service Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Dorel Industries Inc / Cascades Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Global Payments Inc / Cross Country Healthcare Inc / Biogen Inc / JPMorgan Chase & Co / Bank of America Corp / Compass Minerals International Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Essex Property Trust Inc / Camden Property Trust / Celanese Corp / Digital Realty Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Mastercard Inc / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / Mid-America Apartment Communities Inc / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / LTC Properties Inc / National Health Investors Inc / Lululemon Athletica Inc / TrueBlue Inc / Franco-Nevada Corp / Visa Inc / MEDNAX Inc / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / MAG Silver Corp / Retail Opportunity Investments Corp / Pebblebrook Hotel Trust / GoGold Resources Inc / Chatham Lodging Trust / Sabra Health Care REIT Inc / RLJ Lodging Trust / CyrusOne Inc / BRP Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Whitestone REIT / American Homes 4 Rent / Independence Realty Trust Inc / Brixmor Property Group Inc / Ally Financial Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Axalta Coating Systems Ltd / STORE Capital Corp / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Wingstop Inc / Chemours Co / Hersha Hospitality Trust / Westrock Co / PayPal Holdings Inc / Spin Master Corp / Welltower Inc / Block Inc / First-Citizens Bank & Trust Co / Ingevity Corp / Life Storage Inc / Ashland Global Holdings Inc / ECN Capital Corp / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Invitation Homes Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Switch Inc / Lithium Americas Corp / JBG SMITH Properties / Ero Copper Corp / Funko Inc / Stelco Holdings Inc / Encompass Health Corp / ASGN Inc / Smartsheet Inc / KKR & Co Inc / H&R Real Estate Investment Trust / Livent Corp / Linde PLC / Calibre Mining Corp / Dow Inc / Tronox Holdings PLC / Postal Realty Trust Inc / Dupont De Nemours Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Carlyle Group Inc / JAKKS Pacific Inc / Pactiv Evergreen Inc / Nuvei Corp / Centerspace / Abc Technologies Holdings Inc / Broadstone Net Lease Inc / Agiliti Inc / Paysafe Ltd / Bath & Body Works Inc / Phillips Edison & Co Inc / Ecovyst Inc / Allkem Ltd / Innovid Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Chile / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 31, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">DVN / PFE.N / T / HUM.N / GILD.O / MGM.N / VZ / ARNA.O / BYD.N / BPOP.O / CZR.O / TMUS.O / CTRA.K</td><td class="leftalignment">Devon Energy Corp / Pfizer Inc / AT&T Inc / Humana Inc / Gilead Sciences Inc / MGM Resorts International / Verizon Communications Inc / Arena Pharmaceuticals Inc / Boyd Gaming Corp / Popular Inc / Caesars Entertainment Inc / T-Mobile US Inc / Coterra Energy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2434209 / 2000019 / 2023607 / 2085878 / 2206657 / 2270726 / 2670519 / 2100920 / 2623911 / 2632003 / 2684703 / 2825933 / 2931034 / 2170473 / 2857817 / B3D7K31 / B0796X4 / 2949758 / B7TL820 / B4MG4Z6 / BBPK0J0 / B95N910 / BK0VHF6 / BWTN5N1 / BFZ1K46 / BYXJQG9 / BJFSR99 / BKTNTR9 / BJXBP30 / BYYWPW6 / BZ1LFG7 / BYY88Y7 / BL71K91 / BGDQ8B3 / BMGGJK8 / BLF0CW7 / BNLYBF3 / BMVBZF5 / BP2P6L0</td><td class="leftalignment">Home Depot Inc / Amazon.com Inc / Amgen Inc / Bed Bath & Beyond Inc / Coca-Cola Co / Walt Disney Co / Exelon Corp / FirstEnergy Corp / Neurocrine Biosciences Inc / New York Times Co / Pfizer Inc / South Jersey Industries Inc / Vertex Pharmaceuticals Inc / Constellation Brands Inc / Netflix Inc / Discovery Inc / Dexcom Inc / Nexstar Media Group Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / PTC Inc / IDEAYA Biosciences Inc / ETSY Inc / Spotify Technology SA / Spire Inc / Revance Therapeutics Inc / ViacomCBS Inc / Turning Point Therapeutics Inc / Beigene Ltd / Roku Inc / Alphabet Inc / Revolution Medicines Inc / Axonics Inc / Valneva SE / Repare Therapeutics Inc / Erasca Inc / Immuneering Corp / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - January 7, 2022</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">US8336351056 / US0126531013 / US0311621009 / US1101221083 / US3755581036 / US4448591028 / US45337C1027 / US5324571083 / US5463471053 / US5719032022 / US64125C1099 / US6516391066 / US7170811035 / US7549071030 / US75886F1075 / US7802871084 / US92276F1003 / US92532F1003 / US9621661043 / US98389B1008 / CA0679011084 / CA9528451052 / US09062X1037 / US9604131022 / US0534841012 / US29476L1070 / US7588491032 / US2538681030 / US1011211018 / US2644115055 / US5543821012 / US8288061091 / US44107P1049 / US7376301039 / CA1375761048 / US29472R1086 / US8666741041 / US74460D1090 / US9026531049 / US30225T1025 / US35471R1068 / US4219461047 / US63633D1046 / CA3518581051 / US58933Y1055 / NL0009434992 / US74340W1036 / US2296631094 / US92936U1097 / US70509V1008 / US16208T1025 / US78573L1061 / US71943U1043 / US60468T1051 / CA45868C1095 / US14174T1079 / US42225P5017 / US29444U7000 / US27616P1030 / US9840171030 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / CA9628791027 / US87105L1044 / CA53680Q2071 / CA2960061091 / US53814L1089 / CA13000C2058 / US2605571031 / US73757R1023 / US5012701026 / US42250P1030 / CA92625W5072 / US15202L1070 / US11135E2037 / US0708301041 / AU0000193666</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Albemarle Corp / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Humana Inc / Incyte Corp / Eli Lilly and Co / Louisiana-Pacific Corp / Marriott International Inc / Neurocrine Biosciences Inc / Newmont Corporation / Pfizer Inc / Rayonier Inc / Regeneron Pharmaceuticals Inc / Royal Gold Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Weyerhaeuser Co / Xcel Energy Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Biogen Inc / Westlake Chemical Corp / Avalonbay Communities Inc / Equity Residential / Regency Centers Corp / Digital Realty Trust Inc / Boston Properties Inc / Duke Realty Corp / Macerich Co / Simon Property Group Inc / Host Hotels & Resorts Inc / Potlatchdeltic Corp / Canfor Corp / Equity LifeStyle Properties Inc / Sun Communities Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Franklin Street Properties Corp / Healthcare Realty Trust Inc / National Health Investors Inc / Franco-Nevada Corp / Merck & Co Inc / LyondellBasell Industries NV / Prologis Inc / CubeSmart / WP Carey Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Sabra Health Care REIT Inc / Physicians Realty Trust / Mirati Therapeutics Inc / Interfor Corp / CareTrust REIT Inc / Healthcare Trust Of America Inc / Equinix Inc / Easterly Government Properties Inc / Xenia Hotels & Resorts Inc / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Wheaton Precious Metals Corp / Switch Inc / Lithium Americas Corp / Ero Copper Corp / Livent Corp / Calibre Mining Corp / Dow Inc / Postal Realty Trust Inc / Kura Sushi USA Inc / Healthpeak Properties Inc / Victoria Gold Corp / Centerspace / Broadstone Net Lease Inc / Bath & Body Works Inc / Allkem Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Chile / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">01/07/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AME / AR / AZO / BAC / CB / CLR / CMS / CNX / CPE / DIS / DLR / DOW / DVN / EL / EOG / EQT / F.N / FNB / FRC / GM.N / GPS / JNJ / MA / MDT / MGY / MRO / NSC / NTB / OLN / PFE.N / PXD / RRC / SM / SNV / SO / STZ / SWN / SYK / SYY / T / WAL / WLL / TROW.O / AMZN.O / HUM.N / GILD.O / ASB / AAPL.O / CSCO.O / MGM.N / VZ / PACW.O / SNPS.O / EXPE.O / BYD.N / CBSH.O / PENN.O / LPI / CHDN.O / WBS / FBP.N / OFG.N / WYNN.O / PBCT.O / SIVB.O / UMBF.O / BPOP.O / BOKF.O / ACGL.O / UMPQ.O / EWBC.O / PNFP.O / FHN / SBNY.O / LVS.N / QSR / ISBC.O / NOG.A / NXPI.O / FIBK.O / CZR.O / BKU / STAG.K / ESTE.K / MTDR.K / FB.O / PDCE.O / FANG.O / ABBV.N / MAR.O / GOOGL.O / BANC.K / TBK.O / QRVO.O / CIVI.K / TDOC.N / GKOS.K / ZBH / TMUS.O / RRR.O / NTLA.O / FHB.O / CDEV.O / OZK.O / BRY.O / AXNX.O / UBER.K / FLTRF.L / CRWD.O / AVTR.K / OAS.O / OVV.N / DKNG.O / CTRA.K / BALY.N / RSI.N / CHK.O / RIVN.O</td><td class="leftalignment">AMETEK Inc / Antero Resources Corp / Autozone Inc / Bank of America Corp / Chubb Ltd / Continental Resources Inc / CMS Energy Corp / CNX Resources Corp / Callon Petroleum Co / Walt Disney Co / Digital Realty Trust Inc / Dow Inc / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Ford Motor Co / FNB Corp / First Republic Bank / General Motors Co / Gap Inc / Johnson & Johnson / Mastercard Inc / Medtronic PLC / Magnolia Oil & Gas Corp / Marathon Oil Corp / Norfolk Southern Corp / Bank of N T Butterfield & Son Ltd / Olin Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / SM Energy Co / Synovus Financial Corp / Southern Co / Constellation Brands Inc / Southwestern Energy Co / Stryker Corp / Sysco Corp / AT&T Inc / Western Alliance Bancorp / Whiting Petroleum Corp / T Rowe Price Group Inc / Amazon.com Inc / Humana Inc / Gilead Sciences Inc / Associated Banc-Corp / Apple Inc / Cisco Systems Inc / MGM Resorts International / Verizon Communications Inc / PacWest Bancorp / Synopsys Inc / Expedia Group Inc / Boyd Gaming Corp / Commerce Bancshares Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Churchill Downs Inc / Webster Financial Corp / First Bancorp / OFG Bancorp / Wynn Resorts Ltd / People's United Financial Inc / SVB Financial Group / UMB Financial Corp / Popular Inc / BOK Financial Corp / Arch Capital Group Ltd / Umpqua Holdings Corp / East West Bancorp Inc / Pinnacle Financial Partners Inc / First Horizon Corp / Signature Bank / Las Vegas Sands Corp / Restaurant Brands International Inc / Investors Bancorp Inc / Northern Oil and Gas Inc / NXP Semiconductors NV / First Interstate BancSystem Inc / Caesars Entertainment Inc / BankUnited Inc / STAG Industrial Inc / Earthstone Energy Inc / Matador Resources Co / Meta Platforms Inc / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Marriott International Inc / Alphabet Inc / Banc of California Inc / Triumph Bancorp Inc / Qorvo Inc / Civitas Resources Inc / Teladoc Health Inc / Glaukos Corp / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Red Rock Resorts Inc / Intellia Therapeutics Inc / First Hawaiian Inc / Centennial Resource Development Inc / Bank Ozk / Berry Corporation (Bry) / Axonics Inc / Uber Technologies Inc / Flutter Entertainment PLC / CrowdStrike Holdings Inc / Avantor Inc / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Coterra Energy Inc / Bally's Corp / Rush Street Interactive Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / Puerto Rico / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/07/2022</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Navigating the Virtual Circus: Expectations and Mgmt Qs for Next Week's Conf.</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">01/06/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Stock to Own with Emerging COVID Tail OPPY and Deal-Making; New PT $65/sh</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / BA.N / BBY.N / CAH.N / CCK.N / CE.N / EOG.N / F.N / HIG.N / HLT.N / KEY.N / MRK.N / OXY.N / PFE.N / RHI.N / TMX.N / TOL.N / UAL.N / USB.N / VNT.N / ZEN.N / DIS.N / WLK.N / GD.N / CR.N / AFG.N / SPOT.N / AMG.N / RCL.N / IFF.N / DV.N / LH.N / FNF.N / DVN.N / OLN.N / TGT.N / RKT.N / SNV.N / AMP.N / HXL.N / AZO.N / FDS.N / EQT.N / ATO.N / HWM.N / BYD.N / DNB.N / HRL.N / SAM.N / ABC.N / JNPR.N / GME.N / TDY.N / COP.N / INTC.OQ / ORI.N / ADPT.OQ / AGL.N / CRUS.OQ / FAF.N / FISV.OQ / HOLX.OQ / KLAC.OQ / MKL.N / RJF.N / RGEN.OQ / SEIC.OQ / SF.N / FL.N / QCOM.OQ / NKTR.OQ / TPR.N / SRCL.OQ / MRCY.OQ / MRVL.OQ / ILMN.OQ / WOOF.OQ / WYNN.OQ / PA1436583006 / MNST.OQ / MOH.N / EXP.N / OSH.N / LVS.N / OC.N / FRPT.OQ / BX.N / NVR.N / WRB.N / MRNA.OQ / CLH.N / AI.N / AVGO.OQ / NXPI.OQ / BAH.N / CZR.OQ / TRGP.N / MSP.N / HII.N / Z.OQ / TRIP.OQ / ALSN.N / FB.OQ / BERY.N / FANG.OQ / WEX.N / RNG.N / NCLH.N / FIVN.OQ / SYF.N / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / COUP.OQ / UAA.N / OKTA.OQ / CVNA.N / ROKU.OQ / KDP.N / PLAN.N / NFE.OQ / LYFT.O / BYND.OQ / UBER.N / CRWD.OQ / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / JAMF.OQ / BEPC.N / DCT.OQ / PLTR.N / SHC.OQ / SKLZ.N / CLVT.N / SGFY.N / VMEO.OQ / FIGS.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Boeing Co / Best Buy Co Inc / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / KeyCorp / Merck & Co Inc / Occidental Petroleum Corp / Pfizer Inc / Robert Half International Inc / Terminix Global Holdings Inc / Toll Brothers Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Walt Disney Co / Westlake Chemical Corp / General Dynamics Corp / Crane Co / American Financial Group Inc / Spotify Technology SA / Affiliated Managers Group Inc / Royal Caribbean Cruises Ltd / International Flavors & Fragrances Inc / DoubleVerify Holdings Inc / Laboratory Corporation of America Holdings / Fidelity National Financial Inc / Devon Energy Corp / Olin Corp / Target Corp / Rocket Companies Inc / Synovus Financial Corp / Ameriprise Financial Inc / Hexcel Corp / Autozone Inc / Factset Research Systems Inc / EQT Corp / Atmos Energy Corp / Howmet Aerospace Inc / Boyd Gaming Corp / Dun & Bradstreet Holdings Inc / Hormel Foods Corp / Boston Beer Company Inc / Amerisourcebergen Corp / Juniper Networks Inc / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / agilon health Inc / Cirrus Logic Inc / First American Financial Corp / Fiserv Inc / Hologic Inc / KLA Corp / Markel Corp / Raymond James Financial Inc / Repligen Corp / SEI Investments Co / Stifel Financial Corp / Foot Locker Inc / Qualcomm Inc / Nektar Therapeutics / Tapestry Inc / Stericycle Inc / Mercury Systems Inc / Marvell Technology Inc / Illumina Inc / Petco Health and Wellness Company Inc / Wynn Resorts Ltd / Carnival Corp / Monster Beverage Corp / Molina Healthcare Inc / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Owens Corning / Freshpet Inc / Blackstone Inc / NVR Inc / W R Berkley Corp / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / NXP Semiconductors NV / Booz Allen Hamilton Holding Corp / Caesars Entertainment Inc / Targa Resources Corp / Datto Holding Corp / Huntington Ingalls Industries Inc / Zillow Group Inc / Tripadvisor Inc / Allison Transmission Holdings Inc / Meta Platforms Inc / Berry Global Group Inc / Diamondback Energy Inc / WEX Inc / RingCentral Inc / Norwegian Cruise Line Holdings Ltd / Five9 Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Coupa Software Inc / Under Armour Inc / Okta Inc / Carvana Co / Roku Inc / Keurig Dr Pepper Inc / Anaplan Inc / New Fortress Energy Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Jamf Holding Corp / Brookfield Renewable Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / Skillz Inc / CLARIVATE PLC / Signify Health Inc / Vimeo Inc / Figs Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Liberia / Luxembourg / Netherlands / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - SP500</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABBV.N / AFRM.OQ / AEE.N / BA.N / CMS.N / CRM.N / ECL.N / HLT.N / PFE.N / SC.N / TXT.N / U.N / ACI.N / SCI.N / DIS.N / WLK.N / AFG.N / IPG.N / SPOT.N / RCL.N / IFF.N / FNF.N / PCG.N / DVN.N / NRG.N / ATO.N / LNT.N / AME.N / UDR.N / MKC.N / HRL.N / GME.N / TDY.N / COP.N / INTC.OQ / AMGN.OQ / AGL.N / FISV.OQ / HOLX.OQ / RJF.N / RGEN.OQ / QCOM.OQ / NTAP.OQ / TPR.N / NUAN.OQ / MRVL.OQ / ILMN.OQ / PA1436583006 / MNST.OQ / MOH.N / LVS.N / LBTYK.OQ / CME.OQ / STX.OQ / NXPI.OQ / CZR.OQ / CAR.OQ / Z.OQ / RNG.N / LBRDK.O / TDOC.N / PEN.N / TWLO.N / SNAP.N / INVH.N / CVNA.N / ROKU.OQ / XEL.OQ / SYNH.OQ / VICI.N / CDAY.N / KDP.N / FTCH.N / UBER.N / TXG.OQ / PTON.OQ / WTRG.N / DKNG.OQ / PLTR.N / RBLX.N / XM.OQ / CPNG.N</td><td class="leftalignment">Abbvie Inc / Affirm Holdings Inc / Ameren Corp / Boeing Co / CMS Energy Corp / Salesforce.Com Inc / Ecolab Inc / Hilton Worldwide Holdings Inc / Pfizer Inc / Santander Consumer USA Holdings Inc / Textron Inc / Unity Software Inc / Albertsons Companies Inc / Service Corporation International / Walt Disney Co / Westlake Chemical Corp / American Financial Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Royal Caribbean Cruises Ltd / International Flavors & Fragrances Inc / Fidelity National Financial Inc / PG&E Corp / Devon Energy Corp / NRG Energy Inc / Atmos Energy Corp / Alliant Energy Corp / AMETEK Inc / UDR Inc / McCormick & Company Inc / Hormel Foods Corp / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Amgen Inc / agilon health Inc / Fiserv Inc / Hologic Inc / Raymond James Financial Inc / Repligen Corp / Qualcomm Inc / NetApp Inc / Tapestry Inc / Nuance Communications Inc / Marvell Technology Inc / Illumina Inc / Carnival Corp / Monster Beverage Corp / Molina Healthcare Inc / Las Vegas Sands Corp / Liberty Global PLC / CME Group Inc / Seagate Technology Holdings PLC / NXP Semiconductors NV / Caesars Entertainment Inc / Avis Budget Group Inc / Zillow Group Inc / RingCentral Inc / Liberty Broadband Corp / Teladoc Health Inc / Penumbra Inc / Twilio Inc / Snap Inc / Invitation Homes Inc / Carvana Co / Roku Inc / Xcel Energy Inc / Syneos Health Inc / VICI Properties Inc / Ceridian HCM Holding Inc / Keurig Dr Pepper Inc / Farfetch Ltd / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Essential Utilities Inc / DraftKings Inc / Palantir Technologies Inc / Roblox Corp / Qualtrics International Inc / Coupang Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Korea, Republic of / Liberia / Luxembourg / Netherlands / Panama / United States</td><td class="leftalignment">Advertising / Aerospace / Apparel & Textiles / Automotive / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Media / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / HD=US / MCD=US / WEN=US / AGL=US / BLD=US / DGX=US / BC=US / CRM=US / LOW=US / FMS=US / THC=US / BRO=US / LEG=US / HCA=US / MANH=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / SWIM=US / BMRN=US / CBRL=US / ELY=US / FUN=US / CYH=US / COR=US / DRI=US / DVA=US / AJG=US / HAS=US / LH=US / HZO=US / MAS=US / MAT=US / MHK=US / PII=US / REGI=US / SGMO=US / SMG=US / THO=US / WW=US / WEX=US / WGO=US / GOLF=US / CNC=US / MKL=US / NLS=US / ENSG=US / APPN=US / DIN=US / MD=US / JRVR=US / MOH=US / FLT=US / TPX=US / EXP=US / TXRH=US / PLAY=US / DENN=US / LHCG=US / XM=US / ESMT=US / CMG=US / SIX=US / PGTI=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / EHC=US / SEAS=US / WRB=US / CWH=US / JACK=US / VRSK=US / TREX=US / INSE / KNSL=US / OLO=US / FBHS=US / TILE=US / NDLS=US / FOXF=US / MBUU=US / CNCE=US / QURE=US / FIVN=US / LOCO=US / OSH=US / NVRO=US / ANTM=US / WBA=US / WK=US / SHAK=US / ETSY=US / WING=US / MCFT=US / AXSM=US / EDIT=US / NTLA=US / CRSP=US / TVTY=US / 50189K103 / JELD=US / FNKO=US / LAZY=US / TCRR=US / PLMR=US / AHCO=US / PNTG=US / OPCH=US / ONEM=US / ONEW=US / ZI=US / AZEK=US / NCNO=US / HYFM=US / PRVA=US / AVAH=US / HLLY=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Home Depot Inc / McDonald's Corp / Wendys Co / agilon health Inc / TopBuild Corp / Quest Diagnostics Inc / Brunswick Corp / Salesforce.Com Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Tenet Healthcare Corp / Brown & Brown Inc / Leggett & Platt Inc / HCA Healthcare Inc / Manhattan Associates Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / Latham Group Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Cedar Fair LP / Community Health Systems Inc / RespireRx Pharmaceuticals Inc / Darden Restaurants Inc / DaVita Inc / Arthur J Gallagher & Co / Hasbro Inc / Laboratory Corporation of America Holdings / MarineMax Inc / Masco Corp / Mattel Inc / Mohawk Industries Inc / Polaris Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Thor Industries Inc / WW International Inc / WEX Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Centene Corp / Markel Corp / Nautilus Inc / Ensign Group Inc / Appian Corp / Dine Brands Global Inc / MEDNAX Inc / James River Group Holdings Ltd / Molina Healthcare Inc / Fleetcor Technologies Inc / Tempur Sealy International Inc / Eagle Materials Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Qualtrics International Inc / EngageSmart Inc / Chipotle Mexican Grill Inc / Six Flags Entertainment Corp / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / SeaWorld Entertainment Inc / W R Berkley Corp / Camping World Holdings Inc / Jack in the Box Inc / Verisk Analytics Inc / Trex Company Inc / Inspired Entertainment Inc / Kinsale Capital Group Inc / Olo Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Fox Factory Holding Corp / Malibu Boats Inc / Concert Pharmaceuticals Inc / Uniqure NV / Five9 Inc / El Pollo Loco Holdings Inc / Oak Street Health Inc / Nevro Corp / Anthem Inc / Walgreens Boots Alliance Inc / Workiva Inc / Shake Shack Inc / ETSY Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / CRISPR Therapeutics AG / Tivity Health Inc / LCI Industries / JELD-WEN Holding Inc / Funko Inc / Lazydays Holdings Inc / TCR2 Therapeutics Inc / Palomar Holdings Inc / Adapthealth Corp / Pennant Group Inc / Option Care Health Inc / 1Life Healthcare Inc / OneWater Marine Inc / ZoomInfo Technologies Inc / Azek Company Inc / nCino Inc / Hydrofarm Holdings Group Inc / Privia Health Group Inc / Aveanna Healthcare Holdings Inc / Holley Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAP / AR / AZO / BBY / BMY.N / BP.N / CHD / CL / CLR / CLX / CNX / COP / CPE / CVX / DVN / EL / EOG / EQT / FND / HD / HES / KMB / KO / LLY.N / LOW / MGY / MRK.N / MRO / MUR / OLN / OXY / PFE.N / PG / PXD / RH / RRC / SLB.N / SM / SPB / STZ / SWN / TAP.N / W / WLK / WLL / WSM / CNQ.TO / GILD.O / AMGN.O / HAL.N / EPC / MGM.N / SU.TO / BBBY.O / XOM / LBRT.N / PENN.O / LPI / REGN.O / VRTX.O / TSCO.O / COCO.O / SMG.N / WYNN.O / MNST.O / ORLY.O / WOOF.O / BIIB.O / NOV.N / RDSb / NOG.A / CZR.O / BKR.N / ESTE.K / MTDR.K / PDCE.O / AMBA.O / FANG.O / ABBV.N / GTLS.N / COTY.K / CIVI.K / TCON.O / CDEV.O / CVNA.K / IOVA.O / EYE.O / PEP.O / INSP.K / KDP.N / AVRO.O / BRY.O / NWL.O / FLTRF.L / OAS.O / OVV.N / DKNG.O / VRM.O / CTRA.K / GRWG.O / SFT.O / BALY.N / RSI.N / HYFM.O / CHK.O / JOAN.O / ZVIA.N / WEBR.N</td><td class="leftalignment">Advance Auto Parts Inc / Antero Resources Corp / Autozone Inc / Best Buy Co Inc / Bristol-Myers Squibb Co / BP PLC / Church & Dwight Co Inc / Colgate-Palmolive Co / Continental Resources Inc / Clorox Co / CNX Resources Corp / Conocophillips / Callon Petroleum Co / Chevron Corp / Devon Energy Corp / Estee Lauder Companies Inc / EOG Resources Inc / EQT Corp / Floor & Decor Holdings Inc / Home Depot Inc / Hess Corp / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lowe's Companies Inc / Magnolia Oil & Gas Corp / Merck & Co Inc / Marathon Oil Corp / Murphy Oil Corp / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Procter & Gamble Co / Pioneer Natural Resources Co / RH / Range Resources Corp / Schlumberger NV / SM Energy Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Southwestern Energy Co / Molson Coors Beverage Co / Wayfair Inc / Westlake Chemical Corp / Whiting Petroleum Corp / Williams-Sonoma Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Amgen Inc / Halliburton Co / Edgewell Personal Care Co / MGM Resorts International / Suncor Energy Inc / Bed Bath & Beyond Inc / Exxon Mobil Corp / Liberty Oilfield Services Inc / Penn National Gaming Inc / Laredo Petroleum Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Tractor Supply Co / Vita Coco Company Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / Monster Beverage Corp / O'Reilly Automotive Inc / Petco Health and Wellness Company Inc / Biogen Inc / Nov Inc / Royal Dutch Shell PLC / Northern Oil and Gas Inc / Caesars Entertainment Inc / Baker Hughes Co / Earthstone Energy Inc / Matador Resources Co / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / Abbvie Inc / Chart Industries Inc / Coty Inc / Civitas Resources Inc / TRACON Pharmaceuticals Inc / Centennial Resource Development Inc / Carvana Co / Iovance Biotherapeutics Inc / National Vision Holdings Inc / PepsiCo Inc / Inspire Medical Systems Inc / Keurig Dr Pepper Inc / AVROBIO Inc / Berry Corporation (Bry) / Newell Brands Inc / Flutter Entertainment PLC / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Vroom Inc / Coterra Energy Inc / GrowGeneration Corp / Shift Technologies Inc / Bally's Corp / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Joann Inc / Zevia PBC / Weber Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - Feedback from sell-side vaccines meeting</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">SASY.PA / PFE.N / AZN.L / GSK.L / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Sanofi SA / Pfizer Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/05/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Indonesia Market Strategy - CS Daily Insight - Inflationary pressure is building up; New Covid medicine</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ASII.JK / PFE.N</td><td class="leftalignment">Astra International Tbk PT / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Indonesia / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ungfru Hanel T. Topada / Mr. Robert Pranata / Mr. Timothy Handerson / Khun Steven Ho / Mr. Gregorius Gary</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Biopharma—Feedback From our Recent Launch; Slides attached–CC TMRW (1/5) 10:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Locked And Loaded. Ph3 THRIVE-AA1 and -AA2 On Track To Deliver Topline Data 2Q22 And 3Q22</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">CNCE=US / LLY=US / PFE=US / AXSM=US</td><td class="leftalignment">Concert Pharmaceuticals Inc / Eli Lilly and Co / Pfizer Inc / Axsome Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Additional price increases in 2022 for BMRN, LLY and PFE</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / BMRN.OQ / LLY.N / LLY=US / PFE=US / BMRN=US</td><td class="leftalignment">Pfizer Inc / Biomarin Pharmaceutical Inc / Eli Lilly and Co / Eli Lilly and Co / Pfizer Inc / Biomarin Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">January "Monthly Controversies" report & '22 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">163</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / BLD=US / CMA=US / MTN=US / LOW=US / PB=US / EWBC=US / SPOT=US / UMPQ=US / LEG=US / VMC=US / MLM=US / SWIM=US / BLL=US / CCK=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / PACW=US / WAL=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / CNM=US / SSB=US / RF=US / CATY=US / PNFP=US / OGN / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BECN=US / TXRH=US / BLDR=US / GMS=US / CMG=US / XPO=US / PGTI=US / AWI=US / OC=US / AMRX=US / CADE=US / PRPL=US / TREX=US / FBHS=US / TILE=US / NDLS=US / SHAK=US / WING=US / LOB=US / 82982L103 / JELD=US / MBIN=US / HWC=US / OZK=US / APLT=US / FERG=US / AZEK=US / VTRS=US / DASH=US / SNPO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / TopBuild Corp / Comerica Inc / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Spotify Technology SA / Umpqua Holdings Corp / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Ball Corp / Crown Holdings Inc / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Western Alliance Bancorp / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Core & Main Inc / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / Pinnacle Financial Partners Inc / Organon & Co / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / XPO Logistics Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Purple Innovation Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Applied Therapeutics Inc / Ferguson PLC / Azek Company Inc / Viatris Inc / DoorDash Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2206657 / 2270726 / 2684703 / 7103065 / B067BM3 / 2857817 / B02R1L6 / B7TL820 / B7254K9 / BHC8X90 / BD8DJ71 / BJ2Z0H2 / BDT5KT5 / BYSGPK2 / BYXR425 / BGDQ8B3 / BMYRFV6 / BPH0546 / BMHRMK1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Coca-Cola Co / Walt Disney Co / Pfizer Inc / Novartis AG / Molson Coors Beverage Co / Netflix Inc / ALLETE Inc / Meta Platforms Inc / AxoGen Inc / Novo Nordisk A/S / Snap Inc / Pinterest Inc / Inspire Medical Systems Inc / ViewRay Inc / RH / Axonics Inc / Procept Biorobotics Corp / Life Time Group Holdings Inc / Vita Coco Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Jan. 2022</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / BA.N / BAC.N / C.N / CCL.N / CF.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / JPM.N / LLY.N / LUV.N / MDT.N / PFE.N / RHI.N / T.N / TMO.N / WFC.N / DRE.N / SPG.N / PG.N / NUE.N / DIS.N / UNH.N / TFX.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / IT.N / GWW.N / VZ.N / V.N / ACN.N / PLD.N / TWTR.N / MAA.N / HPQ.N / COP.N / AOS.N / AAPL.OQ / AMAT.OQ / CERN.OQ / CSCO.OQ / FISV.OQ / ATVI.OQ / MSFT.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / COST.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / CTXS.OQ / NVDA.OQ / CHTR.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / BIIB.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / CZR.OQ / AMD.OQ / FANG.OQ / ABBV.N / LEGN.DE / NCLH.N / GOOGL.OQ / PAYC.N / ANET.N / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Abbott Laboratories / Boeing Co / Bank of America Corp / Citigroup Inc / Carnival Corp / CF Industries Holdings Inc / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / JPMorgan Chase & Co / Eli Lilly and Co / Southwest Airlines Co / Medtronic PLC / Pfizer Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Duke Realty Corp / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / Visa Inc / Accenture PLC / Prologis Inc / Twitter Inc / Mid-America Apartment Communities Inc / HP Inc / Conocophillips / A O Smith Corp / Apple Inc / Applied Materials Inc / Cerner Corp / Cisco Systems Inc / Fiserv Inc / Activision Blizzard Inc / Microsoft Corp / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Costco Wholesale Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Citrix Systems Inc / NVIDIA Corp / Charter Communications Inc / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Biogen Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Caesars Entertainment Inc / Advanced Micro Devices Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Paycom Software Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Germany / Ireland / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Multi Industry: Time to Revisit Secular Themes in 2022 as Supply Chain Easing Helps Laggards Catch Up</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">ALLE.N / ATKR.N / ASSAB.ST / CB.N / DD.N / ECL.N / EMN.N / FLS.N / GE.N / PFE.N / WAT.N / ROK.N / ETN.N / ITW.N / EMR.N / LII.N / JCI.N / HUBB.N / TT.N / AZPN.OQ / AYI.N / NVT.N / BMI.N / XYL.N / GTLS.N / AQUA.N / CARR.N / HON.OQ / BGRY.OQ</td><td class="leftalignment">Allegion PLC / Atkore Inc / Assa Abloy AB / Chubb Ltd / Dupont De Nemours Inc / Ecolab Inc / Eastman Chemical Co / Flowserve Corp / General Electric Co / Pfizer Inc / Waters Corp / Rockwell Automation Inc / Eaton Corporation PLC / Illinois Tool Works Inc / Emerson Electric Co / Lennox International Inc / Johnson Controls International PLC / Hubbell Inc / Trane Technologies PLC / Aspen Technology Inc / Acuity Brands Inc / nVent Electric PLC / Badger Meter Inc / Xylem Inc / Chart Industries Inc / Evoqua Water Technologies Corp / Carrier Global Corp / Honeywell International Inc / Berkshire Grey Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / Sweden / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. John F. Walsh, Jr / Tamjid Chowdhury / Jing Zhang / Victor Khong</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: 2022 Event Analysis (1): Readouts for major drug candidates; Shionogi has leftover results from 2021, focus on Daiichi Sankyo</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4507.T / 4568.T / 4502.T / 4503.T / 4519.T / 4523.T / PFE.N / 4506.T / 4151.T / AMGN.OQ / SGEN.OQ / 4578.T</td><td class="leftalignment">Shionogi & Co Ltd / Daiichi Sankyo Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Pfizer Inc / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Amgen Inc / Seagen Inc / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">01/04/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 2022イベントアナリシス①：主要な開発品のリードアウト一覧～2021年からの積み残しで塩野義、注目度で第一三共</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / PFE.N / 4506.T / 4151.T / AMGN.OQ / NVAX.OQ / SGEN.OQ / 4568.T / 4578.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Pfizer Inc / Sumitomo Dainippon Pharma Co Ltd / Kyowa Kirin Co Ltd / Amgen Inc / Novavax Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">01/04/2022</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1223</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">112</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">20 Events In 2022 That Could Change Practice, Alter Companies, Move Stocks</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US6402681083 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Nektar Therapeutics / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 4 2022</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">FR0000120271 / GB0007980591 / US00971T1016 / US0116591092 / US0463531089 / US0556221044 / US1101221083 / US30231G1022 / US37733W1053 / US4062161017 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US91913Y1001 / US92343V1044 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US80105N1054 / US20030N1019 / LU0156801721 / US6402681083 / US88031M1099 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / US2538681030 / US19239V3024 / RDSa.AS / US2090341072 / US00206R1023 / US1314761032 / PAP310761054 / US01748X1028 / US2473617023 / US53261M1045 / US25470M1099 / US00507V1098 / US58933Y1055 / US88160R1014 / US9100471096 / US0995021062 / US4361061082 / US56585A1025 / US03027X1000 / US7185461040 / US69318G1067 / US00287Y1091 / US98978V1035 / US81762P1021 / US8725901040 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / US69888T2078 / US0465131078 / CA0089118776 / US22822V1017 / US29444U7000 / US00653A1079 / US12685J1051 / US05464T1043 / US00773U1088 / US16119P1084 / US36165L1089 / GB00BDSFG982 / US78410G1040 / US91325V1089 / US05722G1004 / US24665A1034 / US02156K1034 / US87105L1044 / US5904791358 / US28414H1032 / US0197701065 / US0144421072 / US09203E1055 / CH0499880968 / US15872M1045 / KYG3902L1095 / US62955J1034 / US5502411037 / US25401T1088 / US20717M1036 / US35909D1090 / KYG4701H1092 / US10576N1028 / US4181001037</td><td class="leftalignment">TotalEnergies SE / BP PLC / Akamai Technologies Inc / Alaska Air Group Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Exxon Mobil Corp / GlaxoSmithKline PLC / Halliburton Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Valero Energy Corp / Verizon Communications Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Comcast Corp / Tenaris SA / Nektar Therapeutics / Tenaris SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Consolidated Communications Holdings Inc / AT&T Inc / Calumet Specialty Products Partners LP / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / DISH Network Corp / Activision Blizzard Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / HollyFrontier Corp / Marathon Petroleum Corp / American Tower Corp / Phillips 66 / PBF Energy Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / T-Mobile US Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Crown Castle International Corp / Equinix Inc / Adaptimmune Therapeutics PLC / Cable One Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / GDS Holdings Ltd / TechnipFMC PLC / SBA Communications Corp / Uniti Group Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Switch Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / ADC Therapeutics SA / ChampionX Corp / GDS Holdings Ltd / Nov Inc / Lumen Technologies Inc / DigitalBridge Group Inc / Confluent Inc / Frontier Communications Parent Inc / IHS Holding Ltd / Braze Inc / Hashicorp Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer Inc. in Global Virus-like Particles Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Jan 2022</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / AMGN.OQ / NVAX.OQ / 006280.KS / TEVA.N / MRNA.OQ / 068270.KS / 086900.KQ / 207940.KS / 091990.KQ / 302440.KS</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Amgen Inc / Novavax Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Moderna Inc / Celltrion Inc / Medy Tox Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">01/03/2022</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Indonesia Market Strategy: CS Monthly Insight: Virus mutation, higher rates, and economic recovery</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">7203.T / ASII.JK / CTRA.JK / JNJ.N / PFE.N / SMRA.JK / BMRI.JK / MRNA.OQ / TCSQ.L / ARTO.JK / BUKA.JK</td><td class="leftalignment">Toyota Motor Corp / Astra International Tbk PT / Ciputra Development Tbk PT / Johnson & Johnson / Pfizer Inc / Summarecon Agung Tbk PT / Bank Mandiri (Persero) Tbk PT / Moderna Inc / TCS Group Holding PLC / Bank Jago Tbk PT / Bukalapak.com Tbk PT</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cyprus / Indonesia / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">ECONOMIC REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ungfru Hanel T. Topada / Mr. Gregorius Gary</td></tr>
<tr class="even"><td class="leftalignment">01/01/2022</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Four-bagger Pfizer soars 67% in FY 2021</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer soars 39% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/31/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">Global Sector Strategy: 2021 U.S. Market Recap</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">TTEK=US / WMS=US / PFE=US / ABT=US / HD=US / SCI=US / GWW=US / LOW=US / UNP=US / TPH=US / FAST=US / DLTR=US / TOL=US / DHR=US / EIX=US / CSX=US / MLM=US / AAON=US / RSG=US / SWIM=US / AZO=US / DHI=US / LEN=US / MAS=US / MTH=US / NVR=US / ORLY=US / SSD=US / SKY=US / WSO=US / AAP=US / AOS=US / JHX=US / CCS=US / WCN=US / CVCO=US / BXC=US / BLDR=US / GMS=US / ZTS=US / TREX=US / NEE=US / GCP=US / TMHC=US / TGLS=US / SUM=US / ATKR=US / FERG=US / CARR=US</td><td class="leftalignment">Tetra Tech Inc / Advanced Drainage Systems Inc / Pfizer Inc / Abbott Laboratories / Home Depot Inc / Service Corporation International / W W Grainger Inc / Lowe's Companies Inc / Union Pacific Corp / Tri Pointe Homes Inc (Delaware) / Fastenal Co / Dollar Tree Inc / Toll Brothers Inc / Danaher Corp / Edison International / CSX Corp / Martin Marietta Materials Inc / Aaon Inc / Republic Services Inc / Latham Group Inc / Autozone Inc / D R Horton Inc / Lennar Corp / Masco Corp / Meritage Homes Corp / NVR Inc / O'Reilly Automotive Inc / Simpson Manufacturing Co Inc / Skyline Champion Corp / Watsco Inc / Advance Auto Parts Inc / A O Smith Corp / James Hardie Industries PLC / Century Communities Inc / Waste Connections Inc / Cavco Industries Inc / Bluelinx Holdings Inc / Builders FirstSource Inc / GMS Inc / Zoetis Inc / Trex Company Inc / Nextera Energy Inc / GCP Applied Technologies Inc / Taylor Morrison Home Corp / Tecnoglass Inc / Summit Materials Inc / Atkore Inc / Ferguson PLC / Carrier Global Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Kenley Scott</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / RHHBY.PK / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Quick Thoughts, Who's Gonna Get The Love And Who Could Feel The Pain in 2022</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / US02043Q1076 / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alnylam Pharmaceuticals Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Pfizer Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report</td><td class="leftalignment">English</td><td class="rightalignment">667</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="even"><td class="leftalignment">12/30/2021</td><td class="leftalignment">MarketLine</td><td class="leftalignment">Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">243</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / TUESDAY / STRATEGIC ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">MarketLine Independent Re</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended October 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer top gainer in Sanders Capital [ranked 1 out of 30], soars 36.1%</td><td class="leftalignment">English</td><td class="rightalignment">85</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2002305 / 2973821 / 2542049 / 2689560 / 2684703 / 7103065 / B125XQ6 / B1XGNW4 / B0796X4 / BTN1Y11 / BFNR303 / BF3W461</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Abbott Laboratories / Alliant Energy Corp / Dominion Energy Inc / PG&E Corp / Pfizer Inc / Novartis AG / Portland General Electric Co / Insulet Corp / Dexcom Inc / Medtronic PLC / Northwest Natural Holding Co / Tandem Diabetes Care Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Read through of Kintor's Ph3 COVID drug failure to China biotech</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N / BGNE.OQ / IMAB.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Beigene Ltd / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/27/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT / AM / AMAT.O / APO / ATR / BDX / BX / DCP / DFS / DHI / DOV / H / HE / INTC.O / KBH / KLAC.O / KNX / LEN / LRCX.O / MAS / MCHP.O / MDT / MHK / MSM / OC / PFE.N / PK / QCOM.O / R / RKT / RMBS.O / SRE / HT / GILD.O / ASML.O / ET / JBHT.O / NVDA.O / MGM.N / PEB.N / HUBG.O / PAA.N / AMD.O / ADI.O / CHH.N / SMTC.O / SLAB.O / SNPS.O / BYD.N / PENN.O / CHDN.O / MU.O / MRVL.O / WYNN.O / DIOD.O / EXAS.O / SWKS.O / SHO.N / BECN.O / LVS.N / DXCM.O / CDNS.O / HST.N / XPO / SAIA.O / CQP.A / PODD.O / NXPI.O / CZR.O / SLM.O / RHP.N / AMBA.O / PFSI.K / PAGP.N / CEQP.K / ENLC.K / CAPL.K / QRVO.O / XHR.N / ON.O / APLE.N / OMF / RRR.O / JELD.K / GH.O / AXNX.O / FLTRF.L / FTCH.K / DKNG.O / BALY.N / ALGM.O / RSI.N / HMPT.O / GXO.N / WOLF.N / ARBE.O / ARIS.K / MXL.O</td><td class="leftalignment">Abbott Laboratories / Antero Midstream Corp / Applied Materials Inc / Apollo Global Management Inc / Aptargroup Inc / Becton Dickinson and Co / Blackstone Inc / DCP Midstream LP / Discover Financial Services / D R Horton Inc / Dover Corp / Hyatt Hotels Corp / Hawaiian Electric Industries Inc / Intel Corp / KB Home / KLA Corp / Knight-Swift Transportation Holdings Inc / Lennar Corp / Lam Research Corp / Masco Corp / Microchip Technology Inc / Medtronic PLC / Mohawk Industries Inc / MSC Industrial Direct Co Inc / Owens Corning / Pfizer Inc / Park Hotels & Resorts Inc / Qualcomm Inc / Ryder System Inc / Rocket Companies Inc / Rambus Inc / Sempra Energy / Hersha Hospitality Trust / Gilead Sciences Inc / ASML Holding NV / Energy Transfer LP / J B Hunt Transport Services Inc / NVIDIA Corp / MGM Resorts International / Pebblebrook Hotel Trust / Hub Group Inc / Plains All American Pipeline LP / Advanced Micro Devices Inc / Analog Devices Inc / Choice Hotels International Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Boyd Gaming Corp / Penn National Gaming Inc / Churchill Downs Inc / Micron Technology Inc / Marvell Technology Inc / Wynn Resorts Ltd / Diodes Inc / Exact Sciences Corp / Skyworks Solutions Inc / Sunstone Hotel Investors Inc / Beacon Roofing Supply Inc / Las Vegas Sands Corp / Dexcom Inc / Cadence Design Systems Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Saia Inc / Cheniere Energy Partners LP / Insulet Corp / NXP Semiconductors NV / Caesars Entertainment Inc / SLM Corp / Ryman Hospitality Properties Inc / Ambarella Inc / PennyMac Financial Services Inc / Plains GP Holdings LP / Crestwood Equity Partners LP / EnLink Midstream LLC / Crossamerica Partners LP / Qorvo Inc / Xenia Hotels & Resorts Inc / ON Semiconductor Corp / Apple Hospitality REIT Inc / OneMain Holdings Inc / Red Rock Resorts Inc / JELD-WEN Holding Inc / Guardant Health Inc / Axonics Inc / Flutter Entertainment PLC / Farfetch Ltd / DraftKings Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Home Point Capital Inc / GXO Logistics Inc / Wolfspeed Inc / Arbe Robotics Ltd / Aris Water Solutions Inc / Maxlinear Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Race to the Bottom? Which Biopharma Has Most LOE Risk in 2025-30 Period?</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">12/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 17 to 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US02553E1064 / US0311621009 / US0530151036 / US0584981064 / US0936711052 / US1101221083 / US2017231034 / US2371941053 / US3647601083 / US3703341046 / US3755581036 / US45337C1027 / US5324571083 / US5951121038 / US64125C1099 / US6541061031 / US6556641008 / US6703461052 / US7043261079 / US7170811035 / US75886F1075 / US7782961038 / US8000131040 / US8168511090 / US8270481091 / US8354951027 / US8581191009 / US8589121081 / US8725401090 / US9170471026 / US9182041080 / US92276F1003 / US92532F1003 / US9746371007 / CA1249003098 / CA8029121057 / CA30150P1099 / CA1469001053 / CA9528451052 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / US2283681060 / US2274831047 / US09062X1037 / US0534841012 / US29476L1070 / US2971781057 / CA8911605092 / CA1360691010 / US74144T1088 / US1011211018 / US2644115055 / US9290421091 / CA6445351068 / US9043111072 / US7376301039 / CA1375761048 / US9026531049 / US25960P1093 / US49427F1084 / CA3499151080 / US5500211090 / US02913V1035 / US90384S3031 / US3886891015 / US58933Y1055 / US18538R1032 / US74340W1036 / US6936561009 / US7512121010 / CA07380N1042 / CA96145A2002 / US4440971095 / US78573L1061 / GB00B11DNM70 / US60468T1051 / US1220171060 / US2921041065 / US1785871013 / CA45868C1095 / US14174T1079 / US96145D1054 / US72703H1014 / US95040Q1040 / CA26829L1076 / US7495271071 / CA9628791027 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / US03843E1047 / KYG370921069 / VGG1890L1076 / US73757R1023 / US76156B1070 / US88339P1012 / CA29446Y5020 / US70614W1009 / CA04302L1004 / US82575P1075 / US26484T1060 / US15202L1070 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027 / US1374041093</td><td class="leftalignment">American Eagle Outfitters Inc / Amgen Inc / Automatic Data Processing Inc / Ball Corp / H & R Block Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darden Restaurants Inc / Gap Inc / General Mills Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Micron Technology Inc / Neurocrine Biosciences Inc / Nike Inc / Nordstrom Inc / Nucor Corp / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Sanderson Farms Inc / Sempra Energy / Silgan Holdings Inc / Sonoco Products Co / Steel Dynamics Inc / Stericycle Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Ventas Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / CCL Industries Inc / Saputo Inc / Exco Technologies Ltd / Cascades Inc / West Fraser Timber Co Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Crown Holdings Inc / Cross Country Healthcare Inc / Biogen Inc / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / T Rowe Price Group Inc / Boston Properties Inc / Duke Realty Corp / Vornado Realty Trust / New Gold Inc / Under Armour Inc / Potlatchdeltic Corp / Canfor Corp / UDR Inc / Douglas Emmett Inc / Kilroy Realty Corp / Fortuna Silver Mines Inc / Lululemon Athletica Inc / American Public Education Inc / Ulta Beauty Inc / Graphic Packaging Holding Co / Merck & Co Inc / Clearwater Paper Corp / Prologis Inc / PVH Corp / Ralph Lauren Corp / Bear Creek Mining Corp / Westshore Terminals Investment Corp / Hudson Pacific Properties Inc / Sabra Health Care REIT Inc / Horizonte Minerals PLC / Mirati Therapeutics Inc / Burlington Stores Inc / Empire State Realty Trust Inc / City Office REIT Inc / Interfor Corp / CareTrust REIT Inc / Westrock Co / Planet Fitness Inc / Welltower Inc / ECN Capital Corp / REV Group Inc / Wheaton Precious Metals Corp / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Aquestive Therapeutics Inc / Galaxy Digital Holdings Ltd / Capri Holdings Ltd / Postal Realty Trust Inc / Revolve Group Inc / RealReal Inc / Equinox Gold Corp / Peloton Interactive Inc / Artemis Gold Inc / Sibanye Stillwater Ltd / Dun & Bradstreet Holdings Inc / Centerspace / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/24/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Pfizer Inc. (PFE) - Reaching high with vaccine success</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Pfizer Inc. to Acquire Arena Pharmaceuticals, Inc - “Creates best-in-class innovative potential therapies for the treatment of immuno-inflammatory diseases”</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">PFE.N / ARNA.OQ</td><td class="leftalignment">Pfizer Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">There’s No Biopharma Without M&A; Dip in Deals in 2021 Does Not Make a Trend</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">71708110 / 92532F10 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Australia / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">BB Banco de Investimento S.A.</td><td class="leftalignment">Monitor Diário BDRX-12/23/2021</td><td class="leftalignment">Portuguese</td><td class="rightalignment">9</td><td class="leftalignment">MELI34 / BABA34 / TSLA34 / FBOK34 / GOGL34 / M1RN34 / MSFT34 / AAPL34 / NVDC34 / PFIZ34</td><td class="leftalignment">Mercadolibre Inc / Alibaba Group Holding Ltd / Tesla Inc / Meta Platforms Inc / Alphabet Inc / Moderna Inc / Microsoft Corp / Apple Inc / NVIDIA Corp / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MARKET / COUNTRY-SPECIFIC / EQUITY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Renato Od / Jose Roberto dos Anjos</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MOLN.S: Molecular Partners - Model update post CMD. Major catalyst of COVID data due early 22. CSe 60% POS $1b , NPV SFr 6.5/shr</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MOLN.S / JNJ.N / LLY.N / PFE.N / AZN.L / ROG.S / NOVN.S / GSK.L / AMGN.OQ / REGN.OQ / ABBV.N / ARGX.OQ</td><td class="leftalignment">Molecular Partners AG / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / argenx SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/23/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Pfizer Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Broad EUA, Clean Label and More Supply Spells Dominant Market Position in 2022</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer top gainer in Sanders Capital [ranked 1 out of 28], soars 39.7%</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / AMAT.O / BDX / DFS / KLAC.O / LRCX.O / PFE.N / RKT / RMBS.O / SRE / ASML.O / SNPS.O / CDNS.O / SLM.O / PFSI.K / OMF / HMPT.O</td><td class="leftalignment">Abbott Laboratories / Applied Materials Inc / Becton Dickinson and Co / Discover Financial Services / KLA Corp / Lam Research Corp / Pfizer Inc / Rocket Companies Inc / Rambus Inc / Sempra Energy / ASML Holding NV / Synopsys Inc / Cadence Design Systems Inc / SLM Corp / PennyMac Financial Services Inc / OneMain Holdings Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral Chapter 6, Making It To The Finish Line With Approval Of Its Oral Antiviral Before Year-End</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/22/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Tidbits Beyond Paxlovid Approval; New Capacity and Sensitivities</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BSX=US / NKE=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / MDT=US / BLD=US / PEB=US / H=US / CRM=US / MTN=US / LOW=US / IART=US / MAR=US / LEG=US / TNL=US / VMC=US / HLT=US / MANH=US / MLM=US / PATH=US / SWIM=US / CBRL=US / CCL=US / KIDS=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / VRTX=US / PYPL=US / CNM=US / APPN=US / DIN=US / BDSI=US / DKS=US / OGN / BIIB=US / TPX=US / EXP=US / NUVA=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / HST=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / WH=US / JACK=US / TREX=US / OLO=US / HGV=US / RLJ=US / VAC=US / FBHS=US / GMED=US / RHP=US / TILE=US / NDLS=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / ZBH=US / WING=US / SPNE=US / PEN=US / 82982L103 / EVBG=US / IRTC=US / CRSP=US / PK=US / JELD=US / PLYA=US / SMAR=US / AXNX=US / LYFT=US / UBER=US / FERG=US / AZEK=US / AZYO=US / VTRS=US / DASH=US / DNUT=US / SNPO=US / ROIV=US</td><td class="leftalignment">Boston Scientific Corp / Nike Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / UiPath Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Carnival Corp / OrthoPediatrics Corp / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Vertex Pharmaceuticals Inc / PayPal Holdings Inc / Core & Main Inc / Appian Corp / Dine Brands Global Inc / BioDelivery Sciences International Inc / DICK'S Sporting Goods Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / NuVasive Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Olo Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Zimmer Biomet Holdings Inc / Wingstop Inc / SeaSpine Holdings Corp / Penumbra Inc / SiteOne Landscape Supply Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / Smartsheet Inc / Axonics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Azek Company Inc / Aziyo Biologics Inc / Viatris Inc / DoorDash Inc / Krispy Kreme Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Ireland / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2640147 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2455965 / 2689560 / 2684703 / 7103065 / 2713317 / 2857817 / B125XQ6 / BHC8X90 / BJJMGL2 / BKTNTR9 / BJXBP30 / BYYWPW6 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Biogen Inc / PG&E Corp / Pfizer Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Novo Nordisk A/S / Fox Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Beigene Ltd / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SKAN.S: SKAN - Global market leader for high-end aseptic process solutions</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">SKAN.S / 4502.T / BAX.N / EKTAB.ST / PFE.N / PHG.AS / AZN.L / SASY.PA / ROG.S / DHR.N / GEBN.S / NOVN.S / LONN.S / SATG.DE / PKI.N / BANB.S / GSK.L / 6869.T / HOLX.OQ / GILD.OQ / NVAX.OQ / TECN.S / LOGN.S / BEAN.S / IFCN.S / STMN.S / LEHN.S / SCHP.S / BCHN.S / SIKA.S / SOON.S / DIAS.MI / MRNA.OQ / BRG.AX / ABBV.N / CLLS.OQ / EDIT.OQ / VACN.S / CRSP.OQ / COTNE.S / SENSI.S / SIGNC.S / AVTR.N</td><td class="leftalignment">SKAN Group AG / Takeda Pharmaceutical Co Ltd / Baxter International Inc / Elekta AB (publ) / Pfizer Inc / Koninklijke Philips NV / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Geberit AG / Novartis AG / Lonza Group AG / Sartorius AG / PerkinElmer Inc / Bachem Holding AG / GlaxoSmithKline PLC / Sysmex Corp / Hologic Inc / Gilead Sciences Inc / Novavax Inc / Tecan Group AG / Logitech International SA / Belimo Holding AG / Inficon Holding AG / Straumann Holding AG / Lem Holding SA / Schindler Holding AG / Burckhardt Compression Holding AG / Sika AG / Sonova Holding AG / DiaSorin SpA / Moderna Inc / Breville Group Ltd / Abbvie Inc / Cellectis SA / Editas Medicine Inc / VAT Group AG / CRISPR Therapeutics AG / Comet Holding AG / Sensirion Holding AG / SIG Combibloc Group AG / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / United Kingdom / Italy / Japan / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Herr Patrick Laager / Herr. Christoph Gretler</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AGR / BAC / BEP / C / CP / DG / DOV / GS / JPM / MS / NSC / PEG / PFE.N / PNC / WMT / WRK / GPK / DLTR.O / NEE / BLUE.O / AQN / FIVE.O / ENLC.K / EXC.O / BEPC.K</td><td class="leftalignment">Avangrid Inc / Bank of America Corp / Brookfield Renewable Partners LP / Citigroup Inc / Canadian Pacific Railway Ltd / Dollar General Corp / Dover Corp / Goldman Sachs Group Inc / JPMorgan Chase & Co / Morgan Stanley / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / PNC Financial Services Group Inc / Walmart Inc / Westrock Co / Graphic Packaging Holding Co / Dollar Tree Inc / Nextera Energy Inc / bluebird bio Inc / Algonquin Power & Utilities Corp / Five Below Inc / EnLink Midstream LLC / Exelon Corp / Brookfield Renewable Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: EU Contract Upside — Potential for a Vaccine Subscription Model</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">COVID Vaccine + Paxlovid Could Add $50B In 2022 Sales; Model Updated, PT Raised</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US2371941053 / US5951121038 / US7170811035 / US9746371007 / CA51925D1069 / CA13677F1018 / CA0636711016 / CA0641491075 / CA6330671034 / CA7800871021 / CA8911605092 / CA1360691010 / CA80013R2063 / KYG370921069 / US1255231003</td><td class="leftalignment">Darden Restaurants Inc / Micron Technology Inc / Pfizer Inc / Winnebago Industries Inc / Laurentian Bank of Canada / Canadian Western Bank / Bank of Montreal / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Sandstorm Gold Ltd / Galaxy Digital Holdings Ltd / Cigna Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/20/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1357</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">12/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Equity Strategy: Technology vs. Nasdaq 100</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ASML.AS / BAC.N / CRM.N / IBM.N / JNJ.N / JPM.N / PFE.N / TMO.N / PG.N / DIS.N / UNH.N / HD.N / ORCL.N / V.N / ACN.N / INTC.OQ / ADBE.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / MSFT.OQ / QCOM.OQ / INTU.OQ / COST.OQ / AMZN.OQ / NVDA.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / MA.N / AVGO.OQ / TSLA.OQ / AMD.OQ / NOW.N / GOOGL.OQ / PYPL.OQ / PEP.OQ / FB.PS</td><td class="leftalignment">ASML Holding NV / Bank of America Corp / Salesforce.Com Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Pfizer Inc / Thermo Fisher Scientific Inc / Procter & Gamble Co / Walt Disney Co / UnitedHealth Group Inc / Home Depot Inc / Oracle Corp / Visa Inc / Accenture PLC / Intel Corp / Adobe Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Microsoft Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Amazon.com Inc / NVIDIA Corp / Netflix Inc / Texas Instruments Inc / Comcast Corp / Mastercard Inc / Broadcom Inc / Tesla Inc / Advanced Micro Devices Inc / ServiceNow Inc / Alphabet Inc / PayPal Holdings Inc / PepsiCo Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">12/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.8% Above Pre-Pandemic Base- Week 89</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">Global Sector Strategy: U.S. Defense, EU Quality, and APAC Turning</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">TTEK=US / WMS=US / PFE=US / ABT=US / HD=US / SCI=US / GWW=US / LOW=US / UNP=US / TPH=US / FAST=US / DLTR=US / TOL=US / DHR=US / EIX=US / CSX=US / MLM=US / AAON=US / RSG=US / SWIM=US / AZO=US / DHI=US / LEN=US / MAS=US / MTH=US / NVR=US / ORLY=US / SSD=US / SKY=US / WSO=US / AAP=US / AOS=US / JHX=US / CCS=US / WCN=US / CVCO=US / BXC=US / BLDR=US / GMS=US / ZTS=US / TREX=US / NEE=US / GCP=US / TMHC=US / TGLS=US / GRBK=US / SUM=US / ATKR=US / FERG=US / CARR=US</td><td class="leftalignment">Tetra Tech Inc / Advanced Drainage Systems Inc / Pfizer Inc / Abbott Laboratories / Home Depot Inc / Service Corporation International / W W Grainger Inc / Lowe's Companies Inc / Union Pacific Corp / Tri Pointe Homes Inc (Delaware) / Fastenal Co / Dollar Tree Inc / Toll Brothers Inc / Danaher Corp / Edison International / CSX Corp / Martin Marietta Materials Inc / Aaon Inc / Republic Services Inc / Latham Group Inc / Autozone Inc / D R Horton Inc / Lennar Corp / Masco Corp / Meritage Homes Corp / NVR Inc / O'Reilly Automotive Inc / Simpson Manufacturing Co Inc / Skyline Champion Corp / Watsco Inc / Advance Auto Parts Inc / A O Smith Corp / James Hardie Industries PLC / Century Communities Inc / Waste Connections Inc / Cavco Industries Inc / Bluelinx Holdings Inc / Builders FirstSource Inc / GMS Inc / Zoetis Inc / Trex Company Inc / Nextera Energy Inc / GCP Applied Technologies Inc / Taylor Morrison Home Corp / Tecnoglass Inc / Green Brick Partners Inc / Summit Materials Inc / Atkore Inc / Ferguson PLC / Carrier Global Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Kenley Scott</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ABT / AJG / ALC / AMAT.O / APO / AR / ARW / AVB / AZO / BAX / BDX / BIO / BSX / BX / CLR / CNX / COO / CPE / CPT / CUZ / DGX / DHR / DIS / DLR / DOV / DRE / DVN / EOG / EPD / EQT / F.N / FDX / GM.N / H / HD / HEP / HIW / HPP / INTC.O / IR / JCI / JNJ / KIM / KKR / KLAC.O / KRG / LEN / LH / LOW / LRCX.O / MCHP.O / MDT / MGY / MMP / MRO / NKE / OI / OKE / PEN / PFE.N / PGR / PH / PKI / PLD / PNM / PXD / QCOM.O / RH / RMBS.O / ROK / RRC / SM / SUN / SWK / SWN / SYK / TFX / TMO / TT / UDR / WES / WLL / WMB / XLNX.O / AMZN.O / HT / ASML.O / EW / AAPL.O / CSCO.O / BSM / JBHT.O / BWA.N / LEA.N / KMI / NVDA.O / ADBE.O / PEB.N / MGA.N / SBAC.O / MXL / IART.O / AMD.O / ADI.O / DEI / NTAP.O / ARNA.O / SMTC.O / SLAB.O / SNPS.O / ISRG.O / LPI / AYI / MU.O / MRVL.O / HPQ / HPE / AVGO.O / HOLX.O / NDSN.O / DIOD.O / MMSI.O / ORLY.O / MKSI.O / EQIX.O / WOOF.O / NFLX.O / SWKS.O / VIAC.O / DRH.N / DXCM.O / DISCA.O / CDNS.O / STX.O / XPO / CVLT.O / PODD.O / TNDM.OQ / NOG.A / JNPR.K / NXPI.O / LUNG.O / CZR.O / KEY.TO / LNG.N / STAG.K / ESTE.K / MTDR.K / WDC.O / TRGP.K / PDCE.O / RHP.N / AMBA.O / FANG.O / MPLX.K / ABBV.N / MAR.O / ARES.K / ALLE.K / ANET.K / NVRO.K / QRVO.O / CIVI.K / REXR.K / XHR.N / ON.O / GKOS.K / ZBH / PSTG.K / NVCR.O / NTNX.O / UAA / HLNE.O / CDEV.O / CVNA.K / SWCH.K / EYE.O / QGEN.K / AVT.O / INSP.K / BRY.O / SITC.K / REG.O / AXNX.O / DELL.K / SWAV.O / FLTRF.L / FTCH.K / CHWY.K / ETRN.K / CRNC.O / OAS.O / OVV.N / DKNG.O / NARI.O / CTRA.K / NWE.O / EAR.O / OTIS.K / ALGM.O / CHK.O / NPCE.O / DBRG.N / BRDG.N / GXO.N / PECO.O / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Arthur J Gallagher & Co / Alcon AG / Applied Materials Inc / Apollo Global Management Inc / Antero Resources Corp / Arrow Electronics Inc / Avalonbay Communities Inc / Autozone Inc / Baxter International Inc / Becton Dickinson and Co / Bio Rad Laboratories Inc / Boston Scientific Corp / Blackstone Inc / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Camden Property Trust / Cousins Properties Inc / Quest Diagnostics Inc / Danaher Corp / Walt Disney Co / Digital Realty Trust Inc / Dover Corp / Duke Realty Corp / Devon Energy Corp / EOG Resources Inc / Enterprise Products Partners LP / EQT Corp / Ford Motor Co / FedEx Corp / General Motors Co / Hyatt Hotels Corp / Home Depot Inc / Holly Energy Partners LP / Highwoods Properties Inc / Hudson Pacific Properties Inc / Intel Corp / Ingersoll Rand Inc / Johnson Controls International PLC / Johnson & Johnson / Kimco Realty Corp / KKR & Co Inc / KLA Corp / Kite Realty Group Trust / Lennar Corp / Laboratory Corporation of America Holdings / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Marathon Oil Corp / Nike Inc / O-I Glass Inc / ONEOK Inc / Penumbra Inc / Pfizer Inc / Progressive Corp / Parker-Hannifin Corp / PerkinElmer Inc / Prologis Inc / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / RH / Rambus Inc / Rockwell Automation Inc / Range Resources Corp / SM Energy Co / Sunoco LP / Stanley Black & Decker Inc / Southwestern Energy Co / Stryker Corp / Teleflex Inc / Thermo Fisher Scientific Inc / Trane Technologies PLC / UDR Inc / Western Midstream Partners LP / Whiting Petroleum Corp / Williams Companies Inc / Xilinx Inc / Amazon.com Inc / Hersha Hospitality Trust / ASML Holding NV / Edwards Lifesciences Corp / Apple Inc / Cisco Systems Inc / Black Stone Minerals LP / J B Hunt Transport Services Inc / Borgwarner Inc / Lear Corp / Kinder Morgan Inc / NVIDIA Corp / Adobe Inc / Pebblebrook Hotel Trust / Magna International Inc / SBA Communications Corp / Maxlinear Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Douglas Emmett Inc / NetApp Inc / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Acuity Brands Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Hologic Inc / Nordson Corp / Diodes Inc / Merit Medical Systems Inc / O'Reilly Automotive Inc / MKS Instruments Inc / Equinix Inc / Petco Health and Wellness Company Inc / Netflix Inc / Skyworks Solutions Inc / ViacomCBS Inc / Diamondrock Hospitality Co / Dexcom Inc / Discovery Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / XPO Logistics Inc / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / Northern Oil and Gas Inc / Juniper Networks Inc / NXP Semiconductors NV / Pulmonx Corp / Caesars Entertainment Inc / Keyera Corp / Cheniere Energy Inc / STAG Industrial Inc / Earthstone Energy Inc / Matador Resources Co / Western Digital Corp / Targa Resources Corp / PDC Energy Inc / Ryman Hospitality Properties Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Marriott International Inc / Ares Management Corp / Allegion PLC / Arista Networks Inc / Nevro Corp / Qorvo Inc / Civitas Resources Inc / Rexford Industrial Realty Inc / Xenia Hotels & Resorts Inc / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Pure Storage Inc / Novocure Ltd / Nutanix Inc / Under Armour Inc / Hamilton Lane Inc / Centennial Resource Development Inc / Carvana Co / Switch Inc / National Vision Holdings Inc / Qiagen NV / Avnet Inc / Inspire Medical Systems Inc / Berry Corporation (Bry) / Site Centers Corp / Regency Centers Corp / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Flutter Entertainment PLC / Farfetch Ltd / Chewy Inc / Equitrans Midstream Corp / Cerence Inc / Oasis Petroleum Inc / Ovintiv Inc / DraftKings Inc / Inari Medical Inc / Coterra Energy Inc / NorthWestern Corp / Eargo Inc / Otis Worldwide Corp / Allegro Microsystems Inc / Chesapeake Energy Corp / Neuropace Inc / DigitalBridge Group Inc / Bridge Investment Group Holdings Inc / GXO Logistics Inc / Phillips Edison & Co Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Key Questions and Responses from PFE COVID-19 Conference</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Johnson & Johnson Stock Is Likely To See Higher Levels In The Near Term</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Pfizer Stock See Higher Levels After A Large 18% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Pfizer Call Reinforces Market-Leading Position in COVID-19 Treatment Landscape</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video - ASH & 2022 Outlook Edition</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 10 to 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / GB0000456144 / US00724F1012 / US0236081024 / US0311621009 / US0351282068 / US0383361039 / US0394831020 / US0536111091 / US0584981064 / US1101221083 / US1264081035 / US1564311082 / US2017231034 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4227041062 / US5324571083 / US5463471053 / US6516391066 / US65473P1057 / US6703461052 / US7170811035 / US7445731067 / US7802871084 / US8581191009 / US92276F1003 / US9746371007 / US98389B1008 / CA13321L1085 / CA6979001089 / CA8787422044 / CA2918434077 / CA0679011084 / US9129091081 / CA51925D1069 / CA13677F1018 / CA1349211054 / CA0636711016 / CA0641491075 / CA8765111064 / CA3359341052 / US20825C1045 / US35671D8570 / AU000000FMG4 / US09062X1037 / CA98462Y1007 / US02043Q1076 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / CA39138C1068 / CA4436281022 / CA1360691010 / US3546131018 / US74144T1088 / US09247X1019 / US44107P1049 / CA95083R1001 / US40637H1095 / CA1375761048 / US74460D1090 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / US30225T1025 / CA0966311064 / CA29258Y1034 / CA1999101001 / CA2271071094 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA46071W2058 / BMG491BT1088 / CA3518581051 / GB00B2QPKJ12 / GB0004300496 / US26884L1098 / US91912E1055 / US1921085049 / IE00B4BNMY34 / CA69946Q1046 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US2296631094 / CA54928Q1081 / AU000000EVN4 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09739D1000 / JE00B5TT1872 / US09609G1004 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA1348082035 / CA3874371147 / CA3807381049 / CA87505Y4094 / CA0805581091 / CA9323971023 / CA0158571053 / CA0213611001 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA8661201167 / CA38045Y1025 / US16208T1025 / CA5054401073 / US45845P1084 / CA0266951064 / CA33812R1091 / CA17039A1066 / CA46579R1047 / US45378A1060 / CA65340P1062 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / CA45868C1095 / CA26153P1045 / CA1264621006 / CA7397211086 / US14174T1079 / CA68827L1013 / US78667J1088 / CA30606C1086 / IE00BQPVQZ61 / CA5503711080 / US30040W1080 / CA74273V1067 / US6378701063 / AU000000S320 / US4278255009 / CA0115321089 / CA05329M1041 / US95040Q1040 / CA8283631015 / CY0106002112 / AU000000NST8 / CA4991131083 / CA6882811046 / CA8910546032 / US53223X1072 / CA31730E1016 / CA89621C1059 / US0138721065 / CA68634K1066 / US43300A2033 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US23355L1061 / US93627C1018 / US7045511000 / CA9628791027 / CY0103562118 / CA7847301032 / LU1701428291 / US03753U1060 / CA2960061091 / CA7766521099 / CA8585221051 / US92645B1035 / US3843135084 / US03168L1052 / US2997341035 / CA05585D1033 / US03836N1037 / CA0717341071 / US03843E1047 / CA4039254079 / US04335A1051 / CA38119T8077 / CA13000C2058 / US03990B1017 / CA72765Q8829 / US1255231003 / CA2849025093 / CA45075E1043 / US63253R2013 / AU0000018236 / CA7426943006 / CA57776F4050 / US09260D1072 / CA5625684025 / CA48086P1009 / US30205M1018 / CA29446Y5020 / US03768E1055 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / CA31890B1031 / US14316J1088 / US82575P1075 / CA36352H1001 / US03940R1077 / CA70137W1086 / US44862P1093 / CA83419D2014 / CA67079A1021 / US12529R1077 / US3773201062 / CA9004352071 / US3680361090 / CA64782A1075 / CA00288U1066 / CA36261G1028 / US15202L1070 / US24343R1068 / CA65401N1078 / US90364P1057 / AU0000143729 / CA65532M6062 / GB00BL6K5J42 / CA50202P1053 / CA65343M2094 / US1374041093 / CA0156581070 / CA24477T1003 / CA22289D1078 / CA89531J7868</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Antofagasta PLC / Adobe Inc / Ameren Corp / Amgen Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Ball Corp / Bristol-Myers Squibb Co / CSX Corp / Century Aluminum Co / Commercial Metals Co / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hecla Mining Co / Eli Lilly and Co / Louisiana-Pacific Corp / Newmont Corporation / NiSource Inc / Nucor Corp / Pfizer Inc / Public Service Enterprise Group Inc / Royal Gold Inc / Steel Dynamics Inc / Ventas Inc / Winnebago Industries Inc / Xcel Energy Inc / Cameco Corp / Pan American Silver Corp / Teck Resources Ltd / Empire Company Ltd / Barrick Gold Corp / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Canadian Apartment Properties Real Estate Investment Trust / Bank of Montreal / Bank of Nova Scotia / Taseko Mines Ltd / First Quantum Minerals Ltd / Conocophillips / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Great-West Lifeco Inc / Hudbay Minerals Inc / Canadian Imperial Bank of Commerce / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Host Hotels & Resorts Inc / Wesdome Gold Mines Ltd / Halozyme Therapeutics Inc / Canfor Corp / Public Storage / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Extra Space Storage Inc / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Cominar Real Estate Investment Trust / Crombie Real Estate Investment Trust / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / InterRent Real Estate Investment Trust / Invesco Ltd / Franco-Nevada Corp / Fresnillo PLC / Pan African Resources PLC / EQT Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Parex Resources Inc / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / CubeSmart / Lucara Diamond Corp / Evolution Mining Ltd / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / Boise Cascade Co / Centamin PLC / bluebird bio Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Canacol Energy Ltd / Granite Real Estate Investment Trust / Gold Standard Ventures Corp / Tamarack Valley Energy Ltd / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Algonquin Power & Utilities Corp / AltaGas Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / Summit Industrial Income REIT / GoGold Resources Inc / Chatham Lodging Trust / Labrador Iron Ore Royalty Corp / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Fission Uranium Corp / Choice Properties Real Estate Investment Trust / Ivanhoe Mines Ltd / Independence Realty Trust Inc / Nexgen Energy Ltd / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / Interfor Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / Prairiesky Royalty Ltd / CareTrust REIT Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Falco Resources Ltd / Horizon Therapeutics PLC / Lundin Gold Inc / Eversource Energy / Probe Metals Inc / National Storage Affiliates Trust / South32 Ltd / Hersha Hospitality Trust / Alamos Gold Inc / Automotive Properties Real Estate Investment Trust / Welltower Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Northern Star Resources Ltd / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Life Storage Inc / Filo Mining Corp / Trilogy Metals Inc / Alcoa Corp / Orla Mining Ltd / Hilton Worldwide Holdings Inc / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / DXC Technology Co / Warrior Met Coal Inc / Peabody Energy Corp / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / Nexa Resources SA / Apellis Pharmaceuticals Inc / Ero Copper Corp / Roots Corp / Stelco Holdings Inc / Victory Capital Holdings Inc / GrafTech International Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Aptinyx Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Golden Star Resources Ltd / Calibre Mining Corp / Ares Management Corp / Platinum Group Metals Ltd / Cigna Corp / Eldorado Gold Corp / iA Financial Corporation Inc / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / Maverix Metals Inc / Blackstone Inc / Mandalay Resources Corp / Josemaria Resources Inc / Exicure Inc / Equinox Gold Corp / Apollo Global Management Inc / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / First Capital Real Estate Investment Trust / Carlyle Group Inc / Sibanye Stillwater Ltd / Galiano Gold Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Solaris Resources Inc / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Abcellera Biologics Inc / G Mining Ventures Corp / Centerspace / Decibel Therapeutics Inc / Nickel 28 Capital Corp / UiPath Inc / Sunrise Energy Metals Ltd / Nomad Royalty Company Ltd / Endeavour Mining PLC / Li-Cycle Holdings Corp / NextSource Materials Inc / Candel Therapeutics Inc / Algoma Steel Group Inc / Definity Financial Corp / Coveo Solutions Inc / Trevali Mining Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Raised '22 Vaccine Guidance to $31B and '23 Contracts Indicate >$10B in 2023 Vaccine Sales</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Dec. 17, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Dec. 17, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">62</td><td class="leftalignment">IL0006290147 / US00724F1012 / US0311621009 / US0383361039 / US0584981064 / US1101221083 / US31428X1063 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US81211K1007 / US8581191009 / US92532F1003 / CA59162N1096 / CA5394811015 / CA2918434077 / US9129091081 / CA1349211054 / US7665596034 / US09062X1037 / US02043Q1076 / US3546131018 / US74144T1088 / US09247X1019 / US40637H1095 / CA1375761048 / CA0966311064 / CA6179141065 / CA1999101001 / CA7669101031 / CA2271071094 / CA46071W2058 / BMG491BT1088 / IE00B4BNMY34 / US58933Y1055 / CA0985461049 / JE00B4T3BW64 / US00287Y1091 / CA0194561027 / CA04315L1058 / US09609G1004 / CA3874371147 / CA16141A1030 / IE00B4Q5ZN47 / CA8661201167 / CA38045Y1025 / CA6674951059 / US6951271005 / US45845P1084 / CA0266951064 / CA58546R1091 / CA17039A1066 / US60468T1051 / US45378A1060 / US31189P1021 / CA72820F1036 / IE00BJ3V9050 / US03820J1007 / CA26153P1045 / CA1264621006 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / CA8310211005 / CA82621K1021 / CA83179X1087 / CA05329M1041 / US4622221004 / CA49410M1023 / US5588681057 / US68404V1008 / US03753U1060 / CA46136U1030 / IL0011417206 / US92645B1035 / US03168L1052 / US2997341035 / CA05585D1033 / US80706P1030 / US03836N1037 / US48251W1045 / CA0717341071 / CA60448E1034 / US76029N1063 / US03843E1047 / CA4039254079 / US04335A1051 / US50015M1099 / US03990B1017 / CA2849025093 / US62921N1054 / CA7426943006 / US61775R1059 / US09260D1072 / US03768E1055 / US71722W1071 / CA92625W5072 / CA31890B1031 / US14316J1088 / US80810D1037 / US6544051096 / IL0011326795 / CA67079A1021 / US12529R1077 / US3773201062 / CA33843T1084 / US92556V1061 / CA00288U1066 / CA65342N3159 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Adobe Inc / Amgen Inc / Aptargroup Inc / Ball Corp / Bristol-Myers Squibb Co / FedEx Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sealed Air Corp / Steel Dynamics Inc / Vertex Pharmaceuticals Inc / Metro Inc / Loblaw Companies Ltd / Empire Company Ltd / United States Steel Corp / Canadian Apartment Properties Real Estate Investment Trust / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Franklin Resources Inc / T Rowe Price Group Inc / BlackRock Inc / Halozyme Therapeutics Inc / Canfor Corp / Boardwalk Real Estate Investment Trust / Morguard Real Estate Investment Trust / Cominar Real Estate Investment Trust / RioCan Real Estate Investment Trust / Crombie Real Estate Investment Trust / InterRent Real Estate Investment Trust / Invesco Ltd / Accenture PLC / Merck & Co Inc / Bonterra Energy Corp / Glencore PLC / Abbvie Inc / Allied Properties Real Estate Investment Trust / Artis Real Estate Investment Trust / bluebird bio Inc / Granite Real Estate Investment Trust / Chartwell Retirement Residences / Jazz Pharmaceuticals PLC / Summit Industrial Income REIT / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / American Hotel Income Properties REIT LP / Melcor Real Estate Investment Trust / Choice Properties Real Estate Investment Trust / Mirati Therapeutics Inc / Independence Realty Trust Inc / Fate Therapeutics Inc / Plaza Retail REIT / Endo International PLC / Applied Genetic Technologies Corp / Dream Office Real Estate Investment Trust / CT Real Estate Investment Trust / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Slate Office REIT / Sienna Senior Living Inc / SmartCentres Real Estate Investment Trust / Automotive Properties Real Estate Investment Trust / Ionis Pharmaceuticals Inc / Killam Apartment REIT / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Invesque Inc / Sol Gel Technologies Ltd / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / BSR Real Estate Investment Trust / Scholar Rock Holding Corp / Aptinyx Inc / KKR & Co Inc / Bausch Health Companies Inc / Minto Apartment Real Estate Investment Trust / Replimune Group Inc / Aquestive Therapeutics Inc / H&R Real Estate Investment Trust / Arvinas Inc / Kodiak Sciences Inc / Ares Management Corp / Eldorado Gold Corp / NGM Biopharmaceuticals Inc / PRO Real Estate Investment Trust / Morphic Holding Inc / Blackstone Inc / Apollo Global Management Inc / Phathom Pharmaceuticals Inc / Victoria Gold Corp / First Capital Real Estate Investment Trust / Carlyle Group Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / Nuvei Corp / C4 Therapeutics Inc / Glatfelter Corp / Flagship Communities Real Estate Investment Trust / Viatris Inc / Abcellera Biologics Inc / Nexus Real Estate Investment Trust / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2516152 / 2000019 / 2008154 / 2190750 / 2216850 / 2270726 / 2328915 / 2100920 / 2689560 / 2684703 / 2857817 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / B95N910 / BFLR866 / BD8DJ71 / BWTN5N1 / BJ2Z0H2 / BMQ5T49 / BFZ1K46 / BJJMGL2 / BFNR303 / BYXJQG9 / BKTNTR9 / BYY88Y7 / BKC9SX3 / BDD1B07 / BMPRZV5 / BMGGJK8 / BM8NHS1</td><td class="leftalignment">Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / PTC Inc / Twitter Inc / Snap Inc / ETSY Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / Northwest Natural Holding Co / Spire Inc / ViacomCBS Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Valneva SE / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - December 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABF.L / AFL.N / BAC.N / BB.N / C.N / COF.N / FITB.O / HMb.ST / JD.L / JPM.N / KEY.N / KGF.L / MDT.N / MKS.L / NTRS.O / NXT.L / PFE.N / PNC.N / SMWH.L / USB.N / VC.N / WFC.N / CMA.N / DRE.N / FR.N / TCN.N / HAL.N / MET.N / HEI.N / HBAN.O / WCC.N / REE.MC / ADBE.O / LEN.N / UNM.N / GIS.N / LNC.N / ACN.N / EGP.N / PLD.N / MTB.N / ITX.MC / BMRN.O / PFG.N / SRG.MI / MCO.N / PRU.N / VRNT.O / ENAG.MC / RF.N / ASC.L / BLU.N / BKH.N / DFS.N / AMH.N / SEM.N / TFC.N / HFD.L / NUVA.O / BECN.O / GMS.N / DUFN.S / ARWR.O / 025676206 / ADP.PA / DNLM.L / KTOS.OQ / ENSG.O / DAN.N / 759351604 / JACK.OQ / ADUS.OQ / PCRX.O / MTOR.N / STAG.N / MTDR.N / SMSS.L / BOSSn.DE / SRPT.O / ALLY.N / APAM.N / VOYA.N / DOOR.N / ESNT.N / QURE.O / PETSP.L / VRNS.O / QTWO.N / NMIH.O / CFG.N / ZALG.DE / RGNX.O / SPGI.N / AZRE.N / KNSL.OQ / INVH.N / RCM.OQ / ESTE.N / SWCH.N / AQUA.N / CDMO.OQ / SDRY.L / EAF.N / EQH.N / FOCS.O / HCAT.OQ / CRNC.OQ / EPAC.N / PEAK.N / FRAS.L / FA.OQ / CYXT.OQ / CURY.L / HRT.N / RIVN.OQ</td><td class="leftalignment">Associated British Foods PLC / Aflac Inc / Bank of America Corp / BlackBerry Ltd / Citigroup Inc / Capital One Financial Corp / Fifth Third Bancorp / H & M Hennes & Mauritz AB / JD Sports Fashion PLC / JPMorgan Chase & Co / KeyCorp / Kingfisher PLC / Medtronic PLC / Marks and Spencer Group PLC / Northern Trust Corp / Next PLC / Pfizer Inc / PNC Financial Services Group Inc / WH Smith PLC / US Bancorp / Visteon Corp / Wells Fargo & Co / Comerica Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Tricon Residential Inc / Halliburton Co / MetLife Inc / HEICO Corp / Huntington Bancshares Inc / Wesco International Inc / Red Electrica Corporacion SA / Adobe Inc / Lennar Corp / Unum Group / General Mills Inc / Lincoln National Corp / Accenture PLC / Eastgroup Properties Inc / Prologis Inc / M&T Bank Corp / Industria de Diseno Textil SA / Biomarin Pharmaceutical Inc / Principal Financial Group Inc / Snam SpA / Moody's Corp / Prudential Financial Inc / Verint Systems Inc / Enagas SA / Regions Financial Corp / ASOS PLC / BELLUS Health Inc / Black Hills Corp / Discover Financial Services / American Homes 4 Rent / Select Medical Holdings Corp / Truist Financial Corp / Halfords Group PLC / NuVasive Inc / Beacon Roofing Supply Inc / GMS Inc / Dufry AG / Arrowhead Pharmaceuticals Inc / American Equity Investment Life Holding Co / Aeroports de Paris SA / Dunelm Group PLC / Kratos Defense and Security Solutions Inc / Ensign Group Inc / Dana Inc / Reinsurance Group of America Inc / Jack in the Box Inc / Addus Homecare Corp / Pacira Biosciences Inc / Meritor Inc / STAG Industrial Inc / Matador Resources Co / Smart Metering Systems PLC / Hugo Boss AG / Sarepta Therapeutics Inc / Ally Financial Inc / Artisan Partners Asset Management Inc / Voya Financial Inc / Masonite International Corp / Essent Group Ltd / Uniqure NV / Pets at Home Group PLC / Varonis Systems Inc / Q2 Holdings Inc / NMI Holdings Inc / Citizens Financial Group Inc / Zalando SE / Regenxbio Inc / S&P Global Inc / Azure Power Global Ltd / Kinsale Capital Group Inc / Invitation Homes Inc / R1 RCM Inc / Earthstone Energy Inc / Switch Inc / Evoqua Water Technologies Corp / Avid Bioservices Inc / Superdry PLC / GrafTech International Ltd / Equitable Holdings Inc / Focus Financial Partners Inc / Health Catalyst Inc / Cerence Inc / Enerpac Tool Group Corp / Healthpeak Properties Inc / Frasers Group PLC / First Advantage Corp / Cyxtera Technologies Inc / Currys PLC / HireRight Holdings Corp / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Italy / Mauritius / Netherlands / Russian Federation / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">12/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">KOL Call On Gene Therapy: Takeaways From Our 2nd Annual Healthcare Private Company Conference</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / BMRN.O / SRPT.O / QURE.O / RGNX.O</td><td class="leftalignment">Pfizer Inc / Biomarin Pharmaceutical Inc / Sarepta Therapeutics Inc / Uniqure NV / Regenxbio Inc</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Luca Issi, PHD / Brian Abrahams, MD / Kennen MacKay, PHD / Lisa Walter / Leonid Timashev / Stephen Mallon / Jackie Yan</td></tr>
<tr class="odd"><td class="leftalignment">12/17/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2022 BioPharma Outlook: A Light at the End of the Tunnel as Sector Sentiment Likely to Improve</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">IL0006290147 / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US7665596034 / US09062X1037 / US02043Q1076 / US40637H1095 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US6951271005 / US45845P1084 / US60468T1051 / US31189P1021 / IE00BJ3V9050 / US03820J1007 / US78667J1088 / IE00BQPVQZ61 / US92686J1060 / US4622221004 / US5588681057 / US68404V1008 / US03753U1060 / IL0011417206 / US03168L1052 / US2997341035 / US80706P1030 / US03836N1037 / CA0717341071 / US76029N1063 / US03843E1047 / US04335A1051 / US50015M1099 / US62921N1054 / US61775R1059 / US71722W1071 / US80810D1037 / US6544051096 / IL0011326795 / US12529R1077 / US92556V1061 / CA00288U1066 / US67080N1019 / US24343R1068 / US4718711033 / US1374041093</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Halozyme Therapeutics Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Intercept Pharmaceuticals Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / Endo International PLC / Applied Genetic Technologies Corp / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Viking Therapeutics Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / OptiNose Inc / Apellis Pharmaceuticals Inc / Sol Gel Technologies Ltd / Amneal Pharmaceuticals Inc / Evelo Biosciences Inc / Scholar Rock Holding Corp / Aptinyx Inc / Bausch Health Companies Inc / Replimune Group Inc / Aquestive Therapeutics Inc / Arvinas Inc / Kodiak Sciences Inc / NGM Biopharmaceuticals Inc / Morphic Holding Inc / Phathom Pharmaceuticals Inc / Schrodinger Inc / 9 Meters Biopharma Inc / PolyPid Ltd / C4 Therapeutics Inc / Viatris Inc / Abcellera Biologics Inc / Nuvation Bio Inc / Decibel Therapeutics Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">what NOT to expect on COVID call tomorrow</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">PFE Brings Some Sparkle To The Holidays, Raising PT To $75 From $61 Ahead Of COVID-19 Event Tomorrow</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Biotechnology - ASH 2021: potential winners start to emerge</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">FR0000120578 / GB0009252882 / DK0010272202 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Genmab A/S / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="odd"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.33): First dose rate 79%, 78% have had two doses</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">12/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.33）：ワクチン接種率は1回目が79%、2回目は78%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AJG / AZO / H / HD / KNX / LOW / MDT / MHK / NKE / OC / PFE.N / PGR / PK / RKT / HT / JBHT.O / HUBG.O / CHH.N / TSCO.O / ORLY.O / SHO.N / BECN.O / HST.N / XPO / SAIA.O / FTNT.O / RHP.N / FBHS.K / PFSI.K / FATE.O / CIVI.K / XHR.N / APLE.N / WLTW.O / UAA / JELD.K / HMPT.O / GXO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Autozone Inc / Hyatt Hotels Corp / Home Depot Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Medtronic PLC / Mohawk Industries Inc / Nike Inc / Owens Corning / Pfizer Inc / Progressive Corp / Park Hotels & Resorts Inc / Rocket Companies Inc / Hersha Hospitality Trust / J B Hunt Transport Services Inc / Hub Group Inc / Choice Hotels International Inc / Tractor Supply Co / O'Reilly Automotive Inc / Sunstone Hotel Investors Inc / Beacon Roofing Supply Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Saia Inc / Fortinet Inc / Ryman Hospitality Properties Inc / Fortune Brands Home & Security Inc / PennyMac Financial Services Inc / Fate Therapeutics Inc / Civitas Resources Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Willis Towers Watson PLC / Under Armour Inc / JELD-WEN Holding Inc / Home Point Capital Inc / GXO Logistics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pantera Minerals in bottom 2% performers of Australian market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.AX</td><td class="leftalignment">Pantera Minerals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Updating Model for ARNA; Paxlovid Can Still Offer Upside, More Deals Likely</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">71708110 / ARNA.OQ / PFE.N / 04004760</td><td class="leftalignment">Pfizer Inc / Arena Pharmaceuticals Inc / Pfizer Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AJG / NKE / PFE.N / FTNT.O / FATE.O / CIVI.K / WLTW.O / UAA</td><td class="leftalignment">Arthur J Gallagher & Co / Nike Inc / Pfizer Inc / Fortinet Inc / Fate Therapeutics Inc / Civitas Resources Inc / Willis Towers Watson PLC / Under Armour Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ACI / AJG / CHD / CL / CLX / KMB / KO / NKE / PFE.N / PG / SPB / STZ / TAP.N / ASND.O / EPC / COCO.O / DKS.N / MNST.O / AQN / COTY.K / FATE.O / CIVI.K / OMF / UAA / PEP.O / KDP.N / NWL.O / ASO.O / ZVIA.N</td><td class="leftalignment">Albertsons Companies Inc / Arthur J Gallagher & Co / Church & Dwight Co Inc / Colgate-Palmolive Co / Clorox Co / Kimberly-Clark Corp / Coca-Cola Co / Nike Inc / Pfizer Inc / Procter & Gamble Co / Spectrum Brands Holdings Inc / Constellation Brands Inc / Molson Coors Beverage Co / Ascendis Pharma A/S / Edgewell Personal Care Co / Vita Coco Company Inc / DICK'S Sporting Goods Inc / Monster Beverage Corp / Algonquin Power & Utilities Corp / Coty Inc / Fate Therapeutics Inc / Civitas Resources Inc / OneMain Holdings Inc / Under Armour Inc / PepsiCo Inc / Keurig Dr Pepper Inc / Newell Brands Inc / Academy Sports and Outdoors Inc / Zevia PBC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 9.6% Y/Y Including COVID-19 Vaccine Volume Benefit (1.6% Without)</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra / Jialin (Jay) Jin</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended September 13,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Our Views and Key Debates Heading into PFE COVID Event (12/17)</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AAT / AMT / AVB / BXP / CCI / CP / CPT / CUZ / DGX / DHR / DLR / DOV / DRE / EGP / EMR / EQR / EQT / ESS / ETN / FRT / GE / H / HIW / HLT.N / HPP / IR / ITW / JCI / KBH / KIM / KRC / KRG / LH / MAC / MDC / MMM / MPC / NSC / NVR / OFC / PFE.N / PH / PK / PKI / PLD / PSB / ROK / SLG / SPG / SWK / TMO / TOL / TPH / TT / UDR / WRE / HT / LII / PEB.N / SBAC.O / DEI / ARNA.O / CHH.N / AYI / FTV / BRX / CALA.O / HOLX.O / EQIX.O / SHO.N / DRH.N / TDG.N / HST.N / ROIC.O / RLJ.N / STAG.K / RHP.N / MPLX.K / TMHC.K / MAR.O / ESRT.K / ALLE.K / REXR.K / XHR.N / APLE.N / PGRE.K / HUBB.K / NTLA.O / SWCH.K / QGEN.K / SITC.K / REG.O / SVC.O / CABA.O / PGEN.O / CARR.K / OTIS.K / HON.O / DBRG.N / PECO.O / CMTG.K</td><td class="leftalignment">American Assets Trust Inc / American Tower Corp / Avalonbay Communities Inc / Boston Properties Inc / Crown Castle International Corp / Canadian Pacific Railway Ltd / Camden Property Trust / Cousins Properties Inc / Quest Diagnostics Inc / Danaher Corp / Digital Realty Trust Inc / Dover Corp / Duke Realty Corp / Eastgroup Properties Inc / Emerson Electric Co / Equity Residential / EQT Corp / Essex Property Trust Inc / Eaton Corporation PLC / Federal Realty Investment Trust / General Electric Co / Hyatt Hotels Corp / Highwoods Properties Inc / Hilton Worldwide Holdings Inc / Hudson Pacific Properties Inc / Ingersoll Rand Inc / Illinois Tool Works Inc / Johnson Controls International PLC / KB Home / Kimco Realty Corp / Kilroy Realty Corp / Kite Realty Group Trust / Laboratory Corporation of America Holdings / Macerich Co / MDC Holdings Inc / 3M Co / Marathon Petroleum Corp / Norfolk Southern Corp / NVR Inc / Corporate Office Properties Trust / Pfizer Inc / Parker-Hannifin Corp / Park Hotels & Resorts Inc / PerkinElmer Inc / Prologis Inc / PS Business Parks Inc / Rockwell Automation Inc / SL Green Realty Corp / Simon Property Group Inc / Stanley Black & Decker Inc / Thermo Fisher Scientific Inc / Toll Brothers Inc / Tri Pointe Homes Inc (Delaware) / Trane Technologies PLC / UDR Inc / Washington Real Estate Investment Trust / Hersha Hospitality Trust / Lennox International Inc / Pebblebrook Hotel Trust / SBA Communications Corp / Douglas Emmett Inc / Arena Pharmaceuticals Inc / Choice Hotels International Inc / Acuity Brands Inc / Fortive Corp / Brixmor Property Group Inc / Calithera Biosciences Inc / Hologic Inc / Equinix Inc / Sunstone Hotel Investors Inc / Diamondrock Hospitality Co / TransDigm Group Inc / Host Hotels & Resorts Inc / Retail Opportunity Investments Corp / RLJ Lodging Trust / STAG Industrial Inc / Ryman Hospitality Properties Inc / MPLX LP / Taylor Morrison Home Corp / Marriott International Inc / Empire State Realty Trust Inc / Allegion PLC / Rexford Industrial Realty Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Paramount Group Inc / Hubbell Inc / Intellia Therapeutics Inc / Switch Inc / Qiagen NV / Site Centers Corp / Regency Centers Corp / Service Properties Trust / Cabaletta Bio Inc / Precigen Inc / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc / DigitalBridge Group Inc / Phillips Edison & Co Inc / Claros Mortgage Trust Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : Paxlovid Update Reinforces Benefit in Preventing Severe Cases; Less Impact on Symptoms</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Paxlovid Saves ~90% of COVID Hospitalizations and Deaths – EUA Coming Next</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Updated Paxlovid Data Reinforce Our View It Is the Leading COVID Antiviral</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Epic Efficacy Maintained, Paving Way for EUA in Broad Patient Population</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral Chapter 5, New And Updated Data Support Megablockbuster Potential For Paxlovid</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Dec 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0116591092 / US3695501086 / US45337C1027 / US4581401001 / US6821891057 / US7170811035 / US75886F1075 / US8006771062 / US8447411088 / US8793601050 / US9029251066 / US6402681083 / US21036P1084 / US0003752047 / US8936411003 / US8485741099 / US55616P1049 / US7181721090 / US1940141062 / US26884L1098 / US9100471096 / JE00B783TY65 / US85916J4094 / KYG037AX1015 / US5253271028 / US31189P1021 / US0465131078 / US72703H1014 / US87164F1057 / US45073V1089 / US02081G2012 / US74967X1037 / US23753F1075 / US4990491049 / US29604W1080 / VGG312491084 / US88688T1007 / CA39342L1085 / US0197701065 / US89377M1099 / US75513E1010 / US9663875089 / US5504241051 / US55406W1036 / US7731221062 / US9778521024 / IL0011796625</td><td class="leftalignment">Alaska Air Group Inc / General Dynamics Corp / Incyte Corp / Intel Corp / ON Semiconductor Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Southwest Airlines Co / Teledyne Technologies Inc / USA Truck Inc / Nektar Therapeutics / Constellation Brands Inc / Abb Ltd / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Philip Morris International Inc / Colfax Corp / EQT Corp / United Airlines Holdings Inc / Aptiv PLC / Stereotaxis Inc / Ambarella Inc / Leidos Holdings Inc / Fate Therapeutics Inc / Atara Biotherapeutics Inc / Planet Fitness Inc / Syndax Pharmaceuticals Inc / ITT Inc / Alphatec Holdings Inc / RH / Daseke Inc / Knight-Swift Transportation Holdings Inc / Erytech Pharma SA / Establishment Labs Holdings Inc / Tilray Brands Inc / Green Thumb Industries Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Raytheon Technologies Corp / Whiting Petroleum Corp / Luminar Technologies Inc / MYT Netherlands Parent BV / Rocket Lab USA Inc / Wolfspeed Inc / Arbe Robotics Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / Israel / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SERD Pulse Call Takeaways: Combinability and Tolerability Are Key Features</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">71708110 / 04635310 / 80105N10 / 75046920 / 98943L10 / 04335A10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Sanofi SA / Radius Health Inc / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Christopher Liu, Pharm.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / DIS=US / HD=US / INTC=US / MCD=US / ADI=US / AMD=US / GBT=US / PG=US / WEN=US / BLD=US / TXN=US / NVDA=US / MPWR=US / LOW=US / CHKP=US / DIOD=US / XLNX=US / LEG=US / TTMI=US / SEIC=US / VMC=US / BKI=US / CVS=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / DOC=US / MCHP=US / MHK=US / STRA=US / FORG=US / NET=US / FAF=US / CNM=US / FB=US / AUTL=US / DIN=US / OGN / RPD=US / TPX=US / EXP=US / BDC=US / BECN=US / TXRH=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / TDG=US / PGTI=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / IAC=US / JACK=US / TREX=US / NXPI=US / LPLA=US / FBHS=US / ANGI=US / PANW=US / QLYS=US / BERY=US / TILE=US / NDLS=US / FATE=US / VRNS=US / LOCO=US / SHAK=US / ON=US / WING=US / ZS=US / MIME=US / 82982L103 / JELD=US / OKTA=US / SAIL=US / TENB=US / CRWD=US / FERG=US / AZEK=US / VTRS=US / RBLX=US / KNBE=US / VMEO=US / REPX=US / SNPO=US / MNDT=US / GTLB=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Walt Disney Co / Home Depot Inc / Intel Corp / McDonald's Corp / Analog Devices Inc / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Procter & Gamble Co / Wendys Co / TopBuild Corp / Texas Instruments Inc / NVIDIA Corp / Monolithic Power Systems Inc / Lowe's Companies Inc / Check Point Software Technologies Ltd / Diodes Inc / Xilinx Inc / Leggett & Platt Inc / TTM Technologies Inc / SEI Investments Co / Vulcan Materials Co / Black Knight Inc / CVS Health Corp / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Physicians Realty Trust / Microchip Technology Inc / Mohawk Industries Inc / Strategic Education Inc / ForgeRock Inc / Cloudflare Inc / First American Financial Corp / Core & Main Inc / Meta Platforms Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / TransDigm Group Inc / PGT Innovations Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Fortune Brands Home & Security Inc / Angi Inc / Palo Alto Networks Inc / Qualys Inc / Berry Global Group Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Zscaler Inc / Mimecast Ltd / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Okta Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Ferguson PLC / Azek Company Inc / Viatris Inc / Roblox Corp / Knowbe4 Inc / Vimeo Inc / Riley Exploration Permian Inc / Snap One Holdings Corp / Mandiant Inc / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US1264081035 / US3755581036 / US45337C1027 / US5324571083 / US6745991058 / US7170811035 / US75886F1075 / US20825C1045 / CA56501R1064 / CA8667961053 / CA39138C1068 / US26884L1098 / US58933Y1055 / US69327R1014 / CA21750U1012 / US31189P1021 / US86771W1053 / US03753U1060 / US03843E1047 / CA45075E1043 / US86745K1043 / US30205M1018</td><td class="leftalignment">CSX Corp / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Occidental Petroleum Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Conocophillips / Manulife Financial Corp / Sun Life Financial Inc / Great-West Lifeco Inc / EQT Corp / Merck & Co Inc / PDC Energy Inc / Copper Mountain Mining Corp / Fate Therapeutics Inc / Sunrun Inc / Apellis Pharmaceuticals Inc / Aquestive Therapeutics Inc / iA Financial Corporation Inc / Sunnova Energy International Inc / Exicure Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2008154 / 2778844 / 2050832 / 2270726 / 2829515 / 2689560 / 2684703 / 2048804 / 7103065 / 2857817 / B3D7K31 / BCZS820 / BBGVT40 / BFLR866 / BFZNYB7 / BKVDFF7 / BFZ1K46 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BZ05388 / BJVR9Y9 / BYY88Y7 / BG0Q4Y1 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Adobe Inc / Merck & Co Inc / Ameren Corp / Walt Disney Co / Edison International / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / News Corp / Twitter Inc / Allogene Therapeutics Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Global Blood Therapeutics Inc / iHeartMedia Inc / Alphabet Inc / Exicure Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - 2022: Let's hope it's a good one</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pfizer (PFE US) - The durability debate</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Partner Arena's acquisition by Pfizer is another win for Everest team's BD capabilities. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / 1952.HK / ARNA.OQ / GILD.OQ / LJPC.OQ / UTHR.OQ</td><td class="leftalignment">Pfizer Inc / Everest Medicines Ltd / Arena Pharmaceuticals Inc / Gilead Sciences Inc / La Jolla Pharmaceutical Co / United Therapeutics Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/14/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended December 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Positive on the Arena Deal, Expect More to Come</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio And Commercial Synergies Key To Arena Acquisition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0576652004 / US45168D1046 / US5324571083 / US67018T1051 / US7170811035 / US75886F1075 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US14167L1035 / US1488061029 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US45781M1018 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US54142F1021 / US4158581094 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / US14147L1089 / US7291391057 / US12233L1070 / US04537Y1091 / US4131971040 / US04683R1068 / US66988N2053 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Balchem Corp / IDEXX Laboratories Inc / Eli Lilly and Co / NU Skin Enterprises Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / CareDx Inc / Catalent Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Innoviva Inc / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / LogicBio Therapeutics Inc / Harrow Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Cardiff Oncology Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Aspira Women's Health Inc / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Novan Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - ARNA acquisition: They said what?! Highlights from conf call and our impressions...</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AGR / AMAT.O / AXP / BMY.N / CNC.N / CRM.N / CVS.N / HD / KNX / LOW / PFE.N / PNM / RNG / ADBE.O / SU.TO / SGMO.O / ARNA.O / SNPS.O / ACGL.O / CDNS.O / FATE.O / FIVN.O / MDWD.O / EDIT.O / NTLA.O / EVBG.O / WDAY.O / EGHT.K / ZM.O / ZI.O / NWE.O / BLND.N / WKME.O</td><td class="leftalignment">Avangrid Inc / Applied Materials Inc / American Express Co / Bristol-Myers Squibb Co / Centene Corp / Salesforce.Com Inc / CVS Health Corp / Home Depot Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Pfizer Inc / PNM Resources Inc / RingCentral Inc / Adobe Inc / Suncor Energy Inc / Sangamo Therapeutics Inc / Arena Pharmaceuticals Inc / Synopsys Inc / Arch Capital Group Ltd / Cadence Design Systems Inc / Fate Therapeutics Inc / Five9 Inc / Mediwound Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Everbridge Inc / Workday Inc / 8x8 Inc / Zoom Video Communications Inc / ZoomInfo Technologies Inc / NorthWestern Corp / Blend Labs Inc / Walkme Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / China / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: Key Questions on PFE-ARNA Deal and Our Responses</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Dec 3, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2471950 / 2623911 / 2684703 / 2730190 / 7103065 / B6RS2B3 / B7F2TY6 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Incyte Corp / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Clovis Oncology Inc / Puma Biotechnology Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Mobilizes COVID Windfall – First Stop – IBD and Atopic Derm</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">71708110 / 04004760</td><td class="leftalignment">Pfizer Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : ARNA Acquisition Boosts Immunology Pipeline, Represents Logical Fit Within Portfolio</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">PFE's Arena (ARNA;NR) acquisition focuses on inflammation & immunology pipeline expansion</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Dec. 13, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Dec. 13, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharma/SMIDS: Pharma taking advantage of discounted valuations. Expect M&A to keep up in 2022</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: ARNA Deal Opens a $3B OPPY for PFE; Valuation Appears Reasonable</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / ARNA.OQ / BMY.N / ARNA.O</td><td class="leftalignment">Pfizer Inc / Arena Pharmaceuticals Inc / Bristol-Myers Squibb Co / Arena Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Mohit Bansal / Mr. Derek Archila / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Toe in the Water: Arena Likely the First of Many Acquisitions for Pfizer</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US7170811035 / US1101221083</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Year Is Not Over Yet; PFE Announces Intention To Acquire Arena</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / ARNA.OQ / US0400476075</td><td class="leftalignment">Pfizer Inc / Arena Pharmaceuticals Inc / Arena Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Finally, Some M&A; ARNA to Be Acquired by PFE for $100/Share, CC at 10 a.m. EST</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / 04004760 / 71708110</td><td class="leftalignment">Pfizer Inc / Arena Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph P. Schwartz / Will Soghikian / Joori Park, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SNY, Roche Leading SERD Combos; ARVN Pressured but Differentiation Possible</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">ARVN.OQ / 71708110 / 80105N10 / 75046920 / 04335A10</td><td class="leftalignment">Arvinas Inc / Pfizer Inc / Sanofi SA / Radius Health Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Christopher Liu, Pharm.D. / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASH 2021: Key Pharma Highlights From The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US1101221083 / US7170811035 / US7711951043</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Roche Holding AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE=US / BMY=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / PG=US / WEN=US / AMZN=US / DVN=US / EBAY=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / ENR=US / IGT=US / MGY=US / SWN=US / VRM=US / MUR=US / BYD=US / MAR=US / MRO=US / EXPE=US / TNL=US / MGM=US / HLT=US / PENN=US / NWL=US / W=US / FLO=US / STZ=US / BMRN=US / CBRL=US / CTRA=US / CHD=US / COLL=US / CNX=US / DRI=US / DRH=US / EPC=US / EQT=US / GFF=US / GPOR=US / TREE=US / NOW=US / TEAM=US / REGN=US / SGMO=US / SMG=US / SNAP=US / TRIP=US / WIX=US / CVX=US / POST=US / CGEN=US / SGMS=US / BKNG=US / CNC=US / SNV=US / FB=US / MTCH=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / BDSI=US / MNST=US / PTON=US / IGMS=US / NOMD=US / RNG=US / CZR=US / SHO=US / PLAY=US / FRPT=US / DENN=US / XM=US / THS=US / ESMT=US / CMG=US / ELF=US / TAST=US / CENTA=US / QSR=US / CLR=US / WH=US / NOG=US / IAC=US / JACK=US / AGS=US / RCUS=US / UTZ=US / 45665G303 / INSE / AR=US / OAS=US / HGV=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / SSTK=US / NCLH=US / NDLS=US / GLPI=US / GOOGL=US / VNOM=US / LOCO=US / BABA=US / CIVI=US / CMPR=US / BVH=US / SHAK=US / GDDY=US / ETSY=US / WING=US / ZG=US / EVRI=US / TTD=US / EVBG=US / CDEV=US / TRVG=US / PK=US / PLYA=US / CVNA=US / YEXT=US / SBOW=US / RDFN=US / PETQ=US / CARG=US / SFIX=US / KDP=US / FTDR=US / EB=US / ARVN=US / HARP=US / LYFT=US / UBER=US / FERG=US / BRBR=US / OVV=US / REYN=US / NGMS=US / HYFM=US / CELU=US / ROCC=US / REPX=US / 67421J108 / MNTV=US / DNUT=US / GAMB=US / EWCZ=US / USER=US</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Procter & Gamble Co / Wendys Co / Amazon.com Inc / Devon Energy Corp / eBay Inc / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Vroom Inc / Murphy Oil Corp / Boyd Gaming Corp / Marriott International Inc / Marathon Oil Corp / Expedia Group Inc / Travel + Leisure Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Newell Brands Inc / Wayfair Inc / Flowers Foods Inc / Constellation Brands Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Coterra Energy Inc / Church & Dwight Co Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Gulfport Energy Corp / Lendingtree Inc / ServiceNow Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Post Holdings Inc / Compugen Ltd / Scientific Games Corp / Booking Holdings Inc / Centene Corp / Synovus Financial Corp / Meta Platforms Inc / Match Group Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / BioDelivery Sciences International Inc / Monster Beverage Corp / Peloton Interactive Inc / IGM Biosciences Inc / Nomad Foods Ltd / RingCentral Inc / Caesars Entertainment Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Qualtrics International Inc / TreeHouse Foods Inc / EngageSmart Inc / Chipotle Mexican Grill Inc / elf Beauty Inc / Carrols Restaurant Group Inc / Central Garden & Pet Co / Restaurant Brands International Inc / Continental Resources Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / PlayAGS Inc / Arcus Biosciences Inc / UTZ Brands Inc / Infinity Pharmaceuticals Inc / Inspired Entertainment Inc / Antero Resources Corp / Oasis Petroleum Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Shutterstock Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Gaming and Leisure Properties Inc / Alphabet Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Alibaba Group Holding Ltd / Civitas Resources Inc / Cimpress PLC / Bluegreen Vacations Holding Corp / Shake Shack Inc / GoDaddy Inc / ETSY Inc / Wingstop Inc / Zillow Group Inc / Everi Holdings Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Yext Inc / SilverBow Resources Inc / Redfin Corp / PetIQ Inc / CarGurus Inc / Stitch Fix Inc / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arvinas Inc / Harpoon Therapeutics Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Reynolds Consumer Products Inc / NeoGames SA / Hydrofarm Holdings Group Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc / Oatly Group AB / Momentive Global Inc / Krispy Kreme Inc / Gambling.com Group Ltd / European Wax Center Inc / UserTesting Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">US0311621009 / US0394831020 / US0536111091 / US1101221083 / US1266501006 / US3755581036 / US3976241071 / US45337C1027 / US5324571083 / US5719032022 / US64125C1099 / US65473P1057 / US7170811035 / US7445731067 / US75886F1075 / US92276F1003 / US92532F1003 / US98389B1008 / CA51925D1069 / US09062X1037 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US44107P1049 / US74460D1090 / US9026531049 / US30225T1025 / US58933Y1055 / US65339F1012 / US2296631094 / US09609G1004 / US70509V1008 / US16208T1025 / US60468T1051 / US14174T1079 / US9840171030 / US30040W1080 / US6378701063 / US4278255009 / US95040Q1040 / US53223X1072 / US7005171050 / US43300A2033 / US03753U1060 / US04335A1051 / US15202L1070 / US4718711033 / US1374041093 / CA24477T1003 / CA22289D1078</td><td class="leftalignment">Amgen Inc / Archer-Daniels-Midland Co / Avery Dennison Corp / Bristol-Myers Squibb Co / CVS Health Corp / Gilead Sciences Inc / Greif Inc / Incyte Corp / Eli Lilly and Co / Marriott International Inc / Neurocrine Biosciences Inc / NiSource Inc / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Ventas Inc / Vertex Pharmaceuticals Inc / Xcel Energy Inc / Laurentian Bank of Canada / Biogen Inc / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Host Hotels & Resorts Inc / Public Storage / UDR Inc / Extra Space Storage Inc / Merck & Co Inc / Nextera Energy Inc / CubeSmart / bluebird bio Inc / Pebblebrook Hotel Trust / Chatham Lodging Trust / Mirati Therapeutics Inc / CareTrust REIT Inc / Xenia Hotels & Resorts Inc / Eversource Energy / National Storage Affiliates Trust / Hersha Hospitality Trust / Welltower Inc / Life Storage Inc / Park Hotels & Resorts Inc / Hilton Worldwide Holdings Inc / Apellis Pharmaceuticals Inc / Arvinas Inc / Centerspace / Jasper Therapeutics Inc / Candel Therapeutics Inc / Definity Financial Corp / Coveo Solutions Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AJG / ALL / AM / AMT / AR / AXP / BA.N / BAX / BMY.N / CB / CCI / CLR / CNC.N / CNX / COO / CPE / CPK / CRM.N / CVS.N / D / DG / DGX / DK / DLR / DVN / DY / EOG / EQT / HD / HEP / HIG / IFF / KNX / LOW / MCHP.O / MGY / MMP / MRK.N / MRO / OKE / OLN / OXY / PFE.N / PGR / PNM / PXD / QCOM.O / RKT / RMBS.O / RNG / RRC / SJI / SLG / SM / SWN / T / TFX / TOL / USM / WES / WLK / WLL / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / IRM / MGM.N / ADBE.O / PAA.N / SBAC.O / MXL / ADI.O / VZ / NWN / ARNA.O / SMTC.O / SLAB.O / SNPS.O / DLTR.O / BYD.N / ARGX.O / PENN.O / ISRG.O / LPI / CHDN.O / REGN.O / VRTX.O / MRVL.O / SMG.N / WYNN.O / SIVB.O / DIOD.O / ACGL.O / EQIX.O / OMCL.O / SWKS.O / BIIB.O / DKL / LVS.N / CDNS.O / CNSL.O / CLMT.O / CCOI.O / NOG.A / WRB.N / TSLA.O / NXPI.O / CZR.O / HZNP.O / ESTE.K / MTDR.K / TRGP.K / PDCE.O / AMBA.O / FANG.O / MPLX.K / ABBV.N / PFSI.K / PSXP.K / LGIH.O / FIVN.O / RXDX.O / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / CYAD.O / GBT.O / TMUS.O / RRR.O / EVBG.O / UNIT.O / CLLS.O / CDEV.O / WDAY.O / HESM.K / RYTM.O / SWCH.K / APLS.O / EGHT.K / AUTL.O / BRY.O / KZR.O / AXNX.O / SWAV.O / ZM.O / FLTRF.L / RTLR.O / MORF.O / CABA.O / OAS.O / OVV.N / PGEN.O / BEAM.O / DKNG.O / ZI.O / CTRA.K / GRWG.O / 45258J102 / NWE.O / LUMN.K / BALY.N / ALGM.O / RSI.N / HYFM.O / GRCL.O / CHK.O / HMPT.O / DBRG.N / BLND.N / YOU.N / WKME.O / KLTR.O / WOLF.N / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / American Tower Corp / Antero Resources Corp / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Continental Resources Inc / Centene Corp / CNX Resources Corp / Cooper Companies Inc / Callon Petroleum Co / Chesapeake Utilities Corp / Salesforce.Com Inc / CVS Health Corp / Dominion Energy Inc / Dollar General Corp / Quest Diagnostics Inc / Delek US Holdings Inc / Digital Realty Trust Inc / Devon Energy Corp / Dycom Industries Inc / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / International Flavors & Fragrances Inc / Knight-Swift Transportation Holdings Inc / Lowe's Companies Inc / Microchip Technology Inc / Magnolia Oil & Gas Corp / Magellan Midstream Partners LP / Merck & Co Inc / Marathon Oil Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / PNM Resources Inc / Pioneer Natural Resources Co / Qualcomm Inc / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / SM Energy Co / Southwestern Energy Co / AT&T Inc / Teleflex Inc / Toll Brothers Inc / United States Cellular Corp / Western Midstream Partners LP / Westlake Chemical Corp / Whiting Petroleum Corp / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Iron Mountain Inc / MGM Resorts International / Adobe Inc / Plains All American Pipeline LP / SBA Communications Corp / Maxlinear Inc / Analog Devices Inc / Verizon Communications Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / Dollar Tree Inc / Boyd Gaming Corp / argenx SE / Penn National Gaming Inc / Intuitive Surgical Inc / Laredo Petroleum Inc / Churchill Downs Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Marvell Technology Inc / Scotts Miracle-Gro Co / Wynn Resorts Ltd / SVB Financial Group / Diodes Inc / Arch Capital Group Ltd / Equinix Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / Las Vegas Sands Corp / Cadence Design Systems Inc / Consolidated Communications Holdings Inc / Calumet Specialty Products Partners LP / Cogent Communications Holdings Inc / Northern Oil and Gas Inc / W R Berkley Corp / Tesla Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Horizon Therapeutics PLC / Earthstone Energy Inc / Matador Resources Co / Targa Resources Corp / PDC Energy Inc / Ambarella Inc / Diamondback Energy Inc / MPLX LP / Abbvie Inc / PennyMac Financial Services Inc / Phillips 66 Partners LP / LGI Homes Inc / Five9 Inc / Prometheus Biosciences Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Celyad Oncology SA / Global Blood Therapeutics Inc / T-Mobile US Inc / Red Rock Resorts Inc / Everbridge Inc / Uniti Group Inc / Cellectis SA / Centennial Resource Development Inc / Workday Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Switch Inc / Apellis Pharmaceuticals Inc / 8x8 Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Zoom Video Communications Inc / Flutter Entertainment PLC / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Oasis Petroleum Inc / Ovintiv Inc / Precigen Inc / Beam Therapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / NorthWestern Corp / Lumen Technologies Inc / Bally's Corp / Allegro Microsystems Inc / Rush Street Interactive Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / DigitalBridge Group Inc / Blend Labs Inc / Clear Secure Inc / Walkme Ltd / Kaltura Inc / Wolfspeed Inc / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2126335 / 2516152 / 2000019 / 2094670 / 2008154 / 2065159 / 2280220 / 2270726 / 2542049 / 2829515 / 2457864 / 2689560 / 2680905 / 2684703 / 2857817 / B3D7K31 / BBGVT40 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BJLFHW7 / BD8DJ71 / BKS3SM8 / BFZ1K46 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BYNQ369 / BDZ30Q0 / BN2R582 / BMDCDP2 / BN7K304 / BNTB3N8 / BMGGJK8 / BKPGJQ1 / BMXXBD9 / BNLYJ60</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Adobe Inc / Autodesk Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / ImmunoGen Inc / PG&E Corp / PPL Corp / Pfizer Inc / Netflix Inc / Discovery Inc / News Corp / Twitter Inc / Wix.Com Ltd / Shopify Inc / Chewy Inc / Snap Inc / IGM Biosciences Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Albertsons Companies Inc / Arvinas Inc / Relay Therapeutics Inc / Bigcommerce Holdings Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Valneva SE / Squarespace Inc / Figs Inc / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ARNA: Model Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARNA.OQ / PFE.N</td><td class="leftalignment">Arena Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ARNA: Pfizer to Acquire ARNA for $6.7B</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ARNA.OQ / PFE.N</td><td class="leftalignment">Arena Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">MERGER/ACQUISITION/DIVESTITURE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (from 13 Dec): Omicron concerns fade; certain stocks poised for reappraisal toward year-end</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4528.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / AERI.OQ / 4887.T</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Aerie Pharmaceuticals Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品・医療機器セクター: 週間レビューと見通し（12月13日～）: 変異株オミクロンの懸念後退、年末にかけて個別銘柄の見直しへ</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4528.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / AERI.OQ / 4887.T</td><td class="leftalignment">Ono Pharmaceutical Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Aerie Pharmaceuticals Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Read-through of Roche's TIGIT OS data: Benefiting BeiGene's global ambition</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BGNE.OQ / BMY.N / PFE.N / AZN.L / ROG.S / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 1801.HK / GMAB.CO / IMAB.OQ</td><td class="leftalignment">Beigene Ltd / Bristol-Myers Squibb Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Innovent Biologics Inc / Genmab A/S / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE’s Gene Therapy for Hem-A Does Not Look Viable</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASH Updates (Part 5): Updates from SGMO PRECZN-1 in SCD and Hem A Phase 1/2 updates from PFE/SGMO</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / SGMO.OQ / PFE=US / BMRN=US / SGMO=US</td><td class="leftalignment">Pfizer Inc / Sangamo Therapeutics Inc / Pfizer Inc / Biomarin Pharmaceutical Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral Chapter 4, Happy Holidays, Believing Never Gets Old</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">12/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 88</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Weekly Highlights—December 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AJG / ALL / AM / AR / BA.N / BAX / BMY.N / CB / CLR / CNX / COO / CPK / CRM.N / D / DG / DK / DVN / EOG / EQT / HD / HEP / HIG / LOW / MMP / MRK.N / OKE / OLN / OXY / PFE.N / PGR / RRC / SJI / SLG / SWN / WES / ASND.O / AMZN.O / GILD.O / ET / AMGN.O / EW / PAA.N / ADI.O / NWN / ARNA.O / ARGX.O / ISRG.O / REGN.O / VRTX.O / SMG.N / SIVB.O / ACGL.O / OMCL.O / BIIB.O / DKL / CLMT.O / WRB.N / TSLA.O / HZNP.O / TRGP.K / FANG.O / MPLX.K / ABBV.N / PSXP.K / LGIH.O / RXDX.O / SHLX.K / NVRO.K / CIVI.K / PBFX.K / CDEV.O / HESM.K / RYTM.O / APLS.O / BRY.O / KZR.O / AXNX.O / SWAV.O / RTLR.O / MORF.O / CABA.O / CTRA.K / GRWG.O / 45258J102 / HYFM.O / CHK.O / RIVN.O</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Midstream Corp / Antero Resources Corp / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Chubb Ltd / Continental Resources Inc / CNX Resources Corp / Cooper Companies Inc / Chesapeake Utilities Corp / Salesforce.Com Inc / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Home Depot Inc / Holly Energy Partners LP / Hartford Financial Services Group Inc / Lowe's Companies Inc / Magellan Midstream Partners LP / Merck & Co Inc / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Pfizer Inc / Progressive Corp / Range Resources Corp / South Jersey Industries Inc / SL Green Realty Corp / Southwestern Energy Co / Western Midstream Partners LP / Ascendis Pharma A/S / Amazon.com Inc / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Plains All American Pipeline LP / Analog Devices Inc / Northwest Natural Holding Co / Arena Pharmaceuticals Inc / argenx SE / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Scotts Miracle-Gro Co / SVB Financial Group / Arch Capital Group Ltd / Omnicell Inc / Biogen Inc / Delek Logistics Partners LP / Calumet Specialty Products Partners LP / W R Berkley Corp / Tesla Inc / Horizon Therapeutics PLC / Targa Resources Corp / Diamondback Energy Inc / MPLX LP / Abbvie Inc / Phillips 66 Partners LP / LGI Homes Inc / Prometheus Biosciences Inc / Shell Midstream Partners LP / Nevro Corp / Civitas Resources Inc / PBF Logistics LP / Centennial Resource Development Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Berry Corporation (Bry) / Kezar Life Sciences Inc / Axonics Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Cabaletta Bio Inc / Coterra Energy Inc / GrowGeneration Corp / Immunovant Inc / Hydrofarm Holdings Group Inc / Chesapeake Energy Corp / Rivian Automotive Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Denmark / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT / ACI / AIG / AJG / ALC / ALL / AM / AMAT.O / AMT / AON / AR / ARW / BA.N / BAX / BDX / BEP / BK / BMY.N / BP.N / BSX / CB / CLR / CMA / CNX / COO / COP / COST.O / CPK / CRM.N / CVX / D / DG / DK / DVN / EOG / EQT / F.N / FITB.O / GM.N / HD / HEP / HES / HFC / HIG / INTC.O / JNJ / KLAC.O / KR / LNC / LOW / LRCX.O / MCHP.O / MDT / MET / MMC / MMP / MPC / MRK.N / MUR / NTRS.O / OGE / OKE / OLN / OXY / PEN / PFE.N / PGR / PNC / PRU / PSX / QCOM.O / RE / RKT / RMBS.O / RNG / RNR / RRC / SJI / SLB.N / SLG / STT / SWN / SYK / TFC / TFX / TRV / VLO / WES / WMB / WMT / XLNX.O / ASND.O / AMZN.O / CNQ.TO / GILD.O / ET / AMGN.O / EW / BRO / AAPL.O / CSCO.O / HAL.N / NVDA.O / SU.TO / XOM / PAA.N / PBF / MXL / LBRT.N / IART.O / AMD.O / ADI.O / NWN / NTAP.O / ARNA.O / BJ.N / SMTC.O / SLAB.O / SNPS.O / ARGX.O / AXS / ISRG.O / REGN.O / VRTX.O / MU.O / MRVL.O / HPQ / HPE / AVGO.O / BE.N / SMG.N / FCEL.OQ / PLUG.OQ / SIVB.O / BLUE.O / DIOD.O / MMSI.O / ACGL.O / MKSI.O / OMCL.O / SWKS.O / BIIB.O / DKL / VIAC.O / NOV.N / BLDP.OQ / RDSb / DXCM.O / CDNS.O / STX.O / CLMT.O / CVLT.O / PODD.O / TNDM.OQ / WRB.N / JNPR.K / TSLA.O / NXPI.O / LUNG.O / BKR.N / HZNP.O / WDC.O / TRGP.K / AMBA.O / FANG.O / MPLX.K / UIHC.O / ABBV.N / GTLS.N / VOYA.K / PFSI.K / RNA.O / PSXP.K / FATE.O / LGIH.O / RXDX.O / ANET.K / AFMD.O / SHLX.K / NVRO.K / QRVO.O / CIVI.K / PBFX.K / ON.O / GKOS.K / ZBH / CYAD.O / PSTG.K / NVCR.O / IONS.O / WLTW.O / EDIT.O / NTLA.O / NTNX.O / CLLS.O / CDEV.O / BHF.O / IOVA.O / HESM.K / RYTM.O / APLS.O / EQH / AVT.O / INSP.K / AUTL.O / BRY.O / KZR.O / STRO.O / AXNX.O / DELL.K / SWAV.O / RTLR.O / MORF.O / CHWY.K / BRP.O / CABA.O / PGEN.O / NARI.O / AVNT.K / CTRA.K / BEPC.K / GRWG.O / 45258J102 / ASO.O / EAR.O / ROOT.O / ALGM.O / HYFM.O / GRCL.O / CHK.O / HMPT.O / NPCE.O / RYAN.N / RXST.O / WOLF.N / ARBE.O / RIVN.O</td><td class="leftalignment">Abbott Laboratories / Albertsons Companies Inc / American International Group Inc / Arthur J Gallagher & Co / Alcon AG / Allstate Corp / Antero Midstream Corp / Applied Materials Inc / American Tower Corp / Aon PLC / Antero Resources Corp / Arrow Electronics Inc / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Brookfield Renewable Partners LP / Bank of New York Mellon Corp / Bristol-Myers Squibb Co / BP PLC / Boston Scientific Corp / Chubb Ltd / Continental Resources Inc / Comerica Inc / CNX Resources Corp / Cooper Companies Inc / Conocophillips / Costco Wholesale Corp / Chesapeake Utilities Corp / Salesforce.Com Inc / Chevron Corp / Dominion Energy Inc / Dollar General Corp / Delek US Holdings Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Ford Motor Co / Fifth Third Bancorp / General Motors Co / Home Depot Inc / Holly Energy Partners LP / Hess Corp / HollyFrontier Corp / Hartford Financial Services Group Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kroger Co / Lincoln National Corp / Lowe's Companies Inc / Lam Research Corp / Microchip Technology Inc / Medtronic PLC / MetLife Inc / Marsh & McLennan Companies Inc / Magellan Midstream Partners LP / Marathon Petroleum Corp / Merck & Co Inc / Murphy Oil Corp / Northern Trust Corp / OGE Energy Corp / ONEOK Inc / Olin Corp / Occidental Petroleum Corp / Penumbra Inc / Pfizer Inc / Progressive Corp / PNC Financial Services Group Inc / Prudential Financial Inc / Phillips 66 / Qualcomm Inc / Everest Re Group Ltd / Rocket Companies Inc / Rambus Inc / RingCentral Inc / Renaissancere Holdings Ltd / Range Resources Corp / South Jersey Industries Inc / Schlumberger NV / SL Green Realty Corp / State Street Corp / Southwestern Energy Co / Stryker Corp / Truist Financial Corp / Teleflex Inc / Travelers Companies Inc / Valero Energy Corp / Western Midstream Partners LP / Williams Companies Inc / Walmart Inc / Xilinx Inc / Ascendis Pharma A/S / Amazon.com Inc / Canadian Natural Resources Ltd / Gilead Sciences Inc / Energy Transfer LP / Amgen Inc / Edwards Lifesciences Corp / Brown & Brown Inc / Apple Inc / Cisco Systems Inc / Halliburton Co / NVIDIA Corp / Suncor Energy Inc / Exxon Mobil Corp / Plains All American Pipeline LP / PBF Energy Inc / Maxlinear Inc / Liberty Oilfield Services Inc / Integra Lifesciences Holdings Corp / Advanced Micro Devices Inc / Analog Devices Inc / Northwest Natural Holding Co / NetApp Inc / Arena Pharmaceuticals Inc / BJ's Wholesale Club Holdings Inc / Semtech Corp / Silicon Laboratories Inc / Synopsys Inc / argenx SE / AXIS Capital Holdings Ltd / Intuitive Surgical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Micron Technology Inc / Marvell Technology Inc / HP Inc / Hewlett Packard Enterprise Co / Broadcom Inc / Bloom Energy Corp / Scotts Miracle-Gro Co / Fuelcell Energy Inc / Plug Power Inc / SVB Financial Group / bluebird bio Inc / Diodes Inc / Merit Medical Systems Inc / Arch Capital Group Ltd / MKS Instruments Inc / Omnicell Inc / Skyworks Solutions Inc / Biogen Inc / Delek Logistics Partners LP / ViacomCBS Inc / Nov Inc / Ballard Power Systems Inc / Royal Dutch Shell PLC / Dexcom Inc / Cadence Design Systems Inc / Seagate Technology Holdings PLC / Calumet Specialty Products Partners LP / Commvault Systems Inc / Insulet Corp / Tandem Diabetes Care Inc / W R Berkley Corp / Juniper Networks Inc / Tesla Inc / NXP Semiconductors NV / Pulmonx Corp / Baker Hughes Co / Horizon Therapeutics PLC / Western Digital Corp / Targa Resources Corp / Ambarella Inc / Diamondback Energy Inc / MPLX LP / United Insurance Holdings Corp / Abbvie Inc / Chart Industries Inc / Voya Financial Inc / PennyMac Financial Services Inc / Avidity Biosciences Inc / Phillips 66 Partners LP / Fate Therapeutics Inc / LGI Homes Inc / Prometheus Biosciences Inc / Arista Networks Inc / Affimed NV / Shell Midstream Partners LP / Nevro Corp / Qorvo Inc / Civitas Resources Inc / PBF Logistics LP / ON Semiconductor Corp / Glaukos Corp / Zimmer Biomet Holdings Inc / Celyad Oncology SA / Pure Storage Inc / Novocure Ltd / Ionis Pharmaceuticals Inc / Willis Towers Watson PLC / Editas Medicine Inc / Intellia Therapeutics Inc / Nutanix Inc / Cellectis SA / Centennial Resource Development Inc / Brighthouse Financial Inc / Iovance Biotherapeutics Inc / Hess Midstream LP / Rhythm Pharmaceuticals Inc / Apellis Pharmaceuticals Inc / Equitable Holdings Inc / Avnet Inc / Inspire Medical Systems Inc / Autolus Therapeutics PLC / Berry Corporation (Bry) / Kezar Life Sciences Inc / Sutro Biopharma Inc / Axonics Inc / Dell Technologies Inc / Shockwave Medical Inc / Rattler Midstream LP / Morphic Holding Inc / Chewy Inc / BRP Group Inc / Cabaletta Bio Inc / Precigen Inc / Inari Medical Inc / Avient Corp / Coterra Energy Inc / Brookfield Renewable Corp / GrowGeneration Corp / Immunovant Inc / Academy Sports and Outdoors Inc / Eargo Inc / Root Inc / Allegro Microsystems Inc / Hydrofarm Holdings Group Inc / Gracell Biotechnologies Inc / Chesapeake Energy Corp / Home Point Capital Inc / Neuropace Inc / Ryan Specialty Group Holdings Inc / Rxsight Inc / Wolfspeed Inc / Arbe Robotics Ltd / Rivian Automotive Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ARV-471 Posts Compelling Early Data; Oral SERDs Get First PIII Benchmark</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Evan’s Weekly Dose of Targeted Therapy & Video Link - ASH & Launch Feedback</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for PFE. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - December 3 to 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AU000000CIA2 / US0079031078 / US0091581068 / US0311621009 / US0383361039 / US1101221083 / US1264081035 / US1266501006 / US1270971039 / US1475281036 / US1844961078 / US2017231034 / US22160K1051 / US2372661015 / US25179M1036 / US26875P1012 / US30231G1022 / US31428X1063 / US3755581036 / US38059T1060 / US3976241071 / US4404521001 / US4433201062 / US4456581077 / US45337C1027 / US4581401001 / US4601461035 / US5324571083 / US56418H1005 / US5962781010 / US6267171022 / US64125C1099 / US6558441084 / US6703461052 / US6745991058 / US6819191064 / US68389X1054 / US7170811035 / US7237871071 / US75281A1097 / US8454671095 / US8851601018 / US9024941034 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA29250N1050 / CA0977512007 / CA4530384086 / CA8787422044 / CA1247651088 / CA2918434077 / CA1469001053 / CA0679011084 / CA1363851017 / CA0099051009 / CA7029251088 / CA8959451037 / US1667641005 / CA13645T1003 / US5658491064 / CA13677F1018 / US0017441017 / US20825C1045 / US2274831047 / US09062X1037 / CA8676EP1086 / CA2052491057 / US14040H1059 / BMG169621056 / CA67072Q1046 / CA2265331074 / US6293775085 / CA98462Y1007 / US02043Q1076 / CA4969024047 / CA5503721063 / US15135B1017 / US0534841012 / US29476L1070 / US2971781057 / US1331311027 / CA8935781044 / CA2935701078 / US12008R1077 / CA6993202069 / US8288061091 / US1252691001 / US12541W2098 / CA1125851040 / CA0906971035 / US42809H1077 / US57636Q1040 / CA30041N1078 / US59522J1034 / BMG383271050 / US9026531049 / CA2945051027 / CA6179141065 / CA14068G1046 / US5500211090 / US3932221043 / US3886891015 / US2120151012 / US38500T1016 / US26884L1098 / CA6252841045 / CA89154B1022 / CA9838911027 / CA22576C1014 / CA8672241079 / CA25675T1075 / CA15135U1093 / CA69946Q1046 / US65339F1012 / US78454L1008 / CA5527041084 / CA9237251058 / CA07317Q1054 / CA00208D4084 / CA2927661025 / CA0985461049 / CA7170461064 / US98986T1088 / CA00829Q1019 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / US00287Y1091 / CA89156V1067 / US1091941005 / JE00B5TT1872 / US09609G1004 / US69327R1014 / CA04364G1063 / CA02215R1073 / CA1348082035 / CA96467A2002 / CA87505Y4094 / CA8204391079 / CA0805581091 / CA0213611001 / CA3565001086 / CA69338U1012 / CA74061A1084 / CA96145A2002 / CA09202D2077 / IE00B4Q5ZN47 / CA38045Y1025 / CA81373C1023 / CA04682R1073 / CA29269R1055 / CA3748252069 / US5764852050 / US25278X1090 / CA4882951060 / CA46579R1047 / US31189P1021 / US03674X1063 / US2267181046 / US1630921096 / CA14150G4007 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / US2383371091 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / CA83179X1087 / US95040Q1040 / US4622221004 / CA17040T3001 / US2057683029 / BMG162341090 / US13462K1097 / US15136A1025 / CA87241L1094 / CA46016U1084 / CA85859H1055 / CA6632782083 / CA15713J1049 / US12653C1080 / US8608971078 / CA35905B1076 / US03753U1060 / CA2960061091 / US00191U1025 / US11135F1012 / US87484T1088 / US76029N1063 / US34417P1003 / US08579X1019 / US04335A1051 / VGG1890L1076 / CA7241121077 / CA14179V5036 / US22052L1044 / CA6744822033 / US03768E1055 / US70614W1009 / US91734M1036 / CA31890B1031 / US69047Q1022 / US80810D1037 / MHY0436Q1098 / CA36168Q1046 / CA4220961078 / US03940R1077 / CA84678A1021 / US5168062058 / US05478C1053 / CA2674881040 / US13123X5086 / CA67079A1021 / CA89055A2039 / US23821D1000 / CA74022D4075 / US03750L1098 / US86333M1080 / US15202L1070 / CA83615X4075 / CA1295844056 / US78440X8048 / US1651677353 / US03743Q1085 / US90364P1057 / CA5362211040 / US44891N2080 / US92719V1008 / CA65532M6062 / CA00791P1071 / CA24874B1085 / US60646V1052 / CA03253E1079 / IE0003LFZ4U7 / CA53229C1077 / US98955K1043 / US4718711033 / US1374041093 / CA23344V1085 / CA0156581070</td><td class="leftalignment">Champion Iron Ltd / Advanced Micro Devices Inc / Air Products and Chemicals Inc / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / CSX Corp / CVS Health Corp / Coterra Energy Inc / Caseys General Stores Inc / Clean Harbors Inc / Commercial Metals Co / Costco Wholesale Corp / Darling Ingredients Inc / Devon Energy Corp / EOG Resources Inc / Exxon Mobil Corp / FedEx Corp / Gilead Sciences Inc / Gold Fields Ltd / Greif Inc / Hormel Foods Corp / Hub Group Inc / J B Hunt Transport Services Inc / Incyte Corp / Intel Corp / International Paper Co / Eli Lilly and Co / ManpowerGroup Inc / Middleby Corp / Murphy Oil Corp / Neurocrine Biosciences Inc / Norfolk Southern Corp / Nucor Corp / Occidental Petroleum Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Southwestern Energy Co / Thor Industries Inc / Tyson Foods Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Enbridge Inc / Bombardier Inc / Imperial Oil Ltd / Teck Resources Ltd / CAE Inc / Empire Company Ltd / Cascades Inc / Barrick Gold Corp / Canadian Natural Resources Ltd / AKITA Drilling Ltd / Pason Systems Inc / Trican Well Service Ltd / Chevron Corp / Canadian Pacific Railway Ltd / Marathon Oil Corp / Canadian Western Bank / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Biogen Inc / Sunopta Inc / Computer Modelling Group Ltd / Capital One Financial Corp / Bunge Ltd / Nuvista Energy Ltd / Crew Energy Inc / NRG Energy Inc / Yamana Gold Inc / Alnylam Pharmaceuticals Inc / Kinross Gold Corp / Lundin Mining Corp / Centene Corp / Avalonbay Communities Inc / Equity Residential / Essex Property Trust Inc / Camden Property Trust / Transcontinental Inc / Ensign Energy Services Inc / Builders FirstSource Inc / Paramount Resources Ltd / Simon Property Group Inc / CF Industries Holdings Inc / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Birchcliff Energy Ltd / Hess Corp / Mastercard Inc / Evertz Technologies Ltd / Mid-America Apartment Communities Inc / GeoPark Ltd / UDR Inc / Equitable Group Inc / Morguard Real Estate Investment Trust / Capstone Mining Corp / Lululemon Athletica Inc / Green Plains Inc / Graphic Packaging Holding Co / Continental Resources Inc / Gran Tierra Energy Inc / EQT Corp / Mullen Group Ltd / Total Energy Services Inc / Xebec Adsorption Inc / Crescent Point Energy Corp / Suncor Energy Inc / Dollarama Inc / Cenovus Energy Inc / Parex Resources Inc / Nextera Energy Inc / SM Energy Co / MEG Energy Corp / Vermilion Energy Inc / Baytex Energy Corp / ARC Resources Ltd / Enerplus Corp / Bonterra Energy Corp / Peyto Exploration & Development Corp / Zynga Inc / Africa Oil Corp / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Abbvie Inc / Tourmaline Oil Corp / Bright Horizons Family Solutions Inc / Centamin PLC / bluebird bio Inc / PDC Energy Inc / Ascot Resources Ltd / Altus Group Ltd / Canacol Energy Ltd / Whitecap Resources Inc / Tamarack Valley Energy Ltd / Shawcor Ltd / Belo Sun Mining Corp / AltaGas Ltd / Freehold Royalties Ltd / PHX Energy Services Corp / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Black Diamond Group Ltd / Jazz Pharmaceuticals PLC / GoGold Resources Inc / Secure Energy Services Inc / Athabasca Oil Corp / Enerflex Ltd / Gibson Energy Inc / Matador Resources Co / Diamondback Energy Inc / Kelt Exploration Ltd / Ivanhoe Mines Ltd / Fate Therapeutics Inc / Antero Resources Corp / Criteo SA / Chegg Inc / Cardinal Energy Ltd (Alberta) / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Dave & Buster's Entertainment Inc / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / SmartCentres Real Estate Investment Trust / Welltower Inc / Ionis Pharmaceuticals Inc / Chorus Aviation Inc / Comstock Resources Inc / Brookfield Business Partners LP / Camping World Holdings Inc / Centennial Resource Development Inc / TFI International Inc / International Petroleum Corp / Step Energy Services Ltd / North West Company Inc / CES Energy Solutions Corp / CNX Resources Corp / Stitch Fix Inc / Frontera Energy Corp / Apellis Pharmaceuticals Inc / Ero Copper Corp / ASGN Inc / Broadcom Inc / Talos Energy Inc / Replimune Group Inc / Focus Financial Partners Inc / Berry Corporation (Bry) / Arvinas Inc / Capri Holdings Ltd / Pipestone Energy Corp / Cargojet Inc / Corteva Inc / Obsidian Energy Ltd / Apollo Global Management Inc / Peloton Interactive Inc / US Ecology Inc / First Capital Real Estate Investment Trust / Ovintiv Inc / Schrodinger Inc / Atlas Corp / GFL Environmental Inc / Headwater Exploration Inc / Arch Resources Inc / Spartan Delta Corp / Laredo Petroleum Inc / Azek Company Inc / Dye & Durham Ltd / Callon Petroleum Co / Nuvei Corp / Topaz Energy Corp / Datto Holding Corp / Precision Drilling Corp / Apartment Income REIT Corp / Stride Inc / Centerspace / Source Energy Services Ltd / Calfrac Well Services Ltd / SL Green Realty Corp / Chesapeake Energy Corp / APA Corp (US) / UiPath Inc / Lion Electric Co / IAC/Interactivecorp / Vimeo Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Mister Car Wash Inc / Anaergia Inc / Dole PLC / Lightspeed Commerce Inc / Zevia PBC / Jasper Therapeutics Inc / Candel Therapeutics Inc / D2L Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / France / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 71708110 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Dec. 10, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Dec. 10, 2021 / 8:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE: Key Takeaways from SVB Leerink Global Large Cap Day</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">12/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4507.T: Shionogi - Virtual pharma tour update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4507.T / PFE.N</td><td class="leftalignment">Shionogi & Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ / LLY / MRK / PFE / ARAV</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / LH / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / AFMD.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Laboratory Corporation of America Holdings / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Affimed NV / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Wells Express: Morning Research Highlights—December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AJG / ALL / AR / BMY.N / CB / CNX / DOW / DVN / EOG / EQT / HIG / MRK.N / PFE.N / PGR / RRC / SWN / GILD.O / AMGN.O / EW / REGN.O / VRTX.O / ACGL.O / BIIB.O / SBNY.O / WRB.N / FANG.O / ABBV.N / LGIH.O / ROKU.O / CTRA.K / CHK.O / VZIO.N</td><td class="leftalignment">Arthur J Gallagher & Co / Allstate Corp / Antero Resources Corp / Bristol-Myers Squibb Co / Chubb Ltd / CNX Resources Corp / Dow Inc / Devon Energy Corp / EOG Resources Inc / EQT Corp / Hartford Financial Services Group Inc / Merck & Co Inc / Pfizer Inc / Progressive Corp / Range Resources Corp / Southwestern Energy Co / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Arch Capital Group Ltd / Biogen Inc / Signature Bank / W R Berkley Corp / Diamondback Energy Inc / Abbvie Inc / LGI Homes Inc / Roku Inc / Coterra Energy Inc / Chesapeake Energy Corp / Vizio Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Adam Muro / Alexandra Green / Dian Yuan</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">AU000000CIA2 / US0383361039 / US1264081035 / US1475281036 / US25179M1036 / US31428X1063 / US38059T1060 / US4433201062 / US4456581077 / US56418H1005 / US5770811025 / US5951121038 / US5962781010 / US6558441084 / US7010941042 / US7170811035 / US75886F1075 / US8552441094 / US8851601018 / US9078181081 / US9113121068 / US9311421039 / CA53278L1076 / CA1363751027 / CA0977512007 / CA90457D1006 / CA8787422044 / CA1247651088 / CA0679011084 / CA9528451052 / CA87971M1032 / CA13645T1003 / CA8676EP1086 / US14040H1059 / CA2265331074 / CA56501R1064 / US15135B1017 / US12541W2098 / CA1125851040 / CA95083R1001 / US57636Q1040 / CA30041N1078 / US63633D1046 / CA2945051027 / CA14068G1046 / US3932221043 / CA6252841045 / CA25675T1075 / CA15135U1093 / US65339F1012 / US74340W1036 / US30303M1027 / US4571871023 / CA7063271034 / US6092071058 / JE00B5TT1872 / CA0213611001 / CA3565001086 / CA74061A1084 / CA96145A2002 / CA81373C1023 / US78573L1061 / US6974351057 / CA46579R1047 / US02005N1000 / US14174T1079 / IE00BQPVQZ61 / CA0089118776 / BMG0750C1082 / CA8310211005 / US1638511089 / US95040Q1040 / AU000000NST8 / CA17040T3001 / BMG162341090 / CA87241L1094 / CA6632782083 / CA7847301032 / US87105L1044 / US04335A1051 / VGG1890L1076 / CA14179V5036 / US22052L1044 / US86745K1043 / US03768E1055 / US42250P1030 / CA31890B1031 / MHY0436Q1098 / CA4220961078 / US03940R1077 / US05478C1053 / CA67079A1021 / CA33843T1084 / US86333M1080 / US90364P1057 / CA5362211040 / CA65532M6062 / CA24874B1085 / CA03253E1079 / CA53229C1077 / US98955K1043</td><td class="leftalignment">Champion Iron Ltd / Aptargroup Inc / CSX Corp / Caseys General Stores Inc / Devon Energy Corp / FedEx Corp / Gold Fields Ltd / Hub Group Inc / J B Hunt Transport Services Inc / ManpowerGroup Inc / Mattel Inc / Micron Technology Inc / Middleby Corp / Norfolk Southern Corp / Parker-Hannifin Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Thor Industries Inc / Union Pacific Corp / United Parcel Service Inc / Walmart Inc / Linamar Corp / Canadian National Railway Co / Bombardier Inc / Uni-Select Inc / Teck Resources Ltd / CAE Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Telus Corp / Canadian Pacific Railway Ltd / Sunopta Inc / Capital One Financial Corp / Crew Energy Inc / Manulife Financial Corp / Centene Corp / CH Robinson Worldwide Inc / Brookfield Asset Management Inc / Wesdome Gold Mines Ltd / Mastercard Inc / Evertz Technologies Ltd / National Health Investors Inc / Equitable Group Inc / Capstone Mining Corp / Green Plains Inc / Mullen Group Ltd / Dollarama Inc / Cenovus Energy Inc / Nextera Energy Inc / Prologis Inc / Meta Platforms Inc / Ingredion Inc / Pembina Pipeline Corp / Mondelez International Inc / Centamin PLC / AltaGas Ltd / Freehold Royalties Ltd / Premium Brands Holdings Corp / Westshore Terminals Investment Corp / Secure Energy Services Inc / Sabra Health Care REIT Inc / Palo Alto Networks Inc / Ivanhoe Mines Ltd / Ally Financial Inc / CareTrust REIT Inc / Horizon Therapeutics PLC / Air Canada / Axalta Coating Systems Ltd / Slate Office REIT / Chemours Co / Welltower Inc / Northern Star Resources Ltd / Chorus Aviation Inc / Brookfield Business Partners LP / TFI International Inc / North West Company Inc / SSR Mining Inc / Switch Inc / Arvinas Inc / Capri Holdings Ltd / Cargojet Inc / Corteva Inc / Sunnova Energy International Inc / Apollo Global Management Inc / Healthpeak Properties Inc / First Capital Real Estate Investment Trust / Atlas Corp / Headwater Exploration Inc / Arch Resources Inc / Azek Company Inc / Nuvei Corp / Flagship Communities Real Estate Investment Trust / Stride Inc / UiPath Inc / Lion Electric Co / Nomad Royalty Company Ltd / dentalcorp Holdings Ltd / Anaergia Inc / Lightspeed Commerce Inc / Zevia PBC</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Ireland / United States / Virgin Islands, British / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2000019 / 2216850 / 2222631 / 2542049 / 2567116 / 2317087 / 2328915 / 2632003 / 2684703 / 2048804 / 2895163 / 2212922 / 2857817 / B2R3PV1 / 2390817 / B7TL820 / BBGVT40 / B7577T2 / BDZCRX3 / BFLR866 / BD8DJ71 / BJ2Z0H2 / BZ8FPH3 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BJVR9Y9 / BYQHPK7 / BZ1LFG7 / BYY88Y7 / BYXR425 / BNTB3N8 / BNKGXX2 / BL53KF5 / BM8NHS1 / BMFKLL6 / BMDW0R3</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Consolidated Edison Inc / Cooper Companies Inc / Dominion Energy Inc / Edwards Lifesciences Corp / Entergy Corp / Nextera Energy Inc / New York Times Co / Pfizer Inc / Pinnacle West Capital Corp / United Natural Foods Inc / NRG Energy Inc / Netflix Inc / American Water Works Company Inc / Gray Television Inc / Meta Platforms Inc / News Corp / Renewable Energy Group Inc / RingCentral Inc / Twitter Inc / Snap Inc / Pinterest Inc / Editas Medicine Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Vistra Corp / ViacomCBS Inc / iHeartMedia Inc / Zymeworks Inc / Roku Inc / Alphabet Inc / RH / Vizio Holding Corp / Verve Therapeutics Inc / F45 Training Holdings Inc / Adagio Therapeutics Inc / Aeye Inc / Weave Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/09/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Best of BMO Q4/21</td><td class="leftalignment">English</td><td class="rightalignment">77</td><td class="leftalignment">AU000000CIA2 / US0383361039 / US25179M1036 / US38059T1060 / US56418H1005 / US5770811025 / US5951121038 / US7010941042 / US7170811035 / US75886F1075 / US8552441094 / US9311421039 / CA53278L1076 / CA90457D1006 / CA8787422044 / CA1247651088 / CA0679011084 / CA9528451052 / CA87971M1032 / US14040H1059 / CA2265331074 / CA56501R1064 / US15135B1017 / CA1125851040 / CA95083R1001 / US57636Q1040 / CA2945051027 / CA14068G1046 / CA15135U1093 / US65339F1012 / US74340W1036 / US30303M1027 / US4571871023 / CA0213611001 / CA81373C1023 / US6974351057 / US02005N1000 / IE00BQPVQZ61 / BMG0750C1082 / US95040Q1040 / AU000000NST8 / BMG162341090 / CA7847301032 / US87105L1044 / US04335A1051 / VGG1890L1076 / US22052L1044 / US86745K1043 / US03768E1055 / CA31890B1031 / CA4220961078 / US03940R1077 / US05478C1053 / CA33843T1084 / US86333M1080 / CA24874B1085 / CA03253E1079 / CA53229C1077</td><td class="leftalignment">Champion Iron Ltd / Aptargroup Inc / Devon Energy Corp / Gold Fields Ltd / ManpowerGroup Inc / Mattel Inc / Micron Technology Inc / Parker-Hannifin Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Walmart Inc / Linamar Corp / Uni-Select Inc / Teck Resources Ltd / CAE Inc / Barrick Gold Corp / West Fraser Timber Co Ltd / Telus Corp / Capital One Financial Corp / Crew Energy Inc / Manulife Financial Corp / Centene Corp / Brookfield Asset Management Inc / Wesdome Gold Mines Ltd / Mastercard Inc / Equitable Group Inc / Capstone Mining Corp / Cenovus Energy Inc / Nextera Energy Inc / Prologis Inc / Meta Platforms Inc / Ingredion Inc / AltaGas Ltd / Secure Energy Services Inc / Palo Alto Networks Inc / Ally Financial Inc / Horizon Therapeutics PLC / Axalta Coating Systems Ltd / Welltower Inc / Northern Star Resources Ltd / Brookfield Business Partners LP / SSR Mining Inc / Switch Inc / Arvinas Inc / Capri Holdings Ltd / Corteva Inc / Sunnova Energy International Inc / Apollo Global Management Inc / First Capital Real Estate Investment Trust / Headwater Exploration Inc / Arch Resources Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Stride Inc / dentalcorp Holdings Ltd / Anaergia Inc / Lightspeed Commerce Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Ireland / United States / Virgin Islands, British / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Bert X. Powell, CFA / Mr. Ketan Mamtora / Mr. Sohrab Movahedi / Mr. Devin Dodge / Fadi Chamoun / Mr. Alexander Pearce / Matt Borsch / Mr. Simeon A. Siegel / Mike Murphy / Rene Cartier / Joel Jackson, CFA / Mr. Ben Pham, CFA / Mr. Randy Ollenberger / Mr. Stephen MacLeod, CFA / Mr. Phillip J. Jungwirth, CFA / Daniel Salmon / Jenny Ma / Mr. Raj Ray / Ms. Jackie Przybylowski / Mr. Ray Kwan / Mr. Gary Nachman / Mr. Kenneth B. Zaslow, CFA / Mr. James Fotheringham / Mr. Peter Sklar, CPA / Mr. Jeffrey M. Silber / Gerrick L. Johnson / Tom MacKinnon, FSA / Joanne Chen / Mr. Ambrish Srivastava, PHD / Mr. James M. Thalacker / Mr. Ameet I. Thakkar / Mr. Brian Quast / Keith F. Bachman, CFA / Mr. John Gibson / Mr. Evan D. Seigerman / Mr. Joel G. Tiss / Mr. John P. Kim / Mr. Ryan Thompson / Ari Klein / Tim J. Casey, CFA / Mr. Andrew Mikitchook, CFA / Mr. Juan C. Sanabria / Ms. Kelly A. Bania / Doug Morrow / Mr. Rufus Hone / Jin Li / Mr. Brian G. Belski / Colin Hamilton / David Gagliano / Matthew Luchini / Mr. Mark W. Wilde, PHD / John McNulty</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Fighting Failing Omicron Immunity with Boosters Is Short-Term Strategy</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Dilip Joseph / Na Sun / Greco Song, Ph.D. / Daniel Tarjan, Ph.D. / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">Recently Published Research EQ</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">AJG / BMY.N / EMN / H / KO / LLY.N / MRK.N / OLN / PFE.N / PK / RKT / S.N / SWK / ASND.O / AMZN.O / HT / GILD.O / AMGN.O / EW / ARNA.O / CHH.N / GSK.N / ARGX.O / BMRN.O / REGN.O / VRTX.O / DOL.TO / SIVB.O / BIIB.O / SHO.N / HST.N / HZNP.O / SRPT.O / RHP.N / ABBV.N / PFSI.K / QURE.O / RXDX.O / XHR.N / APLE.N / RYTM.O / SFIX.O / APLS.O / KZR.O / MORF.O / CABA.O / 45258J102 / HMPT.O</td><td class="leftalignment">Arthur J Gallagher & Co / Bristol-Myers Squibb Co / Eastman Chemical Co / Hyatt Hotels Corp / Coca-Cola Co / Eli Lilly and Co / Merck & Co Inc / Olin Corp / Pfizer Inc / Park Hotels & Resorts Inc / Rocket Companies Inc / SentinelOne Inc / Stanley Black & Decker Inc / Ascendis Pharma A/S / Amazon.com Inc / Hersha Hospitality Trust / Gilead Sciences Inc / Amgen Inc / Edwards Lifesciences Corp / Arena Pharmaceuticals Inc / Choice Hotels International Inc / GlaxoSmithKline PLC / argenx SE / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Dollarama Inc / SVB Financial Group / Biogen Inc / Sunstone Hotel Investors Inc / Host Hotels & Resorts Inc / Horizon Therapeutics PLC / Sarepta Therapeutics Inc / Ryman Hospitality Properties Inc / Abbvie Inc / PennyMac Financial Services Inc / Uniqure NV / Prometheus Biosciences Inc / Xenia Hotels & Resorts Inc / Apple Hospitality REIT Inc / Rhythm Pharmaceuticals Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / Kezar Life Sciences Inc / Morphic Holding Inc / Cabaletta Bio Inc / Immunovant Inc / Home Point Capital Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Equity Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">The Skies Are Clearing but Stock Selection Still Important</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">BMY.N / MRK.N / PFE.N / GILD.O / AMGN.O / REGN.O / VRTX.O / BIIB.O / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Croatia / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wells Fargo Securities, LLC</td><td class="leftalignment">PFE: The COVID Play with Near-Term Upside & Durable COVID Business; Initiate at Overweight</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N / MRK.N / ASND.O / GSK.N / BMRN.O / REGN.O / SRPT.O / ABBV.N / QURE.O</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc / Ascendis Pharma A/S / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Mohit Bansal / James Shin / Adam Reineke</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Drug Intelligence Monitor</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">US22663K1079 / US6837501039 / US0576652004 / US45168D1046 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US92345Y1064 / US98978V1035 / US00182C1036 / US23282W6057 / US88322Q1085 / US14888U1016 / US63009R1095 / US48576U1060 / US2697961082 / US1488061029 / CA68620P1018 / US5165441032 / US98978L2043 / CA1380351009 / US00461U1051 / US4622221004 / US45781M1018 / US1710774076 / CA22717L1013 / US71639T1060 / CA4707481046 / US05368M1062 / US40131M1099 / US54142F1021 / US4158581094 / US71535D1063 / US64049K1043 / CA07987C2040 / US24984K1051 / US23725P2092 / US14147L1089 / CA05156X8843 / US7291391057 / US12233L1070 / US04537Y1091 / US4131971040 / US04683R1068 / US66988N2053 / US98422E1038</td><td class="leftalignment">Crinetics Pharmaceuticals Inc / Opiant Pharmaceuticals Inc / Balchem Corp / IDEXX Laboratories Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Verisk Analytics Inc / Zoetis Inc / ANI Pharmaceuticals Inc / Cytokinetics Inc / TG Therapeutics Inc / Catalyst Pharmaceuticals Inc / NanoString Technologies Inc / Karyopharm Therapeutics Inc / Eagle Pharmaceuticals Inc / Catalent Inc / OrganiGram Holdings Inc / Lantheus Holdings Inc / Zogenix Inc / Canopy Growth Corp / Aclaris Therapeutics Inc / Ionis Pharmaceuticals Inc / Innoviva Inc / Chromadex Corp / Cronos Group Inc / PetIQ Inc / Jamieson Wellness Inc / Avid Bioservices Inc / Guardant Health Inc / LogicBio Therapeutics Inc / Harrow Health Inc / Personalis Inc / Neoleukin Therapeutics Inc / BELLUS Health Inc / DermTech Inc / DarioHealth Corp / Cardiff Oncology Inc / Aurora Cannabis Inc / Pliant Therapeutics Inc / Burning Rock Biotech Ltd / Aspira Women's Health Inc / Harmony Biosciences Holdings Inc / Atea Pharmaceuticals Inc / Novan Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">COVID Vaccine Booster Neutralizes Omicron; Read-Across From BioNTech Update Call</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : Omicron Vaccine Update Suggests Booster Likely Effective at Preventing Infections</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">what we did and didn't get with the encouraging omicron update</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - Updated PFE model to include Paxlovid revenues (oral antiviral for COVID)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">December 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">PFE/BNTX Covid-19 Vaccines Can Protect Against Omicron, Supporting Our View That Vaccines Sales Remain Underappreciated</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">US0091581068 / US0311621009 / US1101221083 / US2017231034 / US2372661015 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US8718291078 / US8851601018 / US9078181081 / US9111631035 / US92532F1003 / US9746371007 / CA29250N1050 / CA1247651088 / CA2918434077 / US09062X1037 / BMG169621056 / US6293775085 / US12008R1077 / US1252691001 / CA6179141065 / US58933Y1055 / US65339F1012 / CA04364G1063 / CA0805581091 / CA38045Y1025 / US85208M1027 / US60468T1051 / US2383371091 / US1638511089 / US4622221004 / US13462K1097 / US8608971078 / US80810D1037 / US92719V1008 / US1374041093</td><td class="leftalignment">Air Products and Chemicals Inc / Amgen Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Darling Ingredients Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Sysco Corp / Thor Industries Inc / Union Pacific Corp / United Natural Foods Inc / Vertex Pharmaceuticals Inc / Winnebago Industries Inc / Enbridge Inc / CAE Inc / Empire Company Ltd / Biogen Inc / Bunge Ltd / NRG Energy Inc / Builders FirstSource Inc / CF Industries Holdings Inc / Morguard Real Estate Investment Trust / Merck & Co Inc / Nextera Energy Inc / Ascot Resources Ltd / Belo Sun Mining Corp / GoGold Resources Inc / Sprouts Farmers Market Inc / Mirati Therapeutics Inc / Dave & Buster's Entertainment Inc / Chemours Co / Ionis Pharmaceuticals Inc / Camping World Holdings Inc / Stitch Fix Inc / Schrodinger Inc / Vimeo Inc / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2000019 / 2065955 / 2270726 / 2542049 / 2317087 / 2344922 / 2632003 / 2684703 / 2707677 / 2098876 / 2971029 / 2822019 / 2212922 / 2857817 / B0T7YX2 / B3D7K31 / B28TS42 / 2855930 / B65LWX6 / B7TL820 / B7VD3F2 / BBGVT40 / BFLR866 / BYRY499 / BK0VHF6 / BFZ1K46 / BMYML02 / BLGJ610 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BMZ9Z11 / BNTB3N8 / BMHR7K6 / BMDW0R3</td><td class="leftalignment">Amazon.com Inc / Autozone Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Jack in the Box Inc / New York Times Co / Pfizer Inc / Public Service Enterprise Group Inc / Yum! Brands Inc / LKQ Corp / Advance Auto Parts Inc / NRG Energy Inc / Netflix Inc / Live Nation Entertainment Inc / Discovery Inc / Ulta Beauty Inc / Overstock.com Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / News Corp / Twitter Inc / Kraft Heinz Co / IDEAYA Biosciences Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Evergy Inc / Fox Corp / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Prometheus Biosciences Inc / Vizio Holding Corp / Impel Neuropharma Inc / Weave Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Highlights from Our Prostate Cancer KOL Call on the Shifting Landscape and Opportunity for Emerging Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">5671735 / 0989529 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Paul Jeng, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Clover Biopharmaceuticals: New report: A global COVID vaccine supplier from pandemic to endemic . Initiating Coverage with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2197.HK / MRK.N / PFE.N</td><td class="leftalignment">Clover Biopharmaceuticals Ltd / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">12/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">2197.HK: Clover Biopharmaceuticals - A global COVID vaccine supplier from pandemic to endemic</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">2197.HK / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 000513.SZ / DVAX.OQ / MRNA.OQ / 300122.SZ</td><td class="leftalignment">Clover Biopharmaceuticals Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Livzon Pharmaceutical Group Inc / Dynavax Technologies Corp / Moderna Inc / Chongqing Zhifei Biological Products Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">12/08/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Feedback From Our Launch: PFE’s Longer-Term COVID Benefit Clearer w/ Omicron</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended September 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 06,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended December 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">C-19 CREATING A NEW REALITY IN PHARMACY - 2021 - Is pharma industry evolving with virtual healthcare?</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">PFE.N / 22UAy.DE</td><td class="leftalignment">Pfizer Inc / BioNTech SE</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">RXDX Walks the Walk with '023 Ph 1 Data and Indication Expansion; PT to $47</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas J. Smith / Mike Kratky, CFA / Michael Jones, Ph.D. / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASH Annual Meeting 2021 Planner and Preview</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">71708110 / 37555810 / 75886F10 / 478160104 / 640268108 / 80105N10 / 771195104 / 00287Y10 / 28106W10 / 98401F10 / 41358P10 / 01981810 / 09609G10 / 45826J10 / 77313F10 / 55609910 / N0104510 / 31189P10 / 07725L10 / 00847X10 / 37890U10 / 04685N10 / 34633R10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 03969F10 / 98887Q10 / 92765F10 / 37230320 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 92731L10 / 07373V10 / H1718210</td><td class="leftalignment">Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Nektar Therapeutics / Sanofi SA / Roche Holding AG / Abbvie Inc / Editas Medicine Inc / Xencor Inc / Harpoon Therapeutics Inc / Allovir Inc / bluebird bio Inc / Intellia Therapeutics Inc / Rocket Pharmaceuticals Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / Agios Pharmaceuticals Inc / Global Blood Therapeutics Inc / Athenex Inc / Forma Therapeutics Holdings Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Arcus Biosciences Inc / Zai Lab Ltd / Viracta Therapeutics Inc / Genmab A/S / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Vincerx Pharma Inc / Beam Therapeutics Inc / CRISPR Therapeutics AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / Denmark / France / United Kingdom / Hong Kong / Israel / Japan / Netherlands / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Andrew Berens, M.D. / Daniel Tarjan, Ph.D. / Na Sun / Jeffrey La Rosa / Dilip Joseph / Faisal Khurshid / Nick Huang / Greco Song, Ph.D. / Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Jonathan Chang, Ph.D., CFA / Mani Foroohar, M.D. / Christopher Liu, Pharm.D. / Mr. Rick Bienkowski, Ph.D. / Ken Shields / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / AMD=US / IP=US / WEN=US / BLD=US / KMI=US / PEB=US / SLG=US / H=US / MTN=US / LOW=US / IGT=US / BYD=US / MAR=US / LEG=US / TNL=US / VMC=US / MGM=US / HLT=US / PENN=US / RCL=US / MLM=US / UNH=US / AMED=US / SWIM=US / CBRL=US / ELY=US / CCL=US / FUN=US / CHH=US / DRI=US / DRH=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / WGO=US / SGMS=US / SIVB=US / CNM=US / NLS=US / COP=US / AUTL=US / VICI=US / DIN=US / MGP=US / OGN / BCO=US / MRNS=US / RRR=US / PRG=US / TPX=US / EXP=US / CZR=US / BECN=US / TXRH=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / HST=US / PGTI=US / AWI=US / OC=US / SAIC=US / AMRX=US / TAST=US / QSR=US / WRK=US / PRPL=US / WH=US / JACK=US / AGS=US / TREX=US / HGV=US / LPLA=US / VAC=US / FBHS=US / RHP=US / FANG=US / TILE=US / NCLH=US / NDLS=US / FOXF=US / FATE=US / GLPI=US / COUP=US / LOCO=US / AFMD=US / BVH=US / SHAK=US / WING=US / EVRI=US / 82982L103 / 50189K103 / JELD=US / IOVA=US / ALLO=US / HARP=US / FERG=US / GMAB=US / ONEW=US / DKNG=US / AZEK=US / BALY=US / VTRS=US / CELU=US / ROCC=US / SNPO=US / HLLY=US / PKG=U / GTLB=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / International Paper Co / Wendys Co / TopBuild Corp / Kinder Morgan Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Hyatt Hotels Corp / Vail Resorts Inc / Lowe's Companies Inc / International Game Technology PLC / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Travel + Leisure Co / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Penn National Gaming Inc / Royal Caribbean Cruises Ltd / Martin Marietta Materials Inc / UnitedHealth Group Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Carnival Corp / Cedar Fair LP / Choice Hotels International Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Winnebago Industries Inc / Scientific Games Corp / SVB Financial Group / Core & Main Inc / Nautilus Inc / Conocophillips / Autolus Therapeutics PLC / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / Organon & Co / Brinks Co / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / PROG Holdings Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Science Applications International Corp / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Westrock Co / Purple Innovation Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / PlayAGS Inc / Trex Company Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Fox Factory Holding Corp / Fate Therapeutics Inc / Gaming and Leisure Properties Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Affimed NV / Bluegreen Vacations Holding Corp / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / LCI Industries / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Ferguson PLC / Genmab A/S / OneWater Marine Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Celularity Inc / Ranger Oil Corp / Snap One Holdings Corp / Holley Inc / Packaging Corp of America / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Liberia / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US02553E1064 / US1101221083 / US2017231034 / US3647601083 / US3755581036 / US45337C1027 / US5324571083 / US6541061031 / US6556641008 / US6703461052 / US6819191064 / US68389X1054 / US7170811035 / US75886F1075 / US7782961038 / US8581191009 / US8725401090 / US8851601018 / US9170471026 / US9182041080 / CA8787422044 / CA87971M1032 / US9129091081 / US02043Q1076 / US9043111072 / US5500211090 / US90384S3031 / CA22576C1014 / US58933Y1055 / US6936561009 / US7512121010 / US98986T1088 / US00287Y1091 / US09609G1004 / CA1348082035 / CA96467A2002 / IE00B4Q5ZN47 / CA3748252069 / US31189P1021 / US1220171060 / US14174T1079 / US72703H1014 / US8760301072 / US8608971078 / US03753U1060 / US63845R1077 / CA8585221051 / US76029N1063 / VGG1890L1076 / US76156B1070 / US88339P1012 / US70614W1009 / US80810D1037 / CA2674881040 / US78440X8048 / US44891N2080 / CA00791P1071 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US4718711033 / US53190C1027 / CA0156581070</td><td class="leftalignment">American Eagle Outfitters Inc / Bristol-Myers Squibb Co / Commercial Metals Co / Gap Inc / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Nucor Corp / Omnicom Group Inc / Oracle Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Steel Dynamics Inc / TJX Companies Inc / Thor Industries Inc / Urban Outfitters Inc / VF Corp / Teck Resources Ltd / Telus Corp / United States Steel Corp / Alnylam Pharmaceuticals Inc / Under Armour Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Crescent Point Energy Corp / Merck & Co Inc / PVH Corp / Ralph Lauren Corp / Zynga Inc / Abbvie Inc / bluebird bio Inc / Canacol Energy Ltd / Whitecap Resources Inc / Jazz Pharmaceuticals PLC / Gibson Energy Inc / Fate Therapeutics Inc / Burlington Stores Inc / CareTrust REIT Inc / Planet Fitness Inc / Tapestry Inc / Stitch Fix Inc / Apellis Pharmaceuticals Inc / National Vision Holdings Inc / Stelco Holdings Inc / Replimune Group Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Peloton Interactive Inc / Schrodinger Inc / Dye & Durham Ltd / SL Green Realty Corp / IAC/Interactivecorp / Advantage Energy Ltd / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Jasper Therapeutics Inc / Life Time Group Holdings Inc / Algoma Steel Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2868165 / 2126335 / 2516152 / 2778844 / 2219224 / 2216850 / 2270726 / 2542049 / 2272476 / 2317087 / 2670519 / 2328915 / 2684703 / 2440637 / 7103065 / 2713317 / 2857817 / B125XQ6 / B3D7K31 / B1XGNW4 / 2855930 / B3P93Y7 / B0796X4 / BYVFC94 / BZBY005 / BJ2Z0H2 / BFZ1K46 / BYXJQG9 / BZ1LFG7 / BYY88Y7 / BF3W461 / BMC5RV6 / BMDJ397 / BF0QTY9 / BMDW0R3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Sysco Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Dollar Tree Inc / Entergy Corp / Exelon Corp / Nextera Energy Inc / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / ACADIA Pharmaceuticals Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Insulet Corp / Overstock.com Inc / Anheuser Busch Inbev SA / Dexcom Inc / US Foods Holding Corp / Merus NV / Pinterest Inc / Spotify Technology SA / Spire Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / Adicet Bio Inc / Bolt Biotherapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Weave Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: PRA023 Achieves Greater Target Engagement Relative to PF-06480605</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">RXDX.OQ / PFE.N</td><td class="leftalignment">Prometheus Biosciences Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Contract Manufacturing Sector - Investor feedback on our sector initiation; good place to hide amid Omicron concerns</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">207940.KS / 302440.KS / MRK.N / PFE.N / GSK.L / 006280.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / SK Bioscience Co Ltd / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Green Cross Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">12/07/2021</td><td class="leftalignment">Smart Insider</td><td class="leftalignment">Pfizer Inc: 2 directors</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT / EARNINGS/FINANCIAL STATEMENTS / ECONOMIC INDICATORS / FUNDAMENTAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Company Snapshot</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / AIG.N / ALL.N / AXP.N / BA.N / C.N / CAH.N / CE.N / CF.N / COF.N / EOG.N / F.N / HIG.N / HLT.N / MRK.N / OXY.N / PFE.N / PM.N / PNW.N / TMX.N / TRV.N / UAL.N / USB.N / VNT.N / ZEN.N / NUE.N / HAL.N / DIS.N / WLK.N / GD.N / CR.N / AFG.N / R.N / RCL.N / ADM.N / IFF.N / LH.N / EMR.N / PCG.N / DVN.N / OLN.N / TGT.N / RKT.N / DVA.N / AZO.N / FDS.N / EQT.N / ATO.N / HWM.N / BYD.N / UGI.N / DNB.N / GPC.N / MKC.N / HRL.N / SAM.N / CLF.N / ABC.N / GME.N / TDY.N / COP.N / INTC.OQ / ADPT.OQ / AGL.N / CRUS.OQ / FAF.N / FISV.OQ / HOLX.OQ / KLAC.OQ / MKL.N / RGEN.OQ / SF.N / VMI.N / FL.N / POOL.OQ / TPR.N / UHAL.OQ / PEGA.OQ / LAMR.OQ / STLD.OQ / SRCL.OQ / MRCY.OQ / WTFC.OQ / NUAN.OQ / WYNN.OQ / PA1436583006 / MNST.OQ / OSH.N / LVS.N / OC.N / FRPT.OQ / BX.N / PODD.OQ / VMW.N / NVR.N / WRB.N / MRNA.OQ / CLH.N / AI.N / TRGP.N / Z.OQ / TRIP.OQ / WEN.OQ / BERY.N / WEX.N / RNG.N / WIX.OQ / ARMK.N / NCLH.N / FIVN.OQ / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / SITE.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / JHG.N / ROKU.OQ / PFG.OQ / XEL.OQ / QRTEA.OQ / CTRA.N / NFE.OQ / LYFT.O / BYND.OQ / UBER.N / FSLY.N / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / WTRG.N / DKNG.OQ / APA.OQ / FOUR.N / VRM.OQ / LMND.N / BEPC.N / DCT.OQ / PLTR.N / SHC.OQ / SKLZ.N / CLVT.N / SGFY.N / CHPT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / American International Group Inc / Allstate Corp / American Express Co / Boeing Co / Citigroup Inc / Cardinal Health Inc / Celanese Corp / CF Industries Holdings Inc / Capital One Financial Corp / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / Merck & Co Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Pinnacle West Capital Corp / Terminix Global Holdings Inc / Travelers Companies Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Nucor Corp / Halliburton Co / Walt Disney Co / Westlake Chemical Corp / General Dynamics Corp / Crane Co / American Financial Group Inc / Ryder System Inc / Royal Caribbean Cruises Ltd / Archer-Daniels-Midland Co / International Flavors & Fragrances Inc / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Devon Energy Corp / Olin Corp / Target Corp / Rocket Companies Inc / DaVita Inc / Autozone Inc / Factset Research Systems Inc / EQT Corp / Atmos Energy Corp / Howmet Aerospace Inc / Boyd Gaming Corp / UGI Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / McCormick & Company Inc / Hormel Foods Corp / Boston Beer Company Inc / Cleveland-Cliffs Inc / Amerisourcebergen Corp / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / agilon health Inc / Cirrus Logic Inc / First American Financial Corp / Fiserv Inc / Hologic Inc / KLA Corp / Markel Corp / Repligen Corp / Stifel Financial Corp / Valmont Industries Inc / Foot Locker Inc / Pool Corp / Tapestry Inc / Amerco / Pegasystems Inc / Lamar Advertising Co / Steel Dynamics Inc / Stericycle Inc / Mercury Systems Inc / Wintrust Financial Corp / Nuance Communications Inc / Wynn Resorts Ltd / Carnival Corp / Monster Beverage Corp / Oak Street Health Inc / Las Vegas Sands Corp / Owens Corning / Freshpet Inc / Blackstone Inc / Insulet Corp / VMware Inc / NVR Inc / W R Berkley Corp / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Targa Resources Corp / Zillow Group Inc / Tripadvisor Inc / Wendys Co / Berry Global Group Inc / WEX Inc / RingCentral Inc / Wix.Com Ltd / Aramark / Norwegian Cruise Line Holdings Ltd / Five9 Inc / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / SiteOne Landscape Supply Inc / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Janus Henderson Group PLC / Roku Inc / Principal Financial Group Inc / Xcel Energy Inc / Qurate Retail Inc / Coterra Energy Inc / New Fortress Energy Inc / Lyft Inc / Beyond Meat Inc / Uber Technologies Inc / Fastly Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Essential Utilities Inc / DraftKings Inc / APA Corp (US) / Shift4 Payments Inc / Vroom Inc / Lemonade Inc / Brookfield Renewable Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / Skillz Inc / CLARIVATE PLC / Signify Health Inc / ChargePoint Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / Liberia / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Electrical / Electronics / Engineering & Construction / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - SP500</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABBV.N / AFRM.OQ / AEE.N / CE.N / ECL.N / ED.N / HLT.N / PFE.N / SC.N / TXT.N / U.N / USB.N / ACI.N / BKI.N / SCI.N / DIS.N / WLK.N / AFG.N / IFF.N / FNF.N / VMC.N / PCG.N / DVN.N / ATO.N / LNT.N / AME.N / UDR.N / MKC.N / HRL.N / GME.N / TDY.N / COP.N / INTC.OQ / AMGN.OQ / FISV.OQ / HOLX.OQ / RJF.N / RGEN.OQ / POOL.OQ / TPR.N / UHAL.OQ / STLD.OQ / NUAN.OQ / PA1436583006 / MNST.OQ / MOH.N / LVS.N / PODD.OQ / LBTYK.OQ / CME.OQ / AVGO.OQ / NEE.N / CAR.OQ / Z.OQ / RNG.N / SYF.N / LBRDK.O / TW.OQ / TDOC.N / SITE.N / TWLO.N / TTD.OQ / COUP.OQ / SNAP.N / INVH.N / CVNA.N / ROKU.OQ / XEL.OQ / VICI.N / DOCU.OQ / CDAY.N / KDP.N / FTCH.N / UBER.N / TXG.OQ / PTON.OQ / WTRG.N / DKNG.OQ / ZI.OQ / PLTR.N / RBLX.N / CPNG.N</td><td class="leftalignment">Abbvie Inc / Affirm Holdings Inc / Ameren Corp / Celanese Corp / Ecolab Inc / Consolidated Edison Inc / Hilton Worldwide Holdings Inc / Pfizer Inc / Santander Consumer USA Holdings Inc / Textron Inc / Unity Software Inc / US Bancorp / Albertsons Companies Inc / Black Knight Inc / Service Corporation International / Walt Disney Co / Westlake Chemical Corp / American Financial Group Inc / International Flavors & Fragrances Inc / Fidelity National Financial Inc / Vulcan Materials Co / PG&E Corp / Devon Energy Corp / Atmos Energy Corp / Alliant Energy Corp / AMETEK Inc / UDR Inc / McCormick & Company Inc / Hormel Foods Corp / GameStop Corp / Teledyne Technologies Inc / Conocophillips / Intel Corp / Amgen Inc / Fiserv Inc / Hologic Inc / Raymond James Financial Inc / Repligen Corp / Pool Corp / Tapestry Inc / Amerco / Steel Dynamics Inc / Nuance Communications Inc / Carnival Corp / Monster Beverage Corp / Molina Healthcare Inc / Las Vegas Sands Corp / Insulet Corp / Liberty Global PLC / CME Group Inc / Broadcom Inc / Nextera Energy Inc / Avis Budget Group Inc / Zillow Group Inc / RingCentral Inc / Synchrony Financial / Liberty Broadband Corp / Tradeweb Markets Inc / Teladoc Health Inc / SiteOne Landscape Supply Inc / Twilio Inc / Trade Desk Inc / Coupa Software Inc / Snap Inc / Invitation Homes Inc / Carvana Co / Roku Inc / Xcel Energy Inc / VICI Properties Inc / DocuSign Inc / Ceridian HCM Holding Inc / Keurig Dr Pepper Inc / Farfetch Ltd / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Essential Utilities Inc / DraftKings Inc / ZoomInfo Technologies Inc / Palantir Technologies Inc / Roblox Corp / Coupang Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Korea, Republic of / Panama / United States</td><td class="leftalignment">Aerospace / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Technology / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Acquisition by Predictive Oncology advances patient centric therapies – Reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">Global Sector Strategy: Markets Fall Further; Some Areas in Bear Market Territory</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">TTEK=US / WMS=US / PFE=US / ABT=US / HD=US / SCI=US / GWW=US / LOW=US / UNP=US / TPH=US / FAST=US / DLTR=US / TOL=US / DHR=US / EIX=US / CSX=US / MLM=US / AAON=US / RSG=US / SWIM=US / AZO=US / DHI=US / LEN=US / MAS=US / MTH=US / NVR=US / ORLY=US / SSD=US / SKY=US / WSO=US / AAP=US / AOS=US / JHX=US / CCS=US / WCN=US / CVCO=US / BXC=US / BLDR=US / GMS=US / ZTS=US / TREX=US / NEE=US / GCP=US / TMHC=US / TGLS=US / GRBK=US / SUM=US / ATKR=US / FERG=US / CARR=US</td><td class="leftalignment">Tetra Tech Inc / Advanced Drainage Systems Inc / Pfizer Inc / Abbott Laboratories / Home Depot Inc / Service Corporation International / W W Grainger Inc / Lowe's Companies Inc / Union Pacific Corp / Tri Pointe Homes Inc (Delaware) / Fastenal Co / Dollar Tree Inc / Toll Brothers Inc / Danaher Corp / Edison International / CSX Corp / Martin Marietta Materials Inc / Aaon Inc / Republic Services Inc / Latham Group Inc / Autozone Inc / D R Horton Inc / Lennar Corp / Masco Corp / Meritage Homes Corp / NVR Inc / O'Reilly Automotive Inc / Simpson Manufacturing Co Inc / Skyline Champion Corp / Watsco Inc / Advance Auto Parts Inc / A O Smith Corp / James Hardie Industries PLC / Century Communities Inc / Waste Connections Inc / Cavco Industries Inc / Bluelinx Holdings Inc / Builders FirstSource Inc / GMS Inc / Zoetis Inc / Trex Company Inc / Nextera Energy Inc / GCP Applied Technologies Inc / Taylor Morrison Home Corp / Tecnoglass Inc / Green Brick Partners Inc / Summit Materials Inc / Atkore Inc / Ferguson PLC / Carrier Global Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Kenley Scott</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">111</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">STARTING IN 30 MINUTES: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">CEO Meeting Highlights COVID Opportunities, Capital Allocation, Sector Outlook</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">2021 ASH Preview and Itinerary Planner</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US7170811035 / US75886F1075 / US02043Q1076 / US58933Y1055 / US00287Y1091 / US09609G1004 / IE00B4Q5ZN47 / US31189P1021 / US03753U1060 / US80810D1037 / US4718711033</td><td class="leftalignment">Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc / bluebird bio Inc / Jazz Pharmaceuticals PLC / Fate Therapeutics Inc / Apellis Pharmaceuticals Inc / Schrodinger Inc / Jasper Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Georgia / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Mr. Gary Nachman / Matthew Luchini / Evan Hua</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2000019 / 2023607 / 2486813 / 2778844 / 2065159 / 2270726 / 2542049 / 2317087 / 2632003 / 2657802 / 2689560 / 2684703 / 2048804 / 2730190 / 2440637 / 2829601 / 7103065 / 2857817 / B02R1L6 / B5B1S13 / B7TL820 / B7VD3F2 / B7JYSG3 / BBGVT40 / BDZCRX3 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BD8DJ71 / BJ2Z0H2 / BZ8FPH3 / BYZM6C2 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BYY88Y7 / BRJ3GY4 / BMDCDP2 / BN7K304 / BNTB3N8 / BKPGJQ1 / BNKGXX2 / BMDW0R3 / BYQBFJ8</td><td class="leftalignment">Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Autodesk Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / New York Times Co / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Netflix Inc / ALLETE Inc / Dollar General Corp / Meta Platforms Inc / Duke Energy Corp / Guidewire Software Inc / News Corp / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Shopify Inc / Snap Inc / Pinterest Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Bigcommerce Holdings Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Squarespace Inc / Verve Therapeutics Inc / Weave Communications Inc / Arrowhead Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: U.S. Return Decomposition-Dec. 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ALB.N / ALK.N / BA.N / BAC.N / BMY.N / C.N / CCL.N / CL.N / EOG.N / F.N / FLT.N / GE.N / GPS.N / IBM.N / JNJ.N / JPM.N / KO.N / LLY.N / MDT.N / OXY.N / PFE.N / PM.N / RHI.N / T.N / TMO.N / WFC.N / SPG.N / NUE.N / DIS.N / UNH.N / TFX.N / UNP.N / RCL.N / HD.N / LOW.N / MRO.N / XOM.N / DVN.N / NKE.N / IT.N / GWW.N / VZ.N / DVA.N / V.N / ACN.N / TWTR.N / HPQ.N / COP.N / INTC.OQ / AOS.N / ADBE.OQ / AMGN.OQ / AAPL.OQ / ADSK.OQ / FISV.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / SIVB.OQ / XLNX.OQ / ODFL.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / DISH.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / MTCH.OQ / GPN.N / VRTX.OQ / WYNN.OQ / CMCSA.OQ / EXR.N / MKTX.OQ / LVS.N / VIAC.OQ / DISCA.OQ / FIS.N / STX.AX / MA.N / WU.N / IPGP.OQ / MRNA.OQ / AVGO.OQ / FTNT.OQ / TSLA.OQ / AMD.OQ / ENPH.OQ / FANG.OQ / PTC.OQ / NCLH.N / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / TMUS.OQ / LW.N / FB.PS / TER.OQ / APA.OQ / VTRS.OQ</td><td class="leftalignment">Albemarle Corp / Alaska Air Group Inc / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Citigroup Inc / Carnival Corp / Colgate-Palmolive Co / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Robert Half International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Simon Property Group Inc / Nucor Corp / Walt Disney Co / UnitedHealth Group Inc / Teleflex Inc / Union Pacific Corp / Royal Caribbean Cruises Ltd / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Gartner Inc / W W Grainger Inc / Verizon Communications Inc / DaVita Inc / Visa Inc / Accenture PLC / Twitter Inc / HP Inc / Conocophillips / Intel Corp / A O Smith Corp / Adobe Inc / Amgen Inc / Apple Inc / Autodesk Inc / Fiserv Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / SVB Financial Group / Xilinx Inc / Old Dominion Freight Line Inc / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / DISH Network Corp / Pool Corp / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Wynn Resorts Ltd / Comcast Corp / Extra Space Storage Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / ViacomCBS Inc / Discovery Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / Western Union Co / IPG Photonics Corp / Moderna Inc / Broadcom Inc / Fortinet Inc / Tesla Inc / Advanced Micro Devices Inc / Enphase Energy Inc / Diamondback Energy Inc / PTC Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / Lamb Weston Holdings Inc / San Miguel Food and Beverage Inc / Teradyne Inc / APA Corp (US) / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Ireland / Liberia / Panama / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical Sector: COVID-19 update: Omicron variant still something of a mystery, but looks to be highly transmissible</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">4507.T / 4519.T / PFE.N / ROG.S / GSK.L / REGN.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">12/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品・医療機器セクター: COVID-19に関するアップデート :変異株オミクロンに関しての詳細は依然不透明だが、高い感染性が示唆される</td><td class="leftalignment">Japanese</td><td class="rightalignment">5</td><td class="leftalignment">4507.T / 4519.T / PFE.N / ROG.S / GSK.L / REGN.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">12/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 12.5.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">91324P10 / 71708110 / 44485910 / 30063P10 / 80105N10 / 45784P10 / 25213110 / 45766930 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 04004760 / 21232630 / 05337M104 / 40131M10 / 63230710 / 76029N10 / 41358P10 / 67181A10 / 42226A10 / 09075V10 / 10806X10 / 75615P10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 31189P10 / G3910J11 / 00847X10 / 37890U10 / 34633R10 / 48576U10 / 45845P10 / 82710M10 / 46116X10 / 49232710 / 01671P10 / 28255910 / 28036F10 / 52634L10 / 23003110 / 12552310 / 01626L10 / 60853G10 / 04335A10 / 98422E10 / 00857U10</td><td class="leftalignment">UnitedHealth Group Inc / Pfizer Inc / Humana Inc / Exact Sciences Corp / Sanofi SA / Insulet Corp / Dexcom Inc / Insmed Inc / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Avadel Pharmaceuticals PLC / Guardant Health Inc / Natera Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Oak Street Health Inc / Healthequity Inc / BioNTech SE / BridgeBio Pharma Inc / Reata Pharmaceuticals Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Fate Therapeutics Inc / GlaxoSmithKline PLC / Agios Pharmaceuticals Inc / Global Blood Therapeutics Inc / Forma Therapeutics Holdings Inc / Karyopharm Therapeutics Inc / Intercept Pharmaceuticals Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Keros Therapeutics Inc / Allakos Inc / 89Bio Inc / Edgewise Therapeutics Inc / LENSAR Inc / Cullinan Oncology Inc / Cigna Corp / Aligos Therapeutics Inc / Molecular Partners AG / Arvinas Inc / Xeris Biopharma Holdings Inc / agilon health Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">12/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 87</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">12/04/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">Pfizer Inc.: Credit Rating - Unbiased Research Based on Superior Data</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/04/2021</td><td class="leftalignment">New Constructs, LLC</td><td class="leftalignment">PFE: Forensic Stock Earnings & Valuation</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is A Rise Imminent For Bristol Myers Squibb Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 26 to December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">IL0002810146 / IL0006290147 / US0091581068 / US02553E1064 / US0383361039 / US0536111091 / US0584981064 / US1264081035 / US2017231034 / US2441991054 / US25179M1036 / US2788651006 / US30231G1022 / US31428X1063 / US3154051003 / US3647601083 / US4180561072 / US4282911084 / US4433201062 / US4456581077 / US4523081093 / US5010441013 / US5324571083 / US56418H1005 / US5770811025 / US5949181045 / US64125C1099 / US6516391066 / US6541061031 / US6556641008 / US6558441084 / US6703461052 / US6935061076 / US7170811035 / US7496851038 / US75886F1075 / US7703231032 / US7782961038 / US7802871084 / US81211K1007 / US8243481061 / US8581191009 / US8725401090 / US9078181081 / US9113121068 / US91324P1021 / US9170471026 / US9182041080 / US92532F1003 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA29250N1050 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA2908761018 / CA5592224011 / CA0084741085 / CA0679011084 / CA1363851017 / CA2499061083 / US1667641005 / CA13645T1003 / US9129091081 / CA51925D1069 / CA13677F1018 / CA0641491075 / CA6330671034 / CA7800871021 / US0017441017 / US20825C1045 / US2274831047 / CA5734591046 / US09062X1037 / NO0010208051 / US49446R1095 / CA98462Y1007 / US79466L3024 / US9604131022 / CA5503721063 / US29476L1070 / US7588491032 / US1508701034 / CA8911605092 / CA1360691010 / CA8935781044 / US8288061091 / US44107P1049 / US12541W2098 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / CA32076V1031 / GB00B1FW5029 / US5021751020 / US63633D1046 / CA14068G1046 / US5500211090 / US89785X1019 / US90384S3031 / CA3518581051 / US91912E1055 / CA8672241079 / US58933Y1055 / CA25675T1075 / CA15135U1093 / US2566771059 / CA14042M1023 / NL0009434992 / CA9237251058 / CA07317Q1054 / US18538R1032 / CA00208D4084 / CA2927661025 / US61945C1036 / JE00B4T3BW64 / US6936561009 / US7512121010 / US71922G2093 / CA7063271034 / CA4932711001 / CA89156V1067 / CA55903Q1046 / CA96145A2002 / US70509V1008 / CA04682R1073 / US78573L1061 / US8486371045 / CA87262K1057 / US08579W1036 / US23283R1005 / CA05577W2004 / US1220171060 / US11120U1051 / CA68827L1013 / US78667J1088 / CA0089118776 / BMG0750C1082 / US1638511089 / US92939U1060 / CA8485101031 / US86771W1053 / US72703H1014 / US4622221004 / US45688C1071 / US0441861046 / US7005171050 / CA87241L1094 / US6792951054 / CA9628791027 / GB00BF3ZNS54 / US8760301072 / US8608971078 / US63845R1077 / CA8585221051 / CA67077M1086 / US98980G1022 / US00191U1025 / US83200N1037 / IE00BZ12WP82 / VGG1890L1076 / US28618M1062 / US2605571031 / GB00BJT16S69 / CA87807B1076 / CA14179V5036 / US26614N1028 / US76156B1070 / JE00BJ1F3079 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / MHY0436Q1098 / US03750L1098 / JE00BMVMZ478 / US1651677353 / US24343R1068 / CA00076T1057 / US90364P1057 / US11135E2037 / US5738741041 / US60646V1052 / US0708301041 / US9264001028 / US27923Q1094 / US89269P1030 / US94770D1028 / US53190C1027 / US04302A1043</td><td class="leftalignment">Icl Group Ltd / Teva Pharmaceutical Industries Ltd / Air Products and Chemicals Inc / American Eagle Outfitters Inc / Aptargroup Inc / Avery Dennison Corp / Ball Corp / CSX Corp / Commercial Metals Co / Deere & Co / Devon Energy Corp / Ecolab Inc / Exxon Mobil Corp / FedEx Corp / Ferro Corp / Gap Inc / Hasbro Inc / Hexcel Corp / Hub Group Inc / J B Hunt Transport Services Inc / Illinois Tool Works Inc / Kroger Co / Eli Lilly and Co / ManpowerGroup Inc / Mattel Inc / Microsoft Corp / Neurocrine Biosciences Inc / Newmont Corporation / Nike Inc / Nordstrom Inc / Norfolk Southern Corp / Nucor Corp / PPG Industries Inc / Pfizer Inc / RPM International Inc / Regeneron Pharmaceuticals Inc / Robert Half International Inc / Ross Stores Inc / Royal Gold Inc / Sealed Air Corp / Sherwin-Williams Co / Steel Dynamics Inc / TJX Companies Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Urban Outfitters Inc / VF Corp / Vertex Pharmaceuticals Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Enbridge Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Emera Inc / Magna International Inc / Agnico Eagle Mines Ltd / Barrick Gold Corp / Canadian Natural Resources Ltd / Descartes Systems Group Inc / Chevron Corp / Canadian Pacific Railway Ltd / United States Steel Corp / Laurentian Bank of Canada / Canadian Western Bank / Bank of Nova Scotia / National Bank of Canada / Royal Bank of Canada / AMN Healthcare Services Inc / Conocophillips / Cross Country Healthcare Inc / Martinrea International Inc / Biogen Inc / Yara International ASA / Kimco Realty Corp / Yamana Gold Inc / Salesforce.Com Inc / Westlake Chemical Corp / Lundin Mining Corp / Equity Residential / Regency Centers Corp / Celanese Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / Simon Property Group Inc / Host Hotels & Resorts Inc / CH Robinson Worldwide Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / First Majestic Silver Corp / Hochschild Mining PLC / LTC Properties Inc / National Health Investors Inc / Capstone Mining Corp / Lululemon Athletica Inc / TrueBlue Inc / Ulta Beauty Inc / Franco-Nevada Corp / Vale SA / Suncor Energy Inc / Merck & Co Inc / Dollarama Inc / Cenovus Energy Inc / Dollar General Corp / Capital Power Corp / LyondellBasell Industries NV / Vermilion Energy Inc / Baytex Energy Corp / Clearwater Paper Corp / ARC Resources Ltd / Enerplus Corp / Mosaic Co / Glencore PLC / PVH Corp / Ralph Lauren Corp / PhosAgro PAO / Pembina Pipeline Corp / Keyera Corp / Tourmaline Oil Corp / MAG Silver Corp / Westshore Terminals Investment Corp / Pebblebrook Hotel Trust / Athabasca Oil Corp / Sabra Health Care REIT Inc / Splunk Inc / TMX Group Ltd / Berry Global Group Inc / CyrusOne Inc / BRP Inc / Burlington Stores Inc / Brixmor Property Group Inc / Osisko Gold Royalties Ltd / SAGE Therapeutics Inc / Air Canada / Axalta Coating Systems Ltd / Chemours Co / WEC Energy Group Inc / Spin Master Corp / Sunrun Inc / Planet Fitness Inc / Ionis Pharmaceuticals Inc / Ingevity Corp / Ashland Global Holdings Inc / Park Hotels & Resorts Inc / TFI International Inc / Okta Inc / Wheaton Precious Metals Corp / Venator Materials PLC / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Stelco Holdings Inc / Nutrien Ltd / Zscaler Inc / ASGN Inc / Smartsheet Inc / Linde PLC / Capri Holdings Ltd / Element Solutions Inc / Dow Inc / Tronox Holdings PLC / TC Energy Corp / Cargojet Inc / Dupont De Nemours Inc / Revolve Group Inc / Amcor PLC / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Atlas Corp / Apartment Income REIT Corp / Atotech Ltd / Chesapeake Energy Corp / Decibel Therapeutics Inc / Abc Technologies Holdings Inc / UiPath Inc / Broadstone Net Lease Inc / Marvell Technology Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Ecovyst Inc / Traeger Inc / Weber Inc / Life Time Group Holdings Inc / Arteris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / United Kingdom / Ireland / Israel / Netherlands / Norway / Russian Federation / United States / Virgin Islands, British / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">AZN / 11012210 / 71708110 / 00846U10 / 88162420 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 80105N10 / NOVO B / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / 45845P10</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Sanofi SA / Novo Nordisk A/S / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">REMINDER: KOL Call on Prostate Cancer Landscape and Emerging Therapeutics at 10:00 AM ET on December 6th, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">5671735 / 0989529 / 2023607 / 2778844 / 2475833 / 2576941 / 2684703 / 2730190 / 7103065 / BFDV8K0 / BGCYWN8 / BKVDFF7 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Amgen Inc / Merck & Co Inc / Johnson & Johnson / Exelixis Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / MacroGenics Inc / Xencor Inc / Oric Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COV-BOOST Supports the Status Quo; No Single Best Booster but Some to Avoid</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AZN / 71708110 / 478160104 / 80105N10 / 60770K10</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Johnson & Johnson / Sanofi SA / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / Chad / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">12/03/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - December 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">US0584981064 / US1264081035 / US31428X1063 / US4433201062 / US4456581077 / US5010441013 / US5324571083 / US6516391066 / US6558441084 / US7170811035 / US7802871084 / US9078181081 / US9113121068 / CA53278L1076 / CA1363751027 / CA59162N1096 / CA5394811015 / CA0977512007 / CA30150P1099 / CA1247651088 / CA5592224011 / CA0679011084 / CA13645T1003 / CA5734591046 / US09062X1037 / CA5503721063 / CA8911605092 / CA1360691010 / CA8935781044 / US12541W2098 / CA32076V1031 / US90384S3031 / US2566771059 / CA14042M1023 / JE00B4T3BW64 / CA96145A2002 / CA0089118776 / US4622221004 / CA87241L1094 / CA9628791027 / US83200N1037 / CA14179V5036 / MHY0436Q1098 / CA00076T1057 / US5738741041</td><td class="leftalignment">Ball Corp / CSX Corp / FedEx Corp / Hub Group Inc / J B Hunt Transport Services Inc / Kroger Co / Eli Lilly and Co / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Royal Gold Inc / Union Pacific Corp / United Parcel Service Inc / Linamar Corp / Canadian National Railway Co / Metro Inc / Loblaw Companies Ltd / Bombardier Inc / Exco Technologies Ltd / CAE Inc / Magna International Inc / Barrick Gold Corp / Canadian Pacific Railway Ltd / Martinrea International Inc / Biogen Inc / Lundin Mining Corp / Toronto-Dominion Bank / Canadian Imperial Bank of Commerce / Transcontinental Inc / CH Robinson Worldwide Inc / First Majestic Silver Corp / Ulta Beauty Inc / Dollar General Corp / Capital Power Corp / Glencore PLC / Westshore Terminals Investment Corp / Air Canada / Ionis Pharmaceuticals Inc / TFI International Inc / Wheaton Precious Metals Corp / Smartsheet Inc / Cargojet Inc / Atlas Corp / Abc Technologies Holdings Inc / Marvell Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">12/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 Omicron variant - First data from South Africa suggests immune escape likely</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / ROG.S / GSK.L / REGN.OQ / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Transcript: Expert Call on Alzheimer's Disease</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US5324571083 / US7170811035 / US09062X1037</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer, Inc. in Global Blood Brain Barrier Technologies Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer Inc. in Global Hematuria Treatment Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / BMY=US / IP=US / GILD=US / PEB=US / H=US / CRM=US / MTN=US / MAR=US / TNL=US / HLT=US / AKR=US / APH=US / CHH=US / CSTR=US / DRH=US / REGN=US / ROLL=US / VRTX=US / CVX=US / PSA=US / SPG=US / SNOW=US / SGMS=US / FBK=US / MTCH=US / SRC=US / AUTL=US / BRX=US / PNFP=US / IGMS=US / STRO=US / BIIB=US / EXR=US / BECN=US / SHO=US / PLAY=US / HST=US / WH=US / IAC=US / EPRT=US / HGV=US / RLJ=US / VAC=US / CUBE=US / SPLK=US / RHP=US / ABBV=US / FATE=US / 00770K202 / AFMD=US / BVH=US / NSA=US / EDIT=US / NTLA=US / PK=US / PLYA=US / OKTA=US / ALLO=US / ESTC=US / HARP=US / CRWD=US / GMAB=US / NCNO=US / CELU=US / DHT.UN=CA / REPX=US / ROIV=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Bristol-Myers Squibb Co / International Paper Co / Gilead Sciences Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Salesforce.Com Inc / Vail Resorts Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Amphenol Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Public Storage / Simon Property Group Inc / Snowflake Inc. / Scientific Games Corp / FB Financial Corp / Match Group Inc / Spirit Realty Capital Inc / Autolus Therapeutics PLC / Brixmor Property Group Inc / Pinnacle Financial Partners Inc / IGM Biosciences Inc / Sutro Biopharma Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Host Hotels & Resorts Inc / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Splunk Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Fate Therapeutics Inc / Aemetis Inc / Affimed NV / Bluegreen Vacations Holding Corp / National Storage Affiliates Trust / Editas Medicine Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Allogene Therapeutics Inc / Elastic NV / Harpoon Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / nCino Inc / Celularity Inc / Dri Healthcare Trust / Riley Exploration Permian Inc / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Positive Appeals Court LNP Decision Opens Path to Some Value & Cash for ROIV</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">G7627910 / 71708110 / 09075V10 / 60770K10</td><td class="leftalignment">Roivant Sciences Ltd / Pfizer Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: ASH Planner Highlights 200+ Datapoints Not To Be Missed + Late Breakers</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GILD=US / REGN=US / AUTL=US / IGMS=US / STRO=US / ABBV=US / FATE=US / AFMD=US / EDIT=US / NTLA=US / ALLO=US / HARP=US / GMAB=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Autolus Therapeutics PLC / IGM Biosciences Inc / Sutro Biopharma Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / Editas Medicine Inc / Intellia Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Billal Jahangiri / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">12/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Indonesia Market Strategy - CS Daily Insight - Omicron impact tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / PFE.N / MRNA.OQ</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Indonesia / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Gregorius Gary</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Dec. 01, 2021 / 5:10PM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended December 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US -  Dividend Quality Analysis, for the period ended August 25,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Emerging SARS-COv-2 Variant Is Revenue Growth Opportunity for Vaccine Developer</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">22UAy.DE / PFE.N / MRNA.OQ</td><td class="leftalignment">BioNTech SE / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Big Biopharma Will Have $500Bn in Gross Cash to Deploy YE22 - Get Set for M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AZN / 71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 478160104 / 80105N10 / 58933Y10 / 00287Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Sanofi SA / Merck & Co Inc / Abbvie Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0989529 / 2000019 / 2778844 / 2437071 / 2219224 / 2190750 / 2216850 / 2270726 / 2317087 / 2328915 / 2455965 / 2457864 / 2638625 / 2684703 / B067BM3 / 2857817 / B7TL820 / BDZCRX3 / BZ07BW4 / BYRY499 / BNGY4Q0 / BD9GVY0 / BZ1LFB2 / BZ00V34 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BKTNTR9 / BJVR9Y9 / BYY88Y7 / BDZ30Q0 / BMPRZV5 / BN7K304 / BNNTQY0 / BP7KZP7 / BMHRMK1 / BP81RH5</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / National Beverage Corp / Pfizer Inc / Molson Coors Beverage Co / Netflix Inc / Meta Platforms Inc / RingCentral Inc / Monster Beverage Corp / Kraft Heinz Co / Nextera Energy Partners LP / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Zscaler Inc / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / ViacomCBS Inc / iHeartMedia Inc / Alphabet Inc / Arvinas Inc / Kymera Therapeutics Inc / Academy Sports and Outdoors Inc / Oatly Group AB / Monte Rosa Therapeutics Inc / Vita Coco Company Inc / Allbirds Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Cayman Islands / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Close Vote Reflects Doubts about Molnupiravir Risk Benefit; PFE Should Be OK</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">PFE.N / 71708110 / 58933Y10 / 29251M10 / 04683R10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Merck & Co Inc / Enanta Pharmaceuticals Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Ms. Roanna C. Ruiz / Dilip Joseph / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Insurance Sector: Experts Project COVID "Winter Surge"; Potential Improvement Still Possible by Mid-2022, While Omicron Adds Uncertainty</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">HIG.N / RGA.N / AFL.N / AIG.N / PFE.N / HUM.N / MET.N / PRI.N / UNM.N / AMP.N / LNC.N / PRU.N / GL.N / AEL.N / MRNA.OQ / VOYA.N / BHF.OQ / PFG.OQ / EQH.N</td><td class="leftalignment">Hartford Financial Services Group Inc / Reinsurance Group of America Inc / Aflac Inc / American International Group Inc / Pfizer Inc / Humana Inc / MetLife Inc / Primerica Inc / Unum Group / Ameriprise Financial Inc / Lincoln National Corp / Prudential Financial Inc / Globe Life Inc / American Equity Investment Life Holding Co / Moderna Inc / Voya Financial Inc / Brighthouse Financial Inc / Principal Financial Group Inc / Equitable Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United States</td><td class="leftalignment">Financial Services / Insurance</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Andrew S. Kligerman / Ms. Wilma Burdis</td></tr>
<tr class="even"><td class="leftalignment">12/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">CS Specialty Chemicals Winter Conference 2021: Key Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AIRP.PA / CRDA.L / JMAT.L / PFE.N / CLN.S / LXSG.DE / 3333.HK / WCHG.DE / BASFN.DE / DQ.ZY</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Croda International PLC / Johnson Matthey PLC / Pfizer Inc / Clariant AG / Lanxess AG / China Evergrande Group / Wacker Chemie AG / BASF SE / Daqo New Energy Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Chemicals / Industrial Materials</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Samuel Perry / Tristan Lamotte</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Molnupiravir's FDA AdCom Votes Favorably (13:10) but Challenges Highlighted</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US58933Y1055 / US7170811035</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer up 6.6% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is A Rise Imminent For Merck Stock After An 8% Fall In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">REGN Confirms COVID Ab Cocktail May Be Less Effective Against Omicron</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">REGN.OQ / US5324571083 / US7170811035 / US75886F1075</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / TWTR=US / PG=US / WEN=US / BLD=US / LOW=US / SWN=US / EXPE=US / LEG=US / VMC=US / MLM=US / SWIM=US / BLL=US / CBRL=US / CHD=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / OI=US / REGI=US / SGMO=US / SEE=US / TRIP=US / BKNG=US / SIVB=US / CNM=US / FB=US / DIN=US / MGNI=US / PNFP=US / RGF=US / OGN / MNST=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / BERY=US / TILE=US / NDLS=US / FATE=US / 00770K202 / LOCO=US / AFMD=US / SHAK=US / WING=US / 82982L103 / IRTC=US / TRVG=US / JELD=US / YEXT=US / FERG=US / BRBR=US / AZEK=US / VTRS=US / ABNB=US / 67421J108 / DNUT=US / SNPO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Twitter Inc / Procter & Gamble Co / Wendys Co / TopBuild Corp / Lowe's Companies Inc / Southwestern Energy Co / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Ball Corp / Cracker Barrel Old Country Store Inc / Church & Dwight Co Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / O-I Glass Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Sealed Air Corp / Tripadvisor Inc / Booking Holdings Inc / SVB Financial Group / Core & Main Inc / Meta Platforms Inc / Dine Brands Global Inc / Magnite Inc / Pinnacle Financial Partners Inc / Real Good Food Company Inc / Organon & Co / Monster Beverage Corp / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Berry Global Group Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Affimed NV / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / Trivago NV / JELD-WEN Holding Inc / Yext Inc / Ferguson PLC / Bellring Brands Inc / Azek Company Inc / Viatris Inc / Airbnb Inc / Oatly Group AB / Krispy Kreme Inc / Snap One Holdings Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2936921 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2190750 / 2216850 / 2270726 / 2317087 / 2670519 / 2328915 / 2415204 / 2684703 / 7103065 / 2857817 / B3D7K31 / B7TL820 / B7VD3F2 / BDZCRX3 / BFLR866 / BVVN4Q8 / BXDZ9Z0 / BMYML02 / BFMXGR0 / BKTNTR9 / BWY52P3 / BYY88Y7 / BD6JX35 / BM8MM05 / BYQCZ35 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / Chesapeake Utilities Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Hawaiian Electric Industries Inc / Pfizer Inc / Novartis AG / Netflix Inc / Discovery Inc / Meta Platforms Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Eversource Energy / Shopify Inc / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Blueprint Medicines Corp / Alphabet Inc / Krystal Biotech Inc / Madison Square Garden Entertainment Corp / Madison Square Garden Sports Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Key takeaways from GSK's Management HIV call</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">GSK.L / 4507.T / PFE.N / GILD.OQ / HALO.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / Shionogi & Co Ltd / Pfizer Inc / Gilead Sciences Inc / Halozyme Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">207940.KS: Samsung Biologics Co., Ltd. - A focused large-scale biologics specialist</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">207940.KS / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / ROG.S / DHR.N / 1177.HK / TEVA.TA / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / 005930.KS / 000100.KS / 008930.KS / SFZN.S / BIIB.OQ / 006280.KS / TEVA.N / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / 032830.KS / 128940.KS / ABBV.N / CTLT.N / 196170.KQ / 028260.KS / 2269.HK / 091990.KQ / 302440.KS</td><td class="leftalignment">Samsung Biologics Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Danaher Corp / Sino Biopharmaceutical Ltd / Teva Pharmaceutical Industries Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / Samsung Electronics Co Ltd / Yuhan Corp / Hanmi Science Co Ltd / Siegfried Holding AG / Biogen Inc / Green Cross Corp / Teva Pharmaceutical Industries Ltd / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Samsung Life Insurance Co Ltd / Hanmi Pharm Co Ltd / Abbvie Inc / Catalent Inc / Alteogen Inc / Samsung C&T Corp / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Israel / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">302440.KS: SK Bioscience Co., Ltd. - A rising vaccine manufacturing and development powerhouse</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">302440.KS / 4502.T / 4901.T / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVAX.OQ / 000100.KS / 008930.KS / 006120.KS / 069620.KS / SFZN.S / 006280.KS / EBS.N / INO.OQ / MRNA.OQ / 068270.KS / 1099.HK / 034730.KS / 128940.KS / CTLT.N / 196170.KQ / 207940.KS / 2269.HK / 091990.KQ / 326030.KS / CVAC.OQ / PPGN.S / 2197.HK</td><td class="leftalignment">SK Bioscience Co Ltd / Takeda Pharmaceutical Co Ltd / Fujifilm Holdings Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novavax Inc / Yuhan Corp / Hanmi Science Co Ltd / SK Discovery Co Ltd / Daewoong Pharma / Siegfried Holding AG / Green Cross Corp / Emergent BioSolutions Inc / Inovio Pharmaceuticals Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / SK Inc / Hanmi Pharm Co Ltd / Catalent Inc / Alteogen Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / Celltrion Healthcare Co Ltd / SK Biopharmaceuticals Co Ltd / CureVac NV / PolyPeptide Group AG / Clover Biopharmaceuticals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Japan / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - A committed CMO player within Korean large pharmas</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">006280.KS / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / APNJ.J / NVAX.OQ / SFZN.S / 005250.KS / EBS.N / MRNA.OQ / 068270.KS / 1099.HK / CTLT.N / 207940.KS / 2269.HK / 302440.KS</td><td class="leftalignment">Green Cross Corp / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Aspen Pharmacare Holdings Ltd / Novavax Inc / Siegfried Holding AG / Green Cross Holdings / Emergent BioSolutions Inc / Moderna Inc / Celltrion Inc / Sinopharm Group Co Ltd / Catalent Inc / Samsung Biologics Co Ltd / WuXi Biologics (Cayman) Inc / SK Bioscience Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Korea, Republic of / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Contract Manufacturing Sector: Visible growth pathways for Korean CMOs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">207940.KS / 302440.KS / BAX.N / JNJ.N / PFE.N / TMO.N / AZN.L / SASY.PA / DHR.N / 1177.HK / MRCG.DE / LONN.S / SATG.DE / BANB.S / GSK.L / NVAX.OQ / SFZN.S / 006280.KS / EBS.N / MRNA.OQ / 1099.HK / CTLT.N / 2269.HK</td><td class="leftalignment">Samsung Biologics Co Ltd / SK Bioscience Co Ltd / Baxter International Inc / Johnson & Johnson / Pfizer Inc / Thermo Fisher Scientific Inc / AstraZeneca PLC / Sanofi SA / Danaher Corp / Sino Biopharmaceutical Ltd / Merck KGaA / Lonza Group AG / Sartorius AG / Bachem Holding AG / GlaxoSmithKline PLC / Novavax Inc / Siegfried Holding AG / Green Cross Corp / Emergent BioSolutions Inc / Moderna Inc / Sinopharm Group Co Ltd / Catalent Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">This Pharmaceuticals Stock Is A Better Pick Over Bristol Myers Squibb</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Chase a Check (Vol. 2) — Biopharma/MedTech Cash Runway Map</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">11012210 / 71708110 / 37555810 / 00422510 / 771195104 / 03152W10 / 58933Y10 / 02311120 / 45766930 / 80360710 / 05463X10 / 31572Q80 / 00653A107 / 04351P101 / XERS / 98401F10 / 04004760 / 21232630 / 05337M104 / 23283X20 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 98420N10 / 58949210 / 90041T10 / 09627Y10 / Y9530810 / 30052C10 / 09075V10 / 00289Y10 / 09609G10 / 75901B10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / 01438T10 / 74374N10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 98978L20 / 04685N10 / 13089P10 / 34633R10 / 38341P10 / 43906K10 / 46565G10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 98887Q10 / 98943L10 / 45845P10 / 4525EP10 / 78667J10 / 46116X10 / 90400D10 / 69014510 / 35961610 / 55886810 / 05454B10 / 04539610 / 45249V10 / 80405P10 / 75955J40 / 56400P70 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 28617K10 / 03824M10 / 36322Q10 / N4444510 / 45258J10 / 56854Q20 / 74623710 / H9060V101 / 89422G10 / 82939910 / 87410C10 / 36870G10 / 64128810 / 28036F10 / N5749R10 / 24343R10 / 52634L10 / 49705R10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 29251M10 / 81064810 / G637AM10 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Gilead Sciences Inc / ACADIA Pharmaceuticals Inc / Roche Holding AG / Amicus Therapeutics Inc / Merck & Co Inc / Amarin Corporation PLC / Insmed Inc / Sarepta Therapeutics Inc / AxoGen Inc / FibroGen Inc / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Xeris Biopharma Holdings Inc / Xencor Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Xenon Pharmaceuticals Inc / Mereo Biopharma Group PLC / Turning Point Therapeutics Inc / Blueprint Medicines Corp / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Abeona Therapeutics Inc / bluebird bio Inc / Regenxbio Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Zogenix Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Iteos Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Intra-Cellular Therapies Inc / Ultragenyx Pharmaceutical Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Assembly Biosciences Inc / Imara Inc / Satsuma Pharmaceuticals Inc / Relmada Therapeutics Inc / MannKind Corp / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / Eledon Pharmaceuticals Inc / Applied Molecular Transport Inc. / Galecto Inc / Immatics NV / Immunovant Inc / Marinus Pharmaceuticals Inc / PureTech Health PLC / VectivBio Holding AG / Travere Therapeutics Inc / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Gemini Therapeutics Inc / Neuropace Inc / Edgewise Therapeutics Inc / Merus NV / Decibel Therapeutics Inc / LENSAR Inc / Kinnate Biopharma Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Netherlands / Singapore / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Joseph P. Schwartz / Mr. Thomas J. Smith / Geoffrey Porges, MBBS / Greco Song, Ph.D. / Priya Sachdeva / Rudy Li, Ph.D. / Jeffrey La Rosa / Will Soghikian / Mike Kratky, CFA / Anna Baran, CFA / Ms. Danielle J. Antalffy / Andrew Berens, M.D. / Mr. Rick Bienkowski, Ph.D. / Jonathan Chang, Ph.D., CFA / Mr. Marc Goodman / Daina Graybosch, Ph.D. / Christopher Liu, Pharm.D. / Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">US02553E1064 / US2441991054 / US25179M1036 / US3647601083 / US5324571083 / US6541061031 / US6556641008 / US7170811035 / US75886F1075 / US7782961038 / US8725401090 / US9170471026 / US9182041080 / CA1363851017 / US20825C1045 / US49446R1095 / US29476L1070 / US7588491032 / US8288061091 / US44107P1049 / US9043111072 / US3137472060 / US29472R1086 / US8666741041 / US63633D1046 / US5500211090 / US90384S3031 / CA8672241079 / US58933Y1055 / CA15135U1093 / CA00208D4084 / CA2927661025 / US6936561009 / US7512121010 / CA89156V1067 / US70509V1008 / US78573L1061 / US23283R1005 / CA0266951064 / US1220171060 / US86771W1053 / US72703H1014 / US7005171050 / US8760301072 / US8608971078 / US63845R1077 / VGG1890L1076 / US76156B1070 / US88339P1012 / US86745K1043 / US70614W1009 / US69047Q1022 / US03750L1098 / US1651677353 / US24343R1068 / US11135E2037 / US60646V1052 / US0708301041 / US9264001028 / US89269P1030 / US94770D1028 / US53190C1027</td><td class="leftalignment">American Eagle Outfitters Inc / Deere & Co / Devon Energy Corp / Gap Inc / Eli Lilly and Co / Nike Inc / Nordstrom Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / TJX Companies Inc / Urban Outfitters Inc / VF Corp / Canadian Natural Resources Ltd / Conocophillips / Kimco Realty Corp / Equity Residential / Regency Centers Corp / Simon Property Group Inc / Host Hotels & Resorts Inc / Under Armour Inc / Federal Realty Investment Trust / Equity LifeStyle Properties Inc / Sun Communities Inc / National Health Investors Inc / Lululemon Athletica Inc / Ulta Beauty Inc / Suncor Energy Inc / Merck & Co Inc / Cenovus Energy Inc / ARC Resources Ltd / Enerplus Corp / PVH Corp / Ralph Lauren Corp / Tourmaline Oil Corp / Pebblebrook Hotel Trust / Sabra Health Care REIT Inc / CyrusOne Inc / American Hotel Income Properties REIT LP / Burlington Stores Inc / Sunrun Inc / Planet Fitness Inc / Park Hotels & Resorts Inc / Tapestry Inc / Stitch Fix Inc / National Vision Holdings Inc / Capri Holdings Ltd / Revolve Group Inc / RealReal Inc / Sunnova Energy International Inc / Peloton Interactive Inc / Ovintiv Inc / Apartment Income REIT Corp / Chesapeake Energy Corp / Decibel Therapeutics Inc / Broadstone Net Lease Inc / Mister Car Wash Inc / Bath & Body Works Inc / Victoria's Secret & Co / Traeger Inc / Weber Inc / Life Time Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : COVID Update: Formally Incorporating Paxlovid Estimates, Raising Comirnaty Outlook</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ICT sector: CS ICT Weekly update Vol. 29: Semiconductor shortages, JTOWER, DeCurret, SBG NAV Tracker</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4485.T / 0941.HK / 1951.T / 2317.TW / 9432.T / 9433.T / 9434.T / 9613.T / BT.L / CRM.N / KPN.AS / PFE.N / T.N / TEF.MC / VOD.L / WIPR.BO / 4684.T / 4716.T / 9984.T / 9719.T / SCMN.S / 4704.T / INFY.BO / 8056.T / 4739.T / 0762.HK / VZ.N / ORCL.N / 4768.T / TEL.OL / ACN.N / 7518.T / TEL2B.ST / TELIA.ST / 4307.T / 2327.T / 0728.HK / ADBE.OQ / ADSK.OQ / MSFT.OQ / INTU.OQ / DISH.OQ / CHKP.OQ / ANSS.OQ / AKAM.OQ / TLIT.MI / 1721.T / CG.TO / TCS.BO / 3774.T / PROX.BR / TNET.BR / KKR.N / BX.N / VMW.N / 3626.T / 1417.T / APO.N / NOW.N / ORAN.PA / NOS.LS / CLNX.MC / TMUS.OQ / OBEL.BR / ELISA.HE / WDAY.OQ / AFYA.OQ / SCU.N</td><td class="leftalignment">JTOWER Inc / China Mobile Ltd / EXEO Group Inc / Hon Hai Precision Industry Co Ltd / Nippon Telegraph and Telephone Corp / KDDI Corp / SoftBank Corp / NTT Data Corp / BT Group PLC / Salesforce.Com Inc / Koninklijke KPN NV / Pfizer Inc / AT&T Inc / Telefonica SA / Vodafone Group PLC / Wipro Ltd / Obic Co Ltd / Oracle Corp Japan / SoftBank Group Corp / SCSK Corp / Swisscom AG / Trend Micro Inc / Infosys Ltd / Nihon Unisys Ltd / Itochu Techno-Solutions Corp / China Unicom Hong Kong Ltd / Verizon Communications Inc / Oracle Corp / Otsuka Corp / Telenor ASA / Accenture PLC / Net One Systems Co Ltd / Tele2 AB / Telia Company AB / Nomura Research Institute Ltd / NS Solutions Corp / China Telecom Corp Ltd / Adobe Inc / Autodesk Inc / Microsoft Corp / Intuit Inc / DISH Network Corp / Check Point Software Technologies Ltd / ANSYS Inc / Akamai Technologies Inc / Telecom Italia SpA / Comsys Holdings Corp / Centerra Gold Inc / Tata Consultancy Services Ltd / Internet Initiative Japan Inc / Proximus NV / Telenet Group Holding NV / KKR & Co Inc / Blackstone Inc / VMware Inc / TIS Inc / Mirait Holdings Corp / Apollo Global Management Inc / ServiceNow Inc / Orange SA / NOS SGPS SA / Cellnex Telecom SA / T-Mobile US Inc / Orange Belgium SA / Elisa Oyj / Workday Inc / Afya Ltd / Sculptor Capital Management Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Japan / Netherlands / Norway / Portugal / Sweden / Taiwan / United States</td><td class="leftalignment">Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Hiroyasu Eguchi / Ikuto Itami</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">情報通信セクター: CS ICT Weeklyアップデート Vol.29: 半導体不足、JTOWER、ディーカレット、SBG NAVトラッカー</td><td class="leftalignment">Japanese</td><td class="rightalignment">31</td><td class="leftalignment">0941.HK / 1951.T / 2317.TW / 9432.T / 9433.T / 9434.T / 9613.T / BT.L / CRM.N / KPN.AS / PFE.N / T.N / TEF.MC / VOD.L / WIPR.BO / 4684.T / 4716.T / 9984.T / 9719.T / SCMN.S / 4704.T / INFY.BO / 8056.T / 4739.T / 0762.HK / VZ.N / ORCL.N / 4768.T / TEL.OL / ACN.N / 7518.T / TEL2B.ST / TELIA.ST / 4307.T / 2327.T / 0728.HK / ADBE.OQ / ADSK.OQ / MSFT.OQ / INTU.OQ / DISH.OQ / CHKP.OQ / ANSS.OQ / AKAM.OQ / TLIT.MI / 1721.T / CG.TO / TCS.BO / 3774.T / PROX.BR / TNET.BR / KKR.N / BX.N / VMW.N / 3626.T / 1417.T / APO.N / NOW.N / ORAN.PA / NOS.LS / CLNX.MC / TMUS.OQ / OBEL.BR / ELISA.HE / WDAY.OQ / AFYA.OQ / SCU.N / 4485.T</td><td class="leftalignment">China Mobile Ltd / EXEO Group Inc / Hon Hai Precision Industry Co Ltd / Nippon Telegraph and Telephone Corp / KDDI Corp / SoftBank Corp / NTT Data Corp / BT Group PLC / Salesforce.Com Inc / Koninklijke KPN NV / Pfizer Inc / AT&T Inc / Telefonica SA / Vodafone Group PLC / Wipro Ltd / Obic Co Ltd / Oracle Corp Japan / SoftBank Group Corp / SCSK Corp / Swisscom AG / Trend Micro Inc / Infosys Ltd / Nihon Unisys Ltd / Itochu Techno-Solutions Corp / China Unicom Hong Kong Ltd / Verizon Communications Inc / Oracle Corp / Otsuka Corp / Telenor ASA / Accenture PLC / Net One Systems Co Ltd / Tele2 AB / Telia Company AB / Nomura Research Institute Ltd / NS Solutions Corp / China Telecom Corp Ltd / Adobe Inc / Autodesk Inc / Microsoft Corp / Intuit Inc / DISH Network Corp / Check Point Software Technologies Ltd / ANSYS Inc / Akamai Technologies Inc / Telecom Italia SpA / Comsys Holdings Corp / Centerra Gold Inc / Tata Consultancy Services Ltd / Internet Initiative Japan Inc / Proximus NV / Telenet Group Holding NV / KKR & Co Inc / Blackstone Inc / VMware Inc / TIS Inc / Mirait Holdings Corp / Apollo Global Management Inc / ServiceNow Inc / Orange SA / NOS SGPS SA / Cellnex Telecom SA / T-Mobile US Inc / Orange Belgium SA / Elisa Oyj / Workday Inc / Afya Ltd / Sculptor Capital Management Inc / JTOWER Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / China / Cayman Islands / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Japan / Netherlands / Norway / Portugal / Sweden / Taiwan / United States</td><td class="leftalignment">Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Hiroyasu Eguchi / Ikuto Itami</td></tr>
<tr class="odd"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (29 November-): Concerns over new COVID-19 variant; scope for refocus on Shionogi</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4507.T / 4502.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品・医療機器セクター: 週間レビューと見通し（11月29日～）: COVID-19新変異株の懸念で市場の警戒感が増大、塩野義に見直し余地あり</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4507.T / 4502.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Pfizer - $58.16 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.5% Above Pre-Pandemic Base- Week 86</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Omicron Variant: What We Know, What We Don’t, and the Impact on Our Coverage</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US5324571083 / US7170811035 / US75886F1075 / US58933Y1055</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States / South Africa</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not to be Alarmist but Nu is Alarming – and Good for PFE and Other Incumbents</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">PFE.N / 71708110 / 75886F10 / 58933Y10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Anna Baran, CFA / Daniel Tarjan, Ph.D. / Na Sun / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">COVID/scope Real-Time Update: Emerging Nu Strain Should Remind of Caution, Not Necessarily Cause Panic</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK.N / PFE.N / GILD.O / INCY.O / ENTA.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Incyte Corp / Enanta Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Stephen Mallon / Leonid Timashev</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">2936921 / 2000019 / 2065159 / 2206657 / 2270726 / 2317087 / 2344922 / 2689560 / 2684703 / 2829601 / 2969637 / 2857817 / BVVN4Q8 / BD8DJ71 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BN7K304 / BNTB3N8 / BFYVZ75 / BNKGXX2</td><td class="leftalignment">Walmart Inc / Amazon.com Inc / Autodesk Inc / Coca-Cola Co / Walt Disney Co / Entergy Corp / Jack in the Box Inc / PG&E Corp / Pfizer Inc / Southern Co / DICK'S Sporting Goods Inc / Netflix Inc / Eversource Energy / Snap Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Roku Inc / Academy Sports and Outdoors Inc / Vizio Holding Corp / Seelos Therapeutics Inc / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: How worried should we be about COVID?</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CCL.N / PFE.N / RYA.I / RCL.N / MRCG.DE / EZJ.L / GILD.OQ / NCLH.N</td><td class="leftalignment">Carnival Corp / Pfizer Inc / Ryanair Holdings PLC / Royal Caribbean Cruises Ltd / Merck KGaA / Easyjet PLC / Gilead Sciences Inc / Norwegian Cruise Line Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Germany / United Kingdom / Ireland / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam / Marc el Koussa</td></tr>
<tr class="even"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Initial thoughts on new variant B.1.1.529; Delta displacement concerning</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / ROG.S / GSK.L / REGN.OQ</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Cases and hospitalisation trends: UK hospitalisation rates lower vs rest of Europe - possible link to vaccine choice</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / 1099.HK</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / VTRS / ANIP / ARDS / ETTX / AZYO</td><td class="leftalignment">Pfizer Inc / Viatris Inc / ANI Pharmaceuticals Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/25/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">US7170811035 / CA29250N1050 / US9604131022 / CA1125851040 / CA01626P4033 / CA54928Q1081 / CA7063271034 / CA4932711001 / CA80013R2063 / CA5054401073 / US4622221004 / BMG162341090 / US3843135084 / CA87807B1076</td><td class="leftalignment">Pfizer Inc / Enbridge Inc / Westlake Chemical Corp / Brookfield Asset Management Inc / Alimentation Couche-Tard Inc / Lucara Diamond Corp / Pembina Pipeline Corp / Keyera Corp / Sandstorm Gold Ltd / Labrador Iron Ore Royalty Corp / Ionis Pharmaceuticals Inc / Brookfield Business Partners LP / GrafTech International Ltd / TC Energy Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Access to Medicine Foundation</td><td class="leftalignment">Antimicrobial Resistance  Benchmark 2021</td><td class="leftalignment">English</td><td class="rightalignment">189</td><td class="leftalignment">4507.T / ABT.N / JNJ.N / MRK.N / PFE.N / SASY.PA / NOVN.S / TEVA.TA / GSK.L / CIPL.NS / SUN.NS / ARBN.NS / ALKE.NS / VTRS.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Sanofi SA / Novartis AG / Teva Pharmaceutical Industries Ltd / GlaxoSmithKline PLC / Cipla Ltd / Sun Pharmaceutical Industries Ltd / Aurobindo Pharma Ltd / Alkem Laboratories Ltd / Viatris Inc</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Brazil / Switzerland / China / Germany / France / United Kingdom / India / Israel / Japan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Team Index</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">PFE/IONS Positive Vupanorsen Ph2b Data Helps Validate LICA in Large CV Market</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / IONS.OQ / US7170811035 / US4622221004</td><td class="leftalignment">Pfizer Inc / Ionis Pharmaceuticals Inc / Pfizer Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gary Nachman / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Ownership Timelines & Shareholder Analytics (November 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Germany / Egypt / Spain / France / United Kingdom / India / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Poland / Russian Federation / Singapore / Sweden / Thailand / Turkey / Taiwan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / ADI=US / MDT=US / NVDA=US / MPWR=US / DIOD=US / AIR=US / ATRO=US / AVGO=US / B=US / CBRL=US / ELY=US / CW=US / DCO=US / HEI=US / HXL=US / MRCY=US / MCHP=US / PLAN=US / ROLL=US / TGI=US / VSEC=US / GOLF=US / BKNG=US / SPR=US / MOG.A=US / TDG=US / KTOS=US / JACK=US / NXPI=US / WWD=US / ABBV=US / FATE=US / AFMD=US / ON=US / AJRD=US / BWXT=US / MAXR=US / LHX=US / SPCE=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Medtronic PLC / NVIDIA Corp / Monolithic Power Systems Inc / Diodes Inc / AAR Corp / Astronics Corp / Broadcom Inc / Barnes Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Curtiss-Wright Corp / Ducommun Inc / HEICO Corp / Hexcel Corp / Mercury Systems Inc / Microchip Technology Inc / Anaplan Inc / RBC Bearings Inc / Triumph Group Inc / VSE Corp / Acushnet Holdings Corp / Booking Holdings Inc / Spirit AeroSystems Holdings Inc / Moog Inc / TransDigm Group Inc / Kratos Defense and Security Solutions Inc / Jack in the Box Inc / NXP Semiconductors NV / Woodward Inc / Abbvie Inc / Fate Therapeutics Inc / Affimed NV / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Maxar Technologies Inc / L3harris Technologies Inc / Virgin Galactic Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Ireland / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mexico / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Philippines / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">0925288 / 2936921 / 2360326 / 2000019 / 2094670 / 2293819 / 2778844 / 2050832 / 2065159 / 2270726 / 2272476 / 2317087 / 2641827 / 2689560 / 2680905 / 2684703 / 2746711 / 2138158 / 2989301 / 2857817 / 2951452 / B3D7K31 / 2855930 / B7TL820 / BF311Y5 / B7VD3F2 / B95N910 / BFLR866 / BTN1Y11 / BJ1FD74 / BWTN5N1 / BFD20M9 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BZ1LFG7 / BYY88Y7 / BNTB3N8 / BD5GSZ4 / BMFPHK2 / BL6G4S4</td><td class="leftalignment">GlaxoSmithKline PLC / Walmart Inc / Gap Inc / Amazon.com Inc / Best Buy Co Inc / eBay Inc / Merck & Co Inc / Ameren Corp / Autodesk Inc / Walt Disney Co / Dollar Tree Inc / Entergy Corp / Nordstrom Inc / PG&E Corp / PPL Corp / Pfizer Inc / Ross Stores Inc / Sempra Energy / TJX Companies Inc / Netflix Inc / J M Smucker Co / Discovery Inc / Overstock.com Inc / Meta Platforms Inc / Burlington Stores Inc / Duke Energy Corp / PTC Inc / Twitter Inc / Medtronic PLC / Revolve Group Inc / ETSY Inc / Farfetch Ltd / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc / ThredUp Inc / Poshmark Inc</td><td class="leftalignment"></td><td class="leftalignment">United Arab Emirates / Argentina / Australia / Belgium / Brazil / Canada / Switzerland / China / Cayman Islands / Germany / Egypt / Spain / France / United Kingdom / Greece / Hong Kong / India / Ireland / Iran, Islamic Republic of / Italy / Japan / Korea, Republic of / Kuwait / Mali / Malaysia / Nigeria / Netherlands / Norway / New Zealand / Poland / Russian Federation / Saudi Arabia / Singapore / Slovakia / Sweden / Thailand / Turkey / Taiwan / United States / Vietnam / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMMODITY RESEARCH / COMPANY (EQUITY) REPORTS / ECONOMIC REPORTS / FIXED INCOME/DEBT RESEARCH / FOREIGN EXCHANGE / CURRENCIES / INDUSTRY REPORTS / MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Research Digest / Investment Strategy</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Model Update and raising price targets for ABBV, LLY, MRK, PFE</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / ABBV=US / LLY=US / MRK.N / MRK=US / PFE=US</td><td class="leftalignment">Pfizer Inc / Abbvie Inc / Eli Lilly and Co / Merck & Co Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DNB / FISV=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / OXY=US / RRC=US / EFX=US / WEN=US / AMZN=US / BLD=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / TRU=US / V=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / MGY=US / SWN=US / MUR=US / MRO=US / EXPE=US / LEG=US / VMC=US / BKI=US / MLM=US / UNH=US / PATH=US / SWIM=US / HRT=US / CBRL=US / CTRA=US / CENT=US / CNX=US / CSGP=US / DRI=US / EQT=US / EEFT=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / PCTY=US / SSNC=US / TRIP=US / WEX=US / FOUR=US / CVX=US / GPN=US / PYPL=US / BKNG=US / CNM=US / FB=US / VNO=US / EVOP=US / COP=US / APPN=US / DIN=US / INST=US / MQ / OGN / FLT=US / TPX=US / EXP=US / BECN=US / TXRH=US / PLAY=US / DENN=US / XM=US / BLDR=US / GMS=US / CMG=US / FIS=US / MA=US / PGTI=US / WU=US / AWI=US / OC=US / AMRX=US / TAST=US / CENTA=US / QSR=US / CLR=US / PRPL=US / KTOS=US / NOG=US / JACK=US / VRSK=US / TREX=US / AR=US / OAS=US / GDOT=US / ESTE=US / FBHS=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / VNOM=US / COUP=US / LOCO=US / AFMD=US / CIVI=US / SHAK=US / AJRD=US / WING=US / SQ=US / IBEX=US / 82982L103 / CDEV=US / TRVG=US / JELD=US / SBOW=US / MAXR=US / UBER=US / LSPD=US / FERG=US / LHX=US / RPAY=US / OVV=US / SPCE=US / AZEK=US / PAYA=US / VTRS=US / ABNB=US / AFRM=US / ROCC=US / COUR=US / REPX=US / SNPO=US / UDMY=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Equifax Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / TransUnion / Visa Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / Vulcan Materials Co / Black Knight Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / UiPath Inc / Latham Group Inc / HireRight Holdings Corp / Cracker Barrel Old Country Store Inc / Coterra Energy Inc / Central Garden & Pet Co / CNX Resources Corp / CoStar Group Inc / Darden Restaurants Inc / EQT Corp / Euronet Worldwide Inc / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Paylocity Holding Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / WEX Inc / Shift4 Payments Inc / Chevron Corp / Global Payments Inc / PayPal Holdings Inc / Booking Holdings Inc / Core & Main Inc / Meta Platforms Inc / Vornado Realty Trust / EVO Payments Inc / Conocophillips / Appian Corp / Dine Brands Global Inc / Instructure Holdings Inc / Marqeta Inc / Organon & Co / Fleetcor Technologies Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Mastercard Inc / PGT Innovations Inc / Western Union Co / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Central Garden & Pet Co / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Verisk Analytics Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / Green Dot Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Viper Energy Partners LP / Coupa Software Inc / El Pollo Loco Holdings Inc / Affimed NV / Civitas Resources Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Wingstop Inc / Block Inc / Ibex Ltd / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Maxar Technologies Inc / Uber Technologies Inc / Lightspeed Commerce Inc / Ferguson PLC / L3harris Technologies Inc / Repay Holdings Corp / Ovintiv Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Paya Holdings Inc / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Ranger Oil Corp / Coursera Inc / Riley Exploration Permian Inc / Snap One Holdings Corp / Udemy Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Cash Windfall Coming from Paxlovid with $24bn+ in Sales in 2022E; PFE PT to $52</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">71708110 / G3910J11 / GSK.L / F5548N10</td><td class="leftalignment">Pfizer Inc / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Daniel Tarjan, Ph.D. / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">11/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2023607 / 2293819 / 2778844 / 2050832 / 2026242 / 2270726 / 2317087 / 2670519 / 2415204 / 2623911 / 2684703 / 2967589 / 7103065 / 2170473 / 2857817 / B3D7K31 / 2855930 / BBPK0J0 / BZ07BW4 / BZ1LFB2 / BJ1FD74 / BWTN5N1 / BFD20M9 / BFZ1K46 / BYXJQG9 / BKTNTR9 / BYY88Y7 / BJMLSD2 / BD5GSZ4 / BM8NHS1 / BP2P6L0 / BMFPHK2 / BL6G4S4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / eBay Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Hawaiian Electric Industries Inc / Neurocrine Biosciences Inc / Pfizer Inc / Williams-Sonoma Inc / Novartis AG / Constellation Brands Inc / Netflix Inc / Discovery Inc / Overstock.com Inc / Mirati Therapeutics Inc / Monster Beverage Corp / Deciphera Pharmaceuticals Inc / Revolve Group Inc / ETSY Inc / Farfetch Ltd / Spotify Technology SA / Spire Inc / ViacomCBS Inc / Alphabet Inc / Karuna Therapeutics Inc / Infrastructure and Energy Alternatives Inc / Adagio Therapeutics Inc / Tango Therapeutics Inc / ThredUp Inc / Poshmark Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / TMO / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / Thermo Fisher Scientific Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NYMX-US - Fundamental Analysis, for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NYMX.O / ABT / DGX / JNJ / LLY / PFE / SPHS.PK</td><td class="leftalignment">Nymox Pharmaceutical Corp / Abbott Laboratories / Quest Diagnostics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">0989529 / 0925288 / 2126335 / 2000019 / 2008154 / 2640147 / 2778844 / 2437071 / 2219224 / 2216850 / 2542049 / 2317087 / 2345022 / 2459020 / 2630513 / 2684703 / 2707677 / 2746711 / 2829601 / 2980906 / 2503529 / B00FWN1 / B2R3PV1 / B3D7K31 / B7TL820 / B7JYSG3 / B87ZMX0 / BFZCHN7 / BNGY4Q0 / BXDZ9Z0 / BK0VHF6 / BD9GVY0 / BFZ1K46 / BYXJQG9 / BJFSR99 / BKTNTR9 / BYQHPK7 / BYY88Y7 / BMH0MR7 / BDZ30Q0 / BMG75B4 / BN4RD42 / BMGGJK8 / BKPGJQ1 / BM8NHS1 / BNV0RN1</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Adobe Inc / Nike Inc / Merck & Co Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Consolidated Edison Inc / Dominion Energy Inc / Entergy Corp / Macy's Inc / Intuit Inc / New Jersey Resources Corp / Pfizer Inc / Public Service Enterprise Group Inc / Ross Stores Inc / Southern Co / Foot Locker Inc / World Wrestling Entertainment Inc / Alnylam Pharmaceuticals Inc / American Water Works Company Inc / Discovery Inc / Meta Platforms Inc / Guidewire Software Inc / Palo Alto Networks Inc / Wix.Com Ltd / Nextera Energy Partners LP / Shopify Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / Spotify Technology SA / Spire Inc / Revance Therapeutics Inc / ViacomCBS Inc / Zymeworks Inc / Alphabet Inc / Zendesk Inc / Arvinas Inc / Inventiva SA / CureVac NV / Valneva SE / Squarespace Inc / Adagio Therapeutics Inc / Portillos Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Nov 12: Focus on Tagrisso</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Harry Thomas Da Sephton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">11/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Junshi Biosciences Co., Ltd: US government's additional purchase order of Lilly's COVID cocktail therapy indicates continued demand for array of COVID therapies . Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1877.HK / LLY.N / PFE.N / MRCG.DE / 207940.KS</td><td class="leftalignment">Shanghai Junshi Biosciences Co Ltd / Eli Lilly and Co / Pfizer Inc / Merck KGaA / Samsung Biologics Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM / US38341P1021</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc / Gossamer Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM EST</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Investor Targeting - November 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">11/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.6% Above Pre-Pandemic Base- Week 85</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will The Rally In Pfizer Stock Continue After A Large 21% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pantera Minerals in bottom 4% performers of Australian market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.AX</td><td class="leftalignment">Pantera Minerals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Week in Review - November 12 to 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">GB0007188757 / CA4509131088 / AU000000CIA2 / US8336351056 / GB0000456144 / US0311621009 / US0341641035 / US0351282068 / US0383361039 / US0394831020 / US0530151036 / US1101221083 / US1564311082 / US1924461023 / US2017231034 / US2310211063 / US3755581036 / US38059T1060 / US4227041062 / US45337C1027 / US4891701009 / US5324571083 / US64125C1099 / US6516391066 / US6703461052 / US67066G1040 / US7170811035 / US75886F1075 / US7782961038 / US7802871084 / US8581191009 / US87612E1064 / US9024941034 / US92532F1003 / US9311421039 / CA13321L1085 / CA59162N1096 / CA5394811015 / CA4296951094 / CA9611485090 / CA85472N1096 / CA90457D1006 / CA4609191032 / CA5649051078 / CA6979001089 / CA78460T1057 / CA8787422044 / CA0679011084 / US9129091081 / CA3039011026 / CA1349211054 / CA8765111064 / US0017441017 / CA3359341052 / CA09950M3003 / CA00762V1094 / US2274831047 / US35671D8570 / AU000000FMG4 / US09062X1037 / BMG169621056 / US20451N1019 / CA98462Y1007 / CA56501R1064 / CA4969024047 / CA5503721063 / CA4436281022 / US1011211018 / CA6445351068 / CA95083R1001 / CA0906971035 / US8666741041 / CA0209361009 / CA32076V1031 / CA2483561072 / GB00B1FW5029 / CA0966311064 / CA29258Y1034 / CA4369131079 / CA3499151080 / GB00B1XZS820 / CA14068G1046 / CA82835P1036 / CA3518581051 / BMG162521014 / US00507V1098 / GB00B2QPKJ12 / CA86828P1036 / US91912E1055 / US1921085049 / IE00B4BNMY34 / US58933Y1055 / CA07317Q1054 / CA00208D4084 / CA66510M2040 / CA0985461049 / JE00B4T3BW64 / US74340W1036 / US95058W1009 / CA54928Q1081 / CA00829Q1019 / AU000000EVN4 / JE00B5TT1872 / US09609G1004 / US98138H1014 / CA78165J1057 / CA55903Q1046 / CA04364G1063 / CA7852461093 / CA3449112018 / CA07380N1042 / CA3807381049 / CA0805581091 / CA9323971023 / CA16141A1030 / CA6752221037 / CA21750U1012 / CA80013R2063 / CA04016A1012 / CA11777Q2099 / CA38045Y1025 / CA6674951059 / CA04682R1073 / US16208T1025 / CA89531J1093 / GB00B11DNM70 / US29355A1079 / US8486371045 / US6974351057 / US08579W1036 / CA5054401073 / US23283R1005 / CA33812R1091 / US60468T1051 / CA46579R1047 / CA65340P1062 / US31189P1021 / US03674X1063 / US11120U1051 / CA92938W2022 / CA68827L1013 / CA30606C1086 / CA5503711080 / US29444U7000 / CA74273V1067 / CA82621K1021 / AU000000S320 / CA0115321089 / CA83179X1087 / CA83125J1049 / CA05329M1041 / US72703H1014 / CA8283631015 / CY0106002112 / CA19239C1068 / AU000000NST8 / CA17040T3001 / CA4991131083 / CA6882811046 / CA8910546032 / US5588681057 / CA31730E1016 / CA89621C1059 / US0441861046 / US15136A1025 / US0138721065 / CA68634K1066 / GB00B67KBV28 / US75134P3038 / CA86816U1066 / US93627C1018 / US7045511000 / CA75601Y1007 / CA9628791027 / CY0103562118 / CA7847301032 / CA15713J1049 / CA53680Q2071 / US68404V1008 / LU1701428291 / CA2960061091 / CA8585221051 / CA46136U1030 / US00191U1025 / US3843135084 / US76029N1063 / US08579X1019 / KYG370921069 / CA38119T8077 / CA13000C2058 / CA72765Q8829 / CA2849025093 / US63253R2013 / AU0000018236 / CA7426943006 / CA33767E2024 / CA57776F4050 / US26614N1028 / CA5625684025 / CA48086P1009 / US2681501092 / CA29446Y5020 / AU0000004772 / CA92625W5072 / FR0013467479 / CA59124U6051 / US82575P1075 / MHY0436Q1098 / CA4220961078 / CA3901437093 / CA36352H1001 / US6544051096 / US03940R1077 / CA70137W1086 / US44862P1093 / US05478C1053 / US7501021056 / CA33843T1084 / CA9004352071 / US3680361090 / CA64782A1075 / US87969B1017 / US03750L1098 / CA36261G1028 / CA65401N1078 / US11135E2037 / CA55292X1087 / AU0000143729 / US00848J1043 / US05356F1057 / CA53227W1059 / CA65532M6062 / CA00791P1071 / CA24874B1085 / GB00BL6K5J42 / CA66979W8429 / US45828L1089 / US0708301041 / US9264001028 / US98955K1043 / US89269P1030 / US9778521024 / US4718711033 / US1374041093 / 116833187</td><td class="leftalignment">Rio Tinto PLC / IAMGOLD Corp / Champion Iron Ltd / Sociedad Quimica y Minera de Chile SA / Antofagasta PLC / Amgen Inc / Andersons Inc / AngloGold Ashanti Ltd / Aptargroup Inc / Archer-Daniels-Midland Co / Automatic Data Processing Inc / Bristol-Myers Squibb Co / Century Aluminum Co / Cognizant Technology Solutions Corp / Commercial Metals Co / Cummins Inc / Gilead Sciences Inc / Gold Fields Ltd / Hecla Mining Co / Incyte Corp / Kennametal Inc / Eli Lilly and Co / Neurocrine Biosciences Inc / Newmont Corporation / Nucor Corp / NVIDIA Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Royal Gold Inc / Steel Dynamics Inc / Target Corp / Tyson Foods Inc / Vertex Pharmaceuticals Inc / Walmart Inc / Cameco Corp / Metro Inc / Loblaw Companies Ltd / High Liner Foods Inc / George Weston Ltd / Stantec Inc / Uni-Select Inc / Intertape Polymer Group Inc / Maple Leaf Foods Inc / Pan American Silver Corp / SNC-Lavalin Group Inc / Teck Resources Ltd / Barrick Gold Corp / United States Steel Corp / Fairfax Financial Holdings Ltd / Canadian Apartment Properties Real Estate Investment Trust / Taseko Mines Ltd / AMN Healthcare Services Inc / First Quantum Minerals Ltd / Boralex Inc / Aecon Group Inc / Cross Country Healthcare Inc / Freeport-McMoRan Inc / Fortescue Metals Group Ltd / Biogen Inc / Bunge Ltd / Compass Minerals International Inc / Yamana Gold Inc / Manulife Financial Corp / Kinross Gold Corp / Lundin Mining Corp / Hudbay Minerals Inc / Boston Properties Inc / New Gold Inc / Wesdome Gold Mines Ltd / Birchcliff Energy Ltd / Sun Communities Inc / Altius Minerals Corp / First Majestic Silver Corp / Denison Mines Corp / Hochschild Mining PLC / Boardwalk Real Estate Investment Trust / Endeavour Silver Corp / Home Capital Group Inc / Fortuna Silver Mines Inc / Anglo American PLC / Capstone Mining Corp / Silvercorp Metals Inc / Franco-Nevada Corp / Brookfield Infrastructure Partners LP / Activision Blizzard Inc / Fresnillo PLC / Superior Plus Corp / Vale SA / Coeur Mining Inc / Accenture PLC / Merck & Co Inc / Baytex Energy Corp / ARC Resources Ltd / Northern Dynasty Minerals Ltd / Bonterra Energy Corp / Glencore PLC / Prologis Inc / Wendys Co / Lucara Diamond Corp / Africa Oil Corp / Evolution Mining Ltd / Centamin PLC / bluebird bio Inc / Workday Inc / Rupert Resources Ltd / MAG Silver Corp / Ascot Resources Ltd / Sabina Gold & Silver Corp / Foran Mining Corp / Bear Creek Mining Corp / Gold Standard Ventures Corp / Belo Sun Mining Corp / Wallbridge Mining Company Ltd / Chartwell Retirement Residences / OceanaGold Corp / Copper Mountain Mining Corp / Sandstorm Gold Ltd / Argonaut Gold Inc / B2Gold Corp / GoGold Resources Inc / NorthWest Healthcare Properties REIT / Athabasca Oil Corp / Chatham Lodging Trust / Trevali Mining Corp / Horizonte Minerals PLC / Enphase Energy Inc / Splunk Inc / Palo Alto Networks Inc / Berry Global Group Inc / Labrador Iron Ore Royalty Corp / CyrusOne Inc / Fission Uranium Corp / Mirati Therapeutics Inc / Ivanhoe Mines Ltd / Nexgen Energy Ltd / Fate Therapeutics Inc / Antero Resources Corp / Brixmor Property Group Inc / WSP Global Inc / Osisko Gold Royalties Ltd / Falco Resources Ltd / Lundin Gold Inc / Equinix Inc / Probe Metals Inc / Sienna Senior Living Inc / South32 Ltd / Alamos Gold Inc / SmartCentres Real Estate Investment Trust / Sleep Country Canada Holdings Inc / Automotive Properties Real Estate Investment Trust / Planet Fitness Inc / Silvercrest Metals Inc / Atalaya Mining PLC / Cogeco Communications Inc / Northern Star Resources Ltd / Chorus Aviation Inc / K92 Mining Inc / Osisko Mining Inc / Torex Gold Resources Inc / Madrigal Pharmaceuticals Inc / Filo Mining Corp / Trilogy Metals Inc / Ashland Global Holdings Inc / Centennial Resource Development Inc / Alcoa Corp / Orla Mining Ltd / Central Asia Metals PLC / Ramaco Resources Inc / Superior Gold Inc / Warrior Met Coal Inc / Peabody Energy Corp / Real Matters Inc / Wheaton Precious Metals Corp / Tharisa PLC / SSR Mining Inc / CES Energy Solutions Corp / Lithium Americas Corp / OptiNose Inc / Nexa Resources SA / Ero Copper Corp / Stelco Holdings Inc / Invesque Inc / ASGN Inc / GrafTech International Ltd / Replimune Group Inc / Berry Corporation (Bry) / Galaxy Digital Holdings Ltd / Golden Star Resources Ltd / Calibre Mining Corp / Platinum Group Metals Ltd / Eldorado Gold Corp / NAK Kazatomprom AO / Nickel Mines Ltd / PRO Real Estate Investment Trust / FirstService Corp / Maverix Metals Inc / Dupont De Nemours Inc / Mandalay Resources Corp / Josemaria Resources Inc / Dynatrace Inc / Equinox Gold Corp / Adriatic Metals PLC / Victoria Gold Corp / Constellium SE / Metalla Royalty & Streaming Ltd / Sibanye Stillwater Ltd / Atlas Corp / Headwater Exploration Inc / Great Bear Resources Ltd / Galiano Gold Inc / 9 Meters Biopharma Inc / Arch Resources Inc / Parkland Corp / Hycroft Mining Holding Corporation / Azek Company Inc / Rackspace Technology Inc / Flagship Communities Real Estate Investment Trust / Turquoise Hill Resources Ltd / Gatos Silver Inc / New Pacific Metals Corp / Telos Corp / Apartment Income REIT Corp / G Mining Ventures Corp / Nickel 28 Capital Corp / Broadstone Net Lease Inc / MDA Ltd / Sunrise Energy Metals Ltd / Agiliti Inc / Aveanna Healthcare Holdings Inc / LifeWorks Inc / Nomad Royalty Company Ltd / Advantage Energy Ltd / dentalcorp Holdings Ltd / Endeavour Mining PLC / Nouveau Monde Graphite Inc / Integral Ad Science Holding Corp / Bath & Body Works Inc / Victoria's Secret & Co / Zevia PBC / Traeger Inc / Wolfspeed Inc / Jasper Therapeutics Inc / Candel Therapeutics Inc / NextSource Materials Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Chile / Cayman Islands / Cyprus / France / United Kingdom / Ireland / Kazakhstan / Luxembourg / United States / South Africa / Marshall Islands / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">BMO Research Today - November 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">US8336351056 / US0311621009 / US0383361039 / US1101221083 / US1270971039 / US1924461023 / US25179M1036 / US30231G1022 / US3755581036 / US4062161017 / US45337C1027 / US5324571083 / US64125C1099 / US6745991058 / US7170811035 / US7237871071 / US75281A1097 / US75886F1075 / US7782961038 / AN8068571086 / US81211K1007 / US89531P1057 / US92532F1003 / CA9611485090 / US1667641005 / US5658491064 / US20825C1045 / US09062X1037 / US42809H1077 / US58933Y1055 / US09609G1004 / US98138H1014 / US34964C1062 / US6974351057 / US08579W1036 / US60468T1051 / US03674X1063 / US2057683029 / GB00BDSFG982 / US87484T1088 / US26614N1028 / US69047Q1022 / US05478C1053 / CA33843T1084 / US62955J1034 / US1651677353 / US45828L1089 / US1374041093</td><td class="leftalignment">Sociedad Quimica y Minera de Chile SA / Amgen Inc / Aptargroup Inc / Bristol-Myers Squibb Co / Coterra Energy Inc / Cognizant Technology Solutions Corp / Devon Energy Corp / Exxon Mobil Corp / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Range Resources Corp / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Schlumberger NV / Sealed Air Corp / Trex Company Inc / Vertex Pharmaceuticals Inc / George Weston Ltd / Chevron Corp / Marathon Oil Corp / Conocophillips / Biogen Inc / Hess Corp / Merck & Co Inc / bluebird bio Inc / Workday Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Berry Global Group Inc / Mirati Therapeutics Inc / Antero Resources Corp / Comstock Resources Inc / TechnipFMC PLC / Talos Energy Inc / Dupont De Nemours Inc / Ovintiv Inc / Azek Company Inc / Flagship Communities Real Estate Investment Trust / Nov Inc / Chesapeake Energy Corp / Integral Ad Science Holding Corp / Candel Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Chile / United Kingdom / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">BMO CM Research</td></tr>
<tr class="odd"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">0925288 / 2536763 / 2496113 / 2026242 / 2437071 / 2216850 / 2208073 / 2270726 / 2542049 / 2317087 / 2670519 / 2459020 / 2630513 / 2645409 / 2689560 / 2684703 / 2048804 / 2825933 / 2829601 / 2853688 / 2931034 / 2503529 / 2857817 / B7VD3F2 / B87ZMX0 / BDZCRX3 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BD8DJ71 / BZ8FPH3 / BYZM6C2 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BMH0MR7 / BJTJGC4 / BNRQM83 / BKPGJQ1</td><td class="leftalignment">GlaxoSmithKline PLC / Lowe's Companies Inc / Kohls Corp / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / Consolidated Edison Inc / Copart Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Exelon Corp / Intuit Inc / New Jersey Resources Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / South Jersey Industries Inc / Southern Co / Stryker Corp / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Netflix Inc / Duke Energy Corp / Palo Alto Networks Inc / RingCentral Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Snap Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Roku Inc / Zendesk Inc / Kontoor Brands Inc / Petco Health and Wellness Company Inc / Squarespace Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare Reform: Impact of Build Back Better on global branded pharma</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">4502.T / 4503.T / BMY.N / JNJ.N / LLY.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / AMGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Herr. Christoph Gretler / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Tiago Fauth</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Dropping Coverage Due To Acquisition By Pfizer</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Bullish on BioPharma as We Emerge From COVID-19: Finding Alpha in the Sector That Saved the World</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">US0311621009 / US1101221083 / US3755581036 / US45337C1027 / US5324571083 / US64125C1099 / US7170811035 / US75886F1075 / US92532F1003 / US09062X1037 / US58933Y1055 / US60468T1051 / US1374041093</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Incyte Corp / Eli Lilly and Co / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Merck & Co Inc / Mirati Therapeutics Inc / Candel Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">11/18/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Initiating at OP: Pfizer Opens a New Chapter of BioPharma Innovation</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Discontinuing Coverage</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CA89620X5064 / US45253H1014 / US4277461020</td><td class="leftalignment">Pfizer Inc / ImmunoGen Inc / Heron Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Invest Heroes</td><td class="leftalignment">Pfizer: финансовые результаты за 3 кв. 2021</td><td class="leftalignment">Russian</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dmitrii Novichkov</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CFO Transition Should Be Smooth Sailing</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Nov. 17, 2021 / 12:30PM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Bloom Burton & Co.</td><td class="leftalignment">Trillium Therapeutics Inc. (NASDAQ-TRIL; US$18.44, TSX-TRIL; C$23.16). Discontinuing Coverage.</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">TRIL=US / TRIL=CA</td><td class="leftalignment">Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATING RESULTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David Martin, PHD</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">NTES.O / 00507V109 / 872590104 / M7516K103 / 89620X506 / 25058X10 / 18563410</td><td class="leftalignment">NetEase Inc / Activision Blizzard Inc / T-Mobile US Inc / Nova Ltd / Pfizer Inc / Desktop Metal Inc / Clene Inc.</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Matthew Harrigan / Ms. Fawne Jiang / Long Lin / Mike Hickey / Mr. Mark Miller / Mr. Josh W. Sullivan / Mr. Aydin Huseynov, MD / Mr. Bruce D. Jackson</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Arbitrage Opportunity Is Over; Downgrade To Hold</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">2434209 / 2936921 / 2126335 / 2000019 / 2778844 / 2270726 / 2317087 / 2455965 / 2684703 / 2829601 / 2822019 / B1HMF22 / 2857817 / B7TL820 / B65SQW4 / B7VD3F2 / BFDV8K0 / B87ZMX0 / BDZCRX3 / B424494 / BFLR866 / BQPVQZ6 / BYVY8G0 / BYZLV46 / BZBY005 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BLGJ610 / BJJMGL2 / BFNR303 / BYQHPK7 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BDVLM39 / BF3N4P3 / BMPRZV5 / BGDQ8B3 / 021513106 / BMDJ397 / BMZ9Z11 / BNGJQZ8 / BP96C52</td><td class="leftalignment">Home Depot Inc / Walmart Inc / Bristol-Myers Squibb Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Biogen Inc / Pfizer Inc / Southern Co / Advance Auto Parts Inc / First Solar Inc / Netflix Inc / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / MacroGenics Inc / Palo Alto Networks Inc / RingCentral Inc / Splunk Inc / Twitter Inc / Horizon Therapeutics PLC / Alphabet Inc / InflaRx NV / Merus NV / Snap Inc / Xencor Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Northwest Natural Holding Co / Zymeworks Inc / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / argenx SE / Arena Pharmaceuticals Inc / Kymera Therapeutics Inc / Axonics Inc / Alto Ingredients Inc / Bolt Biotherapeutics Inc / Prometheus Biosciences Inc / Porch Group Inc / Surrozen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Healthcare: AstraZeneca- Most attractive valuation in HOLT in 5-years</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / PFE.N / SASY.PA / NOVOB.CO / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Novo Nordisk A/S / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Emilie Fung</td></tr>
<tr class="odd"><td class="leftalignment">11/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: 2022 Research Outlook: Equities, Regions and Macro</td><td class="leftalignment">English</td><td class="rightalignment">194</td><td class="leftalignment">0291.HK / 1109.HK / 2303.TW / 2330.TW / 2823.TW / 4063.T / 4503.T / 6502.T / 6754.T / 6758.T / 6954.T / 6963.T / 6981.T / 7203.T / 7269.T / 7453.T / 8035.T / 9983.T / ABB.BO / ABF.L / AIRP.PA / ALFAA.MX / ALSO.PA / ALVG.DE / ASML.AS / ASSAB.ST / BATS.L / BOY.L / BT.L / CHG.L / CRDA.L / DSMN.AS / EDP.LS / ELM.L / HEIN.AS / HMB.ST / IBST.L / INCH.L / ITC.BO / ITV.L / JMAT.L / KPN.AS / KSP.I / LAND.L / LART.BO / MO.N / MS.MI / OREP.PA / PFE.N / PM.N / PROC.BO / PRTP.PA / RAND.AS / RHI.N / RTO.L / RWEG.F / SAN.MC / SBI.BO / SBRY.L / SCHN.PA / SECUB.ST / SOGN.PA / STM.PA / SWMA.ST / TSCO.L / TTG.L / ULVR.L / VOD.L / WLSNC.AS / INF.L / 6594.T / 6861.T / TKAG.DE / GFNORTEO.MX / ABBN.S / SIEGN.DE / INFY.BO / ENEI.MI / DTEGN.F / NKE.N / KFY.N / IFXGN.DE / 0857.HK / SPT.L / 6506.T / 2408.TW / CLN.S / RWA.L / 2409.TW / NZYMB.CO / EUFI.PA / DB1GN.DE / ITX.MC / NEXS.PA / 2454.TW / NKT.CO / 2264.T / 2882.TW / 3008.TW / 2883.TW / TDY.N / REL.L / 2890.TW / 2891.TW / APLH.NS / 3034.TW / POG.L / NIO.N / GOCP.BO / AAPL.OQ / MSFT.OQ / ROL.N / AMZN.OQ / NFLX.OQ / COA.L / MRTI.BO / 6723.T / UMI.BR / 010950.KS / 005930.KS / 006400.KS / 005490.KS / 035250.KS / 000270.KS / 005380.KS / 008770.KS / 032640.KS / LOGN.S / BARN.S / 006280.KS / 000120.KS / 035720.KS / SRTR.BO / NESN.S / 2319.HK / 0700.HK / ASOS.L / LXSG.DE / BIDU.OQ / 2313.HK / 3436.T / DRX.L / GAZP.MM / WCHG.DE / HOLN.S / 090430.KS / 3481.TW / SKG.I / PRY.MI / MNDI.L / FXPO.L / AXBK.BO / 601857.SS / FLUI.MC / 3092.T / EONGN.DE / 105560.KS / AVGO.OQ / BNRGN.DE / 002460.SZ / BASFN.DE / 002475.SZ / 300059.SZ / 300012.SZ / 1299.HK / ADSGN.F / ICAG.L / UBBW.NS / 139480.KS / YNDX.OQ / FUNO11.MX / EVRE.L / 4966.TWO / 601012.SS / ALPEKA.MX / TERRA13.MX / RRTL.DE / ORAN.PA / PSMGN.DE / BOOH.L / GOOGL.OQ / APPS.MC / JD.OQ / FIBRAPL14.MX / ONTEX.BR / BABA.N / ZALG.DE / 3697.T / AENA.MC / 002747.SZ / CLNX.MC / WAFGN.DE / INWT.MI / RACE.N / 145020.KQ / BGNE.OQ / IMB.L / PAGE.L / 603986.SS / 1658.HK / VIFN.S / 2269.HK / ESSITYB.ST / TIFS.L / HFGG.DE / 253450.KQ / INS2.DE / FB.PS / 3711.TW / RCH.L / 6160.HK / KAPQ.L / 316140.KS / 6669.TW / 9988.HK / 9618.HK / ENR1N.DE / CCEPC.AS / 9888.HK / ANE.MC</td><td class="leftalignment">China Resources Beer Holdings Co Ltd / China Resources Land Ltd / United Microelectronics Corp / Taiwan Semiconductor Manufacturing Co Ltd / China Life Insurance Co Ltd / Shin-Etsu Chemical Co Ltd / Astellas Pharma Inc / Toshiba Corp / Anritsu Corp / Sony Group Corp / Fanuc Corp / Rohm Co Ltd / Murata Manufacturing Co Ltd / Toyota Motor Corp / Suzuki Motor Corp / Ryohin Keikaku Co Ltd / Tokyo Electron Ltd / Fast Retailing Co Ltd / ABB India Ltd / Associated British Foods PLC / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Alfa SAB de CV / Alstom SA / Allianz SE / ASML Holding NV / Assa Abloy AB / British American Tobacco PLC / Bodycote PLC / BT Group PLC / Chemring Group PLC / Croda International PLC / Koninklijke DSM NV / EDP Energias de Portugal SA / Elementis PLC / Heineken NV / H & M Hennes & Mauritz AB / Ibstock PLC / Inchcape PLC / ITC Ltd / ITV PLC / Johnson Matthey PLC / Koninklijke KPN NV / Kingspan Group PLC / Land Securities Group PLC / Larsen & Toubro Ltd / Altria Group Inc / MFE-MEDIAFOREUROPE NV / L'Oreal SA / Pfizer Inc / Philip Morris International Inc / Procter & Gamble Hygiene and Health Care Ltd / Kering SA / Randstad NV / Robert Half International Inc / Rentokil Initial PLC / Rwe AG / Banco Santander SA / State Bank of India / J Sainsbury PLC / Schneider Electric SE / Securitas AB / Societe Generale SA / STMicroelectronics NV / Swedish Match AB / Tesco PLC / TT electronics PLC / Unilever PLC / Vodafone Group PLC / Wolters Kluwer NV / Informa PLC / Nidec Corp / Keyence Corp / thyssenkrupp AG / Grupo Financiero Banorte SAB de CV / Abb Ltd / Siemens AG / Infosys Ltd / Enel SpA / Deutsche Telekom AG / Nike Inc / Korn Ferry / Infineon Technologies AG / PetroChina Co Ltd / Spirent Communications plc / Yaskawa Electric Corp / Nanya Technology Corp / Clariant AG / Robert Walters PLC / AU Optronics Corp / Novozymes A/S / Eurofins Scientific SE / Deutsche Boerse AG / Industria de Diseno Textil SA / Nexans SA / MediaTek Inc / Nkt A/S / Morinaga Milk Industry Co Ltd / Cathay Financial Holding Co Ltd / LARGAN Precision Co Ltd / China Development Financial Holding Corp / Teledyne Technologies Inc / Relx PLC / Sinopac Financial Holdings Co Ltd / CTBC Financial Holding Co Ltd / Apollo Hospitals Enterprise Ltd / Novatek Microelectronics Corp / Petropavlovsk PLC / NIO Inc / Godrej Consumer Products Ltd / Apple Inc / Microsoft Corp / Rollins Inc / Amazon.com Inc / Netflix Inc / Coats Group PLC / Maruti Suzuki India Ltd / Renesas Electronics Corp / Umicore SA / S-Oil Corp / Samsung Electronics Co Ltd / Samsung SDI Co Ltd / Posco / Kangwon Land Inc / Kia Corp / Hyundai Motor Co / Hotel Shilla Co Ltd / LG Uplus Corp / Logitech International SA / Barry Callebaut AG / Green Cross Corp / CJ Logistics Corp / Kakao Corp / Shriram Transport Finance Company Ltd / Nestle SA / China Mengniu Dairy Co Ltd / Tencent Holdings Ltd / ASOS PLC / Lanxess AG / Baidu Inc / Shenzhou International Group Holdings Ltd / Sumco Corp / Drax Group PLC / Gazprom PAO / Wacker Chemie AG / Holcim AG / AmorePacific Corp / Innolux Corp / Smurfit Kappa Group PLC / Prysmian SpA / Mondi PLC / Ferrexpo PLC / Axis Bank Ltd / PetroChina Co Ltd / Fluidra SA / ZOZO Inc / E.ON SE / KB Financial Group Inc / Broadcom Inc / Brenntag SE / Ganfeng Lithium Co Ltd / BASF SE / Luxshare Precision Industry Co Ltd / East Money Information Co Ltd / Centre Testing International Group Co Ltd / AIA Group Ltd / Adidas AG / International Consolidated Airlines Group SA / United Breweries Ltd / E-Mart Inc / Yandex NV / Fibra Uno Administracion SA de CV / EVRAZ plc / Parade Technologies Ltd / LONGi Green Energy Technology Co Ltd / Alpek SAB de CV / CI Banco SA Institucion de Banca Multiple FF/00939 / RTL Group SA / Orange SA / Prosiebensat 1 Media SE / boohoo group plc / Alphabet Inc / Applus Services SA / JD.Com Inc / Prologis Property Mexico SA de CV / Ontex Group NV / Alibaba Group Holding Ltd / Zalando SE / Shift Inc / Aena SME SA / Estun Automation Co Ltd / Cellnex Telecom SA / Siltronic AG / Infrastrutture Wireless Italiane SpA / Ferrari NV / Hugel Inc / Beigene Ltd / Imperial Brands PLC / Pagegroup PLC / GigaDevice Semiconductor Beijing Inc / Postal Savings Bank of China Co Ltd / Vifor Pharma AG / WuXi Biologics (Cayman) Inc / Essity AB (publ) / TI Fluid Systems PLC / Hellofresh SE / Studio Dragon Corp / Instone Real Estate Group SE / San Miguel Food and Beverage Inc / ASE Technology Holding Co Ltd / Reach PLC / Beigene Ltd / NAK Kazatomprom AO / Woori Financial Group Inc / Wiwynn Corp / Alibaba Group Holding Ltd / JD.Com Inc / Siemens Energy AG / Coca-Cola Europacific Partners PLC / Baidu Inc / Corporacion Acciona Energias Renovables SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Hong Kong / India / Ireland / Italy / Japan / Korea, Republic of / Kazakhstan / Luxembourg / Mexico / Netherlands / Philippines / Portugal / Russian Federation / Sweden / Taiwan / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Asim Ali / Nasr Islam / Marc el Koussa</td></tr>
<tr class="even"><td class="leftalignment">11/17/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for TRIL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">TRIL.OQ</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CPRX-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CPRX.O / ABT / JNJ / PFE / BMRN.O / ACOR.O / SRPT.O</td><td class="leftalignment">Catalyst Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Pfizer Inc / Biomarin Pharmaceutical Inc / Acorda Therapeutics Inc / Sarepta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CARA-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CARA.O / JNJ / PFE / DRRX.O / ACOR.O / CPIX.O / ACRX.O / TRVN.O / FLXN.O / REPH.O</td><td class="leftalignment">Cara Therapeutics Inc / Johnson & Johnson / Pfizer Inc / DURECT Corp / Acorda Therapeutics Inc / Cumberland Pharmaceuticals Inc / AcelRx Pharmaceuticals Inc / Trevena Inc / Pacira Biosciences Inc / Recro Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Johnson & Johnson Stock See Higher Levels After Its Split Announcement?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Patient centric drug development co. POAI reports 3Q21 - Reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / DT=US / CMA=US / AMT=US / EOG=US / CONE=US / CCI=US / PB=US / UMPQ=US / ADS=US / TNL=US / WTFC=US / SWIM=US / CBRL=US / DRI=US / DRH=US / PDM=US / SBAC=US / WAL=US / HTH=US / HIW=US / ABCB=US / CUZ=US / FBK=US / DIN=US / OGN / TCBI=US / FHN=US / NUVA=US / TXRH=US / PLAY=US / WMG=US / DENN=US / CMG=US / MA=US / SIX=US / AMRX=US / TAST=US / QSR=US / NMTR=US / WH=US / JACK=US / HGV=US / LPLA=US / RLJ=US / VAC=US / SPLK=US / GMED=US / NDLS=US / FATE=US / LOCO=US / BVH=US / SHAK=US / WING=US / SPNE=US / SWCH=US / MBIN=US / BTAI=US / OSMT=US / VTRS=US / AVAH=US / 67421J108 / DBRG=US / SNPO=US / ROIV=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Dynatrace Inc / Comerica Inc / American Tower Corp / EOG Resources Inc / CyrusOne Inc / Crown Castle International Corp / Prosperity Bancshares Inc / Umpqua Holdings Corp / Alliance Data Systems Corp / Travel + Leisure Co / Wintrust Financial Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Piedmont Office Realty Trust Inc / SBA Communications Corp / Western Alliance Bancorp / Hilltop Holdings Inc / Highwoods Properties Inc / Ameris Bancorp / Cousins Properties Inc / FB Financial Corp / Dine Brands Global Inc / Organon & Co / Texas Capital Bancshares Inc / First Horizon Corp / NuVasive Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Warner Music Group Corp / Denny's Corp / Chipotle Mexican Grill Inc / Mastercard Inc / Six Flags Entertainment Corp / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Hilton Grand Vacations Inc / LPL Financial Holdings Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Splunk Inc / Globus Medical Inc / Noodles & Co / Fate Therapeutics Inc / El Pollo Loco Holdings Inc / Bluegreen Vacations Holding Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Switch Inc / Merchants Bancorp / BioXcel Therapeutics Inc / Osmotica Pharmaceuticals PLC / Viatris Inc / Aveanna Healthcare Holdings Inc / Oatly Group AB / DigitalBridge Group Inc / Snap One Holdings Corp / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2360326 / 2126335 / 2516152 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2345022 / 2100920 / 2630513 / 2657802 / 2689560 / 2684703 / 2707677 / 2825933 / 7103065 / B00FWN1 / 2822019 / 2857817 / B3D7K31 / 2390817 / B65LWX6 / B7TL820 / B7VD3F2 / BCZS820 / BVVN4Q8 / BTF8CF0 / BYZLV46 / BK0VHF6 / BD8DJ71 / BL2HYY7 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BJ9NFQ3 / BYY88Y7 / BDRW1L7 / BNGJQZ8 / BMHR7K6 / BNNTQY0 / BL98755 / BL53KF5 / BP0TJN7 / BPH0546 / BMV6Y64</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Gap Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Macy's Inc / FirstEnergy Corp / New Jersey Resources Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / South Jersey Industries Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Advance Auto Parts Inc / Netflix Inc / Discovery Inc / Gray Television Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / Fate Therapeutics Inc / Eversource Energy / Restaurant Brands International Inc / InflaRx NV / IDEAYA Biosciences Inc / Snap Inc / Casper Sleep Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Spire Inc / ViacomCBS Inc / Neoleukin Therapeutics Inc / Alphabet Inc / AnaptysBio Inc / Porch Group Inc / Impel Neuropharma Inc / Oatly Group AB / Beachbody Company Inc / F45 Training Holdings Inc / Xponential Fitness Inc / Life Time Group Holdings Inc / Xilio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer climbs 16.3% from 2 week low</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Nov 5, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">William O'Neil + Co.</td><td class="leftalignment">U.S. Elective Surgery</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ABMD=US / MRK=US / PFE=US / INSP=US / SYK=US / DHR=US / CNMD=US / EW=US / INMD=US / ISRG=US / NVST=US / RGEN=US / ALGN=US / AVTR=US / BIO=US / DXCM=US / PODD=US / TNDM=US / PCRX=US / GMED=US / CTLT=US / PEN=US / PGNY=US</td><td class="leftalignment">ABIOMED Inc / Merck & Co Inc / Pfizer Inc / Inspire Medical Systems Inc / Stryker Corp / Danaher Corp / Conmed Corp / Edwards Lifesciences Corp / Inmode Ltd / Intuitive Surgical Inc / Envista Holdings Corp / Repligen Corp / Align Technology Inc / Avantor Inc / Bio Rad Laboratories Inc / Dexcom Inc / Insulet Corp / Tandem Diabetes Care Inc / Pacira Biosciences Inc / Globus Medical Inc / Catalent Inc / Penumbra Inc / Progyny Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Industrial Materials</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Bhavya Joshi / Mr. Rajan Gupta</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA - BUY - Mgmt Discussion Post-Earnings; Early Signs of IDE397 Activity with Data Guided for 1H22 as Broader Execution Remains On-Track</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703 / BLF0CW7 / BP2P6L0</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc / Repare Therapeutics Inc / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Roche Stock May Continue To Trend Higher</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Drug Pricing Reform Proposal: Is This The Long-Awaited Clearing Event?</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">0989529 / 2681511 / 2000019 / 2045623 / 2065159 / 2113434 / 2270726 / 2317087 / 2471950 / 2684703 / 2048804 / 2730190 / 2181334 / 2857817 / B125XQ6 / B02R1L6 / B5B2106 / B7TL820 / B4MG4Z6 / B7VD3F2 / B95N910 / BFLR866 / BFZCHN7 / BXDZ9Z0 / BK1KWF7 / BD9GVY0 / BDHF4K6 / BHC8X90 / BKS3SM8 / BZ00V34 / BGCYWN8 / BWFKZT2 / BFZ1K46 / BLGJ610 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BWY4XV3 / BDD1B07 / BMDCDP2 / BMPRZV5 / BMC5RV6 / BLBLMD5 / BMDJ397 / BMZ9Z11 / BNTB3N8 / BKPGJQ1 / BMW5084 / BM8NHS1 / BNV0RN1 / BMHRMK1</td><td class="leftalignment">AstraZeneca PLC / PepsiCo Inc / Amazon.com Inc / ANSYS Inc / Autodesk Inc / Boston Scientific Corp / Walt Disney Co / Entergy Corp / Incyte Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Check Point Software Technologies Ltd / Netflix Inc / Portland General Electric Co / ALLETE Inc / Fortinet Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / PTC Inc / Twitter Inc / Wix.Com Ltd / Shopify Inc / Grocery Outlet Holding Corp / Zai Lab Ltd / CRISPR Therapeutics AG / Novo Nordisk A/S / IGM Biosciences Inc / Zscaler Inc / Xencor Inc / Cellectis SA / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Spire Inc / ViacomCBS Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Adaptimmune Therapeutics PLC / Rubius Therapeutics Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / Adicet Bio Inc / Array Technologies Inc / Bolt Biotherapeutics Inc / Prometheus Biosciences Inc / Vizio Holding Corp / Squarespace Inc / PMV Pharmaceuticals Inc / Adagio Therapeutics Inc / Portillos Inc / Vita Coco Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Does Smoke from CD47 Program at SITC Signal Further Flames at ASH?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">89620X506 / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">Pfizer Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Canada / Switzerland / China / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / Singapore / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Andrew S. Fein / Andres Y. Maldonado, PhD / Matthew Caufield / Ananda Ghosh, PhD</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - November 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / CB.N / CCI.N / CL.N / CP.TO / EDP.LS / EOG.N / F.N / FSR.N / GM.N / MSFT.O / NA / NSC.N / PFE.N / T.N / VC.N / PXD.N / GILD.O / TEN.N / WLL.N / AMGN.O / INCY.O / THC.N / FER.MC / CNR.TO / DUK.N / BWA.N / LEA.N / FE.N / DISH.O / CSX.N / UNP.N / NICE.O / DV.N / MRO.N / PCG.N / PAA.N / DVN.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / MTG.N / RDN.N / VZ.N / LNC.N / APH.N / RRC.N / EQT.N / V.N / OKE.N / AXL.N / AWK.N / IG.MI / EPAY.O / AJG.N / REGN.O / VRTX.O / SRG.MI / PRU.N / SM.N / TEL.N / GFI.N / COP.N / CPE.N / ST.N / SWN.N / SR.N / CRC.N / PEGA.OQ / PLUG.OQ / GPN.N / LIFE.O / CASY.O / ACGL.O / PAAS.O / EQIX.O / ATDb.TO / BIIB.O / DPM.TO / EDV.TO / TRN.MI / DLR.N / ACAD.O / 416515104 / FIS.N / CCOI.O / MA.N / EHTH.O / AON.N / CLR.N / DAN.N / NOG.A / EDPR.LS / PHR.N / PKI.TO / MSP.N / MTOR.N / MTDR.N / SRPT.O / PANW.N / FFHu.TO / FANG.O / ABBV.N / KPT.TO / TSLA.N / TMUS.N / PTCT.O / 81762P102 / ESNT.N / XNCR.OQ / ITCI.O / SAGE.OQ / HQY.OQ / NMIH.O / NEWR.N / GLPG.O / TDOC.N / PYPL.OQ / RGNX.O / SPGI.N / TTD.O / ADNT.N / AQN.N / UNIT.O / CDEV.O / ESTE.N / WOW.N / ATNX.O / SAIL.N / APTV.N / SMAR.N / VRCA.OQ / ITRM.O / OPRX.OQ / VNE.N / HCAT.OQ / GMAB.O / CRNC.OQ / PNTG.OQ / IGMS.O / OAS.OQ / NKLA.OQ / APA.OQ / FOUR.N / NRIX.OQ / RXT.OQ / GOCO.O / IBEX.O / PLTR.N / AEP.OQ / SPRB.OQ / BSY.O / GATO.N / GDRX.O / MCFE.OQ / RIDE.OQ / MAX.N / TLMD.OQ / LSPD.N / PUBM.O / TIXT.TO / AFRM.O / NUVB.N / CHK.OQ / OLO.N / PATH.N / PSFE.N / TSP.OQ / TFPM.TO / FLYW.O / BHG.N / XMTR.OQ / TASK.O / TRMR.OQ / EVCM.O / NABL.N / RYAN.N / TWKS.OQ / GTLB.OQ / ROCC.O</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / EOG Resources Inc / Ford Motor Co / Fisker Inc / General Motors Co / Microsoft Corp / National Bank of Canada / Norfolk Southern Corp / Pfizer Inc / AT&T Inc / Visteon Corp / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Whiting Petroleum Corp / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Ferrovial SA / Canadian National Railway Co / Duke Energy Corp / Borgwarner Inc / Lear Corp / FirstEnergy Corp / DISH Network Corp / CSX Corp / Union Pacific Corp / Nice Ltd / DoubleVerify Holdings Inc / Marathon Oil Corp / PG&E Corp / Plains All American Pipeline LP / Devon Energy Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / MGIC Investment Corp / Radian Group Inc / Verizon Communications Inc / Lincoln National Corp / Amphenol Corp / Range Resources Corp / EQT Corp / Visa Inc / ONEOK Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Italgas SpA / Bottomline Technologies Inc / Arthur J Gallagher & Co / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Snam SpA / Prudential Financial Inc / SM Energy Co / TE Connectivity Ltd / Gold Fields Ltd / Conocophillips / Callon Petroleum Co / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / California Resources Corp / Pegasystems Inc / Plug Power Inc / Global Payments Inc / aTyr Pharma Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Pan American Silver Corp / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Dundee Precious Metals Inc / Endeavour Mining PLC / Terna Rete Elettrica Nazionale SpA / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hartford Financial Services Group Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mastercard Inc / eHealth Inc / Aon PLC / Continental Resources Inc / Dana Inc / Northern Oil and Gas Inc / EDP Renovaveis SA / Phreesia Inc / Parkland Corp / Datto Holding Corp / Meritor Inc / Matador Resources Co / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Diamondback Energy Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / T-Mobile US Inc / PTC Therapeutics Inc / ServiceNow Inc / Essent Group Ltd / Xencor Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Healthequity Inc / NMI Holdings Inc / New Relic Inc / Galapagos NV / Teladoc Health Inc / PayPal Holdings Inc / Regenxbio Inc / S&P Global Inc / Trade Desk Inc / Adient PLC / Algonquin Power & Utilities Corp / Uniti Group Inc / Centennial Resource Development Inc / Earthstone Energy Inc / WideOpenWest Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / OPTIMIZERx Corp / Veoneer Inc / Health Catalyst Inc / Genmab A/S / Cerence Inc / Pennant Group Inc / IGM Biosciences Inc / Oasis Petroleum Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Nurix Therapeutics Inc / Rackspace Technology Inc / Gohealth Inc / Ibex Ltd / Palantir Technologies Inc / American Electric Power Company Inc / Spruce Biosciences Inc / Bentley Systems Inc / Gatos Silver Inc / Goodrx Holdings Inc / Mcafee Corp / Lordstown Motors Corp / Mediaalpha Inc / Soc Telemed Inc / Lightspeed Commerce Inc / PubMatic Inc / Telus International Cda Inc / Affirm Holdings Inc / Nuvation Bio Inc / Chesapeake Energy Corp / Olo Inc / UiPath Inc / Paysafe Ltd / TuSimple Holdings Inc / Triple Flag Precious Metals Corp / Flywire Corp / Bright Health Group Inc / Xometry Inc / Taskus Inc / Tremor International Ltd / EverCommerce Inc / N-Able Inc / Ryan Specialty Group Holdings Inc / Thoughtworks Holding Inc / GitLab Inc / Ranger Oil Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Spiking European COVID Cases Could Negatively Impact NT Biotech Earnings and Clinical Trial Conduct</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NA / PFE.N / GILD.O / JAZZ.O / VRTX.O / BIIB.O / ACAD.O / SRPT.O / ABBV.N / PTCT.O / ITCI.O / SAGE.OQ / GLPG.O / IGMS.O / SPRB.OQ</td><td class="leftalignment">National Bank of Canada / Pfizer Inc / Gilead Sciences Inc / Jazz Pharmaceuticals PLC / Vertex Pharmaceuticals Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Intra-Cellular Therapies Inc / SAGE Therapeutics Inc / Galapagos NV / IGM Biosciences Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Stephen Mallon / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (15 Nov): Results winding down, expect focus to shift to next-FY earnings and longer-term themes</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">11/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（11月15日～）:決算一巡、来期業績や中長期のテーマへシフトしよう</td><td class="leftalignment">Japanese</td><td class="rightalignment">13</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">11/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MEDACorp Survey Shines Light on the Achondroplasia Competitive Landscape</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">09061G10 / 71708110 / 04351P101 / 10806X10</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Pfizer Inc / Ascendis Pharma A/S / BridgeBio Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Joseph P. Schwartz / Mani Foroohar, M.D. / Joori Park, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Peer Group Analytics - Q3 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.9% Above Pre-Pandemic Base- Week 84</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/13/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">FINAM</td><td class="leftalignment">Вложения в Pfizer по-прежнему актуальны</td><td class="leftalignment">Russian</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Zareena Sayedova</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE TL1A Enthusiasm, Biomarker Data Validate RXDX Precision Approach; PT to $43</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N / 71708110</td><td class="leftalignment">Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas J. Smith / Mike Kratky, CFA / Michael Jones, Ph.D. / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended November 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: Q3 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RXDX.OQ / PFE.N</td><td class="leftalignment">Prometheus Biosciences Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">11/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: November 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">A.N / AAP.N / BBY.N / GPS.N / MDT.N / PFE.N / WMT.N / DE.N / TSN.N / HD.N / LOW.N / TGT.N / TJX.N / HPQ.N / AMAT.OQ / ADSK.OQ / CSCO.OQ / ROST.OQ / SJM.N / INTU.OQ / CPRT.OQ / DLTR.OQ / AMZN.OQ / NVDA.OQ / TDG.N / MRNA.OQ / ADI.OQ / KEYS.N / J.N / BBWI.N</td><td class="leftalignment">Agilent Technologies Inc / Advance Auto Parts Inc / Best Buy Co Inc / Gap Inc / Medtronic PLC / Pfizer Inc / Walmart Inc / Deere & Co / Tyson Foods Inc / Home Depot Inc / Lowe's Companies Inc / Target Corp / TJX Companies Inc / HP Inc / Applied Materials Inc / Autodesk Inc / Cisco Systems Inc / Ross Stores Inc / J M Smucker Co / Intuit Inc / Copart Inc / Dollar Tree Inc / Amazon.com Inc / NVIDIA Corp / TransDigm Group Inc / Moderna Inc / Analog Devices Inc / Keysight Technologies Inc / Jacobs Engineering Group Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">4031976 / 0989529 / 2516152 / 2000019 / 2023607 / 2640147 / 2778844 / 2222631 / 2270726 / 2542049 / 2684703 / 4595739 / 2857817 / 2982924 / B7TL820 / BCZS820 / BBPK0J0 / BDZCRX3 / BFLR866 / BFZCHN7 / BYVYD43 / BF4VBS8 / BFZNYB7 / BDHF4K6 / BJXBP41 / BMQ5T49 / BYY88Y7 / BL71K91 / BYP71H7 / BRJ3GY4 / BN2R582 / BYQCZ35 / BMPRZV5 / BMC5RV6 / BFY7DC4 / BNTB3N8 / BMFPJK6 / BN2RM92 / BMGGJK8 / BMF1LH5 / BMXXBD9 / BLF0CW7 / BP7KZP7 / BNLYJ60 / BNLYBF3 / BMDTR28</td><td class="leftalignment">Adidas AG / AstraZeneca PLC / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Pfizer Inc / Genmab A/S / Netflix Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / Fate Therapeutics Inc / Mirati Therapeutics Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / Performance Food Group Co / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Alcon AG / Zentalis Pharmaceuticals Inc / Alphabet Inc / Revolution Medicines Inc / National Vision Holdings Inc / Xenon Pharmaceuticals Inc / Relay Therapeutics Inc / Madison Square Garden Sports Corp / Kymera Therapeutics Inc / Adicet Bio Inc / Altimmune Inc / Vizio Holding Corp / ACV Auctions Inc / Rain Therapeutics Inc / Valneva SE / Honest Company Inc / Figs Inc / Repare Therapeutics Inc / Monte Rosa Therapeutics Inc / Imago BioSciences Inc / Erasca Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HCM: HUTCHMED (China) Limited - Three targeted oncology drugs present bright globalisation prospect; initiate with OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">0013.HK / HCM.OQ / 1093.HK / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / 1177.HK / MRCG.DE / NVS.N / AMGN.OQ / INCY.OQ / RIGL.OQ / RO.S / BSLN.S / 600276.SS / 4568.T / 002422.SZ / ABBV.N / EPZM.OQ / BGNE.OQ / TPB.N / 300558.SZ / 6160.HK / 1801.HK / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / HUTCHMED (China) Ltd / CSPC Pharmaceutical Group Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Sino Biopharmaceutical Ltd / Merck KGaA / Novartis AG / Amgen Inc / Incyte Corp / Rigel Pharmaceuticals Inc / Roche Holding AG / Basilea Pharmaceutica AG / Jiangsu Hengrui Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Abbvie Inc / Epizyme Inc / Beigene Ltd / Turning Point Brands Inc / Betta Pharmaceuticals Co Ltd / Beigene Ltd / Innovent Biologics Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL - BUY - 3Q21 Recap; R&D Day on Dec.16; Continued Clinical Execution on ZN-c3; Frequent Data Readouts in 2022; PT to $97</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMQ5T49 / 0989529 / 0925288 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">VALN: Raising PT to $64/shr on European Agreement & Pricing Likely Closer to PFE's; Model Also Reflects Recent Raise</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / BMGGJK8 / 0989529 / 2684703 / VLS.PA</td><td class="leftalignment">Pfizer Inc / Valneva SE / AstraZeneca PLC / Pfizer Inc / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reported 3Q, Fyarro PDUFA in November, Further Trial InitiationYE21/1Q22</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US00032Q1040 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Aadi Bioscience Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Down but Not Out? Imminent FDA Meeting Will Likely Decide Roxa’s Fate</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">31572Q80 / 71708110 / 03116210 / 00287Y10</td><td class="leftalignment">FibroGen Inc / Pfizer Inc / Amgen Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Credit Suisse Healthcare Conference Day 3: APLS, ARNA, BMRN, GLTO, and IFRX</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">APLS.OQ / ARNA.OQ / BMRN.OQ / GLTO.OQ / IF0G.DE / PFE.N / SGMO.OQ / IFRX.OQ</td><td class="leftalignment">Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Galecto Inc / InflaRx NV / Pfizer Inc / Sangamo Therapeutics Inc / InflaRx NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HUM: Continuing to Say It Took the Conservative Approach to 2022</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">HUM.N / PFE.N</td><td class="leftalignment">Humana Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. A.J. Rice / Mr. Jonathan C. Yong / Nick Giovacchini</td></tr>
<tr class="odd"><td class="leftalignment">11/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">068270.KS: Celltrion Inc - 3Q21 review: Weak earnings which were largely expected</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">068270.KS / PFE.N / 091990.KQ</td><td class="leftalignment">Celltrion Inc / Pfizer Inc / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Pfizer - $56.13 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Pfizer Partnership Controversy but the Story Remains a Good One</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">G1119610 / 71708110</td><td class="leftalignment">Biohaven Pharmaceutical Holding Company Ltd / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RAIN - BUY - R&D Day Takeaways; Prioritizing Bigger Merkel Cell Carcinoma (MCC) Opp'ty with MDM2 Inhibitor over Niche Intimal Sarcoma</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BN2RM92 / 2778844 / 2684703</td><td class="leftalignment">Rain Therapeutics Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HALO-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HALO.O / BAX / JNJ / LLY / PFE / MNKD.O / SNY.O</td><td class="leftalignment">Halozyme Therapeutics Inc / Baxter International Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / MannKind Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">AMGN / BMY / GILD / JNJ / LLY / MRK / PFE / ACRS / UTHR / ACRX / BIIB / ABBV / AERI / ALDX</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aclaris Therapeutics Inc / United Therapeutics Corp / AcelRx Pharmaceuticals Inc / Biogen Inc / Abbvie Inc / Aerie Pharmaceuticals Inc / Aldeyra Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reports 3Q, FPI-1434 Data 2H22, FPI-1966 Data To Follow 1Q23</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CA36118A1003 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Fusion Pharmaceuticals Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Ladenburg Thalmann & Co. Inc.</td><td class="leftalignment">Terminating Coverage</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">LadenburgThalma Research</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Report 3Q, UpRi and XMT-1592 Data in 2022, UP-NEXT Initiation mid-2022</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US59045L1061 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Mersana Therapeutics Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q: Lead Asset IND Submission On Track for 4Q</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">87583X10 / 71708110 / 03116210 / 75886F10 / 00287Y10</td><td class="leftalignment">Tango Therapeutics Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Andrew Berens, M.D. / Christopher Liu, Pharm.D. / Ken Shields</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">SPEAKER ADDED: Please Join Our KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM / US38341P1021</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc / Gossamer Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">VRS (Valuation & Research Specialists)</td><td class="leftalignment">PFIZER Technical Comment</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TNGX - BUY - Post-Earnings Mgmt Discussion on Lead Asset TNG908 and Broader Pipeline; Maintain BUY, $16 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BP2P6L0 / 0925288 / 2684703 / BBPK0J0 / BK0VHF6</td><td class="leftalignment">Tango Therapeutics Inc / GlaxoSmithKline PLC / Pfizer Inc / Mirati Therapeutics Inc / IDEAYA Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Nov 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">FR0000121014 / US0079031078 / US0079731008 / US02553E1064 / US0382221051 / US09058V1035 / US22160K1051 / US2358511028 / US3647601083 / US3695501086 / US4448591028 / US45167R1041 / US45253H1014 / US4581401001 / US5002551043 / US5128071082 / US55306N1046 / US5950171042 / US5951121038 / US6284641098 / US64125C1099 / US67066G1040 / US8168501018 / US87612E1064 / US8807701029 / US8835561023 / US8968181011 / US91307C1027 / US92532F1003 / US9311421039 / US9581021055 / US21036P1084 / US90385V1070 / US31620M1062 / US82706C1080 / BREMBRACNOR4 / US57636Q1040 / US6247581084 / US79546E1047 / US8485741099 / US55616P1049 / US90384S3031 / US64110D1046 / US7181721090 / US92335C1062 / US29082A1079 / US40412C1018 / US8969452015 / US98986T1088 / US96208T1043 / NL0010273215 / US81762P1021 / US04649U1025 / IE00B4Q5ZN47 / US55405Y1001 / US55345K1034 / US00847X1046 / US60468T1051 / US5253271028 / US4277461020 / NL0010696654 / US67011P1003 / JE00BLG2ZQ72 / US67576A1007 / IE00BQPVQZ61 / US19249H1032 / US3580391056 / CA89620X5064 / US0367521038 / US64829B1008 / US74736K1016 / US46185L1035 / US09627Y1091 / US6323071042 / US70450Y1038 / US74624M1027 / US87164F1057 / US45073V1089 / US87266J1043 / US02081G2012 / US26856L1035 / KYG4740B1059 / US74967X1037 / CA1350861060 / US23355L1061 / US03236M2008 / US74766Q1013 / US15102K1007 / US03753U1060 / US57777K1060 / US05351X1019 / US11135F1012 / US89610F1012 / US2575541055 / US01671P1003 / VGG312491084 / CA39342L1085 / KY30744W1070 / VGG1890L1076 / US89377M1099 / US05352A1007 / CA23126M1023 / US88339P1012 / US92537N1081 / US05380C1027 / US67181A1079 / US58406B1035 / US18914F1030 / US55406W1036 / LU2314763264 / US90364P1057 / US5738741041 / US74276R1023 / IE00BKVD2N49 / US53228F1012 / US23954D1090 / US20717M1036 / US89142B1070 / US45250K1079 / US23285D1090 / US88546E1055 / US88331L1089 / 50066V107 / US00152K1016 / US93403J1060</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Advanced Micro Devices Inc / Advanced Energy Industries Inc / American Eagle Outfitters Inc / Applied Materials Inc / BioCryst Pharmaceuticals Inc / Costco Wholesale Corp / Danaher Corp / Gap Inc / General Dynamics Corp / Humana Inc / IDEX Corp / ImmunoGen Inc / Intel Corp / Kohls Corp / Lam Research Corp / MKS Instruments Inc / Microchip Technology Inc / Micron Technology Inc / Myers Industries Inc / Neurocrine Biosciences Inc / NVIDIA Corp / Semtech Corp / Target Corp / Teradyne Inc / Thermo Fisher Scientific Inc / Triumph Group Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Walmart Inc / Western Digital Corp / Constellation Brands Inc / Ultra Clean Holdings Inc / Fidelity National Information Services Inc / Silicon Motion Technology Corp / Embraer SA / Mastercard Inc / Mueller Water Products Inc / Sally Beauty Holdings Inc / Spirit AeroSystems Holdings Inc / Macy's Inc / Ulta Beauty Inc / NetApp Inc / Philip Morris International Inc / Vera Bradley Inc / Embraer SA / HCA Healthcare Inc / Tripadvisor Inc / Zynga Inc / WEX Inc / ASML Holding NV / ServiceNow Inc / Asure Software Inc / Jazz Pharmaceuticals PLC / MACOM Technology Solutions Holdings Inc / MRC Global Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Leidos Holdings Inc / Heron Therapeutics Inc / Uniqure NV / NOW Inc / Quotient Ltd / Ocular Therapeutix Inc / Horizon Therapeutics PLC / Coherus BioSciences Inc / Freshpet Inc / Pfizer Inc / Anthem Inc / New Relic Inc / Qorvo Inc / Invitae Corp / Blueprint Medicines Corp / Natera Inc / PayPal Holdings Inc / Pure Storage Inc / Syndax Pharmaceuticals Inc / ITT Inc / TPI Composites Inc / Alphatec Holdings Inc / elf Beauty Inc / Ichor Holdings Ltd / RH / Canada Goose Holdings Inc / DXC Technology Co / Amyris Inc / Quanterix Corp / Celcuity Inc / Apellis Pharmaceuticals Inc / MaxCyte Inc / Avaya Holdings Corp / Broadcom Inc / Tricida Inc / Domo Inc / Allakos Inc / Establishment Labs Holdings Inc / Green Thumb Industries Inc / Farfetch Ltd / Capri Holdings Ltd / Transmedics Group Inc / Avantor Inc / Curaleaf Holdings Inc / RealReal Inc / Vertiv Holdings Co / AVITA Medical Inc / Oak Street Health Inc / MedAvail Holdings Inc / Clover Health Investments Corp / MYT Netherlands Parent BV / Arrival SA / UiPath Inc / Marvell Technology Inc / Privia Health Group Inc / Seagate Technology Holdings PLC / Lifestance Health Group Inc / Day One Biopharmaceuticals Inc / Confluent Inc / Torrid Holdings Inc / Imago BioSciences Inc / Cytek Biosciences Inc / Thoughtworks Holding Inc / Beauty Health Co / KORE Group Holdings Inc / AKA Brands Holding Corp / Warby Parker Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / France / Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">BioNTech: Bereits in der (technischen) Baisse</td><td class="leftalignment">German</td><td class="rightalignment">4</td><td class="leftalignment">US7170811035 / US09075V1026</td><td class="leftalignment">Pfizer Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Achim Matzke / Frau Petra von Kerssenbrock / Herr Thorsten Grisse</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2732635 / 2229126 / 2270726 / 2345022 / 2121352 / 2459202 / 2613990 / 2515030 / 2630085 / 2684703 / 2862532 / 2943523 / 2931034 / 7103065 / B0X7DZ3 / 2713317 / 2857817 / 2951452 / 2598246 / B44C366 / B7TL820 / B8L2798 / BBPK0J0 / BDZCRX3 / B95WG16 / BS7K7C9 / BYVFC94 / BYQHP96 / BF5L3T2 / BJLT387 / BJLKVS6 / BZB1XF2 / BYZR4X4 / BJ5FZ74 / BGCYWN8 / BZ8FPH3 / BKVDFF7 / BFXC911 / BHZSB82 / BDH65C8 / BP3YM85 / BL95N25 / BYY88Y7 / BKC9SX3 / BD6JX35 / BKS3RS7 / BYTJZL1 / BDD1B07 / BFY7DC4 / BKPGJQ1 / BFYVZ75 / BF0QTY9 / BMW15J8 / BYYGK12</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / AutoNation Inc / Columbia Sportswear Co / Walt Disney Co / Macy's Inc / Group 1 Automotive Inc / IDEXX Laboratories Inc / Illumina Inc / Lithia Motors Inc / Neogen Corp / Pfizer Inc / E W Scripps Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Novartis AG / Chipotle Mexican Grill Inc / ACADIA Pharmaceuticals Inc / Netflix Inc / J M Smucker Co / Neogenomics Inc / Heska Corp / Meta Platforms Inc / Hemisphere Media Group Inc / Mirati Therapeutics Inc / RingCentral Inc / Zoetis Inc / Nevro Corp / US Foods Holding Corp / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Avantor Inc / Phathom Pharmaceuticals Inc / Tactile Systems Technology Inc / Axsome Therapeutics Inc / Adaptive Biotechnologies Corp / Xencor Inc / Editas Medicine Inc / Oric Pharmaceuticals Inc / Guardant Health Inc / Covetrus Inc / PetIQ Inc / Trupanion Inc / Phibro Animal Health Corp / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / 10X Genomics Inc / Zogenix Inc / Rubius Therapeutics Inc / Altimmune Inc / Squarespace Inc / Seelos Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc / Renalytix PLC / TPI Composites Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: Credit Suisse Healthcare Conference Day 2: ABSI, HGEN, ISEE, KURA, and RXDX</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABSI.OQ / HGEN.OQ / ISEE.OQ / RXDX.OQ / PFE.N / APLS.OQ / KURA.OQ</td><td class="leftalignment">Absci Corp / Humanigen Inc / Iveric Bio Inc / Prometheus Biosciences Inc / Pfizer Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">11/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare sector - Pfizer's Paxlovid expected to have limited impact on near-term vaccine demand; China small-molecule COVID drugs under active development</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRCG.DE / CRL.N / 2269.HK</td><td class="leftalignment">Pfizer Inc / Merck KGaA / Charles River Laboratories International Inc / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Pfizer Stock Continue To Rise?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: Our Top-Read and Most Differentiated Notes</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / GILD.O / JAZZ.O / VRTX.O / BLU.N / BIIB.O / PCRX.O / ABBV.N / ENTA.O / ITCI.O / XENE.O / GMDA.OQ / MTCR.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Jazz Pharmaceuticals PLC / Vertex Pharmaceuticals Inc / BELLUS Health Inc / Biogen Inc / Pacira Biosciences Inc / Abbvie Inc / Enanta Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Xenon Pharmaceuticals Inc / Gamida Cell Ltd / Metacrine Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Leonid Timashev / Yinglu Zhang / Stephen Mallon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FISV=US / BSX=US / PFE=US / OXY=US / GBT=US / IP=US / MDT=US / PD=US / AMZN=US / RUN=US / CMA=US / EOG=US / PB=US / DIOD=US / VRM=US / MUR=US / EWBC=US / UMPQ=US / EXPE=US / ATVI=US / VMC=US / UNM=US / CVS=US / CI=US / W=US / MLM=US / ARCC=US / PATH=US / COLL=US / MAIN=US / DOC=US / ORCC=US / PACW=US / REGN=US / SGMO=US / SNAP=US / TRGP=US / TRIP=US / VRTX=US / WAL=US / WIX=US / CVX=US / GPN=US / FNF=US / BKNG=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / CNM=US / FB=US / KIM=US / MKL=US / MTCH=US / SSB=US / RF=US / CATY=US / SBSI=US / BE=US / APPN=US / PNFP=US / BDSI=US / PTON=US / BIIB=US / TCBI=US / MOG.A=US / FNB=US / EXP=US / FHN=US / APP=US / AINV=US / XM=US / FIS=US / GPRE=US / CADE=US / WRK=US / PNNT=US / NOG=US / ATSG=US / IAC=US / HTA=US / OLO=US / OAS=US / BLND=US / ESTE=US / ANGI=US / ZNGA=US / PDCE=US / TILE=US / VOYA=US / CEQP=US / AERI=US / GOOGL=US / QTWO=US / TSLX=US / 70806A106 / BABA=US / CIVI=US / CMPR=US / RLMD=US / GDDY=US / GSBD=US / CHCT=US / LOB=US / PEN=US / SQ=US / ADVM=US / CDEV=US / ANAB=US / CVNA=US / SBOW=US / RDFN=US / SWCH=US / DCPH=US / MBIN=US / SFIX=US / HWC=US / OZK=US / FOCS=US / FTDR=US / FSK=US / LYFT=US / UBER=US / FERG=US / RPAY=US / AHCO=US / ONEM=US / DKNG=US / NCNO=US / PAYA=US / ABNB=US / RBLX=US / COUR=US / VMEO=US / MNTV=US / DNUT=US / PKG=U / 00152K101 / GTLB=US</td><td class="leftalignment">Fiserv Inc / Boston Scientific Corp / Pfizer Inc / Occidental Petroleum Corp / Global Blood Therapeutics Inc / International Paper Co / Medtronic PLC / PagerDuty Inc / Amazon.com Inc / Sunrun Inc / Comerica Inc / EOG Resources Inc / Prosperity Bancshares Inc / Diodes Inc / Vroom Inc / Murphy Oil Corp / East West Bancorp Inc / Umpqua Holdings Corp / Expedia Group Inc / Activision Blizzard Inc / Vulcan Materials Co / Unum Group / CVS Health Corp / Cigna Corp / Wayfair Inc / Martin Marietta Materials Inc / Ares Capital Corp / UiPath Inc / Collegium Pharmaceutical Inc / Main Street Capital Corp / Physicians Realty Trust / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Snap Inc / Targa Resources Corp / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Wix.Com Ltd / Chevron Corp / Global Payments Inc / Fidelity National Financial Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Core & Main Inc / Meta Platforms Inc / Kimco Realty Corp / Markel Corp / Match Group Inc / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / Southside Bancshares Inc / Bloom Energy Corp / Appian Corp / Pinnacle Financial Partners Inc / BioDelivery Sciences International Inc / Peloton Interactive Inc / Biogen Inc / Texas Capital Bancshares Inc / Moog Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Applovin Corp / Apollo Investment Corp / Qualtrics International Inc / Fidelity National Information Services Inc / Green Plains Inc / Cadence Bank / Westrock Co / Pennantpark Investment Corp / Northern Oil and Gas Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Healthcare Trust Of America Inc / Olo Inc / Oasis Petroleum Inc / Blend Labs Inc / Earthstone Energy Inc / Angi Inc / Zynga Inc / PDC Energy Inc / Interface Inc / Voya Financial Inc / Crestwood Equity Partners LP / Aerie Pharmaceuticals Inc / Alphabet Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Alibaba Group Holding Ltd / Civitas Resources Inc / Cimpress PLC / Relmada Therapeutics Inc / GoDaddy Inc / Goldman Sachs BDC Inc / Community Healthcare Trust Inc / Live Oak Bancshares Inc / Penumbra Inc / Block Inc / Adverum Biotechnologies Inc / Centennial Resource Development Inc / AnaptysBio Inc / Carvana Co / SilverBow Resources Inc / Redfin Corp / Switch Inc / Deciphera Pharmaceuticals Inc / Merchants Bancorp / Stitch Fix Inc / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Frontdoor Inc / FS KKR Capital Corp / Lyft Inc / Uber Technologies Inc / Ferguson PLC / Repay Holdings Corp / Adapthealth Corp / 1Life Healthcare Inc / DraftKings Inc / nCino Inc / Paya Holdings Inc / Airbnb Inc / Roblox Corp / Coursera Inc / Vimeo Inc / Momentive Global Inc / Krispy Kreme Inc / Packaging Corp of America / AKA Brands Holding Corp / GitLab Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Initial Thoughts on Oral COVID Antivirals & Read Across to Tools (AVTR,DHR,TMO)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AVTR.N / TMO.N / US7170811035 / US8835561023 / US05352A1007</td><td class="leftalignment">Avantor Inc / Thermo Fisher Scientific Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Avantor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Daniel Brennan / Tom Stevens / Kyle Boucher</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">2681511 / 2000019 / 2486813 / 2778844 / 2973821 / 2050832 / 2732635 / 2942605 / 2216850 / 2270726 / 2542049 / 2317087 / 2515030 / 2657802 / 2680905 / 2684703 / 2440637 / 2573083 / 2138158 / 2825933 / 2829601 / 2980906 / 2503529 / 2212922 / 2857817 / B125XQ6 / B0T7YX2 / B02R1L6 / 2983563 / B2R3PV1 / B1XGNW4 / B5B2106 / 2390817 / B7TL820 / B4MG4Z6 / B783TY6 / B7VD3F2 / BBPK0J0 / BBGVT40 / B95N910 / B7577T2 / BCGCR79 / BFZCHN7 / BYY8XK8 / BQPVQZ6 / BYZLV46 / BXDZ9Z0 / BF5L3T2 / BJT1RW7 / BD9GVY0 / BZ1LFB2 / BQT3XY6 / BJ2Z0H2 / BWFKZT2 / BMYML02 / BFNR303 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJVR9Y9 / BD6D4Y5 / BYY88Y7 / BDVLM39 / BMDCDP2 / BJRFSB7 / BD72R64 / BKPGJQ1 / BM8NHS1 / BMYRFV6</td><td class="leftalignment">PepsiCo Inc / Amazon.com Inc / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Ameren Corp / AutoNation Inc / Avista Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Lithia Motors Inc / OGE Energy Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Foot Locker Inc / World Wrestling Entertainment Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Carmax Inc / American Water Works Company Inc / Insulet Corp / Fortinet Inc / Gray Television Inc / Meta Platforms Inc / AMC Networks Inc / Aptiv PLC / Duke Energy Corp / Mirati Therapeutics Inc / News Corp / PTC Inc / Renewable Energy Group Inc / Sprouts Farmers Market Inc / Wix.Com Ltd / WEC Energy Group Inc / Horizon Therapeutics PLC / InflaRx NV / Shopify Inc / Elanco Animal Health Inc / Lyft Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Cyberark Software Ltd / Pinterest Inc / Cellectis SA / DraftKings Inc / Northwest Natural Holding Co / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Altair Engineering Inc / Alphabet Inc / argenx SE / Bigcommerce Holdings Inc / Immunovant Inc / Liberty Media Corp / Squarespace Inc / Adagio Therapeutics Inc / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer / Merck : Oral COVID-19 Antivirals And What They Mean For PFE And MRK</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Green Cross Corp: Readacross from Pfizer's oral COVID Ph-2/3 data; Green Cross. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / 006280.KS / MRK.N / REGN.OQ / 068270.KS</td><td class="leftalignment">Pfizer Inc / Green Cross Corp / Merck & Co Inc / Regeneron Pharmaceuticals Inc / Celltrion Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Inc: Readacross from Pfizer's oral COVID Ph-2/3 data (Celltrion Inc). Maintain UNDERPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / 068270.KS / MRK.N / REGN.OQ</td><td class="leftalignment">Pfizer Inc / Celltrion Inc / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Healthcare Co Ltd: Readacross from Pfizer's oral COVID Ph-2/3 data (Celltrion Healthcare). Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / 091990.KQ / MRK.N / REGN.OQ</td><td class="leftalignment">Pfizer Inc / Celltrion Healthcare Co Ltd / Merck & Co Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">11/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Readacross from Pfizer's oral COVID Ph-2/3 data; what additional data should we expect in near future</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / 068270.KS / 091990.KQ / LLY.N / MRK.N / GSK.L / REGN.OQ / 006280.KS</td><td class="leftalignment">Pfizer Inc / Celltrion Inc / Celltrion Healthcare Co Ltd / Eli Lilly and Co / Merck & Co Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Green Cross Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">11/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.7% Above Pre-Pandemic Base- Week 83</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Trillium Therapeutics jumps $370 million (25%) in MCap in 2021, leads Biotechnology sector gains</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE, MRK - The COVID see-saw (buzz saw?) continues with new oral data from Pfizer</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7170811035 / US58933Y1055</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : Paxlovid Data Exceed All Expectations – a Major Step Towards Addressing COVID and Significant Sales Oppty for PFE</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Outlook Improving, But EBITDA Trajectory Still A Big Question Mark</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">G30401106 / 717081103 / 03168L105 / 269796108</td><td class="leftalignment">Endo International PLC / Pfizer Inc / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">v v impressive efficacy with COVID pill!</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral Chapter 4; Think Big</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">11012210 / 71708110 / 00846U10 / 88162420 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / 09062X10 / 478160104 / 30161Q104 / 771195104 / 58933Y10 / 00287Y10 / 45781M10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Biogen Inc / Johnson & Johnson / Exelixis Inc / Roche Holding AG / Merck & Co Inc / Abbvie Inc / Innoviva Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Runs the Table in COVID – MRNA Bubble Continues to Deflate</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / 60770K10 / 71708110</td><td class="leftalignment">Pfizer Inc / Moderna Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Sets New Bar for COVID-19 Antivirals; Positive Readthrough to Enanta's '235</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / ENTA.OQ / 71708110 / 58933Y10 / 29251M10 / 04683R10</td><td class="leftalignment">Pfizer Inc / Enanta Pharmaceuticals Inc / Pfizer Inc / Merck & Co Inc / Enanta Pharmaceuticals Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Roanna C. Ruiz</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Another Feather in the Cap - Effective, Safe Antiviral Signals End of Pandemic</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">PFE's COVID anti-viral could be a hard pill to swallow for competitors</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US / REGN=US</td><td class="leftalignment">Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Going Viral Chapter 3, PFE Reports Better Topline Data Than MRK</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS MORNING: KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Information Content of Earnings Releases 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / BA.N / CAH.N / CCK.N / CE.N / CF.N / COF.N / EIX.N / EOG.N / F.N / HIG.N / HLT.N / IBM.N / ITT.N / KEY.N / MAN.N / NOC.N / PFE.N / PM.N / SC.N / STE.N / TMX.N / UAL.N / USB.N / VNT.N / ZEN.N / DGX.N / PXD.N / NUE.N / DIS.N / WLK.N / CMI.N / GD.N / AIZ.N / AFG.N / R.N / SPOT.N / EVR.N / PRI.N / ADM.N / IFF.N / MRO.N / LH.N / EMR.N / PCG.N / OLN.N / TGT.N / RKT.N / SNV.N / AZO.N / FDS.N / ATO.N / H.N / BYD.N / DNB.N / GPC.N / HRL.N / SAM.N / CVX.N / L.N / GME.N / COP.N / INTC.OQ / ORI.N / ADPT.OQ / CRUS.OQ / FISV.OQ / HOLX.OQ / RJF.N / TYL.N / FL.N / ZION.OQ / QCOM.OQ / ORLY.OQ / DFS.N / LAMR.OQ / MRCY.OQ / WTFC.OQ / UMPQ.OQ / PLUG.OQ / HAIN.OQ / PNFP.OQ / WOOF.OQ / WYNN.OQ / PA1436583006 / OPEN.OQ / TFC.N / OSH.N / LVS.N / THG.N / BRKb.N / OC.N / FRPT.OQ / ULTA.OQ / NVR.N / CFX.N / MRNA.OQ / CME.OQ / CLH.N / AI.N / AVGO.OQ / NEE.N / SABR.OQ / Z.OQ / FB.OQ / BFAM.N / WEX.N / RNG.N / ARMK.N / NCLH.N / SYF.N / CFG.N / ANTM.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / CVNA.N / ROKU.OQ / PFG.OQ / KDP.N / STNE.OQ / NFE.OQ / LYFT.O / PINS.N / BYND.OQ / UBER.N / FSLY.N / GO.OQ / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / DCT.OQ / PLTR.N / SKLZ.N / CLVT.N / SGFY.N / CHPT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Boeing Co / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / CF Industries Holdings Inc / Capital One Financial Corp / Edison International / EOG Resources Inc / Ford Motor Co / Hartford Financial Services Group Inc / Hilton Worldwide Holdings Inc / International Business Machines Corp / ITT Inc / KeyCorp / ManpowerGroup Inc / Northrop Grumman Corp / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / STERIS plc / Terminix Global Holdings Inc / United Airlines Holdings Inc / US Bancorp / Vontier Corp / Zendesk Inc / Quest Diagnostics Inc / Pioneer Natural Resources Co / Nucor Corp / Walt Disney Co / Westlake Chemical Corp / Cummins Inc / General Dynamics Corp / Assurant Inc / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Evercore Inc / Primerica Inc / Archer-Daniels-Midland Co / International Flavors & Fragrances Inc / Marathon Oil Corp / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Olin Corp / Target Corp / Rocket Companies Inc / Synovus Financial Corp / Autozone Inc / Factset Research Systems Inc / Atmos Energy Corp / Hyatt Hotels Corp / Boyd Gaming Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / Hormel Foods Corp / Boston Beer Company Inc / Chevron Corp / Loews Corp / GameStop Corp / Conocophillips / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Cirrus Logic Inc / Fiserv Inc / Hologic Inc / Raymond James Financial Inc / Tyler Technologies Inc / Foot Locker Inc / Zions Bancorporation NA / Qualcomm Inc / O'Reilly Automotive Inc / Discover Financial Services / Lamar Advertising Co / Mercury Systems Inc / Wintrust Financial Corp / Umpqua Holdings Corp / Plug Power Inc / Hain Celestial Group Inc / Pinnacle Financial Partners Inc / Petco Health and Wellness Company Inc / Wynn Resorts Ltd / Carnival Corp / Opendoor Technologies Inc / Truist Financial Corp / Oak Street Health Inc / Las Vegas Sands Corp / Hanover Insurance Group Inc / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Ulta Beauty Inc / NVR Inc / Colfax Corp / Moderna Inc / CME Group Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / Nextera Energy Inc / Sabre Corp / Zillow Group Inc / Meta Platforms Inc / Bright Horizons Family Solutions Inc / WEX Inc / RingCentral Inc / Aramark / Norwegian Cruise Line Holdings Ltd / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Carvana Co / Roku Inc / Principal Financial Group Inc / Keurig Dr Pepper Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Fastly Inc / Grocery Outlet Holding Corp / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / Duck Creek Technologies Inc / Palantir Technologies Inc / Skillz Inc / CLARIVATE PLC / Signify Health Inc / ChargePoint Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Luxembourg / Panama / United States / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Air Transportation / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Containers & Packing / Defense / Education / Electrical / Electronics / Financial Services / Food / Healthcare / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After An Upbeat Q3?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">HCV Revisited (Again) - Revenue Miss, Lower Guide, Reiterate UP</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">60770K10 / 71708110</td><td class="leftalignment">Moderna Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">The Coming SERD Showdown in Texas: SABCS Planner and Preview</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75046920 / 98401F10 / 76029N10 / 55609910 / 04685N10 / 03969F10 / F5548N10 / 98943L10 / 98985W10</td><td class="leftalignment">Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Radius Health Inc / Xencor Inc / Replimune Group Inc / MacroGenics Inc / Athenex Inc / Arcus Biosciences Inc / Sanofi SA / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Andrew Berens, M.D. / Jonathan Chang, Ph.D., CFA / Daniel Tarjan, Ph.D. / Christopher Liu, Pharm.D. / Faisal Khurshid</td></tr>
<tr class="even"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">2000019 / 2497406 / 2486813 / 2942605 / 2544960 / 2085878 / 2111955 / 2270726 / 2829515 / 2037170 / 2317087 / 2670519 / 2632003 / 2645409 / 2689560 / 2680905 / 2684703 / 2048804 / 2707677 / 2799351 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B1XGNW4 / B4Y1MH7 / 2949758 / B7TL820 / B7254K9 / BBFL7S1 / B7JYSG3 / BBGVT40 / B95N910 / B8DPDT7 / BVVN4Q8 / BYY8XK8 / BQPVQZ6 / BJT1RW7 / BDHF4K6 / BJ1N1M9 / BD8DJ71 / BJ5FZ74 / BR4T3B3 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BYWMQJ2 / BDH65C8 / BP3YM85 / BZ1LFG7 / BYY88Y7 / BF3W461 / BKS3RS7 / BDZ30Q0 / BP84RX0 / BMFPJK6 / BWC52Q6</td><td class="leftalignment">Amazon.com Inc / Kroger Co / Kellogg Co / Avista Corp / Beasley Broadcast Group Inc / Bed Bath & Beyond Inc / Borgwarner Inc / Walt Disney Co / Edison International / 8x8 Inc / Entergy Corp / Exelon Corp / New York Times Co / NiSource Inc / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sinclair Broadcast Group Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Insulet Corp / KAR Auction Services Inc / Nexstar Media Group Inc / Meta Platforms Inc / AxoGen Inc / bluebird bio Inc / Guidewire Software Inc / News Corp / PTC Inc / Sarepta Therapeutics Inc / Eversource Energy / WEC Energy Group Inc / Horizon Therapeutics PLC / Lyft Inc / CRISPR Therapeutics AG / Capri Holdings Ltd / Snap Inc / Adaptive Biotechnologies Corp / HubSpot Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Alteryx Inc / PetIQ Inc / Trupanion Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / 10X Genomics Inc / Arvinas Inc / Townsquare Media Inc / ACV Auctions Inc / Solaredge Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended November 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN - BUY - Accelerating ARV-471 Development with Multiple Ph III Initiations Next Year; Upcoming '471 & '110 Data at SABCS and ASCO-GU</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BDZ30Q0 / 2684703</td><td class="leftalignment">Arvinas Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, PFE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">3Q Results Inline With Pre-Annoucement, Focus On 4Q Rebound</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US6951271005 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Pacira Biosciences Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Pfizer Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Another Q With Massive COVID Sales but Core Business Uncertainty, Mktpfrm, $48</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">FISV=US / BSX=US / CACI=US / LSI=US / PFE=US / AMGN=US / AMZN=US / T=US / BLD=US / DVN=US / INCY=US / AKAM=US / CHTR=US / CONE=US / VZ=US / CRK=US / IART=US / FMS=US / MGY=US / LEG=US / ATVI=US / KFRC=US / CMCSA=US / MLM=US / ARCC=US / AIZ=US / AMED=US / DCO=US / EQIX=US / GPOR=US / MAIN=US / MPLX=US / MRCY=US / ASGN=US / OKE=US / ORCC=US / RARE=US / REGI=US / RHI=US / SBAC=US / SGMO=US / SEE=US / VRTX=US / SAGE=US / EPD=US / GPN=US / MANT=US / PYPL=US / DCP=US / MTCH=US / SRC=US / COP=US / RRR=US / MMP=US / CZR=US / KAR=US / AINV=US / HURN=US / BAH=US / DENN=US / NSP=US / FIS=US / XPO=US / WU=US / ICFI=US / PNNT=US / LLNW=US / PAGP=US / IAA=US / CWH=US / NXPI=US / FANG=US / TMUS=US / LDOS=US / NMIH=US / TSLX=US / VNOM=US / 70806A106 / DEA=US / SEDG=US / NXRT=US / GSBD=US / NSA=US / CHCT=US / ZG=US / NVCR=US / MIME=US / 82982L103 / GXO=US / IRTC=US / TVTY=US / 50189K103 / AYX=US / SWCH=US / DCPH=US / EOLS=US / KDP=US / BHC=US / FSK=US / LYFT=US / PLMR=US / OVV=US / COUR=US</td><td class="leftalignment">Fiserv Inc / Boston Scientific Corp / CACI International Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Amazon.com Inc / AT&T Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Akamai Technologies Inc / Charter Communications Inc / CyrusOne Inc / Verizon Communications Inc / Comstock Resources Inc / Integra Lifesciences Holdings Corp / Fresenius Medical Care AG & Co KGaA / Magnolia Oil & Gas Corp / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Comcast Corp / Martin Marietta Materials Inc / Ares Capital Corp / Assurant Inc / Amedisys Inc / Ducommun Inc / Equinix Inc / Gulfport Energy Corp / Main Street Capital Corp / MPLX LP / Mercury Systems Inc / ASGN Inc / ONEOK Inc / Owl Rock Capital Corp / Ultragenyx Pharmaceutical Inc / Renewable Energy Group Inc / Robert Half International Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Sealed Air Corp / Vertex Pharmaceuticals Inc / SAGE Therapeutics Inc / Enterprise Products Partners LP / Global Payments Inc / ManTech International Corp / PayPal Holdings Inc / DCP Midstream LP / Match Group Inc / Spirit Realty Capital Inc / Conocophillips / Red Rock Resorts Inc / Magellan Midstream Partners LP / Caesars Entertainment Inc / KAR Auction Services Inc / Apollo Investment Corp / Huron Consulting Group Inc / Booz Allen Hamilton Holding Corp / Denny's Corp / Insperity Inc / Fidelity National Information Services Inc / XPO Logistics Inc / Western Union Co / ICF International Inc / Pennantpark Investment Corp / Limelight Networks Inc / Plains GP Holdings LP / IAA Inc / Camping World Holdings Inc / NXP Semiconductors NV / Diamondback Energy Inc / T-Mobile US Inc / Leidos Holdings Inc / NMI Holdings Inc / Sixth Street Specialty Lending Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / Easterly Government Properties Inc / Solaredge Technologies Inc / NexPoint Residential Trust Inc / Goldman Sachs BDC Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zillow Group Inc / Novocure Ltd / Mimecast Ltd / SiteOne Landscape Supply Inc / GXO Logistics Inc / iRhythm Technologies Inc / Tivity Health Inc / LCI Industries / Alteryx Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Evolus Inc / Keurig Dr Pepper Inc / Bausch Health Companies Inc / FS KKR Capital Corp / Lyft Inc / Palomar Holdings Inc / Ovintiv Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">5671735 / 2868165 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2973821 / 2544960 / 2437071 / 2219224 / 2206657 / 2208073 / 2829515 / 2037170 / 2317087 / 2576941 / 2328915 / 2100920 / 2459202 / 2471950 / 2645409 / 2689560 / 2684703 / 2048804 / 2707677 / 2931034 / B0PZN11 / B02R1L6 / B570P91 / B5B2106 / B4Y1MH7 / B6197Q2 / 2949758 / B3SWPT2 / B7TL820 / B4V9661 / B8CKK03 / BJ0KXV4 / BYY8XK8 / BYVYD43 / BYVFC94 / BP4GNK9 / BJF8Q81 / BZ1LFB2 / BD8DJ71 / BJ2Z0H2 / BYWMQJ2 / BL95N25 / BZ1LFG7 / BYY88Y7 / BDT5KT5 / BFWGXQ7 / BP84RX0 / BD72R64 / BFY7DC4 / BMZ9Z11 / BNTB3N8 / BMFPJK6 / BJ62Z18</td><td class="leftalignment">Sanofi SA / Sysco Corp / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Alliant Energy Corp / Beasley Broadcast Group Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Coca-Cola Co / Copart Inc / Edison International / 8x8 Inc / Entergy Corp / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / IDEXX Laboratories Inc / Incyte Corp / NiSource Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Vertex Pharmaceuticals Inc / Under Armour Inc / ALLETE Inc / Lear Corp / Fortinet Inc / KAR Auction Services Inc / Generac Holdings Inc / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / Ralph Lauren Corp / Mondelez International Inc / ONE Gas Inc / WEC Energy Group Inc / Performance Food Group Co / US Foods Holding Corp / SAGE Therapeutics Inc / IAA Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Pinterest Inc / Alteryx Inc / Phibro Animal Health Corp / Roku Inc / Alphabet Inc / Inspire Medical Systems Inc / Container Store Group Inc / Townsquare Media Inc / Liberty Media Corp / Altimmune Inc / Prometheus Biosciences Inc / Vizio Holding Corp / ACV Auctions Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RXDX - Positive Readthrough from PFE Trial Further Validates TL1A MoA in Ulcerative Colitis; Precision Medicine Could Boost Efficacy in IBD</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / BMZ9Z11 / 2684703</td><td class="leftalignment">Pfizer Inc / Prometheus Biosciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yatin Suneja / Mr. Eddie Hickman, Ph.D. / Evan Taddeo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: November 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / EOG.N / PFE.N / PNW.N / SO.N / WMT.N / PXD.N / HUM.N / MET.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / HD.N / EMR.N / JCI.N / DHI.N / SRE.N / ATO.N / VTR.N / COP.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / MCHP.OQ / TPR.N / ANSS.OQ / ILMN.OQ / EQIX.OQ / FIS.N / TDG.N / MRNA.OQ / FTNT.OQ / MSI.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Walmart Inc / Pioneer Natural Resources Co / Humana Inc / MetLife Inc / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Home Depot Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Atmos Energy Corp / Ventas Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Microchip Technology Inc / Tapestry Inc / ANSYS Inc / Illumina Inc / Equinix Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Moderna Inc / Fortinet Inc / Motorola Solutions Inc / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">11/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : 3Q Takeaways / Model Update - Raising Comirnaty Estimates (Again), Watching Near-term COVID Antiviral Readout</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">11/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - PFE 3Q21 Postview</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Highlights TL1A Potential, Validates RXDX Precision Approach to IBD</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">PFE.N / 71708110</td><td class="leftalignment">Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas J. Smith / Mike Kratky, CFA / Michael Jones, Ph.D. / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - PFE 3Q21 Conference Call</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q21 Another Quarter Boosted by COVID Windfall & 2022 Could be Even Bigger</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA / Daniel Tarjan, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Take A Closer Look, Solid Execution, New Launches And Pipeline Advancements Underscore PFE's Stock Remains Undervalued</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Beat On COVID Vaccine; 2021 Sales And Top Line Raised</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">vaccine #s concerns put to bed + impt pipeline updates</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : 3Q First Impressions: Vaccine Sales Continue to Move Higher While Core Business Modestly Below Expectations</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is Pfizer Stock Set To See Higher Levels Post Q3 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Pfizer, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Anguilla / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on November 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LYFT.OQ / BP.L / DD.N / EIX.N / EL.N / IBM.N / PEG.N / PFE.N / SEE.N / SLB.N / STE.N / WAT.N / ROK.N / HAL.N / ETN.N / LEA.N / CMI.N / AIZ.N / PGR.N / WEC.N / XOM.N / DVN.N / IT.N / PKI.N / MLM.N / OKE.N / AWK.N / AME.N / PRU.N / COP.N / AMGN.OQ / AAPL.OQ / ATVI.OQ / MSFT.OQ / SBUX.OQ / IDXX.OQ / INCY.OQ / HSIC.OQ / AMZN.OQ / ZBRA.OQ / AKAM.OQ / MTCH.OQ / GPN.N / VRTX.OQ / 0700.HK / RDSa.L / WU.N / 9999.HK / ES.N / VRSK.OQ / GNRC.N / CZR.OQ / MPC.N / BKR.N / XYL.N / MDLZ.OQ / LDOS.N / FMCC.PK / CTLT.N / ZG.OQ / TMUS.OQ / RACE.MI / PUMP.N / PINS.N / BYND.OQ / UBER.N / ZM.OQ / AMCR.N / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Lyft Inc / BP PLC / Dupont De Nemours Inc / Edison International / Estee Lauder Companies Inc / International Business Machines Corp / Public Service Enterprise Group Inc / Pfizer Inc / Sealed Air Corp / Schlumberger NV / STERIS plc / Waters Corp / Rockwell Automation Inc / Halliburton Co / Eaton Corporation PLC / Lear Corp / Cummins Inc / Assurant Inc / Progressive Corp / WEC Energy Group Inc / Exxon Mobil Corp / Devon Energy Corp / Gartner Inc / PerkinElmer Inc / Martin Marietta Materials Inc / ONEOK Inc / American Water Works Company Inc / AMETEK Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Starbucks Corp / IDEXX Laboratories Inc / Incyte Corp / Henry Schein Inc / Amazon.com Inc / Zebra Technologies Corp / Akamai Technologies Inc / Match Group Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Western Union Co / NetEase Inc / Eversource Energy / Verisk Analytics Inc / Generac Holdings Inc / Caesars Entertainment Inc / Marathon Petroleum Corp / Baker Hughes Co / Xylem Inc / Mondelez International Inc / Leidos Holdings Inc / Federal Home Loan Mortgage Corp / Catalent Inc / Zillow Group Inc / T-Mobile US Inc / Ferrari NV / ProPetro Holding Corp / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Amcor PLC / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Netherlands / United States / Jersey / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Nov. 02, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Nov. 02, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Hem A updates from PFE prepared remarks</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / SGMO=US / PFE=US / SGMO.OQ</td><td class="leftalignment">Pfizer Inc / Sangamo Therapeutics Inc / Pfizer Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3 Beat, 2021 Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pivotal Hemophilia A trial on voluntary pause for protocol change; await color on PFE call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / SGMO=US / PFE=US / SGMO.OQ</td><td class="leftalignment">Pfizer Inc / Sangamo Therapeutics Inc / Pfizer Inc / Sangamo Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Look At Beat And Raise 3Q21, Driven By Vaccine Sales</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FISV=US / MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / KO=US / MCD=US / OXY=US / ADI=US / RRC=US / GBT=US / WEN=US / DVN=US / INCY=US / TXN=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / MRO=US / EXPE=US / LEG=US / SEIC=US / KFRC=US / AMK=US / BNL=US / CBRL=US / ENV=US / CTRA=US / CNX=US / DRI=US / EQT=US / EXEL=US / GPOR=US / HZO=US / MCHP=US / REGI=US / SBAC=US / SSNC=US / TRIP=US / WIX=US / CVX=US / PSA=US / SPG=US / CGEN=US / BKNG=US / ADC=US / CUZ=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / MGNI=US / OGN / JRVR=US / BIIB=US / TXRH=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / TIL=US / NOG=US / EPRT=US / JACK=US / RCUS=US / GNRC=US / AR=US / OAS=US / NXPI=US / LPLA=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / ABBV=US / NDLS=US / ANIP=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / BWXT=US / WING=US / MCFT=US / WLTW=US / GXO=US / CDEV=US / CRSP=US / TRVG=US / JELD=US / SBOW=US / IOVA=US / FOCS=US / HARP=US / TCRR=US / NXTC=US / GMAB=US / PNTG=US / OVV=US / ZI=US / VTRS=US / ABNB=US / CELU=US / ROCC=US / REPX=US</td><td class="leftalignment">Fiserv Inc / Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Range Resources Corp / Global Blood Therapeutics Inc / Wendys Co / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Marathon Oil Corp / Expedia Group Inc / Leggett & Platt Inc / SEI Investments Co / Kforce Inc / AssetMark Financial Holdings Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Envestnet Inc / Coterra Energy Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Gulfport Energy Corp / MarineMax Inc / Microchip Technology Inc / Renewable Energy Group Inc / SBA Communications Corp / SS&C Technologies Holdings Inc / Tripadvisor Inc / Wix.Com Ltd / Chevron Corp / Public Storage / Simon Property Group Inc / Compugen Ltd / Booking Holdings Inc / Agree Realty Corp / Cousins Properties Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Organon & Co / James River Group Holdings Ltd / Biogen Inc / Texas Roadhouse Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / Generac Holdings Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / LPL Financial Holdings Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / ANI Pharmaceuticals Inc / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / BWX Technologies Inc / Wingstop Inc / Mastercraft Boat Holdings Inc / Willis Towers Watson PLC / GXO Logistics Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Trivago NV / JELD-WEN Holding Inc / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Focus Financial Partners Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc / Genmab A/S / Pennant Group Inc / Ovintiv Inc / ZoomInfo Technologies Inc / Viatris Inc / Airbnb Inc / Celularity Inc / Ranger Oil Corp / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2045623 / 2206657 / 2270726 / 2829515 / 2317087 / 2670519 / 2100920 / 2623911 / 2689560 / 2684703 / 2048804 / 7103065 / B125XQ6 / B2R3PV1 / B5B2106 / B3SWPT2 / B7TL820 / BBGVT40 / B95N910 / BVVN4Q8 / BD3W133 / BJLT387 / BK7Y2V9 / BD8DJ71 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BGSP7M9 / BD6D4Y5 / BYY88Y7 / BZ0P3Z5 / BMG75B4 / BN0XTW4 / BFY7DC4 / BNTB3N8 / BMW15J8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / ANSYS Inc / Coca-Cola Co / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / FirstEnergy Corp / Neurocrine Biosciences Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Portland General Electric Co / American Water Works Company Inc / Fortinet Inc / Ameresco Inc / Meta Platforms Inc / News Corp / PTC Inc / Eversource Energy / Keurig Dr Pepper Inc / Avantor Inc / Akero Therapeutics Inc / Snap Inc / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc / Altair Engineering Inc / Alphabet Inc / Tegna Inc / Inventiva SA / Orphazyme A/S / Altimmune Inc / Vizio Holding Corp / Renalytix PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: Validating a Precision Approach in IBD; Pfizer Earnings Read-Through</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / RXDX.OQ</td><td class="leftalignment">Pfizer Inc / Prometheus Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: November 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">AAP.N / AIG.N / ALL.N / APD.N / BDX.N / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / PFE.N / PNW.N / SO.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / TSN.N / SYY.N / IFF.N / EMR.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / VTR.N / PRU.N / COP.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / DISH.OQ / TPR.N / ANSS.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / FIS.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / ZTS.N / MAR.OQ / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Allstate Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Ventas Inc / Prudential Financial Inc / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / DISH Network Corp / Tapestry Inc / ANSYS Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">11/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PYXS: Pycking the Right Pieces for Next-Gen ADCs; Initiate Coverage at Outperform with a $19 TP</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">PYXS.OQ / PFE.N / IMGN.OQ / SGEN.OQ / 4568.T / MGNX.OQ / MRSN.OQ</td><td class="leftalignment">Pyxis Oncology Inc / Pfizer Inc / ImmunoGen Inc / Seagen Inc / Daiichi Sankyo Co Ltd / MacroGenics Inc / Mersana Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">11/02/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for PFE</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer strengthens 1.9% in past quarter; Artemis Investment Management LLP jumps back into Pfizer</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for TRIL</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">MacroRisk Analytics/EconomicInvestor</td><td class="leftalignment">The Economy Matters for PFE</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 22</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Harry Thomas Da Sephton / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">11/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: November 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CVS.N / DD.N / EL.N / EOG.N / FLT.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / CMI.N / D.N / PH.N / KIM.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / WEC.N / XOM.N / MTD.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / AWK.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / SBAC.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / MOS.N / FIS.N / ES.N / MRNA.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / MSI.N / MPC.N / EA.OQ / FANG.OQ / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / ANET.N / ETSY.OQ / ZBH.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Fleetcor Technologies Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Kimco Realty Corp / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Mettler-Toledo International Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / American Water Works Company Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / SBA Communications Corp / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Mosaic Co / Fidelity National Information Services Inc / Eversource Energy / Moderna Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Diamondback Energy Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Maternal RSV Vax Data Shows Impressive Newborn Protection</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N / AZN / 71708110 / 04635310 / 478160104 / 58933Y10 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Merck & Co Inc / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer down 7.9% from 7 week high</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">INSM / JNJ / MRK / PFE</td><td class="leftalignment">Insmed Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next In Biotech? "Field Report" From Targeted Protein Degradation Summit (ARVN, KYMR, GLUE, NRIX, AZN-LN, JNJ, NOVN-SW, BMY, SAN-FP, others)</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ARVN.OQ / BMY.N / GLUE.OQ / KYMR.OQ / 5671735 / 0989529 / 2126335 / 2684703 / 7103065 / BMQ5T49 / BYYWPW6 / BDZ30Q0 / BMPRZV5 / BP7KZP7</td><td class="leftalignment">Arvinas Inc / Bristol-Myers Squibb Co / Monte Rosa Therapeutics Inc / Kymera Therapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Pfizer Inc / Novartis AG / Zentalis Pharmaceuticals Inc / Beigene Ltd / Arvinas Inc / Kymera Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Paul Jeng, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III / Mr. Seamus Fernandez</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN - BUY - Strong Momentum Continues as All Three Commercial Products Beat in 3Q, Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">0925288 / 2778844 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / CACI=US / LLY=US / PFE=US / ADI=US / AMD=US / IP=US / AGL=US / AMZN=US / INCY=US / TXN=US / GILD=US / AMT=US / PEB=US / BC=US / MPWR=US / CONE=US / V=US / NOVA=US / CHKP=US / IART=US / XLNX=US / TRMK=US / TNL=US / CMCSA=US / CI=US / W=US / WTFC=US / APH=US / AVT=US / CNX=US / CPRT=US / DVA=US / EQT=US / EXPO=US / FCN=US / AJG=US / LH=US / TREE=US / MHK=US / TEAM=US / NTST=US / ASGN=US / REGN=US / SLGN=US / VSEC=US / WEX=US / FOUR=US / CFR=US / CPT=US / OFC=US / CUZ=US / MAA=US / WRE=US / AMSF=US / VICI=US / ACVA=US / MD=US / MOH=US / FLT=US / TPX=US / KAR=US / TXRH=US / BAH=US / MPW=US / KBR=US / MA=US / SAIA=US / PAG=US / TEL=US / TAST=US / EIG=US / PRPL=US / EHC=US / IAA=US / WH=US / RCUS=US / KNSL=US / AR=US / NXPI=US / NLSN=US / LKQ=US / PTCT=US / 00770K202 / CMPR=US / GDDY=US / ETSY=US / SPNE=US / ARGX=US / NVCR=US / WLTW=US / KDP=US / FTDR=US / EB=US / ARQT=US / AIRC=US / HYFM=US / CELU=US</td><td class="leftalignment">Merck & Co Inc / CACI International Inc / Eli Lilly and Co / Pfizer Inc / Analog Devices Inc / Advanced Micro Devices Inc / International Paper Co / agilon health Inc / Amazon.com Inc / Incyte Corp / Texas Instruments Inc / Gilead Sciences Inc / American Tower Corp / Pebblebrook Hotel Trust / Brunswick Corp / Monolithic Power Systems Inc / CyrusOne Inc / Visa Inc / Sunnova Energy International Inc / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Xilinx Inc / Trustmark Corp / Travel + Leisure Co / Comcast Corp / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Amphenol Corp / Avnet Inc / CNX Resources Corp / Copart Inc / DaVita Inc / EQT Corp / Exponent Inc / FTI Consulting Inc / Arthur J Gallagher & Co / Laboratory Corporation of America Holdings / Lendingtree Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / ASGN Inc / Regeneron Pharmaceuticals Inc / Silgan Holdings Inc / VSE Corp / WEX Inc / Shift4 Payments Inc / Cullen/Frost Bankers Inc / Camden Property Trust / Corporate Office Properties Trust / Cousins Properties Inc / Mid-America Apartment Communities Inc / Washington Real Estate Investment Trust / Amerisafe Inc / VICI Properties Inc / ACV Auctions Inc / MEDNAX Inc / Molina Healthcare Inc / Fleetcor Technologies Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Texas Roadhouse Inc / Booz Allen Hamilton Holding Corp / Medical Properties Trust Inc / KBR Inc / Mastercard Inc / Saia Inc / Penske Automotive Group Inc / TE Connectivity Ltd / Carrols Restaurant Group Inc / Employers Holdings Inc / Purple Innovation Inc / Encompass Health Corp / IAA Inc / Wyndham Hotels & Resorts Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Antero Resources Corp / NXP Semiconductors NV / Nielsen Holdings PLC / LKQ Corp / PTC Therapeutics Inc / Aemetis Inc / Cimpress PLC / GoDaddy Inc / ETSY Inc / SeaSpine Holdings Corp / argenx SE / Novocure Ltd / Willis Towers Watson PLC / Keurig Dr Pepper Inc / Frontdoor Inc / Eventbrite Inc / Arcutis Biotherapeutics Inc / Apartment Income REIT Corp / Hydrofarm Holdings Group Inc / Celularity Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">3Q21: Beat and Raise Follows a String of Positive News</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">58933Y10 / 71708110</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">10/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / MCK.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / KIM.N / RCL.N / CLX.N / SYY.N / IFF.N / VNO.N / EMR.N / XOM.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / O.N / DISH.OQ / TPR.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / CMCSA.OQ / MOS.N / FIS.N / AON.N / ES.N / MRNA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Mckesson Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Emerson Electric Co / Exxon Mobil Corp / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Realty Income Corp / DISH Network Corp / Tapestry Inc / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mosaic Co / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DLR-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE / EQIX.O / FB.O</td><td class="leftalignment">Pfizer Inc / Equinix Inc / Meta Platforms Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / THRX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Theseus Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CBAY-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">CBAY.O / BMY / PFE / PTCT.O / XNCR.O</td><td class="leftalignment">Cymabay Therapeutics Inc / Bristol-Myers Squibb Co / Pfizer Inc / PTC Therapeutics Inc / Xencor Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMPE-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMPE.K / ABT / JNJ / PFE / RIGL.O / REGN.O / ALIM.O / AERI.O / FLXN.O</td><td class="leftalignment">Ampio Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Pfizer Inc / Rigel Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Alimera Sciences Inc / Aerie Pharmaceuticals Inc / Pacira Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SPPI-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SPPI.O / ABT / BMY / JNJ / NVS / PFE / GSK / CRIS.O / SGEN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Spectrum Pharmaceuticals Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Curis Inc / Seagen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Rux cream MAA validation for vitiligo a key step for derm franchise expansion, in our view</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">INCY=US / LLY=US / PFE=US / ARQT=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Pfizer Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Flow of Funds Report for Trillium Therapeutics Inc - prepared by Wright Investors Service</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback - GSK post 3Q21 results virtual breakfast</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GSK.L / 4507.T / PFE.N</td><td class="leftalignment">GlaxoSmithKline PLC / Shionogi & Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AAP.N / AIG.N / APD.N / BDX.N / BEN.AX / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / KO.N / MCK.N / MO.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / DIS.N / D.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / ATO.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / JKHY.OQ / HOLX.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / AON.N / ES.N / MRNA.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">Advance Auto Parts Inc / American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Walt Disney Co / Dominion Energy Inc / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Atmos Energy Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Jack Henry & Associates Inc / Hologic Inc / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aon PLC / Eversource Energy / Moderna Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.26): First dose rate 77%, 70% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / 1099.HK / SVA.OQ</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.26）：ワクチン接種率は1回目が77%、2回目は70%</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / 1099.HK / SVA.OQ</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">10/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IMAB: I-Mab Biopharma - Global innovation with differentiated product portfolio to drive upside</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">IMAB.OQ / 4502.T / BMY.N / LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / GILD.OQ / 000661.SZ / 095700.KQ / 300009.SZ / ABBV.N / TGTX.OQ / MGNX.OQ / BGNE.OQ / CRVS.OQ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / ALXO.OQ</td><td class="leftalignment">I-Mab / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Changchun High & New Technology Industries Group Inc / Genexine Inc / Anhui Anke Biotechnology Group Co Ltd / Abbvie Inc / TG Therapeutics Inc / MacroGenics Inc / Beigene Ltd / Corvus Pharmaceuticals Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / United Kingdom / Japan / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AIN / LLY=US / PFE=US / TWTR=US / AMD=US / RRC=US / EFX=US / BXP=US / TXN=US / GILD=US / GPK=US / APA=US / MPWR=US / TRU=US / V=US / DIOD=US / XLNX=US / BRO=US / BYD=US / MAR=US / SPOT=US / ADS=US / TTWO=US / ATVI=US / ESS=US / MANH=US / AKR=US / EQR=US / AIR=US / ARCC=US / ATRO=US / CSGP=US / DCO=US / ABG=US / HAS=US / HEI=US / HXL=US / MAIN=US / HZO=US / MRCY=US / MCHP=US / ORCC=US / OI=US / PII=US / ST=US / SGMO=US / STRA=US / TGI=US / VSEC=US / BXS=US / HIW=US / PYPL=US / CNC=US / BDN=US / EGP=US / SPR=US / UDR=US / CATY=US / ECPG=US / PRAA=US / JRVR=US / BIIB=US / AINV=US / DLR=US / XM=US / SCPL=US / TDG=US / HST=US / MA=US / AWI=US / CADE=US / CLR=US / PNNT=US / KTOS=US / NMTR=US / APEI=US / RCUS=US / AAN=US / 45665G303 / OAS=US / NXPI=US / RLJ=US / FBHS=US / ZNGA=US / EA=US / MTDR=US / ENPH=US / MEIP=US / SSTK=US / IBTX=US / CEQP=US / GOOGL=US / TSLX=US / 70806A106 / AFMD=US / ON=US / AJRD=US / GSBD=US / BWXT=US / SQ=US / TENB=US / FSK=US / LHX=US / HYFM=US / RBLX=US / SSBK=US / PKG=U / ROIV=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Twitter Inc / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Boston Properties Inc / Texas Instruments Inc / Gilead Sciences Inc / Graphic Packaging Holding Co / APA Corp (US) / Monolithic Power Systems Inc / TransUnion / Visa Inc / Diodes Inc / Xilinx Inc / Brown & Brown Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / Alliance Data Systems Corp / Take-Two Interactive Software Inc / Activision Blizzard Inc / Essex Property Trust Inc / Manhattan Associates Inc / Acadia Realty Trust / Equity Residential / AAR Corp / Ares Capital Corp / Astronics Corp / CoStar Group Inc / Ducommun Inc / Asbury Automotive Group Inc / Hasbro Inc / HEICO Corp / Hexcel Corp / Main Street Capital Corp / MarineMax Inc / Mercury Systems Inc / Microchip Technology Inc / Owl Rock Capital Corp / O-I Glass Inc / Polaris Inc / Sensata Technologies Holding PLC / Sangamo Therapeutics Inc / Strategic Education Inc / Triumph Group Inc / VSE Corp / Cadence Bank / Highwoods Properties Inc / PayPal Holdings Inc / Centene Corp / Brandywine Realty Trust / Eastgroup Properties Inc / Spirit AeroSystems Holdings Inc / UDR Inc / Cathay General Bancorp / Encore Capital Group Inc / PRA Group Inc / James River Group Holdings Ltd / Biogen Inc / Apollo Investment Corp / Digital Realty Trust Inc / Qualtrics International Inc / Sciplay Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / Mastercard Inc / Armstrong World Industries Inc / Cadence Bank / Continental Resources Inc / Pennantpark Investment Corp / Kratos Defense and Security Solutions Inc / 9 Meters Biopharma Inc / American Public Education Inc / Arcus Biosciences Inc / Aaron's Company Inc / Infinity Pharmaceuticals Inc / Oasis Petroleum Inc / NXP Semiconductors NV / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Matador Resources Co / Enphase Energy Inc / MEI Pharma Inc / Shutterstock Inc / Independent Bank Group Inc / Crestwood Equity Partners LP / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Affimed NV / ON Semiconductor Corp / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / BWX Technologies Inc / Block Inc / Tenable Holdings Inc / FS KKR Capital Corp / L3harris Technologies Inc / Hydrofarm Holdings Group Inc / Roblox Corp / Southern States Bancshares Inc / Packaging Corp of America / Roivant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BEN.AX / BMY.N / BSX.N / CAH.N / CI.N / CL.N / CVS.N / DD.N / EL.N / EOG.N / F.N / GM.N / KO.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / IFF.N / VNO.N / SYK.N / ITW.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / GWW.N / JCI.N / DHI.N / SRE.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JKHY.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / PYPL.OQ / WRK.N / TMUS.OQ / APTV.N / BKNG.OQ / CBOE.Z / CTVA.N / EXC.OQ / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bendigo and Adelaide Bank Ltd / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Coca-Cola Co / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / Illinois Tool Works Inc / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / W W Grainger Inc / Johnson Controls International PLC / D R Horton Inc / Sempra Energy / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Jack Henry & Associates Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / Westrock Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / France / Ireland / Liberia / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - 3Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended October 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / THRX.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Theseus Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DLR-US -  Dividend Quality Analysis, for the period ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / EQIX.O / FB.O</td><td class="leftalignment">Pfizer Inc / Equinix Inc / Meta Platforms Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended September 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended October 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Newly listed Pantera Minerals soars 58% from its issue price</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.AX</td><td class="leftalignment">Pantera Minerals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">TRIL.TO - Event Transcript of Trillium Therapeutics Inc conference call, Oct. 26, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb Stock After Q3 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Merck's Q3?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2270726 / 2542049 / 2317087 / 2100920 / 2455965 / 2684703 / 2799351 / 2503529 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BD8DJ71 / BJFSR88 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BYY88Y7 / BFYVZ75 / BP96C52 / BMDTR28</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Sinclair Broadcast Group Inc / World Wrestling Entertainment Inc / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Snap Inc / Uniqure NV / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Alphabet Inc / Seelos Therapeutics Inc / Surrozen Inc / First Watch Restaurant Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: October 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / PNW.N / SO.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / MET.N / ETN.N / DUK.N / D.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / XOM.N / AMT.N / LIN.N / SHW.N / GWW.N / JCI.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / CHD.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / ICE.N / FIS.N / ADP.PA / AON.N / MRNA.OQ / CME.OQ / NWSA.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / PYPL.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / W W Grainger Inc / Johnson Controls International PLC / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Church & Dwight Co Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / News Corp / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / PayPal Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended September 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / TMO / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / Thermo Fisher Scientific Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended October 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss New and Existing Treatments For Pulmonary Arterial Hypertension (PAH) on Dec. 7 at 1PM EST</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ / MRK / PFE / INSM</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Insmed Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: October 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AIG.N / ALB.N / APD.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NEM.N / NSC.N / PFE.N / PNW.N / SO.N / TEL.PS / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / CAT.N / KIM.N / RCL.N / CLX.N / MCD.N / SYY.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / MTD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / APH.N / SRE.N / PWR.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / CHD.N / TWTR.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / NWS.AX / COP.N / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / ORLY.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / TXN.OQ / SWKS.O / CMCSA.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / ADP.PA / AON.N / ES.N / MRNA.OQ / CME.OQ / NWSA.OQ / MSCI.N / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / CDW.OQ / MAR.OQ / GOOGL.OQ / ANET.N / ETSY.OQ / ZBH.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / NWL.OQ / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Ameren Corp / American International Group Inc / Albemarle Corp / Air Products and Chemicals Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / PLDT Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Caterpillar Inc / Kimco Realty Corp / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Mettler-Toledo International Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Amphenol Corp / Sempra Energy / Quanta Services Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Twitter Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / News Corp / Conocophillips / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Texas Instruments Inc / Skyworks Solutions Inc / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / Moderna Inc / CME Group Inc / News Corp / MSCI Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / CDW Corp / Marriott International Inc / Alphabet Inc / Arista Networks Inc / ETSY Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Newell Brands Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China PD-(L)1 on the move: Picking long-term winners in a competitive race</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">BGNE.OQ / 1877.HK / BMY.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / GSK.L / NVS.N / AMGN.OQ / CHRS.OQ / REGN.OQ / INCY.OQ / AGEN.OQ / 600276.SS / 0950.HK / 002437.SZ / 300003.SZ / MRTX.OQ / ZLAB.OQ / 6160.HK / 1801.HK</td><td class="leftalignment">Beigene Ltd / Shanghai Junshi Biosciences Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / GlaxoSmithKline PLC / Novartis AG / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Incyte Corp / Agenus Inc / Jiangsu Hengrui Pharmaceuticals Co Ltd / Lee's Pharmaceutical Holdings Ltd / Harbin Gloria Pharmaceuticals Co Ltd / Lepu Medical Technology Beijing Co Ltd / Mirati Therapeutics Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">10/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.3% Above Pre-Pandemic Base- Week 81</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">NEW SPEAKER ADDED: Please Join Our KOL Video Call to Discuss SITC 2021 and ASH 2021 Abstracts on Friday, November 5 at 11:30 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">0989529 / 2000019 / 2778844 / 2732635 / 2113393 / 2216850 / 2270726 / 2317087 / 2328915 / 2367480 / 2515030 / 2684703 / 2440637 / 2862532 / 2138158 / 2825933 / 2900335 / B0X7DZ3 / B3D7K31 / 2598246 / B7TL820 / B8L2798 / BFLR866 / BVVN4Q8 / BNGY4Q0 / BXDZ9Z0 / BD9GVY0 / BD8DJ71 / BR4T3B3 / BJ2Z0H2 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BD6JX35 / BNGJQZ8 / BMGGJK8 / BMW15J8 / BYYGK12</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Merck & Co Inc / AutoNation Inc / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / Genuine Parts Co / Lithia Motors Inc / Pfizer Inc / CenterPoint Energy Inc / E W Scripps Co / Sempra Energy / South Jersey Industries Inc / Tractor Supply Co / Chipotle Mexican Grill Inc / Discovery Inc / Neogenomics Inc / Meta Platforms Inc / Hemisphere Media Group Inc / Twitter Inc / Eversource Energy / Nextera Energy Partners LP / Shopify Inc / Zai Lab Ltd / Snap Inc / HubSpot Inc / Pinterest Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / Krystal Biotech Inc / Porch Group Inc / Valneva SE / Renalytix PLC / TPI Composites Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">PFE / ALNY / BBIO / IONS : TTR Wars October 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE.N / ALNY.O / BBIO.O / IONS.OQ / ALNY.OQ / IONS.O</td><td class="leftalignment">Pfizer Inc / Alnylam Pharmaceuticals Inc / BridgeBio Pharma Inc / Ionis Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Ionis Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Anupam Rama / Ms. Jessica Fye / Christopher T. Schott, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">10/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: October 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / COF.N / CVS.N / DD.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / MCK.N / MO.N / NSC.N / PFE.N / SLB.N / SO.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / ROK.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / ROP.N / CAT.N / RCL.N / CLX.N / MCD.N / SYY.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / HCA.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / FIS.N / STX.AX / ADP.PA / AON.N / MRNA.OQ / CME.OQ / VRSK.OQ / FTNT.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / APTV.N / BKNG.OQ / WELL.N / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Southern Co / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Royal Caribbean Cruises Ltd / Clorox Co / McDonald's Corp / Sysco Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / HCA Healthcare Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / Moderna Inc / CME Group Inc / Verisk Analytics Inc / Fortinet Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Germany / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / SFT / US09062X1037 / QURE</td><td class="leftalignment">Pfizer Inc / Shift Technologies Inc / Biogen Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">A Year Since Pfizer's Big Breakthrough, Are Vaccine Stocks Still Worth Investing In?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">COVID booster - first randomized data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: October 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / ECL.N / EL.N / FCX.N / GE.N / GM.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / SLB.N / T.N / WMB.N / SPG.N / WY.N / PXD.N / HUM.N / NUE.N / ROK.N / UHS.N / MET.N / ETN.N / DHR.N / GD.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / SYY.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / ATVI.OQ / MSFT.OQ / BRO.N / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / TSCO.OQ / O.N / AMZN.OQ / SBAC.OQ / CHTR.OQ / MTCH.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / TXN.OQ / CMCSA.OQ / MOS.N / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / MAR.OQ / GOOGL.OQ / ANET.N / TMUS.OQ / IQV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / General Dynamics Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Sysco Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Activision Blizzard Inc / Microsoft Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Match Group Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Mosaic Co / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Marriott International Inc / Alphabet Inc / Arista Networks Inc / T-Mobile US Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharmaceuticals: 'Safe harbor' in a cost-inflation storm</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AZN.L / SASY.PA / PFE.N / RECI.MI / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 207940.KS / GMAB.CO</td><td class="leftalignment">AstraZeneca PLC / Sanofi SA / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Samsung Biologics Co Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">10/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Endorsement of PCV15 Trims Upside for PFE, Still Plenty of Opp'ty; PT $50</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110 / 58933Y10</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK Pneumo Recovers to Equal Footing From ACIP, Expanded Indications for All</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / 71708110 / 58933Y10</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Dilip Joseph / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Positive ACIP Recommendation Supports Sales Upside For PFE and MRK's PCVs, But Who Takes The Market Remains To Be Determined</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Report - High Yield Health Care: Italy - one of the leading pharmaceutical markets</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AMPF.MI / PFE.N / AZN.L / SASY.PA / MRCG.DE / GSK.L</td><td class="leftalignment">Amplifon SpA / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Cosmetics & Personal Care / Defense / Electrical / Electronics / Engineering & Construction / Environmental Services / Food / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Retailing / Services / Shipping & Shipbuilding / Tire & Rubber / Transportation / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">SE0000108656 / US09061G1013 / US00971T1016 / US0311621009 / US1924461023 / US2786421030 / US30161Q1040 / US3755581036 / US4062161017 / US4282911084 / US4433201062 / US45253H1014 / US45337C1027 / US4567881085 / US4781601046 / US64125C1099 / US75886F1075 / US91307C1027 / US92343V1044 / US92532F1003 / CA1363751027 / US64110L1061 / US2948216088 / US20030N1019 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US00206R1023 / US3020811044 / US29089Q1058 / US92932M1018 / NL0000687663 / US87874R1005 / US53261M1045 / US03152W1099 / BMG3922B1072 / US90384S3031 / US25470M1099 / IE00B4BNMY34 / US46333X1081 / US9100471096 / US29414B1044 / NL0010273215 / US8725901040 / US09609G1004 / US8036071004 / US4576693075 / US6951271005 / US00912X3026 / US74587V1070 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / US0994061002 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US12685J1051 / US37890U1088 / US4622221004 / US07725L1026 / US16119P1084 / US36165L1089 / US2067871036 / US23355L1061 / IL0011407140 / US02156K1034 / US87105L1044 / US76243J1051 / US5011471027 / US77313F1066 / US89854H1023 / US09354A1007 / US05455M1009 / US29260V1052 / US0197701065 / US61775R1059 / US85205L1070 / US39813G1094 / US4432011082 / US65487U1088 / US07373B1098 / US20451W1018 / US69353Y1038 / US81181C1045 / US50107A1043 / KYG3902L1095 / US74767V1098 / US7761531083 / US15961R1059 / US25401T1088 / US30052F1003 / US88546E1055</td><td class="leftalignment">Telefonaktiebolaget LM Ericsson / Biomarin Pharmaceutical Inc / Akamai Technologies Inc / Amgen Inc / Cognizant Technology Solutions Corp / eBay Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Hexcel Corp / Hub Group Inc / ImmunoGen Inc / Incyte Corp / Infosys Ltd / Johnson & Johnson / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Verizon Communications Inc / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Telefonaktiebolaget LM Ericsson / Comcast Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / AT&T Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / AerCap Holdings NV / TechTarget Inc / Limelight Networks Inc / Amicus Therapeutics Inc / Genpact Ltd / Ulta Beauty Inc / DISH Network Corp / Accenture PLC / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Epam Systems Inc / ASML Holding NV / T-Mobile US Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Air Lease Corp / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Cable One Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Charter Communications Inc / GDS Holdings Ltd / Conduent Inc / DXC Technology Co / Urogen Pharma Ltd / Altice USA Inc / Switch Inc / Rhythm Pharmaceuticals Inc / Krystal Biotech Inc / Rocket Pharmaceuticals Inc / TTEC Holdings Inc / Blink Charging Co / AVROBIO Inc / Endava PLC / Allogene Therapeutics Inc / Morphic Holding Inc / SpringWorks Therapeutics Inc / Grid Dynamics Holdings Inc / Howmet Aerospace Inc / Nkarta Inc / Beam Global / Compass Pathways PLC / PMV Pharmaceuticals Inc / Seagen Inc / Kronos Bio Inc / GDS Holdings Ltd / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc / DigitalBridge Group Inc / EVgo Inc / Thoughtworks Holding Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US6951271005 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Pacira Biosciences Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US81181C1045 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Seagen Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2000019 / 2778844 / 2216850 / 2270726 / 2542049 / 2317087 / 2328915 / 2515030 / 2684703 / 2048804 / 2138158 / 2825933 / 2829601 / 4595739 / B1HMF22 / B1Y9TB3 / 2857817 / 2983563 / B3D7K31 / B28TS42 / 2949758 / B7TL820 / BP4GNK9 / BYZLV46 / BD8DJ71 / BKTNTR9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BDZ30Q0 / BN2R582 / BLBLMD5 / BMDJ085 / BNTB3N8 / BWC52Q6</td><td class="leftalignment">Amazon.com Inc / Merck & Co Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / Lithia Motors Inc / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / South Jersey Industries Inc / Southern Co / Genmab A/S / First Solar Inc / Danone SA / Netflix Inc / Carmax Inc / Discovery Inc / Ulta Beauty Inc / Nexstar Media Group Inc / Meta Platforms Inc / SAGE Therapeutics Inc / InflaRx NV / Snap Inc / ViacomCBS Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Arvinas Inc / Relay Therapeutics Inc / Array Technologies Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Solaredge Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN - BUY - Previewing Upcoming Trial Updates on ARV-471 (ER Degrader) and ARV-110 (AR Degrader) at SABCS and ASCO-GU, Respectively</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BDZ30Q0 / 5671735 / 0989529 / 2516152 / 2684703 / 7103065 / B6RS2B3 / BMQ5T49</td><td class="leftalignment">Arvinas Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc / Novartis AG / Clovis Oncology Inc / Zentalis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">PFIZER sees a downgrade to Slightly Negative on account of less fundamental stars</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">TheScreener</td><td class="leftalignment">TRILLIUM THERAPEUTICS sees a downgrade to Negative on account of less fundamental stars</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Global Comparison: October 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / DD.N / DOW.N / ECL.N / EL.N / F.N / FCX.N / GE.N / GM.N / IBM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / NSC.N / PFE.N / PPG.N / SLB.N / T.N / WMB.N / SPG.N / PG.N / WY.N / NUE.N / ROK.N / UHS.N / ETN.N / DHR.N / ROP.N / CAT.N / UNP.N / CLX.N / MCD.N / VLO.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / ARE.N / CHD.N / CVX.N / MCO.N / PRU.N / RF.N / COP.N / INTC.OQ / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / HOLX.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / BRO.N / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / AMZN.OQ / CHTR.OQ / MTCH.OQ / ALGN.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / AON.N / CME.OQ / MSCI.N / VRSK.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / KEY.TO / MPC.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / LEGN.DE / GOOGL.OQ / ANET.N / ANTM.N / TMUS.OQ / CSX.OQ / IQV.N / FB.PS / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Ecolab Inc / Estee Lauder Companies Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / General Motors Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Norfolk Southern Corp / Pfizer Inc / PPG Industries Inc / Schlumberger NV / AT&T Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Nucor Corp / Rockwell Automation Inc / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / Clorox Co / McDonald's Corp / Valero Energy Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Regions Financial Corp / Conocophillips / Intel Corp / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / Hologic Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / Brown & Brown Inc / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Match Group Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Aon PLC / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Keyera Corp / Marathon Petroleum Corp / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / LEG Immobilien SE / Alphabet Inc / Arista Networks Inc / Anthem Inc / T-Mobile US Inc / CSX Corp / IQVIA Holdings Inc / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / France / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">10/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector - Readacross from JNJ 3Q21 results and Roche/Atea's Ph-2 update on oral COVID drug candidate</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">068270.KS / 091990.KQ / JNJ.N / MRK.N / PFE.N / AMGN.OQ / 000100.KS / RO.S / 006280.KS / MRNA.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Yuhan Corp / Roche Holding AG / Green Cross Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">CoroNation Update: Laterals from AVIR AT-527 MOONSONG Results</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">2778844 / 2684703</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Evan B. Wang / Tarun Soni</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MOGa / HEI.N / FR0000054470 / BE0165385973 / US0079031078 / US0123481089 / US01741R1023 / US0311621009 / US0382221051 / US0463531089 / US0970231058 / US0997241064 / US1101221083 / US1442851036 / US2358511028 / US2855121099 / US3695501086 / US37733W1053 / US4228061093 / US4282911084 / US4385161066 / US4523271090 / US4781601046 / US5128071082 / US5324571083 / US5398301094 / US55306N1046 / US5949181045 / US6668071029 / US66987V1098 / US6701002056 / US7170811035 / US7475251036 / US7711951043 / US8356993076 / US8740541094 / US8835561023 / US8968181011 / US91307C1027 / US9807451037 / CA0977512007 / IL0010824113 / JP3435000009 / US92343X1000 / US80105N1054 / US1167941087 / US6098391054 / US8936411003 / US8485741099 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US34959E1091 / US1920051067 / US88160R1014 / US69404D1081 / US29082A1079 / US92839U2069 / US4464131063 / JE00B783TY65 / US03027X1000 / US98986T1088 / US29414B1044 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US6974351057 / US63009R1095 / US29664W1053 / US60468T1051 / NL0010696654 / US9222801022 / US09062W2044 / US98936J1016 / US04523Y1055 / US22822V1017 / US30050B1017 / GB00BZ09BD16 / US98138J2069 / US07725L1026 / US90138F1021 / US78410G1040 / US23355L1061 / US03236M2008 / US98980G1022 / US92336X1090 / US2575541055 / US01671P1003 / US28414H1032 / US90184D1000 / IL0011571556 / US03828A1016 / US22788C1053 / US5024311095 / US88025U1097 / US18915M1071 / US85205L1070 / US1567271093 / US4432011082 / US75513E1010 / US6541101050 / GB00BMVP7Y09 / US75943R1023 / US8334451098 / US03044L1052 / US22041X1028 / US38246G1085 / US33813J1060 / US81578P1066 / US00810F1066 / US72815L1070 / US67080N1019 / LU2314763264 / US49926T1043 / US90089L1089 / US90364P1057 / US68622V1061 / US23954D1090 / US81730H1095 / US28489L1044 / US30049H1023 / IL0011786154 / US3696043013 / US75340L1044 / US00091E1091 / CA50202P1053 / US45254E1073 / IL0011794802 / US34631B1017 / US90240B1061 / IL0011796625 / US00152K1016 / US8852601090 / US1095041000 / US2297901009</td><td class="leftalignment">Moog Inc / HEICO Corp / Ubisoft Entertainment SA / Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Allegheny Technologies Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / Boeing Co / Borgwarner Inc / Bristol-Myers Squibb Co / Carpenter Technology Corp / Danaher Corp / Electronic Arts Inc / General Dynamics Corp / GlaxoSmithKline PLC / HEICO Corp / Hexcel Corp / Honeywell International Inc / Illumina Inc / Johnson & Johnson / Lam Research Corp / Eli Lilly and Co / Lockheed Martin Corp / MKS Instruments Inc / Microsoft Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Sony Group Corp / Take-Two Interactive Software Inc / Thermo Fisher Scientific Inc / Triumph Group Inc / United Therapeutics Corp / Woodward Inc / Bombardier Inc / Check Point Software Technologies Ltd / Sony Group Corp / Verint Systems Inc / Sanofi SA / Bruker Corp / Monolithic Power Systems Inc / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Fortinet Inc / Codexis Inc / Tesla Inc / Pacific Biosciences of California Inc / Embraer SA / Visteon Corp / Huntington Ingalls Industries Inc / Aptiv PLC / American Tower Corp / Zynga Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / Palo Alto Networks Inc / NanoString Technologies Inc / Esperion Therapeutics Inc / Mirati Therapeutics Inc / Uniqure NV / Varonis Systems Inc / BioLife Solutions Inc / Zendesk Inc / Aspen Aerogels Inc / Crown Castle International Corp / Evolent Health Inc / Atlassian Corporation PLC / Workhorse Group Inc / Beigene Ltd / Twilio Inc / SBA Communications Corp / DXC Technology Co / Amyris Inc / Zscaler Inc / Veoneer Inc / Domo Inc / Allakos Inc / Elanco Animal Health Inc / Twist Bioscience Corp / Tufin Software Technologies Ltd / Applied Therapeutics Inc / CrowdStrike Holdings Inc / L3harris Technologies Inc / 10X Genomics Inc / Cloudflare Inc / SpringWorks Therapeutics Inc / Cerence Inc / Howmet Aerospace Inc / Raytheon Technologies Corp / Nikola Corp / Royalty Pharma PLC / Relay Therapeutics Inc / Snowflake Inc. / American Well Corp / Corsair Gaming Inc / Goodrx Holdings Inc / Fisker Inc / Seer Inc / AerSale Corp / Playtika Holding Corp / Nuvation Bio Inc / Arrival SA / Knowbe4 Inc / TuSimple Holdings Inc / UiPath Inc / Organon & Co / Day One Biopharmaceuticals Inc / SentinelOne Inc / Electric Last Mile Solutions Inc / Evolv Technologies Holdings Inc / REE Automotive Ltd / General Electric Co / Rapid Micro Biosystems Inc / Absci Corp / Li-Cycle Holdings Corp / Immuneering Corp / Cellebrite DI Ltd / ForgeRock Inc / Tyra Biosciences Inc / Arbe Robotics Ltd / AKA Brands Holding Corp / Thorne Healthtech Inc / Brilliant Earth Group Inc / Cue Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Japan / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2550707 / 2486813 / 2778844 / 2050832 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2366799 / 2684703 / 2048804 / 2440637 / 2799351 / 2825933 / 2842255 / 2931034 / 7103065 / B01SD70 / 2857817 / B125XQ6 / B3D7K31 / B4N0JJ6 / B7TL820 / B783TY6 / BFLR866 / BNGY4Q0 / BD8DJ71 / BJLKVS6 / BKTHM05 / BYZR4X4 / BMYML02 / BJJMGL2 / BYXJQG9 / BYY88Y7 / BYNQ369 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / McDonald's Corp / Kellogg Co / Merck & Co Inc / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Starbucks Corp / Vertex Pharmaceuticals Inc / Novartis AG / Domino's Pizza Inc / Netflix Inc / Portland General Electric Co / Discovery Inc / Visteon Corp / Meta Platforms Inc / Aptiv PLC / Twitter Inc / Nextera Energy Partners LP / Snap Inc / Phathom Pharmaceuticals Inc / Passage Bio Inc / Axsome Therapeutics Inc / DraftKings Inc / Fox Corp / Spire Inc / Alphabet Inc / Albertsons Companies Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q3:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From KOL Call on FGFR, BRAF and Other Targeted Therapy Approaches</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0311621009 / US7170811035 / US60468T1051 / US07725L1026 / US85205L1070 / US75943R1023 / US67080N1019 / US23954D1090 / US45254E1073 / US90240B1061</td><td class="leftalignment">Amgen Inc / Pfizer Inc / Mirati Therapeutics Inc / Beigene Ltd / SpringWorks Therapeutics Inc / Relay Therapeutics Inc / Nuvation Bio Inc / Day One Biopharmaceuticals Inc / Immuneering Corp / Tyra Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Biotechnology Team</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">3Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">80</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AXP / 2000019 / 2050832 / 2219224 / 2190750 / 2270726 / 2542049 / 2317087 / 2342034 / 2455965 / 2613990 / 2632003 / 2680905 / 2684703 / 2048804 / 2799351 / 2825933 / 2857817 / B125XQ6 / B02R1L6 / B28TS42 / 2598246 / B0796X4 / B7TL820 / B7VD3F2 / BDZCRX3 / BFLR866 / BD8DJ71 / BJ5FZ74 / BR4T3B3 / BFZ1K46 / BMYML02 / BJFSR99 / BFXC911 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BF3W461 / BKS3RS7 / BQXZP64</td><td class="leftalignment">American Express Co / Amazon.com Inc / Ameren Corp / CMS Energy Corp / Chesapeake Utilities Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Fiserv Inc / Biogen Inc / Illumina Inc / New York Times Co / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / Ulta Beauty Inc / Neogenomics Inc / Dexcom Inc / Meta Platforms Inc / Duke Energy Corp / RingCentral Inc / Twitter Inc / Snap Inc / Adaptive Biotechnologies Corp / HubSpot Inc / Spotify Technology SA / DraftKings Inc / Revance Therapeutics Inc / Guardant Health Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / 10X Genomics Inc / Wayfair Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Johnson & Johnson Stock Rise After Q3 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Small/Mid Cap 3Q21 Earnings Preview Conference Call THIS FRIDAY, October 22 at 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">COLL / GRAY / JAZZ / JNJ / LLY / PFE / BDSI / ARDX / ARDS / MNKD / ZTS</td><td class="leftalignment">Collegium Pharmaceutical Inc / Graybug Vision Inc / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / BioDelivery Sciences International Inc / Ardelyx Inc / Aridis Pharmaceuticals Inc / MannKind Corp / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.1% Above Pre-Pandemic Base- Week 80</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Mix-And-Match COVID Vax Coming to EUAs Soon; Still Favors mRNAs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">SAN / 71708110 / 478160104 / 09075V10 / 60770K10 / F5548N10</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Johnson & Johnson / BioNTech SE / Moderna Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large Cap 3Q21 Earnings Preview Conference Call TODAY, October 15 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ZTS / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">10/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech: RNA-Targeting Small Molecule Drugs? Non-Canonical Roles of Estrogen Receptor (ER) as an RNA Binding Protein</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2778844 / 2576941 / 2455965 / 2684703 / 2931034 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Exelixis Inc / Biogen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Debjit Chattopadhyay, Ph.D. / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Takeaways from Virtual NDRs: Investors Focus on Near-Term Data Readouts as Well as Longer-Term Synthetic Lethality Platform Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703 / BBPK0J0 / BLF0CW7 / BP2P6L0</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc / Mirati Therapeutics Inc / Repare Therapeutics Inc / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 2.8% Y/Y Including COVID-19 Vaccine Volume Benefit (-1.7% Without)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra / Jialin (Jay) Jin</td></tr>
<tr class="odd"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.24) : First dose rate 74%, 65% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / 1099.HK</td><td class="leftalignment">Pfizer Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">10/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.24）：ワクチン接種率は1回目が74%、2回目は65%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / 1099.HK</td><td class="leftalignment">Pfizer Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2050832 / 2206657 / 2317087 / 2684703 / 2799351 / 2825933 / 2900335 / 7103065 / 2712013 / B121557 / 2857817 / 2598246 / B3SWPT2 / B7TL820 / BCZS820 / B7577T2 / BVVN4Q8 / BFZNYB7 / BDHF4K6 / BZ1LFB2 / BR4T3B3 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BN4RD42 / BNTB3N8 / BMVBZF5 / 120483382</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Ameren Corp / Coca-Cola Co / Entergy Corp / Pfizer Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Tractor Supply Co / Novartis AG / Global Payments Inc / Mastercard Inc / Netflix Inc / Neogenomics Inc / Ameresco Inc / Meta Platforms Inc / Fate Therapeutics Inc / Renewable Energy Group Inc / Eversource Energy / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / HubSpot Inc / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / CureVac NV / Vizio Holding Corp / Immuneering Corp / Procept Biorobotics Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Oct 01</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">BMO Capital Markets</td><td class="leftalignment">Portfolio Strategy - US Equity PLUS Portfolio Review – Q3 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0584981064 / US22160K1051 / US7170811035 / CA9528451052 / CA13645T1003 / CA01626P4033</td><td class="leftalignment">Ball Corp / Costco Wholesale Corp / Pfizer Inc / West Fraser Timber Co Ltd / Canadian Pacific Railway Ltd / Alimentation Couche-Tard Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Brian G. Belski / Ryan Bohren / Sooyun Hong</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss What To Expect From RSV Vaccines and Treatments In Development, December 3 at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / ARDS</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Aridis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Oct 1, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Hold on Tight! Soft Biopharma Q3 Coming as Pandemic Pressures Persist, FX Fades</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">00287Y10 / 03116210 / 71708110 / 92532F10 / 37555810 / 75886F10 / 75046920 / G3910J11 / 61776010 / F5548N10</td><td class="leftalignment">Abbvie Inc / Amgen Inc / Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Radius Health Inc / GlaxoSmithKline PLC / MorphoSys AG / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Phase 2 Take 2; SNY’s Protein COVID Vax Shows Strong Responses, Robust Boosting</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">F5548N10 / 71708110 / 60770K10 / G3910J11</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">10/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EFTR: Addressing Large Markets with Novel Targets; Initiating with an Outperform Rating and a $20 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">EFTR.OQ / BMY.N / PFE.N / SASY.PA / ROG.S / AMGN.OQ / NKTR.OQ / SGEN.OQ / MRTX.OQ / ADXS.OQ / IOVA.OQ / MNK.N^J20 / BCAB.OQ</td><td class="leftalignment">eFFECTOR Therapeutics Inc / Bristol-Myers Squibb Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Amgen Inc / Nektar Therapeutics / Seagen Inc / Mirati Therapeutics Inc / Advaxis Inc / Iovance Biotherapeutics Inc / Mallinckrodt PLC / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer climbs 16% in 2021, outperforming Pharmaceuticals sector</td><td class="leftalignment">English</td><td class="rightalignment">64</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US -  Dividend Quality Analysis, for the period ended October 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / THRX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Theseus Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call to Discuss SITC 2021 & ASH 2021 Abstracts on Friday, November 5 at 11:30AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ARAV / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SRPT: R&D Day: SRP-9001 Clinical Progress Continues; Raising PoS with EMBARK Initiation</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">SRPT.OQ / PFE.N / SLDB.OQ</td><td class="leftalignment">Sarepta Therapeutics Inc / Pfizer Inc / Solid Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RPTX - BUY - Early RP-3500 Data Misses Investor Expectations but Supports RP2D Expansion & Combos; Maintain BUY on Valuation & Catalyst Lineup</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BLF0CW7 / 0989529 / 0925288 / 2023607 / 2684703 / BK0VHF6 / BP2P6L0</td><td class="leftalignment">Repare Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Amgen Inc / Pfizer Inc / IDEAYA Biosciences Inc / Tango Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 8.0% Above Pre-Pandemic Base- Week 79</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large Cap 3Q21 Earnings Preview Conference Call on Friday, October 15 at 10:00am ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM / JNJ / LLY / MRK / PFE / ZTS / IMAB</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 22978P106 / 37148K100 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 007002108 / M47364100 / 617760202 / N71542109 / 92790C104 / 76200L309 / G3855L106 / M8001Q118</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Cue Biopharma Inc / Generation Bio Co / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Viridian Therapeutics Inc / Rezolute Inc / GH Research PLC / PolyPid Ltd</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">JMP Therapeutic Research / Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">October 2021 "Monthly Controversies" Report</td><td class="leftalignment">English</td><td class="rightalignment">166</td><td class="leftalignment">US0311621009 / US09062X1037 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US3755581036 / US5324571083 / US7170811035 / US75886F1075 / US7802592060 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Royal Dutch Shell PLC / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended October 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">0925288 / 2126335 / 2000019 / 2002305 / 2085878 / 2113434 / 2270726 / 2542049 / 2317087 / 2684703 / 2048804 / 2799351 / 2825933 / 2503529 / 2783815 / B121557 / 2857817 / B3D7K31 / 2390817 / B7TL820 / B7VD3F2 / BFLR866 / BTN1Y11 / BVVN4Q8 / BYW36M8 / BFZNYB7 / BD8DJ71 / BNFWR44 / BR4T3B3 / BJ2Z0H2 / BKVDFF7 / BFZ1K46 / BJJMGL2 / BKTNTR9 / BJXBP30 / BHRWS81 / BZ1LFG7 / BYY88Y7 / BKC9SX3 / BZ0P3Z5 / BF3N4P3 / BM8MM05 / BMGGJK8 / BLF0CW7 / BM8NHS1 / BF0QTY9</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Abbott Laboratories / Bed Bath & Beyond Inc / Boston Scientific Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Pfizer Inc / Pinnacle West Capital Corp / Sinclair Broadcast Group Inc / South Jersey Industries Inc / World Wrestling Entertainment Inc / Zimmer Biomet Holdings Inc / Mastercard Inc / Netflix Inc / Discovery Inc / Gray Television Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Medtronic PLC / Eversource Energy / PayPal Holdings Inc / Allogene Therapeutics Inc / Snap Inc / Worldline SA / HubSpot Inc / Pinterest Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / Fox Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Levi Strauss & Co / Roku Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Valneva SE / Repare Therapeutics Inc / Adagio Therapeutics Inc / Chicken Soup for The Soul Entertainment Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Ireland / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC - BUY - Still Low Visibility on ORIC-101's Potential in Prostate Cancer Following ENA Update; Go/No-Go Decision in 2022; PT to $27</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BKVDFF7 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Anti-Abeta mAbs Reinvigorated</td><td class="leftalignment">English</td><td class="rightalignment">87</td><td class="leftalignment">71708110 / 09062X10 / 478160104 / H0026310 / 61776010</td><td class="leftalignment">Pfizer Inc / Biogen Inc / Johnson & Johnson / AC Immune SA / MorphoSys AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Marc Goodman / Rudy Li, Ph.D. / Madhu Yennawar, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, PFE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 3Q Earnings And Beyond – Inline Results But Several Major Launches On The Horizon</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2026242 / 2732635 / 2222631 / 2270726 / 2542049 / 2317087 / 2121352 / 2415204 / 2515030 / 2684703 / 2048804 / 2730190 / 2825933 / 2943523 / 2503529 / 2181334 / 2170473 / B00FWN1 / 2769796 / 2857817 / B5B2106 / B7TL820 / B7VD3F2 / B8DPDT7 / BVVN4Q8 / BYW36M8 / BFZNYB7 / BD8DJ71 / BQT3XY6 / BZ1HM42 / BNFWR44 / BR4T3B3 / BFZ1K46 / BZ1LFG7 / BYY88Y7 / BKC9SX3 / BZ0P3Z5 / BNTB3N8 / BMGGJK8 / BM8NHS1</td><td class="leftalignment">Visa Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / AutoNation Inc / Cooper Companies Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Group 1 Automotive Inc / Hawaiian Electric Industries Inc / Lithia Motors Inc / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / South Jersey Industries Inc / Penske Automotive Group Inc / World Wrestling Entertainment Inc / Check Point Software Technologies Ltd / Constellation Brands Inc / Alnylam Pharmaceuticals Inc / Fidelity National Information Services Inc / Netflix Inc / Fortinet Inc / Meta Platforms Inc / Duke Energy Corp / Sarepta Therapeutics Inc / Eversource Energy / PayPal Holdings Inc / Allogene Therapeutics Inc / Snap Inc / Cyberark Software Ltd / Adyen NV / Worldline SA / HubSpot Inc / Spotify Technology SA / Roku Inc / Alphabet Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Vizio Holding Corp / Valneva SE / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOL Positive on Molnupiravir, Intrigued by Pfizer, Points of Caution on Atea</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / AVIR.OQ / 71708110 / 58933Y10 / 04683R10</td><td class="leftalignment">Pfizer Inc / Atea Pharmaceuticals Inc / Pfizer Inc / Merck & Co Inc / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Ms. Roanna C. Ruiz / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.23）：ワクチン接種率は1回目が72%、2回目は62%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="even"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.23): First dose rate 72%, fully vaccinated 62%</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada / Kokoro Nakamura</td></tr>
<tr class="odd"><td class="leftalignment">10/07/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Initiating At Neutral: Current Asset Mix Gives Us Pause</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">68622V106 / 717081103 / 031162100 / 09062X103 / 881624209 / 75886F107 / 216648402 / 58933Y105 / 00287Y109 / G30401106 / G97822103 / 03168L105 / 071734107 / 30048L104 / 92556V106</td><td class="leftalignment">Organon & Co / Pfizer Inc / Amgen Inc / Biogen Inc / Teva Pharmaceutical Industries Ltd / Regeneron Pharmaceuticals Inc / Cooper Companies Inc / Merck & Co Inc / Abbvie Inc / Endo International PLC / Perrigo Company PLC / Amneal Pharmaceuticals Inc / Bausch Health Companies Inc / Evofem Biosciences Inc / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">10/06/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Voyager Shares Lift Off After Firm Signs License Deal With Pfizer for Next-Gen AAV Capsids for Gene Therapy Programs</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / VYGR.OQ</td><td class="leftalignment">Pfizer Inc / Voyager Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">RSVP For RSV Vaccines And Treatments, Our Deep Dive Suggests Many Potential Blockbuster Opportunities</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">CDTX / JNJ / MRK / PFE / GB0009252882 / ARDS / US6700024010</td><td class="leftalignment">Cidara Therapeutics Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Aridis Pharmaceuticals Inc / Novavax Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / AXP.N / CAH.N / CCK.N / CE.N / COF.N / EIX.N / GPS.N / HLT.N / MAN.N / MO.N / NOC.N / PFE.N / PHM.N / PM.N / SC.N / TMX.N / U.N / USB.N / VNT.N / ZEN.N / PXD.N / DELL.N / NUE.N / X.N / JBL.N / DIS.N / GD.N / AIZ.N / CR.N / AFG.N / R.N / SPOT.N / RCL.N / PRI.N / LH.N / EMR.N / PCG.N / TGT.N / AVY.N / RKT.N / SNV.N / ACN.N / H.N / DNB.N / GPC.N / HRL.N / SAM.N / CVX.N / MHK.N / L.N / GME.N / GPK.N / OSK.N / INTC.OQ / ORI.N / ADPT.OQ / CSL.N / FAF.N / RJF.N / TTC.N / TYL.N / FL.N / QCOM.OQ / ORLY.OQ / GILD.OQ / BRKS.OQ / STLD.OQ / MRCY.OQ / UMPQ.OQ / PLUG.OQ / HAIN.OQ / PNFP.OQ / WYNN.OQ / PA1436583006 / CRI.N / BIIB.OQ / OPEN.OQ / BRKR.OQ / EXP.N / OSH.N / LVS.N / THG.N / BRKb.N / OC.N / FRPT.OQ / CFX.N / MRNA.OQ / CME.OQ / CLH.N / AI.N / AVGO.OQ / NXPI.OQ / CZR.OQ / TRGP.N / SABR.OQ / Z.OQ / ALSN.N / FB.OQ / WEX.N / RNG.N / ALLE.N / ARMK.N / NCLH.N / SNOW.N / FIVN.OQ / ANET.N / SYF.N / CTLT.N / AXTA.N / LBRDK.O / QRVO.OQ / TDOC.N / RUN.OQ / PEN.N / USFD.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / ROKU.OQ / MDB.OQ / PFG.OQ / CDAY.N / PLAN.N / STNE.OQ / CPRI.N / NFE.OQ / BYND.OQ / UBER.N / TXG.OQ / PTON.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / NCNO.OQ / JAMF.OQ / DCT.OQ / PLTR.N / SHC.OQ / DASH.N / CERT.OQ / SKLZ.N / DRVN.OQ / SGFY.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / American Express Co / Cardinal Health Inc / Crown Holdings Inc / Celanese Corp / Capital One Financial Corp / Edison International / Gap Inc / Hilton Worldwide Holdings Inc / ManpowerGroup Inc / Altria Group Inc / Northrop Grumman Corp / Pfizer Inc / Pultegroup Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Terminix Global Holdings Inc / Unity Software Inc / US Bancorp / Vontier Corp / Zendesk Inc / Pioneer Natural Resources Co / Dell Technologies Inc / Nucor Corp / United States Steel Corp / Jabil Inc / Walt Disney Co / General Dynamics Corp / Assurant Inc / Crane Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Royal Caribbean Cruises Ltd / Primerica Inc / Laboratory Corporation of America Holdings / Emerson Electric Co / PG&E Corp / Target Corp / Avery Dennison Corp / Rocket Companies Inc / Synovus Financial Corp / Accenture PLC / Hyatt Hotels Corp / Dun & Bradstreet Holdings Inc / Genuine Parts Co / Hormel Foods Corp / Boston Beer Company Inc / Chevron Corp / Mohawk Industries Inc / Loews Corp / GameStop Corp / Graphic Packaging Holding Co / Oshkosh Corp / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Carlisle Companies Inc / First American Financial Corp / Raymond James Financial Inc / Toro Co / Tyler Technologies Inc / Foot Locker Inc / Qualcomm Inc / O'Reilly Automotive Inc / Gilead Sciences Inc / Azenta Inc / Steel Dynamics Inc / Mercury Systems Inc / Umpqua Holdings Corp / Plug Power Inc / Hain Celestial Group Inc / Pinnacle Financial Partners Inc / Wynn Resorts Ltd / Carnival Corp / Carter's Inc / Biogen Inc / Opendoor Technologies Inc / Bruker Corp / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Hanover Insurance Group Inc / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Colfax Corp / Moderna Inc / CME Group Inc / Clean Harbors Inc / C3.ai Inc / Broadcom Inc / NXP Semiconductors NV / Caesars Entertainment Inc / Targa Resources Corp / Sabre Corp / Zillow Group Inc / Allison Transmission Holdings Inc / Meta Platforms Inc / WEX Inc / RingCentral Inc / Allegion PLC / Aramark / Norwegian Cruise Line Holdings Ltd / Snowflake Inc. / Five9 Inc / Arista Networks Inc / Synchrony Financial / Catalent Inc / Axalta Coating Systems Ltd / Liberty Broadband Corp / Qorvo Inc / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / US Foods Holding Corp / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Roku Inc / MongoDB Inc / Principal Financial Group Inc / Ceridian HCM Holding Inc / Anaplan Inc / StoneCo Ltd / Capri Holdings Ltd / New Fortress Energy Inc / Beyond Meat Inc / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / nCino Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / DoorDash Inc / Certara Inc / Skillz Inc / Driven Brands Holdings Inc / Signify Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - SP500</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACI.N / AFRM.OQ / ALL.N / CRM.N / ECL.N / EIX.N / HLT.N / IBM.N / PFE.N / SC.N / TXT.N / U.N / USB.N / PXD.N / DELL.N / BKI.N / DIS.N / AFG.N / IPG.N / SPOT.N / GS.N / RCL.N / KR.N / PCG.N / WHR.N / DVA.N / PWR.N / CHD.N / HRL.N / CVX.N / GME.N / INTC.OQ / AMGN.OQ / FISV.OQ / TYL.N / WSO.N / QCOM.OQ / GILD.OQ / DFS.N / PLUG.OQ / MOH.N / OPEN.OQ / OSH.N / MKTX.OQ / LVS.N / MELI.OQ / LBTYK.OQ / CME.OQ / STX.OQ / NEE.N / TSLA.OQ / FB.OQ / RNG.N / SNOW.N / FIVN.OQ / SYF.N / CTLT.N / KEYS.N / LBRDK.O / TDOC.N / TWLO.N / TTD.OQ / COUP.OQ / SNAP.N / CVNA.N / ROKU.OQ / PAGS.N / CDAY.N / FTCH.N / UBER.N / TXG.OQ / PTON.OQ / PLTR.N / DASH.N</td><td class="leftalignment">Albertsons Companies Inc / Affirm Holdings Inc / Allstate Corp / Salesforce.Com Inc / Ecolab Inc / Edison International / Hilton Worldwide Holdings Inc / International Business Machines Corp / Pfizer Inc / Santander Consumer USA Holdings Inc / Textron Inc / Unity Software Inc / US Bancorp / Pioneer Natural Resources Co / Dell Technologies Inc / Black Knight Inc / Walt Disney Co / American Financial Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Royal Caribbean Cruises Ltd / Kroger Co / PG&E Corp / Whirlpool Corp / DaVita Inc / Quanta Services Inc / Church & Dwight Co Inc / Hormel Foods Corp / Chevron Corp / GameStop Corp / Intel Corp / Amgen Inc / Fiserv Inc / Tyler Technologies Inc / Watsco Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Plug Power Inc / Molina Healthcare Inc / Opendoor Technologies Inc / Oak Street Health Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Mercadolibre Inc / Liberty Global PLC / CME Group Inc / Seagate Technology Holdings PLC / Nextera Energy Inc / Tesla Inc / Meta Platforms Inc / RingCentral Inc / Snowflake Inc. / Five9 Inc / Synchrony Financial / Catalent Inc / Keysight Technologies Inc / Liberty Broadband Corp / Teladoc Health Inc / Twilio Inc / Trade Desk Inc / Coupa Software Inc / Snap Inc / Carvana Co / Roku Inc / PagSeguro Digital Ltd / Ceridian HCM Holding Inc / Farfetch Ltd / Uber Technologies Inc / 10X Genomics Inc / Peloton Interactive Inc / Palantir Technologies Inc / DoorDash Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Argentina / Brazil / Cayman Islands / United Kingdom / Ireland / Liberia / Luxembourg / United States</td><td class="leftalignment">Advertising / Aerospace / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Consumer / Defense / Electrical / Electronics / Engineering & Construction / Financial Services / Food / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Media / Pharmaceuticals / Retailing / Semiconductors / Technology / Utilities / Wholesale / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Mix-And-Match COVID Vax Data Imminent; What’s Coming and Who’s At Risk?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / MDT=US / PATH=US / CBRL=US / DRI=US / MHK=US / REGI=US / SAGE=US / OPT=US / CGEN=US / KRT=US / APPN=US / DIN=US / OGN / BIIB=US / NUVA=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AWI=US / AMRX=US / TAST=US / QSR=US / JACK=US / PCRX=US / ESTE=US / TILE=US / NDLS=US / FEYE=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / WING=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Medtronic PLC / UiPath Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Mohawk Industries Inc / Renewable Energy Group Inc / SAGE Therapeutics Inc / Opthea Ltd / Compugen Ltd / Karat Packaging Inc / Appian Corp / Dine Brands Global Inc / Organon & Co / Biogen Inc / NuVasive Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Armstrong World Industries Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Pacira Biosciences Inc / Earthstone Energy Inc / Interface Inc / Noodles & Co / Mandiant Inc / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2280220 / 2270726 / 2542049 / 2317087 / 2630085 / 2657802 / 2684703 / 2048804 / 2730190 / 7103065 / B121557 / 2857817 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / B7577T2 / BFLR866 / BVVN4Q8 / BD8DJ71 / BJ2Z0H2 / BGCYWN8 / BYZM6C2 / BJJMGL2 / BZ1LFG7 / BYY88Y7 / BRJ3GY4 / BD72R64 / BNTB3N8 / BMW5LX6</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Neogen Corp / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Mastercard Inc / Netflix Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Snap Inc / Pinterest Inc / Xencor Inc / Intellia Therapeutics Inc / Fox Corp / Roku Inc / Alphabet Inc / Xenon Pharmaceuticals Inc / Liberty Media Corp / Vizio Holding Corp / Eliem Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: October 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIG.N / AIRP.PA / ALB.N / AN.N / AXP.N / BA.N / BAC.N / BMY.N / CB.N / CCI.N / CI.N / CL.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / JPM.N / KO.N / LLY.N / MMC.N / NEM.N / OXY.N / PFE.N / PHM.N / PPCJ.J / RHI.N / SC.N / T.N / TMO.N / WFC.N / WMT.N / ACI.N / AA.N / PG.N / HUM.N / NUE.N / DHR.N / DIS.N / UNH.N / DE.N / PGR.N / CAT.N / DT.N / IPG.N / UNP.N / SPOT.N / GS.N / CLX.N / MCD.N / HD.N / LOW.N / MRO.N / UPS.N / MMM.N / XOM.N / DVN.N / NKE.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / PWR.N / V.N / ACN.N / WSM.N / JLL.N / HAE.N / SAM.N / CRL.N / CVX.N / COP.N / INTC.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / AGL.N / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / RGEN.OQ / SIVB.OQ / ZION.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / LNG.A / MRCY.OQ / NVDA.OQ / PACW.OQ / ISRG.OQ / ILMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / BIIB.OQ / TPX.N / TFC.N / SBNY.OQ / ACAD.OQ / MOS.N / MKTX.OQ / MPWR.OQ / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / CMG.N / FIS.N / STX.AX / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / PAG.N / TDC.N / TNDM.OQ / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / NLSN.N / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / ZNGA.OQ / EPAM.N / PSX.N / WDC.OQ / NOW.N / SRPT.OQ / PANW.N / FANG.OQ / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / OLLI.OQ / NVCR.OQ / PSTG.N / TMUS.OQ / IONS.OQ / TWLO.N / COUP.OQ / LW.N / ATUS.N / IOVA.OQ / ROKU.OQ / CBRE.N / FB.PS / STNE.OQ / CTRA.N / TER.OQ / NWL.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / LFG.AX / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">American International Group Inc / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / AutoNation Inc / American Express Co / Boeing Co / Bank of America Corp / Bristol-Myers Squibb Co / Chubb Ltd / Crown Castle International Corp / Cigna Corp / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Marsh & McLennan Companies Inc / Newmont Corporation / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Alcoa Corp / Procter & Gamble Co / Humana Inc / Nucor Corp / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Deere & Co / Progressive Corp / Caterpillar Inc / Dynatrace Inc / Interpublic Group of Companies Inc / Union Pacific Corp / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / McDonald's Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / 3M Co / Exxon Mobil Corp / Devon Energy Corp / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / Quanta Services Inc / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / agilon health Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Repligen Corp / SVB Financial Group / Zions Bancorporation NA / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Cheniere Energy Inc / Mercury Systems Inc / NVIDIA Corp / PacWest Bancorp / Intuitive Surgical Inc / Illumina Inc / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Biogen Inc / Tempur Sealy International Inc / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Mosaic Co / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Penske Automotive Group Inc / Teradata Corp / Tandem Diabetes Care Inc / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Nielsen Holdings PLC / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Zynga Inc / Epam Systems Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Diamondback Energy Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Ollie's Bargain Outlet Holdings Inc / Novocure Ltd / Pure Storage Inc / T-Mobile US Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Altice USA Inc / Iovance Biotherapeutics Inc / Roku Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / Coterra Energy Inc / Teradyne Inc / Newell Brands Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Liberty Financial Group Ltd / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou / Madeleine Zhou</td></tr>
<tr class="even"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Healthcare Co Ltd: 3Q21E preview. Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">091990.KQ / PFE.N / ROG.S / 068270.KS</td><td class="leftalignment">Celltrion Healthcare Co Ltd / Pfizer Inc / Roche Holding AG / Celltrion Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">10/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Korea Biologics Sector - Merck's molnupiravir data and read-across to Celltrion stocks</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">068270.KS / 091990.KQ / MRCG.DE / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / NVAX.OQ / INO.OQ / MRNA.OQ / CVAC.OQ / ABCL.OQ</td><td class="leftalignment">Celltrion Inc / Celltrion Healthcare Co Ltd / Merck KGaA / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / CureVac NV / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Merck Stock May Continue To Rise</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">With Acceleron Acquisition Merck Stock Is Likely To See A Multiple Revision</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 24, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / OGN / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Organon & Co / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Higher Value Biopharm Business, Solid Yield, Compelling Valuation Drive Outlook</td><td class="leftalignment">English</td><td class="rightalignment">107</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Industrials Calendar : October-December 2021</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.L / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / MT.AS / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / EVKn.DE / CSTM.N / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O / HON.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / ArcelorMittal SA / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Evonik Industries AG / Constellium SE / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc / Honeywell International Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / OXY=US / RRC=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / CRM=US / XOM=US / CRK=US / WLL=US / PXD=US / HSII=US / MGY=US / SWN=US / MUR=US / MRO=US / KFRC=US / MANH=US / STZ=US / KFY=US / AMN=US / PATH=US / BLL=US / ENV=US / COLL=US / CNX=US / CCK=US / EQT=US / GPOR=US / MAN=US / ASGN=US / RHI=US / CVX=US / CCRN=US / FB=US / COP=US / BDSI=US / RNG=US / MIC=US / FRPT=US / XM=US / NSP=US / CLR=US / NOG=US / AR=US / OAS=US / BLND=US / ESTE=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / FATE=US / CNCE=US / QTWO=US / VNOM=US / GSBD=US / CDEV=US / PVAC=US / ANAB=US / OKTA=US / SBOW=US / DCPH=US / OVV=US / ARQT=US / NCNO=US / BIGC=US / REPX=US / 67421J108 / DBRG=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Occidental Petroleum Corp / Range Resources Corp / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Salesforce.Com Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Marathon Oil Corp / Kforce Inc / Manhattan Associates Inc / Constellation Brands Inc / Korn Ferry / AMN Healthcare Services Inc / UiPath Inc / Ball Corp / Envestnet Inc / Collegium Pharmaceutical Inc / CNX Resources Corp / Crown Holdings Inc / EQT Corp / Gulfport Energy Corp / ManpowerGroup Inc / ASGN Inc / Robert Half International Inc / Chevron Corp / Cross Country Healthcare Inc / Meta Platforms Inc / Conocophillips / BioDelivery Sciences International Inc / RingCentral Inc / Macquarie Infrastructure Holdings LLC / Freshpet Inc / Qualtrics International Inc / Insperity Inc / Continental Resources Inc / Northern Oil and Gas Inc / Antero Resources Corp / Oasis Petroleum Inc / Blend Labs Inc / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Fate Therapeutics Inc / Concert Pharmaceuticals Inc / Q2 Holdings Inc / Viper Energy Partners LP / Goldman Sachs BDC Inc / Centennial Resource Development Inc / Ranger Oil Corp / AnaptysBio Inc / Okta Inc / SilverBow Resources Inc / Deciphera Pharmaceuticals Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / nCino Inc / Bigcommerce Holdings Inc / Riley Exploration Permian Inc / Oatly Group AB / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">10/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Over or Underreaction? SVBL Analysts on Molnupiravir and Its Impact</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">91390310 / 75991610 / 91324P10 / 71708110 / 44485910 / 88355610 / 94184810 / 04635310 / 75886F10 / 53245710 / 02343610 / 50187A10 / 58933Y10 / 88033G40 / 87918A10 / 03675210 / 40412C10 / 67181A10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / G3910J11 / 05370A10 / F5548N10 / 00288U10 / 00404A10 / 12552310 / 04683R10</td><td class="leftalignment">Universal Health Services Inc / Repligen Corp / UnitedHealth Group Inc / Pfizer Inc / Humana Inc / Thermo Fisher Scientific Inc / Waters Corp / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Amedisys Inc / LHC Group Inc / Merck & Co Inc / Tenet Healthcare Corp / Teladoc Health Inc / Anthem Inc / HCA Healthcare Inc / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC / Avidity Biosciences Inc / Sanofi SA / Abcellera Biologics Inc / Acadia Healthcare Company Inc / Cigna Corp / Atea Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mr. Whit Mayo / Stephanie Davis, CFA / Mr. Puneet Souda / Ms. Roanna C. Ruiz</td></tr>
<tr class="even"><td class="leftalignment">10/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Sep 24</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Vitiligo data robust, further support INCY derm franchise. Maintain Buy, new PT $95/sh (vs. $120/sh)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">INCY=US / LLY=US / PFE=US / ARQT=US</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Pfizer Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Srikripa Devarakonda, PHD / Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Alexander Xenakis</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 10.3.21</td><td class="leftalignment">English</td><td class="rightalignment">82</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 01988P10 / 00282410 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 44485910 / 45253H10 / 07181310 / 10113710 / 04635310 / 43644010 / 64125C10 / 37555810 / 15678210 / 03116210 / 75886F10 / 46120E60 / 11679410 / M2572210 / 45232710 / 02343610 / 09062X10 / 01625510 / 30063P10 / 478160104 / 640268108 / 075887109 / 00422510 / 02043Q10 / 67070410 / 40637H10 / 207410101 / 205306103 / 45784P10 / 25213110 / 50187A10 / 58502B10 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 02311120 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 05463X10 / 45780L10 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 03675210 / 75046920 / 00287Y10 / 40412C10 / G5960L10 / 46222210 / 18946410 / 04004760 / 21232630 / 04280A10 / 05337M104 / 23283X20 / 40131M10 / 604749101 / 63230710 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 67181A10 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 58949210 / 09627Y10 / 68071010 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 04685N10 / 13089P10 / 34633R10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 45332Y10 / 80405P10 / N4482110 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / 16961L10 / 65443P10 / 82939910 / 87410C10 / 19240Q20 / 00288U10 / 36870G10 / 64128810 / 00404A10 / N6960510 / 28036F10 / 51506910 / N5749R10 / 24343R10 / 75629V10 / 26622P10 / 52634L10 / 23003110 / 49705R10 / 38246G10 / 85209E10 / 25056L10 / 09770210 / 82835W10 / N5151710 / 78349D10 / 68386J20 / 30315R10 / 37230320 / 14203810 / 75382E10 / 29251M10 / 81064810 / G637AM10 / 15117B20 / 00038020 / 82489T10 / 00653Q10 / 12552310 / 04683R10 / 01626L10 / 20752310 / 28623U10 / 28658R10 / 38870X10 / 95075A10 / 15673T10 / 60853G10 / 87427V10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Abbott Laboratories / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / ImmunoGen Inc / Baxter International Inc / Boston Scientific Corp / AstraZeneca PLC / Hologic Inc / Neurocrine Biosciences Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Bruker Corp / Compugen Ltd / Illumina Inc / Amedisys Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Becton Dickinson and Co / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / NuVasive Inc / Halozyme Therapeutics Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / LHC Group Inc / MEDNAX Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Amarin Corporation PLC / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / AxoGen Inc / Inogen Inc / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Anthem Inc / Radius Health Inc / Abbvie Inc / HCA Healthcare Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / ContraFect Corp / Arrowhead Pharmaceuticals Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Mirum Pharmaceuticals Inc / Natera Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Oak Street Health Inc / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Olink Holding AB (publ) / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Inari Medical Inc / Satsuma Pharmaceuticals Inc / InflaRx NV / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / Chinook Therapeutics Inc / 908 Devices Inc. / Sio Gene Therapies Inc / Talaris Therapeutics Inc / Cogent Biosciences Inc / Abcellera Biologics Inc / Gemini Therapeutics Inc / Neuropace Inc / Acadia Healthcare Company Inc / Pharvaris NV / Edgewise Therapeutics Inc / Landos Biopharma Inc / Merus NV / Decibel Therapeutics Inc / Recursion Pharmaceuticals Inc / Doximity Inc / LENSAR Inc / Cullinan Oncology Inc / Kinnate Biopharma Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Design Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / LAVA Therapeutics NV / Rxsight Inc / Opthea Ltd / F-Star Therapeutics Inc / Genmab A/S / Caribou Biosciences Inc / Rapt Therapeutics Inc / Enanta Pharmaceuticals Inc / scPharmaceuticals Inc / Myovant Sciences Ltd / Celldex Therapeutics Inc / Abcam PLC / Shockwave Medical Inc / Adapthealth Corp / Cigna Corp / Atea Pharmaceuticals Inc / Aligos Therapeutics Inc / Connect Biopharma Holdings Ltd / Elevation Oncology Inc / Eliem Therapeutics Inc / Graphite Bio Inc / Werewolf Therapeutics Inc / Century Therapeutics Inc / Molecular Partners AG / Talkspace Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.6% Above Pre-Pandemic Base- Week 78</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">10/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">India Pharma Sector - Quick Take - Molnupiravir could be a significant opportunity for multiple Indian companies</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CIPL.BO / SUN.BO / PFE.N / REDY.BO / ARBN.BO / TORP.BO / MRCG.DE / NATP.BO / DIVI.BO / VTRS.OQ</td><td class="leftalignment">Cipla Ltd / Sun Pharmaceutical Industries Ltd / Pfizer Inc / Dr Reddy's Laboratories Ltd / Aurobindo Pharma Ltd / Torrent Pharmaceuticals Ltd / Merck KGaA / Natco Pharma Ltd / Divi's Laboratories Ltd / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / India / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pantera Minerals sinks 21% in past month</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.AX</td><td class="leftalignment">Pantera Minerals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">MRK, PFE, ROG: Molnupiravir – good data; what does it mean for MRK?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US7170811035 / US58933Y1055 / ROG.S / CH0012032048</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc / Roche Holding AG / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRK Data Lets Some Air Out of COVID Vaccine Bubble</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK.N / 60770K10 / 71708110 / MRNA.OQ / 58933Y10 / 09075V10</td><td class="leftalignment">Merck & Co Inc / Moderna Inc / Pfizer Inc / Moderna Inc / Merck & Co Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Bloom Burton & Co.</td><td class="leftalignment">Trillium Therapeutics Inc. (NASDAQ-TRIL; US$17.56, TSX-TRIL; C$22.26).    Moving Target to Acquisition Price (US$18.50); Rating to HOLD.</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">TRIL=US / TRIL=CA</td><td class="leftalignment">Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">MERGER/ACQUISITION/DIVESTITURE / PRICE / RATINGS CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David Martin, PHD</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Oct 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">VSAT / FR0000120271 / GB0007980591 / US00846U1016 / US0556221044 / US1271903049 / US22160K1051 / US2358511028 / US30231G1022 / US3647601083 / US45253H1014 / US4698141078 / US87612E1064 / US8835561023 / US9311421039 / US9418481035 / US1667641005 / US89151E1091 / US5645631046 / US1167941087 / US09062X1037 / US0042251084 / US02043Q1076 / GB00B03MLX29 / RDSa.AS / ACOR.OQ / US48242W1062 / US79546E1047 / US90384S3031 / US58933Y1055 / US92335C1062 / US0995021062 / LU0914713705 / US69327R1014 / US38046C1099 / US63009R1095 / US8086251076 / US5253271028 / US4277461020 / US0465131078 / CA89620X5064 / US9314271084 / US00653A1079 / US30050B1017 / US05464T1043 / US00773U1088 / US26856L1035 / US45782B1044 / US74967X1037 / CA1350861060 / US05351X1019 / US68373M1071 / US0197701065 / US0144421072 / US70202L1026 / US88025U1097 / US4833791035 / US09203E1055 / US92537N1081 / CH0499880968 / US0843101017 / US75943R1023 / US81578P1066 / US65443P1021 / US55406W1036 / US82933R1005 / US89142B1070 / US92747V1061 / US00032Q1040</td><td class="leftalignment">ViaSat Inc / TotalEnergies SE / BP PLC / Agilent Technologies Inc / BP PLC / CACI International Inc / Costco Wholesale Corp / Danaher Corp / Exxon Mobil Corp / Gap Inc / ImmunoGen Inc / Jacobs Engineering Group Inc / Target Corp / Thermo Fisher Scientific Inc / Walmart Inc / Waters Corp / Chevron Corp / TotalEnergies SE / ManTech International Corp / Bruker Corp / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Royal Dutch Shell PLC / Acorda Therapeutics Inc / KBR Inc / Sally Beauty Holdings Inc / Ulta Beauty Inc / Merck & Co Inc / Vera Bradley Inc / Booz Allen Hamilton Holding Corp / Intelsat SA / PDC Energy Inc / Gogo Inc / NanoString Technologies Inc / Science Applications International Corp / Leidos Holdings Inc / Heron Therapeutics Inc / Atara Biotherapeutics Inc / Pfizer Inc / Walgreens Boots Alliance Inc / Adaptimmune Therapeutics PLC / Evolent Health Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / elf Beauty Inc / Inseego Corp / RH / Canada Goose Holdings Inc / Avaya Holdings Corp / Opera Ltd / Allogene Therapeutics Inc / Alector Inc / Parsons Corp / 10X Genomics Inc / Kaleyra Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / ADC Therapeutics SA / Berkeley Lights Inc / Relay Therapeutics Inc / Seer Inc / 908 Devices Inc. / MYT Netherlands Parent BV / Singular Genomics Systems Inc / Torrid Holdings Inc / Vintage Wine Estates Inc / Aadi Bioscience Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Initiation: Bringing Abraxane's Winning Playbook to Sirolimus</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">US00032Q1040 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Aadi Bioscience Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">10/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Oct 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / AMGN.OQ / NVAX.OQ / 006280.KS / BION.BO / TEVA.N / MRNA.OQ / 068270.KS / 086900.KQ / 0460.HK / ABBV.N / 207940.KS / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Amgen Inc / Novavax Inc / Green Cross Corp / Biocon Ltd / Teva Pharmaceutical Industries Ltd / Moderna Inc / Celltrion Inc / Medy Tox Inc / Sihuan Pharmaceutical Holdings Group Ltd / Abbvie Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United Kingdom / India / Israel / Korea, Republic of / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer jumps 11% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">More Serotypes and Less Shots Are Better So Pfizer Wins in PCV</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N / 71708110 / 58933Y10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA / Dilip Joseph</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Competition in Atopic Dermatitis Heating Up, but Nothing Challenges Dupi</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">71708110 / 03116210 / 75886F10 / 00287Y10 / F5548N10</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun / Daniel Tarjan, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker - Wegovy launch insights: For The Week Ended Sep 17</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 22): First dose rate 69%, in line with major European countries and the US; 58% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">09/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.22）：ワクチン接種率は1回目が69%となり欧米主要国並みの水準に、2回目は58%</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">09/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Pfizer Inc. SEPTEMPBER 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">PFE Announces More Positive Data From Its Respiratory Vaccine Portfolio</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0925288 / 2000019 / 2317087 / 2328915 / 2630513 / 2684703 / 2707677 / 2862532 / 2138158 / 2799351 / 2825933 / 2829601 / 2895163 / 7103065 / 2857817 / B02R1L6 / 2390817 / B7TL820 / B7JYSG3 / B8L2798 / B7577T2 / B8DPDT7 / BVVN4Q8 / BYW36M8 / BYNZGK1 / BNFWR44 / BLGJ610 / BJVR9Y9 / BJXBP30 / BYY88Y7 / BZ0P3Z5 / BP84RX0 / BN4RD42 / BFY7DC4 / BMV31Q4 / BMHR7K6 / BMGGJK8</td><td class="leftalignment">Sanofi SA / GlaxoSmithKline PLC / Amazon.com Inc / Entergy Corp / Nextera Energy Inc / New Jersey Resources Corp / Pfizer Inc / Public Service Enterprise Group Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Southern Co / United Natural Foods Inc / Novartis AG / Netflix Inc / ALLETE Inc / Gray Television Inc / Meta Platforms Inc / Guidewire Software Inc / Hemisphere Media Group Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / PayPal Holdings Inc / Block Inc / Worldline SA / Warner Music Group Corp / iHeartMedia Inc / Turning Point Therapeutics Inc / Alphabet Inc / Tegna Inc / Townsquare Media Inc / CureVac NV / Altimmune Inc / Audacy Inc / Impel Neuropharma Inc / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: Updates on global vaccine rollouts, variants, boosters and waning immunity</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / LONN.S / GSK.L / NVAX.OQ / 1099.HK</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">DMD gene tx Ph 3 update -- muscle weakness</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Bristol Myers Squibb Stock After An 11% Fall In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2094670 / 2778844 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2657802 / 2689560 / 2684703 / 2707677 / 2730190 / 2862532 / 2138158 / 2799351 / 2829601 / 7103065 / 2857817 / 2390817 / B7TL820 / B7JYSG3 / B8L2798 / B7577T2 / B8DPDT7 / BFLR866 / BVVN4Q8 / BK0VHF6 / BD8DJ71 / BGCYWN8 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BJVR9Y9 / BZ1LFG7 / BYY88Y7 / BZ0P3Z5 / BP84RX0 / BGKG6M3 / BF3N4P3 / BMV31Q4 / BNNTQY0 / BJ62Z18</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Best Buy Co Inc / Merck & Co Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / Novartis AG / Netflix Inc / Gray Television Inc / Meta Platforms Inc / Guidewire Software Inc / Hemisphere Media Group Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / IDEAYA Biosciences Inc / Snap Inc / Xencor Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / iHeartMedia Inc / Roku Inc / Alphabet Inc / Tegna Inc / Townsquare Media Inc / StoneCo Ltd / Arena Pharmaceuticals Inc / Audacy Inc / Oatly Group AB / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3956</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 17, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Sep. 27, 2021 / 12:10PM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 27 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / BE0165385973 / CH0012032048 / CH0012005267 / US0116591092 / US0234361089 / US0463531089 / US0997241064 / US1101221083 / US1264081035 / US22284P1057 / US23918K1088 / US3021301094 / US31428X1063 / US37733W1053 / US4433201062 / US4448591028 / US4456581077 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8356993076 / US8447411088 / US9029251066 / US9078181081 / US9113121068 / US91324P1021 / US9139031002 / US9507551086 / CA1363751027 / JP3435000009 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US60855R1005 / US15135B1017 / US50187A1079 / US0491642056 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / NL0000687663 / US01748X1028 / US2473617023 / US00922R1059 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / US40412C1018 / JE00B783TY65 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US72919P2020 / US00912X3026 / US00404A1097 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / US03937C1053 / CA0089118776 / US0367521038 / US86881A1007 / US98138J2069 / CA87241L1094 / US74967X1037 / US23753F1075 / US80689H1023 / US4990491049 / US92336X1090 / US5904791358 / US28414H1032 / US1255231003 / US1567271093 / US26142R1041 / US6541101050 / US67181A1079 / US33813J1060 / US18914F1030 / US55406W1036 / US6877931096 / US82671G1004 / US45784A1043 / LU2314763264 / US90089L1089 / US01625V1044 / US74276R1023 / US00857U1079 / US92337R1014 / US68622V1061 / US53228F1012 / US28489L1044 / US10920V1070 / US13781Y1038 / US28623U1016 / IL0011786154 / CA50202P1053 / US14171W1036</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Melexis NV / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amedisys Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / DaVita Inc / Expeditors International of Washington Inc / FedEx Corp / GlaxoSmithKline PLC / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Sony Group Corp / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / United Parcel Service Inc / UnitedHealth Group Inc / Universal Health Services Inc / Werner Enterprises Inc / Canadian National Railway Co / Sony Group Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Molina Healthcare Inc / Centene Corp / LHC Group Inc / Atlas Air Worldwide Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Air Transport Services Group Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / HCA Healthcare Inc / Aptiv PLC / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Plug Power Inc / Air Lease Corp / Acadia Healthcare Company Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / ArcBest Corp / Air Canada / Anthem Inc / Surgery Partners Inc / Workhorse Group Inc / TFI International Inc / RH / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Veoneer Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Cerence Inc / DraftKings Inc / Nikola Corp / Oak Street Health Inc / Fisker Inc / Clover Health Investments Corp / MYT Netherlands Parent BV / Oscar Health Inc / Signify Health Inc / InnovAge Holding Corp / Arrival SA / TuSimple Holdings Inc / Alignment Healthcare Inc / Privia Health Group Inc / agilon health Inc / Vera Therapeutics Inc / Organon & Co / Lifestance Health Group Inc / Electric Last Mile Solutions Inc / Bright Health Group Inc / Cano Health Inc / Elevation Oncology Inc / REE Automotive Ltd / Li-Cycle Holdings Corp / CareMax Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Japan / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CPRX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CPRX.O / ABT / JNJ / PFE / BMRN.O / ACOR.O / SRPT.O</td><td class="leftalignment">Catalyst Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Pfizer Inc / Biomarin Pharmaceutical Inc / Acorda Therapeutics Inc / Sarepta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 7.2% Above Pre-Pandemic Base- Week 77</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 29664W105 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 22978P106 / 37148K100 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 007002108 / M47364100 / 617760202 / N71542109 / 92790C104 / 76200L309 / G3855L106</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Cue Biopharma Inc / Generation Bio Co / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Viridian Therapeutics Inc / Rezolute Inc / GH Research PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">JMP Therapeutic Research / Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">It's All Politics; CDC Director Undermines ACIP and Vax Regs, Good for PFE</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / 71708110 / 60770K10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">One Target With Potential In Many Cancers</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/24/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Recommends PFE Booster for 65+ and High Risk, Pans Backdoor Access for All</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / 71708110 / 09075V10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Booster EUA Arrives In Time; Positive ACIP Meeting and Increasing Competition</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">71708110 / 478160104 / 09075V10 / 60770K10 / F5548N10</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / BioNTech SE / Moderna Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Daniel Tarjan, Ph.D. / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / 2367026 / 2126335 / 2681511 / 2000019 / 2008154 / 2497406 / 2065955 / 2113434 / 2270726 / 2317087 / 2471950 / 2459020 / 2684703 / 2048804 / 2440637 / 2862532 / 2799351 / 2971029 / 2822019 / 2857817 / B03PGL4 / 2390817 / B65LWX6 / B7TL820 / BBFL7S1 / B8L2798 / BFDV8K0 / BBPK0J0 / B7577T2 / BVVN4Q8 / BYW36M8 / BYNZGK1 / BD9GVY0 / BZ1LFB2 / BFZ1K46 / BMYML02 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BJVR9Y9 / BJXBP30 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BKX9VD3 / BKC9SX3 / BYNQ369 / BZ0P3Z5 / BMG75B4 / BP84RX0 / BLBLMD5 / BMV31Q4 / BM8NHS1 / BMFKLL6</td><td class="leftalignment">American Express Co / General Mills Inc / Bristol-Myers Squibb Co / PepsiCo Inc / Amazon.com Inc / Adobe Inc / Kroger Co / Autozone Inc / Boston Scientific Corp / Walt Disney Co / Entergy Corp / Incyte Corp / Intuit Inc / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Sinclair Broadcast Group Inc / LKQ Corp / Advance Auto Parts Inc / Netflix Inc / NorthWestern Corp / Gray Television Inc / O'Reilly Automotive Inc / Meta Platforms Inc / bluebird bio Inc / Hemisphere Media Group Inc / MacroGenics Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Eversource Energy / PayPal Holdings Inc / Block Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Evergy Inc / Vistra Corp / iHeartMedia Inc / Turning Point Therapeutics Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Arcutis Biotherapeutics Inc / Arcturus Therapeutics Holdings Inc / Albertsons Companies Inc / Tegna Inc / Inventiva SA / Townsquare Media Inc / Array Technologies Inc / Audacy Inc / Adagio Therapeutics Inc / Aeye Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - Tagrisso patent lawsuit - limited concerns</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / PFE.N / PBYI.OQ</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Puma Biotechnology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/23/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Will Pfizer Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Merck Stock At $72?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US09058V1035 / US2910111044 / US45253H1014 / US6701002056 / US8636671013 / US8835561023 / US98956P1021 / US5645631046 / RDSa.AS / US2473617023 / US9100471096 / US85916J4094 / IE00B4Q5ZN47 / US60468T1051 / US02376R1023 / DK0060534915 / US4277461020 / IE00BQPVQZ61 / CA89620X5064 / US20717E1010 / US6323071042 / FR0011471135 / US87184Q1076 / IE00BY7QL619 / US29604W1080 / US92511W1080 / VGG312491084 / US89377M1099 / US05352A1007 / US71535D1063 / US85205L1070 / US4432011082 / US65487U1088 / US69353Y1038 / US81181C1045 / US11778X1046 / US03476J1079 / US69120X1072</td><td class="leftalignment">BioCryst Pharmaceuticals Inc / Emerson Electric Co / ImmunoGen Inc / Novo Nordisk A/S / Stryker Corp / Thermo Fisher Scientific Inc / Zimmer Biomet Holdings Inc / ManTech International Corp / Royal Dutch Shell PLC / Delta Air Lines Inc / United Airlines Holdings Inc / Stereotaxis Inc / Jazz Pharmaceuticals PLC / Mirati Therapeutics Inc / American Airlines Group Inc / Novo Nordisk A/S / Heron Therapeutics Inc / Horizon Therapeutics PLC / Pfizer Inc / Conformis Inc / Natera Inc / Erytech Pharma SA / Syros Pharmaceuticals Inc / Johnson Controls International PLC / Erytech Pharma SA / Verrica Pharmaceuticals Inc / Establishment Labs Holdings Inc / Transmedics Group Inc / Avantor Inc / Personalis Inc / SpringWorks Therapeutics Inc / Howmet Aerospace Inc / Nkarta Inc / PMV Pharmaceuticals Inc / Seagen Inc / BTRS Holdings Inc / Angion Biomedica Corp / Owlet Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / France / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2100920 / 2689560 / 2684703 / 2730190 / 2842255 / 2098876 / 7103065 / B121557 / 2769796 / 2857817 / B7TL820 / B4MG4Z6 / BBPK0J0 / B7577T2 / B8DPDT7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BHC8X90 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BNTB3N8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Starbucks Corp / Yum! Brands Inc / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Mirati Therapeutics Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Novo Nordisk A/S / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (21 September-): Terumo, Sysmex, and other healthcare stocks continue to gain</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4543.T / 6869.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / CSL.AX / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Terumo Corp / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / CSL Ltd / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">09/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（9月21日～）: テルモとシスメックスなどヘルスケア銘柄が続伸</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4543.T / 6869.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / CSL.AX / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / NVAX.OQ / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Terumo Corp / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / CSL Ltd / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / Novavax Inc / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It's Getting Hot In Here, Key Questions For Our Fireside Chats at the Cantor Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AMRN / GRAY / JNJ / LLY / PFE / ACRS / ARAV / SPRO / TXMD / FBIO / EYPT / PCVX / VYNE / EFTR</td><td class="leftalignment">Amarin Corporation PLC / Graybug Vision Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Aclaris Therapeutics Inc / Aravive Inc / Spero Therapeutics Inc / TherapeuticsMD Inc / Fortress Biotech Inc / EyePoint Pharmaceuticals Inc / Vaxcyte Inc / Vyne Therapeutics Inc / eFFECTOR Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 10, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">More Progress on the Vaccine Front This AM With The Announcement of Positive Data for 5 - 11 Year-Olds</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Boosting EUA & ACIP Recommendations Will Also Boost PFE’s Share & Sales, PT $50</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">71708110 / 478160104</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Narrowed VRBPAC Rec for PFE/BNTX Highlights Limits of Booster Opp’y for MRNA</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / 22UAy.DE / 60770K10 / 71708110 / 09075V10</td><td class="leftalignment">Pfizer Inc / BioNTech SE / Moderna Inc / Pfizer Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Greco Song, Ph.D. / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 0989529 / 2126335 / 2681511 / 2000019 / 2023607 / 2640147 / 2778844 / 2270726 / 2542049 / 2829515 / 2317087 / 2576941 / 2689560 / 2684703 / 2440637 / B1F76F9 / B121557 / 2857817 / 2983563 / B5B2106 / 2982924 / BBPK0J0 / B95N910 / B7577T2 / BFLR866 / BVVN4Q8 / BYNZGK1 / BZ1LFB2 / BKS3SM8 / BNFWR44 / BMQ5T49 / BKVDFF7 / BLGJ610 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BD6JX35 / BN2R582 / BQXZP64 / BLF0CW7 / BMVBZF5</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Nike Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Entergy Corp / Exelixis Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Western Union Co / Mastercard Inc / Netflix Inc / Carmax Inc / Fortinet Inc / Spectrum Pharmaceuticals Inc / Mirati Therapeutics Inc / PTC Inc / Renewable Energy Group Inc / Twitter Inc / Eversource Energy / Block Inc / Deciphera Pharmaceuticals Inc / IGM Biosciences Inc / Worldline SA / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Evergy Inc / Fox Corp / ViacomCBS Inc / Krystal Biotech Inc / Relay Therapeutics Inc / Wayfair Inc / Repare Therapeutics Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/20/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1176</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="even"><td class="leftalignment">09/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 38, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">JNJ / AMRN / CDTX / GRAY / HCM / LLY / MRK / MSB / PFE / ACRS / CKPT / SPRO / ZTS / OMER / AERI / SCYX / LPCN / FBIO / AYTU / EYPT / PDSB / ARQT / IMAB / VYNE</td><td class="leftalignment">Johnson & Johnson / Amarin Corporation PLC / Cidara Therapeutics Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Pfizer Inc / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Lipocine Inc / Fortress Biotech Inc / Aytu Biopharma Inc / EyePoint Pharmaceuticals Inc / PDS Biotechnology Corp / Arcutis Biotherapeutics Inc / I-Mab / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Remain Stable Amidst Delta - Week 76</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not Sitting Still – VRBPAC Endorses PFE Boosters for High Risk, HCW’s and 65+</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / 71708110 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Daina Graybosch, Ph.D. / Anna Baran, CFA / Na Sun / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UG-US -  Dividend Quality Analysis, for the period ended June 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">UG.O / ASH / IFF / JNJ / PFE / SCL / TFX</td><td class="leftalignment">United-Guardian Inc / Ashland Global Holdings Inc / International Flavors & Fragrances Inc / Johnson & Johnson / Pfizer Inc / Stepan Co / Teleflex Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US -  Dividend Quality Analysis, for the period ended September 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE / PRTA / US0311621009 / US88688T1007 / US12482W1018 / CA05156X8843</td><td class="leftalignment">Pfizer Inc / Prothena Corporation PLC / Amgen Inc / Tilray Brands Inc / cbdMD Inc / Aurora Cannabis Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29664W105 / 45826J105 / 558868105 / 23306J101 / 12648L601 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 22978P106 / 37148K100 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 007002108 / M47364100 / 617760202 / N71542109 / 92790C104 / 76200L309 / G3855L106</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Esperion Therapeutics Inc / Intellia Therapeutics Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Cue Biopharma Inc / Generation Bio Co / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Viridian Therapeutics Inc / Rezolute Inc / GH Research PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">JMP Therapeutic Research / Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US00846U1016 / US0463531089 / US1101221083 / US2435371073 / US5324571083 / US6541061031 / US66987V1098 / US7170811035 / US7711951043 / US9418481035 / US3448491049 / US80105N1054 / US2533931026 / FI0009013296 / US9043111072 / US58933Y1055 / US5560991094 / US64104Y1064 / US30057T1051 / US89377M1099 / US0843101017</td><td class="leftalignment">Agilent Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Deckers Outdoor Corp / Eli Lilly and Co / Nike Inc / Novartis AG / Pfizer Inc / Roche Holding AG / Waters Corp / Foot Locker Inc / Sanofi SA / DICK'S Sporting Goods Inc / Neste Oyj / Under Armour Inc / Merck & Co Inc / MacroGenics Inc / Neste Oyj / Evoqua Water Technologies Corp / Transmedics Group Inc / Berkeley Lights Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Finland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">09/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Our Take On Data In ESMO Abstracts Ahead Of The Weekend</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Is Third Dose A Charm? Thoughts On Booster Dose Ahead of VRBPAC Meeting Tomorrow</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Pfizer Stock Can Rebound After Falling Nearly 15% From Its Peak Last Month</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Johnson & Johnson Stock Rebound After A 4% Fall In A Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Merck Stock After A 5% Fall In A Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not If but When; VRBPAC Documents Positive for PFE Booster Approval</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N / 71708110 / 04635310 / 478160104 / 02043Q10 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Alnylam Pharmaceuticals Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Daina Graybosch, Ph.D. / Anna Baran, CFA / Na Sun / Greco Song, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">09/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">NEJM Article Provides More Ammunition for Booster Bulls; Over 65 Seems Likely</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Sep. 15, 2021 / 11:45AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Cologuard Sales Rep Expansion Bound to Drive Meaningful Growth into YE and 2022</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">30063P10 / 71708110</td><td class="leftalignment">Exact Sciences Corp / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Puneet Souda / Chad Wiatrowski</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2000019 / 2050832 / 2270726 / 2317087 / 2670519 / 2328915 / 2100920 / 2459020 / 2684703 / 2048804 / B121557 / 2769796 / 2857817 / B0T7YX2 / B87ZMX0 / B7577T2 / B8DPDT7 / BVVN4Q8 / BP4GNK9 / BYNZGK1 / BFZ1K46 / BLGJ610 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BGSP7M9 / BKS3RS7 / BN4RD42 / 021513106 / BMF1LH5 / BKVK9N4 / BMW5LX6 / BP96C52</td><td class="leftalignment">Amazon.com Inc / Ameren Corp / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / Pfizer Inc / Pinnacle West Capital Corp / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / Palo Alto Networks Inc / Renewable Energy Group Inc / Sarepta Therapeutics Inc / Eversource Energy / SAGE Therapeutics Inc / Block Inc / Spotify Technology SA / Warner Music Group Corp / Fox Corp / Spire Inc / ViacomCBS Inc / Zoom Video Communications Inc / 10X Genomics Inc / CureVac NV / Alto Ingredients Inc / Honest Company Inc / European Wax Center Inc / Eliem Therapeutics Inc / Surrozen Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 8.6% Y/Y Including COVID-19 Vaccine Volume Benefit (+3.4% Without)</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.20): First dose rate 64%, 52% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">09/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.20）：国内ワクチン接種率、1回目が64%、2回目が52%に</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Roche Stock Rebound After A 3% Fall In A Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Sep. 14, 2021 / 10:15AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">V / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2023607 / 2778844 / 2026242 / 2270726 / 2317087 / 2670519 / 2328915 / 2459020 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2212922 / 2857817 / 2982924 / B7VD3F2 / BFDV8K0 / BBPK0J0 / B95N910 / BVVN4Q8 / BYW36M8 / BZ1LFB2 / BJXBP30 / BYQHPK7 / BYYWPW6 / BZ1LFG7 / BJDX8Y8 / BWY4XV3 / BGT0PL8 / BNTB3N8 / BMGGJK8</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Spectrum Pharmaceuticals Inc / Duke Energy Corp / MacroGenics Inc / Mirati Therapeutics Inc / PTC Inc / Eversource Energy / PayPal Holdings Inc / Deciphera Pharmaceuticals Inc / Turning Point Therapeutics Inc / Zymeworks Inc / Beigene Ltd / Roku Inc / Mirum Pharmaceuticals Inc / Adaptimmune Therapeutics PLC / DiaMedica Therapeutics Inc / Vizio Holding Corp / Valneva SE</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Everest-Providence BD deal conference call key takeaways. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / PFE.N / 2196.HK / MRNA.OQ</td><td class="leftalignment">Everest Medicines Ltd / Pfizer Inc / Shanghai Fosun Pharmaceutical Group Co Ltd / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">09/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US healthcare reform back in focus: Build Back Better includes direct negotiation</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / CSL.AX / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / 4768.T / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Sep 03, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : Revisiting BNT-162 Vaccine Outlook and Broader PFE Valuation Case – Is There Any More Room to Run?</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 37, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - GSK Consumer sell side meeting feedback</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">GSK.L / CL.N / PFE.N / ULVR.L / PG.N / BEIG.DE / RKT.L</td><td class="leftalignment">GlaxoSmithKline PLC / Colgate-Palmolive Co / Pfizer Inc / Unilever PLC / Procter & Gamble Co / Beiersdorf AG / Reckitt Benckiser Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China insulin VBP moves forward: Tendering expected Oct/Nov for early 2022 implementation</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / FMEG.DE / MRCG.DE / GSK.L / BAYGN.DE</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Fresenius Medical Care AG & Co KGaA / Merck KGaA / GlaxoSmithKline PLC / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">09/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ESG & Corporate Tax Sustainability Scorecard</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">ALK.N / FMC.N / IBM.N / PFE.N / MGM.N / COO.N / EW.N / OKE.N / MSFT.OQ / XLNX.OQ / QCOM.OQ / HSIC.OQ / AMZN.OQ / NVDA.OQ / CHTR.OQ / MPWR.OQ / AVGO.OQ / FB.OQ / PTC.OQ / TMUS.OQ / HPE.N</td><td class="leftalignment">Alaska Air Group Inc / FMC Corp / International Business Machines Corp / Pfizer Inc / MGM Resorts International / Cooper Companies Inc / Edwards Lifesciences Corp / ONEOK Inc / Microsoft Corp / Xilinx Inc / Qualcomm Inc / Henry Schein Inc / Amazon.com Inc / NVIDIA Corp / Charter Communications Inc / Monolithic Power Systems Inc / Broadcom Inc / Meta Platforms Inc / PTC Inc / T-Mobile US Inc / Hewlett Packard Enterprise Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">ECONOMIC REPORTS / MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Ron Graziano / Mr. Amit Varshney / Adrian Szumilo / HOLT Americas</td></tr>
<tr class="odd"><td class="leftalignment">09/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 9.12.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">09061G10 / 71708110 / 87936910 / 640268108 / 45784P10 / 25213110 / 03152W10 / 58933Y10 / 45766930 / 92337F10 / 87918A10 / 00287Y10 / G5960L10 / 05337M104 / 40131M10 / 604749101 / 45773010 / 98420N10 / 90041T10 / 68071010 / 74340E10 / 01981810 / 10806X10 / 16383L10 / 55609910 / 14843C10 / 01438T10 / G3910J11 / 34633R10 / 43906K10 / 45781K20 / 60468T10 / 03969F10 / F5548N10 / 45845P10 / 82710M10 / G8807B10 / 90400D10 / 01671P10 / 56400P70 / 87808K10 / N4444510 / 15912K10 / 87410C10 / 09770210 / 82835W10 / G637AM10</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Pfizer Inc / Teleflex Inc / Nektar Therapeutics / Insulet Corp / Dexcom Inc / Amicus Therapeutics Inc / Merck & Co Inc / Insmed Inc / Veracyte Inc / Teladoc Health Inc / Abbvie Inc / Medtronic PLC / Avadel Pharmaceuticals PLC / Guardant Health Inc / Mirum Pharmaceuticals Inc / Inspire Medical Systems Inc / Xenon Pharmaceuticals Inc / Turning Point Therapeutics Inc / Olink Holding AB (publ) / Progyny Inc / Allovir Inc / BridgeBio Pharma Inc / ChemoCentryx Inc / MacroGenics Inc / Castle Biosciences Inc / Aldeyra Therapeutics Inc / GlaxoSmithKline PLC / Forma Therapeutics Holdings Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Mirati Therapeutics Inc / Arcus Biosciences Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Silk Road Medical Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Allakos Inc / MannKind Corp / TCR2 Therapeutics Inc / Immatics NV / Change Healthcare Inc / Talaris Therapeutics Inc / Bolt Biotherapeutics Inc / Silverback Therapeutics Inc / Myovant Sciences Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / Sweden / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">09/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 75</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / OPTN / PFE / RMTI / SIBN / ACRS / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / ARDS / CUTR / BSLN / MNKD / RANI / ARAV / AVTX / SPRO / ZTS / RDHL / OMER / AXGN / TXMD / HRTX / TRVN / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / OptiNose Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Aclaris Therapeutics Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Rani Therapeutics Holdings Inc / Aravive Inc / Avalo Therapeutics Inc / Spero Therapeutics Inc / Zoetis Inc / Redhill Biopharma Ltd / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 22978P106 / 37148K100 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 007002108 / M47364100 / 617760202 / N71542109 / 92790C104 / 76200L309 / G3855L106</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Cue Biopharma Inc / Generation Bio Co / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Viridian Therapeutics Inc / Rezolute Inc / GH Research PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">JMP Therapeutic Research / Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended September 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - Key takeaways from 2021 CMD</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE / 2330.TW / 4063.T / 4185.T / A.N / BDX.N / PFE.N / PHG.AS / RECI.MI / STDM.PA / TMO.N / WAT.N / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / WST.N / GSK.L / UCB.BR / INTC.OQ / RGEN.OQ / TECH.OQ / CCMP.OQ / ENTG.OQ / 005930.KS / IPN.PA / ORNBV.HE / QGEN.N / ALM.MC / GRLS.MC / WAFGN.DE / VIFN.S / GMAB.CO</td><td class="leftalignment">Merck KGaA / Taiwan Semiconductor Manufacturing Co Ltd / Shin-Etsu Chemical Co Ltd / JSR Corp / Agilent Technologies Inc / Becton Dickinson and Co / Pfizer Inc / Koninklijke Philips NV / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / West Pharmaceutical Services Inc / GlaxoSmithKline PLC / Ucb SA / Intel Corp / Repligen Corp / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Samsung Electronics Co Ltd / Ipsen SA / Orion Oyj / Qiagen NV / Almirall SA / Grifols SA / Siltronic AG / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Japan / Korea, Republic of / Netherlands / Taiwan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">09/10/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MRNA Commits to RSV With Adult Pivotal Plan and Maternal Vax Coming</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA.OQ / 71708110 / 478160104 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Moderna Inc / Pfizer Inc / Johnson & Johnson / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Anna Baran, CFA / Na Sun / Mr. Rick Bienkowski, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOL Call Takeaways: JAK Use in RA May Suffer, PsA and AS Use Unchanged (Small)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">71708110 / 00287Y10 / 00461U10</td><td class="leftalignment">Pfizer Inc / Abbvie Inc / Aclaris Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Mr. Thomas J. Smith / Anna Baran, CFA / Na Sun / Mike Kratky, CFA / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 2126335 / 2516152 / 2732635 / 2437071 / 2208073 / 2270726 / 2317087 / 2670519 / 2328915 / 2457864 / 2515030 / 2689560 / 2684703 / B121557 / 2857817 / 2983563 / B3D7K31 / B23FN39 / B7TL820 / B7VD3F2 / BBGVT40 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYZLV46 / BJF8Q81 / BD8DJ71 / BJLKVS6 / BZB1XF2 / BYXJQG9 / BYY88Y7 / BMG75B4 / BYXR425 / BZ4CHH2 / BMDJ397 / BLR6S36 / BMFPJK6 / BNLYBF3</td><td class="leftalignment">Sanofi SA / Bristol-Myers Squibb Co / Eli Lilly and Co / AutoNation Inc / Biomarin Pharmaceutical Inc / Copart Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / ImmunoGen Inc / Lithia Motors Inc / PG&E Corp / Pfizer Inc / Mastercard Inc / Netflix Inc / Carmax Inc / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Duke Energy Corp / News Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / InflaRx NV / IAA Inc / Snap Inc / Phathom Pharmaceuticals Inc / Tactile Systems Technology Inc / Spire Inc / Alphabet Inc / Inventiva SA / RH / Soleno Therapeutics Inc / Bolt Biotherapeutics Inc / Longboard Pharmaceuticals Inc / ACV Auctions Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / HCM / JNJ / LLY / PFE / BSLN / IMAB</td><td class="leftalignment">Merck & Co Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Basilea Pharmaceutica AG / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended September 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended September 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pantera Minerals lifts 9.1% in past month</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.AX</td><td class="leftalignment">Pantera Minerals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - Clinical Collaboration With PFE To Support HERKULES-3 Trial; ERAS-007 Clinical Development On Track; Maintain BUY</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / BNLYBF3 / 2684703</td><td class="leftalignment">Pfizer Inc / Erasca Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BMRN: FDA Puts BMRN’s Phenylketonuria Program (BMN 307) on Clinical Hold Moments After the CTGTAC Offers Minimal Guidance on AAV-Based Therapies</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2437071 / 2684703</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Debjit Chattopadhyay, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Flash - Health Care: Vaccination is not enough - spotlight on COVID-19 drugs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK.L / PFE.N / AZN.L / SASY.PA / MRCG.DE / JP3463000004</td><td class="leftalignment">GlaxoSmithKline PLC / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / Takeda Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Transportation</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">FDA’s JAK Warnings Create Opportunity for Novel Drugs in 2nd Line Atopic Derm</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">45337C10 / 71708110 / 03116210 / 75886F10 / CNTB / 00287Y10 / 04004760 / 00461U10 / 51506910 / 75382E10</td><td class="leftalignment">Incyte Corp / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Connect Biopharma Holdings Ltd / Abbvie Inc / Arena Pharmaceuticals Inc / Aclaris Therapeutics Inc / Landos Biopharma Inc / Rapt Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Mr. Thomas J. Smith / Anna Baran, CFA / Na Sun / Mike Kratky, CFA / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOL Call Takeaways: IBD Still a Big Market for JAKs, 2L+ Was Always the Spot</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">71708110 / 09062X10 / 478160104 / 640268108 / 58933Y10 / 00287Y10 / 38341P10 / 4525EP10 / 74366E10 / G8807B10 / 00461U10 / 51506910</td><td class="leftalignment">Pfizer Inc / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Merck & Co Inc / Abbvie Inc / Gossamer Bio Inc / Immunic Inc / Protagonist Therapeutics Inc / Theravance Biopharma Inc / Aclaris Therapeutics Inc / Landos Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Hong Kong / Israel / Japan / Luxembourg / Norway / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Mr. Thomas J. Smith / Anna Baran, CFA / Na Sun / Mike Kratky, CFA / Nat Charoensook, Ph.D., CFA</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2367026 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2270726 / 2317087 / 2670519 / 2328915 / 2689560 / 2684703 / 2048804 / 2829601 / 7103065 / B1F76F9 / 2857817 / B3D7K31 / BCZS820 / BFDV8K0 / BVVN4Q8 / BYW36M8 / BJLT387 / BD8DJ71 / BJ5FZ74 / BFZ1K46 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BWY4XV3 / BMG5660 / BMHR7K6 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / General Mills Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Southern Co / Novartis AG / Western Union Co / Netflix Inc / Discovery Inc / Fate Therapeutics Inc / MacroGenics Inc / Eversource Energy / PayPal Holdings Inc / Avantor Inc / Snap Inc / Adaptive Biotechnologies Corp / Spotify Technology SA / ViacomCBS Inc / Roku Inc / Alphabet Inc / Adaptimmune Therapeutics PLC / Joann Inc / Impel Neuropharma Inc / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 19): First dose rate 60%, 48% fully vaccinated</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / PFE.N / AZN.L / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">09/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.19）：国内ワクチン接種率、1回目が60%、2回目が48%に</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / PFE.N / AZN.L / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Highlights; What We'll Be Watching At ESMO Next Week</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / HCM / JNJ / LLY / PFE / BSLN / IMAB</td><td class="leftalignment">Merck & Co Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Basilea Pharmaceutica AG / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 27, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Sep 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000120578 / GB0009895292 / FR0000054470 / GB0009252882 / DE0006969603 / US09061G1013 / CH0012032048 / CH0012005267 / US0116591092 / US0311621009 / US0463531089 / US1101221083 / US1311931042 / US14149Y1082 / US1985161066 / US2435371073 / US2855121099 / US3377381088 / US3755581036 / US37733W1053 / US45337C1027 / US5324571083 / US58155Q1031 / US6541061031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US7782961038 / US8305661055 / US8308791024 / US8447411088 / US8725401090 / US8740541094 / US9182041080 / US03073E1055 / US3448491049 / US37940X1028 / US4771431016 / US4198791018 / US80105N1054 / US2533931026 / US09062X1037 / US9043111072 / US31620M1062 / US1314761032 / US4103451021 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US6936561009 / US7512121010 / JE00B783TY65 / US98986T1088 / US00287Y1091 / US85916J4094 / US41068X1000 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / DK0060534915 / CA0089118776 / US83417M1045 / US00653A1079 / VGG312491084 / US5904791358 / US98585X1046 / US89377M1099 / US26142R1041 / US02875D1090 / US04271T1007 / US82489W1071 / US30320C1036 / US1241551027 / US30260D1037 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Ubisoft Entertainment SA / GlaxoSmithKline PLC / Puma SE / Biomarin Pharmaceutical Inc / Roche Holding AG / Novartis AG / Alaska Air Group Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cardinal Health Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Electronic Arts Inc / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Eli Lilly and Co / Mckesson Corp / Nike Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Ross Stores Inc / Skechers USA Inc / SkyWest Inc / Southwest Airlines Co / TJX Companies Inc / Take-Two Interactive Software Inc / VF Corp / Amerisourcebergen Corp / Foot Locker Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / DICK'S Sporting Goods Inc / Biogen Inc / Under Armour Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / HanesBrands Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / PVH Corp / Ralph Lauren Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / Stereotaxis Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Solaredge Technologies Inc / Adaptimmune Therapeutics PLC / Establishment Labs Holdings Inc / Mesa Air Group Inc / Yeti Holdings Inc / Transmedics Group Inc / DraftKings Inc / American Outdoor Brands Inc / Array Technologies Inc / Shoals Technologies Group Inc / FTC Solar Inc / Butterfly Network Inc / Figs Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Panama / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">09/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Two RSV Becomes Three, Then Four; Updating Model for New Entrants</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">71708110 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TNGX - The Next Innovative Player in "La Cumparsita" of Synthetic Lethality; Initiating Coverage of Tango Therapeutics with a BUY Rating and $16 PT</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BP2P6L0 / 0989529 / 0925288 / 2126335 / 2369174 / 2455965 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0 / BK0VHF6 / BYYWPW6 / BL71K91 / BN2RM92 / BLF0CW7</td><td class="leftalignment">Tango Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / IDEAYA Biosciences Inc / Beigene Ltd / Revolution Medicines Inc / Rain Therapeutics Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Pfizer, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Anguilla / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">09/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Thailand Tourism Sector: Bottoming out: Decent recovery next year</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">AOT.BK / MINT.BK / 0045.HK / 0069.HK / 0520.HK / ACCP.PA / AIA.NZ / JFC.PS / PFE.N / SYD.AX / WTB.L / AZN.L / MAHB.KL / 0694.HK / CHH.N / ASR.N / FRAG.DE / 1179.HK / 000089.SZ / 600009.SS / IHG.L / 600004.SS / DPZ.N / 600258.SS / DMP.AX / CENTEL.BK / PAC.N / ADP.PA / 2006.HK / H.TO / OMAB.OQ / MRNA.OQ / 1099.HK / JUBI.BO / HTHT.OQ / FHZN.S / ERW.BK / MEL.MC / MAR.OQ / MAXS.PS / AENA.MC / PIZZA.PS / AWC.BK / SHR.BK</td><td class="leftalignment">Airports of Thailand PCL / Minor International PCL / Hongkong and Shanghai Hotels Ltd / Shangri-La Asia Ltd / Xiabuxiabu Catering Management (China) Holdings Co Ltd / Accor SA / Auckland International Airport Ltd / Jollibee Foods Corp / Pfizer Inc / Sydney Airport / Whitbread PLC / AstraZeneca PLC / Malaysia Airports Holdings Bhd / Beijing Capital International Airport Co Ltd / Choice Hotels International Inc / Grupo Aeroportuario del Sureste SAB de CV / Fraport AG Frankfurt Airport Services Worldwide / Huazhu Group Ltd / Shenzhen Airport Co Ltd / Shanghai International Airport Co Ltd / InterContinental Hotels Group PLC / Guangzhou Baiyun International Airport Co Ltd / Domino's Pizza Inc / BTG Hotels Group Co Ltd / Domino's Pizza Enterprises Ltd / Central Plaza Hotel PCL / Grupo Aeroportuario del Pacifico SAB de CV / Aeroports de Paris SA / Shanghai Jin Jiang Capital Co Ltd / Hydro One Ltd / Grupo Aeroportuario del Centro Norte SAB de CV / Moderna Inc / Sinopharm Group Co Ltd / Jubilant Foodworks Ltd / Huazhu Group Ltd / Flughafen Zuerich AG / Erawan Group PCL / Melia Hotels International SA / Marriott International Inc / Max's Group Inc / Aena SME SA / Shakey's Pizza Asia Ventures Inc / Asset World Corp PCL / S Hotels and Resorts PCL</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / Hong Kong / India / Mexico / Malaysia / New Zealand / Philippines / Thailand / United States</td><td class="leftalignment">Consumer / Leisure & Entertainment / Lodging & Restaurants</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Thaniya Kevalee / Ms. Siriporn Sothikul</td></tr>
<tr class="odd"><td class="leftalignment">09/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 74</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">09/04/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">BUY & SELL Lists - Large Cap</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ABBV.N / AGNC.OQ / ALL.N / AXP.N / CAH.N / CE.N / COF.N / CRM.N / EIX.N / EOG.N / F.N / FCX.N / GPS.N / HLT.N / KEY.N / MO.N / NOC.N / OXY.N / PFE.N / PHM.N / PM.N / SC.N / STE.N / TXT.N / U.N / USB.N / ZEN.N / PXD.N / NUE.N / X.N / BKI.N / JBL.N / DIS.N / LEA.N / WLK.N / GD.N / CR.N / DE.N / AFG.N / R.N / SPOT.N / PRI.N / MRO.N / GLW.N / LH.N / PCG.N / DVN.N / TGT.N / RKT.N / SNV.N / KSS.N / OKE.N / BYD.N / DNB.N / SAM.N / MHK.N / GME.N / OSK.N / COP.N / INTC.OQ / ORI.N / ADPT.OQ / AMAT.OQ / CSL.N / CSCO.OQ / LRCX.OQ / RJF.N / RGEN.OQ / FL.N / QCOM.OQ / CREE.OQ / ORLY.OQ / TPR.N / PEGA.OQ / MRCY.OQ / UMPQ.OQ / EWBC.OQ / PLUG.OQ / HAIN.OQ / MRVL.OQ / EQIX.OQ / WOOF.OQ / CRI.N / OPEN.OQ / BRKR.OQ / EXP.N / OSH.N / LVS.N / BRKb.N / OC.N / FRPT.OQ / PODD.OQ / ES.N / MRNA.OQ / CLH.N / AI.N / NEE.N / TSLA.OQ / NXPI.OQ / TRGP.N / HII.N / Z.OQ / WEN.OQ / FB.OQ / WEX.N / RNG.N / SNOW.N / SYF.N / CTLT.N / AXTA.N / LBRDK.O / TDOC.N / RUN.OQ / PEN.N / TWLO.N / VVV.N / TTD.OQ / COUP.OQ / OKTA.OQ / CVNA.N / ROKU.OQ / SMAR.N / AVLR.N / ESTC.N / PLAN.N / STNE.OQ / CPRI.N / NFE.OQ / PINS.N / BYND.OQ / UBER.N / CRWD.OQ / GO.OQ / TXG.OQ / DDOG.OQ / SPCE.N / AZEK.N / DKNG.OQ / APA.OQ / VRM.OQ / LMND.N / GOCO.OQ / NCNO.OQ / JAMF.OQ / DCT.OQ / PLTR.N / SHC.OQ / DASH.N / CERT.OQ / SKLZ.N / DRVN.OQ / CLVT.N</td><td class="leftalignment">Abbvie Inc / AGNC Investment Corp / Allstate Corp / American Express Co / Cardinal Health Inc / Celanese Corp / Capital One Financial Corp / Salesforce.Com Inc / Edison International / EOG Resources Inc / Ford Motor Co / Freeport-McMoRan Inc / Gap Inc / Hilton Worldwide Holdings Inc / KeyCorp / Altria Group Inc / Northrop Grumman Corp / Occidental Petroleum Corp / Pfizer Inc / Pultegroup Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / STERIS plc / Textron Inc / Unity Software Inc / US Bancorp / Zendesk Inc / Pioneer Natural Resources Co / Nucor Corp / United States Steel Corp / Black Knight Inc / Jabil Inc / Walt Disney Co / Lear Corp / Westlake Chemical Corp / General Dynamics Corp / Crane Co / Deere & Co / American Financial Group Inc / Ryder System Inc / Spotify Technology SA / Primerica Inc / Marathon Oil Corp / Corning Inc / Laboratory Corporation of America Holdings / PG&E Corp / Devon Energy Corp / Target Corp / Rocket Companies Inc / Synovus Financial Corp / Kohls Corp / ONEOK Inc / Boyd Gaming Corp / Dun & Bradstreet Holdings Inc / Boston Beer Company Inc / Mohawk Industries Inc / GameStop Corp / Oshkosh Corp / Conocophillips / Intel Corp / Old Republic International Corp / Adaptive Biotechnologies Corp / Applied Materials Inc / Carlisle Companies Inc / Cisco Systems Inc / Lam Research Corp / Raymond James Financial Inc / Repligen Corp / Foot Locker Inc / Qualcomm Inc / Wolfspeed Inc / O'Reilly Automotive Inc / Tapestry Inc / Pegasystems Inc / Mercury Systems Inc / Umpqua Holdings Corp / East West Bancorp Inc / Plug Power Inc / Hain Celestial Group Inc / Marvell Technology Inc / Equinix Inc / Petco Health and Wellness Company Inc / Carter's Inc / Opendoor Technologies Inc / Bruker Corp / Eagle Materials Inc / Oak Street Health Inc / Las Vegas Sands Corp / Berkshire Hathaway Inc / Owens Corning / Freshpet Inc / Insulet Corp / Eversource Energy / Moderna Inc / Clean Harbors Inc / C3.ai Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / Targa Resources Corp / Huntington Ingalls Industries Inc / Zillow Group Inc / Wendys Co / Meta Platforms Inc / WEX Inc / RingCentral Inc / Snowflake Inc. / Synchrony Financial / Catalent Inc / Axalta Coating Systems Ltd / Liberty Broadband Corp / Teladoc Health Inc / Sunrun Inc / Penumbra Inc / Twilio Inc / Valvoline Inc / Trade Desk Inc / Coupa Software Inc / Okta Inc / Carvana Co / Roku Inc / Smartsheet Inc / Avalara Inc / Elastic NV / Anaplan Inc / StoneCo Ltd / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / CrowdStrike Holdings Inc / Grocery Outlet Holding Corp / 10X Genomics Inc / Datadog Inc / Virgin Galactic Holdings Inc / Azek Company Inc / DraftKings Inc / APA Corp (US) / Vroom Inc / Lemonade Inc / Gohealth Inc / nCino Inc / Jamf Holding Corp / Duck Creek Technologies Inc / Palantir Technologies Inc / Sotera Health Co / DoorDash Inc / Certara Inc / Skillz Inc / Driven Brands Holdings Inc / CLARIVATE PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment">Aerospace / Agriculture / Apparel & Textiles / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Defense / Electrical / Electronics / Financial Services / Food / Healthcare / Household Products / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Real Estate / Retailing / Semiconductors / Services / Technology / Telecommunications / Transportation / Utilities / Oil & Gas / Internet</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Trillium Therapeutics in top 1% performers of Canadian market in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for PFE. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 37148K100 / 02155H200 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 007002108 / M47364100 / 617760202 / N71542109 / 92790C104 / 76200L309 / G3855L106</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Generation Bio Co / Altimmune Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Viridian Therapeutics Inc / Rezolute Inc / GH Research PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">JMP Therapeutic Research / Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: September 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">AIRP.PA / ALB.N / AXP.N / BA.N / BAC.N / BAX.N / CB.N / CI.N / CL.N / CNC.N / COF.N / CRM.N / EOG.N / F.N / FDX.N / FMC.N / GM.N / GPS.N / IBM.N / JNJ.N / JPM.N / LLY.N / LMT.N / MDT.N / OXY.N / PFE.N / PM.N / PPCJ.J / RHI.N / SC.N / SLB.N / T.N / TMO.N / U.N / WAT.N / WFC.N / WMT.N / ACI.N / SPG.N / PG.N / HUM.N / NUE.N / CPB.N / HAL.N / DHR.N / UNH.N / IPG.N / SPOT.N / GS.N / CLX.N / VLO.N / HD.N / LOW.N / MRO.N / JWN.N / UPS.N / KR.N / PCG.N / XOM.N / DVN.N / AMT.N / OLN.N / IT.N / TGT.N / VZ.N / HCA.N / WST.N / MUR.N / JCI.N / ORCL.N / VFC.N / V.N / ACN.N / WSM.N / PLD.N / JLL.N / HAE.N / SAM.N / BLK.N / CRL.N / CVX.N / IRM.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TEAM.OQ / REGN.OQ / RGEN.OQ / QDEL.OQ / SNPS.OQ / CACC.OQ / QCOM.OQ / INTU.OQ / COST.OQ / INCY.OQ / PENN.OQ / DLTR.OQ / AMED.OQ / PCTY.OQ / CTXS.OQ / STLD.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / ERIE.OQ / NVDA.OQ / PLUG.OQ / MTCH.OQ / ISRG.OQ / BLUE.OQ / GRMN.OQ / ARRY.OQ / EXAS.OQ / GPN.N / VRTX.OQ / NFLX.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / SBNY.OQ / ACAD.OQ / EXR.N / MKTX.OQ / MPWR.OQ / LVS.N / NOV.N / DXCM.OQ / MS.N / CMG.N / FIS.N / STX.AX / HES.N / MA.N / IPGP.OQ / AON.N / CLR.N / BX.N / JAZZ.OQ / TDC.N / MRNA.OQ / BIO.N / SWI.N / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / EPAM.N / PSX.N / NOW.N / SRPT.OQ / FANG.OQ / ABBV.N / BLDR.N / RNG.N / COMM.OQ / WIX.OQ / SNOW.N / GOOGL.OQ / PAYC.N / ARES.N / SAGE.OQ / GLOB.N / CTLT.N / HUBS.N / TDOC.N / PYPL.OQ / NVCR.OQ / PSTG.N / IONS.OQ / TWLO.N / COUP.OQ / LW.N / AYX.N / IOVA.OQ / ROKU.OQ / ZS.OQ / FB.PS / STNE.OQ / NFE.OQ / LYFT.OQ / PINS.N / BYND.OQ / ZM.OQ / FSLY.N / PTON.OQ / DDOG.OQ / SPCE.N / LMND.N / GOCO.OQ / AMWL.N / VTRS.OQ / MRVI.OQ / PSFE.N / TSP.OQ / BBWI.N</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Salesforce.Com Inc / EOG Resources Inc / Ford Motor Co / FedEx Corp / FMC Corp / General Motors Co / Gap Inc / International Business Machines Corp / Johnson & Johnson / JPMorgan Chase & Co / Eli Lilly and Co / Lockheed Martin Corp / Medtronic PLC / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / PPC Ltd / Robert Half International Inc / Santander Consumer USA Holdings Inc / Schlumberger NV / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Walmart Inc / Albertsons Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Humana Inc / Nucor Corp / Campbell Soup Co / Halliburton Co / Danaher Corp / UnitedHealth Group Inc / Interpublic Group of Companies Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Valero Energy Corp / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / Nordstrom Inc / United Parcel Service Inc / Kroger Co / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Olin Corp / Gartner Inc / Target Corp / Verizon Communications Inc / HCA Healthcare Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Johnson Controls International PLC / Oracle Corp / VF Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Prologis Inc / Jones Lang LaSalle Inc / Haemonetics Corp / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Iron Mountain Inc / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / Repligen Corp / Quidel Corp / Synopsys Inc / Credit Acceptance Corp / Qualcomm Inc / Intuit Inc / Costco Wholesale Corp / Incyte Corp / Penn National Gaming Inc / Dollar Tree Inc / Amedisys Inc / Paylocity Holding Corp / Citrix Systems Inc / Steel Dynamics Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / Erie Indemnity Co / NVIDIA Corp / Plug Power Inc / Match Group Inc / Intuitive Surgical Inc / bluebird bio Inc / Garmin Ltd / Array Technologies Inc / Exact Sciences Corp / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Signature Bank / ACADIA Pharmaceuticals Inc / Extra Space Storage Inc / Marketaxess Holdings Inc / Monolithic Power Systems Inc / Las Vegas Sands Corp / Nov Inc / Dexcom Inc / Morgan Stanley / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Hess Corp / Mastercard Inc / IPG Photonics Corp / Aon PLC / Continental Resources Inc / Blackstone Inc / Jazz Pharmaceuticals PLC / Teradata Corp / Moderna Inc / Bio Rad Laboratories Inc / SolarWinds Corp / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Epam Systems Inc / Phillips 66 / ServiceNow Inc / Sarepta Therapeutics Inc / Diamondback Energy Inc / Abbvie Inc / Builders FirstSource Inc / RingCentral Inc / CommScope Holding Company Inc / Wix.Com Ltd / Snowflake Inc. / Alphabet Inc / Paycom Software Inc / Ares Management Corp / SAGE Therapeutics Inc / Globant SA / Catalent Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / Novocure Ltd / Pure Storage Inc / Ionis Pharmaceuticals Inc / Twilio Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Roku Inc / Zscaler Inc / San Miguel Food and Beverage Inc / StoneCo Ltd / New Fortress Energy Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Zoom Video Communications Inc / Fastly Inc / Peloton Interactive Inc / Datadog Inc / Virgin Galactic Holdings Inc / Lemonade Inc / Gohealth Inc / American Well Corp / Viatris Inc / Maravai LifeSciences Holdings Inc / Paysafe Ltd / TuSimple Holdings Inc / Bath & Body Works Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Luxembourg / Philippines / United States / South Africa / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">09/03/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Pfizer Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Lower JAK Sales After FDA Actions but Impact on Value for PFE, ABBV Is Modest</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">71708110 / 00287Y10</td><td class="leftalignment">Pfizer Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 2126335 / 2516152 / 2000019 / 2065159 / 2270726 / 2317087 / 2670519 / 2328915 / 2471950 / 2689560 / 2684703 / 2048804 / 2730190 / 7103065 / 2857817 / B0T7YX2 / B7VD3F2 / B85KFY9 / BFH3N85 / BVVN4Q8 / BZ1HM42 / BNFWR44 / BLGJ610 / BJJMGL2 / BKTNTR9 / BDFZSP1</td><td class="leftalignment">Sanofi SA / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Autodesk Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Nextera Energy Inc / Incyte Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / Netflix Inc / Live Nation Entertainment Inc / Duke Energy Corp / Five Below Inc / Veeva Systems Inc / Eversource Energy / Adyen NV / Worldline SA / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Okta Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">09/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Sep-2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 004170.KS / 069620.KS / 006280.KS / 078930.KS / MRNA.OQ / 068270.KS / 086900.KQ / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Shinsegae Inc / Daewoong Pharma / Green Cross Corp / GS Holdings Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Defending AbbVie Here as Rinvoq Should Still Hit $7-8bn Globally</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.N / 71708110 / 37555810 / 00287Y10</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippines Market Strategy - New report: COVID-19 Tracker-first dose vaccination picks up in August despite lockdown and Delta surge</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="even"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Philippines Market Strategy: COVID-19 Tracker: First dose vaccination picks up in August despite lockdown and Delta surge</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="odd"><td class="leftalignment">09/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Two new BD deals in 2H21 to drive stock; Trodelvy Ph3 HR+ mBC data could add upside. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">1952.HK / PFE.N / AZN.L / 4568.T</td><td class="leftalignment">Everest Medicines Ltd / Pfizer Inc / AstraZeneca PLC / Daiichi Sankyo Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UG-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">UG.O / ASH / IFF / JNJ / PFE / SCL / TFX</td><td class="leftalignment">United-Guardian Inc / Ashland Global Holdings Inc / International Flavors & Fragrances Inc / Johnson & Johnson / Pfizer Inc / Stepan Co / Teleflex Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Monthly: Pfizer (PFE: $46.07) adds $18 billion in MCap in August, leads Pharmaceuticals sector gains</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Bristol Myers Squibb Stock Rebound After A 4% Fall Last Week?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Advancing personalized medical treatment using AI – POAI – reports 2Q21 and strong balance sheet – Reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2681511 / 2000019 / 2778844 / 2002305 / 2026242 / 2113434 / 2216850 / 2270726 / 2829515 / 2317087 / 2670519 / 2328915 / 2100920 / 2689560 / 2684703 / 2048804 / 2138158 / 2799351 / 2829601 / 2503529 / 7103065 / 2212922 / 2857817 / BDZCRX3 / BFH3N85 / BVVN4Q8 / BJJMGL2 / BKTNTR9 / BZ1LFG7 / BGKG6M3 / BNTB3N8 / BP8GHT2 / BLF0CW7 / BM8NHS1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Merck & Co Inc / Abbott Laboratories / American Electric Power Company Inc / Boston Scientific Corp / Consolidated Edison Inc / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / Sinclair Broadcast Group Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / NRG Energy Inc / Netflix Inc / RingCentral Inc / Veeva Systems Inc / Eversource Energy / Fox Corp / ViacomCBS Inc / Roku Inc / StoneCo Ltd / Vizio Holding Corp / Vascular Biogenics Ltd / Repare Therapeutics Inc / Adagio Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/31/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Comirnaty COVID Vaccine Recommended, but 3rd Doses in September Are Uncertain</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">09075V10 / 71708110</td><td class="leftalignment">BioNTech SE / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">08/31/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Fundamental Research Corp</td><td class="leftalignment">Equity Markets and Commodities Rally on Fed’s Dovish Comments</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BABA=US / HALO / PFE=US / KNR / SGO=CA / NXS=CA / FT=CA / AUN=CA / UEX=CA / SOI=CA / PWR=CA / KTN=CA / AMY=CA / THC=CA / GRSL=CA / CBI=CA / RFR=CA / PULL=CA / TAAT=CA / AYUR=CA / AUC=CA</td><td class="leftalignment">Alibaba Group Holding Ltd / Halo Collective Inc / Pfizer Inc / Kontrol Technologies Corp / Sonoro Gold Corp / Nexus Gold Corp / Fortune Minerals Ltd / Aurcana Silver Corp / Uex Corp / Sirios Resources Inc / Captiva Verde Wellness Corp / Kootenay Silver Inc / American Manganese Inc / THC Biomed Intl Ltd / GR Silver Mining Ltd / Colibri Resource Corp / Renforth Resources Inc / Pure Extracts Technologies Corp / TAAT Global Alternatives Inc / Ayurcann Holdings Corp / Goldplay Mining Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment">Consumer / Metals & Minerals / Technology</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Siddharth Rajeev</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Merck Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 20, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 30 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US0079731008 / US0116591092 / US0126531013 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US00287Y1091 / NL0010273215 / US8485771021 / US21240E1055 / US02376R1023 / DK0060534915 / CA0089118776 / KYG4740B1059 / CA53680Q2071 / SE0009414576 / US5904791358 / US53814L1089 / US5533681012 / US58406B1035 / US68622V1061</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Albemarle Corp / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Novo Nordisk A/S / Air Canada / Ichor Holdings Ltd / Lithium Americas Corp / Oncopeptides AB / Mesa Air Group Inc / Livent Corp / Mp Materials Corp / MedAvail Holdings Inc / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (30 Aug-): Focus on domestically produced COVID-19 vaccines and treatments</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4507.T / 6869.T / 4502.T / 4503.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Shionogi & Co Ltd / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">08/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（8月30日～）: COVID-19国産ワクチンや治療薬の動向に引き続き注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4543.T / 6869.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 4541.T / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Terumo Corp / Sysmex Corp / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">08/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 73</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Dropping Coverage, Final Thoughts</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 37148K100 / 02155H200 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 007002108 / M47364100 / 617760202 / N71542109 / 92790C104 / 76200L309 / G3855L106</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Generation Bio Co / Altimmune Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Viridian Therapeutics Inc / Rezolute Inc / GH Research PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">JMP Therapeutic Research / Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Business Services: McVeigh's Selected Services Recap in a Minute</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MAN.N / PFE.N / FDS.N / MCO.N / MSCI.N / PYCR.OQ / ALIT.N</td><td class="leftalignment">ManpowerGroup Inc / Pfizer Inc / Factset Research Systems Inc / Moody's Corp / MSCI Inc / Paycor HCM Inc / Alight Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Manufacturing / Services</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kevin D. McVeigh / Mr. Bryan M. Wynn / Corey Shubiak</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BDSI-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BDSI.O / JNJ / PFE / ENDP.O / MNOV.O / ACRX.O / TTNP.O</td><td class="leftalignment">BioDelivery Sciences International Inc / Johnson & Johnson / Pfizer Inc / Endo International PLC / MediciNova Inc / AcelRx Pharmaceuticals Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">After The Recent 4% Fall Will Pfizer Stock Rebound To Make Fresh Highs?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.17）：国内のワクチン接種完了率が4割を超える</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">08/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 17): Over 40% fully vaccinated in Japan</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Updated Post Recent News, Estimates Adjusted, Price Target Raised</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US / MDT=US / GILD=US / VRM=US / ESS=US / HEI=US / MAN=US / CPT=US / MAA=US / MGNI=US / PTON=US / LLNW=US / 45665G303 / NXRT=US / YEXT=US</td><td class="leftalignment">Pfizer Inc / Medtronic PLC / Gilead Sciences Inc / Vroom Inc / Essex Property Trust Inc / HEICO Corp / ManpowerGroup Inc / Camden Property Trust / Mid-America Apartment Communities Inc / Magnite Inc / Peloton Interactive Inc / Limelight Networks Inc / Infinity Pharmaceuticals Inc / NexPoint Residential Trust Inc / Yext Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Aug 13</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Despite mRNA vaccine approval timing uncertainty, Proxalutamide COVID data in 2H21 important to watch. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2196.HK / 600196.SS / PFE.N</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ATRS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ATRS.O / BDX / JNJ / LLY / PFE / WST / RVP / ANIP.O / TEVA.K</td><td class="leftalignment">Antares Pharma Inc / Becton Dickinson and Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / West Pharmaceutical Services Inc / Retractable Technologies Inc / ANI Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NYMX-US - Fundamental Analysis, for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NYMX.O / ABT / DGX / JNJ / LLY / PFE / SPHS.PK</td><td class="leftalignment">Nymox Pharmaceutical Corp / Abbott Laboratories / Quest Diagnostics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sophiris Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bahamas / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What Are The New Developments For Pfizer's Covid-19 Vaccine?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Craig Hallum</td><td class="leftalignment">TRIL: Pfizer To Acquire Trillium At Implied Equity Value Of $2.3B ($18.50/Share) In Cash. Lowering Rating To HOLD, Reducing Price Target To $18.50.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">TRIL=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Robin Garner</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">428567101 / 53220K504 / 89620X506 / 47215P106 / 09624H208</td><td class="leftalignment">Hibbett Inc / Ligand Pharmaceuticals Inc / Pfizer Inc / JD.Com Inc / Bluelinx Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Fawne Jiang / Long Lin / Mr. Robert M. Wasserman / Mr. Aydin Huseynov, MD / Mr. John Lawrence / Mr. Reuben Garner / Mr. Michael P. Ward, CFA</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">The Acquisition Will Likely Close; Lowering PT To $18.5</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Macrophage targeting heating up, in our view - M&A read-through from PFE/TRIL acquisition</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / 45665G303 / PFE=US / GILD=US / INFI.OQ</td><td class="leftalignment">Pfizer Inc / Infinity Pharmaceuticals Inc / Pfizer Inc / Gilead Sciences Inc / Infinity Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BHP.AX / RWEG.DE / PFE.N / LXSG.DE</td><td class="leftalignment">BHP Group Ltd / Rwe AG / Pfizer Inc / Lanxess AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Germany / United States</td><td class="leftalignment">Aerospace / Air Transportation / Banks / Biotechnology / Chemicals / Conglomerates / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Healthcare / Industrial Materials / Insurance / Machinery / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Real Estate / Shipping & Shipbuilding / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / FIXED INCOME/DEBT RESEARCH</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Frau. Jana Schuler / Frau Silke Stegemann / Herr Sven Kreitmair, CFA / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2973821 / 2216850 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2459020 / 2680905 / 2684703 / 2048804 / 2503529 / 7103065 / B125XQ6 / B0T7YX2 / 2949758 / B7577T2 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BYZR4X4 / BMYML02 / BKTNTR9 / BD72R64 / 021513106 / BN4NJG4 / BKPGJQ1 / BMVBZF5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / World Wrestling Entertainment Inc / Novartis AG / Portland General Electric Co / Live Nation Entertainment Inc / Nexstar Media Group Inc / Renewable Energy Group Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Axsome Therapeutics Inc / DraftKings Inc / ViacomCBS Inc / Liberty Media Corp / Alto Ingredients Inc / Freeline Therapeutics Holdings PLC / Squarespace Inc / Immuneering Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Wuxi Biologics: First look: 1H21 rev/NP up 127%/163% YoY, still surprised us despite previous profit alert. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2269.HK / PFE.N</td><td class="leftalignment">WuXi Biologics (Cayman) Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">08/24/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">CD47 Remains the Target of Choice on Merger Monday</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Fundamental Research Corp</td><td class="leftalignment">FDA’s Approval of Pfizer’s Vaccine to Lift Consumer Confidence</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Metals & Minerals / Retailing</td><td class="leftalignment">North America</td><td class="leftalignment">INDUSTRY OVERVIEW / OPERATING RESULTS / PRICE / RATINGS CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Siddharth Rajeev</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 13, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Trillium Acquisition Enhances PFE Oncology Pipeline with Anti-CD47 Biologics</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">Trillium Receives US$2.26B Buyout Bid, Shares Trade 190% Higher</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">TRIL.TO / PFE.N</td><td class="leftalignment">Pfizer Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / OVERVIEW / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CD47 still remains one of the hot targets in IO combos - reads to GILD and ALX from PFE deal</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / US3755581036 / LLY / PFE / ALXO</td><td class="leftalignment">Pfizer Inc / Gilead Sciences Inc / Eli Lilly and Co / Pfizer Inc / ALX Oncology Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Ms. Li W. Watsek / Ms. Emma K. Nealon, III / Emily Bodnar</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Acquisition of Trillium Therapeutics Expands PFE's First In Class, Best In Class Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pfizer Offers to Acquire Trillium For $18.50/Share</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CA89620X5064 / US7170811035</td><td class="leftalignment">Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Aug. 23, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Aug. 23, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Pfizer Agrees to Acquire Rest of Trillium; Downgrade to Neutral with $18.50 PT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Pfizer Inc (PFE) - Vaccine Success leading the growth</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 33, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Pfizer Inc / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="even"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ALXO: TRIL Acquisition Underscores Interest in CD47 Landscape; ALXO Remains Well-Positioned</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ALXO.OQ / PFE.N / GILD.OQ</td><td class="leftalignment">ALX Oncology Holdings Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">08/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Revisiting modelling assumptions and raising target price from DKK 470 to DKK 625</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">NOVOB.CO / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / BAYGN.DE</td><td class="leftalignment">Novo Nordisk A/S / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Ownership Timelines & Shareholder Analytics (August 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">08/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.3% Above Pre-Pandemic Base- Week 72</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q2 2021: Pfizer reports 14.1% sequential rise in Quarterly Net Profit; Institutional Ownership up 2%</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Suspending Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / AQST.O / OSMT.O / 269796108 / VTRS.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">08/20/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / ABUS / 29251M106 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 81750R102 / 45826J105 / 558868105 / 23306J101 / 12648L601 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 22978P106 / 37148K100 / 02155H200 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 04746L104 / 007002108 / M47364100 / 617760202 / N71542109 / 92790C104 / 76200L309 / G3855L106</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Arbutus Biopharma Corp / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Seres Therapeutics Inc / Intellia Therapeutics Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Cue Biopharma Inc / Generation Bio Co / Altimmune Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Athira Pharma Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Viridian Therapeutics Inc / Rezolute Inc / GH Research PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 13, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will The Gains Continue For Johnson & Johnson Stock After A 7% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reports 2Q, Pepaxto Outlook Uncertain, Full OCEAN Details At IMW In September</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">SE0009414576 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Oncopeptides AB / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Geoffrey Weiner, M.D., Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">INDs For TSC-100/101 On Track For 4Q21, Data Expected 2H22</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US89854M1018 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">TScan Therapeutics Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Vital Signs - Charts of the Day: CLF, CMC, NUE, RYI, AA, ACH, IR, RXN, XYL, AGFY, ABB, ETN, JCI, CSL, PNR, MXL, MPWR, SITM, SYNA, GRMN, MSI, TXT, ZBRA, FTNT, SD, AMR, ARCH, CEIX, BTU, METC, LTHM, SQM, EYPT, GSK, PFE, INVA, ALKS, DVAX, REGN, and PCVX.</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">PFE.N / AA.N / AGFY.OQ / ALKS.OQ / CEIX.N / CLF.N / DVAX.OQ / ETN.N / EYPT.OQ / GSK.L / LTHM.N / MXL.N / NUE.N / PCVX.OQ / REGN.OQ / RXN.N / RYI.N / SITM.OQ / SQMa.SN / SYNA.OQ / TXT.N / XYL.N / ZBRA.OQ / AMR.N / IR.N / ABB.NS / JCI.N / CMC.N / MPWR.OQ / SD.N / FTNT.OQ / MSI.N / ARCH.V</td><td class="leftalignment">Pfizer Inc / Alcoa Corp / Agrify Corp / Alkermes Plc / CONSOL Energy Inc / Cleveland-Cliffs Inc / Dynavax Technologies Corp / Eaton Corporation PLC / EyePoint Pharmaceuticals Inc / GlaxoSmithKline PLC / Livent Corp / Maxlinear Inc / Nucor Corp / Vaxcyte Inc / Regeneron Pharmaceuticals Inc / Zurn Water Solutions Corp / Ryerson Holding Corp / SiTime Corp / Sociedad Quimica y Minera de Chile SA / Synaptics Inc / Textron Inc / Xylem Inc / Zebra Technologies Corp / Alpha Metallurgical Resources Inc / Ingersoll Rand Inc / ABB India Ltd / Johnson Controls International PLC / Commercial Metals Co / Monolithic Power Systems Inc / SandRidge Energy Inc / Fortinet Inc / Motorola Solutions Inc / Arch Biopartners Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Chile / United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / QUANANTITATIVE/TECH RESEARCH / Equity</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer Inc. In Final Pharmaceutical Intermediates Market- Formatted File Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 16): Over half the population in Japan had at least one vaccination</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / NYT.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / New York Times Co / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">08/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.16）：国内人口のおよそ半数が1回目のワクチン接種完了</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / NYT.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / New York Times Co / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Pfizer - $51.83 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">As We Expected, Q2 Beats and Raises for Biopharma and Stocks Now Repricing</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110 / 92532F10 / 37555810 / 03116210 / 75886F10 / 00287Y10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / Vertex Pharmaceuticals Inc / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">08/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 7.7% Y/Y Including COVID-19 Vaccine Volume Benefit (+4.2% Without)</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Pipeline Advancements and Product Sales Exceeding Our Expectations, Raising PT to $61 from $53</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LGND-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LGND.O / BAX / BMY / JNJ / LLY / MRK / PFE / AMGN.O / GSK / SPPI.O</td><td class="leftalignment">Ligand Pharmaceuticals Inc / Baxter International Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Spectrum Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PBH-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PBH / ABT / CLX / CVS / JNJ / NVS / PFE / PG / RAD / GSK / TARO.K</td><td class="leftalignment">Prestige Consumer Healthcare Inc / Abbott Laboratories / Clorox Co / CVS Health Corp / Johnson & Johnson / Novartis AG / Pfizer Inc / Procter & Gamble Co / Rite Aid Corp / GlaxoSmithKline PLC / Taro Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HALO-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HALO.O / BAX / JNJ / LLY / PFE / MNKD.O / SNY.O</td><td class="leftalignment">Halozyme Therapeutics Inc / Baxter International Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / MannKind Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Newly listed Pantera Minerals soars 88% from its issue price</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.AX</td><td class="leftalignment">Pantera Minerals Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia</td><td class="leftalignment"></td><td class="leftalignment">Australasia</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2486813 / 2778844 / 2026242 / 2270726 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B17HG57 / B0T7YX2 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BYNZGK1 / BK1KWF7 / BMYML02 / BLGJ610 / BYXJQG9 / BKTNTR9 / BD72R64 / BP8GHT2 / BMHR7K6 / BNNTQY0 / BP0TJN7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / American Electric Power Company Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Cardiovascular Systems Inc / Live Nation Entertainment Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Block Inc / Grocery Outlet Holding Corp / DraftKings Inc / Warner Music Group Corp / Spire Inc / ViacomCBS Inc / Liberty Media Corp / Vascular Biogenics Ltd / Impel Neuropharma Inc / Oatly Group AB / Xponential Fitness Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TARO-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">TARO.K / JNJ / MRK / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Taro Pharmaceutical Industries Ltd / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Craig Hallum</td><td class="leftalignment">TRIL: TRIL Reported In-Line Q2; Delivers Solid Execution On Phase Ib/II Strategic Plan With Four Of Six Trial Initiations Planned For 2021.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">TRIL=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Robin Garner</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer climbs 8.4% from 1 week low</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">2Q21 Update – Enrolling Multiple Combination Studies Underway</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Aug 6, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">285512109 / 40049J206 / 749360400 / US50077B2079 / 89620X506 / 68247W109 / 16106R109 / 12482W101 / 14686910 / 451622203 / 51818V106 / 431636109</td><td class="leftalignment">Electronic Arts Inc / Grupo Televisa SAB / R C M Technologies Inc / Kratos Defense and Security Solutions Inc / Pfizer Inc / One Stop Systems Inc / Charlotte's Web Holdings Inc / cbdMD Inc / Carvana Co / Ideal Power Inc / Latch Inc / Hillman Solutions Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Mexico / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">David Williams / Mr. Michael P. Ward, CFA / Mike Hickey / Mr. Matthew Harrigan / Mr. Josh W. Sullivan / Mr. Reuben Garner / Mr. Mark W. Schappel / Mr. Aydin Huseynov, MD / Mr. Bill Sutherland / Benchmark Research</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">2Q21: A Couple Aggressively Pursued Targets Would Make It</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE=US / HD=US / AMZN=US / BLD=US / CMA=US / BR=US / LOW=US / PB=US / VRM=US / EWBC=US / TRMK=US / BRO=US / UMPQ=US / EXPE=US / TTWO=US / LEG=US / ATVI=US / W=US / FLO=US / WTFC=US / CSTR=US / COLL=US / AJG=US / IBP=US / MAS=US / MHK=US / PACW=US / PCTY=US / SNAP=US / TRIP=US / WAL=US / WIX=US / HTH=US / PSA=US / SPG=US / BXS=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / EPR=US / FB=US / FBK=US / MTCH=US / ASB=US / SSB=US / SRC=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / INST=US / PNFP=US / SBCF=US / BDSI=US / PTON=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / APP=US / EXR=US / BECN=US / RNST=US / BLDR=US / SCPL=US / KBR=US / CCOI=US / PGTI=US / OC=US / CADE=US / PRPL=US / KTOS=US / EPRT=US / TREX=US / CUBE=US / FBHS=US / ANGI=US / ZNGA=US / EA=US / IBTX=US / FATE=US / GOOGL=US / 00770K202 / BABA=US / OSH=US / CMPR=US / GDDY=US / LOB=US / ACBI=US / WLTW=US / 82982L103 / CVNA=US / SBOW=US / CARG=US / MBIN=US / SFIX=US / HWC=US / OZK=US / FTDR=US / AMTB=US / LYFT=US / UBER=US / AHCO=US / REYN=US / AZEK=US / AIRC=US / RBLX=US / AVAH=US / VMEO=US / MNTV=US / 100017125 / PYCR=US</td><td class="leftalignment">Pfizer Inc / Home Depot Inc / Amazon.com Inc / TopBuild Corp / Comerica Inc / Broadridge Financial Solutions Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Brown & Brown Inc / Umpqua Holdings Corp / Expedia Group Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Wayfair Inc / Flowers Foods Inc / Wintrust Financial Corp / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / Arthur J Gallagher & Co / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Paylocity Holding Corp / Snap Inc / Tripadvisor Inc / Western Alliance Bancorp / Wix.Com Ltd / Hilltop Holdings Inc / Public Storage / Simon Property Group Inc / Cadence Bank / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / EPR Properties / Meta Platforms Inc / FB Financial Corp / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit Realty Capital Inc / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Instructure Holdings Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / Peloton Interactive Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Applovin Corp / Extra Space Storage Inc / Beacon Roofing Supply Inc / Renasant Corp / Builders FirstSource Inc / Sciplay Corp / KBR Inc / Cogent Communications Holdings Inc / PGT Innovations Inc / Owens Corning / Cadence Bank / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Essential Properties Realty Trust Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Angi Inc / Zynga Inc / Electronic Arts Inc / Independent Bank Group Inc / Fate Therapeutics Inc / Alphabet Inc / Aemetis Inc / Alibaba Group Holding Ltd / Oak Street Health Inc / Cimpress PLC / GoDaddy Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Carvana Co / SilverBow Resources Inc / CarGurus Inc / Merchants Bancorp / Stitch Fix Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Adapthealth Corp / Reynolds Consumer Products Inc / Azek Company Inc / Apartment Income REIT Corp / Roblox Corp / Aveanna Healthcare Holdings Inc / Vimeo Inc / Momentive Global Inc / SVB Financial Group / Paycor HCM Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Steady Pipeline Progress; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 32, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / MRNA.OQ / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Moderna Inc / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Lebrikizumab P3 studies positive at week 16 in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / SASY.PA / REGN.OQ / ALM.MC / ABBV.N</td><td class="leftalignment">Pfizer Inc / Sanofi SA / Regeneron Pharmaceuticals Inc / Almirall SA / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Spain / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: South Korea - Celltrion Healthcare Co Ltd: 2Q21 review: Profitability hit despite ongoing US biosimilar share gains; all about Regkirona sales in 2H21. Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">091990.KQ / LLY.N / PFE.N / ROG.S / GSK.L / REGN.OQ / 068270.KS</td><td class="leftalignment">Celltrion Healthcare Co Ltd / Eli Lilly and Co / Pfizer Inc / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Celltrion Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">08/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 71</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">45337C10 / 03116210 / 09058V10 / 00422510 / 40637H10 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 29664W105 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 37148K100 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 517125100 / 877619106 / 07160F107 / 007002108 / M47364100 / 617760202 / N71542109 / 45168K405 / 206022105 / 92790C104 / 76200L309</td><td class="leftalignment">Incyte Corp / Amgen Inc / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Generation Bio Co / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Baudax Bio Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Viridian Therapeutics Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Incremental Q2 Update, Broad Clinical Development Plan Remains On Track</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CA89620X5064 / US45253H1014 / US4277461020</td><td class="leftalignment">Pfizer Inc / ImmunoGen Inc / Heron Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reports 2Q, SPLASH On Track, PNT2003 Data Expected 1H22, Cash Into 2024</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US7305411099 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">POINT Biopharma Global Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Geoffrey Weiner, M.D., Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Booster shots added to EUA; mgmt color on margins</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending August 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 13 2021</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US0116591092 / US0231351067 / US1264081035 / US22284P1057 / US2546871060 / US3021301094 / US31428X1063 / US4433201062 / US4456581077 / US45253H1014 / US45337C1027 / US5150981018 / US5719032022 / US64125C1099 / US6558441084 / US6795801009 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9113121068 / US92532F1003 / US9507551086 / CA1363751027 / CA13645T1003 / US4771431016 / US4198791018 / US21036P1084 / US0491642056 / US2090341072 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / NL0000687663 / US01748X1028 / US2473617023 / US7181721090 / US00922R1059 / US9100471096 / JE00B783TY65 / US03027X1000 / US30303M1027 / US9837931008 / US00912X3026 / US23283R1005 / US41068X1000 / US00847X1046 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US09062W2044 / US70432V1026 / US03937C1053 / KYG8807B1068 / LU0974299876 / CA0089118776 / CA89620X5064 / US22822V1017 / US29444U7000 / US83417M1045 / US09627Y1091 / US02079K1079 / US87164F1057 / CA87241L1094 / US91325V1089 / US23753F1075 / US23355L1061 / US80689H1023 / US4990491049 / US87105L1044 / US74766Q1013 / US6085501095 / US05351X1019 / US09857L1089 / US4380831077 / US15677J1088 / US49372L1008 / US68373M1071 / US5904791358 / CA39342L1085 / US90353T1007 / US85205L1070 / US30068X1037 / US09203E1055 / US92537N1081 / CA1973091079 / US7602731025 / US00973J1016 / US57667L1070 / US65487U1088 / US75943R1023 / US03044L1052 / US07373B1098 / US38246G1085 / US69353Y1038 / US50107A1043 / US0090661010 / US21077C1071 / US5502411037 / US03476J1079 / US67080N1019 / US15961R1059 / LU2314763264 / US45783C1018 / US28489L1044 / US28623U1016 / US38870X1046 / US69120X1072 / US89854M1018</td><td class="leftalignment">Alaska Air Group Inc / Amazon.com Inc / CSX Corp / Covenant Logistics Group Inc / Walt Disney Co / Expeditors International of Washington Inc / FedEx Corp / Hub Group Inc / J B Hunt Transport Services Inc / ImmunoGen Inc / Incyte Corp / Landstar System Inc / Marriott International Inc / Neurocrine Biosciences Inc / Norfolk Southern Corp / Old Dominion Freight Line Inc / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / United Parcel Service Inc / Vertex Pharmaceuticals Inc / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Constellation Brands Inc / Atlas Air Worldwide Holdings Inc / Consolidated Communications Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Philip Morris International Inc / Air Transport Services Group Inc / United Airlines Holdings Inc / Aptiv PLC / American Tower Corp / Meta Platforms Inc / XPO Logistics Inc / Air Lease Corp / CyrusOne Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Agios Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / BioLife Solutions Inc / Paycom Software Inc / ArcBest Corp / Theravance Biopharma Inc / Globant SA / Air Canada / Pfizer Inc / Crown Castle International Corp / Equinix Inc / Solaredge Technologies Inc / Blueprint Medicines Corp / Alphabet Inc / Syndax Pharmaceuticals Inc / TFI International Inc / Uniti Group Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Switch Inc / Quanterix Corp / Molecular Templates Inc / Avaya Holdings Corp / Booking Holdings Inc / Homology Medicines Inc / Ceridian HCM Holding Inc / Kezar Life Sciences Inc / Opera Ltd / Mesa Air Group Inc / Green Thumb Industries Inc / Uber Technologies Inc / SpringWorks Therapeutics Inc / Exagen Inc / Black Diamond Therapeutics Inc / Vertiv Holdings Co / Columbia Care Inc / Repare Therapeutics Inc / Akouos Inc / Match Group Inc / Nkarta Inc / Relay Therapeutics Inc / American Well Corp / Beam Global / Goodrx Holdings Inc / PMV Pharmaceuticals Inc / Kronos Bio Inc / Airbnb Inc / ContextLogic Inc / Lumen Technologies Inc / Angion Biomedica Corp / Nuvation Bio Inc / ChargePoint Holdings Inc / Arrival SA / Instil Bio Inc / Electric Last Mile Solutions Inc / Elevation Oncology Inc / Graphite Bio Inc / Owlet Inc / TScan Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">08/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2126335 / 2293819 / 2486813 / 2026242 / 2270726 / 2670519 / 2328915 / 2630513 / 2684703 / 2707677 / 2829601 / 2503529 / B125XQ6 / B0T7YX2 / B3D7K31 / 2982924 / B7TL820 / B4MG4Z6 / BFLR866 / BFZCHN7 / B95WG16 / BYVY8G0 / B0SDJB4 / BMQ5T49 / BFZ1K46 / BMYML02 / BKTNTR9 / BFWK4R7 / BHZSB82 / BDH65C8 / BDZ30Q0 / BYP71H7 / BN2R582 / BG0Q4Y1 / BMC5RV6 / BGT0PL8 / BD72R64 / BMDJ397 / BMC8SQ7 / BNTB3N8 / BN2RM92 / BN2S6Y8 / BLF0CW7 / BNKGXX2 / BP7KZP7 / BMW5084 / BNLYJ60</td><td class="leftalignment">Visa Inc / Bristol-Myers Squibb Co / eBay Inc / Kellogg Co / American Electric Power Company Inc / Walt Disney Co / Exelon Corp / Nextera Energy Inc / New Jersey Resources Corp / Pfizer Inc / Public Service Enterprise Group Inc / Southern Co / World Wrestling Entertainment Inc / Portland General Electric Co / Live Nation Entertainment Inc / Discovery Inc / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / AMC Networks Inc / Twitter Inc / Wix.Com Ltd / Zoetis Inc / Alphabet Inc / Zealand Pharma A/S / Zentalis Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / ViacomCBS Inc / PagSeguro Digital Ltd / Covetrus Inc / PetIQ Inc / Arvinas Inc / National Vision Holdings Inc / Relay Therapeutics Inc / Exicure Inc / Adicet Bio Inc / DiaMedica Therapeutics Inc / Liberty Media Corp / Bolt Biotherapeutics Inc / BTRS Holdings Inc / Vizio Holding Corp / Rain Therapeutics Inc / Talaris Therapeutics Inc / Repare Therapeutics Inc / Verve Therapeutics Inc / Monte Rosa Therapeutics Inc / PMV Pharmaceuticals Inc / Imago BioSciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Denmark / Israel / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EBS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / MRK / PFE / GSK / XOMA.O / SIGA.O / CLDX.O / CMRX.O / SNGX.O / TEVA.K</td><td class="leftalignment">Emergent BioSolutions Inc / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / XOMA Corp / SIGA Technologies Inc / Celldex Therapeutics Inc / Chimerix Inc / Soligenix Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">IK-930 And IK-175 Preclinical Data Coming In 2021, IK-412 IND Delayed</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US45175G1085 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Ikena Oncology Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - 2Q21 Recap; Pipeline On Track With Continued Execution on Clinical Trial Initiations</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMQ5T49 / 0925288 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">08/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2023607 / 2486813 / 2778844 / 2190750 / 2270726 / 2328915 / 2100920 / 2415204 / 2689560 / 2684703 / 2829601 / 2931034 / 2503529 / 4595739 / B1F76F9 / B0T7YX2 / B3D7K31 / B4MG4Z6 / B3NXMJ9 / BFZCHN7 / BYVY8G0 / BYVFC94 / BYW36M8 / BQT3XY6 / BMYML02 / BLGJ610 / BJJMGL2 / BKTNTR9 / BYY88Y7 / BL71K91 / BRJ3GY4 / BLBLMD5 / BD72R64 / BMC8SQ7 / BMZ9Z11 / BMFPJK6 / BD5GSZ4 / BMBP1Q0</td><td class="leftalignment">AstraZeneca PLC / Amgen Inc / Kellogg Co / Merck & Co Inc / Chesapeake Utilities Corp / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / PG&E Corp / Pfizer Inc / Southern Co / Vertex Pharmaceuticals Inc / World Wrestling Entertainment Inc / Genmab A/S / Western Union Co / Live Nation Entertainment Inc / Discovery Inc / AMC Networks Inc / Wendys Co / Wix.Com Ltd / Alphabet Inc / US Foods Holding Corp / PayPal Holdings Inc / Cyberark Software Ltd / DraftKings Inc / Warner Music Group Corp / Fox Corp / ViacomCBS Inc / Alphabet Inc / Revolution Medicines Inc / Xenon Pharmaceuticals Inc / Array Technologies Inc / Liberty Media Corp / BTRS Holdings Inc / Prometheus Biosciences Inc / ACV Auctions Inc / Infrastructure and Energy Alternatives Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Aug 11 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0231351067 / US1101221083 / US1266501006 / US5719032022 / US7170811035 / US8552441094 / US8968181011 / US9021041085 / US9282981086 / US21036P1084 / US8936411003 / US7181721090 / US4485791028 / US30212P3038 / US8969452015 / US00287Y1091 / US85916J4094 / US87918A1051 / US00938A1043 / US89686D1054 / US43300A2033 / US83304A1060 / US02083G1004 / VGG273581030 / US09857L1089 / US80706P1030 / US03836N1037 / US05455M1009 / CA39342L1085 / US90353T1007 / US39874R1014 / US89677Q1076 / ACRGau.CD / US85209E1091 / US3441741077 / US68062P1066 / US0090661010 / US73739W1045 / US82489W1071 / US23954D1090 / US47103J1051 / US00109K1051</td><td class="leftalignment">Amazon.com Inc / Bristol-Myers Squibb Co / CVS Health Corp / Marriott International Inc / Pfizer Inc / Starbucks Corp / Triumph Group Inc / II-VI Inc / Vishay Intertechnology Inc / Constellation Brands Inc / TransDigm Group Inc / Philip Morris International Inc / Hyatt Hotels Corp / Expedia Group Inc / Tripadvisor Inc / Abbvie Inc / Stereotaxis Inc / Teladoc Health Inc / Airgain Inc / Trivago NV / Hilton Worldwide Holdings Inc / Snap Inc / Alpine Immune Sciences Inc / Despegar.com Corp / Booking Holdings Inc / Scholar Rock Holding Corp / Aptinyx Inc / AVROBIO Inc / Green Thumb Industries Inc / Uber Technologies Inc / Grocery Outlet Holding Corp / Trip.com Group Ltd / Acreage Holdings Inc / Spruce Biosciences Inc / Foghorn Therapeutics Inc. / Olema Pharmaceuticals Inc / Airbnb Inc / Poshmark Inc / Shoals Technologies Group Inc / Day One Biopharmaceuticals Inc / Janux Therapeutics Inc / AFC Gamma Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Israel / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Highlights From Virtual Company Visits - Day 1</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US1101221083 / US7170811035 / US00287Y1091</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Chris LoBianco</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2868165 / 2000019 / 2486813 / 2778844 / 2732635 / 2113393 / 2270726 / 2328915 / 2515030 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 2829601 / 2503529 / B0T7YX2 / B7TL820 / B7VD3F2 / BFLR866 / BFZCHN7 / BYVY8G0 / BYZLV46 / BF4VBS8 / BK0VHF6 / BJLKVS6 / BKDS4H5 / BL2HYY7 / BKVDFF7 / BMYML02 / BZ1LFG7 / BYNQ369 / BK71LV3 / BD72R64 / BFY7DC4 / BMDJ085 / BNTB3N8 / BN2RM92 / BMGGJK8 / BKPGJQ1 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Sysco Corp / Amazon.com Inc / Kellogg Co / Merck & Co Inc / AutoNation Inc / Boston Beer Company Inc / Walt Disney Co / Nextera Energy Inc / Lithia Motors Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Southern Co / World Wrestling Entertainment Inc / Live Nation Entertainment Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Wix.Com Ltd / Alphabet Inc / InflaRx NV / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Phathom Pharmaceuticals Inc / Bill.com Holdings Inc / Casper Sleep Inc / Oric Pharmaceuticals Inc / DraftKings Inc / Roku Inc / Albertsons Companies Inc / Relmada Therapeutics Inc / Liberty Media Corp / Altimmune Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Rain Therapeutics Inc / Valneva SE / Squarespace Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">France / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: Q2 Earnings Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RXDX.OQ / PFE.N</td><td class="leftalignment">Prometheus Biosciences Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for TRIL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">TRIL.OQ</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NBIX-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NBIX.O / LLY / PFE / PTN / RGEN.O / RPRX.O / ATHX.O / ANIP.O / ABBV.K / CASI.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Eli Lilly and Co / Pfizer Inc / Palatin Technologies Inc / Repligen Corp / Royalty Pharma PLC / Athersys Inc / ANI Pharmaceuticals Inc / Abbvie Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/11/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Mgmt Discussion Post-Earnings Highlights Near-Term Clinical Data Updates & Pipeline Milestones Through Rest of 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703 / BLF0CW7</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc / Repare Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / DIS=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / ENR=US / MGY=US / SWN=US / SCOR=US / MUR=US / SPOT=US / MRO=US / LEG=US / VMC=US / EQR=US / MLM=US / DISH=US / SWIM=US / CBRL=US / ELY=US / CNX=US / DRI=US / EQT=US / GFF=US / GPOR=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / SGMS=US / BKNG=US / DCP=US / NHI=US / PRA=US / NLS=US / COP=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / APEI=US / NOG=US / JACK=US / TREX=US / AR=US / OAS=US / BLND=US / APTS=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / MODN=US / NDLS=US / HTRG=US / VNOM=US / 70806A106 / LOCO=US / OSH=US / SHAK=US / GSBD=US / WING=US / CABO=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / CDEV=US / PVAC=US / ANAB=US / JELD=US / SBOW=US / SAIL=US / RTLR=US / FERG=US / RPAY=US / PNTG=US / OVV=US / DKNG=US / AZEK=US / PAYA=US / AZYO=US / BALY=US / VTRS=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Walt Disney Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Energizer Holdings Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Spotify Technology SA / Marathon Oil Corp / Leggett & Platt Inc / Vulcan Materials Co / Equity Residential / Martin Marietta Materials Inc / DISH Network Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Gulfport Energy Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Scientific Games Corp / Booking Holdings Inc / DCP Midstream LP / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Conocophillips / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / American Public Education Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / Blend Labs Inc / Preferred Apartment Communities Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Model N Inc / Noodles & Co / Heritage Insurance Holdings Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Oak Street Health Inc / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Cable One Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / Centennial Resource Development Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / SilverBow Resources Inc / SailPoint Technologies Holdings Inc / Rattler Midstream LP / Ferguson PLC / Repay Holdings Corp / Pennant Group Inc / Ovintiv Inc / DraftKings Inc / Azek Company Inc / Paya Holdings Inc / Aziyo Biologics Inc / Bally's Corp / Viatris Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2486813 / 2778844 / 2973821 / 2050832 / 2280220 / 2542049 / 2829515 / 2670519 / 2328915 / 2689560 / 2684703 / 2829601 / 2503529 / 7103065 / B0T7YX2 / B570P91 / BBFL7S1 / B7VD3F2 / B8L2798 / BFDV8K0 / BBPK0J0 / BQPVQZ6 / BYVY8G0 / BYW36M8 / BYQHP96 / BF5L3T2 / BYNZGK1 / BD9GVY0 / BKS3SM8 / BYZR4X4 / BYQNYR5 / BMYML02 / BLGJ610 / BYXJQG9 / BJXBP30 / BZ1LFG7 / BKC9SX3 / BD6JX35 / BDVLM39 / BZ0P3Z5 / BYSFJV8 / BYTJZL1 / BWY4XV3 / BDD1B07 / BDRW1L7 / BF3N4P3 / BJRFSB7 / BD72R64 / BLR6S36 / BNTB3N8 / BMV31Q4 / BKPGJQ1 / BFYVZ75 / BNLYJ60 / BNLYBF3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / Ameren Corp / DTE Energy Co / Dominion Energy Inc / Edison International / Exelon Corp / Nextera Energy Inc / PG&E Corp / Pfizer Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Live Nation Entertainment Inc / Lear Corp / bluebird bio Inc / Duke Energy Corp / Hemisphere Media Group Inc / MacroGenics Inc / Mirati Therapeutics Inc / Horizon Therapeutics PLC / Alphabet Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Elanco Animal Health Inc / Block Inc / Zai Lab Ltd / IGM Biosciences Inc / Axsome Therapeutics Inc / Senseonics Holdings Inc / DraftKings Inc / Warner Music Group Corp / Spire Inc / Turning Point Therapeutics Inc / Roku Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / argenx SE / Tegna Inc / Planet Fitness Inc / Zogenix Inc / Adaptimmune Therapeutics PLC / Rubius Therapeutics Inc / AnaptysBio Inc / Arena Pharmaceuticals Inc / Immunovant Inc / Liberty Media Corp / Longboard Pharmaceuticals Inc / Vizio Holding Corp / Audacy Inc / Squarespace Inc / Seelos Therapeutics Inc / Imago BioSciences Inc / Erasca Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ERAS (BUY) - ERASe CAncer with a Deep RAS/MAPK-Focused Pipeline - Initiating Coverage with a BUY Rating and $25 PT</td><td class="leftalignment">English</td><td class="rightalignment">95</td><td class="leftalignment">BNLYBF3 / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / 2713317 / BBFL7S1 / BBPK0J0 / BD9GVY0 / BDHF4K6 / BZ1LFB2 / BZ8FPH3 / BWY52P3 / BL71K91 / BDZ30Q0 / BN2R582 / BMPRZV5 / BMDJ397 / BN2RM92 / BP7KZP7</td><td class="leftalignment">Erasca Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / ACADIA Pharmaceuticals Inc / bluebird bio Inc / Mirati Therapeutics Inc / Zai Lab Ltd / CRISPR Therapeutics AG / Deciphera Pharmaceuticals Inc / Editas Medicine Inc / Blueprint Medicines Corp / Revolution Medicines Inc / Arvinas Inc / Relay Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRVI: 2Q Beat & Raise; CleanCap Continues to Exceed Expectations; Increasing Conviction on '22 Prospects; Raising TP</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRVI.OQ / PFE.N / SASY.PA / NOVN.S / GSK.L</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Pfizer Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Katie A. Tryhane</td></tr>
<tr class="even"><td class="leftalignment">08/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharma Food for Thought : US healthcare in FY22 Budget Resolution bill & latest touted FDA Commissioner candidate tough views on pricing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / UCB.BR / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 Miss And FY21 Guidance Lowered But Zynrelef Launch Seems To Be On Track</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US4277461020 / US45253H1014 / CA89620X5064</td><td class="leftalignment">Heron Therapeutics Inc / ImmunoGen Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregory D. Fraser / Ms. Robyn S. Karnauskas / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Minimal Q2 Update, Initial STRO-002 Dose Expansion Data in 2H21</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US8693671021 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Sutro Biopharma Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Groundhog earnings</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">FR0000121485 / FR0000121014 / GB0009895292 / GB0002374006 / FR0000052292 / DE0006231004 / US7170811035 / US8740391003 / NL0000009165 / DE000BASF111 / BE0974293251</td><td class="leftalignment">Kering SA / LVMH Moet Hennessy Louis Vuitton SE / AstraZeneca PLC / Diageo PLC / Hermes International SCA / Infineon Technologies AG / Pfizer Inc / Taiwan Semiconductor Manufacturing Co Ltd / Heineken NV / BASF SE / Anheuser Busch Inbev SA</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Germany / France / United Kingdom / Netherlands / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cem Keltek</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Erholung setzt sich fort</td><td class="leftalignment">German</td><td class="rightalignment">8</td><td class="leftalignment">FR0000121485 / FR0000121014 / GB0009895292 / GB0002374006 / FR0000052292 / DE0006231004 / US7170811035 / US8740391003 / NL0000009165 / DE000BASF111 / BE0974293251</td><td class="leftalignment">Kering SA / LVMH Moet Hennessy Louis Vuitton SE / AstraZeneca PLC / Diageo PLC / Hermes International SCA / Infineon Technologies AG / Pfizer Inc / Taiwan Semiconductor Manufacturing Co Ltd / Heineken NV / BASF SE / Anheuser Busch Inbev SA</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Germany / France / United Kingdom / Netherlands / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cem Keltek</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FISV=US / PFE=US / ICLR=US / MDT=US / AMZN=US / T=US / EBAY=US / RUN=US / APA=US / PLUG=US / CRM=US / VRM=US / EXPE=US / TNL=US / MDRX=US / MGM=US / W=US / DV=US / AMED=US / AMN=US / PATH=US / ATRO=US / ENV=US / CENT=US / CERN=US / CRL=US / COLL=US / DVA=US / EPC=US / EXAS=US / GPOR=US / MEDP=US / SGMO=US / SMG=US / SNAP=US / TRGP=US / TRIP=US / WIX=US / POST=US / GPN=US / CCRN=US / BKNG=US / AVTR=US / PRI=US / FB=US / MTCH=US / NTRA=US / VICI=US / MGP=US / MGPI=US / BDSI=US / MD=US / MNST=US / PTON=US / NOMD=US / APP=US / BECN=US / AWH / FRPT=US / THS=US / BLDR=US / CHNG=US / FIS=US / CENTA=US / LUMN=US / NXGN=US / ATSG=US / NEO=US / 45665G303 / HGV=US / ESTE=US / VAC=US / ANGI=US / TILE=US / NCLH=US / VEEV=US / VCYT=US / GOOGL=US / QTWO=US / FIVN=US / 00770K202 / HQY=US / BABA=US / CMPR=US / GDDY=US / EVH=US / TDOC=US / WVE=US / EDIT=US / TRHC=US / LGF.B=US / CVNA=US / IOVA=US / RDFN=US / PETQ=US / IQV=US / SFIX=US / SYNH=US / EQH=US / FTDR=US / EB=US / ARVN=US / LYFT=US / UBER=US / NXTC=US / PSNL=US / RPAY=US / HCAT=US / BRBR=US / REYN=US / SPCE=US / DKNG=US / PAYA=US / DHT.UN=CA / VMEO=US / MNTV=US / CNVY</td><td class="leftalignment">Fiserv Inc / Pfizer Inc / ICON PLC / Medtronic PLC / Amazon.com Inc / AT&T Inc / eBay Inc / Sunrun Inc / APA Corp (US) / Plug Power Inc / Salesforce.Com Inc / Vroom Inc / Expedia Group Inc / Travel + Leisure Co / Allscripts Healthcare Solutions Inc / MGM Resorts International / Wayfair Inc / DoubleVerify Holdings Inc / Amedisys Inc / AMN Healthcare Services Inc / UiPath Inc / Astronics Corp / Envestnet Inc / Central Garden & Pet Co / Cerner Corp / Charles River Laboratories International Inc / Collegium Pharmaceutical Inc / DaVita Inc / Edgewell Personal Care Co / Exact Sciences Corp / Gulfport Energy Corp / Medpace Holdings Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Snap Inc / Targa Resources Corp / Tripadvisor Inc / Wix.Com Ltd / Post Holdings Inc / Global Payments Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Avantor Inc / Primerica Inc / Meta Platforms Inc / Match Group Inc / Natera Inc / VICI Properties Inc / MGM Growth Properties LLC / MGP Ingredients Inc / BioDelivery Sciences International Inc / MEDNAX Inc / Monster Beverage Corp / Peloton Interactive Inc / Nomad Foods Ltd / Applovin Corp / Beacon Roofing Supply Inc / Aspira Women's Health Inc / Freshpet Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Change Healthcare Inc / Fidelity National Information Services Inc / Central Garden & Pet Co / Lumen Technologies Inc / NextGen Healthcare Inc / Air Transport Services Group Inc / Neogenomics Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / Veeva Systems Inc / Veracyte Inc / Alphabet Inc / Q2 Holdings Inc / Five9 Inc / Aemetis Inc / Healthequity Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / Evolent Health Inc / Teladoc Health Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Tabula Rasa HealthCare Inc / Lions Gate Entertainment Corp / Carvana Co / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / IQVIA Holdings Inc / Stitch Fix Inc / Syneos Health Inc / Equitable Holdings Inc / Frontdoor Inc / Eventbrite Inc / Arvinas Inc / Lyft Inc / Uber Technologies Inc / NextCure Inc / Personalis Inc / Repay Holdings Corp / Health Catalyst Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / DraftKings Inc / Paya Holdings Inc / Dri Healthcare Trust / Vimeo Inc / Momentive Global Inc / Convey Health Solutions Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Ireland / Israel / Singapore / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 2516152 / 2496113 / 2486813 / 2640147 / 2973821 / 2050832 / 2113393 / 2216850 / 2270726 / 2542049 / 2328915 / 2342034 / 2100920 / 2369174 / 2471950 / 2630513 / 2657802 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2503529 / B121557 / 2212922 / 2769796 / 2857817 / B0T7YX2 / B570P91 / 2598246 / 2982924 / B4MG4Z6 / B7VD3F2 / B83YYY6 / BBGVT40 / B7577T2 / BCGCR79 / BTN1Y11 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BD8DJ71 / BP7RS48 / BWFKZT2 / BMYML02 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BG31GH0 / BKTNTR9 / BJVR9Y9 / BFWK4R7 / BD6D4Y5 / BMH0MR7 / BMDCDP2 / BMPRZV5 / BD72R64 / BNGJQZ8 / BMHR7K6 / BKPGJQ1 / BMBP1Q0 / BL53KF5</td><td class="leftalignment">Sanofi SA / Eli Lilly and Co / Kohls Corp / Kellogg Co / Nike Inc / Alliant Energy Corp / Ameren Corp / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Gilead Sciences Inc / Incyte Corp / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Mastercard Inc / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / Lear Corp / Neogenomics Inc / Spectrum Pharmaceuticals Inc / AMC Networks Inc / Duke Energy Corp / ICAD Inc / News Corp / Renewable Energy Group Inc / Sprouts Farmers Market Inc / Medtronic PLC / PayPal Holdings Inc / Shopify Inc / Block Inc / Snap Inc / Intersect Ent Inc / Cellectis SA / DraftKings Inc / Evergy Inc / Spire Inc / Vistra Corp / Y-mAbs Therapeutics Inc / ViacomCBS Inc / iHeartMedia Inc / PagSeguro Digital Ltd / Altair Engineering Inc / Zendesk Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / Liberty Media Corp / Porch Group Inc / Impel Neuropharma Inc / Squarespace Inc / Flywire Corp / F45 Training Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 30</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">08/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 70</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RDY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RDY / NVS / PFE / GSK / CPLFY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Dr Reddy's Laboratories Ltd / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Cipla Ltd / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / India / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INCY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">INCY.O / LLY / NVS / PFE / AMGN.O / CTIC.O / LGND.O / GERN.O / AVEO.O / ARDX.O</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / CTI Biopharma Corp / Ligand Pharmaceuticals Inc / Geron Corp / Aveo Pharmaceuticals Inc / Ardelyx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DLR-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE / EQIX.O / FB.O</td><td class="leftalignment">Pfizer Inc / Equinix Inc / Meta Platforms Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">GILD.O / BIOb / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / ABT / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended August 02,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ARVN Is Just Getting Started. High Conviction Buy</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ARVN=US / PFE=US</td><td class="leftalignment">Arvinas Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 29664W105 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 37148K100 / 02155H200 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 07160F107 / 007002108 / M47364100 / 617760202 / N71542109 / 206022105 / 92790C104 / 76200L309</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Generation Bio Co / Altimmune Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Baudax Bio Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / Viridian Therapeutics Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reports 2Q, UpRi Trials On Track, Lung And Ovarian Data In 4Q21</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US59045L1061 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Mersana Therapeutics Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Geoffrey Weiner, M.D., Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">DNB / PFE=US / T=US / TXN=US / RUN=US / CMA=US / GILD=US / EOG=US / PLUG=US / WLL=US / PB=US / DIOD=US / MUR=US / EWBC=US / TRMK=US / UMPQ=US / MRO=US / EXPE=US / VMC=US / PENN=US / BKI=US / CI=US / W=US / WTFC=US / ARCC=US / AMED=US / AMN=US / SWIM=US / ARW=US / AVT=US / KIDS=US / CHH=US / CSTR=US / COLL=US / CSGP=US / DRH=US / EXEL=US / IBP=US / MAIN=US / MCHP=US / NTST=US / ORCC=US / PACW=US / PCTY=US / REGN=US / ROLL=US / STOR=US / TRGP=US / TRIP=US / WAL=US / GOLF=US / FOUR=US / HTH=US / BXS=US / NET=US / FNF=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / ADC=US / BOKF=US / BDN=US / FB=US / FBK=US / MKL=US / ASB=US / SSB=US / SRC=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / REG=US / APPN=US / AUTL=US / UCBI=US / DIN=US / MGNI=US / PNFP=US / ATRS=US / SBCF=US / PRAA=US / MNST=US / BCO=US / JRVR=US / NOMD=US / TCBI=US / FNB=US / CRD.B=US / FHN=US / AINV=US / RNST=US / DENN=US / LHCG=US / THS=US / BLDR=US / AAWW=US / CMG=US / FIS=US / CCOI=US / CADE=US / PNNT=US / SEAS=US / NOG=US / ATSG=US / IAC=US / EPRT=US / AGS=US / RCUS=US / RLJ=US / ANGI=US / ZNGA=US / PDCE=US / HCI=US / IBTX=US / FOXF=US / FEYE=US / CNCE=US / QTWO=US / TSLX=US / 70806A106 / LOCO=US / SHAK=US / ON=US / GSBD=US / LOB=US / ZG=US / ACBI=US / SQ=US / NTLA=US / VVV=US / CDEV=US / IRTC=US / PK=US / CVNA=US / VRNA=US / RDFN=US / SWCH=US / MBIN=US / FNKO=US / COLD=US / LAZY=US / HWC=US / OZK=US / FOCS=US / EB=US / AXNX=US / FSK=US / AMTB=US / TCRR=US / LSPD=US / PLMR=US / DDOG=US / AHCO=US / BIGC=US / 96758W101 / VMEO=US / MNTV=US / DBRG=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Pfizer Inc / AT&T Inc / Texas Instruments Inc / Sunrun Inc / Comerica Inc / Gilead Sciences Inc / EOG Resources Inc / Plug Power Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Diodes Inc / Murphy Oil Corp / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / Vulcan Materials Co / Penn National Gaming Inc / Black Knight Inc / Cigna Corp / Wayfair Inc / Wintrust Financial Corp / Ares Capital Corp / Amedisys Inc / AMN Healthcare Services Inc / Latham Group Inc / Arrow Electronics Inc / Avnet Inc / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Collegium Pharmaceutical Inc / CoStar Group Inc / Diamondrock Hospitality Co / Exelixis Inc / Installed Building Products Inc / Main Street Capital Corp / Microchip Technology Inc / Netstreit Corp / Owl Rock Capital Corp / PacWest Bancorp / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / RBC Bearings Inc / STORE Capital Corp / Targa Resources Corp / Tripadvisor Inc / Western Alliance Bancorp / Acushnet Holdings Corp / Shift4 Payments Inc / Hilltop Holdings Inc / Cadence Bank / Cloudflare Inc / Fidelity National Financial Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / Brandywine Realty Trust / Meta Platforms Inc / FB Financial Corp / Markel Corp / Associated Banc-Corp / SouthState Corp / Spirit Realty Capital Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Regency Centers Corp / Appian Corp / Autolus Therapeutics PLC / United Community Banks Inc / Dine Brands Global Inc / Magnite Inc / Pinnacle Financial Partners Inc / Antares Pharma Inc / Seacoast Banking Corporation of Florida / PRA Group Inc / Monster Beverage Corp / Brinks Co / James River Group Holdings Ltd / Nomad Foods Ltd / Texas Capital Bancshares Inc / FNB Corp / Crawford & Co / First Horizon Corp / Apollo Investment Corp / Renasant Corp / Denny's Corp / LHC Group Inc / TreeHouse Foods Inc / Builders FirstSource Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Cadence Bank / Pennantpark Investment Corp / SeaWorld Entertainment Inc / Northern Oil and Gas Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / PlayAGS Inc / Arcus Biosciences Inc / RLJ Lodging Trust / Angi Inc / Zynga Inc / PDC Energy Inc / Hci Group Inc / Independent Bank Group Inc / Fox Factory Holding Corp / Mandiant Inc / Concert Pharmaceuticals Inc / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Zillow Group Inc / Atlantic Capital Bancshares Inc / Block Inc / Intellia Therapeutics Inc / Valvoline Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Carvana Co / Verona Pharma PLC / Redfin Corp / Switch Inc / Merchants Bancorp / Funko Inc / Americold Realty Trust / Lazydays Holdings Inc / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Eventbrite Inc / Axonics Inc / FS KKR Capital Corp / Amerant Bancorp Inc / TCR2 Therapeutics Inc / Lightspeed Commerce Inc / Palomar Holdings Inc / Datadog Inc / Adapthealth Corp / Bigcommerce Holdings Inc / WideOpenWest Inc / Vimeo Inc / Momentive Global Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">08/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">AXP / V / 4031976 / 5671735 / 2023607 / 2486813 / 2640147 / 2778844 / 2002305 / 2003698 / 2050832 / 2045623 / 2942605 / 2544960 / 2219224 / 2206657 / 2216850 / 2037170 / 2317087 / 2576941 / 2670519 / 2328915 / 2342034 / 2613990 / 2471950 / 2630513 / 2645409 / 2657802 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2440637 / 2138158 / 2825933 / 2829601 / 2928683 / 2503529 / B1F76F9 / 2212922 / B19FQ48 / B0T7YX2 / B02R1L6 / 2390817 / B7TL820 / B4MG4Z6 / B783TY6 / B7VD3F2 / BBPK0J0 / BBGVT40 / B7577T2 / BDZCRX3 / B95WG16 / BZ07BW4 / BYZLV46 / BYNZGK1 / BZBY005 / BD8DJ71 / BJ1FD74 / BKTHM05 / BR4T3B3 / BMYML02 / BFMXGR0 / BJJMGL2 / BFNR303 / BYXJQG9 / BZ8VJQ8 / BJFSR99 / BFXC911 / BKTNTR9 / BJVR9Y9 / BYWMQJ2 / BYYWPW6 / BHZSB82 / BP3YM85 / BD6D4Y5 / BJ9NFQ3 / BZ1LFG7 / BYY88Y7 / BF3W461 / BYSGPK2 / BKX9VD3 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BDZ30Q0 / BJMLSD2 / BYTJZL1 / BJTJGC4 / BG0Q4Y1 / BF3N4P3 / BQXZP64 / BMDCDP2 / BYXB1Y8 / BGDQ8B3 / BD72R64 / BNTB3N8 / BMGGJK8 / BKPGJQ1 / BJLV8T9</td><td class="leftalignment">American Express Co / Visa Inc / Adidas AG / Sanofi SA / Amgen Inc / Kellogg Co / Nike Inc / Merck & Co Inc / Abbott Laboratories / ABIOMED Inc / Ameren Corp / ANSYS Inc / Avista Corp / Beasley Broadcast Group Inc / CMS Energy Corp / Coca-Cola Co / Consolidated Edison Inc / 8x8 Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Nextera Energy Inc / Fiserv Inc / Illumina Inc / Incyte Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / VF Corp / World Wrestling Entertainment Inc / Western Union Co / NRG Energy Inc / Amicus Therapeutics Inc / Live Nation Entertainment Inc / ALLETE Inc / Gray Television Inc / Meta Platforms Inc / AMC Networks Inc / Aptiv PLC / Duke Energy Corp / Mirati Therapeutics Inc / News Corp / Renewable Energy Group Inc / RingCentral Inc / Zoetis Inc / Monster Beverage Corp / InflaRx NV / Block Inc / Merus NV / Snap Inc / Revolve Group Inc / Passage Bio Inc / HubSpot Inc / DraftKings Inc / Evergy Inc / Fox Corp / Northwest Natural Holding Co / Spire Inc / Vistra Corp / Revance Therapeutics Inc / Guardant Health Inc / ViacomCBS Inc / iHeartMedia Inc / Alteryx Inc / Beigene Ltd / Covetrus Inc / Trupanion Inc / Altair Engineering Inc / Neoleukin Therapeutics Inc / Roku Inc / Alphabet Inc / Tandem Diabetes Care Inc / ViewRay Inc / Arcutis Biotherapeutics Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Arvinas Inc / Karuna Therapeutics Inc / Zogenix Inc / Kontoor Brands Inc / Exicure Inc / Arena Pharmaceuticals Inc / Wayfair Inc / Bigcommerce Holdings Inc / Sunrun Inc / Axonics Inc / Liberty Media Corp / Vizio Holding Corp / Valneva SE / Squarespace Inc / Celldex Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / France / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Forecast Of The Day: Bristol-Myers Squibb's Cardiovascular Drugs Revenue</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">BMY.N / PFE.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Good Q; Growth story on track; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ATRS=US / PFE=US</td><td class="leftalignment">Antares Pharma Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reports 2Q, INNATE And SELECT On Track, Cash Sufficient Through 3Q23</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US4811161011 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Jounce Therapeutics Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Geoffrey Weiner, M.D., Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) - Investors Look Towards 2H Prostate Cancer Data Following PFE Deal on ER Degrader ARV-471; Maintain BUY, $132 PT</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / BDZ30Q0 / 2684703</td><td class="leftalignment">Pfizer Inc / Arvinas Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reports 2Q, Pivotal Upro On Track For YE, Data Rich 2022, Cash Into 1Q23</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US38000Q1022 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">GlycoMimetics Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Geoffrey Weiner, M.D., Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / T=US / DVN=US / CMA=US / GILD=US / PEB=US / APA=US / CPE=US / EOG=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PB=US / MGY=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / MRO=US / TNL=US / KFRC=US / VMC=US / MGM=US / HLT=US / UNM=US / CVS=US / RCL=US / UNH=US / MAC=US / WTFC=US / AIZ=US / AMED=US / AMN=US / APH=US / FUN=US / CENT=US / KIDS=US / CHH=US / CSTR=US / CW=US / DRH=US / EEFT=US / MPLX=US / DOC=US / ASGN=US / OKE=US / PACW=US / RHI=US / SGMO=US / SMG=US / TGI=US / WAL=US / HTH=US / BXS=US / CCRN=US / FNF=US / BKNG=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / DCP=US / FRT=US / FBK=US / JAZZ=US / MTCH=US / ASB=US / SSB=US / SPR=US / RF=US / CRTO=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / EVOP=US / UCBI=US / VICI=US / ECPG=US / MGP=US / PNFP=US / SBCF=US / BDSI=US / JRVR=US / RPD=US / BIIB=US / FLT=US / TCBI=US / FNB=US / FHN=US / KAR=US / BDC=US / SHO=US / RNST=US / LHCG=US / CHNG=US / HST=US / MA=US / GPRE=US / ELF=US / WU=US / TEL=US / CADE=US / WH=US / IAC=US / PSN=US / JACK=US / SWI=US / VRSK=US / OAS=US / HGV=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ANGI=US / EA=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / UPLD=US / GDDY=US / ETSY=US / LOB=US / EVRI=US / ACBI=US / EDIT=US / 82982L103 / VVV=US / PK=US / PVAC=US / TVTY=US / 50189K103 / PLYA=US / SBOW=US / PETQ=US / ROKU=US / MBIN=US / MAXR=US / EOLS=US / HWC=US / OZK=US / FTDR=US / ALLO=US / AMTB=US / UBER=US / RTLR=US / IMVT=US / 100017125</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / AT&T Inc / Devon Energy Corp / Comerica Inc / Gilead Sciences Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Travel + Leisure Co / Kforce Inc / Vulcan Materials Co / MGM Resorts International / Hilton Worldwide Holdings Inc / Unum Group / CVS Health Corp / Royal Caribbean Cruises Ltd / UnitedHealth Group Inc / Macerich Co / Wintrust Financial Corp / Assurant Inc / Amedisys Inc / AMN Healthcare Services Inc / Amphenol Corp / Cedar Fair LP / Central Garden & Pet Co / OrthoPediatrics Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / Euronet Worldwide Inc / MPLX LP / Physicians Realty Trust / ASGN Inc / ONEOK Inc / PacWest Bancorp / Robert Half International Inc / Sangamo Therapeutics Inc / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Cross Country Healthcare Inc / Fidelity National Financial Inc / Booking Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / DCP Midstream LP / Federal Realty Investment Trust / FB Financial Corp / Jazz Pharmaceuticals PLC / Match Group Inc / Associated Banc-Corp / SouthState Corp / Spirit AeroSystems Holdings Inc / Regions Financial Corp / Criteo SA / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / EVO Payments Inc / United Community Banks Inc / VICI Properties Inc / Encore Capital Group Inc / MGM Growth Properties LLC / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / BioDelivery Sciences International Inc / James River Group Holdings Ltd / Rapid7 Inc / Biogen Inc / Fleetcor Technologies Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / KAR Auction Services Inc / Belden Inc / Sunstone Hotel Investors Inc / Renasant Corp / LHC Group Inc / Change Healthcare Inc / Host Hotels & Resorts Inc / Mastercard Inc / Green Plains Inc / elf Beauty Inc / Western Union Co / TE Connectivity Ltd / Cadence Bank / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Parsons Corp / Jack in the Box Inc / SolarWinds Corp / Verisk Analytics Inc / Oasis Petroleum Inc / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Angi Inc / Electronic Arts Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / Upland Software Inc / GoDaddy Inc / ETSY Inc / Live Oak Bancshares Inc / Everi Holdings Inc / Atlantic Capital Bancshares Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / Valvoline Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / Tivity Health Inc / LCI Industries / Playa Hotels & Resorts NV / SilverBow Resources Inc / PetIQ Inc / Roku Inc / Merchants Bancorp / Maxar Technologies Inc / Evolus Inc / Hancock Whitney Corp / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Amerant Bancorp Inc / Uber Technologies Inc / Rattler Midstream LP / Immunovant Inc / SVB Financial Group</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / France / Ireland / Liberia / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Key takeaways from expert call on recent COVID-19 Delta variant case surge</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / SASY.PA / 2196.HK / MRNA.OQ / BGNE.OQ / 2269.HK / 1877.HK</td><td class="leftalignment">Pfizer Inc / Sanofi SA / Shanghai Fosun Pharmaceutical Group Co Ltd / Moderna Inc / Beigene Ltd / WuXi Biologics (Cayman) Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / France / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Pfizer Stock Has Risen 11% In A Month But Will The Gains Continue?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech: SMID-Cap Oncology Take-Aways From Big-Cap 2Q21 Earnings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / GILD=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene</td></tr>
<tr class="even"><td class="leftalignment">08/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">0989529 / 0925288 / 2434209 / 2516152 / 2681511 / 2000019 / 2023607 / 2486813 / 2778844 / 2229126 / 2208073 / 2270726 / 2829515 / 2670519 / 2328915 / 2100920 / 2471950 / 2623911 / 2657802 / 2689560 / 2684703 / 2048804 / 2707677 / 2730190 / 2829601 / 2853688 / 7103065 / 2783815 / 2712013 / B00FWN1 / B0PZN11 / B121557 / 2769796 / 2857817 / B0T7YX2 / B2R3PV1 / B3D7K31 / B4Y1MH7 / 2390817 / B44C366 / B3SWPT2 / B4V9661 / BJ0KXV4 / BDZCRX3 / BFLR866 / BFZCHN7 / BYY8XK8 / BYVY8G0 / BTF8CF0 / BP4GNK9 / BYW36M8 / BYNZGK1 / BJT1RW7 / BD9GVY0 / BJF8Q81 / BZ1LFB2 / BR4T3B3 / BJ2Z0H2 / BLGJ610 / BJJMGL2 / BZ05388 / BDT5KT5 / BKC9SX3 / BFWGXQ7 / BP84RX0 / 021513106 / BNTB3N8</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Eli Lilly and Co / PepsiCo Inc / Amazon.com Inc / Amgen Inc / Kellogg Co / Merck & Co Inc / Columbia Sportswear Co / Copart Inc / Walt Disney Co / Edison International / Exelon Corp / Nextera Energy Inc / FirstEnergy Corp / Incyte Corp / Neurocrine Biosciences Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Southern Co / Stryker Corp / Novartis AG / Zimmer Biomet Holdings Inc / Global Payments Inc / Alnylam Pharmaceuticals Inc / Under Armour Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Discovery Inc / KAR Auction Services Inc / Gray Television Inc / Heska Corp / Ameresco Inc / Ralph Lauren Corp / ONE Gas Inc / RingCentral Inc / Twitter Inc / Wix.Com Ltd / WEC Energy Group Inc / Alphabet Inc / Restaurant Brands International Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Block Inc / Lyft Inc / Zai Lab Ltd / IAA Inc / Deciphera Pharmaceuticals Inc / HubSpot Inc / Pinterest Inc / Warner Music Group Corp / Fox Corp / Global Blood Therapeutics Inc / Inspire Medical Systems Inc / Arcturus Therapeutics Holdings Inc / Container Store Group Inc / Townsquare Media Inc / Alto Ingredients Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">2Q21 Earnings As Preannounced, Record Quarter For Revenue Driven By Exparel</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US6951271005 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Pacira Biosciences Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FISV=US / WMB=US / PFE=US / MCD=US / WEN=US / EBAY=US / INCY=US / AMT=US / SYK=US / CRK=US / PXD=US / HSII=US / DIOD=US / MGY=US / VRM=US / TTWO=US / LEG=US / KFRC=US / KFY=US / ARCC=US / AMN=US / CBRL=US / DRI=US / GFF=US / MAIN=US / MAN=US / MCHP=US / ASGN=US / ORCC=US / RARE=US / RHI=US / SBAC=US / WIX=US / SPG=US / GPN=US / CCRN=US / OHI=US / VNO=US / CRTO=US / BRX=US / DIN=US / MGNI=US / AINV=US / PLAY=US / FRPT=US / DENN=US / NSP=US / SIBN=US / CMG=US / FIS=US / XPO=US / GPRE=US / TAST=US / QSR=US / CLR=US / PNNT=US / NOG=US / JACK=US / TREX=US / NXPI=US / WWD=US / BCEI=US / FANG=US / NDLS=US / FATE=US / VRNS=US / TSLX=US / ARCB=US / 00770K202 / VNOM=US / 70806A106 / LOCO=US / CMPR=US / WK=US / SHAK=US / ON=US / SEDG=US / GSBD=US / BWXT=US / WING=US / SPNE=US / SQ=US / GXO=US / JELD=US / ROKU=US / GSKY=US / FSK=US / TCRR=US / IMVT=US / ARQT=US / REYN=US / ZI=US / FBRX=US / COUR-US / KNBE=US / DBRG=US</td><td class="leftalignment">Fiserv Inc / Williams Companies Inc / Pfizer Inc / McDonald's Corp / Wendys Co / eBay Inc / Incyte Corp / American Tower Corp / Stryker Corp / Comstock Resources Inc / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Diodes Inc / Magnolia Oil & Gas Corp / Vroom Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Kforce Inc / Korn Ferry / Ares Capital Corp / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Main Street Capital Corp / ManpowerGroup Inc / Microchip Technology Inc / ASGN Inc / Owl Rock Capital Corp / Ultragenyx Pharmaceutical Inc / Robert Half International Inc / SBA Communications Corp / Wix.Com Ltd / Simon Property Group Inc / Global Payments Inc / Cross Country Healthcare Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Brixmor Property Group Inc / Dine Brands Global Inc / Magnite Inc / Apollo Investment Corp / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Insperity Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / XPO Logistics Inc / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Northern Oil and Gas Inc / Jack in the Box Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / Civitas Resources Inc / Diamondback Energy Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Sixth Street Specialty Lending Inc / ArcBest Corp / Aemetis Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Cimpress PLC / Workiva Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / Goldman Sachs BDC Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Block Inc / GXO Logistics Inc / JELD-WEN Holding Inc / Roku Inc / GreenSky Inc / FS KKR Capital Corp / TCR2 Therapeutics Inc / Immunovant Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / ZoomInfo Technologies Inc / Forte Biosciences Inc / Coursera Inc / Knowbe4 Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2000019 / 2778844 / 2270726 / 2542049 / 2829515 / 2328915 / 2100920 / 2415204 / 2689560 / 2684703 / 2829601 / 7103065 / 2712013 / B1HMF22 / B125XQ6 / B3SWPT2 / BCZS820 / BDZCRX3 / BFLR866 / BVVN4Q8 / BQPVQZ6 / BYVY8G0 / BYNZGK1 / BJLT387 / BZB1XF2 / BR4T3B3 / BYXJQG9 / BGSP7M9 / BZ1LFG7 / BDVLM39 / BG0Q4Y1 / BJRFSB7 / BMZ9Z11 / BNTB3N8 / BWC52Q6 / BJ62Z18</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / PG&E Corp / Pfizer Inc / Southern Co / Novartis AG / Global Payments Inc / First Solar Inc / Portland General Electric Co / Ameresco Inc / Fate Therapeutics Inc / RingCentral Inc / Twitter Inc / Eversource Energy / Horizon Therapeutics PLC / Alphabet Inc / Block Inc / Avantor Inc / Tactile Systems Technology Inc / HubSpot Inc / Spire Inc / Zoom Video Communications Inc / Roku Inc / argenx SE / Exicure Inc / Immunovant Inc / Prometheus Biosciences Inc / Vizio Holding Corp / Solaredge Technologies Inc / Ultragenyx Pharmaceutical Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: August 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AIRP.PA / ALB.N / ALK.N / AXP.N / BA.N / BAC.N / BAX.N / BDX.N / C.N / CCL.N / CI.N / COF.N / CRM.N / DAL.N / FCX.N / GM.N / GPS.N / JNJ.N / JPM.N / KMB.N / LLY.N / LSI.N / LUV.N / MDT.N / MO.N / NEM.N / PFE.N / PM.N / SC.N / T.N / TMO.N / U.N / WAT.N / WFC.N / PG.N / NUE.N / CPB.N / W.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / D.N / DE.N / CAT.N / MGM.N / SPOT.N / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / DVN.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / PKI.N / VZ.N / WST.N / MUR.N / KSS.N / ORCL.N / PWR.N / COG.N / EFX.N / V.N / EW.N / CPT.N / HWM.N / ACN.N / PLD.N / CHD.N / AIV.N / HAE.N / MKC.N / MAA.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / MHK.N / GME.N / INTC.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / ATVI.OQ / MSFT.OQ / PBCT.OQ / TEAM.OQ / REGN.OQ / SIVB.OQ / QDEL.OQ / CACC.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / GILD.OQ / DFS.N / COST.OQ / CPRT.OQ / INCY.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / TPR.N / NBIX.OQ / CTXS.OQ / AMZN.OQ / MANH.OQ / NVDA.OQ / BMRN.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / EXAS.OQ / ALGN.OQ / VRTX.OQ / JBLU.OQ / DKS.N / WYNN.OQ / CMCSA.OQ / TPX.N / TFC.N / ACAD.OQ / CG.TO / DPZ.N / MOS.N / DLR.N / LVS.N / DXCM.OQ / WAL.N / DISCA.OQ / MS.N / STX.AX / MA.N / IVZ.N / TDC.N / MRNA.OQ / MSCI.N / AVGO.OQ / FTNT.OQ / MU.OQ / GNRC.N / TSLA.OQ / Z.OQ / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / EPAM.N / SPLK.OQ / PSX.N / SRPT.OQ / GMED.N / ALLY.N / PRGO.N / COTY.N / COMM.OQ / NCLH.N / GOOGL.OQ / SAGE.OQ / HUBS.N / WBA.OQ / TDOC.N / PYPL.OQ / GBT.OQ / IONS.OQ / RETA.OQ / COUP.OQ / LW.N / AYX.N / DXC.N / CVNA.N / IOVA.OQ / AXON.OQ / WDAY.OQ / ROKU.OQ / BKNG.OQ / CBRE.N / FB.PS / CPRI.N / NFE.OQ / PINS.N / FSLY.N / CRWD.OQ / RTX.N / LMND.N / GOCO.OQ / CVAC.OQ / AMWL.N / PLTR.N / VTRS.OQ / TSP.OQ / HON.OQ</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Albemarle Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Baxter International Inc / Becton Dickinson and Co / Citigroup Inc / Carnival Corp / Cigna Corp / Capital One Financial Corp / Salesforce.Com Inc / Delta Air Lines Inc / Freeport-McMoRan Inc / General Motors Co / Gap Inc / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Eli Lilly and Co / Life Storage Inc / Southwest Airlines Co / Medtronic PLC / Altria Group Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / AT&T Inc / Thermo Fisher Scientific Inc / Unity Software Inc / Waters Corp / Wells Fargo & Co / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Wayfair Inc / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Dominion Energy Inc / Deere & Co / Caterpillar Inc / MGM Resorts International / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / PerkinElmer Inc / Verizon Communications Inc / West Pharmaceutical Services Inc / Murphy Oil Corp / Kohls Corp / Oracle Corp / Quanta Services Inc / Coterra Energy Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Camden Property Trust / Howmet Aerospace Inc / Accenture PLC / Prologis Inc / Church & Dwight Co Inc / Apartment Investment and Management Co / Haemonetics Corp / McCormick & Company Inc / Mid-America Apartment Communities Inc / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Mohawk Industries Inc / GameStop Corp / Intel Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Activision Blizzard Inc / Microsoft Corp / People's United Financial Inc / Atlassian Corporation PLC / Regeneron Pharmaceuticals Inc / SVB Financial Group / Quidel Corp / Credit Acceptance Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Gilead Sciences Inc / Discover Financial Services / Costco Wholesale Corp / Copart Inc / Incyte Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Tapestry Inc / Neurocrine Biosciences Inc / Citrix Systems Inc / Amazon.com Inc / Manhattan Associates Inc / NVIDIA Corp / Biomarin Pharmaceutical Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Exact Sciences Corp / Align Technology Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Comcast Corp / Tempur Sealy International Inc / Truist Financial Corp / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Mosaic Co / Digital Realty Trust Inc / Las Vegas Sands Corp / Dexcom Inc / Western Alliance Bancorp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Mastercard Inc / Invesco Ltd / Teradata Corp / Moderna Inc / MSCI Inc / Broadcom Inc / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Tesla Inc / Zillow Group Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Epam Systems Inc / Splunk Inc / Phillips 66 / Sarepta Therapeutics Inc / Globus Medical Inc / Ally Financial Inc / Perrigo Company PLC / Coty Inc / CommScope Holding Company Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / SAGE Therapeutics Inc / HubSpot Inc / Walgreens Boots Alliance Inc / Teladoc Health Inc / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Lamb Weston Holdings Inc / Alteryx Inc / DXC Technology Co / Carvana Co / Iovance Biotherapeutics Inc / Axon Enterprise Inc / Workday Inc / Roku Inc / Booking Holdings Inc / CBRE Group Inc / San Miguel Food and Beverage Inc / Capri Holdings Ltd / New Fortress Energy Inc / Pinterest Inc / Fastly Inc / CrowdStrike Holdings Inc / Raytheon Technologies Corp / Lemonade Inc / Gohealth Inc / CureVac NV / American Well Corp / Palantir Technologies Inc / Viatris Inc / TuSimple Holdings Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / France / United Kingdom / Ireland / Luxembourg / Netherlands / Panama / Philippines / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">08/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Philippines Market Strategy: Vaccination rate picks up significantly, but lockdowns to impact earnings</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BPI.PS / JNJ.N / PFE.N / AZN.L / RLC.PS / MRNA.OQ / SVA.OQ / PGOLD.PS / CNPF.PS / HOME.PS</td><td class="leftalignment">Bank of the Philippine Islands / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Robinsons Land Corp / Moderna Inc / Sinovac Biotech Ltd / Puregold Price Club Inc / Century Pacific Food Inc / AllHome Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Hazel Tanedo / Mr. Justin J. Cimafranca</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Setting the bar for Phase 2 data: mgmt color and investor questions we're getting</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">FBRX=US / PFE=US / INCY=US / ARQT=US</td><td class="leftalignment">Forte Biosciences Inc / Pfizer Inc / Incyte Corp / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">WMB=US / PFE=US / MCD=US / GBT=US / CL=US / PG=US / PLD=US / AMZN=US / T=US / KMI=US / PEB=US / CHTR=US / CRM=US / V=US / XOM=US / PAA=US / FMS=US / SWN=US / VRM=US / EXPE=US / VMC=US / NWL=US / W=US / MLM=US / B=US / CERN=US / CHD=US / CYH=US / DRH=US / EXPO=US / SAFE=US / MPLX=US / MHK=US / OKE=US / PLAN=US / RARE=US / SGMO=US / SSNC=US / SNAP=US / TRGP=US / TRIP=US / VRTX=US / WIX=US / HTH=US / CVX=US / SAGE=US / EPD=US / SNOW=US / PYPL=US / BKNG=US / ADC=US / AVTR=US / DCP=US / FB=US / FR=US / INTA=US / MTCH=US / APPN=US / MRNS=US / PTON=US / MMP=US / MOG.A=US / APTX=US / APP=US / HURN=US / SHO=US / BAH=US / XM=US / HST=US / XPO=US / CPRX=US / QSR=US / PAGP=US / NXGN=US / KNSL=US / OLO=US / RLJ=US / ANGI=US / LKQ=US / RHP=US / SMLP=US / HCI=US / CEQP=US / GLPI=US / CNCE=US / GOOGL=US / HTRG=US / BABA=US / CMPR=US / WK=US / RLMD=US / GDDY=US / ETSY=US / VKTX=US / ARGX=US / SQ=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / EVBG=US / CRSP=US / TRVG=US / PK=US / ANAB=US / AYX=US / CVNA=US / VRNA=US / SFIX=US / FTDR=US / EB=US / ARVN=US / LYFT=US / UBER=US / RTLR=US / BIGC=US / CRMD.US / TSHA / ABNB=US / AIRC=US / AFRM=US / VMEO=US / MNTV=US</td><td class="leftalignment">Williams Companies Inc / Pfizer Inc / McDonald's Corp / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Procter & Gamble Co / Prologis Inc / Amazon.com Inc / AT&T Inc / Kinder Morgan Inc / Pebblebrook Hotel Trust / Charter Communications Inc / Salesforce.Com Inc / Visa Inc / Exxon Mobil Corp / Plains All American Pipeline LP / Fresenius Medical Care AG & Co KGaA / Southwestern Energy Co / Vroom Inc / Expedia Group Inc / Vulcan Materials Co / Newell Brands Inc / Wayfair Inc / Martin Marietta Materials Inc / Barnes Group Inc / Cerner Corp / Church & Dwight Co Inc / Community Health Systems Inc / Diamondrock Hospitality Co / Exponent Inc / Safehold Inc / MPLX LP / Mohawk Industries Inc / ONEOK Inc / Anaplan Inc / Ultragenyx Pharmaceutical Inc / Sangamo Therapeutics Inc / SS&C Technologies Holdings Inc / Snap Inc / Targa Resources Corp / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Hilltop Holdings Inc / Chevron Corp / SAGE Therapeutics Inc / Enterprise Products Partners LP / Snowflake Inc. / PayPal Holdings Inc / Booking Holdings Inc / Agree Realty Corp / Avantor Inc / DCP Midstream LP / Meta Platforms Inc / First Industrial Realty Trust Inc / Intapp Inc / Match Group Inc / Appian Corp / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / Magellan Midstream Partners LP / Moog Inc / Aptinyx Inc / Applovin Corp / Huron Consulting Group Inc / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / Qualtrics International Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Catalyst Pharmaceuticals Inc / Restaurant Brands International Inc / Plains GP Holdings LP / NextGen Healthcare Inc / Kinsale Capital Group Inc / Olo Inc / RLJ Lodging Trust / Angi Inc / LKQ Corp / Ryman Hospitality Properties Inc / Summit Midstream Partners LP / Hci Group Inc / Crestwood Equity Partners LP / Gaming and Leisure Properties Inc / Concert Pharmaceuticals Inc / Alphabet Inc / Heritage Insurance Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / Relmada Therapeutics Inc / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / argenx SE / Block Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Everbridge Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / AnaptysBio Inc / Alteryx Inc / Carvana Co / Verona Pharma PLC / Stitch Fix Inc / Frontdoor Inc / Eventbrite Inc / Arvinas Inc / Lyft Inc / Uber Technologies Inc / Rattler Midstream LP / Bigcommerce Holdings Inc / CorMedix Inc / Taysha Gene Therapies Inc / Airbnb Inc / Apartment Income REIT Corp / Affirm Holdings Inc / Vimeo Inc / Momentive Global Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pfizer (PFE US) - Double bubble</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Aug-2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 004170.KS / 069620.KS / 006280.KS / 078930.KS / MRNA.OQ / 068270.KS / 086900.KQ / 0460.HK / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Shinsegae Inc / Daewoong Pharma / Green Cross Corp / GS Holdings Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Sihuan Pharmaceutical Holdings Group Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - 2Q21 review: OP miss by increased SG&A items, but stronger 3Q21E seasonality on track</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">006280.KS / PFE.N / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">08/02/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Perception is Reality – Spate of FDA Surprises Eroding Physician Confidence</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">0989529 / 717081103 / 375558103 / 532457108 / 09062X103 / 09061G101 / 45337C102 / 00287Y109 / 039697107 / 00972D105</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Gilead Sciences Inc / Eli Lilly and Co / Biogen Inc / Biomarin Pharmaceutical Inc / Incyte Corp / Abbvie Inc / Ardelyx Inc / Akebia Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Christopher J. Raymond / Yasmeen Rahimi, Ph.D. / Mr. Allison M. Bratzel, CFA / Nicole Gabreski, PhD</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">PMVP - Precision Oncology Against Mutant p53 - The Next KRAS? Initiating Coverage with a BUY Rating and $56 PT</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">BMW5084 / 0989529 / 2126335 / 2023607 / 2684703 / 7103065 / BCBVTX1 / BN2RM92</td><td class="leftalignment">PMV Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Amgen Inc / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">08/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 69</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / FR0000120578 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/31/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Peer Group Analytics - Q2 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Pfizer (PFE: $42.81) shares post best month in eight months</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">FDA likely to approve boosters, in our view</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - July 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">NL0000226223 / FR0000120578 / GB0009895292 / DE0006231004 / GB0009252882 / CH0012032048 / CH0012005267 / US0079031078 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1985161066 / US2435371073 / US2546871060 / US37733W1053 / US4581401001 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US5951121038 / US6541061031 / US6549022043 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US8610121027 / US8807701029 / US9282981086 / US9581021055 / US83088M1027 / US80105N1054 / US1572101053 / US6098391054 / US9043111072 / US82706C1080 / US5500211090 / US25470F1049 / US58933Y1055 / US4485791028 / US25470F3029 / US00164V1035 / US30212P3038 / US8969452015 / US00287Y1091 / NL0010273215 / US55405Y1001 / KYG037AX1015 / DK0060534915 / US74736K1016 / KYG4740B1059 / LGFb / US89686D1054 / US43300A2033 / LGFa / VGG273581030 / US09857L1089 / US11135F1012 / US98585X1046 / US35137L1052 / US70614W1009 / US89677Q1076 / US92556H2067 / GB00BMVP7Y09 / US0090661010 / US5738741041 / IE00BKVD2N49 / US30260D1037 / US68622V1061 / US81730H1095 / US89142B1070 / US69120X1072 / US30049H1023</td><td class="leftalignment">STMicroelectronics NV / Sanofi SA / AstraZeneca PLC / Infineon Technologies AG / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Advanced Micro Devices Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / GlaxoSmithKline PLC / Intel Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Micron Technology Inc / Nike Inc / Nokia Oyj / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / STMicroelectronics NV / Teradyne Inc / Vishay Intertechnology Inc / Western Digital Corp / Skyworks Solutions Inc / Sanofi SA / CEVA Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / Lululemon Athletica Inc / Discovery Inc / Merck & Co Inc / Hyatt Hotels Corp / Discovery Inc / AMC Networks Inc / Expedia Group Inc / Tripadvisor Inc / Abbvie Inc / ASML Holding NV / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Novo Nordisk A/S / Qorvo Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Trivago NV / Hilton Worldwide Holdings Inc / Lions Gate Entertainment Corp / Despegar.com Corp / Booking Holdings Inc / Broadcom Inc / Yeti Holdings Inc / Fox Corp / Peloton Interactive Inc / Trip.com Group Ltd / ViacomCBS Inc / Royalty Pharma PLC / Airbnb Inc / Marvell Technology Inc / Seagate Technology Holdings PLC / Figs Inc / Organon & Co / SentinelOne Inc / Torrid Holdings Inc / Owlet Inc / Evolv Technologies Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 37148K100 / 02155H200 / 24344T101 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 4525EP101 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 04746L104 / G637AM102 / 007002108 / M47364100 / 617760202 / N71542109 / 72942A107 / 92790C104 / 76200L309</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Generation Bio Co / Altimmune Inc / Deciphera Pharmaceuticals Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Immunic Inc / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Athira Pharma Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / PLx Pharma Inc / Viridian Therapeutics Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Reports 2Q, Focus On SORAYA 4Q Readout And BLA Submission 1Q22</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Geoffrey Weiner, M.D., Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Initiation: Integrated Approach to Companion Diagnostics and Targeted Therapy</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US15102K1007 / US45253H1014 / US4277461020 / CA89620X5064</td><td class="leftalignment">Celcuity Inc / ImmunoGen Inc / Heron Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, PFE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Pfizer Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Third Time Might Be the Charm, Get Ready for Another COVID Shot</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Germany / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Dilip Joseph / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Vaults into RSV Race, Can They Leapfrog GSK/JNJ for Another Blockbuster?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N / GSK.L / JNJ.N / 71708110 / 478160104 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / GlaxoSmithKline PLC / Johnson & Johnson / Pfizer Inc / Johnson & Johnson / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / V / 0989529 / 2126335 / 2550707 / 2437071 / 2280220 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2369174 / 2600088 / 2689560 / 2684703 / 2730190 / 2829601 / 2943523 / 2931034 / 2769796 / B28TS42 / B5B2106 / B03PGL4 / B65LWX6 / B7TL820 / B95N910 / BYVY8G0 / BYW36M8 / BXDZ9Z0 / BYNZGK1 / BNFWR44 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BFXC911 / BYY88Y7 / BKS3RS7 / BMG75B4 / BMDCDP2 / BZ4CHH2 / BMZ9Z11</td><td class="leftalignment">American Express Co / Visa Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / McDonald's Corp / Biomarin Pharmaceutical Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / Monro Inc / PG&E Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Penske Automotive Group Inc / Vertex Pharmaceuticals Inc / Fidelity National Information Services Inc / Ulta Beauty Inc / Fortinet Inc / NorthWestern Corp / O'Reilly Automotive Inc / Meta Platforms Inc / PTC Inc / Alphabet Inc / PayPal Holdings Inc / Shopify Inc / Block Inc / Worldline SA / Spotify Technology SA / Fox Corp / Spire Inc / Guardant Health Inc / Alphabet Inc / 10X Genomics Inc / Inventiva SA / Bigcommerce Holdings Inc / Soleno Therapeutics Inc / Prometheus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">CAS.TO / CB.N / CCO.TO / CL.N / F.N / IP.N / NSC.N / PB.N / PFE.N / RYN.N / EQR.N / WY.N / HUM.N / CFP.TO / LPX.N / AGI.N / IEX.N / DT.N / DBKGn.DE / MCD.N / AEM.N / KGC.N / GIBa.TO / CONE.O / OLN.N / CYH.N / CINF.O / APH.N / EPD.N / CTSH.O / BMRN.O / REGN.O / PFG.N / TEL.N / SSNC.O / MEOH.O / CHE.N / PEGA.OQ / SIGI.O / ACGL.O / TCW.TO / FM.TO / 878742204 / DRX.L / ISBC.O / TEVA.N / OC.N / 550372106 / ATL.MI / ENSG.O / CLW.N / 80105N105 / ADN.TO / NXT.AX / PCH.O / SUBC.OL / CTT.N / IFP.TO / FBHS.N / RFP.N / NYCB.N / UKWG.L / 81762P102 / CEQP.N / CFF.TO / PTC.O / CFG.N / SHOP.N / PYPL.OQ / WRK.N / ZG.O / GDS.O / ATUS.N / RDFN.O / KL.N / EHC.N / GSHD.O / OVV.N / PTVE.O / WFG.N / WING.N / MTCH,OQ</td><td class="leftalignment">Cascades Inc / Chubb Ltd / Cameco Corp / Colgate-Palmolive Co / Ford Motor Co / International Paper Co / Norfolk Southern Corp / Prosperity Bancshares Inc / Pfizer Inc / Rayonier Inc / Equity Residential / Weyerhaeuser Co / Humana Inc / Canfor Corp / Louisiana-Pacific Corp / Alamos Gold Inc / IDEX Corp / Dynatrace Inc / Deutsche Bank AG / McDonald's Corp / Agnico Eagle Mines Ltd / Kinross Gold Corp / CGI Inc / CyrusOne Inc / Olin Corp / Community Health Systems Inc / Cincinnati Financial Corp / Amphenol Corp / Enterprise Products Partners LP / Cognizant Technology Solutions Corp / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / TE Connectivity Ltd / SS&C Technologies Holdings Inc / Methanex Corp / Chemed Corp / Pegasystems Inc / Selective Insurance Group Inc / Arch Capital Group Ltd / Trican Well Service Ltd / First Quantum Minerals Ltd / Teck Resources Ltd / Drax Group PLC / Investors Bancorp Inc / Teva Pharmaceutical Industries Ltd / Owens Corning / Lundin Mining Corp / Atlantia SpA / Ensign Group Inc / Clearwater Paper Corp / Sanofi SA / Acadian Timber Corp / NEXTDC Ltd / Potlatchdeltic Corp / Subsea 7 SA / CatchMark Timber Trust Inc / Interfor Corp / Fortune Brands Home & Security Inc / Resolute Forest Products Inc / New York Community Bancorp Inc / Greencoat UK Wind PLC / ServiceNow Inc / Crestwood Equity Partners LP / Conifex Timber Inc / PTC Inc / Citizens Financial Group Inc / Shopify Inc / PayPal Holdings Inc / Westrock Co / Zillow Group Inc / GDS Holdings Ltd / Altice USA Inc / Redfin Corp / Kirkland Lake Gold Ltd / Encompass Health Corp / Goosehead Insurance Inc / Ovintiv Inc / Pactiv Evergreen Inc / West Fraser Timber Co Ltd / Wingstop Inc / Match Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Israel / Italy / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : Post 2Q21 Model Update - Again Raising 2021/22 COVID-19 Vaccine Estimates</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: Notes from GSK management meeting</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">GSK.L / MRK.N / PFE.N / SASY.PA / CVAC.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Pfizer Inc / Sanofi SA / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BDX.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / PFE.N / SO.N / STE.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / TSN.N / SYY.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / PRU.N / L.N / COP.N / AMGN.OQ / KLAC.OQ / ATVI.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / EBAY.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / AON.N / ES.N / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / FANG.OQ / ABBV.N / ZTS.N / PRGO.N / MAR.OQ / NCLH.N / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Becton Dickinson and Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Pfizer Inc / Southern Co / STERIS plc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / Tyson Foods Inc / Sysco Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / KLA Corp / Activision Blizzard Inc / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / eBay Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aon PLC / Eversource Energy / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Vaccines Are the New Green; Raising Ests. for COVID and Other Vaccines; PT $49</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">71708110 / G3910J11</td><td class="leftalignment">Pfizer Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">07/29/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - PFE: 2Q21 Full Postview: Guidance higher again on COVID vaccine, otherwise fairly quiet</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Vaccine momentum helps drive another beat and raise; Biopharma performance also encouraging</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PBH-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PBH / ABT / CLX / CVS / JNJ / NVS / PFE / PG / RAD / GSK / TARO.K</td><td class="leftalignment">Prestige Consumer Healthcare Inc / Abbott Laboratories / Clorox Co / CVS Health Corp / Johnson & Johnson / Novartis AG / Pfizer Inc / Procter & Gamble Co / Rite Aid Corp / GlaxoSmithKline PLC / Taro Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">R&D Day Highlights PRA023 Ph2 Details and Precision Medicine Approach to IBD</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas J. Smith / Mike Kratky, CFA</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Suddenly Keen on Vaccines – Q2 Windfall from COVID and RSV a New Pipeline Star</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">71708110 / 09075V10</td><td class="leftalignment">Pfizer Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : 2Q Takeaways – Near-Term COVID Vaccine Forecasts Continue to Move Higher; Incrementally Positive Core Updates as Well</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HP.N / AFL.N / BA.N / BMY.N / BP.L / F.N / HIG.N / IBM.N / IR.N / NSC.N / PFE.N / SLB.N / TMO.N / AVB.N / DRE.N / HUM.N / HAL.N / GD.N / URI.N / MCD.N / XOM.N / AVY.N / RE.N / APH.N / UDR.N / MAA.N / MCO.N / TEL.N / TDY.N / CTSH.OQ / AAPL.OQ / CINF.OQ / HOLX.OQ / LRCX.OQ / MSFT.OQ / ROL.N / TYL.N / XLNX.OQ / SBUX.OQ / ODFL.OQ / QCOM.OQ / ORLY.OQ / AMZN.OQ / EQIX.OQ / GRMN.OQ / ALGN.OQ / 0700.HK / RDSA.L / HES.N / 9999.HK / CME.OQ / ADP.OQ / GNRC.N / BKR.N / FBHS.N / FB.OQ / NOW.N / PTC.OQ / PYPL.OQ / LYFT.OQ / PINS.N / BYND.OQ / UBER.N / ZM.OQ / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Helmerich and Payne Inc / Aflac Inc / Boeing Co / Bristol-Myers Squibb Co / BP PLC / Ford Motor Co / Hartford Financial Services Group Inc / International Business Machines Corp / Ingersoll Rand Inc / Norfolk Southern Corp / Pfizer Inc / Schlumberger NV / Thermo Fisher Scientific Inc / Avalonbay Communities Inc / Duke Realty Corp / Humana Inc / Halliburton Co / General Dynamics Corp / United Rentals Inc / McDonald's Corp / Exxon Mobil Corp / Avery Dennison Corp / Everest Re Group Ltd / Amphenol Corp / UDR Inc / Mid-America Apartment Communities Inc / Moody's Corp / TE Connectivity Ltd / Teledyne Technologies Inc / Cognizant Technology Solutions Corp / Apple Inc / Cincinnati Financial Corp / Hologic Inc / Lam Research Corp / Microsoft Corp / Rollins Inc / Tyler Technologies Inc / Xilinx Inc / Starbucks Corp / Old Dominion Freight Line Inc / Qualcomm Inc / O'Reilly Automotive Inc / Amazon.com Inc / Equinix Inc / Garmin Ltd / Align Technology Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Hess Corp / NetEase Inc / CME Group Inc / Automatic Data Processing Inc / Generac Holdings Inc / Baker Hughes Co / Fortune Brands Home & Security Inc / Meta Platforms Inc / ServiceNow Inc / PTC Inc / PayPal Holdings Inc / Lyft Inc / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / United Kingdom / United States / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 EPS and Sales Beat; 2021 Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">impt R&D takeaways</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : 2Q First Impressions: COVID Vaccine Upward Revisions Continue</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Jul. 28, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Jul. 28, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE reports a 2Q beat and raise with updated full-year COVID-19 vaccine guidance coming in at $33.5 billion; conference call at 10AM ET</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2 EPS And Revenue Beat Estimates, 2021 Guidance Raised</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Earnings Beat In Cards For Merck's Q2?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BE0165385973 / US0079031078 / US0123481089 / US0311621009 / US0323325045 / US0378331005 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1265011056 / US1985161066 / US2435371073 / US37733W1053 / US45167R1041 / US4657411066 / US48203R1041 / US5128071082 / US5324571083 / US5370081045 / US55306N1046 / US5949181045 / US6541061031 / US66987V1098 / US6745991058 / US7170811035 / US7237871071 / US7711951043 / US8552441094 / US8636671013 / US8807701029 / US9113121068 / US9282981086 / US98956P1021 / US00508Y1029 / US4198791018 / US80105N1054 / US6098391054 / US6866881021 / US12541W2098 / US9043111072 / US42330P1075 / US3364331070 / US5500211090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US13100M5094 / US88160R1014 / US92839U2069 / US8676524064 / JE00B783TY65 / US00287Y1091 / US72919P2020 / US5764852050 / US29355A1079 / US41068X1000 / IE00BLS09M33 / US83417M1045 / US89400J1079 / US87918A1051 / US02079K1079 / US98138J2069 / US87266J1043 / CH0371153492 / US92336X1090 / US0937121079 / US04206A1016 / KY30744W1070 / US98585X1046 / US35952H6018 / US76156B1070 / US86150R1077 / US88339P1012 / US70614W1009 / US1567271093 / US69047Q1022 / US75513E1010 / US6541101050 / US04271T1007 / US33813J1060 / US74767V1098 / US62955J1034 / US73739W1045 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036 / US83089J1088 / US30260D1037</td><td class="leftalignment">Melexis NV / Advanced Micro Devices Inc / Albany International Corp / Amgen Inc / Amtech Systems Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / CTS Corp / Columbia Sportswear Co / Deckers Outdoor Corp / GlaxoSmithKline PLC / IDEX Corp / Itron Inc / Juniper Networks Inc / Lam Research Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Microsoft Corp / Nike Inc / Novartis AG / Occidental Petroleum Corp / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Starbucks Corp / Stryker Corp / Teradyne Inc / United Parcel Service Inc / Vishay Intertechnology Inc / Zimmer Biomet Holdings Inc / Acuity Brands Inc / Hawaiian Holdings Inc / Sanofi SA / Monolithic Power Systems Inc / Ormat Technologies Inc / CH Robinson Worldwide Inc / Under Armour Inc / Helix Energy Solutions Group Inc / First Solar Inc / Lululemon Athletica Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Calix Inc / Tesla Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Abbvie Inc / Plug Power Inc / Matador Resources Co / Enphase Energy Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Pentair PLC / Solaredge Technologies Inc / TransUnion / Teladoc Health Inc / Alphabet Inc / Workhorse Group Inc / TPI Composites Inc / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Arlo Technologies Inc / Farfetch Ltd / Yeti Holdings Inc / Fuelcell Energy Inc / Revolve Group Inc / Stoke Therapeutics Inc / RealReal Inc / Peloton Interactive Inc / Cerence Inc / Ovintiv Inc / Raytheon Technologies Corp / Nikola Corp / Array Technologies Inc / Fisker Inc / Quantumscape Corp / Nov Inc / Poshmark Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc / Skywater Technology Inc / Figs Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: R&D Day Unveils Novel PRA023 Ph2 Program Design and Dosing Strategy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">RXDX.OQ / PFE.N</td><td class="leftalignment">Prometheus Biosciences Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Style Comparisons: July 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / GM.N / LLY.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / STE.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / RCL.N / MCD.N / TSN.N / IFF.N / VNO.N / ITW.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / BLL.N / JCI.N / PSA.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / AON.N / ES.N / CME.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / General Motors Co / Eli Lilly and Co / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / STERIS plc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / Royal Caribbean Cruises Ltd / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Illinois Tool Works Inc / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Ball Corp / Johnson Controls International PLC / Public Storage / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Aon PLC / Eversource Energy / CME Group Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / France / Ireland / Liberia / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: The need for a booster shot enhancing mRNA vaccine's commercial prospect. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2196.HK / 600196.SS / PFE.N</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">07/28/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for PFE</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharma Pipelines: Number of Pharma Pipeline Candidates Up 15% YoY</td><td class="leftalignment">English</td><td class="rightalignment">129</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will Roche's Stock Rebound After A 4% Fall Following Its H1 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb Stock After Q2 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is Pfizer Stock Set To See Higher Levels Post Q2 Results?</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AIN / MRK=US / LLY=US / PFE=US / BMY=US / HD=US / INTC=US / MCD=US / AMD=US / RRC=US / WEN=US / PD=US / AMZN=US / DT=US / BLD=US / TEVA=US / NVDA=US / PEB=US / LOW=US / CHKP=US / HSII=US / CHRS=US / BRO=US / SPOT=US / LEG=US / VMC=US / HLT=US / MLM=US / KFY=US / SWIM=US / BNL=US / CBRL=US / DRI=US / ENDP=US / AJG=US / GFF=US / HAS=US / HXL=US / IBP=US / TREE=US / NOW=US / MAS=US / MEDP=US / MHK=US / TEAM=US / NTST=US / PRGO=US / REGI=US / ROLL=US / SNOW=US / BXS=US / CFB=US / LCI=US / ADC=US / BDN=US / FB=US / SSB=US / CATY=US / GBCI=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / LUMN=US / APEI=US / TIL=US / EPRT=US / JACK=US / ZTS=US / TREX=US / AR=US / RLJ=US / FBHS=US / SPLK=US / ABBV=US / TILE=US / NDLS=US / QURE=US / 00770K202 / LOCO=US / NEWR=US / SHAK=US / WING=US / ACBI=US / WLTW=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / AYX=US / IOVA=US / ARVN=US / ESTC=US / FERG=US / DDOG=US / AZEK=US / BALY=US / DBRG=US</td><td class="leftalignment">Albany International Corp / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / McDonald's Corp / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / PagerDuty Inc / Amazon.com Inc / Dynatrace Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / Pebblebrook Hotel Trust / Lowe's Companies Inc / Check Point Software Technologies Ltd / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Brown & Brown Inc / Spotify Technology SA / Leggett & Platt Inc / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Korn Ferry / Latham Group Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Endo International PLC / Arthur J Gallagher & Co / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / Lendingtree Inc / ServiceNow Inc / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Atlassian Corporation PLC / Netstreit Corp / Perrigo Company PLC / Renewable Energy Group Inc / RBC Bearings Inc / Snowflake Inc. / Cadence Bank / Crossfirst Bankshares Inc / Lannett Company Inc / Agree Realty Corp / Brandywine Realty Trust / Meta Platforms Inc / SouthState Corp / Cathay General Bancorp / Glacier Bancorp Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Lumen Technologies Inc / American Public Education Inc / Instil Bio Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Zoetis Inc / Trex Company Inc / Antero Resources Corp / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Splunk Inc / Abbvie Inc / Interface Inc / Noodles & Co / Uniqure NV / Aemetis Inc / El Pollo Loco Holdings Inc / New Relic Inc / Shake Shack Inc / Wingstop Inc / Atlantic Capital Bancshares Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Alteryx Inc / Iovance Biotherapeutics Inc / Arvinas Inc / Elastic NV / Ferguson PLC / Datadog Inc / Azek Company Inc / Bally's Corp / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2681511 / 2550707 / 2778844 / 2973821 / 2026242 / 2270726 / 2829515 / 2328915 / 2100920 / 2344922 / 2689560 / 2684703 / 2829601 / 2842255 / 2098876 / 2181334 / 7103065 / 7123870 / B0X7DZ3 / B01SD70 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / BFLR866 / B3NXMJ9 / BNGY4Q0 / BYVY8G0 / BTF8CF0 / BXDZ9Z0 / BJLFHW7 / BD8DJ71 / BJFSR88 / BYXJQG9 / BKTNTR9 / BDH65C8 / BMH0MR7 / BYSFJV8 / BMBP1Q0 / BL98755</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / PepsiCo Inc / McDonald's Corp / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / Walt Disney Co / Edison International / Nextera Energy Inc / FirstEnergy Corp / Jack in the Box Inc / PG&E Corp / Pfizer Inc / Southern Co / Starbucks Corp / Yum! Brands Inc / Check Point Software Technologies Ltd / Novartis AG / Nestle SA / Chipotle Mexican Grill Inc / Domino's Pizza Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Twitter Inc / Wendys Co / Nextera Energy Partners LP / Alphabet Inc / Restaurant Brands International Inc / Shopify Inc / Chewy Inc / Snap Inc / Uniqure NV / Spire Inc / ViacomCBS Inc / PetIQ Inc / Zendesk Inc / Planet Fitness Inc / Flywire Corp / Beachbody Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ANTO.L / CE.N / EMN.N / MRK.N / PFE.N / RWEG.DE / CHKP.O / UHS.N / AAL.L / HSY.N / RMD.N / IG.MI / ENDP.O / BRO.N / LTC.N / FFIV.O / FM.TO / 35671D857 / HICL.L / TEVA.N / CS.TO / 550372106 / VALE.N / BHPB.L / LYB.N / PCH.O / ABBV.N / TSLA.N / QURE.O / CIA.TO / AGRX.O / NEXA.TO / CDMO.OQ / KDP.N / TFII.N / 900435207</td><td class="leftalignment">Antofagasta PLC / Celanese Corp / Eastman Chemical Co / Merck & Co Inc / Pfizer Inc / Rwe AG / Check Point Software Technologies Ltd / Universal Health Services Inc / Anglo American PLC / Hershey Co / Resmed Inc / Italgas SpA / Endo International PLC / Brown & Brown Inc / LTC Properties Inc / F5 Inc / First Quantum Minerals Ltd / Freeport-McMoRan Inc / HICL Infrastructure PLC / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Lundin Mining Corp / Vale SA / BHP Group PLC / LyondellBasell Industries NV / Potlatchdeltic Corp / Abbvie Inc / Tesla Inc / Uniqure NV / Champion Iron Ltd / Agile Therapeutics Inc / Nexa Resources SA / Avid Bioservices Inc / Keurig Dr Pepper Inc / TFI International Inc / Turquoise Hill Resources Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Germany / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Revisions: July 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AIG.N / APD.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CF.N / CI.N / CL.N / CVS.N / DD.N / ED.N / EOG.N / FLT.N / GE.N / GM.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PFE.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / MET.N / ETN.N / DUK.N / CMI.N / D.N / PH.N / CAT.N / MCD.N / TSN.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / BLL.N / JCI.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / LEG.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / CTVA.N / EXC.OQ / RTX.N / VTRS.OQ</td><td class="leftalignment">American International Group Inc / Air Products and Chemicals Inc / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / CF Industries Holdings Inc / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / Consolidated Edison Inc / EOG Resources Inc / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Pfizer Inc / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / Parker-Hannifin Corp / Caterpillar Inc / McDonald's Corp / Tyson Foods Inc / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Ball Corp / Johnson Controls International PLC / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Leggett & Platt Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Viatris Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 16: Focus on Almirall's US TRx trends</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">ALM.MC / 4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Almirall SA / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/27/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RDY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RDY / NVS / PFE / GSK / CPLFY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Dr Reddy's Laboratories Ltd / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Cipla Ltd / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / India / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / PFE / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / AZYO</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Aziyo Biologics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assuming coverage of ABBV, BMY, LLY, MRK, and PFE</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / ABBV=US / BMY=US / LLY.N / MRK.N / MRK=US / LLY=US / PFE=US</td><td class="leftalignment">Pfizer Inc / Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD / Ms. Nicole Germino</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">109</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / TEVA.N / ABBV.N / AGRX.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Agile Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">AXP / V / 2868165 / 2000019 / 2026242 / 2437071 / 2219224 / 2270726 / 2829515 / 2328915 / 2100920 / 2366799 / 2367480 / 2684703 / 2440637 / 2829601 / 2931034 / 7103065 / 2971029 / B121557 / B19FQ48 / 2713317 / B125XQ6 / 2983563 / B3D7K31 / B7TL820 / BFLR866 / BNGY4Q0 / BZ19F50 / BXDZ9Z0 / BDHF4K6 / BD8DJ71 / BZ1HM42 / BKTNTR9 / BMH0MR7 / BDZ30Q0 / BDRW1L7 / BD5GSZ4</td><td class="leftalignment">American Express Co / Visa Inc / Sysco Corp / Amazon.com Inc / American Electric Power Company Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Walt Disney Co / Edison International / Nextera Energy Inc / FirstEnergy Corp / Gentex Corp / Genuine Parts Co / Pfizer Inc / CenterPoint Energy Inc / Southern Co / Vertex Pharmaceuticals Inc / Novartis AG / LKQ Corp / Mastercard Inc / Amicus Therapeutics Inc / ACADIA Pharmaceuticals Inc / Portland General Electric Co / Carmax Inc / Discovery Inc / Meta Platforms Inc / Twitter Inc / Nextera Energy Partners LP / Veoneer Inc / Shopify Inc / CRISPR Therapeutics AG / Snap Inc / Adyen NV / ViacomCBS Inc / Zendesk Inc / Arvinas Inc / AnaptysBio Inc / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) - Model Update Post-Pfizer Collaboration; Increasing PT to $132</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / BDZ30Q0 / 2684703</td><td class="leftalignment">Pfizer Inc / Arvinas Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Pentathlon: Which Pharma's R&D Is Faster, Higher, Stronger?- Ahead of Curve</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / GB0009895292 / FR0000120578 / GB0009252882 / CH0012032048 / CH0012005267 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / DK0060534915 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Novo Nordisk A/S / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AEE.N / AES.N / AIG.N / AXP.N / BA.N / BAX.N / BDX.N / BMY.N / BSX.N / CAH.N / CB.N / CI.N / CL.N / CNC.N / CVS.N / DD.N / ECL.N / ED.N / EOG.N / F.N / FLT.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / OXY.N / PEG.N / PFE.N / SO.N / TEL.PS / TMO.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / UHS.N / MET.N / ADML.L / ETN.N / DUK.N / CMI.N / D.N / GD.N / PH.N / K.N / CAT.N / MCD.N / IFF.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / VMC.N / WEC.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / GWW.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / CHD.N / AME.N / VTR.N / CVX.N / MCO.N / PRU.N / L.N / COP.N / CNP.N / HAYS.L / AMGN.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DISH.OQ / ANSS.OQ / AMZN.OQ / TTWO.OQ / ZBRA.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ILMN.OQ / EQIX.OQ / ALGN.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / MSCI.N / VRSK.OQ / TSLA.OQ / NXPI.OQ / LYB.N / MSI.N / MPC.N / EA.OQ / PSX.N / WDC.OQ / NOW.N / FANG.OQ / ABBV.N / ZTS.N / CDW.OQ / MAR.OQ / NCLH.N / GOOGL.OQ / ANET.N / QRVO.OQ / ETSY.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / IQV.N / APTV.N / XEL.OQ / BKNG.OQ / WELL.N / FB.PS / CBOE.Z / CTVA.N / EXC.OQ / RTX.N / CARR.N / OTIS.N / HON.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Baxter International Inc / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cardinal Health Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / Centene Corp / CVS Health Corp / Dupont De Nemours Inc / Ecolab Inc / Consolidated Edison Inc / EOG Resources Inc / Ford Motor Co / Fleetcor Technologies Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Occidental Petroleum Corp / Public Service Enterprise Group Inc / Pfizer Inc / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Universal Health Services Inc / MetLife Inc / Admiral Group PLC / Eaton Corporation PLC / Duke Energy Corp / Cummins Inc / Dominion Energy Inc / General Dynamics Corp / Parker-Hannifin Corp / Kellogg Co / Caterpillar Inc / McDonald's Corp / International Flavors & Fragrances Inc / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Vulcan Materials Co / WEC Energy Group Inc / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / W W Grainger Inc / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Church & Dwight Co Inc / AMETEK Inc / Ventas Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Conocophillips / CenterPoint Energy Inc / Hays PLC / Amgen Inc / Apple Inc / Cerner Corp / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / DISH Network Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Zebra Technologies Corp / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Illumina Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / MSCI Inc / Verisk Analytics Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Motorola Solutions Inc / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / Western Digital Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / CDW Corp / Marriott International Inc / Norwegian Cruise Line Holdings Ltd / Alphabet Inc / Arista Networks Inc / Qorvo Inc / ETSY Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / IQVIA Holdings Inc / Aptiv PLC / Xcel Energy Inc / Booking Holdings Inc / Welltower Inc / San Miguel Food and Beverage Inc / Cboe Global Markets Inc / Corteva Inc / Exelon Corp / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ABOS: A Differentiated A  Approach; Initiate with an Outperform Rating, $26 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">ABOS.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / ROG.S / NOVN.S / AMGN.OQ / BIIB.OQ / PRTA.OQ / ACIU.OQ</td><td class="leftalignment">Acumen Pharmaceuticals Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Novartis AG / Amgen Inc / Biogen Inc / Prothena Corporation PLC / AC Immune SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.7% Above Pre-Pandemic Base- Week 68</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended July 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Breakfast to Discuss Topics in Dermatology on Friday, July 30, at 8:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / JNJ / LLY / ACRS / US0311621009 / US45337C1027 / US75886F1075 / US00289Y1073 / US0400476075 / US15117B2025 / US75382E1091 / VYNE</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Eli Lilly and Co / Aclaris Therapeutics Inc / Amgen Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Abeona Therapeutics Inc / Arena Pharmaceuticals Inc / Celldex Therapeutics Inc / Rapt Therapeutics Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 37148K100 / 02155H200 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / 81181C104 / 21900C308 / 877619106 / 04746L104 / 007002108 / M47364100 / 617760202 / N71542109 / 72942A107 / 76200L309</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Generation Bio Co / Altimmune Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Athira Pharma Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / PLx Pharma Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">2000019 / 2002305 / 2026242 / 2113393 / 2270726 / 2829515 / 2317087 / 2328915 / 2342034 / 2100920 / 2367480 / 2455965 / 2689560 / 2684703 / 2440637 / 2138158 / 2829601 / 2900335 / 2769796 / 2857817 / B3D7K31 / B7TL820 / BFLR866 / BYVY8G0 / BP4GNK9 / BD8DJ71 / BP7RS48 / BR4T3B3 / BFZ1K46 / BMYML02 / BLGJ610 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BDZ30Q0 / BMPRZV5 / BD5GSZ4 / BP7KZP7</td><td class="leftalignment">Amazon.com Inc / Abbott Laboratories / American Electric Power Company Inc / Boston Beer Company Inc / Walt Disney Co / Edison International / Entergy Corp / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Genuine Parts Co / Biogen Inc / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Sempra Energy / Southern Co / Tractor Supply Co / Fidelity National Information Services Inc / Netflix Inc / Discovery Inc / Meta Platforms Inc / Twitter Inc / Alphabet Inc / SAGE Therapeutics Inc / Snap Inc / Intersect Ent Inc / HubSpot Inc / Spotify Technology SA / DraftKings Inc / Warner Music Group Corp / Fox Corp / Vistra Corp / ViacomCBS Inc / Roku Inc / Arvinas Inc / Kymera Therapeutics Inc / Infrastructure and Energy Alternatives Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">2308.TW / 4502.T / AKZO.AS / ATCOA.ST / BA.N / BARC.L / CPG.L / CSL.AX / DNB.OL / EDP.LS / ELUXB.ST / ERICB.ST / HEIN.AS / HSBA.L / III.L / JNJ.N / LGEN.L / LLOY.L / LLY.N / PFE.N / RR.L / RYA.I / SAN.MC / SAPJ.J / SCHN.PA / SHBA.ST / SN.L / SOGN.PA / STAN.L / TW.L / ULVR.L / WLSNC.AS / WTB.L / AIR.PA / AZN.L / SASY.PA / TKAG.DE / ROG.S / LUN.CO / NOVN.S / ENEI.MI / MRCG.DE / DTEGN.F / UHR.S / NZYMB.CO / GSK.L / NEXS.PA / NKT.CO / UCB.BR / AMA.MC / ALFA.ST / AER.N / TOP.CO / NWG.L / MAERSKB.CO / KNIN.S / RIEN.S / LOGN.S / BEAN.S / IFCN.S / STMN.S / INGA.AS / YAR.OL / ASOS.L / PGHN.S / RMG.L / WCHG.DE / AKE.PA / TEVA.N / HOLN.S / KCOGN.DE / ERIC.OQ / MBTN.S / SKG.I / PRY.MI / ALM.MC / GRLS.MC / ZO1G.DE / BKGH.L / BNRGN.DE / AGES.BR / BASFN.DE / SHLG.DE / DKSH.S / ABBV.N / OCI.AS / FDEV.L / FBK.MI / UBSG.S / COTNE.S / ENPLQ.L / MEDA.S / SFOR.L / DEMANT.CO / MOVE.S / NWG.N</td><td class="leftalignment">Delta Electronics Inc / Takeda Pharmaceutical Co Ltd / Akzo Nobel NV / Atlas Copco AB / Boeing Co / Barclays PLC / Compass Group PLC / CSL Ltd / DNB Bank ASA / EDP Energias de Portugal SA / Electrolux AB / Telefonaktiebolaget LM Ericsson / Heineken NV / HSBC Holdings PLC / 3i Group PLC / Johnson & Johnson / Legal & General Group PLC / Lloyds Banking Group PLC / Eli Lilly and Co / Pfizer Inc / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Banco Santander SA / Sappi Ltd / Schneider Electric SE / Svenska Handelsbanken AB / Smith & Nephew PLC / Societe Generale SA / Standard Chartered PLC / Taylor Wimpey PLC / Unilever PLC / Wolters Kluwer NV / Whitbread PLC / Airbus SE / AstraZeneca PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / H Lundbeck A/S / Novartis AG / Enel SpA / Merck KGaA / Deutsche Telekom AG / Swatch Group AG / Novozymes A/S / GlaxoSmithKline PLC / Nexans SA / Nkt A/S / Ucb SA / Amadeus IT Group SA / Alfa Laval AB / AerCap Holdings NV / Topdanmark A/S / Natwest Group PLC / AP Moeller - Maersk A/S / Kuehne und Nagel International AG / Rieter Holding AG / Logitech International SA / Belimo Holding AG / Inficon Holding AG / Straumann Holding AG / ING Groep NV / Yara International ASA / ASOS PLC / Partners Group Holding AG / Royal Mail PLC / Wacker Chemie AG / Arkema SA / Teva Pharmaceutical Industries Ltd / Holcim AG / Kloeckner & Co SE / Telefonaktiebolaget LM Ericsson / Meyer Burger Technology AG / Smurfit Kappa Group PLC / Prysmian SpA / Almirall SA / Grifols SA / Zooplus AG / Berkeley Group Holdings PLC / Brenntag SE / Ageas SA / BASF SE / Siemens Healthineers AG / DKSH Holding AG / Abbvie Inc / OCI NV / Frontier Developments PLC / FinecoBank Banca Fineco SpA / UBS Group AG / Comet Holding AG / En+ Group MKPAO / Medartis Holding AG / S4 Capital PLC / Demant A/S / Medacta Group SA / Natwest Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / Norway / Portugal / Russian Federation / Sweden / Taiwan / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="even"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: July 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AEE.N / AES.N / AIG.N / AXP.N / BA.N / BDX.N / BMY.N / BSX.N / CB.N / CI.N / CL.N / CVS.N / DD.N / EOG.N / GE.N / GM.N / KMB.N / LLY.N / LMT.N / MCK.N / MO.N / MRK.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DUK.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / IFF.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / EMR.N / XOM.N / AMT.N / RMD.N / LIN.N / SHW.N / PKG.N / BLL.N / JCI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / REGN.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ILMN.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / MOS.N / DLR.N / VIAC.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / PPL.TO / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / ZTS.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / APTV.N / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / HON.OQ</td><td class="leftalignment">Abbott Laboratories / Ameren Corp / AES Corp / American International Group Inc / American Express Co / Boeing Co / Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Dupont De Nemours Inc / EOG Resources Inc / General Electric Co / General Motors Co / Kimberly-Clark Corp / Eli Lilly and Co / Lockheed Martin Corp / Mckesson Corp / Altria Group Inc / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Duke Energy Corp / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / International Flavors & Fragrances Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Resmed Inc / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Ball Corp / Johnson Controls International PLC / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Illumina Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Mosaic Co / Digital Realty Trust Inc / ViacomCBS Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Pembina Pipeline Corp / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Aptiv PLC / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) - New PFE Deal Positions ARV-471 as Potl. Best-in-Class ER Degrader, Removes Downside Scenario and Further Validates TPD Category</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / BDZ30Q0 / 2369174 / 2455965 / 2684703 / BMPRZV5 / BP7KZP7</td><td class="leftalignment">Pfizer Inc / Arvinas Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Kymera Therapeutics Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL THIS MORNING To Discuss Where The Pandemic Is Headed And the Future of COVID-19 Vaccines/ Treatments at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / LLY / MRK / PFE / CERC / AYTU / HGEN / IMAB</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Avalo Therapeutics Inc / Aytu Biopharma Inc / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">Louise Chen / Ms. Jennifer M. Kim / Brandon Folkes, CFA / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Price Action: July 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CL.N / COF.N / CVS.N / DD.N / DOW.N / EOG.N / FCX.N / GE.N / GM.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MCK.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / MET.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / MMM.N / EMR.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / TROW.OQ / SIVB.OQ / TT.N / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / O.N / ANSS.OQ / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EQIX.OQ / GPN.N / VRTX.OQ / MNST.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / TDG.N / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / MPC.N / EA.OQ / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / BKNG.OQ / FB.PS / EXC.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Colgate-Palmolive Co / Capital One Financial Corp / CVS Health Corp / Dupont De Nemours Inc / Dow Inc / EOG Resources Inc / Freeport-McMoRan Inc / General Electric Co / General Motors Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Mckesson Corp / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / MetLife Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / 3M Co / Emerson Electric Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / T Rowe Price Group Inc / SVB Financial Group / Trane Technologies PLC / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Realty Income Corp / ANSYS Inc / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Monster Beverage Corp / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / TransDigm Group Inc / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Marathon Petroleum Corp / Electronic Arts Inc / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / Exelon Corp / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - 2Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/22/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Pfizer Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Company Of The Day: Merck</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">FR0000054470 / US09061G1013 / US8816242098 / US00971T1016 / US02553E1064 / US0311621009 / US0366421065 / US09058V1035 / US30161Q1040 / US3755581036 / US4062161017 / US45337C1027 / US64125C1099 / US66987V1098 / US75886F1075 / US8305661055 / US91307C1027 / US92532F1003 / CA1363751027 / US64110L1061 / US09062X1037 / US0042251084 / US02043Q1076 / US2538681030 / US1696561059 / US29089Q1058 / US2521311074 / US45784P1012 / US53261M1045 / US03152W1099 / US0231112063 / US7181721090 / US46333X1081 / US9100471096 / US4464131063 / NL0010273215 / US5017971046 / US8036071004 / US4576693075 / US88338N1072 / IE00B4Q5ZN47 / US6951271005 / US74587V1070 / US8684591089 / US45845P1084 / US23283R1005 / US29428V1044 / US69366J2006 / US29664W1053 / US00771V1089 / US4277461020 / US5034596040 / US90400D1081 / US7613301099 / IE00BJ3V9050 / KYG8807B1068 / US78667J1088 / IE00BQPVQZ61 / US19249H1032 / US2681582019 / US31572Q8087 / CA89620X5064 / US29444U7000 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / US87184Q1076 / US36165L1089 / NL0012169213 / IL0011407140 / VGG111961055 / US04016X1019 / US87105L1044 / US8753722037 / US76243J1051 / US68404V1008 / US05455M1009 / CA0717341071 / KY30744W1070 / US8740602052 / US61775R1059 / US85205L1070 / US65487U1088 / US69353Y1038 / US81181C1045 / US55406W1036 / US92941V2097 / US25401T1088 / US35909D1090</td><td class="leftalignment">Ubisoft Entertainment SA / Biomarin Pharmaceutical Inc / Teva Pharmaceutical Industries Ltd / Akamai Technologies Inc / American Eagle Outfitters Inc / Amgen Inc / Antares Pharma Inc / BioCryst Pharmaceuticals Inc / Exelixis Inc / Gilead Sciences Inc / Halliburton Co / Incyte Corp / Neurocrine Biosciences Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Skechers USA Inc / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Canadian National Railway Co / Netflix Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Digital Realty Trust Inc / Chipotle Mexican Grill Inc / Emergent BioSolutions Inc / Dexcom Inc / Insulet Corp / Limelight Networks Inc / Amicus Therapeutics Inc / Amarin Corporation PLC / Philip Morris International Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / Huntington Ingalls Industries Inc / ASML Holding NV / Bath & Body Works Inc / Sarepta Therapeutics Inc / Insmed Inc / TherapeuticsMD Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc / Puma Biotechnology Inc / Supernus Pharmaceuticals Inc / Intercept Pharmaceuticals Inc / CyrusOne Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Revance Therapeutics Inc / Endo International PLC / Theravance Biopharma Inc / SAGE Therapeutics Inc / Horizon Therapeutics PLC / Coherus BioSciences Inc / Dynavax Technologies Corp / FibroGen Inc / Pfizer Inc / Equinix Inc / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Syros Pharmaceuticals Inc / GDS Holdings Ltd / Qiagen NV / Urogen Pharma Ltd / Biohaven Pharmaceutical Holding Company Ltd / argenx SE / Switch Inc / Tandem Diabetes Care Inc / Rhythm Pharmaceuticals Inc / OptiNose Inc / AVROBIO Inc / Bausch Health Companies Inc / Farfetch Ltd / Takeda Pharmaceutical Co Ltd / Morphic Holding Inc / SpringWorks Therapeutics Inc / Nkarta Inc / PMV Pharmaceuticals Inc / Seagen Inc / MYT Netherlands Parent BV / Vyne Therapeutics Inc / DigitalBridge Group Inc / Frontier Communications Parent Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Japan / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">SGEN Model Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US81181C1045 / CA89620X5064</td><td class="leftalignment">Seagen Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D. / Geoffrey Weiner, M.D., Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">MEDACorp Survey Provides Color on a Launch That Is a Shot in the Dark; $178 PT</td><td class="leftalignment">English</td><td class="rightalignment">54</td><td class="leftalignment">04351P101 / 71708110</td><td class="leftalignment">Ascendis Pharma A/S / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph P. Schwartz / Joori Park, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">BMRN: Roctavian 5yr Ph1/2 Update Continues to Suggest a Commercially Viable Product</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMRN.OQ / PFE.N / ROG.S / SGMO.OQ</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Pfizer Inc / Roche Holding AG / Sangamo Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief: U.S. vs. ROW: July 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DD.N / DOW.N / FCX.N / GE.N / JNJ.N / KMB.N / KO.N / LLY.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / PEG.N / PFE.N / PM.N / SLB.N / SO.N / TMO.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / ETN.N / DHR.N / CMI.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / PSA.N / V.N / EW.N / AWK.N / ARE.N / LEG.N / TWTR.N / AME.N / MTB.N / CVX.N / MCO.N / PRU.N / L.N / RF.N / COP.N / HAYS.L / INTC.OQ / AMGN.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / ATVI.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / MCHP.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / FIS.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / PSX.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / ANTM.N / ZBH.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dupont De Nemours Inc / Dow Inc / Freeport-McMoRan Inc / General Electric Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Eli Lilly and Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Eaton Corporation PLC / Danaher Corp / Cummins Inc / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Public Storage / Visa Inc / Edwards Lifesciences Corp / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Leggett & Platt Inc / Twitter Inc / AMETEK Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Prudential Financial Inc / Loews Corp / Regions Financial Corp / Conocophillips / Hays PLC / Intel Corp / Amgen Inc / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Activision Blizzard Inc / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Microchip Technology Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Fidelity National Information Services Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Phillips 66 / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Anthem Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol.12): Japan now at over 70mn total doses</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">07/21/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.12）：国内ワクチン総接種、7,000万回を超える</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Johnson & Johnson In Q2?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">2Q21 EPS preview - model changes & updated perspectives</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Trillium Therapeutics Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 20 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">NL0000226223 / DE0006231004 / DE0007164600 / US00724F1012 / US0079031078 / US0231351067 / US02553E1064 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1265011056 / US1266501006 / US14149Y1082 / US1727551004 / US17275R1023 / US1924461023 / US22160K1051 / US2545431015 / US2910111044 / US30226D1063 / US3156161024 / US3647601083 / US37733W1053 / US4456581077 / US45167R1041 / US4567881085 / US4581401001 / US48203R1041 / US4824801009 / US5002551043 / US5128071082 / US5184151042 / US5261071071 / US5324571083 / US5370081045 / US55306N1046 / US5719032022 / US58155Q1031 / US5949181045 / US5950171042 / US5951121038 / US6556641008 / US66987V1098 / US6701002056 / US67066G1040 / US6821891057 / US68389X1054 / US7170811035 / US7274931085 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8030542042 / US8168501018 / US8269191024 / US8610121027 / US8725401090 / US87612E1064 / US9282981086 / US9311421039 / US9581021055 / US9839191015 / IL0010824113 / US03073E1055 / US83088M1027 / US80105N1054 / US21036P1084 / US1572101053 / US79466L3024 / US6098391054 / US82706C1080 / US55616P1049 / US88076W1036 / US90384S3031 / IE00B4BNMY34 / US58933Y1055 / US4485791028 / US34959E1091 / NL0009538784 / US03027X1000 / US30212P3038 / US8969452015 / US29414B1044 / US00287Y1091 / US98978V1035 / US5017971046 / US81762P1021 / US98138H1014 / US55405Y1001 / US8486371045 / US6974351057 / KYG037AX1015 / US9222801022 / US98936J1016 / US0404131064 / US0396971071 / LU0974299876 / IL0011334468 / US4435731009 / US0994061002 / US64829B1008 / US22822V1017 / US74736K1016 / US74624M1027 / GB00BZ09BD16 / US90138F1021 / IE00BY7QL619 / US89686D1054 / US43300A2033 / US78410G1040 / US02156B1035 / US23355L1061 / US6792951054 / US03782L1017 / US8760301072 / US76674Q1076 / VGG273581030 / US09354A1007 / US09857L1089 / US98980G1022 / US11135F1012 / US2575541055 / US29260V1052 / US28414H1032 / CA64079L1058 / KY30744W1070 / US69553P1003 / IL0011571556 / US22788C1053 / US39874R1014 / US18915M1071 / US89677Q1076 / IE00BK9ZQ967 / US39813G1094 / US14448C1045 / GB00BMVP7Y09 / US8334451098 / US07373B1098 / US86646P1030 / US74767V1098 / US0090661010 / US7761531083 / US55406W1036 / US15961R1059 / US49926T1043 / US90364P1057 / US5738741041 / US68622V1061 / IL0011762130 / US20717M1036 / US02080L1026 / IE000GID8VI0 / US28623U1016 / US38870X1046</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / SAP SE / Adobe Inc / Advanced Micro Devices Inc / Amazon.com Inc / American Eagle Outfitters Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / CTS Corp / CVS Health Corp / Cardinal Health Inc / Cirrus Logic Inc / Cisco Systems Inc / Cognizant Technology Solutions Corp / Costco Wholesale Corp / Diodes Inc / Emerson Electric Co / Extreme Networks Inc / F5 Inc / Gap Inc / GlaxoSmithKline PLC / J B Hunt Transport Services Inc / IDEX Corp / Infosys Ltd / Intel Corp / Juniper Networks Inc / KLA Corp / Kohls Corp / Lam Research Corp / Lattice Semiconductor Corp / Lennox International Inc / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Marriott International Inc / Mckesson Corp / Microsoft Corp / Microchip Technology Inc / Micron Technology Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / ON Semiconductor Corp / Oracle Corp / Pfizer Inc / Plantronics Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SAP SE / Semtech Corp / Silicon Laboratories Inc / STMicroelectronics NV / TJX Companies Inc / Target Corp / Vishay Intertechnology Inc / Walmart Inc / Western Digital Corp / Xilinx Inc / Check Point Software Technologies Ltd / Amerisourcebergen Corp / Skyworks Solutions Inc / Sanofi SA / Constellation Brands Inc / CEVA Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Macy's Inc / Teradata Corp / Ulta Beauty Inc / Accenture PLC / Merck & Co Inc / Hyatt Hotels Corp / Fortinet Inc / NXP Semiconductors NV / American Tower Corp / Expedia Group Inc / Tripadvisor Inc / Epam Systems Inc / Abbvie Inc / Zoetis Inc / Bath & Body Works Inc / ServiceNow Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Palo Alto Networks Inc / Ambarella Inc / Varonis Systems Inc / Zendesk Inc / Arista Networks Inc / Ardelyx Inc / Globant SA / Cyberark Software Ltd / HubSpot Inc / Boot Barn Holdings Inc / New Relic Inc / Crown Castle International Corp / Qorvo Inc / Pure Storage Inc / Atlassian Corporation PLC / Twilio Inc / Johnson Controls International PLC / Trivago NV / Hilton Worldwide Holdings Inc / SBA Communications Corp / Alteryx Inc / DXC Technology Co / Okta Inc / Appian Corp / Tapestry Inc / Rimini Street Inc / Despegar.com Corp / Blink Charging Co / Booking Holdings Inc / Zscaler Inc / Broadcom Inc / Domo Inc / Endava PLC / Elanco Animal Health Inc / Neptune Wellness Solutions Inc / Farfetch Ltd / PagerDuty Inc / Tufin Software Technologies Ltd / CrowdStrike Holdings Inc / Grocery Outlet Holding Corp / Cloudflare Inc / Trip.com Group Ltd / Trane Technologies PLC / Grid Dynamics Holdings Inc / Carrier Global Corp / Royalty Pharma PLC / Snowflake Inc. / Beam Global / Sumo Logic Inc / Quantumscape Corp / Airbnb Inc / Romeo Power Inc / MYT Netherlands Parent BV / ChargePoint Holdings Inc / Knowbe4 Inc / UiPath Inc / Marvell Technology Inc / Organon & Co / Monday.Com Ltd / Confluent Inc / Alpha Teknova Inc / GH Research PLC / Elevation Oncology Inc / Graphite Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AIN / AN=US / MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / CAG=US / HD=US / KO=US / MCD=US / TWTR=US / CL=US / PG=US / WEN=US / PLD=US / T=US / BLD=US / INCY=US / TEVA=US / APA=US / LOW=US / ENR=US / CHRS=US / BRO=US / LEG=US / ATVI=US / VMC=US / NWL=US / MLM=US / FLO=US / STZ=US / DISH=US / WTFC=US / AIR=US / SWIM=US / ATRO=US / B=US / BMRN=US / CBRL=US / CENT=US / CHD=US / CW=US / DRI=US / DCO=US / EPC=US / AJG=US / GFF=US / HAIN=US / HEI=US / HXL=US / IBP=US / MAS=US / MRCY=US / MHK=US / PACW=US / REGI=US / ROLL=US / SMG=US / SNAP=US / TGI=US / VSEC=US / WIX=US / POST=US / ZION=US / FB=US / FBK=US / SPR=US / NTRA=US / DIN=US / MGP=US / MGPI=US / MNST=US / NOMD=US / RPD=US / RNG=US / TPX=US / MOG.A=US / EXP=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / TDG=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / KTOS=US / TIL=US / JACK=US / AAN=US / UTZ=US / TREX=US / WWD=US / FBHS=US / TILE=US / NDLS=US / FIVN=US / 00770K202 / LOCO=US / NVRO=US / SHAK=US / AJRD=US / BWXT=US / WING=US / WLTW=US / 82982L103 / JELD=US / IOVA=US / PETQ=US / MAXR=US / KDP=US / FERG=US / LHX=US / BRBR=US / REYN=US / SPCE=US / AZEK=US / VTRS=US / HYFM=US / 67421J108</td><td class="leftalignment">Albany International Corp / AutoNation Inc / Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Conagra Brands Inc / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Twitter Inc / Colgate-Palmolive Co / Procter & Gamble Co / Wendys Co / Prologis Inc / AT&T Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / APA Corp (US) / Lowe's Companies Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Brown & Brown Inc / Leggett & Platt Inc / Activision Blizzard Inc / Vulcan Materials Co / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Constellation Brands Inc / DISH Network Corp / Wintrust Financial Corp / AAR Corp / Latham Group Inc / Astronics Corp / Barnes Group Inc / Biomarin Pharmaceutical Inc / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Ducommun Inc / Edgewell Personal Care Co / Arthur J Gallagher & Co / Griffon Corp / Hain Celestial Group Inc / HEICO Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / RBC Bearings Inc / Scotts Miracle-Gro Co / Snap Inc / Triumph Group Inc / VSE Corp / Wix.Com Ltd / Post Holdings Inc / Zions Bancorporation NA / Meta Platforms Inc / FB Financial Corp / Spirit AeroSystems Holdings Inc / Natera Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Nomad Foods Ltd / Rapid7 Inc / RingCentral Inc / Tempur Sealy International Inc / Moog Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / TransDigm Group Inc / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / Instil Bio Inc / Jack in the Box Inc / Aaron's Company Inc / UTZ Brands Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Five9 Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Nevro Corp / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / BWX Technologies Inc / Wingstop Inc / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Iovance Biotherapeutics Inc / PetIQ Inc / Maxar Technologies Inc / Keurig Dr Pepper Inc / Ferguson PLC / L3harris Technologies Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Azek Company Inc / Viatris Inc / Hydrofarm Holdings Group Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Luxembourg / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2732635 / 2942605 / 2219224 / 2270726 / 2829515 / 2328915 / 2684703 / 2829601 / 2900335 / 2980906 / 2503529 / 7103065 / B17HG57 / B121557 / 2857817 / B7TL820 / B4MG4Z6 / B7VD3F2 / BFLR866 / BYNZGK1 / BP7RS48 / BFMXGR0 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BDT5KT5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / AutoNation Inc / Avista Corp / CMS Energy Corp / Walt Disney Co / Edison International / Nextera Energy Inc / Pfizer Inc / Southern Co / Tractor Supply Co / Foot Locker Inc / World Wrestling Entertainment Inc / Novartis AG / Cardiovascular Systems Inc / Mastercard Inc / Netflix Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Twitter Inc / Block Inc / Intersect Ent Inc / Evergy Inc / Fox Corp / Spire Inc / ViacomCBS Inc / Inspire Medical Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q2:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma - 2Q21 Quarterly Prep Pack</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / LONN.S / GSK.L / UCB.BR / IPN.PA / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Israel / Italy / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Future Forecasts: July 20, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / COF.N / DOW.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / PXD.N / UHS.N / HAL.N / ETN.N / DHR.N / DOV.N / ROP.N / CAT.N / UNP.N / MCD.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / LIN.N / SHW.N / PKG.N / VZ.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / FISV.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / O.N / AMZN.OQ / TTWO.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / ISRG.OQ / EQIX.OQ / GPN.N / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / NDAQ.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / CME.OQ / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / TMUS.OQ / CSX.OQ / FB.PS / UAL.OQ / RTX.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Capital One Financial Corp / Dow Inc / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Pioneer Natural Resources Co / Universal Health Services Inc / Halliburton Co / Eaton Corporation PLC / Danaher Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / Verizon Communications Inc / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Fiserv Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Realty Income Corp / Amazon.com Inc / Take-Two Interactive Software Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Intuitive Surgical Inc / Equinix Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Nasdaq Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / CME Group Inc / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / T-Mobile US Inc / CSX Corp / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations: State of the CRO Industry: Sustained Healthy Biotech Funding; CT.gov Analysis; CRO Deal Activity Update</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">CRL.N / IQV.N / PFE.N / TMO.N / DGX.N / LH.N / WST.N / ICLR.OQ / CTLT.N / MEDP.OQ / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Charles River Laboratories International Inc / IQVIA Holdings Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / West Pharmaceutical Services Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane</td></tr>
<tr class="even"><td class="leftalignment">07/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: 2H21 Outlook: Sector fundamentals remain strong, quantifying company catalysts</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">0867.HK / 1515.HK / 1066.HK / 1093.HK / PFE.N / AZN.L / 1177.HK / NOVN.S / 0241.HK / 0853.HK / 2196.HK / 000538.SZ / 600196.SS / 600276.SS / MRNA.OQ / JD.OQ / BGNE.OQ / 2269.HK / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / 1951.HK / 2500.HK / 6618.HK / 9618.HK / GTH.OQ / 1952.HK / 2142.HK / 2160.HK</td><td class="leftalignment">China Medical System Holdings Ltd / China Resources Medical Holdings Company Ltd / Shandong Weigao Group Medical Polymer Co Ltd / CSPC Pharmaceutical Group Ltd / Pfizer Inc / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Novartis AG / Alibaba Health Information Technology Ltd / Microport Scientific Corp / Shanghai Fosun Pharmaceutical Group Co Ltd / Yunnan Baiyao Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Jiangsu Hengrui Pharmaceuticals Co Ltd / Moderna Inc / JD.Com Inc / Beigene Ltd / WuXi Biologics (Cayman) Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Jinxin Fertility Group Ltd / Venus Medtech Hangzhou Inc / JD Health International Inc / JD.Com Inc / Genetron Holdings Ltd / Everest Medicines Ltd / Hbm Holdings Ltd / Microport Cardioflow Medtech Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Higher Value Biopharm Business, Solid Yield, Compelling Valuation Drive Outlook</td><td class="leftalignment">English</td><td class="rightalignment">103</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1205</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09 / US68622V1061</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC / Organon & Co</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 09, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jul 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">FR0000121014 / FR0000054470 / US0028241000 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1567821046 / US1925761066 / US22284P1057 / US2855121099 / US2944291051 / US3021301094 / US3377381088 / US37733W1053 / US4433201062 / US4456581077 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5763231090 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US74762E1029 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8807701029 / US9029251066 / US91347P1057 / US91913Y1001 / US92343V1044 / US9507551086 / US37940X1028 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US20030N1019 / US21036P1084 / US3463751087 / US90385V1070 / US12541W2098 / US00206R1023 / US31620M1062 / US1314761032 / US57636Q1040 / US78709Y1055 / PAP310761054 / US75025X1000 / US3364331070 / US01748X1028 / US2473617023 / US25470M1099 / US7181721090 / US92826C8394 / US00507V1098 / DE000A0DJ6J9 / US58933Y1055 / US39304D1028 / US9100471096 / US3390411052 / US4361061082 / US56585A1025 / US8676524064 / US98986T1088 / US7185461040 / US9837931008 / US96208T1043 / US69318G1067 / US00287Y1091 / NL0010273215 / US98978V1035 / US8725901040 / US29355A1079 / PR30040P1032 / US69366J2006 / US00847X1046 / US8485771021 / US21240E1055 / CH0210483332 / US90184L1026 / US02376R1023 / US03937C1053 / KYG8807B1068 / US69888T2078 / US94419L1017 / CA0089118776 / US83417M1045 / US09627Y1091 / US12685J1051 / US89400J1079 / US70450Y1038 / CA1380351009 / US8522341036 / US16119P1084 / KYG4740B1059 / CA87241L1094 / GB00BDSFG982 / US83304A1060 / US23753F1075 / US80689H1023 / US05722G1004 / US24665A1034 / US02156K1034 / US4990491049 / US26927E1047 / US46571Y1073 / US74275G1076 / US5904791358 / CA39342L1085 / US28414H1032 / KY30744W1070 / US26142R1041 / US22041X1028 / CA67079A1021 / US04271T1007 / US11778X1046 / US72815L1070 / US55406W1036 / US82489W1071 / US30320C1036 / BMG6964L1072 / US20717M1036 / US61225M1027</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Ubisoft Entertainment SA / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cerner Corp / Cohu Inc / Covenant Logistics Group Inc / Electronic Arts Inc / Equifax Inc / Expeditors International of Washington Inc / Fiserv Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / MasTec Inc / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Quanta Services Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teradyne Inc / USA Truck Inc / Universal Display Corp / Valero Energy Corp / Verizon Communications Inc / Werner Enterprises Inc / Global Payments Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / Comcast Corp / Constellation Brands Inc / FormFactor Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / AT&T Inc / Fidelity National Information Services Inc / Calumet Specialty Products Partners LP / Mastercard Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / DISH Network Corp / Philip Morris International Inc / Visa Inc / Activision Blizzard Inc / SMA Solar Technology AG / Merck & Co Inc / Green Dot Corp / United Airlines Holdings Inc / Fleetcor Technologies Inc / HollyFrontier Corp / Marathon Petroleum Corp / SunPower Corp / Zynga Inc / Phillips 66 / XPO Logistics Inc / WEX Inc / PBF Energy Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / T-Mobile US Inc / Enphase Energy Inc / Evertec Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / Twitter Inc / American Airlines Group Inc / ArcBest Corp / Theravance Biopharma Inc / Par Pacific Holdings Inc / Wayfair Inc / Air Canada / Solaredge Technologies Inc / Blueprint Medicines Corp / Cable One Inc / TransUnion / PayPal Holdings Inc / Canopy Growth Corp / Block Inc / Charter Communications Inc / Ichor Holdings Ltd / TFI International Inc / TechnipFMC PLC / Snap Inc / Daseke Inc / Schneider National Inc / Baker Hughes Co / Delek US Holdings Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / EVO Payments Inc / I3 Verticals Inc / Priority Technology Holdings Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Farfetch Ltd / DraftKings Inc / Corsair Gaming Inc / Nuvei Corp / Array Technologies Inc / BTRS Holdings Inc / Playtika Holding Corp / MYT Netherlands Parent BV / Shoals Technologies Group Inc / FTC Solar Inc / Paysafe Ltd / Confluent Inc / Monte Rosa Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Puerto Rico / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABF.L / AEP.N / AES.N / ALV.N / CB.N / CCK.N / CL.N / DFDS.CO / EIX.N / EL.N / F.N / FOUG.PA / GM.N / GPS.N / KMB.N / KO.N / MO.N / MRK.N / NA / NEM.N / PD.N / PFE.N / PPG.N / RWEG.DE / SO.N / T.N / WMT.N / SSE.L / PEP.N / BFb.N / PG.N / CPB.N / CMCSA.O / THC.N / UHS.N / FER.MC / MET.N / DUK.N / DIS.N / LEA.N / K.N / DISH.O / CLX.N / CAG.N / MRO.N / GIS.N / EPC.N / KGC.N / BBVA.MC / JAZZ.O / SHW.N / NG.L / VZ.N / STT.N / HCA.N / CYH.N / XEL.N / STZ.N / RRC.N / FISV.O / EQT.N / V.N / CPT.N / ROST.O / CHTR.O / RPM.N / CHD.N / NWN.N / SAM.N / BMRN.O / ENR.N / CEY.L / NCR.N / GPK.N / ALFA.ST / ENDP.O / MEOH.O / CPK.N / SWN.N / SR.N / SGEN.OQ / GPN.N / MNST.O / GOLD.N / TFC.N / FHN.N / EDV.TO / DLR.N / VIAC.O / 427866108 / WAL.N / EDF.PA / DISCA.O / SJW.N / CMG.N / FIS.N / CFR.S / ADP.PA / TEVA.N / MA.N / CLR.N / BGS.N / HOCM.L / GETP.PA / FRES.L / EDPR.LS / NGD.A / SWI.N / SPB.N / NEE.N / MTDR.N / XYL.N / SPLK.OQ / MDLZ.OQ / ADT.N / FANG.O / ABBV.N / PRGO.N / PRMW.N / TMUS.N / VOYA.N / COTY.N / FOXA.OQ / PRTA.O / BEP.N / COUP.N / BTG.N / HQY.OQ / ZALG.DE / AXTA.N / GBT.OQ / RUN.O / SQ.N / MESO.O / SRENH.S / AZRE.N / TTD.O / GDS.O / LGFB.N / OKTA.OQ / WOW.N / ATUS.N / AQUA.N / SAIL.N / AMRX.N / NTGY.MC / KDP.N / NWL.O / GMAB.O / DOCU.N / PEAK.N / AZEK.N / WTRG.N / REYN.O / CARR.N / FOUR.N / NRIX.OQ / LUMN.N / LSEG.L / WFG.N / AFRM.O / NAPA.N / OTLY.O / BHG.N / FA.OQ / TRMR.OQ / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / AES Corp / Autoliv Inc / Chubb Ltd / Crown Holdings Inc / Colgate-Palmolive Co / DFDS AS / Edison International / Estee Lauder Companies Inc / Ford Motor Co / Eiffage SA / General Motors Co / Gap Inc / Kimberly-Clark Corp / Coca-Cola Co / Altria Group Inc / Merck & Co Inc / National Bank of Canada / Newmont Corporation / PagerDuty Inc / Pfizer Inc / PPG Industries Inc / Rwe AG / Southern Co / AT&T Inc / Walmart Inc / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Comcast Corp / Tenet Healthcare Corp / Universal Health Services Inc / Ferrovial SA / MetLife Inc / Duke Energy Corp / Walt Disney Co / Lear Corp / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / Edgewell Personal Care Co / Kinross Gold Corp / Banco Bilbao Vizcaya Argentaria SA / Jazz Pharmaceuticals PLC / Sherwin-Williams Co / National Grid PLC / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Xcel Energy Inc / Constellation Brands Inc / Range Resources Corp / Fiserv Inc / EQT Corp / Visa Inc / Camden Property Trust / Ross Stores Inc / Charter Communications Inc / RPM International Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Energizer Holdings Inc / Centamin PLC / NCR Corp / Graphic Packaging Holding Co / Alfa Laval AB / Endo International PLC / Methanex Corp / Chesapeake Utilities Corp / Southwestern Energy Co / Spire Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Barrick Gold Corp / Truist Financial Corp / First Horizon Corp / Endeavour Mining PLC / Digital Realty Trust Inc / ViacomCBS Inc / Hershey Co / Western Alliance Bancorp / Electricite de France SA / Discovery Inc / SJW Group / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Compagnie Financiere Richemont SA / Aeroports de Paris SA / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Continental Resources Inc / B&G Foods Inc / Hochschild Mining PLC / Getlink SE / Fresnillo PLC / EDP Renovaveis SA / New Gold Inc / SolarWinds Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Matador Resources Co / Xylem Inc / Splunk Inc / Mondelez International Inc / ADT Inc / Diamondback Energy Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Voya Financial Inc / Coty Inc / Fox Corp / Prothena Corporation PLC / Brookfield Renewable Partners LP / Coupa Software Inc / B2Gold Corp / Healthequity Inc / Zalando SE / Axalta Coating Systems Ltd / Global Blood Therapeutics Inc / Sunrun Inc / Block Inc / Mesoblast Ltd / Swiss Re AG / Azure Power Global Ltd / Trade Desk Inc / GDS Holdings Ltd / Lions Gate Entertainment Corp / Okta Inc / WideOpenWest Inc / Altice USA Inc / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Amneal Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / DocuSign Inc / Healthpeak Properties Inc / Azek Company Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / London Stock Exchange Group PLC / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Oatly Group AB / Bright Health Group Inc / First Advantage Corp / Tremor International Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Mauritius / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GLUE (BUY) - Molecular Glue - Differentiated Approach to Targeted Protein Degradation - Initiating Coverage with a BUY Rating and $30 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BP7KZP7 / 5671735 / 0989529 / 0925288 / 2126335 / 2023607 / 2369174 / 2455965 / 2684703 / 2573083 / 2931034 / 7103065 / BBFL7S1 / BDHF4K6 / BZ8FPH3 / BWY52P3 / BDZ30Q0 / BN2R582 / BDD1B07 / BMPRZV5 / BMDJ397 / BN2RM92</td><td class="leftalignment">Monte Rosa Therapeutics Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Gilead Sciences Inc / Biogen Inc / Pfizer Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Novartis AG / bluebird bio Inc / CRISPR Therapeutics AG / Editas Medicine Inc / Blueprint Medicines Corp / Arvinas Inc / Relay Therapeutics Inc / Rubius Therapeutics Inc / Kymera Therapeutics Inc / Bolt Biotherapeutics Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">07/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Earnings Brief & Calendar: July 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ABT.N / AXP.N / BA.N / BAX.N / BMY.N / BSX.N / CB.N / CCI.N / CL.N / CNC.N / COF.N / DOW.N / ECL.N / F.N / FCX.N / GE.N / IBM.N / JNJ.N / KMB.N / KO.N / LMT.N / LUV.N / MMC.N / MO.N / MRK.N / NEM.N / NSC.N / OMC.N / PFE.N / PM.N / PPG.N / SLB.N / SO.N / TEL.PS / TMO.N / TRV.N / WMB.N / SPG.N / PG.N / WY.N / PXD.N / HUM.N / NUE.N / UHS.N / HAL.N / ADML.L / ETN.N / DHR.N / FE.N / GD.N / DOV.N / ROP.N / CAT.N / IPG.N / UNP.N / MCD.N / YUM.N / VNO.N / SYK.N / UPS.N / WM.N / ITW.N / MMM.N / XOM.N / AMT.N / WHR.N / LIN.N / SHW.N / PKG.N / GWW.N / VZ.N / STT.N / HCA.N / JCI.N / DHI.N / AMP.N / VFC.N / KMI.N / EFX.N / V.N / EW.N / ARE.N / PLD.N / CHD.N / TWTR.N / MTB.N / CVX.N / MCO.N / RF.N / HAYS.L / INTC.OQ / AAPL.OQ / CERN.OQ / FISV.OQ / JBHT.OQ / KLAC.OQ / LRCX.OQ / MSFT.OQ / NTRS.OQ / TROW.OQ / SIVB.OQ / ZION.OQ / SBUX.OQ / IDXX.OQ / QCOM.OQ / GILD.OQ / DFS.N / TSCO.OQ / O.N / POOL.OQ / AMZN.OQ / TTWO.OQ / VRSN.OQ / FFIV.OQ / SBAC.OQ / CHTR.OQ / EXPE.OQ / ISRG.OQ / EQIX.OQ / ALGN.OQ / GPN.N / FITB.OQ / VRTX.OQ / NFLX.OQ / TXN.OQ / CMCSA.OQ / BIIB.OQ / MOS.N / DLR.N / MKTX.OQ / LVS.N / NDAQ.OQ / DXCM.OQ / CDNS.OQ / ICE.N / CMG.N / STX.AX / ADP.PA / ES.N / NVR.N / CME.OQ / MSCI.N / SCHW.N / NEE.N / TSLA.OQ / NXPI.OQ / LYB.N / KEY.TO / BKR.N / NOW.N / FANG.OQ / ABBV.N / GOOGL.OQ / ANET.N / SYF.N / CFG.N / ANTM.N / PYPL.OQ / CSX.OQ / IQV.N / XEL.OQ / WELL.N / FB.PS / UAL.OQ / RTX.N / CARR.N / OTIS.N / AEP.OQ / HON.OQ</td><td class="leftalignment">Abbott Laboratories / American Express Co / Boeing Co / Baxter International Inc / Bristol-Myers Squibb Co / Boston Scientific Corp / Chubb Ltd / Crown Castle International Corp / Colgate-Palmolive Co / Centene Corp / Capital One Financial Corp / Dow Inc / Ecolab Inc / Ford Motor Co / Freeport-McMoRan Inc / General Electric Co / International Business Machines Corp / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Lockheed Martin Corp / Southwest Airlines Co / Marsh & McLennan Companies Inc / Altria Group Inc / Merck & Co Inc / Newmont Corporation / Norfolk Southern Corp / Omnicom Group Inc / Pfizer Inc / Philip Morris International Inc / PPG Industries Inc / Schlumberger NV / Southern Co / PLDT Inc / Thermo Fisher Scientific Inc / Travelers Companies Inc / Williams Companies Inc / Simon Property Group Inc / Procter & Gamble Co / Weyerhaeuser Co / Pioneer Natural Resources Co / Humana Inc / Nucor Corp / Universal Health Services Inc / Halliburton Co / Admiral Group PLC / Eaton Corporation PLC / Danaher Corp / FirstEnergy Corp / General Dynamics Corp / Dover Corp / Roper Technologies Inc / Caterpillar Inc / Interpublic Group of Companies Inc / Union Pacific Corp / McDonald's Corp / Yum! Brands Inc / Vornado Realty Trust / Stryker Corp / United Parcel Service Inc / Waste Management Inc / Illinois Tool Works Inc / 3M Co / Exxon Mobil Corp / American Tower Corp / Whirlpool Corp / Linde PLC / Sherwin-Williams Co / Packaging Corp of America / W W Grainger Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Johnson Controls International PLC / D R Horton Inc / Ameriprise Financial Inc / VF Corp / Kinder Morgan Inc / Equifax Inc / Visa Inc / Edwards Lifesciences Corp / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / Twitter Inc / M&T Bank Corp / Chevron Corp / Moody's Corp / Regions Financial Corp / Hays PLC / Intel Corp / Apple Inc / Cerner Corp / Fiserv Inc / J B Hunt Transport Services Inc / KLA Corp / Lam Research Corp / Microsoft Corp / Northern Trust Corp / T Rowe Price Group Inc / SVB Financial Group / Zions Bancorporation NA / Starbucks Corp / IDEXX Laboratories Inc / Qualcomm Inc / Gilead Sciences Inc / Discover Financial Services / Tractor Supply Co / Realty Income Corp / Pool Corp / Amazon.com Inc / Take-Two Interactive Software Inc / Verisign Inc / F5 Inc / SBA Communications Corp / Charter Communications Inc / Expedia Group Inc / Intuitive Surgical Inc / Equinix Inc / Align Technology Inc / Global Payments Inc / Fifth Third Bancorp / Vertex Pharmaceuticals Inc / Netflix Inc / Texas Instruments Inc / Comcast Corp / Biogen Inc / Mosaic Co / Digital Realty Trust Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Nasdaq Inc / Dexcom Inc / Cadence Design Systems Inc / Intercontinental Exchange Inc / Chipotle Mexican Grill Inc / Strike Energy Ltd / Aeroports de Paris SA / Eversource Energy / NVR Inc / CME Group Inc / MSCI Inc / Charles Schwab Corp / Nextera Energy Inc / Tesla Inc / NXP Semiconductors NV / LyondellBasell Industries NV / Keyera Corp / Baker Hughes Co / ServiceNow Inc / Diamondback Energy Inc / Abbvie Inc / Alphabet Inc / Arista Networks Inc / Synchrony Financial / Citizens Financial Group Inc / Anthem Inc / PayPal Holdings Inc / CSX Corp / IQVIA Holdings Inc / Xcel Energy Inc / Welltower Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / Raytheon Technologies Corp / Carrier Global Corp / Otis Worldwide Corp / American Electric Power Company Inc / Honeywell International Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / France / United Kingdom / Ireland / Netherlands / Philippines / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/18/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AMRX.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Amneal Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">83</td><td class="leftalignment">ACRS / ALKS / AMRN / CDTX / CERS / COLL / COX / EBS / GRAY / HCM / JAZZ / JNJ / LLY / MRK / MSB / NOVN / PFE / RMTI / SIBN / SMTI / CKPT / BDSI / UBX / ACRX / ARDX / ANIP / CERC / ARDS / CUTR / BSLN / MNKD / ARAV / SPRO / ZTS / OMER / AXGN / TXMD / HRTX / TRVN / AERI / SCYX / EGRX / LPCN / CFRX / FBIO / SPNE / JAGX / AYTU / VRAY / VERU / EYPT / EOLS / PDSB / ETTX / HGEN / ARQT / IMAB / PCVX / SRGA / VYNE / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Alkermes Plc / Amarin Corporation PLC / Cidara Therapeutics Inc / Cerus Corp / Collegium Pharmaceutical Inc / Nicox SA / Emergent BioSolutions Inc / Graybug Vision Inc / HUTCHMED (China) Ltd / Jazz Pharmaceuticals PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Novan Inc / Pfizer Inc / Rockwell Medical Inc / SI-BONE Inc / Sanara Medtech Inc / Checkpoint Therapeutics Inc / BioDelivery Sciences International Inc / UNITY Biotechnology Inc / AcelRx Pharmaceuticals Inc / Ardelyx Inc / ANI Pharmaceuticals Inc / Avalo Therapeutics Inc / Aridis Pharmaceuticals Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Aravive Inc / Spero Therapeutics Inc / Zoetis Inc / Omeros Corp / AxoGen Inc / TherapeuticsMD Inc / Heron Therapeutics Inc / Trevena Inc / Aerie Pharmaceuticals Inc / SCYNEXIS Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / ContraFect Corp / Fortress Biotech Inc / SeaSpine Holdings Corp / Jaguar Health Inc / Aytu Biopharma Inc / ViewRay Inc / Veru Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / PDS Biotechnology Corp / Entasis Therapeutics Holdings Inc / Humanigen Inc / Arcutis Biotherapeutics Inc / I-Mab / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Nice Way To End The Week, VAXNEUVANCE Approval Opens An Opportunity For MRK</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / PFE / PCVX</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Vaxcyte Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 67</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ACAD / ACET / ALLO / ALT / AMTI / MRTX / SPPI / STRO / TRIL / CRTX / ARNA / SGEN / CLSD / 45337C10 / 09058V10 / TPTX / 00422510 / 84763A108 / CRMD / ZGNX / ABUS / 29251M106 / 23282W605 / OCUL / PRQR / 89620X506 / BPMC / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / NTLA / PTGX / CRSP / PLXP / RZLT / 81750R102 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 54142F102 / 019770106 / AQST / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / BCYC / 37148K100 / 02155H200 / 74366E102 / RLAY / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 4525EP101 / 56854Q200 / ATHA / TSHA / 81181C104 / 21900C308 / 877619106 / 04746L104 / 007002108 / M47364100 / 617760202 / N71542109 / 72942A107 / 76200L309</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Adicet Bio Inc / Allogene Therapeutics Inc / Altimmune Inc / Applied Molecular Transport Inc. / Mirati Therapeutics Inc / Spectrum Pharmaceuticals Inc / Sutro Biopharma Inc / Pfizer Inc / Cortexyme Inc / Arena Pharmaceuticals Inc / Seagen Inc / Clearside Biomedical Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Turning Point Therapeutics Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / CorMedix Inc / Zogenix Inc / Arbutus Biopharma Corp / Enanta Pharmaceuticals Inc / Cytokinetics Inc / Ocular Therapeutix Inc / ProQR Therapeutics NV / Pfizer Inc / Blueprint Medicines Corp / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Intellia Therapeutics Inc / Protagonist Therapeutics Inc / CRISPR Therapeutics AG / PLx Pharma Inc / Rezolute Inc / Seres Therapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Aquestive Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Bicycle Therapeutics PLC / Generation Bio Co / Altimmune Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Immunic Inc / Marinus Pharmaceuticals Inc / Athira Pharma Inc / Taysha Gene Therapies Inc / Seagen Inc / CorMedix Inc / Taysha Gene Therapies Inc / Athira Pharma Inc / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / PLx Pharma Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Biopharma / IQVIA Script Trends for the Week Ended July 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS MORNING: Please Join Our Large-Cap 2Q21 Earnings Preview Conference Call On July 16 At 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE / HCM / JNJ / LLY / MRK / ZTS / IMAB</td><td class="leftalignment">Pfizer Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US / HD=US / AMZN=US / T=US / TEVA=US / LOW=US / IGT=US / VRM=US / BYD=US / EXPE=US / LEG=US / MGM=US / PENN=US / W=US / UNH=US / MAS=US / MHK=US / MCRI=US / SNAP=US / TRIP=US / WAL=US / WIX=US / SGMS=US / BKNG=US / FB=US / ATRS=US / RRR=US / PTON=US / BIIB=US / TPX=US / EXP=US / CZR=US / APP=US / BECN=US / BLDR=US / GMS=US / SCPL=US / CHNG=US / PGTI=US / AWI=US / OC=US / PRPL=US / TREX=US / FBHS=US / ANGI=US / TILE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / GDDY=US / GDS=US / JELD=US / CVNA=US / SFIX=US / FTDR=US / LYFT=US / UBER=US / FERG=US / DKNG=US / AZEK=US / BALY=US / VMEO=US / DBRG=US</td><td class="leftalignment">Pfizer Inc / Home Depot Inc / Amazon.com Inc / AT&T Inc / Teva Pharmaceutical Industries Ltd / Lowe's Companies Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Expedia Group Inc / Leggett & Platt Inc / MGM Resorts International / Penn National Gaming Inc / Wayfair Inc / UnitedHealth Group Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Snap Inc / Tripadvisor Inc / Western Alliance Bancorp / Wix.Com Ltd / Scientific Games Corp / Booking Holdings Inc / Meta Platforms Inc / Antares Pharma Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Applovin Corp / Beacon Roofing Supply Inc / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Change Healthcare Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Purple Innovation Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Angi Inc / Interface Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / GoDaddy Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Lyft Inc / Uber Technologies Inc / Ferguson PLC / DraftKings Inc / Azek Company Inc / Bally's Corp / Vimeo Inc / DigitalBridge Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">07/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Initiating with a Buy, $7 PT</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">ATRS=US / PFE=US / TEVA=US</td><td class="leftalignment">Antares Pharma Inc / Pfizer Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">07/15/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's New With Pfizer's Covid-19 Vaccine?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways from the Therapeutics Forum Retinal Disease Panel</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">OPT / 71708110 / 75886F10 / 36870G10</td><td class="leftalignment">Opthea Ltd / Pfizer Inc / Regeneron Pharmaceuticals Inc / Gemini Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Marc Goodman / Geoffrey Porges, MBBS / Na Sun / Rudy Li, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Takeaways From Our Therapeutics Day Panel on Inflammatory Bowel Disease</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">71708110 / 00287Y10 / 04004760 / 38341P10 / 74366E10 / G8807B10 / 51506910</td><td class="leftalignment">Pfizer Inc / Abbvie Inc / Arena Pharmaceuticals Inc / Gossamer Bio Inc / Protagonist Therapeutics Inc / Theravance Biopharma Inc / Landos Biopharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Hong Kong / Israel / Luxembourg / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Joseph P. Schwartz / Mr. Thomas J. Smith / Anna Baran, CFA / Kelly Girskis, Ph.D. / Mike Kratky, CFA</td></tr>
<tr class="even"><td class="leftalignment">07/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 10% Including COVID-19 Vaccine Volume Benefit (+5% Without)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US -  Dividend Quality Analysis, for the period ended July 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / INTC=US / MCD=US / OXY=US / ADI=US / AMD=US / RRC=US / WEN=US / AMZN=US / BLD=US / DVN=US / TXN=US / TEVA=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / DIOD=US / MGY=US / SWN=US / XLNX=US / MUR=US / CHRS=US / BRO=US / UMPQ=US / MRO=US / LEG=US / TTMI=US / VMC=US / MLM=US / APH=US / SWIM=US / ARW=US / AVGO=US / AVT=US / CBRL=US / CERN=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAN=US / MAS=US / MCHP=US / MHK=US / PACW=US / REGI=US / ST=US / WAL=US / CVX=US / BXS=US / SNV=US / FB=US / CATY=US / COP=US / DIN=US / BIIB=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BDC=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / TEL=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / JACK=US / TREX=US / AR=US / OAS=US / NXPI=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / TILE=US / NDLS=US / GOOGL=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / WING=US / WLTW=US / EDIT=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / MPWR-US / HWC=US / OZK=US / RTLR=US / FERG=US / GMAB=US / OVV=US / AZEK=US / VTRS=US / VMEO=US / REPX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / Intel Corp / McDonald's Corp / Occidental Petroleum Corp / Analog Devices Inc / Advanced Micro Devices Inc / Range Resources Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Xilinx Inc / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / TTM Technologies Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Amphenol Corp / Latham Group Inc / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Cracker Barrel Old Country Store Inc / Cerner Corp / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Microchip Technology Inc / Mohawk Industries Inc / PacWest Bancorp / Renewable Energy Group Inc / Sensata Technologies Holding PLC / Western Alliance Bancorp / Chevron Corp / Cadence Bank / Synovus Financial Corp / Meta Platforms Inc / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Biogen Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / TE Connectivity Ltd / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Antero Resources Corp / Oasis Petroleum Inc / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Interface Inc / Noodles & Co / Alphabet Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / Willis Towers Watson PLC / Editas Medicine Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Monolithic Power Systems Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Azek Company Inc / Viatris Inc / Vimeo Inc / Riley Exploration Permian Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2026242 / 2219224 / 2270726 / 2542049 / 2829515 / 2100920 / 2455965 / 2684703 / 2048804 / 2707677 / 2138158 / 2825933 / 2829601 / 2503529 / 7103065 / B121557 / 2857817 / B125XQ6 / B02R1L6 / B7TL820 / BFLR866 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BNFWR44 / BFZ1K46 / BKTNTR9 / BRJ3GY4 / BJ9N563 / BNKGXX2</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Edison International / FirstEnergy Corp / Biogen Inc / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / World Wrestling Entertainment Inc / Novartis AG / Mastercard Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / Meta Platforms Inc / Twitter Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Worldline SA / Spotify Technology SA / ViacomCBS Inc / Xenon Pharmaceuticals Inc / Sunnova Energy International Inc / Verve Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2Q Earnings Preview - Easy Comps and Receding COVID-19 Headwinds</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">07/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: European re-opening trades: Where next?</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">9434.T / ACCP.PA / AXAF.PA / BARC.L / BLND.L / BNPP.PA / BP.L / CCL.N / CRDI.MI / DGE.L / DNB.OL / HEIN.AS / HKLD.SI / HLT.N / HSBA.L / LAND.L / MAN.N / PERP.PA / PFE.N / RAND.AS / RCOP.PA / RYA.I / SAN.MC / SEBF.PA / STAN.L / WTB.L / INF.L / AIRF.PA / AZN.L / DBKGN.F / RCL.N / XOM.N / BBVA.MC / CARLB.CO / ADEN.S / RWA.L / EZJ.L / LEG.N / KBC.BR / DANSKE.CO / IHG.L / INGA.AS / RDSA.L / ROSNQ.L / SWEDA.ST / ISP.MI / ABI.BR / ICAG.L / CABK.MC / BKR.N / MAR.OQ / WIZZ.L / ABND.AS / UBSG.S / ORSTED.CO / EQNR.OL / NDASE.ST / 2222.SE / STEMS.L</td><td class="leftalignment">SoftBank Corp / Accor SA / AXA SA / Barclays PLC / British Land Company PLC / BNP Paribas SA / BP PLC / Carnival Corp / UniCredit SpA / Diageo PLC / DNB Bank ASA / Heineken NV / Hongkong Land Holdings Ltd / Hilton Worldwide Holdings Inc / HSBC Holdings PLC / Land Securities Group PLC / ManpowerGroup Inc / Pernod Ricard SA / Pfizer Inc / Randstad NV / Remy Cointreau SA / Ryanair Holdings PLC / Banco Santander SA / SEB SA / Standard Chartered PLC / Whitbread PLC / Informa PLC / Air France KLM SA / AstraZeneca PLC / Deutsche Bank AG / Royal Caribbean Cruises Ltd / Exxon Mobil Corp / Banco Bilbao Vizcaya Argentaria SA / Carlsberg A/S / Adecco Group AG / Robert Walters PLC / Easyjet PLC / Leggett & Platt Inc / KBC Groep NV / Danske Bank A/S / InterContinental Hotels Group PLC / ING Groep NV / Royal Dutch Shell PLC / NK Rosneft' PAO / Swedbank AB / Intesa Sanpaolo SpA / Anheuser Busch Inbev SA / International Consolidated Airlines Group SA / Caixabank SA / Baker Hughes Co / Marriott International Inc / Wizz Air Holdings PLC / ABN Amro Bank NV / UBS Group AG / Orsted A/S / Equinor ASA / Nordea Bank Abp / Saudi Arabian Oil Co / SThree PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Japan / Liberia / Netherlands / Norway / Panama / Russian Federation / Saudi Arabia / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Mr Mengyuan Yuan / Asim Ali / Nasr Islam</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / CUTR.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / LPCN.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / CERC.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Lipocine Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / Avalo Therapeutics Inc / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending July 02, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEP.N / AES.N / AXP.N / CCI.N / CI.N / COF.N / CVS.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / NA / PB.N / PFE.N / REP.MC / SO.N / T.N / ZION.O / PEP.N / CMA.N / WY.N / HUM.N / CFP.TO / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / HBAN.O / UNH.N / NICE.O / CAG.N / PCG.N / CONE.O / VZ.N / VLY.N / SNV.N / PACW.O / FISV.O / V.N / AWK.N / NBIX.O / NWN.N / STL.N / VRTX.O / NCR.N / CPE.N / CFR.N / BLU.N / CPK.N / FRC.N / WBS.N / FCF.N / DFS.N / ADS.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / BCRX.O / COLB.O / WTFC.O / ICPT.O / EQIX.O / TCBI.O / ATDb.TO / BIIB.O / SJ.TO / MTL.TO / FHN.N / DPZ.N / DLR.N / ACAD.O / WEF.TO / WAL.N / DISCA.O / SJW.N / BKD.N / CMG.N / FIS.N / ISBC.O / MA.N / GALP.LS / INO.OQ / HOMB.O / AND.TO / INPP.L / NEE.N / NXT.AX / PCH.O / CJT.TO / CFX.TO / BKU.N / PCRX.O / IFP.TO / WTE.TO / SLM.OQ / RFP.N / SRPT.O / ALLY.N / NYCB.N / ENTA.O / TMUS.N / PTCT.O / BEP.N / ONB.OQ / KPTI.O / XNCR.OQ / ITCI.O / FLXN.O / AGRX.O / SYF.N / GWB.N / ANTM.N / ASB.N / 03835T200 / 78667J108 / CRBP.OQ / GLPG.O / PYPL.OQ / GBT.OQ / MP1.AX / PVAC.O / CADE.N / OVID.O / ATNX.O / 05971J102 / ITRM.O / NTGY.MC / PRVB.O / GMDA.OQ / LSPD.TO / NBSE.OQ / KRTX.OQ / MORF.OQ / APRE.OQ / IGMS.O / ETNB.O / WTRG.N / TFII.N / FOUR.N / DCT.O / SPRB.OQ / MTCR.O / WFG.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American Express Co / Crown Castle International Corp / Cigna Corp / Capital One Financial Corp / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / National Bank of Canada / Prosperity Bancshares Inc / Pfizer Inc / Repsol SA / Southern Co / AT&T Inc / Zions Bancorporation NA / PepsiCo Inc / Comerica Inc / Weyerhaeuser Co / Humana Inc / Canfor Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Huntington Bancshares Inc / UnitedHealth Group Inc / Nice Ltd / Conagra Brands Inc / PG&E Corp / CyrusOne Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / PacWest Bancorp / Fiserv Inc / Visa Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Northwest Natural Holding Co / Sterling Bancorp / Vertex Pharmaceuticals Inc / NCR Corp / Callon Petroleum Co / Cullen/Frost Bankers Inc / BELLUS Health Inc / Chesapeake Utilities Corp / First Republic Bank / Webster Financial Corp / First Commonwealth Financial Corp / Discover Financial Services / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / BioCryst Pharmaceuticals Inc / Columbia Banking System Inc / Wintrust Financial Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / Biogen Inc / Stella-Jones Inc / Mullen Group Ltd / First Horizon Corp / Domino's Pizza Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Western Forest Products Inc / Western Alliance Bancorp / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / Investors Bancorp Inc / Mastercard Inc / Galp Energia SGPS SA / Inovio Pharmaceuticals Inc / Home BancShares Inc / Andlauer Healthcare Group Inc / International Public Partnerships Ltd / Nextera Energy Inc / NEXTDC Ltd / Potlatchdeltic Corp / Cargojet Inc / Canfor Pulp Products Inc / BankUnited Inc / Pacira Biosciences Inc / Interfor Corp / Westshore Terminals Investment Corp / SLM Corp / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Ally Financial Inc / New York Community Bancorp Inc / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Old National Bancorp / Karyopharm Therapeutics Inc / Xencor Inc / Intra-Cellular Therapies Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Synchrony Financial / Great Western Bancorp Inc / Anthem Inc / Associated Banc-Corp / Aptose Biosciences Inc / SAGE Therapeutics Inc / Corbus Pharmaceuticals Holdings Inc / Galapagos NV / PayPal Holdings Inc / Global Blood Therapeutics Inc / Megaport Ltd / Ranger Oil Corp / Cadence Bank / Ovid Therapeutics Inc / Athenex Inc / Cadence Bank / Iterum Therapeutics PLC / Naturgy Energy Group SA / Provention Bio Inc / Gamida Cell Ltd / Lightspeed Commerce Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / Morphic Holding Inc / Aprea Therapeutics Inc / IGM Biosciences Inc / 89Bio Inc / Essential Utilities Inc / TFI International Inc / Shift4 Payments Inc / Duck Creek Technologies Inc / Spruce Biosciences Inc / Metacrine Inc / West Fraser Timber Co Ltd / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Spain / Ireland / Israel / Portugal / United States / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jul 02, 2021: Focus on Shingrix trends</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Taiwan vaccine order could generate sales of US$300 mn in 2021. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2330.TW / 2196.HK / 600196.SS / 2317.TW / PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Hon Hai Precision Industry Co Ltd / Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / Taiwan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">US Healthcare policy: new and updated democrat proposals: Biden drug proposals via EO; Pelosi & Wyden seek legislative approach</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / REGN.OQ / GILD.OQ / INCY.OQ / BMRN.OQ / BIIB.OQ / IPN.PA / TEVA.N / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Biomarin Pharmaceutical Inc / Biogen Inc / Ipsen SA / Teva Pharmaceutical Industries Ltd / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / PCRX.O / FLXN.O / AGRX.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Pacira Biosciences Inc / Pacira Biosciences Inc / Agile Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.8% Above Pre-Pandemic Base- Week 66</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/10/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">More Cancer I/O Noise, Hemophilia A Stumble, ICER's AD Review & More</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US00287Y1091 / US45337C1027 / US75886F1075 / US09609G1004 / CA89620X5064 / US04351P1012 / BMG637AM1024 / US38341P1021 / US45781K1051 / US81181C1045 / US92765F1084</td><td class="leftalignment">Abbvie Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / bluebird bio Inc / Pfizer Inc / Ascendis Pharma A/S / Myovant Sciences Ltd / Gossamer Bio Inc / Innate Pharma SA / Seagen Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen / Chanie Howard</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Booster data boost our bull call for LUNAR-COV19</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARCT.O / PFE</td><td class="leftalignment">Arcturus Therapeutics Holdings Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Brian Cheng / Ms. Alethia R. Young</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending July 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Quarterly Investor Sentiment Survey: What's Your View? 2Q21 Investor Sentiment Survey</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">CI.N / CNC.N / CVS.N / PFE.N / HUM.N / THC.N / UHS.N / SCI.N / UNH.N / HCA.N / CYH.N / MORR.AT / AMN.N / HCSG.OQ / AMED.OQ / SEM.N / CCRN.OQ / LHCG.OQ / MD.N / ACHC.OQ / ANTM.N / WBA.OQ / EHC.N / GENN.PK / AVAH.N</td><td class="leftalignment">Cigna Corp / Centene Corp / CVS Health Corp / Pfizer Inc / Humana Inc / Tenet Healthcare Corp / Universal Health Services Inc / Service Corporation International / UnitedHealth Group Inc / HCA Healthcare Inc / Community Health Systems Inc / Motor Oil Hellas Corinth Refineries SA / AMN Healthcare Services Inc / Healthcare Services Group Inc / Amedisys Inc / Select Medical Holdings Corp / Cross Country Healthcare Inc / LHC Group Inc / MEDNAX Inc / Acadia Healthcare Company Inc / Anthem Inc / Walgreens Boots Alliance Inc / Encompass Health Corp / Genesis Healthcare Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Greece / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. A.J. Rice / Alexander Khan</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">PFE/BNTX Stay One Step Ahead Of COVID-19 Virus With Plans To Seek Approval Of Booster</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DLR-US -  Dividend Quality Analysis, for the period ended June 30,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / EQIX.O / FB.O</td><td class="leftalignment">Pfizer Inc / Equinix Inc / Meta Platforms Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended June 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended July 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Large-Cap 2Q21 Earnings Preview Conference Call On July 16 At 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE / ZTS / HCM.L / JNJ / LLY / MRK / IMAB.O</td><td class="leftalignment">Pfizer Inc / Zoetis Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccination update weekly (Vol. 10): Over 25% of adults in Japan have received at least first dose</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">07/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナワクチン接種Weekly（Vol.10）：ワクチン接種比率、人口の25％を超える</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Craig Hallum</td><td class="leftalignment">TRIL: TRIL Doses First Patient In Acute Myeloid Leukemia Combination Study With TTI-622; Second Phase Ib/II Trial Initiation in One Week.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">TRIL=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Robin Garner</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2497406 / 2026242 / 2219224 / 2280220 / 2270726 / 2670519 / 2342034 / 2100920 / 2684703 / 2707677 / 2138158 / 2829601 / 7103065 / 2857817 / B3D7K31 / B6197Q2 / B7TL820 / BFLR866 / BYVY8G0 / BG31GH0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BZ4CHH2 / BKPGJQ1 / BFYVZ75</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kroger Co / American Electric Power Company Inc / CMS Energy Corp / DTE Energy Co / Walt Disney Co / Exelon Corp / Fiserv Inc / FirstEnergy Corp / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Novartis AG / Netflix Inc / Discovery Inc / Generac Holdings Inc / Meta Platforms Inc / Twitter Inc / Alphabet Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / Soleno Therapeutics Inc / Squarespace Inc / Seelos Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Return Decomposition Monthly: July 2021</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABT.N / AL.N / ALK.N / AXP.N / BA.N / BAC.N / BDX.N / C.N / CL.N / COF.N / CRM.N / CVS.N / DAL.N / ECL.N / EIX.N / EOG.N / F.N / GPS.N / IBM.N / JPM.N / KO.N / LLY.N / LUV.N / MO.N / OXY.N / PFE.N / PM.N / SC.N / SEE.N / T.N / U.N / WFC.N / WMT.N / SPG.N / PG.N / NUE.N / CPB.N / AAL.L / DHR.N / DIS.N / UNH.N / CMI.N / DE.N / CAT.N / SPOT.N / GS.N / CLX.N / HD.N / LOW.N / MRO.N / UPS.N / PCG.N / XOM.N / DVN.N / AMT.N / RMD.N / NKE.N / OLN.N / IT.N / TGT.N / RKT.N / BLL.N / VZ.N / NYT.N / WST.N / MUR.N / HRB.N / ORCL.N / VFC.N / NEU.N / EFX.N / EQT.N / V.N / ACN.N / WSM.N / ESI.N / HAE.N / LB.TO / SAM.N / BLK.N / CRL.N / CVX.N / COP.N / INTC.OQ / CTSH.OQ / ADPT.OQ / ADBE.OQ / ANAT.OQ / AMGN.OQ / AAPL.OQ / AMAT.OQ / CSCO.OQ / COHR.OQ / FISV.OQ / HOLX.OQ / HBAN.OQ / LRCX.OQ / MSFT.OQ / ROL.N / THO.N / ALKS.OQ / QDEL.OQ / IDXX.OQ / QCOM.OQ / SMG.N / INTU.OQ / COST.OQ / NKTR.OQ / PENN.OQ / DLTR.OQ / POOL.OQ / CTXS.OQ / AMZN.OQ / TTWO.OQ / MRCY.OQ / CSGP.OQ / ERIE.OQ / NVDA.OQ / FFIV.OQ / TREE.OQ / EXEL.OQ / ISRG.OQ / BLUE.OQ / ARRY.OQ / GPN.N / VRTX.OQ / JBLU.OQ / NFLX.OQ / DKS.N / CMCSA.OQ / TFC.N / SBNY.OQ / ACAD.OQ / CG.TO / DPZ.N / MKTX.OQ / LVS.N / DISCA.OQ / MS.N / STX.AX / RPRX.OQ / HES.N / IVZ.N / CLR.N / TDC.N / ES.N / MRNA.OQ / LOPE.OQ / MSCI.N / VRSK.OQ / SCHW.N / FTNT.OQ / MU.OQ / GNRC.N / NEE.N / TSLA.OQ / TRGP.N / APO.N / AMD.OQ / SLM.OQ / ENPH.OQ / TRIP.OQ / SPLK.OQ / SRPT.OQ / ADT.N / FANG.OQ / BFAM.N / RNG.N / COMM.OQ / MAR.OQ / GOOGL.OQ / PAYC.N / SAGE.OQ / HUBS.N / TDOC.N / PYPL.OQ / BWXT.K / PEN.N / NVCR.OQ / TMUS.OQ / IONS.OQ / IAC.OQ / NTNX.OQ / RETA.OQ / COUP.OQ / AYX.N / DXC.N / IOVA.OQ / WDAY.OQ / ROKU.OQ / SWCH.N / IQV.N / BKNG.OQ / FB.PS / UAL.OQ / STNE.OQ / FSLY.N / CRWD.OQ / PTON.OQ / NLOK.OQ / RTX.N / AMWL.N / VTRS.OQ / PLTK.OQ</td><td class="leftalignment">Abbott Laboratories / Air Lease Corp / Alaska Air Group Inc / American Express Co / Boeing Co / Bank of America Corp / Becton Dickinson and Co / Citigroup Inc / Colgate-Palmolive Co / Capital One Financial Corp / Salesforce.Com Inc / CVS Health Corp / Delta Air Lines Inc / Ecolab Inc / Edison International / EOG Resources Inc / Ford Motor Co / Gap Inc / International Business Machines Corp / JPMorgan Chase & Co / Coca-Cola Co / Eli Lilly and Co / Southwest Airlines Co / Altria Group Inc / Occidental Petroleum Corp / Pfizer Inc / Philip Morris International Inc / Santander Consumer USA Holdings Inc / Sealed Air Corp / AT&T Inc / Unity Software Inc / Wells Fargo & Co / Walmart Inc / Simon Property Group Inc / Procter & Gamble Co / Nucor Corp / Campbell Soup Co / Anglo American PLC / Danaher Corp / Walt Disney Co / UnitedHealth Group Inc / Cummins Inc / Deere & Co / Caterpillar Inc / Spotify Technology SA / Goldman Sachs Group Inc / Clorox Co / Home Depot Inc / Lowe's Companies Inc / Marathon Oil Corp / United Parcel Service Inc / PG&E Corp / Exxon Mobil Corp / Devon Energy Corp / American Tower Corp / Resmed Inc / Nike Inc / Olin Corp / Gartner Inc / Target Corp / Rocket Companies Inc / Ball Corp / Verizon Communications Inc / New York Times Co / West Pharmaceutical Services Inc / Murphy Oil Corp / H & R Block Inc / Oracle Corp / VF Corp / NewMarket Corp / Equifax Inc / EQT Corp / Visa Inc / Accenture PLC / Williams-Sonoma Inc / Element Solutions Inc / Haemonetics Corp / Laurentian Bank of Canada / Boston Beer Company Inc / BlackRock Inc / Charles River Laboratories International Inc / Chevron Corp / Conocophillips / Intel Corp / Cognizant Technology Solutions Corp / Adaptive Biotechnologies Corp / Adobe Inc / American National Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / Cisco Systems Inc / Coherent Inc / Fiserv Inc / Hologic Inc / Huntington Bancshares Inc / Lam Research Corp / Microsoft Corp / Rollins Inc / Thor Industries Inc / Alkermes Plc / Quidel Corp / IDEXX Laboratories Inc / Qualcomm Inc / Scotts Miracle-Gro Co / Intuit Inc / Costco Wholesale Corp / Nektar Therapeutics / Penn National Gaming Inc / Dollar Tree Inc / Pool Corp / Citrix Systems Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Mercury Systems Inc / CoStar Group Inc / Erie Indemnity Co / NVIDIA Corp / F5 Inc / Lendingtree Inc / Exelixis Inc / Intuitive Surgical Inc / bluebird bio Inc / Array Technologies Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / JetBlue Airways Corp / Netflix Inc / DICK'S Sporting Goods Inc / Comcast Corp / Truist Financial Corp / Signature Bank / ACADIA Pharmaceuticals Inc / Centerra Gold Inc / Domino's Pizza Inc / Marketaxess Holdings Inc / Las Vegas Sands Corp / Discovery Inc / Morgan Stanley / Strike Energy Ltd / Royalty Pharma PLC / Hess Corp / Invesco Ltd / Continental Resources Inc / Teradata Corp / Eversource Energy / Moderna Inc / Grand Canyon Education Inc / MSCI Inc / Verisk Analytics Inc / Charles Schwab Corp / Fortinet Inc / Micron Technology Inc / Generac Holdings Inc / Nextera Energy Inc / Tesla Inc / Targa Resources Corp / Apollo Global Management Inc / Advanced Micro Devices Inc / SLM Corp / Enphase Energy Inc / Tripadvisor Inc / Splunk Inc / Sarepta Therapeutics Inc / ADT Inc / Diamondback Energy Inc / Bright Horizons Family Solutions Inc / RingCentral Inc / CommScope Holding Company Inc / Marriott International Inc / Alphabet Inc / Paycom Software Inc / SAGE Therapeutics Inc / HubSpot Inc / Teladoc Health Inc / PayPal Holdings Inc / BWX Technologies Inc / Penumbra Inc / Novocure Ltd / T-Mobile US Inc / Ionis Pharmaceuticals Inc / IAC/Interactivecorp / Nutanix Inc / Reata Pharmaceuticals Inc / Coupa Software Inc / Alteryx Inc / DXC Technology Co / Iovance Biotherapeutics Inc / Workday Inc / Roku Inc / Switch Inc / IQVIA Holdings Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc / United Airlines Holdings Inc / StoneCo Ltd / Fastly Inc / CrowdStrike Holdings Inc / Peloton Interactive Inc / NortonLifeLock Inc / Raytheon Technologies Corp / American Well Corp / Viatris Inc / Playtika Holding Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / United Kingdom / Ireland / Luxembourg / Philippines / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">07/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 pandemic overview: July 2021 update</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">4507.T / JNJ.N / PFE.N / AZN.L / SASY.PA / MRCG.DE / LONN.S / GSK.L / NVAX.OQ / INO.OQ / MRNA.OQ / 1099.HK / CVAC.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Inovio Pharmaceuticals Inc / Moderna Inc / Sinopharm Group Co Ltd / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / Switzerland / Chile / China / Germany / France / United Kingdom / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Trillium Executes on Clinical Strategy with Multiple Trial Initiations</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Geoffrey Weiner, M.D., Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 25, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 7103065 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Continue To Ride Johnson & Johnson Stock For Higher Levels</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / BARC.L / CCI.N / CMS.N / CNA.L / EIX.N / HSBA.L / LLOY.L / MRK.N / PD.N / PEG.N / PFE.N / PNN.L / SO.N / STO.AX / T.N / SSE.L / CNQ.TO / CMCSA.O / SJRb.TO / RCIb.TO / DUK.N / FE.N / PCG.N / PPL.N / JAZZ.O / GIBa.TO / CONE.O / NG.L / VZ.N / EXEL.O / ALA.TO / EXC.N / RRC.N / EQT.N / ADSK.O / EPD.N / AWK.N / NWN.N / FTS.TO / FRAG.DE / BMRN.O / OPTN.O / REGN.O / EMA.TO / ENAG.MC / CU.TO / COP.N / ENDP.O / CPK.N / CRC.N / LNG.A / NWG.L / RGLD.O / EQIX.O / DPM.TO / MNKD.OQ / DLR.N / SCL.TO / RDSb.L / DISCA.O / SJW.N / DRX.L / TEVA.N / H.TO / PPL.TO / CBRO.L / ARX.TO / CVE.TO / NEE.N / TOU.TO / CFX.TO / FRU.TO / PCRX.O / CTT.N / TVE.TO / ABBV.N / PRGO.N / TMUS.N / BEP.N / AGIO.O / AGRX.O / EVA.N / WRK.N / MESO.O / MTRO.L / TWLO.N / AZRE.N / AKERBP.OL / SAND.N / AQN.N / OKTA.OQ / AMRX.N / AQST.O / 269796108 / ZM.O / FSLY.N / DOCU.N / VMUK.L / PAGPA.L / WTRG.N / AKES.OL / ASAN.N / COUR.N / TASK.O</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Barclays PLC / Crown Castle International Corp / CMS Energy Corp / Centrica PLC / Edison International / HSBC Holdings PLC / Lloyds Banking Group PLC / Merck & Co Inc / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Pennon Group PLC / Southern Co / Santos Ltd / AT&T Inc / SSE PLC / Canadian Natural Resources Ltd / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Duke Energy Corp / FirstEnergy Corp / PG&E Corp / PPL Corp / Jazz Pharmaceuticals PLC / CGI Inc / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / AltaGas Ltd / Exelon Corp / Range Resources Corp / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Northwest Natural Holding Co / Fortis Inc / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Emera Inc / Enagas SA / Canadian Utilities Ltd / Conocophillips / Endo International PLC / Chesapeake Utilities Corp / California Resources Corp / Cheniere Energy Inc / Natwest Group PLC / Royal Gold Inc / Equinix Inc / Dundee Precious Metals Inc / MannKind Corp / Digital Realty Trust Inc / Shawcor Ltd / Royal Dutch Shell PLC / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Hydro One Ltd / Pembina Pipeline Corp / Close Brothers Group PLC / ARC Resources Ltd / Cenovus Energy Inc / Nextera Energy Inc / Tourmaline Oil Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Tamarack Valley Energy Ltd / Abbvie Inc / Perrigo Company PLC / T-Mobile US Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Agile Therapeutics Inc / Enviva Inc / Westrock Co / Mesoblast Ltd / Metro Bank PLC / Twilio Inc / Azure Power Global Ltd / Aker BP ASA / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / DocuSign Inc / Virgin Money UK PLC / Paragon Banking Group PLC / Essential Utilities Inc / Aker Solutions ASA / Asana Inc / Coursera Inc / Taskus Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Spain / United Kingdom / Ireland / Israel / Mauritius / Norway / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / FUNO11.MX / FIBRAMQ12.MX / DANHOS13.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - CDE guidance on cancer drug development: Not overtightening regulation but long-term nudge for industry</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / REGN.OQ / INCY.OQ / BAYGN.DE / 2269.HK</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Regeneron Pharmaceuticals Inc / Incyte Corp / Bayer AG / WuXi Biologics (Cayman) Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">07/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippine Market Strategy - Finding Alpha: Vaccines and mobility</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MEG.PS / PFE.N / SMPH.PS / AZN.L / MRNA.OQ / SVA.OQ</td><td class="leftalignment">Megaworld Corp / Pfizer Inc / SM Prime Holdings Inc / AstraZeneca PLC / Moderna Inc / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Hazel Tanedo</td></tr>
<tr class="odd"><td class="leftalignment">07/05/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: PFE - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="even"><td class="leftalignment">07/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.5% Above Pre-Pandemic Base- Week 65</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">07/03/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">W/E Updates: KRYS' 105 Looks Good; NVAX/myocarditis; SPRO Gain, VRTX Unlocks Fra</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US00287Y1091 / KRYS.OQ / SPRO.OQ / VRTX.OQ / US75886F1075 / US92532F1003 / US02043Q1076 / ABBV.N / US8036071004 / US4277461020 / CA89620X5064 / US4622221004 / US5588681057 / US8051111016 / US24823R1059 / US5011471027 / US84833T1034 / US35655L1070 / US12529R1077 / US2300311063</td><td class="leftalignment">Abbvie Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Vertex Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Abbvie Inc / Sarepta Therapeutics Inc / Heron Therapeutics Inc / Pfizer Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Savara Inc / Denali Therapeutics Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Freeline Therapeutics Holdings PLC / C4 Therapeutics Inc / Cullinan Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACAD / ACET / ALLO / ALT / AMTI / MRTX / SPPI / STRO / TRIL / CRTX / ARNA / SGEN / CLSD / TPTX / 00422510 / CRMD / ZGNX / ABUS / 23282W605 / OCUL / PRQR / BPMC / 98978L204 / 60468T105 / 45845P108 / NTLA / PTGX / CRSP / PLXP / RZLT / 81750R102 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 54142F102 / AQST / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 04016X101 / 87184Q107 / 185063104 / BCYC / 37148K100 / 02155H200 / 74366E102 / RLAY / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / ATHA / TSHA / 21900C308 / 877619106 / M47364100 / N71542109 / 206022105 / 76200L309</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Adicet Bio Inc / Allogene Therapeutics Inc / Altimmune Inc / Applied Molecular Transport Inc. / Mirati Therapeutics Inc / Spectrum Pharmaceuticals Inc / Sutro Biopharma Inc / Pfizer Inc / Cortexyme Inc / Arena Pharmaceuticals Inc / Seagen Inc / Clearside Biomedical Inc / Turning Point Therapeutics Inc / ACADIA Pharmaceuticals Inc / CorMedix Inc / Zogenix Inc / Arbutus Biopharma Corp / Cytokinetics Inc / Ocular Therapeutix Inc / ProQR Therapeutics NV / Blueprint Medicines Corp / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Intellia Therapeutics Inc / Protagonist Therapeutics Inc / CRISPR Therapeutics AG / PLx Pharma Inc / Rezolute Inc / Seres Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / LogicBio Therapeutics Inc / Aquestive Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Bicycle Therapeutics PLC / Generation Bio Co / Altimmune Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Athira Pharma Inc / Taysha Gene Therapies Inc / CorMedix Inc / Taysha Gene Therapies Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">07/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">07/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: Jul 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">000100.KS / 145020.KQ / JNJ.N / PFE.N / AZN.L / NVAX.OQ / 005930.KS / 006280.KS / MRNA.OQ / 068270.KS / 086900.KQ / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Samsung Electronics Co Ltd / Green Cross Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Really Committed: €400M/Yr for mRNA Flu, COVID, Maybe RSV; Cautious COVID View</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">F5548N10 / 71708110 / 58933Y10 / 09075V10 / 60770K10 / G3910J11</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Merck & Co Inc / BioNTech SE / Moderna Inc / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - July 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CAS.TO / DANO.PA / MRK.N / PFE.N / ULVR.L / SSE.L / SJRb.TO / GIS.N / JAZZ.O / NG.L / STZ.N / PVH.N / OPTN.O / PFG.N / COP.N / ENDP.O / AMED.O / NESN.S / MNKD.OQ / DRX.L / TEVA.N / CLW.N / ENV.N / PCRX.O / RFP.N / ABBV.N / KPT.TO / PRGO.N / FLXN.O / AGRX.O / AMRX.N / VRCA.OQ / NTGY.MC / AQST.O / OSMT.O / 269796108 / VTRS.OQ / OTLY.O</td><td class="leftalignment">Cascades Inc / Danone SA / Merck & Co Inc / Pfizer Inc / Unilever PLC / SSE PLC / Shaw Communications Inc / General Mills Inc / Jazz Pharmaceuticals PLC / National Grid PLC / Constellation Brands Inc / PVH Corp / OptiNose Inc / Principal Financial Group Inc / Conocophillips / Endo International PLC / Amedisys Inc / Nestle SA / MannKind Corp / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Clearwater Paper Corp / Envestnet Inc / Pacira Biosciences Inc / Resolute Forest Products Inc / Abbvie Inc / KP Tissue Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Naturgy Energy Group SA / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Spain / France / United Kingdom / Ireland / Israel / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">07/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Our top catalysts for 2H2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / VRCA.OQ / AQST.O / OSMT.O / 269796108 / VTRS.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">07/01/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">Long-term Investment Strategy Uses Short Selling to Augment Holdings</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / GME.N / AAPL.OQ / MSFT.OQ / AMZN.OQ / NVDA.OQ / NFLX.OQ / GOOG.OQ / MRNA.OQ / AMD.OQ / FB.OQ / AMC.N</td><td class="leftalignment">Pfizer Inc / GameStop Corp / Apple Inc / Microsoft Corp / Amazon.com Inc / NVIDIA Corp / Netflix Inc / Alphabet Inc / Moderna Inc / Advanced Micro Devices Inc / Meta Platforms Inc / AMC Entertainment Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Q1 2021: Pfizer reports Net Profit of $4.9b</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer lifts 9.5% in past quarter</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Zilebesiran has potential to be the company's first foray into a prevalent market opportunity</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US02043Q1076 / PFE.N</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Craig Hallum</td><td class="leftalignment">TRIL: TRIL Doses First Patient In Solid Tumor Combination Study With TTI-621.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">TRIL=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Robin Garner</td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TODAY @ 11 AM ET: Please Join Our Virtual Call to Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / US3755581036 / HTBX.OQ / US62818Q1040 / MRKR.OQ / IMAB.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Heat Biologics Inc / Mustang Bio Inc / Marker Therapeutics Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">06/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Aerospace & Defense: Widebody Renaissance: Significant Fleet Reduction Could Spur Upside Wave of Replacement Demand</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">BA.N / HXL.N / HEIG.DE / PFE.N / AIR.PA / AZN.L / HWM.N / MOGA.N / TDG.N / SPR.N / WWD.OQ / RTX.N</td><td class="leftalignment">Boeing Co / Hexcel Corp / HeidelbergCement AG / Pfizer Inc / Airbus SE / AstraZeneca PLC / Howmet Aerospace Inc / Moog Inc / TransDigm Group Inc / Spirit AeroSystems Holdings Inc / Woodward Inc / Raytheon Technologies Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / United Kingdom / Netherlands / United States</td><td class="leftalignment">Aerospace / Defense / Manufacturing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Robert M. Spingarn / Scott Deuschle</td></tr>
<tr class="odd"><td class="leftalignment">06/30/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Pfizer Inc. JUNE 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AIN / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / LOW=US / LEG=US / LSTR=US / VMC=US / HUM=US / MLM=US / AMED=US / SWIM=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HXL=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / SPR=US / DIN=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / LHCG=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / EHC=US / JACK=US / TREX=US / WWD=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / ARCB=US / 00770K202 / LOCO=US / SHAK=US / RLMD=US / ETSY=US / WING=US / EDIT=US / NTLA=US / 82982L103 / CRSP=US / JELD=US / FERG=US / PNTG=US / ARQT=US / AZEK=US / AVAH=US</td><td class="leftalignment">Albany International Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Leggett & Platt Inc / Landstar System Inc / Vulcan Materials Co / Humana Inc / Martin Marietta Materials Inc / Amedisys Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hexcel Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Spirit AeroSystems Holdings Inc / Dine Brands Global Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / LHC Group Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / Jack in the Box Inc / Trex Company Inc / Woodward Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / ArcBest Corp / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Relmada Therapeutics Inc / ETSY Inc / Wingstop Inc / Editas Medicine Inc / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Ferguson PLC / Pennant Group Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2023607 / 2113393 / 2280220 / 2270726 / 2576941 / 2670519 / 2100920 / 2369174 / 2455965 / 2471950 / 2689560 / 2672689 / 2684703 / 2707677 / 2138158 / 2825933 / 2829601 / 7103065 / 2857817 / B125XQ6 / B3D7K31 / B7TL820 / B4MG4Z6 / B7VD3F2 / BCZS820 / BDZCRX3 / BYVY8G0 / BYW36M8 / BFZNYB7 / BK0VHF6 / BDHF4K6 / BHC8X90 / BD8DJ71 / BMQ5T49 / BWFKZT2 / BJJMGL2 / BKTNTR9 / BGSP7M9</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Boston Beer Company Inc / DTE Energy Co / Walt Disney Co / Exelixis Inc / Exelon Corp / FirstEnergy Corp / Gilead Sciences Inc / Biogen Inc / Incyte Corp / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / South Jersey Industries Inc / Southern Co / Novartis AG / Netflix Inc / Portland General Electric Co / Discovery Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Fate Therapeutics Inc / RingCentral Inc / Alphabet Inc / PayPal Holdings Inc / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / CRISPR Therapeutics AG / Novo Nordisk A/S / Snap Inc / Zentalis Pharmaceuticals Inc / Cellectis SA / Fox Corp / ViacomCBS Inc / Zoom Video Communications Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail : Vaccination & Hospitalization Weekly Tracker - Week 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - Mid-Year Updates Include ZN-c5 New Data; ZN-c3 Pivotal Trial Initiated</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMQ5T49 / 5671735 / 0989529 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 18, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Mgmt Discussion Highlights Early & Encouraging Initial IDE397 Data; Darovasertib Execution Continues Heading Into Regulatory Guidance</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703 / BCBVTX1</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc / Agios Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 28 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US1101221083 / US1924221039 / US3695501086 / US37733W1053 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US87612E1064 / US8832031012 / CA0977512007 / US4771431016 / US4198791018 / US80105N1054 / US31620M1062 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US29082A1079 / US00287Y1091 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US70450Y1038 / US5588681057 / US8760301072 / US5904791358 / US28414H1032 / US76156B1070 / US88339P1012 / US26142R1041 / US12769G1004 / CA67079A1021 / US05875B1061 / US73739W1045 / BMG6964L1072</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cognex Corp / General Dynamics Corp / GlaxoSmithKline PLC / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Target Corp / Textron Inc / Bombardier Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Embraer SA / Abbvie Inc / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / PayPal Holdings Inc / Madrigal Pharmaceuticals Inc / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Revolve Group Inc / RealReal Inc / DraftKings Inc / Caesars Entertainment Inc / Nuvei Corp / Bally's Corp / Poshmark Inc / Paysafe Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Brazil / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AEP.N / AES.N / CCI.N / EDP.LS / EIX.N / ELE.MC / IBE.MC / IP.N / MRK.N / PD.N / PFE.N / PNN.L / RWEG.DE / SO.N / T.N / SSE.L / DRE.N / TRI.N / GILD.O / CMCSA.O / AMGN.O / INCY.O / DUK.N / REE.MC / GIS.N / JAZZ.O / CONE.O / NG.L / VZ.N / EXEL.O / KMX.N / AWK.N / NWN.N / BMRN.O / REGN.O / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / SEM.N / CASY.O / EQIX.O / ATDb.TO / BIIB.O / DLR.N / WEF.TO / ALNY.O / DISCA.O / SJW.N / DRX.L / TEVA.N / SLRS.MC / EONGn.DE / BHPB.L / NEE.N / CIO.N / SPLK.OQ / ABBV.N / TMUS.N / PRTA.O / BEP.N / ESNT.N / NEP.N / DEA.N / 78667J108 / EDIT.O / NTLA.O / TWLO.N / UN01.DE / NTNX.O / CRSP.OQ / GREG.MC / VST.N / ORSTED.CO / EHC.N / SMAR.N / DBX.O / CWEN.N / OSMT.O / 269796108 / ZM.O / FSLY.N / GMAB.O / DOCU.N / WTRG.N / BEAM.O / IGIC.OQ</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / EDP Energias de Portugal SA / Edison International / Endesa SA / Iberdrola SA / International Paper Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Rwe AG / Southern Co / AT&T Inc / SSE PLC / Duke Realty Corp / Thomson Reuters Corp / Gilead Sciences Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Red Electrica Corporacion SA / General Mills Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / Carmax Inc / American Water Works Company Inc / Northwest Natural Holding Co / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Select Medical Holdings Corp / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Digital Realty Trust Inc / Western Forest Products Inc / Alnylam Pharmaceuticals Inc / Discovery Inc / SJW Group / Drax Group PLC / Teva Pharmaceutical Industries Ltd / Solaria Energia y Medio Ambiente SA / E.ON SE / BHP Group PLC / Nextera Energy Inc / City Office REIT Inc / Splunk Inc / Abbvie Inc / T-Mobile US Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Essent Group Ltd / Nextera Energy Partners LP / Easterly Government Properties Inc / SAGE Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Twilio Inc / Uniper SE / Nutanix Inc / CRISPR Therapeutics AG / Grenergy Renovables SA / Vistra Corp / Orsted A/S / Encompass Health Corp / Smartsheet Inc / Dropbox Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Genmab A/S / DocuSign Inc / Essential Utilities Inc / Beam Therapeutics Inc / International General Insurance Holdings Ltd</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Portugal / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Learn your ADC</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">006280.KS: Green Cross Corp - Market not giving credits on the vaccine CMO initiative; upgrade on CMO prospects in FY22E and beyond</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">006280.KS / JNJ.N / PFE.N / AZN.L / NVAX.OQ / EBS.N / MRNA.OQ</td><td class="leftalignment">Green Cross Corp / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Novavax Inc / Emergent BioSolutions Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For The Week Ended Jun 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (28 June-): Short-term lull for Eisai; value back in play this week?</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="odd"><td class="leftalignment">06/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（6月28日～）: エーザイ小休止、今週はバリュー系回帰か</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / BIIB.OQ / 2413.T / 4568.T / 4578.T / 4581.T / 4587.T / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Biogen Inc / M3 Inc / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai / Kasumi Haruta</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Pfizer - $49.89 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">RPTX - Synthetic Lethal Targeting of DNA Damage "Repare"; Initiating Coverage with a BUY Rating and $46 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">BLF0CW7 / 0989529 / 0925288 / 2126335 / 2516152 / 2778844 / 2684703 / B6RS2B3 / BK0VHF6 / BMQ5T49 / BWY52P3</td><td class="leftalignment">Repare Therapeutics Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Clovis Oncology Inc / IDEAYA Biosciences Inc / Zentalis Pharmaceuticals Inc / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / ABBV.N / OSMT.O / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.6% Above Pre-Pandemic Base- Week 64</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">I Am the One Who Knocks (Out TTR) - NTLA-2001 Exceeds Expectations</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">45826J10 / 71708110 / 02043Q10 / 46222210 / 10806X10</td><td class="leftalignment">Intellia Therapeutics Inc / Pfizer Inc / Alnylam Pharmaceuticals Inc / Ionis Pharmaceuticals Inc / BridgeBio Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mani Foroohar, M.D. / Mr. Rick Bienkowski, Ph.D. / Greco Song, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE/MRK - Takeaways from today's ACIP session on pneumococcal vaccines; important vote on recommendations coming in October</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Trillium Therapeutics soars 44% in past month</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer down 4.3% from 2 week high</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ABBV Confident In Rinvoq New Indications Post Delay; KOLs Lean More Cautiously</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ABBV - Thoughts on today's RINVOQ updates following our discussion with the company; no change to our overall outlook though atopic dermatitis launch timing could slip</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N / ABBV.N</td><td class="leftalignment">Pfizer Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - June 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0378331005 / US0382221051 / US1727551004 / US37733W1053 / US4523271090 / US5261071071 / US5951121038 / US7170811035 / US7392761034 / US7475251036 / US8168501018 / US8610121027 / US8807701029 / US91347P1057 / US9581021055 / US87157D1090 / US83088M1027 / US80105N1054 / US1572101053 / US82706C1080 / US79546E1047 / US58933Y1055 / NL0010273215 / US74736K1016 / IE00BY7QL619 / US11135F1012 / IE00BK9ZQ967 / US14448C1045 / US6833731044 / US55406W1036 / US1241551027 / US30260D1037 / US82933R1005</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Apple Inc / Applied Materials Inc / Cirrus Logic Inc / GlaxoSmithKline PLC / Illumina Inc / Lennox International Inc / Micron Technology Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Semtech Corp / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Western Digital Corp / Synaptics Inc / Skyworks Solutions Inc / Sanofi SA / CEVA Inc / Silicon Motion Technology Corp / Sally Beauty Holdings Inc / Merck & Co Inc / ASML Holding NV / Qorvo Inc / Johnson Controls International PLC / Broadcom Inc / Trane Technologies PLC / Carrier Global Corp / Ontrak Inc / MYT Netherlands Parent BV / Butterfly Network Inc / Figs Inc / Singular Genomics Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">06/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 18, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">06/25/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / CUTR.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / LPCN.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / CERC.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Lipocine Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Avalo Therapeutics Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call to Discuss Current and Developing Treatments in Atopic Dermatitis and Psoriasis on Thursday, July 15 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARQT.O / JNJ / LLY / PFE / AMGN.O / INCY.O / ARNA.O / REGN.O / ACRS.O / EVLO.O / RAPT.O / PHGE.K / VYNE.O</td><td class="leftalignment">Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Incyte Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Aclaris Therapeutics Inc / Evelo Biosciences Inc / Rapt Therapeutics Inc / Biomx Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Key takeaways from New GSK</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">GSK.L / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / HALO.OQ / BAYGN.DE / CVAC.OQ</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Halozyme Therapeutics Inc / Bayer AG / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/24/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">Risk/Reward Equation Points to Picks in Malls, Homebuilding, Pharma</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ALL.N / AXP.N / BAC.N / JPM.N / MRK.N / PFE.N / SPG.N / PGR.N / LEN.N / HD.N / TGT.N / DHI.N / MAC.N / AMGN.OQ / AAPL.OQ / COST.OQ / AMZN.OQ / CRI.N / GOOG.OQ / CMG.N / CLR.N / NVR.N / UBER.N</td><td class="leftalignment">Allstate Corp / American Express Co / Bank of America Corp / JPMorgan Chase & Co / Merck & Co Inc / Pfizer Inc / Simon Property Group Inc / Progressive Corp / Lennar Corp / Home Depot Inc / Target Corp / D R Horton Inc / Macerich Co / Amgen Inc / Apple Inc / Costco Wholesale Corp / Amazon.com Inc / Carter's Inc / Alphabet Inc / Chipotle Mexican Grill Inc / Continental Resources Inc / NVR Inc / Uber Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE - Takeaways from Day 1 of CDC's June ACIP meeting on COVID-19 vaccine safety and booster doses; no change to our vaccine outlook</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="even"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - First take on Consumer spin and Pharma standalone business</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK.L / PFE.N</td><td class="leftalignment">GlaxoSmithKline PLC / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">600276.SS: Jiangsu Hengrui Medicine Co. Ltd - Deep-dive for innovative drug pipeline supporting upside; reiterate OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">600276.SS / 1093.HK / 4503.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / 1177.HK / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / 600267.SS / 0867.HK / 4568.T / 3933.HK / BAYGN.DE / 0460.HK / 601607.SS / 002422.SZ / 300003.SZ / 2607.HK / ABBV.N / 1513.HK / 2186.HK / 1530.HK / 1558.HK / BGNE.OQ / 300558.SZ / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK</td><td class="leftalignment">Jiangsu Hengrui Pharmaceuticals Co Ltd / CSPC Pharmaceutical Group Ltd / Astellas Pharma Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sino Biopharmaceutical Ltd / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / Zhejiang Hisun Pharmaceutical Co Ltd / China Medical System Holdings Ltd / Daiichi Sankyo Co Ltd / United Laboratories International Holdings Ltd / Bayer AG / Sihuan Pharmaceutical Holdings Group Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd / Lepu Medical Technology Beijing Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Abbvie Inc / Livzon Pharmaceutical Group Inc / Luye Pharma Group Ltd / 3SBio Inc / YiChang HEC ChangJiang Pharmaceutical Co Ltd / Beigene Ltd / Betta Pharmaceuticals Co Ltd / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang / Shirley Chen</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">More Positive Signals for RSV; COVID Protein Subunits Coming of Age</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">F5548N10 / 71708110 / 04635310 / 58933Y10 / 09075V10 / G3910J11</td><td class="leftalignment">Sanofi SA / Pfizer Inc / AstraZeneca PLC / Merck & Co Inc / BioNTech SE / GlaxoSmithKline PLC</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Information Content of Earnings Releases 2015-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CBER Director Concerned Slowing Vaccination Rate Could Re-start COVID Fire</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 09075V10 / 60770K10 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">Germany / France / United Kingdom / Hong Kong / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / GILD=US / LOW=US / LEG=US / VMC=US / MLM=US / SWIM=US / CBRL=US / CW=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / CRTO=US / DIN=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / RCUS=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / 00770K202 / LOCO=US / UPLD=US / SHAK=US / WING=US / EVRI=US / 82982L103 / JELD=US / FOCS=US / UBER=US / FERG=US / ARQT=US / AZEK=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Gilead Sciences Inc / Lowe's Companies Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Curtiss-Wright Corp / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Criteo SA / Dine Brands Global Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Aemetis Inc / El Pollo Loco Holdings Inc / Upland Software Inc / Shake Shack Inc / Wingstop Inc / Everi Holdings Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Focus Financial Partners Inc / Uber Technologies Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Highlights from our Vaccine Forum Conversation with Management</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">09075V10 / 71708110</td><td class="leftalignment">BioNTech SE / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2008154 / 2544960 / 2280220 / 2270726 / 2670519 / 2342034 / 2684703 / 2440637 / 2829601 / 7103065 / B121557 / 2769796 / B02R1L6 / B3D7K31 / B03PGL4 / B7VD3F2 / BYW36M8 / BXDZ9Z0 / BHC8X90 / BKDS4H5 / BMYML02 / BLGJ610 / BFNR303 / BKTNTR9 / BJVR9Y9 / BP3YM85 / BZ1LFG7 / BQXZP64 / BP8XZL1 / BMBP1Q0</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Adobe Inc / Beasley Broadcast Group Inc / DTE Energy Co / Walt Disney Co / Exelon Corp / Fiserv Inc / Pfizer Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Mastercard Inc / Fidelity National Information Services Inc / ALLETE Inc / Discovery Inc / NorthWestern Corp / Duke Energy Corp / PayPal Holdings Inc / Shopify Inc / Novo Nordisk A/S / Bill.com Holdings Inc / DraftKings Inc / Warner Music Group Corp / Northwest Natural Holding Co / ViacomCBS Inc / iHeartMedia Inc / Trupanion Inc / Roku Inc / Wayfair Inc / Healthequity Inc / Flywire Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - CS forecasts 2.2% CAGR Rev Growth to 2030 range of 0% to 6.4% based on R&D success</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / CL.N / JNJ.N / LLY.N / MRK.N / OREP.PA / PFE.N / ULVR.L / PG.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / BEIG.DE / ABBV.N / RKT.L</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Colgate-Palmolive Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / L'Oreal SA / Pfizer Inc / Unilever PLC / Procter & Gamble Co / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Beiersdorf AG / Abbvie Inc / Reckitt Benckiser Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Ms Jo Walton / Elizabeth Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/22/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">JMP Securities' 2021 Life Sciences Conference Takeaways</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">ACAD / ACET / ALLO / ALT / AMTI / MRTX / SPPI / STRO / TRIL / CRTX / ARNA / SGEN / CLSD / 09058V10 / 405024100 / TPTX / 40637H10 / 84763A108 / CRMD / ZGNX / ABUS / 29251M106 / M25722105 / 23282W605 / 05463X106 / 44934S206 / OCUL / PRQR / BPMC / 60468T105 / NTLA / PTGX / CRSP / PLXP / RZLT / 29604W108 / 29664W105 / 462260100 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 825704109 / 54142F102 / 019770106 / AQST / 67576A100 / 483347100 / 299734103 / 22053A107 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 872381108 / BCYC / 65343E108 / 68752L100 / 22978P106 / 37148K100 / 64131A105 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / RLAY / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 4525EP101 / 74017N105 / 56854Q200 / ATHA / TSHA / 21900C308 / 517125100 / 877619106 / 04746L104 / 07160F107 / G637AM102 / M47364100 / N71542109 / 206022105 / 03837C106 / 72942A107 / 92790C104 / 76200L309</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Adicet Bio Inc / Allogene Therapeutics Inc / Altimmune Inc / Applied Molecular Transport Inc. / Mirati Therapeutics Inc / Spectrum Pharmaceuticals Inc / Sutro Biopharma Inc / Pfizer Inc / Cortexyme Inc / Arena Pharmaceuticals Inc / Seagen Inc / Clearside Biomedical Inc / BioCryst Pharmaceuticals Inc / Haemonetics Corp / Turning Point Therapeutics Inc / Halozyme Therapeutics Inc / Spectrum Pharmaceuticals Inc / CorMedix Inc / Zogenix Inc / Arbutus Biopharma Corp / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / AxoGen Inc / ICAD Inc / Ocular Therapeutix Inc / ProQR Therapeutics NV / Blueprint Medicines Corp / Mirati Therapeutics Inc / Intellia Therapeutics Inc / Protagonist Therapeutics Inc / CRISPR Therapeutics AG / PLx Pharma Inc / Rezolute Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / SI-BONE Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Aquestive Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Cortexyme Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / TELA Bio Inc / Bicycle Therapeutics PLC / NextCure Inc / OrthoPediatrics Corp / Cue Biopharma Inc / Generation Bio Co / Neuronetics Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Immunic Inc / Precigen Inc / Marinus Pharmaceuticals Inc / Athira Pharma Inc / Taysha Gene Therapies Inc / CorMedix Inc / Larimar Therapeutics Inc / Taysha Gene Therapies Inc / Athira Pharma Inc / Baudax Bio Inc / Myovant Sciences Ltd / Gamida Cell Ltd / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / Apyx Medical Corp / PLx Pharma Inc / Viridian Therapeutics Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. David Turkaly / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Daniel Stauder / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 11, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US37733W1053 / US4523271090 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US34959E1091 / US9100471096 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US70438V1061 / CA0089118776 / US07725L1026 / KYG4740B1059 / US8760301072 / US5904791358 / US28414H1032 / US46583P1021 / US26142R1041 / US83089J1088 / US1241551027 / US30260D1037 / US82933R1005 / US23954D1090</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Fortinet Inc / United Airlines Holdings Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paylocity Holding Corp / Air Canada / Beigene Ltd / Ichor Holdings Ltd / Tapestry Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Iveric Bio Inc / DraftKings Inc / Skywater Technology Inc / Butterfly Network Inc / Figs Inc / Singular Genomics Systems Inc / Day One Biopharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / BB.N / CAS.TO / CCI.N / CCK.N / CL.N / EIX.N / EL.N / FOUG.PA / GPS.N / IP.N / KMB.N / KO.N / MRK.N / PD.N / PFE.N / PNN.L / SGEF.PA / SO.N / SVT.L / T.N / VIEV.VI / SSE.L / PEP.N / BFb.N / PG.N / CFP.TO / GILD.O / FNV.N / CPB.N / CMCSA.O / THC.N / DUK.N / LEA.N / REE.MC / K.N / DISH.O / ADBE.O / CLX.N / CAG.N / GIS.N / EPC.N / AMT.N / JAZZ.O / CONE.O / NG.L / VZ.N / STZ.N / FISV.O / AWK.N / CHD.N / NWN.N / APT.AX / SAM.N / FRAG.DE / ENR.N / NCR.N / GPK.N / ENAG.MC / ENDP.O / CPK.N / PEGA.OQ / GPN.N / MNST.O / EQIX.O / 02209S103 / TRN.MI / MNKD.OQ / 427866108 / SJW.N / FIS.N / ADP.PA / ATL.MI / BGS.N / GETP.PA / SPB.N / FHZN.S / TXG.TO / NEE.N / SLS.TO / PCH.O / XYL.N / MDLZ.OQ / PRMW.N / VOYA.N / COTY.N / BEP.N / 81762P102 / CEQP.N / ESNT.N / BTG.N / NEP.N / HQY.OQ / AENA.MC / WRK.N / GBT.OQ / RUN.O / TRHC.OQ / AZRE.N / NTNX.O / VST.N / AQUA.N / SAIL.N / DBX.O / AMRX.N / NTGY.MC / KDP.N / CWEN.N / NWL.O / LSPD.TO / 269796108 / PEAK.N / AZEK.N / WTRG.N / REYN.O / IGIC.OQ / FOUR.N / ZI.O / IBEX.O / LUMN.N / NVEIu.TO / PUBM.O / WFG.N / AFRM.O / NAPA.N / OTLY.O / FLYW.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / BlackBerry Ltd / Cascades Inc / Crown Castle International Corp / Crown Holdings Inc / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eiffage SA / Gap Inc / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Pennon Group PLC / Vinci SA / Southern Co / Severn Trent PLC / AT&T Inc / Flughafen Wien AG / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Comcast Corp / Tenet Healthcare Corp / Duke Energy Corp / Lear Corp / Red Electrica Corporacion SA / Kellogg Co / DISH Network Corp / Adobe Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Constellation Brands Inc / Fiserv Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Afterpay Ltd / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Energizer Holdings Inc / NCR Corp / Graphic Packaging Holding Co / Enagas SA / Endo International PLC / Chesapeake Utilities Corp / Pegasystems Inc / Global Payments Inc / Monster Beverage Corp / Equinix Inc / Altria Group Inc / Terna Rete Elettrica Nazionale SpA / MannKind Corp / Hershey Co / SJW Group / Fidelity National Information Services Inc / Aeroports de Paris SA / Atlantia SpA / B&G Foods Inc / Getlink SE / Spectrum Brands Holdings Inc / Flughafen Zuerich AG / Torex Gold Resources Inc / Nextera Energy Inc / Solaris Resources Inc / Potlatchdeltic Corp / Xylem Inc / Mondelez International Inc / Primo Water Corp / Voya Financial Inc / Coty Inc / Brookfield Renewable Partners LP / ServiceNow Inc / Crestwood Equity Partners LP / Essent Group Ltd / B2Gold Corp / Nextera Energy Partners LP / Healthequity Inc / Aena SME SA / Westrock Co / Global Blood Therapeutics Inc / Sunrun Inc / Tabula Rasa HealthCare Inc / Azure Power Global Ltd / Nutanix Inc / Vistra Corp / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Dropbox Inc / Amneal Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Clearway Energy Inc / Newell Brands Inc / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / Healthpeak Properties Inc / Azek Company Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / Shift4 Payments Inc / ZoomInfo Technologies Inc / Ibex Ltd / Lumen Technologies Inc / Nuvei Corp / PubMatic Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Oatly Group AB / Flywire Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Austria / Bermuda / Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Italy / Mauritius / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">RSV: Large, Unmet Market Offers Investment Opportunities - Ahead Of The Curve</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">US37733W1053 / US58933Y1055 / US7170811035 / US80105N1054</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Pfizer Inc / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Does The Valuation Gap Between Merck Stock And Zoetis Make Sense?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is There More Room For Growth In Roche Stock After A 12% Rise In A Month?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/20/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / MNKD.OQ / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / MannKind Corp / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6.4% Above Pre-Pandemic Base- Week 63</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 6.18.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">00365410 / 28176E10 / 62855J10 / 00282410 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 58949210 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710 / 00288U10 / 90184D10</td><td class="leftalignment">ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Abbott Laboratories / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / Mereo Biopharma Group PLC / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc / Abcellera Biologics Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Is Pfizer Stock A Better Bet Compared To Eli Lilly?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1175</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">404251100 / 192005106 / 89620X506 / 22564L105 / 68839R10</td><td class="leftalignment">HNI Corp / Codexis Inc / Pfizer Inc / LiveVox Holdings Inc / Blacksky Technology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Reuben Garner / Mr. Robert M. Wasserman / Mr. Aydin Huseynov, MD / Mr. Mark W. Schappel / Mr. Nathan Martin / Mr. Josh W. Sullivan</td></tr>
<tr class="even"><td class="leftalignment">06/18/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">CD47 Field Is Warm. It Will Become Warmer In 4Q21 And Hot In 2022</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">06/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 11, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AAP.N / CCI.N / GOG.L / PFE.N / SGC.L / T.N / WY.N / CFP.TO / GILD.O / CMCSA.O / SBAC.O / AMT.N / CONE.O / VZ.N / CHTR.O / EQIX.O / DLR.N / DRX.L / CCOI.O / ADP.PA / ATL.MI / EDPR.LS / ADUS.OQ / NXT.AX / PCH.O / IFP.TO / RFP.N / NYCB.N / JACK.N / TMUS.N / RYAM.N / AZRE.N / GDS.O / UNIT.O / WOW.N / ATUS.N / APRE.OQ / LUMN.N / PUBM.O / WFG.N / PPM.AX</td><td class="leftalignment">Advance Auto Parts Inc / Crown Castle International Corp / Go-Ahead Group PLC / Pfizer Inc / Stagecoach Group PLC / AT&T Inc / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Comcast Corp / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Verizon Communications Inc / Charter Communications Inc / Equinix Inc / Digital Realty Trust Inc / Drax Group PLC / Cogent Communications Holdings Inc / Aeroports de Paris SA / Atlantia SpA / EDP Renovaveis SA / Addus Homecare Corp / NEXTDC Ltd / Potlatchdeltic Corp / Interfor Corp / Resolute Forest Products Inc / New York Community Bancorp Inc / Jack in the Box Inc / T-Mobile US Inc / Rayonier Advanced Materials Inc / Azure Power Global Ltd / GDS Holdings Ltd / Uniti Group Inc / WideOpenWest Inc / Altice USA Inc / Aprea Therapeutics Inc / Lumen Technologies Inc / PubMatic Inc / West Fraser Timber Co Ltd / Pepper Money Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Cayman Islands / Spain / France / United Kingdom / Italy / Mauritius / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Revisiting our COVID-19 vaccine model and raising our forecasts ahead of near-term booster data</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 9.4% Including COVID-19 Vaccine Volume Benefit</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">CAH.N / JNJ.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MCK: Quick Thoughts on the U.S. Purchase of Incremental COVID Vaccine Doses from Moderna</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MCK.N / MRNA.OQ / PFE.N</td><td class="leftalignment">Mckesson Corp / Moderna Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">06/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Factor Trends: 06/16/21</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Juliette Criqui Monfort / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">GSK Licensing Deal Hugely Validating for EOS-448 and TIGIT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">11012210 / 45337C10 / 71708110 / 04635310 / 37555810 / 03116210 / 66987V10 / 75886F10 / 53245710 / M2572210 / 09062X10 / 478160104 / 640268108 / 771195104 / 58933Y10 / 92337C10 / 04651310 / 75046920 / 00287Y10 / 98401F10 / ITOS.OQ / 58949210 / 09627Y10 / 07725L10 / G3910J11 / 81181C10 / K3967W10 / 46565G10 / 61776010 / 03969F10 / F5548N10 / 48111610</td><td class="leftalignment">Bristol-Myers Squibb Co / Incyte Corp / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Compugen Ltd / Biogen Inc / Johnson & Johnson / Nektar Therapeutics / Roche Holding AG / Merck & Co Inc / Verastem Inc / Atara Biotherapeutics Inc / Radius Health Inc / Abbvie Inc / Xencor Inc / Iteos Therapeutics Inc / Mereo Biopharma Group PLC / Blueprint Medicines Corp / Beigene Ltd / GlaxoSmithKline PLC / Seagen Inc / Genmab A/S / Iteos Therapeutics Inc / MorphoSys AG / Arcus Biosciences Inc / Sanofi SA / Jounce Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Jeffrey La Rosa / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / MCD=US / OXY=US / RRC=US / WEN=US / DVN=US / INCY=US / APA=US / CPE=US / EOG=US / REI=US / XOM=US / CRK=US / WLL=US / PXD=US / PB=US / IGT=US / MGY=US / SWN=US / MUR=US / EWBC=US / BRO=US / BYD=US / UMPQ=US / MRO=US / EXPE=US / MGM=US / PENN=US / CBRL=US / CNX=US / DRI=US / EQIX=US / EQT=US / AJG=US / MCRI=US / PACW=US / REGI=US / TRIP=US / WAL=US / CVX=US / SGMS=US / BXS=US / BKNG=US / SNV=US / FBK=US / MKL=US / PRA=US / CATY=US / COP=US / DIN=US / PNFP=US / RRR=US / JRVR=US / BIIB=US / TCBI=US / FNB=US / CZR=US / PLAY=US / DENN=US / NSP=US / CMG=US / REX=US / GPRE=US / TAST=US / QSR=US / CLR=US / NMTR=US / NOG=US / JACK=US / KNSL=US / AR=US / ESTE=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / FANG=US / ABBV=US / NDLS=US / FATE=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / DEA=US / WING=US / ARGX=US / WLTW=US / CDEV=US / TRVG=US / PVAC=US / SBOW=US / HWC=US / OZK=US / RTLR=US / AHCO=US / OVV=US / ARQT=US / DKNG=US / ZI=US / BALY=US / ABNB=US / VMEO=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Devon Energy Corp / Incyte Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / International Game Technology PLC / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / East West Bancorp Inc / Brown & Brown Inc / Boyd Gaming Corp / Umpqua Holdings Corp / Marathon Oil Corp / Expedia Group Inc / MGM Resorts International / Penn National Gaming Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / Equinix Inc / EQT Corp / Arthur J Gallagher & Co / Monarch Casino & Resort Inc / PacWest Bancorp / Renewable Energy Group Inc / Tripadvisor Inc / Western Alliance Bancorp / Chevron Corp / Scientific Games Corp / Cadence Bank / Booking Holdings Inc / Synovus Financial Corp / FB Financial Corp / Markel Corp / ProAssurance Corp / Cathay General Bancorp / Conocophillips / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Red Rock Resorts Inc / James River Group Holdings Ltd / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / Caesars Entertainment Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / 9 Meters Biopharma Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Easterly Government Properties Inc / Wingstop Inc / argenx SE / Willis Towers Watson PLC / Centennial Resource Development Inc / Trivago NV / Ranger Oil Corp / SilverBow Resources Inc / Hancock Whitney Corp / Bank Ozk / Rattler Midstream LP / Adapthealth Corp / Ovintiv Inc / Arcutis Biotherapeutics Inc / DraftKings Inc / ZoomInfo Technologies Inc / Bally's Corp / Airbnb Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2008154 / 2050832 / 2026242 / 2216850 / 2280220 / 2270726 / 2328915 / 2100920 / 2680905 / 2684703 / 2707677 / 2829601 / 7103065 / B067BM3 / B125XQ6 / B02R1L6 / B3D7K31 / B03PGL4 / BVVN4Q8 / BJLFHW7 / BFZ1K46 / BMYML02 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BGKG6M3 / BN2S6Y8</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Adobe Inc / Ameren Corp / American Electric Power Company Inc / Consolidated Edison Inc / DTE Energy Co / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / Southern Co / Novartis AG / Molson Coors Beverage Co / Portland General Electric Co / ALLETE Inc / Discovery Inc / NorthWestern Corp / Eversource Energy / Chewy Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / ViacomCBS Inc / Roku Inc / Alphabet Inc / StoneCo Ltd / Talaris Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/15/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Pay for performance: CEO compensation</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Another Effective Vaccine, With Clean Tolerability, Safety and Easy to Use</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Three's Company - NVAX a Serious Contender to mRNA in the COVID Booster Market</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mani Foroohar, M.D. / Daina Graybosch, Ph.D. / Mr. Rick Bienkowski, Ph.D. / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments, Wednesday June 30th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARAV.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / BSLN.S / HGEN.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending June 04, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: to Discuss European Hematology Association (EHA) Highlights at 11:00 AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / MRK.N / 0715.HK / LLY.N / PFE.N / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / China Oceanwide Holdings Ltd / Eli Lilly and Co / Pfizer Inc / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Bristol Myers Squibb Stock Remains Undervalued After Positive Data From Clinical Trials</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US02553E1064 / US0463531089 / US09058V1035 / US1101221083 / US37733W1053 / US45337C1027 / US4663671091 / US4781601046 / US5002551043 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9699041011 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US90384S3031 / US58933Y1055 / US9100471096 / US00287Y1091 / US98978V1035 / IE00B4Q5ZN47 / US8485771021 / US21240E1055 / CA05156V1022 / US02376R1023 / IE00BQPVQZ61 / CA0089118776 / US07725L1026 / US74967X1037 / US5904791358 / US28414H1032 / US0144421072 / US98420X1037 / US26142R1041</td><td class="leftalignment">Alaska Air Group Inc / American Eagle Outfitters Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Incyte Corp / Jack in the Box Inc / Johnson & Johnson / Kohls Corp / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Williams-Sonoma Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / Zoetis Inc / Jazz Pharmaceuticals PLC / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Horizon Therapeutics PLC / Air Canada / Beigene Ltd / RH / Mesa Air Group Inc / Elanco Animal Health Inc / Alector Inc / X4 Pharmaceuticals Inc / DraftKings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / PFE=US / HD=US / GBT=US / BLD=US / INCY=US / LOW=US / ADS=US / LEG=US / VMC=US / MLM=US / SWIM=US / COLL=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / VRTX=US / WAL=US / AUTL=US / BDSI=US / OGN / BIIB=US / TPX=US / EXP=US / BECN=US / BLDR=US / GMS=US / PGTI=US / GPRE=US / AWI=US / OC=US / PRPL=US / APEI=US / ZTS=US / TREX=US / FBHS=US / MEIP=US / ABBV=US / TILE=US / PTCT=US / 00770K202 / 82982L103 / CRSP=US / JELD=US / FOCS=US / AXNX=US / FERG=US / ZI=US / AZEK=US / 67421J108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Home Depot Inc / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Lowe's Companies Inc / Alliance Data Systems Corp / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Latham Group Inc / Collegium Pharmaceutical Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Vertex Pharmaceuticals Inc / Western Alliance Bancorp / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Organon & Co / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Builders FirstSource Inc / GMS Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Purple Innovation Inc / American Public Education Inc / Zoetis Inc / Trex Company Inc / Fortune Brands Home & Security Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / PTC Therapeutics Inc / Aemetis Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / JELD-WEN Holding Inc / Focus Financial Partners Inc / Axonics Inc / Ferguson PLC / ZoomInfo Technologies Inc / Azek Company Inc / Oatly Group AB</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">EDF.PA / FREG.F / PFE.N / AZN.L / SASY.PA / FMEG.DE / MRCG.DE / DANSKE.CO / SE0009922164</td><td class="leftalignment">Electricite de France SA / Fresenius SE & Co KGaA / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Fresenius Medical Care AG & Co KGaA / Merck KGaA / Danske Bank A/S / Essity AB (publ)</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / France / United Kingdom / Ireland / Italy / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Sven Kreitmair, CFA / Frau Silke Stegemann / Herr Tobias Keller / Herr. Stefan Kolek</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">To RSV or Not to RSV? Prevention Could Generate $10bn in Vaccine Sales 2030</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / 60770K10</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Anna Baran, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">06/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / CCI.N / CL.N / CMS.N / CRM.N / CVS.N / EIX.N / EL.N / KMB.N / KO.N / MRK.N / PD.N / PFE.N / RWEG.DE / SO.N / T.N / PEP.N / AVB.N / EQR.N / BFb.N / PG.N / HUM.N / CPB.N / CMCSA.O / FER.MC / UNH.N / K.N / DISH.O / CLX.N / CAG.N / GIS.N / PPL.N / EPC.N / SBAC.O / AMT.N / CONE.O / NG.L / VZ.N / HCA.N / STZ.N / AMP.N / FISV.O / ADSK.O / V.N / CPT.N / CHTR.O / AWK.N / CHD.N / ESS.N / NWN.N / UDR.N / SUI.N / MAA.N / SAM.N / FRAG.DE / ENR.N / NCR.N / ENDP.O / TYL.N / PEGA.OQ / AMH.N / GPN.N / MNST.O / CASY.O / JCOM.O / ATDb.TO / 02209S103 / MNKD.OQ / DLR.N / ELS.N / 427866108 / WEF.TO / SJW.N / FIS.N / MA.N / ATL.MI / IVZ.N / BGS.N / SPB.N / NEE.N / NXT.AX / FHI.N / RFP.N / MDLZ.OQ / APAM.N / PRMW.N / TMUS.N / COTY.N / BEP.N / WIX.O / COUP.N / 03835T200 / WRK.N / SGRY.O / SQ.N / SCWX.O / TWLO.N / INVH.N / ROOT.TO / ORSTED.CO / VCTR.N / SMAR.N / DBX.O / AMRX.N / KDP.N / ESTC.N / NWL.O / ZM.O / FSLY.N / DOCU.N / WTRG.N / REYN.O / FOUR.N / DCT.O / ASAN.N / SUMO.O / WFG.N / AFRM.O / NAPA.N / COUR.N / PATH.N / SQSP.N / OTLY.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Crown Castle International Corp / Colgate-Palmolive Co / CMS Energy Corp / Salesforce.Com Inc / CVS Health Corp / Edison International / Estee Lauder Companies Inc / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / PagerDuty Inc / Pfizer Inc / Rwe AG / Southern Co / AT&T Inc / PepsiCo Inc / Avalonbay Communities Inc / Equity Residential / Brown-Forman Corp / Procter & Gamble Co / Humana Inc / Campbell Soup Co / Comcast Corp / Ferrovial SA / UnitedHealth Group Inc / Kellogg Co / DISH Network Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / PPL Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Constellation Brands Inc / Ameriprise Financial Inc / Fiserv Inc / Autodesk Inc / Visa Inc / Camden Property Trust / Charter Communications Inc / American Water Works Company Inc / Church & Dwight Co Inc / Essex Property Trust Inc / Northwest Natural Holding Co / UDR Inc / Sun Communities Inc / Mid-America Apartment Communities Inc / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Energizer Holdings Inc / NCR Corp / Endo International PLC / Tyler Technologies Inc / Pegasystems Inc / American Homes 4 Rent / Global Payments Inc / Monster Beverage Corp / Caseys General Stores Inc / Ziff Davis Inc / Alimentation Couche-Tard Inc / Altria Group Inc / MannKind Corp / Digital Realty Trust Inc / Equity LifeStyle Properties Inc / Hershey Co / Western Forest Products Inc / SJW Group / Fidelity National Information Services Inc / Mastercard Inc / Atlantia SpA / Invesco Ltd / B&G Foods Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / NEXTDC Ltd / Federated Hermes Inc / Resolute Forest Products Inc / Mondelez International Inc / Artisan Partners Asset Management Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Brookfield Renewable Partners LP / Wix.Com Ltd / Coupa Software Inc / Aptose Biosciences Inc / Westrock Co / Surgery Partners Inc / Block Inc / SecureWorks Corp / Twilio Inc / Invitation Homes Inc / Roots Corp / Orsted A/S / Victory Capital Holdings Inc / Smartsheet Inc / Dropbox Inc / Amneal Pharmaceuticals Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Fastly Inc / DocuSign Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Duck Creek Technologies Inc / Asana Inc / Sumo Logic Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Coursera Inc / UiPath Inc / Squarespace Inc / Oatly Group AB / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Our spin on spins</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">OGN / MRK=US / PFE=US / ZTS=US / ABBV=US</td><td class="leftalignment">Organon & Co / Merck & Co Inc / Pfizer Inc / Zoetis Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / MNKD.OQ / AMRX.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / MannKind Corp / Amneal Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Catalyst Tracker 6.13.21: Highlights Top Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">00282410 / 71708110 / 00846U10 / 10113710 / 92532F10 / 88355610 / 87936910 / 37555810 / M2572210 / 45232710 / 30063P10 / 98956P10 / 67070410 / 45784P10 / 58933Y10 / 00653A107 / 04351P101 / 00287Y10 / 04004760 / 04280A10 / 40131M10 / 604749101 / 98420N10 / 42226A10 / 90041T10 / 74340E10 / 87337910 / 45826J10 / 55609910 / 74374N10 / 31189P10 / G3910J11 / H0026310 / 24344T10 / 92857F10 / 04685N10 / 34633R10 / 46565G10 / 60468T10 / 03969F10 / 78667J10 / 64157F10 / 55886810 / 49232710 / 75955J40 / 87808K10 / 87166L10 / 89422G10</td><td class="leftalignment">Abbott Laboratories / Pfizer Inc / Agilent Technologies Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Teleflex Inc / Gilead Sciences Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Zimmer Biomet Holdings Inc / NuVasive Inc / Insulet Corp / Merck & Co Inc / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Abbvie Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Guardant Health Inc / Mirum Pharmaceuticals Inc / Xenon Pharmaceuticals Inc / Healthequity Inc / Turning Point Therapeutics Inc / Progyny Inc / Tabula Rasa HealthCare Inc / Intellia Therapeutics Inc / MacroGenics Inc / Provention Bio Inc / Fate Therapeutics Inc / GlaxoSmithKline PLC / AC Immune SA / Deciphera Pharmaceuticals Inc / Vocera Communications Inc / Athenex Inc / Forma Therapeutics Holdings Inc / Iteos Therapeutics Inc / Mirati Therapeutics Inc / Arcus Biosciences Inc / SAGE Therapeutics Inc / Nevro Corp / Madrigal Pharmaceuticals Inc / Keros Therapeutics Inc / Relmada Therapeutics Inc / TCR2 Therapeutics Inc / Synlogic Inc / Travere Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / United Kingdom / Israel / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">06/13/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 62</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech - Evasion of Anti-Tumor Immunity? It's Just Been Revoked. Inhibiting Autophagy as a Lethal Weapon to KRAS+ / STK11+ Lung Cancer</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">5671735 / 2684703 / 7103065 / BZ1LFB2</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Novartis AG / Deciphera Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">BMY ASCO Call Highlights; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US1101221083 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Bristol-Myers Squibb Co / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending June 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">75</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / CUTR.O / BSLN.S / MNKD.O / SIBN.MM / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / CERC.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Gazprom Neft' PAO / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / Avalo Therapeutics Inc / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Russian Federation / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended June 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">NVS ASCO Call Highlights; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US66987V1098 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Novartis AG / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: TRIL - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">TRIL</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="odd"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jun 10 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US2358511028 / US4781601046 / US7140461093 / US7170811035 / US8636671013 / US8835561023 / US9113121068 / US98956P1021 / US9837931008 / IE00BTN1Y115 / US02081G2012 / US74967X1037 / US03236M2008 / US53814L1089 / US05352A1007 / US76156B1070 / US5024311095</td><td class="leftalignment">Danaher Corp / Johnson & Johnson / PerkinElmer Inc / Pfizer Inc / Stryker Corp / Thermo Fisher Scientific Inc / United Parcel Service Inc / Zimmer Biomet Holdings Inc / XPO Logistics Inc / Medtronic PLC / Alphatec Holdings Inc / RH / Amyris Inc / Livent Corp / Avantor Inc / Revolve Group Inc / L3harris Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharmaceuticals: Five key takeaways from ASCO breast cancer expert call</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GILD.OQ / SGEN.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Gilead Sciences Inc / Seagen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / CUTR.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / CERC.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Cutera Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Avalo Therapeutics Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Prevnar 20 Approved For Adults; Pricing Upon August Launch Not Yet Announced</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Pfizer Inc. (PFE) - COVID-19 vaccine makes it a “HERO”</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Johnson & Johnson's Covid-19 Vaccine?</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE receives FDA approval for PREVNAR 20 in adults; next up is a potential MRK V114 approval in July and October ACIP meeting</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / BMY=US / GBT=US / BLD=US / INCY=US / GL=US / GILD=US / PAA=US / CHRS=US / LEG=US / VMC=US / MLM=US / PATH=US / BNL=US / DRI=US / ENDP=US / IBP=US / MHK=US / NTST=US / REGN=US / THO=US / VRTX=US / HIW=US / BDN=US / PRI=US / EGP=US / KIM=US / MAA=US / UDR=US / DRE=US / AUTL=US / DIN=US / OGN / BCO=US / TPX=US / EXP=US / BECN=US / TXRH=US / BLDR=US / PGTI=US / OC=US / KTOS=US / TREX=US / OLO=US / APTS=US / MEIP=US / ABBV=US / TILE=US / HTRG=US / DEA=US / 82982L103 / CRSP=US / YEXT=US / COLD=US / EOLS=US / UBER=US / GMAB=US / AZEK=US / VTRS=US / DASH=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / TopBuild Corp / Incyte Corp / Globe Life Inc / Gilead Sciences Inc / Plains All American Pipeline LP / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / UiPath Inc / Bunzl plc / Darden Restaurants Inc / Endo International PLC / Installed Building Products Inc / Mohawk Industries Inc / Netstreit Corp / Regeneron Pharmaceuticals Inc / Thor Industries Inc / Vertex Pharmaceuticals Inc / Highwoods Properties Inc / Brandywine Realty Trust / Primerica Inc / Eastgroup Properties Inc / Kimco Realty Corp / Mid-America Apartment Communities Inc / UDR Inc / Duke Realty Corp / Autolus Therapeutics PLC / Dine Brands Global Inc / Organon & Co / Brinks Co / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Texas Roadhouse Inc / Builders FirstSource Inc / PGT Innovations Inc / Owens Corning / Kratos Defense and Security Solutions Inc / Trex Company Inc / Olo Inc / Preferred Apartment Communities Inc / MEI Pharma Inc / Abbvie Inc / Interface Inc / Heritage Insurance Holdings Inc / Easterly Government Properties Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Yext Inc / Americold Realty Trust / Evolus Inc / Uber Technologies Inc / Genmab A/S / Azek Company Inc / Viatris Inc / DoorDash Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ASCO: Puts and Takes for Keytruda</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">58933Y10 / 71708110 / 04635310</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">V / 0989529 / 0925288 / 2126335 / 2000019 / 2023607 / 2778844 / 2973821 / 2026242 / 2219224 / 2270726 / 2829515 / 2317087 / 2342034 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2705198 / 2707677 / 2829601 / 4595739 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / B7VD3F2 / BFLR866 / BYVY8G0 / BYZLV46 / BXDZ9Z0 / BNFWR44 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BN7K304 / BMHR7K6</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amazon.com Inc / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Edison International / Entergy Corp / Fiserv Inc / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / Progress Software Corp / Public Service Enterprise Group Inc / Southern Co / Genmab A/S / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / Duke Energy Corp / Twitter Inc / Alphabet Inc / InflaRx NV / Shopify Inc / Worldline SA / Evergy Inc / ViacomCBS Inc / Roku Inc / Academy Sports and Outdoors Inc / Impel Neuropharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v2.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">06/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">2021 HOLT Conference | Global Tax Reforms, Cash Deployment and Accounting Quality</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">2330.TW / ABT.N / ASML.AS / BSX.N / JNJ.N / LVMH.PA / OREP.PA / PFE.N / TMO.N / WMT.N / PG.N / ROG.S / DHR.N / UNH.N / HD.N / LOW.N / RMD.N / VZ.N / COO.N / V.N / INTC.OQ / ADBE.OQ / AAPL.OQ / MSFT.OQ / CTXS.OQ / AMZN.OQ / NVDA.OQ / NFLX.OQ / NESN.S / 0700.HK / MA.N / FSLR.OQ / HAS.OQ / FB.OQ / ABBV.N / GOOGL.OQ / ZBH.N / PYPL.OQ / KHC.OQ / TMUS.OQ / 9988.HK / 2222.SE</td><td class="leftalignment">Taiwan Semiconductor Manufacturing Co Ltd / Abbott Laboratories / ASML Holding NV / Boston Scientific Corp / Johnson & Johnson / LVMH Moet Hennessy Louis Vuitton SE / L'Oreal SA / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Procter & Gamble Co / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Home Depot Inc / Lowe's Companies Inc / Resmed Inc / Verizon Communications Inc / Cooper Companies Inc / Visa Inc / Intel Corp / Adobe Inc / Apple Inc / Microsoft Corp / Citrix Systems Inc / Amazon.com Inc / NVIDIA Corp / Netflix Inc / Nestle SA / Tencent Holdings Ltd / Mastercard Inc / First Solar Inc / Hasbro Inc / Meta Platforms Inc / Abbvie Inc / Alphabet Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / Kraft Heinz Co / T-Mobile US Inc / Alibaba Group Holding Ltd / Saudi Arabian Oil Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / France / Netherlands / Saudi Arabia / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ron Graziano / Mr. Amit Varshney / Selim Gogus / Adrian Szumilo / HOLT Americas</td></tr>
<tr class="odd"><td class="leftalignment">06/09/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for TRIL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">TRIL.OQ</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BLUE, AMGN (NEUTRAL), GMAB.DC (BUY)- Read-through from ASCO MM Session Highlights Emerging Competition in Late Line; Darzalex Largely Shielded for Now</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.OQ / BLUE.OQ / 0925288 / 2126335 / 2023607 / 2475833 / 2684703 / 4595739 / BBFL7S1</td><td class="leftalignment">Amgen Inc / bluebird bio Inc / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Amgen Inc / Johnson & Johnson / Pfizer Inc / Genmab A/S / bluebird bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">TRIL.TO - Event Transcript of Trillium Therapeutics Inc conference call, Jun. 08, 2021 / 1:00PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / INCY=US / TEVA=US / MTN=US / LOW=US / PB=US / CHRS=US / LEG=US / VMC=US / MLM=US / AIR=US / SWIM=US / CBRL=US / CSTR=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / REGN=US / REGI=US / FOUR=US / CGEN=US / FMBI=US / SNV=US / SIVB=US / ABCB=US / FBK=US / SSB=US / RF=US / FFIN=US / GBCI=US / DIN=US / PNFP=US / SBCF=US / BIIB=US / TPX=US / EXP=US / BDC=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / IBTX=US / NDLS=US / FATE=US / 00770K202 / COUP=US / LOCO=US / HQY=US / SHAK=US / WING=US / ARGX=US / ACBI=US / SQ=US / 82982L103 / TVTY=US / JELD=US / SFIX=US / HWC=US / BTAI=US / LSPD=US / FERG=US / OPCH=US / ARQT=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Vail Resorts Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / AAR Corp / Latham Group Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Shift4 Payments Inc / Compugen Ltd / First Midwest Bancorp Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / SouthState Corp / Regions Financial Corp / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Belden Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Fate Therapeutics Inc / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Wingstop Inc / argenx SE / Atlantic Capital Bancshares Inc / Block Inc / SiteOne Landscape Supply Inc / Tivity Health Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Hancock Whitney Corp / BioXcel Therapeutics Inc / Lightspeed Commerce Inc / Ferguson PLC / Option Care Health Inc / Arcutis Biotherapeutics Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2973821 / 2065159 / 2216850 / 2270726 / 2542049 / 2829515 / 2576941 / 2328915 / 2455965 / 2457864 / 2689560 / 2684703 / 2048804 / 2705198 / 2707677 / 2730190 / 2138158 / 2829601 / 7103065 / B02R1L6 / B7TL820 / BBFL7S1 / BBGVT40 / BYVY8G0 / BP4GNK9 / BYNZGK1 / BJ2Z0H2 / BMQ5T49 / BFMXGR0 / BFNR303 / BKTNTR9 / BZ1LFG7 / BYY88Y7 / BDVLM39 / BP8XZL1 / BMG5660</td><td class="leftalignment">American Express Co / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Alliant Energy Corp / Autodesk Inc / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelixis Inc / Nextera Energy Inc / Biogen Inc / ImmunoGen Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Progress Software Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / Sempra Energy / Southern Co / Novartis AG / ALLETE Inc / Meta Platforms Inc / bluebird bio Inc / News Corp / Alphabet Inc / SAGE Therapeutics Inc / Block Inc / Pinterest Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Northwest Natural Holding Co / ViacomCBS Inc / Roku Inc / Alphabet Inc / argenx SE / Healthequity Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Monthly IQVIA Tracker: Japan focus</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">4506.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / PFE.N / 4516.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">06/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 月次IQVIAトラッカー：日本フォーカス</td><td class="leftalignment">Japanese</td><td class="rightalignment">40</td><td class="leftalignment">4506.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / BMY.N / PFE.N / 4516.T / ROG.S / 4151.T / 4568.T / 4578.T</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BAYRY-US -  Dividend Quality Analysis, for the period ended May 10,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BAYRY.PK / JNJ / LLY / MRK / NVS / PFE / GSK / REGN.O / NKTR.O / TEVA.K / SNY.O</td><td class="leftalignment">Bayer AG / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SNY-US -  Dividend Quality Analysis, for the period ended May 26,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SNY.O / ABT / BMY / JNJ / LLY / MRK / NVO / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Sanofi SA / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novo Nordisk A/S / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended June 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 28, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Latest ASP data provides some insight into biosimilar price trends</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: KOL Video Call To Discuss ASCO Highlights at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM / JNJ / LLY / MRK / PFE / GILD.O / US75886F1075 / BSLN.S / HTBX.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Basilea Pharmaceutica AG / Heat Biologics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy and Solid Tumor Treatments, Wednesday June 30th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ARAV.OQ / IMAB.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / BSLN.S / HGEN.OQ</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - June 7 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">BE0165385973 / US0091581068 / US00971T1016 / US0116591092 / US0311621009 / US0323325045 / US0463531089 / US0997241064 / US1101221083 / US17275R1023 / US2310211063 / US34354P1057 / US37733W1053 / US45167R1041 / US4523271090 / US45337C1027 / US4657411066 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7010941042 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8835561023 / US92343V1044 / US9427491025 / CA8265161064 / US30063P1057 / US00508Y1029 / US4771431016 / US4198791018 / US80105N1054 / US64111Q1040 / US1281261099 / US79466L3024 / US6866881021 / US2538681030 / US00206R1023 / US6247581084 / PAP310761054 / US16115Q3083 / US3364331070 / US01748X1028 / US2473617023 / US53261M1045 / US90384S3031 / US1940141062 / DE000A0DJ6J9 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US69404D1081 / US92839U2069 / US8676524064 / JE00B783TY65 / US98419M1009 / US00287Y1091 / US98978V1035 / US8725901040 / US72919P2020 / US64051T1007 / US29355A1079 / US23283R1005 / US41068X1000 / US8485771021 / US21240E1055 / US5560991094 / US02376R1023 / IE00BLS09M33 / US0404131064 / CA0089118776 / US29444U7000 / US46185L1035 / US83417M1045 / US6323071042 / US98138J2069 / US45073V1089 / US34959J1088 / US87266J1043 / US36165L1089 / US45782B1044 / NL0012169213 / US87105L1044 / US8760301072 / US30057T1051 / US4622601007 / US05351X1019 / CH0371153492 / US92336X1090 / US0937121079 / US5904791358 / US28414H1032 / KY30744W1070 / US40131M1099 / US35952H6018 / US71535D1063 / US1567271093 / US23725P2092 / US92537N1081 / US26142R1041 / US6541101050 / US12233L1070 / US04271T1007 / KYG3902L1095 / US5502411037 / US55406W1036 / US82489W1071 / US03783T1034 / LU2314763264 / US90089L1089 / US30320C1036</td><td class="leftalignment">Melexis NV / Air Products and Chemicals Inc / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Amtech Systems Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cisco Systems Inc / Cummins Inc / Flowserve Corp / GlaxoSmithKline PLC / IDEX Corp / Illumina Inc / Incyte Corp / Itron Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Thermo Fisher Scientific Inc / Verizon Communications Inc / Watts Water Technologies Inc / Sierra Wireless Inc / Exact Sciences Corp / Acuity Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / NETGEAR Inc / CalAmp Corp / Salesforce.Com Inc / Ormat Technologies Inc / Digital Realty Trust Inc / AT&T Inc / Mueller Water Products Inc / Copa Holdings SA / Chart Industries Inc / First Solar Inc / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Ulta Beauty Inc / Colfax Corp / SMA Solar Technology AG / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Visteon Corp / SunPower Corp / Aptiv PLC / Xylem Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / Plug Power Inc / NeoPhotonics Corp / Enphase Energy Inc / CyrusOne Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / Pentair PLC / Arista Networks Inc / Air Canada / Equinix Inc / Invitae Corp / Solaredge Technologies Inc / Natera Inc / Workhorse Group Inc / ITT Inc / Fortive Corp / TPI Composites Inc / GDS Holdings Ltd / Inseego Corp / Qiagen NV / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Iovance Biotherapeutics Inc / Avaya Holdings Corp / Landis+Gyr Group AG / Veoneer Inc / Bloom Energy Corp / Mesa Air Group Inc / Elanco Animal Health Inc / Farfetch Ltd / Guardant Health Inc / Fuelcell Energy Inc / Personalis Inc / Cerence Inc / DarioHealth Corp / Vertiv Holdings Co / DraftKings Inc / Nikola Corp / Burning Rock Biotech Ltd / Array Technologies Inc / GDS Holdings Ltd / Lumen Technologies Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc / AppHarvest Inc / Arrival SA / TuSimple Holdings Inc / FTC Solar Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ROG.S: Roche - ASCO 2021: Tecentriq in adjuvant lung cancer likely practice changing in a limited population</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ROG.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Roche Holding AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">AZN.L: AstraZeneca - ASCO 2021 weekend takeaways</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">06/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVN.S: Novartis - ASCO 2021 Weekend highlights</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">NOVN.S / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novartis AG / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">06/06/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 61</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACAD / ACET / ALLO / ALT / AMTI / MRTX / SPPI / STRO / TRIL / CRTX / ARNA / SGEN / CLSD / 45337C10 / 09058V10 / TPTX / 00422510 / 84763A108 / CRMD / ZGNX / ABUS / 29251M106 / M25722105 / 23282W605 / OCUL / PRQR / 89620X506 / BPMC / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / NTLA / PTGX / CRSP / PLXP / RZLT / 81750R102 / 29604W108 / 29664W105 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / AQST / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / BCYC / 02155H200 / 24344T101 / 48576A100 / 74366E102 / RLAY / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / ATHA / TSHA / 81181C104 / 21900C308 / 517125100 / 07160F107 / G637AM102 / 007002108 / M47364100 / 617760202 / N71542109 / 45168K405 / 206022105 / 92790C104 / 76200L309</td><td class="leftalignment">ACADIA Pharmaceuticals Inc / Adicet Bio Inc / Allogene Therapeutics Inc / Altimmune Inc / Applied Molecular Transport Inc. / Mirati Therapeutics Inc / Spectrum Pharmaceuticals Inc / Sutro Biopharma Inc / Pfizer Inc / Cortexyme Inc / Arena Pharmaceuticals Inc / Seagen Inc / Clearside Biomedical Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Turning Point Therapeutics Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / CorMedix Inc / Zogenix Inc / Arbutus Biopharma Corp / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Ocular Therapeutix Inc / ProQR Therapeutics NV / Pfizer Inc / Blueprint Medicines Corp / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Intellia Therapeutics Inc / Protagonist Therapeutics Inc / CRISPR Therapeutics AG / PLx Pharma Inc / Rezolute Inc / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / Aquestive Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Bicycle Therapeutics PLC / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Athira Pharma Inc / Taysha Gene Therapies Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Baudax Bio Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Viridian Therapeutics Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">06/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">2021 Global Chemicals, Agriculture, Packaging and Cement  Conference: Feedback from London Conference - Day 2</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AKZO.AS / CRDA.L / DSMN.AS / ELM.L / PFE.N / NZYMB.CO / MNDI.L / SYNTS.L</td><td class="leftalignment">Akzo Nobel NV / Croda International PLC / Koninklijke DSM NV / Elementis PLC / Pfizer Inc / Novozymes A/S / Mondi PLC / Synthomer PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Chemicals / Industrial Materials</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Samuel Perry / Herr. Lars F. Kjellberg / Mr. Charlie Bentley / Zheng Li</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">AI focused biotech, Predictive Oncology, advances on plan - reiterate Buy and $5 PT</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Pfizer, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Anguilla / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BOUY.PA / ORSTED.CO / PFE.N / AZN.L / MRCG.DE / MOSS.NS</td><td class="leftalignment">Bouygues SA / Orsted A/S / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Motherson Sumi Systems Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / India / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Energy / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Telecommunications / Transportation / Utilities / Oil & Gas</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Jonathan Schroer / Frau Silke Stegemann / Herr Sven Kreitmair, CFA</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 2126335 / 2973821 / 2216850 / 2270726 / 2542049 / 2829515 / 2670519 / 2328915 / 2471950 / 2689560 / 2684703 / 2707677 / 2138158 / 2829601 / 2980906 / 5531000 / 2822019 / 2969637 / B0T7YX2 / B02R1L6 / B3D7K31 / B6197Q2 / B7TL820 / B65SQW4 / B7VD3F2 / B7JYSG3 / B3V9F12 / BFLR866 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BKDS4H5 / BJ2Z0H2 / BKVDFF7 / BFZ1K46 / BMYML02 / BFMXGR0 / BZ8VJQ8 / BGSP7M9 / BFWK4R7 / BGKG6M3 / BYXR425 / BZ4CHH2 / BYXB1Y8 / BMCC9R7 / BMDJ397 / BNTB3N8 / BWC52Q6 / BJ9N563</td><td class="leftalignment">American Express Co / Visa Inc / Bristol-Myers Squibb Co / Alliant Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Exelon Corp / Nextera Energy Inc / Incyte Corp / PG&E Corp / Pfizer Inc / Public Service Enterprise Group Inc / Sempra Energy / Southern Co / Foot Locker Inc / MorphoSys AG / Advance Auto Parts Inc / DICK'S Sporting Goods Inc / Live Nation Entertainment Inc / ALLETE Inc / Discovery Inc / Generac Holdings Inc / Meta Platforms Inc / Enphase Energy Inc / Duke Energy Corp / Guidewire Software Inc / PVH Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Bill.com Holdings Inc / Pinterest Inc / Oric Pharmaceuticals Inc / Spotify Technology SA / DraftKings Inc / Evergy Inc / Vistra Corp / Zoom Video Communications Inc / PagSeguro Digital Ltd / StoneCo Ltd / RH / Soleno Therapeutics Inc / Sunrun Inc / SCYNEXIS Inc / Bolt Biotherapeutics Inc / Vizio Holding Corp / Solaredge Technologies Inc / Sunnova Energy International Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Germany / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) - Signals of Clinical Activity and a Good Safety Profile Highlight the Potential for ORIC-101 in PDAC (and Perhaps Other Cancers)</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">06/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Ada's Insights-Quant Strategy: Financials: Both Growth and Value Leading</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AFL.N / AIG.N / ALL.AX / AXP.N / BAC.N / BK.N / C.N / CB.N / COF.N / HIG.N / JPM.N / MMC.N / PFE.N / PNC.N / PRU.L / TRV.N / USB.N / WFC.N / CMA.N / BEN.N / MET.N / AIZ.N / PGR.N / GS.N / UNM.N / STT.N / RE.N / AMP.N / LNC.N / MTB.N / BLK.N / AJG.N / MCO.N / RF.N / CINF.OQ / FRC.N / HBAN.OQ / NTRS.OQ / PBCT.OQ / TROW.OQ / RJF.N / SIVB.OQ / ZION.OQ / DFS.N / GL.N / TFC.N / MKTX.OQ / NDAQ.OQ / ICE.N / MS.N / AON.N / IVZ.N / WRB.N / CME.OQ / SCHW.N / 2378.HK / KEY.TO / SYF.N / CFG.N / WLTW.OQ / SPGI.K / PFG.OQ</td><td class="leftalignment">Aflac Inc / American International Group Inc / Aristocrat Leisure Ltd / American Express Co / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Chubb Ltd / Capital One Financial Corp / Hartford Financial Services Group Inc / JPMorgan Chase & Co / Marsh & McLennan Companies Inc / Pfizer Inc / PNC Financial Services Group Inc / Prudential PLC / Travelers Companies Inc / US Bancorp / Wells Fargo & Co / Comerica Inc / Franklin Resources Inc / MetLife Inc / Assurant Inc / Progressive Corp / Goldman Sachs Group Inc / Unum Group / State Street Corp / Everest Re Group Ltd / Ameriprise Financial Inc / Lincoln National Corp / M&T Bank Corp / BlackRock Inc / Arthur J Gallagher & Co / Moody's Corp / Regions Financial Corp / Cincinnati Financial Corp / First Republic Bank / Huntington Bancshares Inc / Northern Trust Corp / People's United Financial Inc / T Rowe Price Group Inc / Raymond James Financial Inc / SVB Financial Group / Zions Bancorporation NA / Discover Financial Services / Globe Life Inc / Truist Financial Corp / Marketaxess Holdings Inc / Nasdaq Inc / Intercontinental Exchange Inc / Morgan Stanley / Aon PLC / Invesco Ltd / W R Berkley Corp / CME Group Inc / Charles Schwab Corp / Prudential PLC / Keyera Corp / Synchrony Financial / Citizens Financial Group Inc / Willis Towers Watson PLC / S&P Global Inc / Principal Financial Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / QUANANTITATIVE/TECH RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / INCY=US / KMI=US / V=US / LOW=US / HSII=US / LEG=US / KFRC=US / VMC=US / MLM=US / KFY=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAN=US / MAS=US / MRCY=US / MHK=US / ASGN=US / REGI=US / RHI=US / SMG=US / SHOP=US / TRIP=US / CGEN=US / CCRN=US / PYPL=US / AVTR=US / CRTO=US / NFLX=US / DIN=US / PTON=US / RNG=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / MA=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / KTOS=US / NXGN=US / JACK=US / TREX=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / PTCT=US / CEQP=US / FATE=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / BWXT=US / WING=US / 100095108 / 82982L103 / IRTC=US / JELD=US / ROKU=US / SYNH=US / MAXR=US / BTAI=US / FERG=US / LHX=US / IMVT=US / ARQT=US / SPCE=US / FBRX=US / AZEK=US / AFRM=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Incyte Corp / Kinder Morgan Inc / Visa Inc / Lowe's Companies Inc / Heidrick & Struggles International Inc / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Korn Ferry / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / ASGN Inc / Renewable Energy Group Inc / Robert Half International Inc / Scotts Miracle-Gro Co / Shopify Inc / Tripadvisor Inc / Compugen Ltd / Cross Country Healthcare Inc / PayPal Holdings Inc / Avantor Inc / Criteo SA / Netflix Inc / Dine Brands Global Inc / Peloton Interactive Inc / RingCentral Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Kratos Defense and Security Solutions Inc / NextGen Healthcare Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / PTC Therapeutics Inc / Crestwood Equity Partners LP / Fate Therapeutics Inc / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / BWX Technologies Inc / Wingstop Inc / Bank of America Corp / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Roku Inc / Syneos Health Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Ferguson PLC / L3harris Technologies Inc / Immunovant Inc / Arcutis Biotherapeutics Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Affirm Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / France / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">5671735 / 0989529 / 2367026 / 2701271 / 2126335 / 2516152 / 2000019 / 2486813 / 2002305 / 2973821 / 2050832 / 2216850 / 2270726 / 2670519 / 2684703 / 2048804 / 2707677 / 2440637 / 2829601 / 7103065 / 2857817 / B02R1L6 / B2R3PV1 / B3D7K31 / BFLR866 / BYRY499 / BTN1Y11 / BQPVQZ6 / BYVY8G0 / BNFWR44 / BWFKZT2 / BMYML02 / BFMXGR0 / BJJMGL2 / BKTNTR9 / BYY88Y7 / BDVLM39 / BKWD3M9 / BGKG6M3 / BJRFSB7 / BMDJ085 / BMFPJK6</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / General Mills Inc / Costco Wholesale Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Kellogg Co / Abbott Laboratories / Alliant Energy Corp / Ameren Corp / Consolidated Edison Inc / Walt Disney Co / Exelon Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Southern Co / Novartis AG / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Twitter Inc / Kraft Heinz Co / Medtronic PLC / Horizon Therapeutics PLC / Alphabet Inc / Worldline SA / Cellectis SA / DraftKings Inc / Evergy Inc / Fox Corp / ViacomCBS Inc / Alphabet Inc / argenx SE / Progyny Inc / StoneCo Ltd / Immunovant Inc / Shoals Technologies Group Inc / ACV Auctions Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">06/02/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 06 01</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AAPL.OQ / ARMK.N / ABT.N / AEP.N / CVS.N / KO.N / MO.N / PFE.N / PM.N / EW.N / SNA.N / ISRG.OQ / TXN.OQ / GNRC.N / TSLA.OQ / ANTM.N / CHWY.N</td><td class="leftalignment">Apple Inc / Aramark / Abbott Laboratories / American Electric Power Company Inc / CVS Health Corp / Coca-Cola Co / Altria Group Inc / Pfizer Inc / Philip Morris International Inc / Edwards Lifesciences Corp / Snap-On Inc / Intuitive Surgical Inc / Texas Instruments Inc / Generac Holdings Inc / Tesla Inc / Anthem Inc / Chewy Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Automotive / Beverages & Tobacco / Electrical / Healthcare / Info. Tech./Peripheral / Lodging & Restaurants / Machinery / Pharmaceuticals / Semiconductors / Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EBS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">EBS / MRK / PFE / GSK / XOMA.O / SIGA.O / CLDX.O / CMRX.O / SNGX.O / TEVA.K</td><td class="leftalignment">Emergent BioSolutions Inc / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / XOMA Corp / SIGA Technologies Inc / Celldex Therapeutics Inc / Chimerix Inc / Soligenix Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 21, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, PFE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung</td></tr>
<tr class="even"><td class="leftalignment">06/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - June 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / BMO.TO / CAS.TO / CL.N / CM.TO / CRM.N / EDP.LS / EIX.N / EL.N / ELE.MC / IBE.MC / IP.N / KMB.N / KO.N / MRK.N / NA.TO / PD.N / PEG.N / PFE.N / RYN.N / SO.N / STO.AX / T.N / T.TO / TD.TO / PEP.N / DRE.N / FR.N / TRI.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / GILD.O / CPB.N / LPX.N / CMCSA.O / AMGN.O / INCY.O / AAL.L / DUK.N / TRP.TO / K.N / DT.N / ADBE.O / SU.TO / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / CONE.O / VZ.N / HCA.N / STZ.N / EXC.N / FISV.O / EQT.N / ADSK.O / EPD.N / AWK.N / EGP.N / PLD.N / NBIX.O / CHD.N / NWN.N / WSP.TO / SAM.N / ENR.N / VRTX.O / JHX.AX / CEY.L / NCR.N / VRNT.O / COP.N / CNP.N / WCN.N / CPK.N / DOL.TO / TYL.N / CRC.N / LNG.A / NTCT.OQ / GPN.N / MNST.O / EFX.TO / CCLb.TO / CASY.O / PCTY.O / ICPT.O / EQIX.O / ATDb.TO / BIIB.O / TIH.TO / 02209S103 / NTR.N / DLR.N / SCL.TO / ACAD.O / 427866108 / WEF.TO / RDSb.L / BAM.N / SJW.N / DRX.L / FIS.N / CSU.TO / MERC.O / 3IN.L / BGS.N / PPL.TO / HOCM.L / ARX.TO / UTL.N / CLW.N / VALE.N / IFC.TO / CVE.TO / ADN.TO / SPB.N / NEE.N / TOU.TO / NXT.AX / PCH.O / CFX.TO / FRU.TO / SXY.AX / CTT.N / STAG.N / IFP.TO / PXT.TO / POLYP.L / EFN.TO / SPLK.OQ / RFP.N / SRPT.O / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / PRMW.N / TMUS.N / COTY.N / PRTA.O / BEP.N / 81762P102 / CFF.TO / COUP.N / VRNS.O / QTWO.N / RYAM.N / HUBS.N / QSR.N / CAR.AX / 78667J108 / EVA.N / GLPG.O / WRK.N / IONS.O / NTNX.O / GDS.O / AQN.N / OKTA.OQ / WPM.N / ZS.OQ / SMAR.N / VRCA.OQ / ITRM.O / NTGY.MC / KDP.N / ESTC.N / NWL.O / ZM.O / MORF.OQ / CRWD.O / PING.N / FCR_u.TO / REYN.O / GFL.N / FOUR.N / ZI.O / AKES.OL / PLTR.N / ASAN.N / WFG.N / AFRM.O / TEEC.L / NAPA.N / PATH.N / AVAH.OQ / GIP.V / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Bank of Montreal / Cascades Inc / Colgate-Palmolive Co / Canadian Imperial Bank of Commerce / Salesforce.Com Inc / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / Iberdrola SA / International Paper Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Rayonier Inc / Southern Co / Santos Ltd / AT&T Inc / Telus Corp / Toronto-Dominion Bank / PepsiCo Inc / Duke Realty Corp / First Industrial Realty Trust Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / Gilead Sciences Inc / Campbell Soup Co / Louisiana-Pacific Corp / Comcast Corp / Amgen Inc / Incyte Corp / Anglo American PLC / Duke Energy Corp / TC Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Suncor Energy Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / HCA Healthcare Inc / Constellation Brands Inc / Exelon Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Enterprise Products Partners LP / American Water Works Company Inc / Eastgroup Properties Inc / Prologis Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / WSP Global Inc / Boston Beer Company Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Verint Systems Inc / Conocophillips / CenterPoint Energy Inc / Waste Connections Inc / Chesapeake Utilities Corp / Dollarama Inc / Tyler Technologies Inc / California Resources Corp / Cheniere Energy Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / CCL Industries Inc / Caseys General Stores Inc / Paylocity Holding Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Toromont Industries Ltd / Altria Group Inc / Nutrien Ltd / Digital Realty Trust Inc / Shawcor Ltd / ACADIA Pharmaceuticals Inc / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Brookfield Asset Management Inc / SJW Group / Drax Group PLC / Fidelity National Information Services Inc / Constellation Software Inc / Mercer International Inc / 3I Infrastructure PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / ARC Resources Ltd / Unitil Corp / Clearwater Paper Corp / Vale SA / Intact Financial Corp / Cenovus Energy Inc / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Freehold Royalties Ltd / Senex Energy Ltd / CatchMark Timber Trust Inc / STAG Industrial Inc / Interfor Corp / Parex Resources Inc / Polymetal International PLC / Element Fleet Management Corp / Splunk Inc / Resolute Forest Products Inc / Sarepta Therapeutics Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / ServiceNow Inc / Conifex Timber Inc / Coupa Software Inc / Varonis Systems Inc / Q2 Holdings Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Restaurant Brands International Inc / Carsales.Com Ltd / SAGE Therapeutics Inc / Enviva Inc / Galapagos NV / Westrock Co / Ionis Pharmaceuticals Inc / Nutanix Inc / GDS Holdings Ltd / Algonquin Power & Utilities Corp / Okta Inc / Wheaton Precious Metals Corp / Zscaler Inc / Smartsheet Inc / Verrica Pharmaceuticals Inc / Iterum Therapeutics PLC / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / Morphic Holding Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / First Capital Real Estate Investment Trust / Reynolds Consumer Products Inc / GFL Environmental Inc / Shift4 Payments Inc / ZoomInfo Technologies Inc / Aker Solutions ASA / Palantir Technologies Inc / Asana Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Duckhorn Portfolio Inc / UiPath Inc / Aveanna Healthcare Holdings Inc / Green Impact Partners Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Brazil / Canada / Cayman Islands / Spain / United Kingdom / Ireland / Netherlands / Norway / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">06/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: June 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">000100.KS / 145020.KQ / PFE.N / AZN.L / 006280.KS / MRNA.OQ / 068270.KS / 086900.KQ / 207940.KS / 091990.KQ</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Pfizer Inc / AstraZeneca PLC / Green Cross Corp / Moderna Inc / Celltrion Inc / Medy Tox Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IMGN (BUY) - Management Discussion Highlights Confidence in Mirvetuximab Opp'ty, ADC Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2457864 / 2684703 / BFDV8K0</td><td class="leftalignment">ImmunoGen Inc / Pfizer Inc / MacroGenics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7 at 12PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IMAB.O / JNJ / LLY / MRK / PFE / US3755581036 / BSLN / HCM.O / MBIO.O</td><td class="leftalignment">I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/31/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ABBV.N / VRCA.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Abbvie Inc / Verrica Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/31/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/30/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Base - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.28.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for PFE. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">45337C10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 74366E102 / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / 81181C104 / 21900C308 / 517125100 / 007002108 / M47364100 / N71542109 / 45168K405 / 76200L309</td><td class="leftalignment">Incyte Corp / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Protagonist Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Roy Buchanan, PhD, PHD / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 21, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/28/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">PFE - Embedded Expectations Analysis - 2021 05 27</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ALV.N / BMO.TO / F.N / FCL.AX / MRK.N / PFE.N / TOL.N / AMGN.O / SU.TO / JAZZ.O / SGMO.O / NG.L / V.N / EXPE.O / WSM.N / EPAY.O / ANF.N / APT.AX / JKHY.O / VRTX.O / NCR.N / SSNC.O / ENDP.O / SKY.N / GPN.N / DKS.N / FIS.N / TEVA.N / AEO.N / ATL.MI / WDAY.N / ABBV.N / WIX.O / ZG.O / SQ.N / NTNX.O / OKTA.OQ / DXC.N / CVNA.N / RDFN.O / 00183L102 / ORSTED.CO / CARG.O / Z1P.AX / COLD.N / BKNG.O / VRCA.OQ / NXGN.O / LSPD.TO / LYFT.O / 269796108 / UBER.N / FVRR.N / SZL.AX / FOUR.N / IBEX.O / NVEIu.TO / ABNB.OQ / DASH.N / AFRM.O / PSFE.N / AVAH.OQ</td><td class="leftalignment">Autoliv Inc / Bank of Montreal / Ford Motor Co / FINEOS Corporation Holdings PLC / Merck & Co Inc / Pfizer Inc / Toll Brothers Inc / Amgen Inc / Suncor Energy Inc / Jazz Pharmaceuticals PLC / Sangamo Therapeutics Inc / National Grid PLC / Visa Inc / Expedia Group Inc / Williams-Sonoma Inc / Bottomline Technologies Inc / Abercrombie & Fitch Co / Afterpay Ltd / Jack Henry & Associates Inc / Vertex Pharmaceuticals Inc / NCR Corp / SS&C Technologies Holdings Inc / Endo International PLC / Skyline Champion Corp / Global Payments Inc / DICK'S Sporting Goods Inc / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / American Eagle Outfitters Inc / Atlantia SpA / Workday Inc / Abbvie Inc / Wix.Com Ltd / Zillow Group Inc / Block Inc / Nutanix Inc / Okta Inc / DXC Technology Co / Carvana Co / Redfin Corp / Angi Inc / Orsted A/S / CarGurus Inc / Zip Co Ltd / Americold Realty Trust / Booking Holdings Inc / Verrica Pharmaceuticals Inc / NextGen Healthcare Inc / Lightspeed Commerce Inc / Lyft Inc / Eagle Pharmaceuticals Inc / Uber Technologies Inc / Fiverr International Ltd / Sezzle Inc / Shift4 Payments Inc / Ibex Ltd / Nuvei Corp / Airbnb Inc / DoorDash Inc / Affirm Holdings Inc / Paysafe Ltd / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Denmark / United Kingdom / Ireland / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/27/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Top near-term catalysts to watch</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / ABBV.N / VRCA.OQ / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Verrica Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">05/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">ASND: GH Launch: Looking Beyond Near-Term Expectations</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">ASND.OQ / PFE.N / ROG.S / NOVOB.CO / MRCG.DE / IPN.PA</td><td class="leftalignment">Ascendis Pharma A/S / Pfizer Inc / Roche Holding AG / Novo Nordisk A/S / Merck KGaA / Ipsen SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Roger Xu / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / AMZN=US / T=US / INCY=US / GILD=US / VZ=US / CHRS=US / EWBC=US / MANH=US / MLM=US / DV=US / WTFC=US / AIZ=US / CBRL=US / ELY=US / EXEL=US / HEI=US / MAIN=US / OKE=US / HOOK=US / REGN=US / GOLF=US / CGEN=US / CFB=US / SNV=US / SIVB=US / ABCB=US / FB=US / FBK=US / SSB=US / GBCI=US / NLS=US / PNFP=US / SBCF=US / JRVR=US / STRO=US / RNG=US / IAC=US / RCUS=US / CLNY=US / KNSL=US / MEIP=US / ABBV=US / IBTX=US / TMUS=US / FATE=US / TSLX=US / ACBI=US / ZS=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / OZK=US / FTDR=US / ALLO=US / HARP=US / UBER=US / GMAB=US / AVAH=US / VMEO=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Amazon.com Inc / AT&T Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / Coherus BioSciences Inc / East West Bancorp Inc / Manhattan Associates Inc / Martin Marietta Materials Inc / DoubleVerify Holdings Inc / Wintrust Financial Corp / Assurant Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Exelixis Inc / HEICO Corp / Main Street Capital Corp / ONEOK Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Acushnet Holdings Corp / Compugen Ltd / Crossfirst Bankshares Inc / Synovus Financial Corp / SVB Financial Group / Ameris Bancorp / Meta Platforms Inc / FB Financial Corp / SouthState Corp / Glacier Bancorp Inc / Nautilus Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Sutro Biopharma Inc / RingCentral Inc / IAC/Interactivecorp / Arcus Biosciences Inc / DigitalBridge Group Inc / Kinsale Capital Group Inc / MEI Pharma Inc / Abbvie Inc / Independent Bank Group Inc / T-Mobile US Inc / Fate Therapeutics Inc / Sixth Street Specialty Lending Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Bank Ozk / Frontdoor Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / Genmab A/S / Aveanna Healthcare Holdings Inc / Vimeo Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist Securities ASCO Planner v2.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer jumps 17% in past quarter; Institutional Ownership steady</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">LLY=US / LSI=US / PFE=US / AMGN=US / BMY=US / MCD=US / WEN=US / INCY=US / CHKP=US / IART=US / MAC=US / BMRN=US / BNL=US / CBRL=US / CRL=US / DRI=US / EXEL=US / NOW=US / REGI=US / STOR=US / PSA=US / NET=US / OFC=US / SRC=US / NTRA=US / DIN=US / RPD=US / BIIB=US / EXR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / CMG=US / REX=US / GPRE=US / EHTH=US / OC=US / TAST=US / QSR=US / JACK=US / NEO=US / CUBE=US / PANW=US / ABBV=US / NDLS=US / FEYE=US / VRNS=US / 00770K202 / LOCO=US / SHAK=US / NSA=US / WING=US / LOB=US / ZS=US / LGF.B=US / OKTA=US / YEXT=US / SAIL=US / TENB=US / CRWD=US / ARQT=US / 96758W101 / VTRS=US / ABNB=US / HYFM=US / HIMS=US / KNBE=US</td><td class="leftalignment">Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / McDonald's Corp / Wendys Co / Incyte Corp / Check Point Software Technologies Ltd / Integra Lifesciences Holdings Corp / Macerich Co / Biomarin Pharmaceutical Inc / Bunzl plc / Cracker Barrel Old Country Store Inc / Charles River Laboratories International Inc / Darden Restaurants Inc / Exelixis Inc / ServiceNow Inc / Renewable Energy Group Inc / STORE Capital Corp / Public Storage / Cloudflare Inc / Corporate Office Properties Trust / Spirit Realty Capital Inc / Natera Inc / Dine Brands Global Inc / Rapid7 Inc / Biogen Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / eHealth Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / Neogenomics Inc / CubeSmart / Palo Alto Networks Inc / Abbvie Inc / Noodles & Co / Mandiant Inc / Varonis Systems Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / National Storage Affiliates Trust / Wingstop Inc / Live Oak Bancshares Inc / Zscaler Inc / Lions Gate Entertainment Corp / Okta Inc / Yext Inc / SailPoint Technologies Holdings Inc / Tenable Holdings Inc / CrowdStrike Holdings Inc / Arcutis Biotherapeutics Inc / WideOpenWest Inc / Viatris Inc / Airbnb Inc / Hydrofarm Holdings Group Inc / Hims & Hers Health Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2973821 / 2942605 / 2317087 / 2576941 / 2100920 / 2459020 / 2657802 / 2684703 / 2048804 / 2440637 / 2138158 / 2829601 / 7103065 / B125XQ6 / B02R1L6 / B3D7K31 / B03PGL4 / B7TL820 / B7VD3F2 / BFLR866 / BK7Y2V9 / BD8DJ71 / BJ2Z0H2 / BFMXGR0 / BYY88Y7 / BK71LY6 / BMG75B4 / BKLCX50 / BMTVQT8 / BMDJ085</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Alliant Energy Corp / Avista Corp / Entergy Corp / Exelixis Inc / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sempra Energy / Southern Co / Novartis AG / Portland General Electric Co / ALLETE Inc / Discovery Inc / NorthWestern Corp / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Akero Therapeutics Inc / Snap Inc / Pinterest Inc / Evergy Inc / Alphabet Inc / WW International Inc / Inventiva SA / Health Catalyst Inc / Goodrx Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/25/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 14, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NBIX-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">NBIX.O / LLY / PFE / PTN / RGEN.O / RPRX.O / ATHX.O / ANIP.O / ABBV.K / CASI.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Eli Lilly and Co / Pfizer Inc / Palatin Technologies Inc / Repligen Corp / Royalty Pharma PLC / Athersys Inc / ANI Pharmaceuticals Inc / Abbvie Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual Non-Deal-Roadshow with BSLN Management on Wednesday, June 23 and Thursday, June 24</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BSLN.S / PFE.N</td><td class="leftalignment">Basilea Pharmaceutica AG / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call on New and Emerging Heme Malignancy Treatments | 5/27 @ 11am ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US62818Q1040 / MRKR.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / BSLN.S / ARAV.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Mustang Bio Inc / Marker Therapeutics Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Basilea Pharmaceutica AG / Aravive Inc / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / PFE=US / INTC=US / ADI=US / AMD=US / AMZN=US / TXN=US / NVDA=US / H=US / CRM=US / IART=US / DIOD=US / XLNX=US / TTMI=US / EQR=US / FLO=US / ARCC=US / PATH=US / APH=US / ARW=US / AVGO=US / AVT=US / COLL=US / DRH=US / MAIN=US / MCHP=US / ORCC=US / ROLL=US / ST=US / BDSI=US / BIIB=US / BDC=US / AINV=US / SHO=US / BAH=US / REX=US / HST=US / TEL=US / PNNT=US / AGS=US / NXPI=US / PCRX=US / RHP=US / AERI=US / GOOGL=US / TSLX=US / 70806A106 / WK=US / ON=US / GSBD=US / LOB=US / NTLA=US / PK=US / PLYA=US / MPWR-US / SMAR=US / FSK=US / SPCE=US / FSKR=US / VTRS=US / PRVA=US / AVAH=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Amazon.com Inc / Texas Instruments Inc / NVIDIA Corp / Hyatt Hotels Corp / Salesforce.Com Inc / Integra Lifesciences Holdings Corp / Diodes Inc / Xilinx Inc / TTM Technologies Inc / Equity Residential / Flowers Foods Inc / Ares Capital Corp / UiPath Inc / Amphenol Corp / Arrow Electronics Inc / Broadcom Inc / Avnet Inc / Collegium Pharmaceutical Inc / Diamondrock Hospitality Co / Main Street Capital Corp / Microchip Technology Inc / Owl Rock Capital Corp / RBC Bearings Inc / Sensata Technologies Holding PLC / BioDelivery Sciences International Inc / Biogen Inc / Belden Inc / Apollo Investment Corp / Sunstone Hotel Investors Inc / Booz Allen Hamilton Holding Corp / REX American Resources Corp / Host Hotels & Resorts Inc / TE Connectivity Ltd / Pennantpark Investment Corp / PlayAGS Inc / NXP Semiconductors NV / Pacira Biosciences Inc / Ryman Hospitality Properties Inc / Aerie Pharmaceuticals Inc / Alphabet Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Workiva Inc / ON Semiconductor Corp / Goldman Sachs BDC Inc / Live Oak Bancshares Inc / Intellia Therapeutics Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Monolithic Power Systems Inc / Smartsheet Inc / FS KKR Capital Corp / Virgin Galactic Holdings Inc / FS KKR Capital Corp / Viatris Inc / Privia Health Group Inc / Aveanna Healthcare Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079031078 / US0079731008 / US0116591092 / US0311001004 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1727551004 / US1925761066 / US37733W1053 / US4581401001 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US5324571083 / US5370081045 / US55306N1046 / US5951121038 / US66987V1098 / US6701002056 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US91347P1057 / US9282981086 / US9581021055 / US9699041011 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US79466L3024 / US6098391054 / US82706C1080 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US0995021062 / US7512121010 / US00287Y1091 / NL0010273215 / US98978V1035 / US98138H1014 / US55405Y1001 / US8486371045 / KYG037AX1015 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / CA0089118776 / US74736K1016 / IE00BTN1Y115 / CA1380351009 / US40434L1052 / KYG4740B1059 / US74967X1037 / US11135F1012 / US2575541055 / US5904791358 / US28414H1032 / US24703L2025 / US85205L1070 / US75943R1023 / US8334451098 / US5738741041 / US30320C1036 / US83089J1088 / IE00BKVD2N49</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / AMETEK Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cirrus Logic Inc / Cohu Inc / GlaxoSmithKline PLC / Intel Corp / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / Eli Lilly and Co / Littelfuse Inc / MKS Instruments Inc / Micron Technology Inc / Novartis AG / Novo Nordisk A/S / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / Universal Display Corp / Vishay Intertechnology Inc / Western Digital Corp / Williams-Sonoma Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / Salesforce.Com Inc / Monolithic Power Systems Inc / Silicon Motion Technology Corp / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Abbvie Inc / ASML Holding NV / Zoetis Inc / Workday Inc / MACOM Technology Solutions Holdings Inc / Splunk Inc / Ambarella Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / Air Canada / Qorvo Inc / Medtronic PLC / Canopy Growth Corp / HP Inc / Ichor Holdings Ltd / RH / Broadcom Inc / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Dell Technologies Inc / SpringWorks Therapeutics Inc / Relay Therapeutics Inc / Snowflake Inc. / Marvell Technology Inc / FTC Solar Inc / Skywater Technology Inc / Seagate Technology Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">RSV Could Be the Next $10bn Vaccine Market. Who’s Best Positioned?</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">71708110 / 04635310 / 75886F10 / 478160104 / 58933Y10 / 60770K10 / G3910J11 / F5548N10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Johnson & Johnson / Merck & Co Inc / Moderna Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun / Anna Baran, CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 24, 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">AEP.N / AES.N / ANTO.L / BAC.N / BK.N / C.N / CL.N / CMS.N / COF.N / CRM.N / EIX.N / EL.N / FGP.L / FITB.O / JPM.N / KEY.N / KMB.N / KO.N / MRK.N / NTRS.O / PEG.N / PFE.N / PNC.N / RWEG.DE / SO.N / T.N / USB.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CFP.TO / CPB.N / CMCSA.O / CHKP.O / AAL.L / DUK.N / HBAN.O / D.N / K.N / DT.N / DISH.O / ADBE.O / CLX.N / CAG.N / SUN.N / GIS.N / PAA.N / EPC.N / AMT.N / VZ.N / STT.N / HCA.N / EXEL.O / XEL.N / ARNA.O / STZ.N / VFC.N / GEL.N / EXC.N / FISV.O / ADSK.O / V.N / EPD.N / CHTR.O / AWK.N / ARE.N / CHD.N / NWN.N / MTB.N / VTR.N / SAM.N / BMRN.O / REGN.O / ENR.N / NCR.N / GFI.N / VRNT.O / RF.N / CNP.N / APF.L / BKH.N / CPK.N / FRC.N / SR.N / WES.N / LTC.N / AMH.N / LNG.A / NTCT.OQ / SGEN.OQ / GPN.N / MNST.O / SIVB.O / CASY.O / MMP.N / ATDb.TO / TFC.N / DCP.N / 02209S103 / CWX.TO / EDR.N / 427866108 / WEF.TO / MPW.N / RDSb.L / DISCA.O / SJW.N / BKD.N / FIS.N / MA.N / BGS.N / EDPR.LS / UTL.N / VALE.N / SPB.N / NEE.N / PCH.O / TRGP.N / IFP.TO / ACHC.O / RFP.N / PANW.N / MDLZ.OQ / SMLP.N / WDAY.N / MPLX.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / DOC.N / BEP.N / 81762P102 / CEQP.N / COUP.N / ENLC.N / RYAM.N / CFG.N / CAPL.N / SHLX.N / CTRE.O / PYPL.OQ / SGRY.O / SQ.N / MESO.O / NTNX.O / GDS.O / INVH.N / UNIT.O / OKTA.OQ / ATNX.O / WELL.N / ZS.OQ / KDP.N / ETRN.N / NWL.O / ZM.O / GMAB.O / PEAK.N / DHC.O / WTRG.N / REYN.O / IGIC.OQ / FOUR.N / NRIX.OQ / LUMN.N / WFG.N / NUVB.N / NAPA.N / OSO.N / AVAH.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Antofagasta PLC / Bank of America Corp / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Salesforce.Com Inc / Edison International / Estee Lauder Companies Inc / FirstGroup PLC / Fifth Third Bancorp / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Public Service Enterprise Group Inc / Pfizer Inc / PNC Financial Services Group Inc / Rwe AG / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Anglo American PLC / Duke Energy Corp / Huntington Bancshares Inc / Dominion Energy Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Adobe Inc / Clorox Co / Conagra Brands Inc / Sunoco LP / General Mills Inc / Plains All American Pipeline LP / Edgewell Personal Care Co / American Tower Corp / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Exelixis Inc / Xcel Energy Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / VF Corp / Genesis Energy LP / Exelon Corp / Fiserv Inc / Autodesk Inc / Visa Inc / Enterprise Products Partners LP / Charter Communications Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / M&T Bank Corp / Ventas Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / NCR Corp / Gold Fields Ltd / Verint Systems Inc / Regions Financial Corp / CenterPoint Energy Inc / Anglo Pacific Group PLC / Black Hills Corp / Chesapeake Utilities Corp / First Republic Bank / Spire Inc / Western Midstream Partners LP / LTC Properties Inc / American Homes 4 Rent / Cheniere Energy Inc / Netscout Systems Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Magellan Midstream Partners LP / Alimentation Couche-Tard Inc / Truist Financial Corp / DCP Midstream LP / Altria Group Inc / Doman Building Materials Group Ltd / Endeavor Group Holdings Inc / Hershey Co / Western Forest Products Inc / Medical Properties Trust Inc / Royal Dutch Shell PLC / Discovery Inc / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Mastercard Inc / B&G Foods Inc / EDP Renovaveis SA / Unitil Corp / Vale SA / Spectrum Brands Holdings Inc / Nextera Energy Inc / Potlatchdeltic Corp / Targa Resources Corp / Interfor Corp / Acadia Healthcare Company Inc / Resolute Forest Products Inc / Palo Alto Networks Inc / Mondelez International Inc / Summit Midstream Partners LP / Workday Inc / MPLX LP / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Physicians Realty Trust / Brookfield Renewable Partners LP / ServiceNow Inc / Crestwood Equity Partners LP / Coupa Software Inc / EnLink Midstream LLC / Rayonier Advanced Materials Inc / Citizens Financial Group Inc / Crossamerica Partners LP / Shell Midstream Partners LP / CareTrust REIT Inc / PayPal Holdings Inc / Surgery Partners Inc / Block Inc / Mesoblast Ltd / Nutanix Inc / GDS Holdings Ltd / Invitation Homes Inc / Uniti Group Inc / Okta Inc / Athenex Inc / Welltower Inc / Zscaler Inc / Keurig Dr Pepper Inc / Equitrans Midstream Corp / Newell Brands Inc / Zoom Video Communications Inc / Genmab A/S / Healthpeak Properties Inc / Diversified Healthcare Trust / Essential Utilities Inc / Reynolds Consumer Products Inc / International General Insurance Holdings Ltd / Shift4 Payments Inc / Nurix Therapeutics Inc / Lumen Technologies Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc / Aveanna Healthcare Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / United States / South Africa</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Organon spin = Opportunity</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">MRK=US / PFE=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : COVID-19 Vaccine – How Much Value for BNT162?</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review and outlook (from 24 May): Focus on stocks with strong earnings and themes, now that results releases are over</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / PFE.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / GKOS.N / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Glaukos Corp / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">05/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（5月24日～）: 決算発表一巡、好業績とテーマ性のある銘柄物色に注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">8</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / BMY.N / PFE.N / 4516.T / AZN.L / 4506.T / 4536.T / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 2413.T / 4568.T / MRNA.OQ / 4578.T / 4581.T / 4587.T / GKOS.N / 4887.T</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Bristol-Myers Squibb Co / Pfizer Inc / Nippon Shinyaku Co Ltd / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / M3 Inc / Daiichi Sankyo Co Ltd / Moderna Inc / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc / Glaukos Corp / Sawai Group Holdings Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">05/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Model update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level - Week 60</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">05/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Pfizer - $49.89 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/22/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Biotech - Biospiracy, Updates & Upcoming</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US09061G1013 / US45337C1027 / US75886F1075 / US6402681083 / US09609G1004 / US8036071004 / US88322Q1085 / US1894641000 / US90400D1081 / CA89620X5064 / US4622221004 / BMG637AM1024 / US84833T1034 / US65487U1088 / US59101E1038 / US81181C1045 / US2300311063 / US92765F1084</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Incyte Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / bluebird bio Inc / Sarepta Therapeutics Inc / TG Therapeutics Inc / Clovis Oncology Inc / Ultragenyx Pharmaceutical Inc / Pfizer Inc / Ionis Pharmaceuticals Inc / Myovant Sciences Ltd / Spero Therapeutics Inc / Nkarta Inc / Metacrine Inc / Seagen Inc / Cullinan Oncology Inc / Viracta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko / Jingming Chen</td></tr>
<tr class="odd"><td class="leftalignment">05/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 14, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our KOL Video Call To Discuss ASCO Highlights, Monday, June 7th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / MRKR.O / MBIO.O</td><td class="leftalignment">Aravive Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / Marker Therapeutics Inc / Mustang Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Key Abstracts And Our Take On The Data</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0463531089 / US1101221083 / US5324571083 / US66987V1098 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Novartis AG / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Abstracts Review: Few Surprises Overall, but BMY's Relatlimab Looks Additive to Us</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / 5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Bristol-Myers Squibb Co / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/20/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Where To Find Sun And Fun At ASCO This Year</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE / ARAV.O / JNJ / LLY / MRK / BSLN.S / HCM.O / HGEN.O / IMAB.O</td><td class="leftalignment">Pfizer Inc / Aravive Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Humanigen Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">73</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / HCM.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / HGEN.O / AZYO.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / HUTCHMED (China) Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Aziyo Biologics Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Ownership Timelines & Shareholder Analytics (May 2021)</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">KOL Video Call To Discuss New and Emerging Heme Malignancy Treatments, Thursday May 27th at 11AM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ARAV.O / IMAB.O / JNJ / LLY / MRK / PFE / GILD.O / BSLN.S / HCM.O / MRKR.O / MBIO.O / HGEN.O</td><td class="leftalignment">Aravive Inc / I-Mab / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Basilea Pharmaceutica AG / HUTCHMED (China) Ltd / Marker Therapeutics Inc / Mustang Bio Inc / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY), ARVN (BUY) - Potential Read-Through from SAN-FP's AMEERA-3 Trial - Bellwether for Oral SERDs?</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">ARVN.OQ / ZNTL.OQ / 5671735 / 0989529 / 2516152 / 2684703 / 7103065 / BMQ5T49 / BDZ30Q0</td><td class="leftalignment">Arvinas Inc / Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc / Novartis AG / Zentalis Pharmaceuticals Inc / Arvinas Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Seamus Fernandez / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippines Market Strategy - New report: COVID-19 tracker-pace of vaccination picks up in May as vaccine supply doubles</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="odd"><td class="leftalignment">05/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Philippines Market Strategy: COVID-19 tracker: Pace of vaccination picks up in May as vaccine supply doubles</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Justin J. Cimafranca / Ms. Hazel Tanedo</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Does Johnson & Johnson's Covid Vaccine Still Matter?</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / INCY=US / AMT=US / LOW=US / SCOR=US / LEG=US / VMC=US / MANH=US / MLM=US / UNH=US / AMN=US / SWIM=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / CVX=US / CCRN=US / NFLX=US / DIN=US / MGNI=US / MRNS=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / OLO=US / NLSN=US / FBHS=US / ABBV=US / TILE=US / NDLS=US / VCYT=US / 00770K202 / LOCO=US / SHAK=US / WING=US / 82982L103 / LGF.B=US / JELD=US / ROKU=US / FERG=US / ARQT=US / ZI=US / AZEK=US / HIMS=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Incyte Corp / American Tower Corp / Lowe's Companies Inc / Comscore Inc / Leggett & Platt Inc / Vulcan Materials Co / Manhattan Associates Inc / Martin Marietta Materials Inc / UnitedHealth Group Inc / AMN Healthcare Services Inc / Latham Group Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Chevron Corp / Cross Country Healthcare Inc / Netflix Inc / Dine Brands Global Inc / Magnite Inc / Marinus Pharmaceuticals Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Olo Inc / Nielsen Holdings PLC / Fortune Brands Home & Security Inc / Abbvie Inc / Interface Inc / Noodles & Co / Veracyte Inc / Aemetis Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Lions Gate Entertainment Corp / JELD-WEN Holding Inc / Roku Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc / Hims & Hers Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2973821 / 2050832 / 2219224 / 2270726 / 2542049 / 2670519 / 2342034 / 2415204 / 2471950 / 2657802 / 2689560 / 2684703 / 2829601 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B125XQ6 / B02R1L6 / B3D7K31 / B7TL820 / B7254K9 / BFLR866 / B95WG16 / BVVN4Q8 / BNGY4Q0 / BYVY8G0 / BYNZGK1 / BD8DJ71 / BKTHM05 / BZ1HM42 / BMQ5T49 / BFZ1K46 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BKS3RS7 / BK71LV3 / BQXZP64 / BMC5RV6 / BGT0PL8 / BMCC9R7 / BMDJ085 / BNTB3N8 / BD9MK29 / BP8GHT2 / BMHR7K6 / BN2RM92</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Alliant Energy Corp / Ameren Corp / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Exelon Corp / Fiserv Inc / Hawaiian Electric Industries Inc / Incyte Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / Southern Co / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Meta Platforms Inc / AxoGen Inc / Twitter Inc / Zoetis Inc / Eversource Energy / Nextera Energy Partners LP / Alphabet Inc / Block Inc / Snap Inc / Passage Bio Inc / Adyen NV / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Evergy Inc / Vistra Corp / ViacomCBS Inc / Roku Inc / 10X Genomics Inc / Relmada Therapeutics Inc / Wayfair Inc / Adicet Bio Inc / DiaMedica Therapeutics Inc / SCYNEXIS Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Onconova Therapeutics Inc / Vascular Biogenics Ltd / Impel Neuropharma Inc / Rain Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">INCY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">INCY.O / LLY / NVS / PFE / AMGN.O / CTIC.O / LGND.O / GERN.O / AVEO.O / ARDX.O</td><td class="leftalignment">Incyte Corp / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / CTI Biopharma Corp / Ligand Pharmaceuticals Inc / Geron Corp / Aveo Pharmaceuticals Inc / Ardelyx Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Peer Group Analytics - Q1 FY2021</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - 1Q Recap; ZN-c5 SERD Update Guided to 2Q21; Pipeline Remains On Track</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMQ5T49 / 0925288 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / GlaxoSmithKline PLC / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending May 07, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 17 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1311931042 / US17275R1023 / US37733W1053 / US5324571083 / US5398301094 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US00206R1023 / PAP310761054 / US29089Q1058 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US9100471096 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US70432V1026 / CA0089118776 / US23355L1061 / US81141R1005 / US5904791358 / US49926T1043 / US90364P1057 / US83089J1088 / US98985X1000</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Callaway Golf Co / Cisco Systems Inc / GlaxoSmithKline PLC / Eli Lilly and Co / Lockheed Martin Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / AT&T Inc / Copa Holdings SA / Emergent BioSolutions Inc / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / United Airlines Holdings Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Paycom Software Inc / Air Canada / DXC Technology Co / Sea Ltd / Mesa Air Group Inc / Knowbe4 Inc / UiPath Inc / Skywater Technology Inc / Zymergen Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / TWTR=US / GBT=US / CL=US / AMZN=US / T=US / EBAY=US / INCY=US / GILD=US / VZ=US / IGT=US / VRM=US / BYD=US / SPOT=US / EXPE=US / MGM=US / AKR=US / PENN=US / W=US / DV=US / AMK=US / PATH=US / COLL=US / TREE=US / NOW=US / MCRI=US / REGN=US / SNAP=US / TRIP=US / TRUE=US / VRTX=US / WIX=US / PSA=US / SNOW=US / SGMS=US / NET=US / HIW=US / PYPL=US / BKNG=US / EGP=US / FB=US / MTCH=US / AUTL=US / BDSI=US / RRR=US / PTON=US / BIIB=US / RNG=US / CZR=US / EXR=US / GMS=US / PGTI=US / WH=US / TIL=US / IAC=US / 45665G303 / OLO=US / NLSN=US / ANGI=US / MEIP=US / SSTK=US / ABBV=US / VOYA=US / PTCT=US / FATE=US / GOOGL=US / COUP=US / BABA=US / CMPR=US / VCEL=US / GDDY=US / ETSY=US / ARGX=US / ZG=US / SQ=US / WVE=US / MIME=US / TTD=US / CRSP=US / TRVG=US / GDS=US / CVNA=US / YEXT=US / IOVA=US / RDFN=US / ROKU=US / CARG=US / SFIX=US / ROOT=US / COLD=US / FTDR=US / SVMK=US / EB=US / SITC=US / AMTB=US / LYFT=US / UBER=US / GMAB=US / DKNG=US / CRMD.US / BALY=US / ABNB=US / DASH=US / NGMS=US / COUR-US / KNBE=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Twitter Inc / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / AT&T Inc / eBay Inc / Incyte Corp / Gilead Sciences Inc / Verizon Communications Inc / International Game Technology PLC / Vroom Inc / Boyd Gaming Corp / Spotify Technology SA / Expedia Group Inc / MGM Resorts International / Acadia Realty Trust / Penn National Gaming Inc / Wayfair Inc / DoubleVerify Holdings Inc / AssetMark Financial Holdings Inc / UiPath Inc / Collegium Pharmaceutical Inc / Lendingtree Inc / ServiceNow Inc / Monarch Casino & Resort Inc / Regeneron Pharmaceuticals Inc / Snap Inc / Tripadvisor Inc / TrueCar Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Public Storage / Snowflake Inc. / Scientific Games Corp / Cloudflare Inc / Highwoods Properties Inc / PayPal Holdings Inc / Booking Holdings Inc / Eastgroup Properties Inc / Meta Platforms Inc / Match Group Inc / Autolus Therapeutics PLC / BioDelivery Sciences International Inc / Red Rock Resorts Inc / Peloton Interactive Inc / Biogen Inc / RingCentral Inc / Caesars Entertainment Inc / Extra Space Storage Inc / GMS Inc / PGT Innovations Inc / Wyndham Hotels & Resorts Inc / Instil Bio Inc / IAC/Interactivecorp / Infinity Pharmaceuticals Inc / Olo Inc / Nielsen Holdings PLC / Angi Inc / MEI Pharma Inc / Shutterstock Inc / Abbvie Inc / Voya Financial Inc / PTC Therapeutics Inc / Fate Therapeutics Inc / Alphabet Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Cimpress PLC / Vericel Corp / GoDaddy Inc / ETSY Inc / argenx SE / Zillow Group Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / Trade Desk Inc / CRISPR Therapeutics AG / Trivago NV / GDS Holdings Ltd / Carvana Co / Yext Inc / Iovance Biotherapeutics Inc / Redfin Corp / Roku Inc / CarGurus Inc / Stitch Fix Inc / Root Inc / Americold Realty Trust / Frontdoor Inc / Momentive Global Inc / Eventbrite Inc / Site Centers Corp / Amerant Bancorp Inc / Lyft Inc / Uber Technologies Inc / Genmab A/S / DraftKings Inc / CorMedix Inc / Bally's Corp / Airbnb Inc / DoorDash Inc / NeoGames SA / Coursera Inc / Knowbe4 Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / Cayman Islands / Denmark / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 17, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AEP.N / AES.N / AXAF.PA / CL.N / DFDS.CO / EIX.N / EL.N / KMB.N / KO.N / MRK.N / MUVGn.DE / NA / PEG.N / PFE.N / SCOR.PA / SO.N / T.N / PEP.N / BFb.N / PG.N / GILD.O / CPB.N / CMCSA.O / CHKP.O / INCY.O / DUK.N / K.N / DISH.O / CTXS.O / CLX.N / CAG.N / DV.N / GIS.N / EPC.N / SBAC.O / KGC.N / JAZZ.O / CONE.O / NG.L / VZ.N / STZ.N / AMP.N / EXC.N / FISV.O / AWK.N / CHD.N / NWN.N / JKHY.O / SAM.N / OPTN.O / ENR.N / NCR.N / NET.N / SSNC.O / ENAG.MC / CNP.N / ENDP.O / CPK.N / GPN.N / MNST.O / IMGN.O / HOOK.O / BLUE.O / CASY.O / FFIV.O / EQIX.O / ATDb.TO / 02209S103 / MNKD.OQ / DLR.N / 427866108 / SJW.N / FIS.N / CVLT.O / 3IN.L / IVZ.N / BGS.N / RENE.LS / BEZG.L / GETP.PA / INO.OQ / UTL.N / NGD.A / FTNT.O / SPB.N / NEE.N / FHI.N / TWO.N / PCRX.O / PANW.N / QLYS.O / MDLZ.OQ / APAM.N / ABBV.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / BEP.N / AGIO.O / KPTI.O / FLXN.O / AGRX.O / RPD.O / SQ.N / MIME.OQ / SRENH.S / MP1.AX / OR.N / CRSP.OQ / UNIT.O / GREG.MC / DXC.N / ROOT.TO / VCTR.N / AMRX.N / VRCA.OQ / NTGY.MC / KDP.N / XERS.O / AQST.O / OSMT.O / NWL.O / 269796108 / PING.N / DDOG.O / APRE.OQ / NLOK.O / REYN.O / FOUR.N / RXT.OQ / IBEX.O / LUMN.N / PLTR.N / ALOO.O / VTRS.OQ / TIXT.TO / AFRM.O / NAPA.N / PATH.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / AXA SA / Colgate-Palmolive Co / DFDS AS / Edison International / Estee Lauder Companies Inc / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / Public Service Enterprise Group Inc / Pfizer Inc / Scor SE / Southern Co / AT&T Inc / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Campbell Soup Co / Comcast Corp / Check Point Software Technologies Ltd / Incyte Corp / Duke Energy Corp / Kellogg Co / DISH Network Corp / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / DoubleVerify Holdings Inc / General Mills Inc / Edgewell Personal Care Co / SBA Communications Corp / Kinross Gold Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / National Grid PLC / Verizon Communications Inc / Constellation Brands Inc / Ameriprise Financial Inc / Exelon Corp / Fiserv Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Jack Henry & Associates Inc / Boston Beer Company Inc / OptiNose Inc / Energizer Holdings Inc / NCR Corp / Cloudflare Inc / SS&C Technologies Holdings Inc / Enagas SA / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Global Payments Inc / Monster Beverage Corp / ImmunoGen Inc / HOOKIPA Pharma Inc / bluebird bio Inc / Caseys General Stores Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / MannKind Corp / Digital Realty Trust Inc / Hershey Co / SJW Group / Fidelity National Information Services Inc / Commvault Systems Inc / 3I Infrastructure PLC / Invesco Ltd / B&G Foods Inc / Ren Redes Energeticas Nacionais SGPS SA / Beazley PLC / Getlink SE / Inovio Pharmaceuticals Inc / Unitil Corp / New Gold Inc / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Federated Hermes Inc / Two Harbors Investment Corp / Pacira Biosciences Inc / Palo Alto Networks Inc / Qualys Inc / Mondelez International Inc / Artisan Partners Asset Management Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Karyopharm Therapeutics Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Rapid7 Inc / Block Inc / Mimecast Ltd / Swiss Re AG / Megaport Ltd / Osisko Gold Royalties Ltd / CRISPR Therapeutics AG / Uniti Group Inc / Grenergy Renovables SA / DXC Technology Co / Roots Corp / Victory Capital Holdings Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Eagle Pharmaceuticals Inc / Ping Identity Holding Corp / Datadog Inc / Aprea Therapeutics Inc / NortonLifeLock Inc / Reynolds Consumer Products Inc / Shift4 Payments Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Palantir Technologies Inc / Allogene Therapeutics Inc / Viatris Inc / Telus International Cda Inc / Affirm Holdings Inc / Duckhorn Portfolio Inc / UiPath Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Increases 15% Including COVID-19 Vaccine Volume Benefit</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">05/17/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Everest Medicines: Trodelvy potential China approval expected YE21; Potential first Trop2 ADC in China with high commercial potential. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">1952.HK / 1093.HK / PFE.N / AZN.L / MRCG.DE / GILD.OQ / 4568.T / 002422.SZ</td><td class="leftalignment">Everest Medicines Ltd / CSPC Pharmaceutical Group Ltd / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Sichuan Kelun Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Germany / United Kingdom / Hong Kong / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 5.16.21</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">ABT / ACAD / 00365410 / 28176E10 / 62855J10 / 01988P10 / 45337C10 / 75991610 / 09061G10 / 86366710 / 71708110 / 00846U10 / 45253H10 / 12665010 / 07181310 / 10113710 / 92532F10 / 88355610 / 35802910 / 94184810 / 04635310 / 43644010 / 76115210 / 64125C10 / 87936910 / 37555810 / 15678210 / 03116210 / 66987V10 / 75886F10 / 46120E60 / M2572210 / 45232710 / 09062X10 / 01625510 / 30063P10 / 478160104 / 98956P10 / 159864107 / 640268108 / 075887109 / 02043Q10 / 67070410 / 207410101 / 205306103 / 45784P10 / 25213110 / 04963C20 / 03152W10 / 64049M20 / 58933Y10 / 14161910 / G0176710 / 45766930 / G5087110 / 80360710 / 74051N10 / 92337F10 / 05463X10 / 45780L10 / 92247510 / 09073M104 / 82621J10 / 31572Q80 / 87918A10 / 46185L10 / 00653A107 / 04351P101 / 75046920 / 74587V10 / 00287Y10 / 92346J10 / 98401F10 / 46071F10 / G5960L10 / 46222210 / 18946410 / 04004760 / 04280A10 / 92686J10 / 05337M104 / 23283X20 / 40131M10 / 63230710 / 89853L10 / 71944F10 / 45773010 / 05358830 / 38942Q10 / 76029N10 / 41358P10 / N9006410 / 42226A10 / 68269G10 / 00437E10 / 74939710 / 90041T10 / 09627Y10 / 68071010 / Y9530810 / 30052C10 / 09075V10 / 60770K10 / 74340E10 / 42225T10 / 87337910 / 00289Y10 / 00773U10 / 01981810 / 05455M10 / 09609G10 / 10806X10 / 45826J10 / 75901B10 / 77313F10 / 05464T10 / 05156V10 / 75615P10 / 16383L10 / 55609910 / N0104510 / 14843C10 / 01438T10 / 74374N10 / 51654410 / 31189P10 / 07725L10 / G3910J11 / H0026310 / 00847X10 / 24344T10 / 29428V10 / 37890U10 / 81181C10 / G1119610 / 40422M10 / 98978L20 / 92857F10 / 04685N10 / 13089P10 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 98887Q10 / 45845P10 / 4525EP10 / 78667J10 / 82710M10 / 46116X10 / 74366E10 / 37957720 / 22905030 / G8807B10 / 90400D10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 55886810 / 05454B10 / 49232710 / 22663K10 / 05465P10 / 00461U10 / 04539610 / 81727U10 / 59045L10 / 01671P10 / 68621F10 / 45249V10 / F4373810 / 80405P10 / N4482110 / 92765F10 / 75955J40 / 56400P70 / 28255910 / 87808K10 / 87166L10 / 03836N10 / 23257D10 / 40434H20 / 28617K10 / 29446K10 / 83422E10 / 03824M10 / N1976T10 / 23306J10 / 34385P10 / 36322Q10 / N4444510 / 45258J10 / 48349710 / 56854Q20 / 65343C10 / 74623710 / 75974E10 / H9060V101</td><td class="leftalignment">Abbott Laboratories / ACADIA Pharmaceuticals Inc / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Allscripts Healthcare Solutions Inc / Incyte Corp / Repligen Corp / Biomarin Pharmaceutical Inc / Stryker Corp / Pfizer Inc / Agilent Technologies Inc / ImmunoGen Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Vertex Pharmaceuticals Inc / Thermo Fisher Scientific Inc / Fresenius Medical Care AG & Co KGaA / Waters Corp / AstraZeneca PLC / Hologic Inc / Resmed Inc / Neurocrine Biosciences Inc / Teleflex Inc / Gilead Sciences Inc / Cerner Corp / Amgen Inc / Novartis AG / Regeneron Pharmaceuticals Inc / Intuitive Surgical Inc / Compugen Ltd / Illumina Inc / Biogen Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Zimmer Biomet Holdings Inc / Charles River Laboratories International Inc / Nektar Therapeutics / Becton Dickinson and Co / Alnylam Pharmaceuticals Inc / NuVasive Inc / Conmed Corp / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Amicus Therapeutics Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Alkermes Plc / Insmed Inc / Jazz Pharmaceuticals PLC / Sarepta Therapeutics Inc / Premier Inc / Veracyte Inc / AxoGen Inc / Inogen Inc / Veeva Systems Inc / Bio-Techne Corp / Sientra Inc / FibroGen Inc / Teladoc Health Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Ascendis Pharma A/S / Radius Health Inc / Puma Biotechnology Inc / Abbvie Inc / Vericel Corp / Xencor Inc / Intersect Ent Inc / Medtronic PLC / Ionis Pharmaceuticals Inc / Clovis Oncology Inc / Arena Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Viking Therapeutics Inc / Avadel Pharmaceuticals PLC / Cytosorbents Corp / Guardant Health Inc / Natera Inc / T2 Biosystems Inc / Phreesia Inc / Inspire Medical Systems Inc / Aveo Pharmaceuticals Inc / Graybug Vision Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Uniqure NV / Healthequity Inc / 1Life Healthcare Inc / Accolade Inc / R1 RCM Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Olink Holding AB (publ) / WAVE Life Sciences Ltd / Evolus Inc / BioNTech SE / Moderna Inc / Progyny Inc / Health Catalyst Inc / Tabula Rasa HealthCare Inc / Abeona Therapeutics Inc / Adverum Biotechnologies Inc / Allovir Inc / AVROBIO Inc / bluebird bio Inc / BridgeBio Pharma Inc / Intellia Therapeutics Inc / Regenxbio Inc / Rocket Pharmaceuticals Inc / Axsome Therapeutics Inc / Aurinia Pharmaceuticals Inc / Reata Pharmaceuticals Inc / ChemoCentryx Inc / MacroGenics Inc / Affimed NV / Castle Biosciences Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Lantheus Holdings Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / AC Immune SA / Agios Pharmaceuticals Inc / Deciphera Pharmaceuticals Inc / Epizyme Inc / Global Blood Therapeutics Inc / Seagen Inc / Biohaven Pharmaceutical Holding Company Ltd / H Lundbeck A/S / Zogenix Inc / Vocera Communications Inc / Athenex Inc / Calithera Biosciences Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Zai Lab Ltd / Intercept Pharmaceuticals Inc / Immunic Inc / SAGE Therapeutics Inc / Silk Road Medical Inc / Intra-Cellular Therapies Inc / Protagonist Therapeutics Inc / Globus Medical Inc / Cryoport Inc / Theravance Biopharma Inc / Ultragenyx Pharmaceutical Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Madrigal Pharmaceuticals Inc / Axcella Health Inc / Keros Therapeutics Inc / Crinetics Pharmaceuticals Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Senseonics Holdings Inc / Mersana Therapeutics Inc / Allakos Inc / Organogenesis Holdings Inc / Imara Inc / Genfit SA / Satsuma Pharmaceuticals Inc / InflaRx NV / Viracta Therapeutics Inc / Relmada Therapeutics Inc / MannKind Corp / 89Bio Inc / TCR2 Therapeutics Inc / Synlogic Inc / Aptinyx Inc / Cymabay Therapeutics Inc / HTG Molecular Diagnostics Inc / Eledon Pharmaceuticals Inc / Equillium Inc / Solid Biosciences Inc / Applied Molecular Transport Inc. / Centogene NV / DBV Technologies SA / Fluidigm Corp / Galecto Inc / Immatics NV / Immunovant Inc / Kalvista Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / NextGen Healthcare Inc / PureTech Health PLC / Reneo Pharmaceuticals Inc / VectivBio Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / Singapore / Sweden / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="even"><td class="leftalignment">05/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / MNKD.OQ / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / VRCA.OQ / XERS.O / AQST.O / OSMT.O / 269796108 / VTRS.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / MannKind Corp / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Verrica Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 6% Above Pre-Pandemic Level- Week 59</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.14.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist EHA Planner v1.0 Highlights 100+ Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / GILD=US / REGN=US / VRTX=US / AUTL=US / MEIP=US / ABBV=US / CRSP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Autolus Therapeutics PLC / MEI Pharma Inc / Abbvie Inc / CRISPR Therapeutics AG / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">45337C10 / 00422510 / 40637H10 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 81750R102 / 29604W108 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 22978P106 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 4525EP101 / 74017N105 / 56854Q200 / 81181C104 / 21900C308 / 517125100 / 04746L104 / G637AM102 / 007002108 / M47364100 / N71542109 / 45168K405 / 76200L309</td><td class="leftalignment">Incyte Corp / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Seres Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Cue Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Immunic Inc / Precigen Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Athira Pharma Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: More Key Abstracts</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending May 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 14 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">FR0000121014 / US02553E1064 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1264081035 / US22160K1051 / US2546871060 / US3647601083 / US5002551043 / US6556641008 / US6558441084 / US66987V1098 / US7170811035 / US7274931085 / US7711951043 / US7782961038 / US8725401090 / US87612E1064 / US9078181081 / US9311421039 / CA1363751027 / CA13645T1003 / US21036P1084 / US19239V3024 / US55616P1049 / US90384S3031 / US58933Y1055 / US30212P3038 / US5017971046 / US60468T1051 / US09062W2044 / LU0974299876 / US0994061002 / US64829B1008 / US4622221004 / US74967X1037 / CA1350861060 / IL0011407140 / US8760301072 / US6085501095 / US09354A1007 / US09857L1089 / US4380831077 / US03836N1037 / US05455M1009 / KY30744W1070 / US7172241090 / CA89788C1041 / US39874R1014 / US24984K1051 / US85205L1070 / US1266541028 / US7602731025 / US05380C1027 / US65487U1088 / US75943R1023 / US38246G1085 / US0090661010 / US7761531083 / US55406W1036 / US8808811074 / US6877931096 / US35909R1086 / US45175G1085</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / American Eagle Outfitters Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / CSX Corp / Costco Wholesale Corp / Walt Disney Co / Gap Inc / Kohls Corp / Nordstrom Inc / Norfolk Southern Corp / Novartis AG / Pfizer Inc / Plantronics Inc / Roche Holding AG / Ross Stores Inc / TJX Companies Inc / Target Corp / Union Pacific Corp / Walmart Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Constellation Brands Inc / Cogent Communications Holdings Inc / Macy's Inc / Ulta Beauty Inc / Merck & Co Inc / Expedia Group Inc / Bath & Body Works Inc / Mirati Therapeutics Inc / BioLife Solutions Inc / Globant SA / Boot Barn Holdings Inc / New Relic Inc / Ionis Pharmaceuticals Inc / RH / Canada Goose Holdings Inc / Urogen Pharma Ltd / Tapestry Inc / Molecular Templates Inc / Blink Charging Co / Booking Holdings Inc / Homology Medicines Inc / Aptinyx Inc / AVROBIO Inc / Farfetch Ltd / PhaseBio Pharmaceuticals Inc / Trulieve Cannabis Corp / Grocery Outlet Holding Corp / DermTech Inc / SpringWorks Therapeutics Inc / CV Sciences Inc / Repare Therapeutics Inc / AVITA Medical Inc / Nkarta Inc / Relay Therapeutics Inc / Goodrx Holdings Inc / Airbnb Inc / Romeo Power Inc / MYT Netherlands Parent BV / Terns Pharmaceuticals Inc / Oscar Health Inc / Frontier Group Holdings Inc / Ikena Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">05/14/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">V / 2000019 / 2026242 / 2219224 / 2216850 / 2270726 / 2100920 / 2459020 / 2657802 / 2680905 / 2684703 / 2048804 / 2440637 / B17HG57 / B121557 / B1Y9TB3 / 2857817 / B125XQ6 / B1XGNW4 / 2982924 / B7TL820 / B4MG4Z6 / BCZS820 / BJ0XLZ3 / BBPK0J0 / B3X26D8 / BFZCHN7 / BYW36M8 / BK7Y2V9 / BL2HYY7 / BKTHM05 / BYQNYR5 / BYYWPW6 / BDH65C8 / BGT3960 / BYP71H7 / BN2R582 / BLBLMD5 / BMTVQT8 / 021513106 / BMDJ085 / BMC8SQ7 / BMZ9Z11 / BMFPJK6</td><td class="leftalignment">Visa Inc / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / FirstEnergy Corp / Intuit Inc / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Cardiovascular Systems Inc / Mastercard Inc / Danone SA / Netflix Inc / Portland General Electric Co / Insulet Corp / Spectrum Pharmaceuticals Inc / Meta Platforms Inc / AMC Networks Inc / Fate Therapeutics Inc / Heron Therapeutics Inc / Mirati Therapeutics Inc / Pacira Biosciences Inc / Wix.Com Ltd / PayPal Holdings Inc / Akero Therapeutics Inc / Casper Sleep Inc / Passage Bio Inc / Senseonics Holdings Inc / Beigene Ltd / PetIQ Inc / Orchard Therapeutics PLC / National Vision Holdings Inc / Relay Therapeutics Inc / Array Technologies Inc / Goodrx Holdings Inc / Alto Ingredients Inc / Shoals Technologies Group Inc / BTRS Holdings Inc / Prometheus Biosciences Inc / ACV Auctions Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Trillium Therapeutics Revenue up 19.4%</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">CDC Opens the Door to Teens; Plus Re-vaccination and Variant Vaccines</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">71708110 / 04635310 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Dilip Joseph</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Can the $2bn Meningitis Vaccine Market Break Out with Pentavalents?</td><td class="leftalignment">English</td><td class="rightalignment">50</td><td class="leftalignment">G3910J11 / F5548N10 / 71708110</td><td class="leftalignment">GlaxoSmithKline PLC / Sanofi SA / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2000019 / 2050832 / 2732635 / 2219224 / 2542049 / 2342034 / 2369174 / 2471950 / 2515030 / 2657802 / 2689560 / 2684703 / 2048804 / 5531000 / B1F76F9 / B125XQ6 / B7TL820 / BCBVTX1 / B4MG4Z6 / BBFL7S1 / B8DPDT7 / BFLR866 / BFZCHN7 / BJ36RM8 / BYVY8G0 / BYZLV46 / BDHF4K6 / BD8DJ71 / BKS3SM8 / B0SDJB4 / BZ1HM42 / BJ2Z0H2 / BFMXGR0 / BZ05388 / BYYWPW6 / BJ9NFQ3 / BWY52P3 / BMG75B4 / BD8Q1B8 / BYNPPC6 / BG0Q4Y1 / BKT6B38 / BK71LV3 / BMDCDP2 / BMPRZV5 / BN0SDK5 / BLBLMD5 / BFY7DC4 / BMDJ085 / BMC8SQ7 / BNTB3N8 / BD5GSZ4</td><td class="leftalignment">AstraZeneca PLC / Amazon.com Inc / Ameren Corp / AutoNation Inc / CMS Energy Corp / Dominion Energy Inc / Fiserv Inc / Gilead Sciences Inc / Incyte Corp / Lithia Motors Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / MorphoSys AG / Western Union Co / Portland General Electric Co / Meta Platforms Inc / Agios Pharmaceuticals Inc / AMC Networks Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Twitter Inc / Wix.Com Ltd / Pacira Biosciences Inc / Alphabet Inc / InflaRx NV / CRISPR Therapeutics AG / Snap Inc / IGM Biosciences Inc / Zealand Pharma A/S / Adyen NV / Pinterest Inc / Evergy Inc / Global Blood Therapeutics Inc / Beigene Ltd / Neoleukin Therapeutics Inc / Blueprint Medicines Corp / Inventiva SA / Tivity Health Inc / DENTSPLY SIRONA Inc / Exicure Inc / SmileDirectClub Inc / Relmada Therapeutics Inc / Bigcommerce Holdings Inc / Kymera Therapeutics Inc / American Well Corp / Array Technologies Inc / Altimmune Inc / Shoals Technologies Group Inc / BTRS Holdings Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">RXDX: Q1 Update; PRA023 Progressing as Planned</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RXDX.OQ / PFE.N</td><td class="leftalignment">Prometheus Biosciences Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Cash Deployment and Debt Trends - The Pandemic and the FAAMG Impact</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">PFE.N / HD.N / AAPL.OQ / MSFT.OQ / ODFL.OQ / AMZN.OQ / FB.OQ / GOOGL.OQ</td><td class="leftalignment">Pfizer Inc / Home Depot Inc / Apple Inc / Microsoft Corp / Old Dominion Freight Line Inc / Amazon.com Inc / Meta Platforms Inc / Alphabet Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Consumer / Healthcare / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Manufacturing / Pharmaceuticals / Railroads / Retailing / Telecommunications / Transportation</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ron Graziano / Mr. Amit Varshney / Adrian Szumilo / HOLT Americas</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRCG.DE: Merck KGaA - 1Q21 - Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRCG.DE / 4063.T / 4185.T / 4901.T / A.N / BDX.N / LLY.N / PFE.N / RECI.MI / STDM.PA / TMO.N / WAT.N / ROG.S / DHR.N / LUN.CO / GLW.N / MTD.N / LONN.S / PKI.N / WST.N / UCB.BR / TECH.OQ / CCMP.OQ / ENTG.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / MRNA.OQ / VIFN.S / 2269.HK / GMAB.CO</td><td class="leftalignment">Merck KGaA / Shin-Etsu Chemical Co Ltd / JSR Corp / Fujifilm Holdings Corp / Agilent Technologies Inc / Becton Dickinson and Co / Eli Lilly and Co / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Sartorius Stedim Biotech SA / Thermo Fisher Scientific Inc / Waters Corp / Roche Holding AG / Danaher Corp / H Lundbeck A/S / Corning Inc / Mettler-Toledo International Inc / Lonza Group AG / PerkinElmer Inc / West Pharmaceutical Services Inc / Ucb SA / Bio-Techne Corp / CMC Materials Inc / Entegris Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Moderna Inc / Vifor Pharma AG / WuXi Biologics (Cayman) Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / Italy / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/13/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer Inc. (Pfe) In Systemic Aspergillosis And Systemic Candidasis Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/13/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer Inc. (Pfe) In Gastroparesis Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Paragon Intel</td><td class="leftalignment">ZTS CFO Comparison: Wetteny Joseph and Glenn David</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / CTLT.N / ZTS.N</td><td class="leftalignment">Pfizer Inc / Catalent Inc / Zoetis Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MANAGEMENT / CAPITALIZATION / MISCELLANEOUS / INDEX</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paragon Intel</td></tr>
<tr class="odd"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Quantum Research Group, LLC</td><td class="leftalignment">IPO of NuGenerex Immuno-Oncology Reveals Generex's Undervaluation</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GNBT=US / PFE=US / AZN=US / JNJ=US / NVAX=US / MRNA=US</td><td class="leftalignment">Generex Biotechnology Corp / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">INITIATING COVERAGE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Karl Egeland</td></tr>
<tr class="even"><td class="leftalignment">05/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Positive takeaways from JV conference call; JV to start commercial production in mid-2022. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">2196.HK / 600196.SS / PFE.N / NOVN.S</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Pfizer Inc / Novartis AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Cancer Immunotherapy Market: Current Analysis and Forecast (2021-2027)</td><td class="leftalignment">English</td><td class="rightalignment">261</td><td class="leftalignment">FACT=US / MRK=US / PFE=US / AMGN=US / BMY=US / A=US / NOVN=CH / AZN=GB / BLUE=US / null / 500680=IN / 506820=IN / ABBV=US / CNTO=US</td><td class="leftalignment">Freedom Acquisition I Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Novartis AG / AstraZeneca PLC / bluebird bio Inc / One 97 Communications Ltd / Pfizer Ltd / Astrazeneca Pharma India Ltd / Abbvie Inc / Centor Energy Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Cayman Islands / Germany / Spain / France / United Kingdom / India / Italy / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / ICLR=US / WEN=US / BLD=US / INCY=US / TEVA=US / KMI=US / CMA=US / REI=US / PLUG=US / CRM=US / LOW=US / ENR=US / FMS=US / VRM=US / CHRS=US / MAR=US / LEG=US / VMC=US / MLM=US / CBRL=US / ELY=US / CHH=US / CSGP=US / DRI=US / GFF=US / IBP=US / NOW=US / MAS=US / MPLX=US / MHK=US / SHOP=US / GOLF=US / SAGE=US / SPG=US / EPD=US / SGMS=US / BKNG=US / NLS=US / DIN=US / MGNI=US / PTON=US / RNG=US / TCBI=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / APEI=US / WH=US / JACK=US / TREX=US / APTS=US / FBHS=US / BCEI=US / ABBV=US / TILE=US / NDLS=US / LOCO=US / OSH=US / VCEL=US / SHAK=US / GSBD=US / WING=US / SQ=US / AXSM=US / 82982L103 / TTD=US / EVBG=US / JELD=US / ATNX=US / SWCH=US / SAIL=US / EQH=US / BTAI=US / SVMK=US / PLMR=US / FERG=US / RPAY=US / ARQT=US / REYN=US / SPCE=US / FBRX=US / AZEK=US / BALY=US / VTRS=US / ABNB=US / AFRM=US / RBLX=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / ICON PLC / Wendys Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / Comerica Inc / Ring Energy Inc / Plug Power Inc / Salesforce.Com Inc / Lowe's Companies Inc / Energizer Holdings Inc / Fresenius Medical Care AG & Co KGaA / Vroom Inc / Coherus BioSciences Inc / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CoStar Group Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / ServiceNow Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Shopify Inc / Acushnet Holdings Corp / SAGE Therapeutics Inc / Simon Property Group Inc / Enterprise Products Partners LP / Scientific Games Corp / Booking Holdings Inc / Nautilus Inc / Dine Brands Global Inc / Magnite Inc / Peloton Interactive Inc / RingCentral Inc / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / American Public Education Inc / Wyndham Hotels & Resorts Inc / Jack in the Box Inc / Trex Company Inc / Preferred Apartment Communities Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Abbvie Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Oak Street Health Inc / Vericel Corp / Shake Shack Inc / Goldman Sachs BDC Inc / Wingstop Inc / Block Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Trade Desk Inc / Everbridge Inc / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / SailPoint Technologies Holdings Inc / Equitable Holdings Inc / BioXcel Therapeutics Inc / Momentive Global Inc / Palomar Holdings Inc / Ferguson PLC / Repay Holdings Corp / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Virgin Galactic Holdings Inc / Forte Biosciences Inc / Azek Company Inc / Bally's Corp / Viatris Inc / Airbnb Inc / Affirm Holdings Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Germany / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">1Q21: COVID-19 Vaccine Continues to Lead, but Major Uncertainties Remain</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">09075V10 / 71708110</td><td class="leftalignment">BioNTech SE / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daina Graybosch, Ph.D. / Dilip Joseph / Jeffrey La Rosa</td></tr>
<tr class="even"><td class="leftalignment">05/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2973821 / 2219224 / 2175672 / 2222631 / 2037170 / 2328915 / 2369174 / 2415204 / 2457864 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 4595739 / 7103065 / B1F76F9 / B121557 / B19FQ48 / B125XQ6 / B7TL820 / B4MG4Z6 / B7VD3F2 / BJ0XLZ3 / BDZCRX3 / BFH3N85 / BFZCHN7 / BVVN4Q8 / BYVY8G0 / BYVFC94 / BF4VBS8 / BK0VHF6 / BD9GVY0 / BJXPS33 / BD8DJ71 / BJFSR88 / BYZR4X4 / BP7RS48 / BKVDFF7 / BYXJQG9 / BZ1LFG7 / BL71K91 / BD6JX35 / BZ0P3Z5 / BYTJZL1 / BDD1B07 / BKT6B38 / BF3N4P3 / BM8MM05 / BLBLMD5 / BNG3RZ7 / BMDJ085 / BLR6S36</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Alliant Energy Corp / CMS Energy Corp / Cardinal Health Inc / Cooper Companies Inc / 8x8 Inc / Nextera Energy Inc / Gilead Sciences Inc / Hawaiian Electric Industries Inc / ImmunoGen Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Genmab A/S / Novartis AG / Western Union Co / Mastercard Inc / Amicus Therapeutics Inc / Portland General Electric Co / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Heron Therapeutics Inc / RingCentral Inc / Veeva Systems Inc / Wix.Com Ltd / Eversource Energy / Alphabet Inc / US Foods Holding Corp / BioXcel Therapeutics Inc / IDEAYA Biosciences Inc / Zai Lab Ltd / BELLUS Health Inc / Snap Inc / Uniqure NV / Axsome Therapeutics Inc / Intersect Ent Inc / Oric Pharmaceuticals Inc / Spire Inc / Roku Inc / Revolution Medicines Inc / Krystal Biotech Inc / Tegna Inc / Zogenix Inc / Rubius Therapeutics Inc / SmileDirectClub Inc / Arena Pharmaceuticals Inc / Madison Square Garden Entertainment Corp / Array Technologies Inc / Leslie's Inc / Shoals Technologies Group Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/11/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">1Q21 Update – To Combinations and Beyond</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – Takeaways from Our Virtual NDR; Focus on GR antagonist, Early Pipeline of Potl. Best-in-Class Inhibitors Targeting EGFR, CD73, and PRC2</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Updated Outlook Report</td><td class="leftalignment">English</td><td class="rightalignment">97</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 30, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">90389910 / 75886F107 / 640268108 / 17243V102 / 12008R107 / 40637H109 / US8110544025 / 192005106 / 52186520 / 00165C104 / 21676P10 / 09062W204 / 89620X506 / 09739D100 / 45780R101 / 00183L102 / 00108J109 / 930752100 / 640671400 / 65343E108 / 26142R104 / 34960Q10 / 17143G106</td><td class="leftalignment">Ultralife Corp / Regeneron Pharmaceuticals Inc / Nektar Therapeutics / Cinemark Holdings Inc / Builders FirstSource Inc / Halozyme Therapeutics Inc / E W Scripps Co / Codexis Inc / Lear Corp / AMC Entertainment Holdings Inc / Cooper-Standard Holdings Inc / BioLife Solutions Inc / Pfizer Inc / Boise Cascade Co / Installed Building Products Inc / Angi Inc / ACM Research Inc / Waitr Holdings Inc / Nephros Inc / NextCure Inc / DraftKings Inc / Fortress Biotech Inc / Skillsoft Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Aydin Huseynov, MD / Mr. Daniel L. Kurnos, CFA / Mike Hickey / Mr. Michael P. Ward, CFA / Mr. Reuben Garner / Mr. Robert M. Wasserman / Mr. Josh W. Sullivan / Mr. Mark Miller / Mr. Mark W. Schappel</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">1Q21 Model Update</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Earnings In-Line; Multiple 2H21 Milestones Including MAT2A Data and Darovasertib Data + Regulatory Guidance; Maintain BUY, $34 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Video Call on Current and Emerging Cardiovascular Disease Treatments Thursday, May 20 at 11 AM EST</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMRN.O / JNJ / LLY / MRK / MSB / PFE</td><td class="leftalignment">Amarin Corporation PLC / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Mesoblast Ltd / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 10 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1925761066 / US2371941053 / US37733W1053 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US5801351017 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8552441094 / US8807701029 / US91347P1057 / US9884981013 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US90385V1070 / US25754A2015 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / DE000A1EWWW0 / US95058W1009 / US00287Y1091 / NL0010273215 / LU0914713705 / US38046C1099 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / CA76131D1033 / US8190471016 / US9741551033 / US45782B1044 / KYG4740B1059 / CA35805P1071 / US05351X1019 / US68373M1071 / US5904791358 / IE00BZ12WP82 / US4833791035 / US92556H2067 / US92537N1081 / US26142R1041 / US38246G1085 / US90089L1089</td><td class="leftalignment">Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / GlaxoSmithKline PLC / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Teradyne Inc / Universal Display Corp / Yum! Brands Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Adidas AG / Wendys Co / Abbvie Inc / ASML Holding NV / Intelsat SA / Gogo Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Restaurant Brands International Inc / Shake Shack Inc / Wingstop Inc / Inseego Corp / Ichor Holdings Ltd / Freshii Inc / Avaya Holdings Corp / Opera Ltd / Mesa Air Group Inc / Linde PLC / Kaleyra Inc / ViacomCBS Inc / Vertiv Holdings Co / DraftKings Inc / Goodrx Holdings Inc / TuSimple Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">4031976 / 2126335 / 2023607 / 2640147 / 2973821 / 2219224 / 2216850 / 2328915 / 2415204 / 2459202 / 2459020 / 2630513 / 2657802 / 2680905 / 2684703 / 2048804 / 2440637 / 2799351 / 2825933 / 2795393 / B121557 / 2212922 / 2769796 / B125XQ6 / B0T7YX2 / B02R1L6 / B2R3PV1 / B1HJLW5 / B3P93Y7 / B570P91 / B7TL820 / B4MG4Z6 / BCDWBX6 / BJ3V905 / BBPK0J0 / BBGVT40 / BCGCR79 / BFLR866 / BFZCHN7 / B95WG16 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BYQHP96 / BFNF1D6 / BF5L3T2 / BYNZGK1 / BD8DJ71 / BKDS4H5 / BR4T3B3 / BKVDFF7 / BMYML02 / BFMXGR0 / BYXJQG9 / BG31GH0 / BKTNTR9 / BJVR9Y9 / BD6D4Y5 / BZ1LFG7 / BL71K91 / BN0XTW4 / BN7K304 / BLBLMD5 / BD8QGD5 / BNTB3N8</td><td class="leftalignment">Adidas AG / Bristol-Myers Squibb Co / Amgen Inc / Nike Inc / Alliant Energy Corp / CMS Energy Corp / Consolidated Edison Inc / Nextera Energy Inc / Hawaiian Electric Industries Inc / IDEXX Laboratories Inc / Intuit Inc / New Jersey Resources Corp / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Amerisourcebergen Corp / Mastercard Inc / NRG Energy Inc / Fidelity National Information Services Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / American Water Works Company Inc / Emergent BioSolutions Inc / Anheuser Busch Inbev SA / Lear Corp / Meta Platforms Inc / AMC Networks Inc / ANI Pharmaceuticals Inc / Endo International PLC / Mirati Therapeutics Inc / News Corp / Sprouts Farmers Market Inc / Twitter Inc / Wix.Com Ltd / Zoetis Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Floor & Decor Holdings Inc / Amneal Pharmaceuticals Inc / Elanco Animal Health Inc / Block Inc / Snap Inc / Bill.com Holdings Inc / HubSpot Inc / Oric Pharmaceuticals Inc / DraftKings Inc / Evergy Inc / Spire Inc / Y-mAbs Therapeutics Inc / ViacomCBS Inc / iHeartMedia Inc / Altair Engineering Inc / Roku Inc / Revolution Medicines Inc / Orphazyme A/S / Academy Sports and Outdoors Inc / Array Technologies Inc / Liberty Media Corp / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Germany / Denmark / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AEP.N / AES.N / AIG.N / ALV.N / AU.N / BARC.L / CCO.TO / CL.N / DFDS.CO / EIX.N / EL.N / EOG.N / F.N / GM.N / KMB.N / KO.N / PEG.N / PFE.N / PNN.L / SO.N / T.N / T.TO / VC.N / PEP.N / BFb.N / PG.N / GILD.O / CPB.N / TEN.N / CMCSA.O / CHKP.O / FER.MC / DUK.N / BWA.N / LEA.N / ENB.TO / TRP.TO / K.N / CTXS.O / CLX.N / CAG.N / GIS.N / EPC.N / SBAC.O / AMT.N / VZ.N / EXEL.O / STZ.N / APH.N / EXC.N / FISV.O / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ENR.N / NCR.N / NET.N / TEL.N / CNP.N / ENDP.O / CPK.N / CHE.N / PII.N / ST.N / AMH.N / SEM.N / GPN.N / MNST.O / FFIV.O / EQIX.O / 02209S103 / DLR.N / 427866108 / KOS.N / SJW.N / BKD.N / FIS.N / CCOI.O / HOG.N / CVLT.O / BGS.N / PPL.TO / GETP.PA / DAN.N / NOG.A / SII.TO / UTL.N / 759351604 / CVE.TO / FTNT.O / SPB.N / NEE.N / ERF.TO / PCRX.O / MTOR.N / QLYS.O / MDLZ.OQ / GRT_u.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / BEP.N / ESNT.N / IBP.N / FLXN.O / AENA.MC / GLPG.O / PYPL.OQ / RPD.O / SQ.N / RACE.MI / TRHC.OQ / ADNT.N / UNIT.O / WOW.N / ATNX.O / APTV.N / AMRX.N / VNE.N / KDP.N / XERS.O / OSMT.O / NWL.O / 269796108 / HCAT.OQ / GMAB.O / PING.N / DDOG.O / CRNC.OQ / PNTG.OQ / REYN.O / NKLA.OQ / APA.OQ / FOUR.N / RXT.OQ / JAMF.O / LUMN.N / PTVE.O / BSY.O / VTRS.OQ / TIXT.TO / AFRM.O / NAPA.N / OSO.N / TSP.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / American International Group Inc / Autoliv Inc / AngloGold Ashanti Ltd / Barclays PLC / Cameco Corp / Colgate-Palmolive Co / DFDS AS / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Public Service Enterprise Group Inc / Pfizer Inc / Pennon Group PLC / Southern Co / AT&T Inc / Telus Corp / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Ferrovial SA / Duke Energy Corp / Borgwarner Inc / Lear Corp / Enbridge Inc / TC Energy Corp / Kellogg Co / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Verizon Communications Inc / Exelixis Inc / Constellation Brands Inc / Amphenol Corp / Exelon Corp / Fiserv Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Energizer Holdings Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Chemed Corp / Polaris Inc / Sensata Technologies Holding PLC / American Homes 4 Rent / Select Medical Holdings Corp / Global Payments Inc / Monster Beverage Corp / F5 Inc / Equinix Inc / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Kosmos Energy Ltd / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Harley-Davidson Inc / Commvault Systems Inc / B&G Foods Inc / Pembina Pipeline Corp / Getlink SE / Dana Inc / Northern Oil and Gas Inc / Sprott Inc / Unitil Corp / Reinsurance Group of America Inc / Cenovus Energy Inc / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Enerplus Corp / Pacira Biosciences Inc / Meritor Inc / Qualys Inc / Mondelez International Inc / Granite Real Estate Investment Trust / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / Brookfield Renewable Partners LP / Essent Group Ltd / Installed Building Products Inc / Pacira Biosciences Inc / Aena SME SA / Galapagos NV / PayPal Holdings Inc / Rapid7 Inc / Block Inc / Ferrari NV / Tabula Rasa HealthCare Inc / Adient PLC / Uniti Group Inc / WideOpenWest Inc / Athenex Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Eagle Pharmaceuticals Inc / Health Catalyst Inc / Genmab A/S / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Pennant Group Inc / Reynolds Consumer Products Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rackspace Technology Inc / Jamf Holding Corp / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Viatris Inc / Telus International Cda Inc / Affirm Holdings Inc / Duckhorn Portfolio Inc / Olo Inc / TuSimple Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Multiple Study Initiations in 2021; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee / Sean Kang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pfizer (PFE US) - The multi-billion-dollar question</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRVI: 1Q Operational Beat; Healthy FY21 Guide with Ample Room for CleanCap Upside</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI.OQ / PFE.N</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Term sheet for BioNTech JV a strong positive; raise H-share TP to HK$60 . Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2196.HK / 600196.SS / PFE.N</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">05/10/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">DS-1062 Data Early, But Suggest Best-In-Class Potential; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / PCRX.O / PRGO.N / FLXN.O / XERS.O / OSMT.O / 269796108 / VTRS.OQ</td><td class="leftalignment">Pfizer Inc / Pacira Biosciences Inc / Perrigo Company PLC / Pacira Biosciences Inc / Xeris Biopharma Holdings Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Holding Steady - Week 58</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / ABUS / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 29664W105 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / 81181C104 / 517125100 / 07160F107 / G637AM102 / 007002108 / M47364100 / 617760202 / N71542109 / 45168K405 / 206022105 / 92790C104 / 76200L309</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Arbutus Biopharma Corp / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Larimar Therapeutics Inc / Baudax Bio Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Viridian Therapeutics Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 5.7.21</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABT / 00365410 / 28176E10 / 62855J10 / 75991610 / 71708110 / 00846U10 / 44485910 / 12665010 / 07181310 / 10113710 / 88355610 / 04635310 / 43644010 / 87936910 / 37555810 / 75886F10 / 53245710 / 46120E60 / 11679410 / 45232710 / 01625510 / 30063P10 / 478160104 / 075887109 / 60855R10 / 205306103 / 45784P10 / 25213110 / 04963C20 / 64049M20 / 58933Y10 / 14161910 / 45766930 / 80360710 / 92337F10 / 09073M104 / 82621J10 / 92346J10 / G5960L10 / 23283X20 / 40131M10 / 89853L10 / 71944F10 / 42226A10 / 68269G10 / 09075V10 / 60770K10 / 05156V10 / 01438T10 / 74374N10 / 31189P10 / 07725L10 / G3910J11 / 37242740 / 43906K10 / 45781K20 / 48576U10 / F5548N10 / 45845P10 / 4525EP10 / 22905030 / G8807B10 / 64157F10 / 74766Q10 / 87537220 / 69014510 / 35961610 / 05465P10 / 00461U10 / 04539610 / F4373810 / N4482110 / 28255910 / 29446K10 / N1976T10 / 36322Q10 / 74623710 / 15912K10 / 69512710</td><td class="leftalignment">Abbott Laboratories / ABIOMED Inc / Edwards Lifesciences Corp / Myriad Genetics Inc / Repligen Corp / Pfizer Inc / Agilent Technologies Inc / Humana Inc / CVS Health Corp / Baxter International Inc / Boston Scientific Corp / Thermo Fisher Scientific Inc / AstraZeneca PLC / Hologic Inc / Teleflex Inc / Gilead Sciences Inc / Regeneron Pharmaceuticals Inc / Eli Lilly and Co / Intuitive Surgical Inc / Bruker Corp / Illumina Inc / Align Technology Inc / Exact Sciences Corp / Johnson & Johnson / Becton Dickinson and Co / Molina Healthcare Inc / Computer Programs and Systems Inc / Insulet Corp / Dexcom Inc / AtriCure Inc / Neogenomics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Insmed Inc / Sarepta Therapeutics Inc / Veracyte Inc / Bio-Techne Corp / Sientra Inc / Vericel Corp / Medtronic PLC / Cytosorbents Corp / Guardant Health Inc / T2 Biosystems Inc / Phreesia Inc / Healthequity Inc / 1Life Healthcare Inc / BioNTech SE / Moderna Inc / Aurinia Pharmaceuticals Inc / Aldeyra Therapeutics Inc / Provention Bio Inc / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Genocea Biosciences Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Karyopharm Therapeutics Inc / Sanofi SA / Intercept Pharmaceuticals Inc / Immunic Inc / Cryoport Inc / Theravance Biopharma Inc / Nevro Corp / Quanterix Corp / Tandem Diabetes Care Inc / Outset Medical Inc / Fulcrum Therapeutics Inc / Axonics Inc / Aclaris Therapeutics Inc / Assembly Biosciences Inc / Genfit SA / InflaRx NV / 89Bio Inc / Equillium Inc / Centogene NV / Galecto Inc / PureTech Health PLC / Change Healthcare Inc / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Equ Research</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Update With 1Q21 Results, Accounting Change</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Ladenburg Thalmann & Co. Inc.</td><td class="leftalignment">1Q21 Results; Takeaway From Recent R&D Day Update; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wangzhi Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) - Positive Competitor Data Provides External Clinical Validation For ORIC's GR Antagonist ORIC-101</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Pfizer For 25% Gains?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/07/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Flash - Health Care: Proposal to waive intellectual property rights for COVID-19 vaccines</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRCG.DE / PFE.N / SASY.PA</td><td class="leftalignment">Merck KGaA / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Transportation</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="even"><td class="leftalignment">05/07/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AXP / 2516152 / 2486813 / 2778844 / 2973821 / 2045623 / 2219224 / 2175672 / 2216850 / 2576941 / 2670519 / 2345022 / 2459202 / 2459020 / 2378534 / 2630513 / 2645409 / 2657802 / 2680905 / 2684703 / 2048804 / 2707677 / 2730190 / 2440637 / 2416962 / 2138158 / 2799351 / 2825933 / 5531000 / 7103065 / 2212922 / 2769796 / 2857817 / B125XQ6 / B0T7YX2 / B02R1L6 / B3P93Y7 / B44C366 / B7TL820 / B783TY6 / BBPK0J0 / BBGVT40 / B95N910 / BDZCRX3 / B8DPDT7 / BFLR866 / B6WXT12 / B95WG16 / BZ07BW4 / BYVY8G0 / BYW36M8 / BF09HX3 / BYNZGK1 / BJT1RW7 / BZBY005 / BKS3SM8 / BQT3XY6 / BJ1FD74 / BJFSR88 / BKDS4H5 / BR4T3B3 / BWFKZT2 / BKVDFF7 / BFMXGR0 / BJJMGL2 / BFXC911 / BKTNTR9 / BK6N347 / BJVR9Y9 / BYWMQJ2 / BHZSB82 / BL95N25 / BD6D4Y5 / BZ1LFG7 / BYY88Y7 / BYSGPK2 / BJDX8Y8 / BYWVTY5 / BMVWYW8 / BJMLSD2 / BYQBFS7 / BYSFJV8 / BKWD3M9 / BYTJZL1 / BX7RSN3 / BYNPPC6 / BWY4XV3 / BJTJGC4 / BKLCX50 / BYQCZ35 / BQXZP64 / BGDW0N7 / BMPRZV5 / BGT0PL8 / BLBLMD5 / BNTB3N8</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Kellogg Co / Merck & Co Inc / Alliant Energy Corp / ANSYS Inc / CMS Energy Corp / Cardinal Health Inc / Consolidated Edison Inc / Exelixis Inc / Exelon Corp / Macy's Inc / IDEXX Laboratories Inc / Intuit Inc / Mckesson Corp / New Jersey Resources Corp / NiSource Inc / OGE Energy Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Henry Schein Inc / Sempra Energy / Sinclair Broadcast Group Inc / South Jersey Industries Inc / MorphoSys AG / Novartis AG / NRG Energy Inc / Fidelity National Information Services Inc / Netflix Inc / Portland General Electric Co / Live Nation Entertainment Inc / ALLETE Inc / Anheuser Busch Inbev SA / Heska Corp / Meta Platforms Inc / Aptiv PLC / Mirati Therapeutics Inc / News Corp / PTC Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / TherapeuticsMD Inc / Zoetis Inc / Monster Beverage Corp / Alphabet Inc / PayPal Holdings Inc / Tapestry Inc / Block Inc / Lyft Inc / Merus NV / IGM Biosciences Inc / Cyberark Software Ltd / Revolve Group Inc / Uniqure NV / Bill.com Holdings Inc / HubSpot Inc / Cellectis SA / Oric Pharmaceuticals Inc / Evergy Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Alteryx Inc / Covetrus Inc / Phibro Animal Health Corp / Altair Engineering Inc / Roku Inc / Alphabet Inc / ViewRay Inc / Mirum Pharmaceuticals Inc / CytomX Therapeutics Inc / Protara Therapeutics Inc / Karuna Therapeutics Inc / Tabula Rasa HealthCare Inc / Planet Fitness Inc / Progyny Inc / Zogenix Inc / Collegium Pharmaceutical Inc / DENTSPLY SIRONA Inc / Adaptimmune Therapeutics PLC / Kontoor Brands Inc / Health Catalyst Inc / Madison Square Garden Sports Corp / Wayfair Inc / Trevena Inc / Kymera Therapeutics Inc / DiaMedica Therapeutics Inc / Array Technologies Inc / Vizio Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – 1Q21 Recap; ORIC-101 Updates at ASCO While 3 Addl. Programs Move Towards IND in 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Pfizer - $49.89 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">DNB / WMB=US / PFE=US / AMGN=US / BMY=US / GBT=US / INCY=US / RUN=US / AMT=US / PEB=US / APA=US / BR=US / CPE=US / H=US / V=US / MTN=US / CRK=US / WLL=US / PXD=US / MGY=US / MAR=US / MRO=US / TNL=US / VMC=US / HLT=US / BKI=US / MLM=US / AMK=US / AIZ=US / AMN=US / FUN=US / CENT=US / CHH=US / CSGP=US / CW=US / DRH=US / EQT=US / DOC=US / SMG=US / WW=US / WIX=US / CCRN=US / MANT=US / PYPL=US / BKNG=US / DCP=US / EPR=US / FRT=US / JAZZ=US / MTCH=US / SRC=US / SPR=US / CRTO=US / AUTL=US / DIN=US / ECPG=US / MGPI=US / PTON=US / IGMS=US / FLT=US / CZR=US / NUVA=US / KAR=US / BDC=US / HURN=US / SHO=US / LHCG=US / AAWW=US / SPWR=US / HST=US / MA=US / LUMN=US / KTOS=US / WH=US / ATSG=US / IAC=US / PSN=US / RCUS=US / VRSK=US / HTA=US / HGV=US / GDOT=US / SBRA=US / RLJ=US / ESTE=US / VAC=US / ZNGA=US / ENPH=US / PDCE=US / RHP=US / TSLX=US / HUBS=US / VCEL=US / NVRO=US / GDDY=US / ETSY=US / EVRI=US / EDIT=US / 82982L103 / CRSP=US / PK=US / TVTY=US / ANAB=US / PLYA=US / SBOW=US / IOVA=US / RDFN=US / PETQ=US / DCPH=US / ROOT=US / GSKY=US / HARP=US / UBER=US / TCRR=US / PLMR=US / NXTC=US / GMAB=US / ARQT=US / REYN=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Williams Companies Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Incyte Corp / Sunrun Inc / American Tower Corp / Pebblebrook Hotel Trust / APA Corp (US) / Broadridge Financial Solutions Inc / Callon Petroleum Co / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Comstock Resources Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Marriott International Inc / Marathon Oil Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Black Knight Inc / Martin Marietta Materials Inc / AssetMark Financial Holdings Inc / Assurant Inc / AMN Healthcare Services Inc / Cedar Fair LP / Central Garden & Pet Co / Choice Hotels International Inc / CoStar Group Inc / Curtiss-Wright Corp / Diamondrock Hospitality Co / EQT Corp / Physicians Realty Trust / Scotts Miracle-Gro Co / WW International Inc / Wix.Com Ltd / Cross Country Healthcare Inc / ManTech International Corp / PayPal Holdings Inc / Booking Holdings Inc / DCP Midstream LP / EPR Properties / Federal Realty Investment Trust / Jazz Pharmaceuticals PLC / Match Group Inc / Spirit Realty Capital Inc / Spirit AeroSystems Holdings Inc / Criteo SA / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / MGP Ingredients Inc / Peloton Interactive Inc / IGM Biosciences Inc / Fleetcor Technologies Inc / Caesars Entertainment Inc / NuVasive Inc / KAR Auction Services Inc / Belden Inc / Huron Consulting Group Inc / Sunstone Hotel Investors Inc / LHC Group Inc / Atlas Air Worldwide Holdings Inc / SunPower Corp / Host Hotels & Resorts Inc / Mastercard Inc / Lumen Technologies Inc / Kratos Defense and Security Solutions Inc / Wyndham Hotels & Resorts Inc / Air Transport Services Group Inc / IAC/Interactivecorp / Parsons Corp / Arcus Biosciences Inc / Verisk Analytics Inc / Healthcare Trust Of America Inc / Hilton Grand Vacations Inc / Green Dot Corp / Sabra Health Care REIT Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Zynga Inc / Enphase Energy Inc / PDC Energy Inc / Ryman Hospitality Properties Inc / Sixth Street Specialty Lending Inc / HubSpot Inc / Vericel Corp / Nevro Corp / GoDaddy Inc / ETSY Inc / Everi Holdings Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Tivity Health Inc / AnaptysBio Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / Deciphera Pharmaceuticals Inc / Root Inc / GreenSky Inc / Harpoon Therapeutics Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Palomar Holdings Inc / NextCure Inc / Genmab A/S / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Fireside Highlights: HARP, TCRR, IOVA, AUTL @ The Truist Life Sciences Summit (May 5)</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AUTL.OQ / HARP.OQ / IOVA.OQ / TCRR.OQ / PFE=US / AMGN=US / BMY=US / AUTL=US / IOVA=US / HARP=US / TCRR=US / NXTC=US</td><td class="leftalignment">Autolus Therapeutics PLC / Harpoon Therapeutics Inc / Iovance Biotherapeutics Inc / TCR2 Therapeutics Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Autolus Therapeutics PLC / Iovance Biotherapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / NextCure Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Asthika Goonewardene / Avi Dahan</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Get Your 2nd Dose; Post-Marketing Study Suggests BNT162b2 Holds Up vs. B1.351</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">71708110 / 04635310 / 09075V10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / Qatar / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Daina Graybosch, Ph.D. / Geoffrey Porges, MBBS / Dilip Joseph</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GMAB.CO: Genmab - 1Q21 Second Opinion</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GMAB.CO / JNJ.N / PFE.N / RECI.MI / ROG.S / LUN.CO / NOVN.S / MRCG.DE / LONN.S / UCB.BR / REGN.OQ / SGEN.OQ / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / HZNP.OQ / ABBV.N / VIFN.S</td><td class="leftalignment">Genmab A/S / Johnson & Johnson / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / Roche Holding AG / H Lundbeck A/S / Novartis AG / Merck KGaA / Lonza Group AG / Ucb SA / Regeneron Pharmaceuticals Inc / Seagen Inc / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Horizon Therapeutics PLC / Abbvie Inc / Vifor Pharma AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / Ireland / Italy / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">05/06/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRVI: Pfizer 1Q Commentary Offers Encouraging Read-Through; CleanCap Drivers Should Continue</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE.N / MRVI.OQ / CVAC.OQ</td><td class="leftalignment">Pfizer Inc / Maravai LifeSciences Holdings Inc / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">05/06/2021</td><td class="leftalignment">The Wall Street Transcript</td><td class="leftalignment">Balanced Fund Ups Stock Allocation After Defensive Turn to Fixed Income</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / LLY.N / NSRGY / PFE.N / PXD.N / UNH.N / CAT.N / UNP.N / VLO.N / RMD.N / RF.N / HELE.OQ / SIVB.OQ / AMZN.OQ / FITB.OQ / GOOG.OQ / SBGSY / ZTS.N / AZN.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Nestle SA / Pfizer Inc / Pioneer Natural Resources Co / UnitedHealth Group Inc / Caterpillar Inc / Union Pacific Corp / Valero Energy Corp / Resmed Inc / Regions Financial Corp / Helen of Troy Ltd / SVB Financial Group / Amazon.com Inc / Fifth Third Bancorp / Alphabet Inc / Schneider Electric SE / Zoetis Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">No Industry</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / ASSET MANAGEMENT / ECONOMIC ANALYSIS / FUNDAMENTAL ANALYSIS / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">The Wall St Transcript</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended May 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from fireside chat with PFE</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, May 05, 2021 / 1:50PM ET</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID Vaccine Delivers Revenue Windfall, Margins Hurt but Cash Grows; PT to $43</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">71708110</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">FISV=US / LLY=US / LSI=US / PFE=US / DIS=US / DVN=US / INCY=US / BR=US / AKAM=US / H=US / CRK=US / PXD=US / MGY=US / EXPE=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / VMC=US / CVS=US / MLM=US / AIR=US / AIZ=US / BMRN=US / BNL=US / CYH=US / DVA=US / DCO=US / EEFT=US / EXEL=US / MPLX=US / MRCY=US / ASGN=US / RARE=US / HOOK=US / TRIP=US / SAGE=US / GPN=US / MANT=US / BKNG=US / JAZZ=US / MTCH=US / COP=US / MRNS=US / RRR=US / IGMS=US / STRO=US / KAR=US / HURN=US / WMG=US / DENN=US / SCPL=US / FIS=US / HST=US / XPO=US / WU=US / ICFI=US / PAGP=US / IAA=US / CWH=US / 45665G303 / VRSK=US / ZNGA=US / BCEI=US / EA=US / GMED=US / FANG=US / TMUS=US / PTCT=US / LDOS=US / NMIH=US / MBUU=US / CNCE=US / ARCB=US / VNOM=US / DEA=US / RLMD=US / SEDG=US / NSA=US / CHCT=US / ZBH=US / BWXT=US / ZG=US / 82982L103 / CDEV=US / TRVG=US / PVAC=US / AYX=US / MPWR-US / DCPH=US / BHC=US / ARVN=US / LYFT=US / RTLR=US / ARQT=US / FBRX=US / 96758W101 / ABNB=US / RBLX=US</td><td class="leftalignment">Fiserv Inc / Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Walt Disney Co / Devon Energy Corp / Incyte Corp / Broadridge Financial Solutions Inc / Akamai Technologies Inc / Hyatt Hotels Corp / Comstock Resources Inc / Pioneer Natural Resources Co / Magnolia Oil & Gas Corp / Expedia Group Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Vulcan Materials Co / CVS Health Corp / Martin Marietta Materials Inc / AAR Corp / Assurant Inc / Biomarin Pharmaceutical Inc / Bunzl plc / Community Health Systems Inc / DaVita Inc / Ducommun Inc / Euronet Worldwide Inc / Exelixis Inc / MPLX LP / Mercury Systems Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Tripadvisor Inc / SAGE Therapeutics Inc / Global Payments Inc / ManTech International Corp / Booking Holdings Inc / Jazz Pharmaceuticals PLC / Match Group Inc / Conocophillips / Marinus Pharmaceuticals Inc / Red Rock Resorts Inc / IGM Biosciences Inc / Sutro Biopharma Inc / KAR Auction Services Inc / Huron Consulting Group Inc / Warner Music Group Corp / Denny's Corp / Sciplay Corp / Fidelity National Information Services Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / Western Union Co / ICF International Inc / Plains GP Holdings LP / IAA Inc / Camping World Holdings Inc / Infinity Pharmaceuticals Inc / Verisk Analytics Inc / Zynga Inc / Civitas Resources Inc / Electronic Arts Inc / Globus Medical Inc / Diamondback Energy Inc / T-Mobile US Inc / PTC Therapeutics Inc / Leidos Holdings Inc / NMI Holdings Inc / Malibu Boats Inc / Concert Pharmaceuticals Inc / ArcBest Corp / Viper Energy Partners LP / Easterly Government Properties Inc / Relmada Therapeutics Inc / Solaredge Technologies Inc / National Storage Affiliates Trust / Community Healthcare Trust Inc / Zimmer Biomet Holdings Inc / BWX Technologies Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Trivago NV / Ranger Oil Corp / Alteryx Inc / Monolithic Power Systems Inc / Deciphera Pharmaceuticals Inc / Bausch Health Companies Inc / Arvinas Inc / Lyft Inc / Rattler Midstream LP / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / WideOpenWest Inc / Airbnb Inc / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">V / 5671735 / 0925288 / 2868165 / 2367026 / 2577609 / 2000019 / 2486813 / 2026242 / 2045623 / 2544960 / 2219224 / 2542049 / 2317087 / 2670519 / 2459202 / 2471950 / 2657802 / 2689560 / 2684703 / 2440637 / 2416962 / 2783815 / 2712013 / B1F76F9 / B0PZN11 / B121557 / 2857817 / B125XQ6 / B2R3PV1 / B4Y1MH7 / 2949758 / B3SWPT2 / BJ0KXV4 / B3X26D8 / BDZCRX3 / B8DPDT7 / BFLR866 / BYRY499 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BP4GNK9 / BYW36M8 / BYNZGK1 / BJT1RW7 / BJF8Q81 / BJXBP41 / BZ1LFB2 / BKDS4H5 / BNFWR44 / BLGJ610 / BJJMGL2 / BDT5KT5 / BKX9VD3 / BDZ30Q0 / BFFVVC1 / BDRW1L7 / BN4RD42 / BLBLMD5 / BFY7DC4 / BMDJ085 / BNTB3N8 / BD5GSZ4</td><td class="leftalignment">Visa Inc / Sanofi SA / GlaxoSmithKline PLC / Sysco Corp / General Mills Inc / CVS Health Corp / Amazon.com Inc / Kellogg Co / American Electric Power Company Inc / ANSYS Inc / Beasley Broadcast Group Inc / CMS Energy Corp / Dominion Energy Inc / Entergy Corp / Exelon Corp / IDEXX Laboratories Inc / Incyte Corp / OGE Energy Corp / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Henry Schein Inc / Zimmer Biomet Holdings Inc / Global Payments Inc / Western Union Co / Under Armour Inc / Mastercard Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / KAR Auction Services Inc / Nexstar Media Group Inc / Ameresco Inc / ONE Gas Inc / Pacira Biosciences Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / Kraft Heinz Co / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / SAGE Therapeutics Inc / PayPal Holdings Inc / Block Inc / Lyft Inc / IAA Inc / Alcon AG / Deciphera Pharmaceuticals Inc / Bill.com Holdings Inc / Worldline SA / Warner Music Group Corp / Fox Corp / Inspire Medical Systems Inc / Arcutis Biotherapeutics Inc / Arvinas Inc / Bausch Health Companies Inc / AnaptysBio Inc / CureVac NV / Array Technologies Inc / Altimmune Inc / Shoals Technologies Group Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">CC.N / CCI.N / CVS.N / DD.N / FLS.N / PFE.N / PNN.L / TRI.N / PXD.N / GILD.O / LPX.N / INCY.O / ETN.N / K.N / SU.TO / UNP.N / VMC.N / PAA.N / DVN.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / SGMO.O / RDN.N / NBIX.O / EPAY.O / AME.N / JKHY.O / PRU.N / COP.N / BKH.N / LNG.A / GPN.N / MNST.O / ICPT.O / EQIX.O / DLR.N / ACAD.O / ARWR.O / MWA.N / WU.N / CVLT.O / CQP.A / ATL.MI / IVZ.N / ADUS.OQ / FHI.N / PCRX.O / STAG.N / MPC.N / XYL.N / SRPT.O / MPLX.N / FANG.O / USAC.N / ENTA.O / TMUS.N / PTCT.O / BEP.N / ITCI.O / CIA.TO / PAYC.N / BTG.N / CTLT.N / NMIH.O / 03835T200 / 78667J108 / CIGI.O / GDS.O / UAA.N / RCM.OQ / CDEV.O / OVID.O / ATNX.O / OMP.N / ORSTED.CO / NEXA.TO / BHC.N / ETRN.N / PEAK.N / ETNB.O / OAS.OQ / VMD.OQ / MTCR.O / MCFE.OQ</td><td class="leftalignment">Chemours Co / Crown Castle International Corp / CVS Health Corp / Dupont De Nemours Inc / Flowserve Corp / Pfizer Inc / Pennon Group PLC / Thomson Reuters Corp / Pioneer Natural Resources Co / Gilead Sciences Inc / Louisiana-Pacific Corp / Incyte Corp / Eaton Corporation PLC / Kellogg Co / Suncor Energy Inc / Union Pacific Corp / Vulcan Materials Co / Plains All American Pipeline LP / Devon Energy Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Sangamo Therapeutics Inc / Radian Group Inc / Neurocrine Biosciences Inc / Bottomline Technologies Inc / AMETEK Inc / Jack Henry & Associates Inc / Prudential Financial Inc / Conocophillips / Black Hills Corp / Cheniere Energy Inc / Global Payments Inc / Monster Beverage Corp / Intercept Pharmaceuticals Inc / Equinix Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Mueller Water Products Inc / Western Union Co / Commvault Systems Inc / Cheniere Energy Partners LP / Atlantia SpA / Invesco Ltd / Addus Homecare Corp / Federated Hermes Inc / Pacira Biosciences Inc / STAG Industrial Inc / Marathon Petroleum Corp / Xylem Inc / Sarepta Therapeutics Inc / MPLX LP / Diamondback Energy Inc / USA Compression Partners LP / Enanta Pharmaceuticals Inc / T-Mobile US Inc / PTC Therapeutics Inc / Brookfield Renewable Partners LP / Intra-Cellular Therapies Inc / Champion Iron Ltd / Paycom Software Inc / B2Gold Corp / Catalent Inc / NMI Holdings Inc / Aptose Biosciences Inc / SAGE Therapeutics Inc / Colliers International Group Inc / GDS Holdings Ltd / Under Armour Inc / R1 RCM Inc / Centennial Resource Development Inc / Ovid Therapeutics Inc / Athenex Inc / Oasis Midstream Partners LP / Orsted A/S / Nexa Resources SA / Bausch Health Companies Inc / Equitrans Midstream Corp / Healthpeak Properties Inc / 89Bio Inc / Oasis Petroleum Inc / Viemed Healthcare Inc / Metacrine Inc / Mcafee Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Ireland / Italy / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Vaccine upside drives 1Q beat while upcoming catalysts should help inform on Biopharma outlook</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SRPT: Q1 Earnings Update - Largely In-Line</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">SRPT.OQ / PFE.N</td><td class="leftalignment">Sarepta Therapeutics Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Judah C. Frommer / Mark Connolly / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEE.N / AES.N / APD.N / BDX.N / CI.N / CVS.N / ED.N / GM.N / PFE.N / SPG.N / MET.N / DUK.N / IFF.N / EMR.N / LIN.N / VTR.N / COP.N / ATVI.OQ / REGN.OQ / FIS.N / TDG.N / HBI.N / EA.OQ / ZTS.N / PRGO.N / MAR.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / General Motors Co / Pfizer Inc / Simon Property Group Inc / MetLife Inc / Duke Energy Corp / International Flavors & Fragrances Inc / Emerson Electric Co / Linde PLC / Ventas Inc / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Fidelity National Information Services Inc / TransDigm Group Inc / HanesBrands Inc / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">05/05/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : 1Q Takeaways: Raising Estimates On Higher COVID Vaccine Sales</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">05/05/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - 1Q21 Full Postview: COVID Vx sales strong; otherwise quiet; guidance probably still too low!</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - PFE: 1Q21 - They said what? Highlights from conference call that just ended</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID Vaccine Lifts 1Q Results; Outlook for Core Business Unchanged</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">71708110 / 09075V10</td><td class="leftalignment">Pfizer Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Geoffrey Porges, MBBS / Na Sun</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on May 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / BR.N / CVS.N / DD.N / SEE.N / BEN.N / PXD.N / ETN.N / CMI.N / AIZ.N / PGR.N / SYY.N / VMC.N / DVN.N / IT.N / PKI.N / MLM.N / AME.N / PRU.N / COP.N / ATVI.OQ / XLNX.OQ / IDXX.OQ / INCY.OQ / HSIC.OQ / ZBRA.OQ / AKAM.OQ / GPN.N / WYNN.OQ / MPWR.OQ / WU.N / IPGP.OQ / VRSK.OQ / AMRC.N / CZR.OQ / MPC.N / XYL.N / LDOS.N / PAYC.N / ANET.N / CTLT.N / ZBH.N / TMUS.OQ / VREX.OQ / UPWK.OQ / CTVA.N / AMCR.N / PEAK.N / HST.OQ</td><td class="leftalignment">Pfizer Inc / Broadridge Financial Solutions Inc / CVS Health Corp / Dupont De Nemours Inc / Sealed Air Corp / Franklin Resources Inc / Pioneer Natural Resources Co / Eaton Corporation PLC / Cummins Inc / Assurant Inc / Progressive Corp / Sysco Corp / Vulcan Materials Co / Devon Energy Corp / Gartner Inc / PerkinElmer Inc / Martin Marietta Materials Inc / AMETEK Inc / Prudential Financial Inc / Conocophillips / Activision Blizzard Inc / Xilinx Inc / IDEXX Laboratories Inc / Incyte Corp / Henry Schein Inc / Zebra Technologies Corp / Akamai Technologies Inc / Global Payments Inc / Wynn Resorts Ltd / Monolithic Power Systems Inc / Western Union Co / IPG Photonics Corp / Verisk Analytics Inc / Ameresco Inc / Caesars Entertainment Inc / Marathon Petroleum Corp / Xylem Inc / Leidos Holdings Inc / Paycom Software Inc / Arista Networks Inc / Catalent Inc / Zimmer Biomet Holdings Inc / T-Mobile US Inc / Varex Imaging Corp / Upwork Inc / Corteva Inc / Amcor PLC / Healthpeak Properties Inc / Host Hotels & Resorts Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States / Jersey</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Big Engine That Could, 1Q21 Sales And EPS Beat Underscore That PFE's Stock Is Undervalued</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 EPS and Sales Beat; 2021 Guidance Raised On Boosted Vaccine Forecast</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">impt updates on vaccines & beyond</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Strong 1Q results and revised outlook on COVID vaccine sales; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : 1Q First Impressions: Vaccine Sales Driving Further Upside To Guidance; Core Biz Largely In Line</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) - Earnings In-Line Heading Into 2H 2021 Data Updates for Degrader Pipeline; Maintain BUY, $100 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BDZ30Q0 / 2684703</td><td class="leftalignment">Arvinas Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, May 04, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, May 04, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE delivers a 1Q beat and raise on COVID-19 vaccine upside, while core Biopharma business holds up well; call at 10AM ET</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1 EPS And Revenue Beat, 2021 Guidance Raised On Strong COVID Vaccine Sales</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Sunny Side Up, First Look At 1Q21 Sales And EPS Beat</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / MDT=US / BLD=US / DVN=US / INCY=US / GILD=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / DIOD=US / MGY=US / SWN=US / SCOR=US / MUR=US / CHRS=US / MRO=US / LEG=US / KFRC=US / VMC=US / MLM=US / CBRL=US / CNX=US / DRI=US / EQT=US / EXEL=US / GFF=US / IBP=US / HZO=US / MAS=US / MHK=US / HOOK=US / REGN=US / REGI=US / RHI=US / WIX=US / CVX=US / SAGE=US / PSA=US / EPD=US / CGEN=US / BXS=US / SNV=US / ADC=US / CUZ=US / OHI=US / VNO=US / CRTO=US / COP=US / BRX=US / DIN=US / STRO=US / TPX=US / EXP=US / FHN=US / CDLX=US / BECN=US / SHO=US / PLAY=US / FRPT=US / DENN=US / BLDR=US / GMS=US / NSP=US / SIBN=US / KBR=US / CMG=US / REX=US / CCOI=US / XPO=US / PGTI=US / GPRE=US / AWI=US / OC=US / TAST=US / QSR=US / CLR=US / PRPL=US / NOG=US / IAC=US / EPRT=US / JACK=US / RCUS=US / CLNY=US / TREX=US / AR=US / NLSN=US / WWD=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / MEIP=US / PDCE=US / GMED=US / RHP=US / FANG=US / ABBV=US / TILE=US / NDLS=US / FATE=US / VRNS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / ON=US / SEDG=US / BWXT=US / WING=US / SPNE=US / CABO=US / ACBI=US / AXSM=US / 82982L103 / CDEV=US / CRSP=US / PVAC=US / JELD=US / CVNA=US / SBOW=US / IOVA=US / ATNX=US / ROKU=US / SWCH=US / DCPH=US / MAXR=US / BTAI=US / FTDR=US / SVMK=US / ALLO=US / KOD=US / HARP=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / ZI=US / AZEK=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / Medtronic PLC / TopBuild Corp / Devon Energy Corp / Incyte Corp / Gilead Sciences Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Diodes Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Comscore Inc / Murphy Oil Corp / Coherus BioSciences Inc / Marathon Oil Corp / Leggett & Platt Inc / Kforce Inc / Vulcan Materials Co / Martin Marietta Materials Inc / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Exelixis Inc / Griffon Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mohawk Industries Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / Wix.Com Ltd / Chevron Corp / SAGE Therapeutics Inc / Public Storage / Enterprise Products Partners LP / Compugen Ltd / Cadence Bank / Synovus Financial Corp / Agree Realty Corp / Cousins Properties Inc / Omega Healthcare Investors Inc / Vornado Realty Trust / Criteo SA / Conocophillips / Brixmor Property Group Inc / Dine Brands Global Inc / Sutro Biopharma Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Cardlytics Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SI-BONE Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / XPO Logistics Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Essential Properties Realty Trust Inc / Jack in the Box Inc / Arcus Biosciences Inc / DigitalBridge Group Inc / Trex Company Inc / Antero Resources Corp / Nielsen Holdings PLC / Woodward Inc / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / MEI Pharma Inc / PDC Energy Inc / Globus Medical Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Fate Therapeutics Inc / Varonis Systems Inc / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / ON Semiconductor Corp / Solaredge Technologies Inc / BWX Technologies Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / Atlantic Capital Bancshares Inc / Axsome Therapeutics Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Carvana Co / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Athenex Inc / Roku Inc / Switch Inc / Deciphera Pharmaceuticals Inc / Maxar Technologies Inc / BioXcel Therapeutics Inc / Frontdoor Inc / Momentive Global Inc / Allogene Therapeutics Inc / Kodiak Sciences Inc / Harpoon Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / ZoomInfo Technologies Inc / Azek Company Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2045623 / 2437071 / 2219224 / 2542049 / 2670519 / 2613990 / 2501578 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 7103065 / B1F76F9 / B125XQ6 / 2679204 / 2390817 / B7TL820 / BDZCRX3 / B8DPDT7 / BFLR866 / B76LYJ2 / BYY8XK8 / BJLT387 / BZBY005 / BZB1XF2 / BR4T3B3 / BMQ5T49 / BFMXGR0 / BYQRFY1 / BKT6B38 / BMPRZV5 / BLBLMD5 / BNTB3N8 / BD5GSZ4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / ANSYS Inc / Biomarin Pharmaceutical Inc / CMS Energy Corp / Dominion Energy Inc / Exelon Corp / Illumina Inc / Ligand Pharmaceuticals Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Novartis AG / Western Union Co / Portland General Electric Co / Align Technology Inc / Gray Television Inc / Meta Platforms Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / Vocera Communications Inc / WEC Energy Group Inc / Avantor Inc / Merus NV / Tactile Systems Technology Inc / HubSpot Inc / Zentalis Pharmaceuticals Inc / Evergy Inc / Teladoc Health Inc / SmileDirectClub Inc / Kymera Therapeutics Inc / Array Technologies Inc / Vizio Holding Corp / Infrastructure and Energy Alternatives Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / BMY.N / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / SUN.BO / NOVOB.CO / NOVN.S / 4768.T / GSK.L / UCB.BR / AMGN.OQ / ALKS.OQ / GILD.OQ / UTHR.OQ / BIIB.OQ / 4568.T / TEVA.N / ALM.MC / BAYGN.DE / 4578.T / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Otsuka Corp / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Alkermes Plc / Gilead Sciences Inc / United Therapeutics Corp / Biogen Inc / Daiichi Sankyo Co Ltd / Teva Pharmaceutical Industries Ltd / Almirall SA / Bayer AG / Otsuka Holdings Co Ltd / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / Spain / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">05/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 4, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AEE.N / AES.N / APD.N / BDX.N / CI.N / CVS.N / ED.N / EL.N / GM.N / PFE.N / WMB.N / SPG.N / MET.N / DUK.N / IFF.N / EMR.N / WEC.N / LIN.N / AWK.N / VTR.N / COP.N / ATVI.OQ / REGN.OQ / O.N / FIS.N / TDG.N / HBI.N / EA.OQ / ZTS.N / PRGO.N / MAR.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">Ameren Corp / AES Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / CVS Health Corp / Consolidated Edison Inc / Estee Lauder Companies Inc / General Motors Co / Pfizer Inc / Williams Companies Inc / Simon Property Group Inc / MetLife Inc / Duke Energy Corp / International Flavors & Fragrances Inc / Emerson Electric Co / WEC Energy Group Inc / Linde PLC / American Water Works Company Inc / Ventas Inc / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Realty Income Corp / Fidelity National Information Services Inc / TransDigm Group Inc / HanesBrands Inc / Electronic Arts Inc / Zoetis Inc / Perrigo Company PLC / Marriott International Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">05/04/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for PFE</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - PFE: Updated model ahead of Q1 results</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">All Eyes On Covid-19 Vaccine Contribution As Pfizer Reports Its Q1</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">PFE.N / JNJ.N / MRK.N / RHHBY.PK</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Merck & Co Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Trefis Report: Pfizer - $40.48 Trefis Price Estimate</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) — Takeaways From Our Virtual NDR With ZNTL; Investors Focus On WEE1 Development Strategy and Near Term Oral SERD Updates</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMQ5T49 / 5671735 / 0989529 / 0925288 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Streetwise Reports</td><td class="leftalignment">BioNTech Shares Gain 11% on Filing COVID-19 Vaccine Expanded Use Request to EMA in Children Ages 12 to 15</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">22UAy.DE / PFE.N</td><td class="leftalignment">BioNTech SE / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / GOVERNMENT RELATIONS/REGULATIONS / INDUSTRY OVERVIEW / MARKET COMMENT / COMMENTARY / COMMODITIES / OVERVIEW / PORTFOLIO STRATEGY / SECTOR / EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DLR-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE / EQIX.O / FB.O</td><td class="leftalignment">Pfizer Inc / Equinix Inc / Meta Platforms Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What Bristol Myers Squibb's Q1 Results Say About Its Stock</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What?s Next For Merck Stock After A 5% Drop Following Q1 Miss?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech & Pharma: Truist ASCO Planner v1.0 Highlights ~200 Datapoints of Interest</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / INCY=US / GILD=US / CHRS=US / EXEL=US / HOOK=US / REGN=US / CGEN=US / STRO=US / RCUS=US / MEIP=US / ABBV=US / FATE=US / CRSP=US / IOVA=US / ATNX=US / DCPH=US / BTAI=US / ALLO=US / HARP=US / GMAB=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Incyte Corp / Gilead Sciences Inc / Coherus BioSciences Inc / Exelixis Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Sutro Biopharma Inc / Arcus Biosciences Inc / MEI Pharma Inc / Abbvie Inc / Fate Therapeutics Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Athenex Inc / Deciphera Pharmaceuticals Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / Genmab A/S</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Asthika Goonewardene / Ms. Robyn S. Karnauskas / Mr. Gregg Gilbert / Ms. Srikripa Devarakonda, PHD / Mr. Joon Lee, MD</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 23, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - May 3 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">MOGa / US0116591092 / US0231351067 / US0463531089 / US0758871091 / US1101221083 / US14149Y1082 / US37733W1053 / US4234521015 / US5324571083 / US58155Q1031 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US03073E1055 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / ACOR.OQ / US5380341090 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US7185461040 / US69318G1067 / US00287Y1091 / US55345K1034 / US8485771021 / US21240E1055 / US02376R1023 / US94419L1017 / US0465131078 / CA0089118776 / US00653A1079 / US05464T1043 / US00773U1088 / GB00BDSFG982 / US7493971052 / US02156B1035 / US5904791358 / US0197701065 / US0144421072 / US5024311095 / US70614W1009 / US09203E1055 / US26142R1041 / CH0499880968 / US15872M1045 / US44891N1090 / US69353Y1038 / US62955J1034</td><td class="leftalignment">Moog Inc / Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Becton Dickinson and Co / Bristol-Myers Squibb Co / Cardinal Health Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Eli Lilly and Co / Mckesson Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Amerisourcebergen Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Acorda Therapeutics Inc / Live Nation Entertainment Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Phillips 66 / PBF Energy Inc / Abbvie Inc / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Wayfair Inc / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / TechnipFMC PLC / R1 RCM Inc / Alteryx Inc / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / L3harris Technologies Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / ChampionX Corp / IAC/Interactivecorp / PMV Pharmaceuticals Inc / Nov Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK=US / PFE=US / BMY=US / GBT=US / CL=US / AMZN=US / DVN=US / GILD=US / EOG=US / REI=US / CHTR=US / XOM=US / WLL=US / PXD=US / HSII=US / SWN=US / VRM=US / MRO=US / EXPE=US / KFRC=US / MANH=US / NWL=US / W=US / DISH=US / KFY=US / AMN=US / B=US / BMRN=US / COLL=US / EXPO=US / GFF=US / LH=US / TREE=US / MAN=US / HZO=US / MHK=US / ASGN=US / RARE=US / RHI=US / SGMO=US / STRA=US / SNAP=US / THO=US / TRIP=US / VRTX=US / WIX=US / WGO=US / CVX=US / SAGE=US / CCRN=US / BKNG=US / CFR=US / FB=US / ENSG=US / AMSF=US / VICI=US / MGP=US / BDSI=US / MRNS=US / PTON=US / PRG=US / BIIB=US / MOG.A=US / APTX=US / NUVA=US / WMG=US / AAWW=US / NSP=US / CPRX=US / EIG=US / QSR=US / CLR=US / TIL=US / NOG=US / CWH=US / RCUS=US / KNSL=US / OLO=US / ESTE=US / ANGI=US / FANG=US / ABBV=US / GLPI=US / CNCE=US / GOOGL=US / FIVN=US / HTRG=US / BABA=US / CMPR=US / WK=US / RLMD=US / GDDY=US / ETSY=US / VKTX=US / ARGX=US / NVCR=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / EVBG=US / CRSP=US / PVAC=US / ANAB=US / JELD=US / CVNA=US / VRNA=US / SBOW=US / IOVA=US / SFIX=US / LAZY=US / FTDR=US / SVMK=US / ARVN=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / LHX=US / OVV=US / ONEW=US / CRMD.US / DASH=US / COUR-US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Colgate-Palmolive Co / Amazon.com Inc / Devon Energy Corp / Gilead Sciences Inc / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Exxon Mobil Corp / Whiting Petroleum Corp / Pioneer Natural Resources Co / Heidrick & Struggles International Inc / Southwestern Energy Co / Vroom Inc / Marathon Oil Corp / Expedia Group Inc / Kforce Inc / Manhattan Associates Inc / Newell Brands Inc / Wayfair Inc / DISH Network Corp / Korn Ferry / AMN Healthcare Services Inc / Barnes Group Inc / Biomarin Pharmaceutical Inc / Collegium Pharmaceutical Inc / Exponent Inc / Griffon Corp / Laboratory Corporation of America Holdings / Lendingtree Inc / ManpowerGroup Inc / MarineMax Inc / Mohawk Industries Inc / ASGN Inc / Ultragenyx Pharmaceutical Inc / Robert Half International Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Snap Inc / Thor Industries Inc / Tripadvisor Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Winnebago Industries Inc / Chevron Corp / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Cullen/Frost Bankers Inc / Meta Platforms Inc / Ensign Group Inc / Amerisafe Inc / VICI Properties Inc / MGM Growth Properties LLC / BioDelivery Sciences International Inc / Marinus Pharmaceuticals Inc / Peloton Interactive Inc / PROG Holdings Inc / Biogen Inc / Moog Inc / Aptinyx Inc / NuVasive Inc / Warner Music Group Corp / Atlas Air Worldwide Holdings Inc / Insperity Inc / Catalyst Pharmaceuticals Inc / Employers Holdings Inc / Restaurant Brands International Inc / Continental Resources Inc / Instil Bio Inc / Northern Oil and Gas Inc / Camping World Holdings Inc / Arcus Biosciences Inc / Kinsale Capital Group Inc / Olo Inc / Earthstone Energy Inc / Angi Inc / Diamondback Energy Inc / Abbvie Inc / Gaming and Leisure Properties Inc / Concert Pharmaceuticals Inc / Alphabet Inc / Five9 Inc / Heritage Insurance Holdings Inc / Alibaba Group Holding Ltd / Cimpress PLC / Workiva Inc / Relmada Therapeutics Inc / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / argenx SE / Novocure Ltd / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Everbridge Inc / CRISPR Therapeutics AG / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Carvana Co / Verona Pharma PLC / SilverBow Resources Inc / Iovance Biotherapeutics Inc / Stitch Fix Inc / Lazydays Holdings Inc / Frontdoor Inc / Momentive Global Inc / Arvinas Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / L3harris Technologies Inc / Ovintiv Inc / OneWater Marine Inc / CorMedix Inc / DoorDash Inc / Coursera Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - May 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AEP.N / AES.N / AKER.OL / ALV.N / CL.N / ED.N / EL.N / ENI.MI / F.N / FLS.N / GM.N / KMB.N / KO.N / MRK.N / MSFT.O / NA / PFE.N / REP.MC / SO.N / STO.AX / T.N / TRV.N / VC.N / PEP.N / AVB.N / TRI.N / BFb.N / PG.N / WY.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DT.N / DISH.O / SU.TO / CTXS.O / CLX.N / CAG.N / GIS.N / EMR.N / PCG.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / STZ.N / APH.N / FISV.O / EQT.N / EPD.N / CPT.N / CHTR.O / AXL.N / AWK.N / CHD.N / AME.N / BC.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / MHK.N / SM.N / NCR.N / NET.N / TEL.N / COP.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / LNG.A / SGEN.OQ / GPN.N / PFS.N / MNST.O / EFX.TO / WSBC.O / CASY.O / PCTY.O / FFIV.O / EQIX.O / ATDb.TO / 02209S103 / NVT.N / DLR.N / SCL.TO / 427866108 / MPW.N / RDSb.L / DRX.L / FIS.N / CCOI.O / MWA.N / HOG.N / MERC.O / BGS.N / PPL.TO / TDC.N / ENSG.O / DAN.N / ARX.TO / FTNT.O / SPB.N / NEE.N / LYB.N / TOU.TO / FRU.TO / PCRX.O / MTOR.N / PXT.TO / XYL.N / PSX.N / HTGC.N / FFHu.TO / MDLZ.OQ / APAM.N / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / AGIO.O / PAYC.N / AGRX.O / SHLX.N / QSR.N / EVA.N / PYPL.OQ / AROC.N / SQ.N / WVE.OQ / MIME.OQ / OMF.N / MESO.O / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / JELD.N / VST.N / ATUS.N / AQUA.N / APTV.N / GTES.N / WELL.N / BSIG.N / AMRX.N / VNE.N / KDP.N / AQST.O / CWEN.N / NWL.O / NBSE.OQ / PING.N / DDOG.O / CRNC.OQ / EPAC.N / 2222.SE / REYN.O / NKLA.OQ / FOUR.N / AKES.OL / NRIX.OQ / NAPA.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aker ASA / Autoliv Inc / Colgate-Palmolive Co / Consolidated Edison Inc / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / Flowserve Corp / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Microsoft Corp / National Bank of Canada / Pfizer Inc / Repsol SA / Southern Co / Santos Ltd / AT&T Inc / Travelers Companies Inc / Visteon Corp / PepsiCo Inc / Avalonbay Communities Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Suncor Energy Inc / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Emerson Electric Co / PG&E Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Enterprise Products Partners LP / Camden Property Trust / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / AMETEK Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Mohawk Industries Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / Cheniere Energy Inc / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / Monster Beverage Corp / Enerflex Ltd / WesBanco Inc / Caseys General Stores Inc / Paylocity Holding Corp / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / nVent Electric PLC / Digital Realty Trust Inc / Shawcor Ltd / Hershey Co / Medical Properties Trust Inc / Royal Dutch Shell PLC / Drax Group PLC / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / Mueller Water Products Inc / Harley-Davidson Inc / Mercer International Inc / B&G Foods Inc / Pembina Pipeline Corp / Teradata Corp / Ensign Group Inc / Dana Inc / ARC Resources Ltd / Fortinet Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / LyondellBasell Industries NV / Tourmaline Oil Corp / Freehold Royalties Ltd / Pacira Biosciences Inc / Meritor Inc / Parex Resources Inc / Xylem Inc / Phillips 66 / Hercules Capital Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Artisan Partners Asset Management Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Agios Pharmaceuticals Inc / Paycom Software Inc / Agile Therapeutics Inc / Shell Midstream Partners LP / Restaurant Brands International Inc / Enviva Inc / PayPal Holdings Inc / Archrock Inc / Block Inc / WAVE Life Sciences Ltd / Mimecast Ltd / OneMain Holdings Inc / Mesoblast Ltd / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / JELD-WEN Holding Inc / Vistra Corp / Altice USA Inc / Evoqua Water Technologies Corp / Aptiv PLC / Gates Industrial Corporation PLC / Welltower Inc / Brightsphere Investment Group Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Clearway Energy Inc / Newell Brands Inc / NeuBase Therapeutics Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Aker Solutions ASA / Nurix Therapeutics Inc / Duckhorn Portfolio Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Norway / Saudi Arabia / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">2021 Guggenheim ASCO Preview and Planner – Key Updates Across Our Global Pharma / Biotech Coverage</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : Thoughts As We Wrap Up A Difficult 1Q Earnings Season</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: May 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AES.N / APD.N / BDX.N / CI.N / CL.N / CVS.N / ED.N / EL.N / GM.N / PFE.N / WMB.N / SPG.N / MET.N / DUK.N / IFF.N / EMR.N / WEC.N / LIN.N / AWK.N / VTR.N / COP.N / ATVI.OQ / REGN.OQ / O.N / CHTR.OQ / FIS.N / ZTS.N / MAR.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">AES Corp / Air Products and Chemicals Inc / Becton Dickinson and Co / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Consolidated Edison Inc / Estee Lauder Companies Inc / General Motors Co / Pfizer Inc / Williams Companies Inc / Simon Property Group Inc / MetLife Inc / Duke Energy Corp / International Flavors & Fragrances Inc / Emerson Electric Co / WEC Energy Group Inc / Linde PLC / American Water Works Company Inc / Ventas Inc / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Realty Income Corp / Charter Communications Inc / Fidelity National Information Services Inc / Zoetis Inc / Marriott International Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">05/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Korea Healthcare Sector: Korea Healthcare Monthly Tracker: May 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">000100.KS / 145020.KQ / PFE.N / 008930.KS / 001060.KS / 069620.KS / 003850.KS / 003520.KS / 006280.KS / 000250.KQ / 041960.KQ / 005250.KS / 084990.KQ / 048260.KQ / 086450.KQ / 068270.KS / 086900.KQ / 095700.KQ / 128940.KS / 096530.KQ / 200130.KQ / 196170.KQ / 207940.KS / 091990.KQ / 326030.KS</td><td class="leftalignment">Yuhan Corp / Hugel Inc / Pfizer Inc / Hanmi Science Co Ltd / JW Pharmaceutical Corp / Daewoong Pharma / Boryung Pharm Co Ltd / Yungjin Pharm Co Ltd / Green Cross Corp / Sam Chun Dang Pharm Co Ltd / Komipharm International Co Ltd / Green Cross Holdings / Helixmith Co Ltd / OsstemImplant Co Ltd / Dongkook Pharmaceutical Co Ltd / Celltrion Inc / Medy Tox Inc / Genexine Inc / Hanmi Pharm Co Ltd / Seegene Inc / KolmarBNH Co Ltd / Alteogen Inc / Samsung Biologics Co Ltd / Celltrion Healthcare Co Ltd / SK Biopharmaceuticals Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Korea, Republic of / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Ray Kim / Jeff Jeon</td></tr>
<tr class="even"><td class="leftalignment">05/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / PCRX.O / AGRX.O / AMRX.N / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">05/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Activity Remains Positive - Week 57</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">05/01/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Stephens Inc.</td><td class="leftalignment">1Q21 Wrap: Raise EBITDA & EPS Estimates on Solid 1Q Results & Sequester Benefit</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">B1YWPP8 / PFE</td><td class="leftalignment">Ensign Group Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Scott J. Fidel / Caleb Ezell</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Monthly Update - Pfizer (PFE:$38.65) rises for a second consecutive month, a two-month rise of 15%</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Biotech Monthly Recap and Preview for May</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">PFE=US / GBT=US / RARE=US / VRTX=US / SAGE=US / MRNS=US / APTX=US / CPRX=US / CNCE=US / RLMD=US / VKTX=US / ARGX=US / WVE=US / AXSM=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ANAB=US / VRNA=US / ARVN=US / CRMD.US</td><td class="leftalignment">Pfizer Inc / Global Blood Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Vertex Pharmaceuticals Inc / SAGE Therapeutics Inc / Marinus Pharmaceuticals Inc / Aptinyx Inc / Catalyst Pharmaceuticals Inc / Concert Pharmaceuticals Inc / Relmada Therapeutics Inc / Viking Therapeutics Inc / argenx SE / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / AnaptysBio Inc / Verona Pharma PLC / Arvinas Inc / CorMedix Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Japan / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / ABUS / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 29664W105 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / 81181C104 / 517125100 / G637AM102 / 007002108 / M47364100 / N71542109 / 45168K405 / 76200L309</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Arbutus Biopharma Corp / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Larimar Therapeutics Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 23, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">71708110 / 04635310 / 37555810 / 03116210 / 75886F10 / 09062X10 / 478160104 / 58933Y10 / 00287Y10 / G3910J11 / F5548N10 / 45845P10</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Johnson & Johnson / Merck & Co Inc / Abbvie Inc / GlaxoSmithKline PLC / Sanofi SA / Intercept Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">SVB Leerink Biopharma Team</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">ASGCT abstracts highlights SGMO's gene regulation platform in neurogedenerative diseases</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SGMO=US / PFE=US / BIIB=US</td><td class="leftalignment">Sangamo Therapeutics Inc / Pfizer Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Nicole Germino / Ms. Robyn S. Karnauskas / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 Virtual ASCO Planner</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">45337C10 / 75991610 / 71708110 / 45253H10 / 04635310 / 37555810 / 03116210 / 75886F10 / M2572210 / 45232710 / 30063P10 / 478160104 / 640268108 / 30161Q104 / 64049M20 / 58933Y10 / G0176710 / 53220K50 / 92337F10 / 46185L10 / 00653A107 / 74587V10 / 00287Y10 / 98401F10 / 18946410 / 40131M10 / 58490H10 / 63230710 / 05358830 / 76029N10 / 41358P10 / 09627Y10 / 09075V10 / 09609G10 / 55609910 / N0104510 / 31189P10 / 07725L10 / G3910J11 / 24344T10 / 29428V10 / 81181C10 / 04685N10 / 13089P10 / 22101510 / 34633R10 / K3967W10 / 37242740 / 38341P10 / 43906K10 / 45781K20 / 46565G10 / 48576U10 / 50127T10 / 61776010 / 60468T10 / 03969F10 / 05370A10 / 78116T10 / 76155X10 / F5548N10 / 89620X50 / 98887Q10 / 98943L10 / 98985W10</td><td class="leftalignment">Incyte Corp / Repligen Corp / Pfizer Inc / ImmunoGen Inc / AstraZeneca PLC / Gilead Sciences Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Compugen Ltd / Illumina Inc / Exact Sciences Corp / Johnson & Johnson / Nektar Therapeutics / Exelixis Inc / Neogenomics Inc / Merck & Co Inc / Alkermes Plc / Ligand Pharmaceuticals Inc / Veracyte Inc / Invitae Corp / Adaptimmune Therapeutics PLC / Puma Biotechnology Inc / Abbvie Inc / Xencor Inc / Clovis Oncology Inc / Guardant Health Inc / Medicenna Therapeutics Corp / Natera Inc / Aveo Pharmaceuticals Inc / Replimune Group Inc / Harpoon Therapeutics Inc / Blueprint Medicines Corp / BioNTech SE / bluebird bio Inc / MacroGenics Inc / Affimed NV / Fate Therapeutics Inc / Beigene Ltd / GlaxoSmithKline PLC / Deciphera Pharmaceuticals Inc / Epizyme Inc / Seagen Inc / Athenex Inc / Calithera Biosciences Inc / Corvus Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Genmab A/S / Genocea Biosciences Inc / Gossamer Bio Inc / HOOKIPA Pharma Inc / Innate Pharma SA / Iteos Therapeutics Inc / Karyopharm Therapeutics Inc / Kura Oncology Inc / MorphoSys AG / Mirati Therapeutics Inc / Arcus Biosciences Inc / Avidity Biosciences Inc / Rubius Therapeutics Inc / Revolution Medicines Inc / Sanofi SA / Pfizer Inc / Zai Lab Ltd / Zentalis Pharmaceuticals Inc / Zymeworks Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Jonathan Chang, Ph.D., CFA / Daina Graybosch, Ph.D. / Andrew Berens, M.D. / Geoffrey Porges, MBBS / Mani Foroohar, M.D. / Mr. Puneet Souda</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 30, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">AES.N / BDX.N / CI.N / CL.N / CVS.N / ED.N / EL.N / GM.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / EMR.N / WEC.N / XOM.N / LIN.N / AWK.N / VTR.N / CVX.N / COP.N / ATVI.OQ / REGN.OQ / O.N / AMZN.OQ / CHTR.OQ / CMCSA.OQ / FIS.N / ABBV.N / ZTS.N / PYPL.OQ / TMUS.OQ / BKNG.OQ</td><td class="leftalignment">AES Corp / Becton Dickinson and Co / Cigna Corp / Colgate-Palmolive Co / CVS Health Corp / Consolidated Edison Inc / Estee Lauder Companies Inc / General Motors Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Linde PLC / American Water Works Company Inc / Ventas Inc / Chevron Corp / Conocophillips / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Realty Income Corp / Amazon.com Inc / Charter Communications Inc / Comcast Corp / Fidelity National Information Services Inc / Abbvie Inc / Zoetis Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">SGEN (BUY) - Small 1Q Revenue Miss, But Early Stage Pipeline Starts to Emerge as Key Growth Driver With SEA-CD40 Data Guided for 2H21</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">0989529 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Craig Hallum</td><td class="leftalignment">TRIL: TRIL Differentiates Again With New Complete Responses And NK Activation; Announces New Combinations/Indications on R&D Day.</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">TRIL=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Robin Garner</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">US0453271035 / US2786421030 / US7055731035 / US9022521051 / 34537086 / 878742204 / 655844108 / 09227Q100 / 690742101 / 70959W10 / 404251100 / 483007704 / 918284100 / 89620X506 / 16119P108 / 02156K103</td><td class="leftalignment">Aspen Technology Inc / eBay Inc / Pegasystems Inc / Tyler Technologies Inc / Ford Motor Co / Teck Resources Ltd / Norfolk Southern Corp / Blackbaud Inc / Owens Corning / Penske Automotive Group Inc / HNI Corp / Kaiser Aluminum Corp / VSE Corp / Pfizer Inc / Charter Communications Inc / Altice USA Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Matthew Harrigan / Mr. Nathan Martin / Mr. Daniel L. Kurnos, CFA / Mr. Mark W. Schappel / Mr. Reuben Garner / Mr. Bill Sutherland / Mr. Michael P. Ward, CFA / Mike Hickey / Mr. Josh W. Sullivan / Mr. Aydin Huseynov, MD</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">R&D Day Was Colorful; Market Still Wants Shortcuts</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">R&D Day Highlights Substantial Monotherapy Data and Path Forward in Combo</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Bloom Burton & Co.</td><td class="leftalignment">Trillium Therapeutics Inc. (NASDAQ-TRIL; US$8.52, TSX-TRIL; C$10.52). R&D Day: More Monotx Responses – Wait Begins for Combo Results.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">TRIL=US / TRIL=CA</td><td class="leftalignment">Pfizer Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / RATINGS CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David Martin, PHD</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">DE0006969603 / US0378331005 / US0382221051 / US0463531089 / US0530151036 / US0970231058 / US1011371077 / US1101221083 / US2254471012 / US2786421030 / US30226D1063 / US3695501086 / US4364401012 / US4824801009 / US5128071082 / US5951121038 / US66987V1098 / US7170811035 / US7475251036 / US7711951043 / US7766961061 / US8168501018 / US8269191024 / US9021041085 / US91347P1057 / US9507551086 / US9581021055 / CA1363751027 / US89151E1091 / CA13645T1003 / US9884981013 / US83088M1027 / US88031M1099 / US3463751087 / US90385V1070 / FI0009013296 / US19239V3024 / RDSa.AS / US9043111072 / US82706C1080 / US78709Y1055 / US1717793095 / US48242W1062 / NL0000687663 / US64110D1046 / US2120151012 / US58933Y1055 / US13100M5094 / IE00B58JVZ52 / US30303M1027 / US75972A3014 / NL0010273215 / US81762P1021 / US5764852050 / US23283R1005 / US03674X1063 / CA89620X5064 / US74736K1016 / US29444U7000 / US87918A1051 / US74624M1027 / US00773U1088 / US90138F1021 / US64104Y1064 / KYG4740B1059 / US02156K1034 / US03753U1060 / US05351X1019 / US05352A1007 / US88339P1012 / US69047Q1022 / US92537N1081 / US15872M1045 / US03044L1052 / US5738741041</td><td class="leftalignment">Puma SE / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boeing Co / Boston Scientific Corp / Bristol-Myers Squibb Co / Wolfspeed Inc / eBay Inc / Extreme Networks Inc / General Dynamics Corp / Hologic Inc / KLA Corp / Lam Research Corp / Micron Technology Inc / Novartis AG / Pfizer Inc / Qualcomm Inc / Roche Holding AG / Roper Technologies Inc / Semtech Corp / Silicon Laboratories Inc / II-VI Inc / Universal Display Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / TotalEnergies SE / Canadian Pacific Railway Ltd / Yum! Brands Inc / Skyworks Solutions Inc / Tenaris SA / FormFactor Inc / Ultra Clean Holdings Inc / Neste Oyj / Cogent Communications Holdings Inc / Royal Dutch Shell PLC / Under Armour Inc / Silicon Motion Technology Corp / Saia Inc / Ciena Corp / KBR Inc / AerCap Holdings NV / NetApp Inc / Continental Resources Inc / Merck & Co Inc / Calix Inc / Seagate Technology Holdings PLC / Meta Platforms Inc / Renewable Energy Group Inc / ASML Holding NV / ServiceNow Inc / Matador Resources Co / CyrusOne Inc / Antero Resources Corp / Pfizer Inc / Qorvo Inc / Equinix Inc / Teladoc Health Inc / Pure Storage Inc / Adverum Biotechnologies Inc / Twilio Inc / Neste Oyj / Ichor Holdings Ltd / Altice USA Inc / Apellis Pharmaceuticals Inc / Avaya Holdings Corp / Avantor Inc / RealReal Inc / Ovintiv Inc / Vertiv Holdings Co / ChampionX Corp / American Well Corp / Marvell Technology Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Finland / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BSX=US / PFE=US / AMGN=US / ICLR=US / PLD=US / AVB=US / EBAY=US / TEVA=US / PEB=US / H=US / CONE=US / V=US / MTN=US / IART=US / PB=US / BYD=US / MAR=US / SPOT=US / EXPE=US / TTWO=US / TTMI=US / TNL=US / ATVI=US / MGM=US / HLT=US / AKR=US / CI=US / ARCC=US / AMED=US / APH=US / AVT=US / CHH=US / CYH=US / DRH=US / EQIX=US / EEFT=US / NOW=US / MAIN=US / MAS=US / MCRI=US / ASGN=US / ORCC=US / PDM=US / VSEC=US / VRTX=US / PSA=US / R=US / FB=US / MKL=US / MAA=US / SSB=US / WRE=US / DRE=US / BCO=US / MOH=US / AINV=US / EXR=US / SHO=US / RNST=US / SCPL=US / CCOI=US / HST=US / MA=US / SIX=US / SAIA=US / WU=US / PAG=US / OC=US / CLR=US / PNNT=US / EHC=US / WH=US / 45665G303 / AR=US / HGV=US / RLJ=US / VAC=US / ZNGA=US / EA=US / MTDR=US / ENPH=US / RHP=US / TSLX=US / 70806A106 / GSBD=US / VKTX=US / WING=US / TDOC=US / CABO=US / VVV=US / CRSP=US / TRVG=US / PK=US / PLYA=US / HWC=US / FSK=US / OVV=US / FSKR=US / RBLX=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Amgen Inc / ICON PLC / Prologis Inc / Avalonbay Communities Inc / eBay Inc / Teva Pharmaceutical Industries Ltd / Pebblebrook Hotel Trust / Hyatt Hotels Corp / CyrusOne Inc / Visa Inc / Vail Resorts Inc / Integra Lifesciences Holdings Corp / Prosperity Bancshares Inc / Boyd Gaming Corp / Marriott International Inc / Spotify Technology SA / Expedia Group Inc / Take-Two Interactive Software Inc / TTM Technologies Inc / Travel + Leisure Co / Activision Blizzard Inc / MGM Resorts International / Hilton Worldwide Holdings Inc / Acadia Realty Trust / Cigna Corp / Ares Capital Corp / Amedisys Inc / Amphenol Corp / Avnet Inc / Choice Hotels International Inc / Community Health Systems Inc / Diamondrock Hospitality Co / Equinix Inc / Euronet Worldwide Inc / ServiceNow Inc / Main Street Capital Corp / Masco Corp / Monarch Casino & Resort Inc / ASGN Inc / Owl Rock Capital Corp / Piedmont Office Realty Trust Inc / VSE Corp / Vertex Pharmaceuticals Inc / Public Storage / Ryder System Inc / Meta Platforms Inc / Markel Corp / Mid-America Apartment Communities Inc / SouthState Corp / Washington Real Estate Investment Trust / Duke Realty Corp / Brinks Co / Molina Healthcare Inc / Apollo Investment Corp / Extra Space Storage Inc / Sunstone Hotel Investors Inc / Renasant Corp / Sciplay Corp / Cogent Communications Holdings Inc / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / Saia Inc / Western Union Co / Penske Automotive Group Inc / Owens Corning / Continental Resources Inc / Pennantpark Investment Corp / Encompass Health Corp / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Antero Resources Corp / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Zynga Inc / Electronic Arts Inc / Matador Resources Co / Enphase Energy Inc / Ryman Hospitality Properties Inc / Sixth Street Specialty Lending Inc / PennantPark Floating Rate Capital Ltd / Goldman Sachs BDC Inc / Viking Therapeutics Inc / Wingstop Inc / Teladoc Health Inc / Cable One Inc / Valvoline Inc / CRISPR Therapeutics AG / Trivago NV / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Hancock Whitney Corp / FS KKR Capital Corp / Ovintiv Inc / FS KKR Capital Corp / Roblox Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Ireland / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">ASCO 2021: Key Abstract Titles And What To Watch For</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US0463531089 / US1101221083 / US66987V1098 / US7170811035 / US7711951043 / US58933Y1055</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Novartis AG / Pfizer Inc / Roche Holding AG / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Ladenburg Thalmann & Co. Inc.</td><td class="leftalignment">R&D Day Takeaway: Consistent Mono Efficacy + 9 Ph1b/2 Trials w/ Lead in Several</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wangzhi Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">V / 5671735 / 0925288 / 2434209 / 2293819 / 2486813 / 2113434 / 2219224 / 2115902 / 2280220 / 2270726 / 2829515 / 2317087 / 2670519 / 2328915 / 2342034 / 2689560 / 2684703 / 2048804 / 2707677 / 2730190 / 2440637 / 2883878 / 2943523 / 2503529 / B125XQ6 / B02R1L6 / B3D7K31 / 2679204 / B5B2106 / B65LWX6 / B7TL820 / B7VD3F2 / B83YYY6 / B95N910 / BDZCRX3 / BYW36M8 / BZ19F50 / BXDZ9Z0 / BF5L3T2 / BJLT387 / BD8DJ71 / BJFSR88 / BJ2Z0H2 / BFZ1K46 / BMYML02 / BKTNTR9 / BFWK4R7 / BZ1LFG7 / BYY88Y7 / BMVWYW8 / BYQRFY1 / BLBLMD5</td><td class="leftalignment">Visa Inc / Sanofi SA / GlaxoSmithKline PLC / Home Depot Inc / eBay Inc / Kellogg Co / Boston Scientific Corp / CMS Energy Corp / OPKO Health Inc / DTE Energy Co / Walt Disney Co / Edison International / Entergy Corp / Exelon Corp / Nextera Energy Inc / Fiserv Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Public Service Enterprise Group Inc / Regeneron Pharmaceuticals Inc / CenterPoint Energy Inc / Teva Pharmaceutical Industries Ltd / Penske Automotive Group Inc / World Wrestling Entertainment Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Align Technology Inc / Fortinet Inc / O'Reilly Automotive Inc / Meta Platforms Inc / Duke Energy Corp / ICAD Inc / PTC Inc / RingCentral Inc / PayPal Holdings Inc / Veoneer Inc / Shopify Inc / Elanco Animal Health Inc / Avantor Inc / Snap Inc / Uniqure NV / Pinterest Inc / Spotify Technology SA / DraftKings Inc / ViacomCBS Inc / PagSeguro Digital Ltd / Roku Inc / Alphabet Inc / Protara Therapeutics Inc / Teladoc Health Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Multiple Shots on Goal for TTI-622 and TTI-621; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee / Sean Kang</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Broad Development Program Highlighted, 2022 To Be Data Rich Year</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BDX.N / CL.N / CVS.N / EL.N / GM.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / YUM.N / EMR.N / WEC.N / XOM.N / LIN.N / AWK.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / REGN.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / CMCSA.OQ / FIS.N / ABBV.N / ZTS.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / FB.PS</td><td class="leftalignment">Boeing Co / Becton Dickinson and Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / General Motors Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Yum! Brands Inc / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Linde PLC / American Water Works Company Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Regeneron Pharmaceuticals Inc / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Comcast Corp / Fidelity National Information Services Inc / Abbvie Inc / Zoetis Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Stronger-than-expected business recovery in 1Q21; mRNA vaccine to be approved by June/July; TP to HK$52. Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2196.HK / 600196.SS / PFE.N</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Earnings Beat In Cards For Merck's Q1?</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">1Q21 results; AMGN facing competitive foes; maintain Hold</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN=US / PFE=US</td><td class="leftalignment">Amgen Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Robyn S. Karnauskas / Ms. Nicole Germino / Ms. Srikripa Devarakonda, PHD</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Getting Pumped About Cardiovascular Drugs</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">PFE.N / MRK.N / JNJ.N / LLY.N / AMRN.OQ / MSB.AX</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc / Johnson & Johnson / Eli Lilly and Co / Amarin Corporation PLC / Mesoblast Ltd</td><td class="leftalignment"></td><td class="leftalignment">Australia / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Peer Group Analytics - Q4 FY2020</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">TRIL.TO - Event Transcript of Trillium Therapeutics Inc conference call, Apr. 28, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biopharma: Our Top 15 Most Interesting/Surprising Takeaways From RBC's Doctor Days</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / GILD.O / BMRN.O / REGN.O / BLU.N / SGEN.OQ / BCRX.O / ALNY.O / ARWR.O / ABBV.N / ADVM.OQ / PRVB.O / KRTX.OQ / ETNB.O / SPRB.OQ</td><td class="leftalignment">Pfizer Inc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / BELLUS Health Inc / Seagen Inc / BioCryst Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Arrowhead Pharmaceuticals Inc / Abbvie Inc / Adverum Biotechnologies Inc / Provention Bio Inc / Karuna Therapeutics Inc / 89Bio Inc / Spruce Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Brian Abrahams, MD / Steve Daddeo / Michael Murray / Kennen MacKay, PHD / Mr. Gregory J. Renza, MD / Mr. Luca Issi, PHD / Daniel Busby / Leonid Timashev / David Szeto / Yinglu Zhang / Lisa Walter</td></tr>
<tr class="odd"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BA.N / CL.N / CVS.N / EL.N / GM.N / LLY.N / MRK.N / PFE.N / TMO.N / WMB.N / MET.N / MCD.N / EMR.N / WEC.N / XOM.N / V.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / NOW.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / FB.PS</td><td class="leftalignment">Boeing Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / General Motors Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / MetLife Inc / McDonald's Corp / Emerson Electric Co / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / ServiceNow Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / San Miguel Food and Beverage Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">04/28/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">Valens Equity Insights and Inflections - 2021 04 27</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">LGIH.OQ / XOM.N / MRK.N / PFE.N / CLX.N / HIW.N / DK.N / ENR.N / CSCO.OQ / QCOM.OQ / SHOO.OQ / LYV.N / SIX.N / VAC.N / LDOS.N / PUMP.N / PEP.OQ / GO.OQ / PTON.OQ / MSGS.N / ABNB.OQ</td><td class="leftalignment">LGI Homes Inc / Exxon Mobil Corp / Merck & Co Inc / Pfizer Inc / Clorox Co / Highwoods Properties Inc / Delek US Holdings Inc / Energizer Holdings Inc / Cisco Systems Inc / Qualcomm Inc / Steven Madden Ltd / Live Nation Entertainment Inc / Six Flags Entertainment Corp / Marriott Vacations Worldwide Corp / Leidos Holdings Inc / ProPetro Holding Corp / PepsiCo Inc / Grocery Outlet Holding Corp / Peloton Interactive Inc / Madison Square Garden Sports Corp / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Apparel & Textiles / Beverages & Tobacco / Building & Building Materials / Household Products / Leisure & Entertainment / Lodging & Restaurants / Media / Pharmaceuticals / Real Estate / Semiconductors / Technology / Telecommunications / Oil & Gas</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / AMRN / EBS / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / HCM.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Amarin Corporation PLC / Emergent BioSolutions Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / HUTCHMED (China) Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">MRK=US / LLY=US / PEP=US / PFE=US / AMGN=US / BMY=US / DIS=US / HD=US / KO=US / MCD=US / OXY=US / TWTR=US / RRC=US / CL=US / WEN=US / PLD=US / AMZN=US / BLD=US / DVN=US / INCY=US / KMI=US / APA=US / CPE=US / EOG=US / DGX=US / REI=US / XOM=US / CRK=US / LOW=US / WLL=US / CHKP=US / PXD=US / ENR=US / HSII=US / MGY=US / SWN=US / MUR=US / BRO=US / BYD=US / MRO=US / LEG=US / HCA=US / VMC=US / MGM=US / PENN=US / NWL=US / MLM=US / FLO=US / KFY=US / ARCC=US / CBRL=US / CENT=US / CHD=US / CNX=US / DRI=US / EPC=US / EQT=US / GFF=US / HAIN=US / IBP=US / SAFE=US / TREE=US / MAIN=US / MAS=US / MEDP=US / MHK=US / MCRI=US / ORCC=US / PACW=US / REGN=US / REGI=US / SBAC=US / SMG=US / SSNC=US / SNAP=US / VRTX=US / CVX=US / POST=US / BXS=US / BKNG=US / FBK=US / FR=US / FFIN=US / COP=US / VICI=US / DIN=US / MGP=US / MGPI=US / MNST=US / RRR=US / NOMD=US / TPX=US / FNB=US / EXP=US / CZR=US / NUVA=US / AINV=US / BECN=US / PLAY=US / FRPT=US / DENN=US / THS=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / ELF=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / NOG=US / JACK=US / AAN=US / TREX=US / AR=US / NXPI=US / ESTE=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / NDLS=US / GLPI=US / TSLX=US / 00770K202 / VNOM=US / 70806A106 / LOCO=US / ANTM=US / SHAK=US / AJRD=US / GSBD=US / WING=US / ARGX=US / 82982L103 / CDEV=US / PVAC=US / JELD=US / SBOW=US / PETQ=US / ROKU=US / CARG=US / COLD=US / EOLS=US / KDP=US / OZK=US / FSK=US / LYFT=US / RTLR=US / FERG=US / BRBR=US / OVV=US / ARQT=US / REYN=US / DKNG=US / FSKR=US / AZEK=US / BALY=US / HYFM=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Home Depot Inc / Coca-Cola Co / McDonald's Corp / Occidental Petroleum Corp / Twitter Inc / Range Resources Corp / Colgate-Palmolive Co / Wendys Co / Prologis Inc / Amazon.com Inc / TopBuild Corp / Devon Energy Corp / Incyte Corp / Kinder Morgan Inc / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Quest Diagnostics Inc / Ring Energy Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Pioneer Natural Resources Co / Energizer Holdings Inc / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Brown & Brown Inc / Boyd Gaming Corp / Marathon Oil Corp / Leggett & Platt Inc / HCA Healthcare Inc / Vulcan Materials Co / MGM Resorts International / Penn National Gaming Inc / Newell Brands Inc / Martin Marietta Materials Inc / Flowers Foods Inc / Korn Ferry / Ares Capital Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Church & Dwight Co Inc / CNX Resources Corp / Darden Restaurants Inc / Edgewell Personal Care Co / EQT Corp / Griffon Corp / Hain Celestial Group Inc / Installed Building Products Inc / Safehold Inc / Lendingtree Inc / Main Street Capital Corp / Masco Corp / Medpace Holdings Inc / Mohawk Industries Inc / Monarch Casino & Resort Inc / Owl Rock Capital Corp / PacWest Bancorp / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / Scotts Miracle-Gro Co / SS&C Technologies Holdings Inc / Snap Inc / Vertex Pharmaceuticals Inc / Chevron Corp / Post Holdings Inc / Cadence Bank / Booking Holdings Inc / FB Financial Corp / First Industrial Realty Trust Inc / First Financial Bankshares Inc / Conocophillips / VICI Properties Inc / Dine Brands Global Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Monster Beverage Corp / Red Rock Resorts Inc / Nomad Foods Ltd / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / Caesars Entertainment Inc / NuVasive Inc / Apollo Investment Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Freshpet Inc / Denny's Corp / TreeHouse Foods Inc / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / elf Beauty Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / Northern Oil and Gas Inc / Jack in the Box Inc / Aaron's Company Inc / Trex Company Inc / Antero Resources Corp / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / Noodles & Co / Gaming and Leisure Properties Inc / Sixth Street Specialty Lending Inc / Aemetis Inc / Viper Energy Partners LP / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Anthem Inc / Shake Shack Inc / Aerojet Rocketdyne Holdings Inc / Goldman Sachs BDC Inc / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / PetIQ Inc / Roku Inc / CarGurus Inc / Americold Realty Trust / Evolus Inc / Keurig Dr Pepper Inc / Bank Ozk / FS KKR Capital Corp / Lyft Inc / Rattler Midstream LP / Ferguson PLC / Bellring Brands Inc / Ovintiv Inc / Arcutis Biotherapeutics Inc / Reynolds Consumer Products Inc / DraftKings Inc / FS KKR Capital Corp / Azek Company Inc / Bally's Corp / Hydrofarm Holdings Group Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Luxembourg / Netherlands / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Pfizer Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2434209 / 2126335 / 2516152 / 2778844 / 2219224 / 2270726 / 2542049 / 2317087 / 2328915 / 2100920 / 2613990 / 2630513 / 2689560 / 2684703 / 2440637 / 2825933 / 2829601 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / BH65L93 / BYVY8G0 / BJFSR88 / BNFWR44 / BYZR4X4 / BFZ1K46 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BJ9NFQ3 / BYNQ369 / BMH0MR7 / BQXZP64 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / CMS Energy Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Illumina Inc / New Jersey Resources Corp / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / South Jersey Industries Inc / Southern Co / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Seacoast Banking Corporation of Florida / Alphabet Inc / Uniqure NV / Worldline SA / Axsome Therapeutics Inc / Spotify Technology SA / Fox Corp / Vistra Corp / ViacomCBS Inc / Neoleukin Therapeutics Inc / Albertsons Companies Inc / Zendesk Inc / Wayfair Inc / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 1Q21 Preview</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">SASY.PA / PFE.N / REGN.OQ</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Dominic Lunn / Mr. Trung Huynh / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: April 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BA.N / CL.N / CVS.N / EL.N / LLY.N / MRK.N / PFE.N / TMO.N / WMB.N / MCD.N / WEC.N / XOM.N / V.N / CVX.N / COP.N / AAPL.OQ / ATVI.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / SBAC.OQ / CHTR.OQ / TXN.OQ / CMCSA.OQ / CDNS.OQ / TSLA.OQ / NXPI.OQ / NOW.N / ABBV.N / GOOGL.OQ / TMUS.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Boeing Co / Colgate-Palmolive Co / CVS Health Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Williams Companies Inc / McDonald's Corp / WEC Energy Group Inc / Exxon Mobil Corp / Visa Inc / Chevron Corp / Conocophillips / Apple Inc / Activision Blizzard Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / SBA Communications Corp / Charter Communications Inc / Texas Instruments Inc / Comcast Corp / Cadence Design Systems Inc / Tesla Inc / NXP Semiconductors NV / ServiceNow Inc / Abbvie Inc / Alphabet Inc / T-Mobile US Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Apr 16, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer increases 6.2% in 2021, tracking Pharmaceuticals sector; quarterly dividends steady</td><td class="leftalignment">English</td><td class="rightalignment">63</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000054470 / US00971T1016 / US0116591092 / US0311621009 / US0378331005 / US0463531089 / US0718131099 / US1101221083 / US1266501006 / US2855121099 / US37733W1053 / US45337C1027 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / AN8068571086 / US8308791024 / US8447411088 / US8636671013 / US8740541094 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US2538681030 / US0491642056 / PAP310761054 / NL0000687663 / US01748X1028 / US2473617023 / US53261M1045 / US00922R1059 / US00507V1098 / US58933Y1055 / US9100471096 / US98986T1088 / US00287Y1091 / US00912X3026 / US23283R1005 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US29444U7000 / US20717E1010 / US36165L1089 / US87105L1044 / US8760301072 / US19626G1085 / US5904791358 / CH0499880968 / US22041X1028 / US72815L1070 / US35909R1086</td><td class="leftalignment">Ubisoft Entertainment SA / Akamai Technologies Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / AstraZeneca PLC / Baxter International Inc / Bristol-Myers Squibb Co / CVS Health Corp / Electronic Arts Inc / GlaxoSmithKline PLC / Incyte Corp / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Schlumberger NV / SkyWest Inc / Southwest Airlines Co / Stryker Corp / Take-Two Interactive Software Inc / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Digital Realty Trust Inc / Atlas Air Worldwide Holdings Inc / Copa Holdings SA / AerCap Holdings NV / Allegiant Travel Co / Delta Air Lines Inc / Limelight Networks Inc / Air Transport Services Group Inc / Activision Blizzard Inc / Merck & Co Inc / United Airlines Holdings Inc / Zynga Inc / Abbvie Inc / Air Lease Corp / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Equinix Inc / Conformis Inc / GDS Holdings Ltd / Switch Inc / Tapestry Inc / DigitalBridge Group Inc / Mesa Air Group Inc / ADC Therapeutics SA / Corsair Gaming Inc / Playtika Holding Corp / Frontier Group Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/26/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0013.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/25/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 1Q Earnings Season : What to Watch for the Week Ahead (LLY, BMY, MRK, ABBV)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ABBV.N / BMY.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">04/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Maintain Momentum - Week 56</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/24/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">R&D Day This Week- Quick Preview</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">04/24/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Recommends JNJ Vax Again, CDC and FDA Provide Cautions but No Restrictions</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / 71708110 / 04635310 / 478160104 / 09075V10 / 60770K10</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE / Moderna Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Danielle J. Antalffy / Geoffrey Porges, MBBS / Daina Graybosch, Ph.D. / Mani Foroohar, M.D. / Andrew Berens, M.D. / Rebecca Wang, CFA / Na Sun</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45337C10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 088786108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / 81181C104 / 517125100 / G637AM102 / 007002108 / M47364100 / N71542109 / 45168K405 / 76200L309</td><td class="leftalignment">Incyte Corp / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Bicycle Therapeutics PLC / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Larimar Therapeutics Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Pfizer Covid-19 Vaccine Updates: Booster Shots, E.U. Supplies</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">What's Next in Biotech - Targeted Degradation Meets Synthetic Lethality? AMBRA1 as a Novel & Potentially Actionable Biomarker in Cancer Therapy</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0989529 / 0925288 / 2516152 / 2576941 / 2684703 / 7103065 / BK0VHF6 / BMQ5T49 / BWY52P3</td><td class="leftalignment">AstraZeneca PLC / GlaxoSmithKline PLC / Eli Lilly and Co / Exelixis Inc / Pfizer Inc / Novartis AG / IDEAYA Biosciences Inc / Zentalis Pharmaceuticals Inc / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Mr. Etzer Darout / Yige Guo, Ph.D. / Kelsey Goodwin / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / LLY=US / PFE=US / BMY=US / INTC=US / AMD=US / RRC=US / EFX=US / AMZN=US / T=US / GL=US / NVDA=US / DGX=US / TRU=US / MTN=US / VZ=US / CCI=US / VRM=US / EWBC=US / BRO=US / EXPE=US / LSTR=US / HCA=US / CVS=US / UNH=US / AVGO=US / AJG=US / SAFE=US / HZO=US / MAT=US / RARE=US / SNAP=US / TRIP=US / WIX=US / BXS=US / BKNG=US / FAF=US / FB=US / MKL=US / PTON=US / JRVR=US / BIIB=US / NUVA=US / KAR=US / CADE=US / EIG=US / KNSL=US / AR=US / ANGI=US / TMUS=US / GOOGL=US / ASMB=US / BABA=US / CMPR=US / ANTM=US / GDDY=US / LOB=US / WLTW=US / ANAB=US / CVNA=US / SFIX=US / FTDR=US / SVMK=US / SITC=US / LYFT=US / UBER=US / PLMR=US</td><td class="leftalignment">CACI International Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Range Resources Corp / Equifax Inc / Amazon.com Inc / AT&T Inc / Globe Life Inc / NVIDIA Corp / Quest Diagnostics Inc / TransUnion / Vail Resorts Inc / Verizon Communications Inc / Crown Castle International Corp / Vroom Inc / East West Bancorp Inc / Brown & Brown Inc / Expedia Group Inc / Landstar System Inc / HCA Healthcare Inc / CVS Health Corp / UnitedHealth Group Inc / Broadcom Inc / Arthur J Gallagher & Co / Safehold Inc / MarineMax Inc / Mattel Inc / Ultragenyx Pharmaceutical Inc / Snap Inc / Tripadvisor Inc / Wix.Com Ltd / Cadence Bank / Booking Holdings Inc / First American Financial Corp / Meta Platforms Inc / Markel Corp / Peloton Interactive Inc / James River Group Holdings Ltd / Biogen Inc / NuVasive Inc / KAR Auction Services Inc / Cadence Bank / Employers Holdings Inc / Kinsale Capital Group Inc / Antero Resources Corp / Angi Inc / T-Mobile US Inc / Alphabet Inc / Assembly Biosciences Inc / Alibaba Group Holding Ltd / Cimpress PLC / Anthem Inc / GoDaddy Inc / Live Oak Bancshares Inc / Willis Towers Watson PLC / AnaptysBio Inc / Carvana Co / Stitch Fix Inc / Frontdoor Inc / Momentive Global Inc / Site Centers Corp / Lyft Inc / Uber Technologies Inc / Palomar Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 0989529 / 0925288 / 2000019 / 2050832 / 2026242 / 2113393 / 2219224 / 2270726 / 2317087 / 2576941 / 2670519 / 2367480 / 2455965 / 2459020 / 2645409 / 2689560 / 2680905 / 2684703 / 2440637 / 2138158 / 2900335 / 2928683 / 2503529 / 7103065 / 7123870 / B121557 / 2769796 / 2857817 / B125XQ6 / B02R1L6 / B03PGL4 / B6RS2B3 / B7VD3F2 / BDZCRX3 / BK0VHF6 / BD8DJ71 / BNFWR44 / BMQ5T49 / BFZ1K46 / BFMXGR0 / BG31GH0 / BGSP7M9 / BZ1LFG7 / BWY52P3 / BKS3RS7 / BDRW1L7 / BLBLMD5 / BMZ9Z11</td><td class="leftalignment">Visa Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Amazon.com Inc / Ameren Corp / American Electric Power Company Inc / Boston Beer Company Inc / CMS Energy Corp / Walt Disney Co / Entergy Corp / Exelixis Inc / Exelon Corp / Genuine Parts Co / Biogen Inc / Intuit Inc / NiSource Inc / PG&E Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Sempra Energy / Tractor Supply Co / VF Corp / World Wrestling Entertainment Inc / Novartis AG / Nestle SA / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / Portland General Electric Co / ALLETE Inc / NorthWestern Corp / Clovis Oncology Inc / Duke Energy Corp / RingCentral Inc / IDEAYA Biosciences Inc / Snap Inc / Worldline SA / Zentalis Pharmaceuticals Inc / Spotify Technology SA / Evergy Inc / Y-mAbs Therapeutics Inc / Zoom Video Communications Inc / Roku Inc / Blueprint Medicines Corp / 10X Genomics Inc / AnaptysBio Inc / Array Technologies Inc / Prometheus Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">The Long and the Short of it: Developments Down Under - Climate Change, Climate Leaders, New targets, Coal</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AGL.AX / BHP.AX / C.N / JPM.N / PFE.N / RIO.AX / RIO.L / STO.AX / TOTF.PA / WPL.AX / ILU.AX / NKE.N / ORG.AX / STT.N / BLK.N / CVX.N / BPT.AX / AMZN.OQ / NHC.AX / FMG.AX / COE.AX / NESN.S / 2331.HK / MSB.AX / WHC.AX / ORE.AX / MRNA.OQ / BHPB.L / TSLA.OQ / ADSGN.F / AZJ.AX / GOOGL.OQ / S32.AX / UBSG.S / SRENH.S / NCZ.AX</td><td class="leftalignment">AGL Energy Ltd / BHP Group Ltd / Citigroup Inc / JPMorgan Chase & Co / Pfizer Inc / Rio Tinto Ltd / Rio Tinto PLC / Santos Ltd / TotalEnergies SE / Woodside Petroleum Ltd / Iluka Resources Ltd / Nike Inc / Origin Energy Ltd / State Street Corp / BlackRock Inc / Chevron Corp / Beach Energy Ltd / Amazon.com Inc / New Hope Corporation Ltd / Fortescue Metals Group Ltd / Cooper Energy Ltd / Nestle SA / Li Ning Co Ltd / Mesoblast Ltd / Whitehaven Coal Ltd / Allkem Ltd / Moderna Inc / BHP Group PLC / Tesla Inc / Adidas AG / Aurizon Holdings Ltd / Alphabet Inc / South32 Ltd / UBS Group AG / Swiss Re AG / New Century Resources Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Cayman Islands / Germany / France / United Kingdom / Papua New Guinea / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity / Environmental, Social, Governance</td><td class="leftalignment">Phineas Glover / Alfred Chang</td></tr>
<tr class="even"><td class="leftalignment">04/23/2021</td><td class="leftalignment">Valens Research</td><td class="leftalignment">PFE - Embedded Expectations Analysis - 2021 04 22</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">CAPITALIZATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Valens Research</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Key takes from our Expert call on BMY’s LAG-3 inhibitor relatlimab</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY=US / LLY=US / PFE=US</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">S3 Partners</td><td class="leftalignment">S3 Analytics: Biotech - Pharma Short Selling Recap</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / GSK.L / AMGN.OQ / CVM.A / CHRS.OQ / REGN.OQ / GILD.OQ / NVAX.OQ / UTHR.OQ / BMRN.OQ / ESPR.OQ / EXAS.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / MNKD.OQ / RPRX.OQ / JAZZ.OQ / INO.OQ / MRNA.OQ / OMER.OQ / CYDY.PK / ABBV.N / ZTS.N / SRNE.OQ / HRTX.OQ / NVTA.N / IONS.OQ / EDIT.OQ / MDGL.OQ / KALA.OQ / VXRT.OQ / TLRY.OQ / 6160.HK / IGMS.OQ / OCGN.OQ / BEAM.OQ / PGEN.OQ / NRIX.OQ / 22UAy.DE / IBRX.OQ</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / CEL-SCI Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Novavax Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / Exact Sciences Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / MannKind Corp / Royalty Pharma PLC / Jazz Pharmaceuticals PLC / Inovio Pharmaceuticals Inc / Moderna Inc / Omeros Corp / Cytodyn Inc / Abbvie Inc / Zoetis Inc / Sorrento Therapeutics Inc / Heron Therapeutics Inc / Invitae Corp / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / Kala Pharmaceuticals Inc / Vaxart Inc / Tilray Brands Inc / Beigene Ltd / IGM Biosciences Inc / Ocugen Inc / Beam Therapeutics Inc / Precigen Inc / Nurix Therapeutics Inc / BioNTech SE / Immunitybio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Ihor Dusaniwsky</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Apr. 22, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">BE0165385973 / FR0000077919 / US0997241064 / US1271903049 / US22284P1057 / US2944291051 / US4062161017 / US5128071082 / US5719032022 / US68389X1054 / US9029251066 / US9113121068 / US92343V1044 / NL0000200384 / CA13645T1003 / US37940X1028 / US2948216088 / US64111Q1040 / US31620M1062 / US1696561059 / US29089Q1058 / US88076W1036 / CA9609083097 / CA0585861085 / CH0102993182 / US5218652049 / US4485791028 / US88160R1014 / US92839U2069 / JE00B783TY65 / US30212P3038 / US8969452015 / US9837931008 / US96208T1043 / NL0010273215 / LU0914713705 / US72919P2020 / US38046C1099 / US8485771021 / CA89620X5064 / US0367521038 / US98138J2069 / US45782B1044 / US89686D1054 / CA87241L1094 / US43300A2033 / US23753F1075 / US04016X1019 / US05722G1004 / US4990491049 / US1010441053 / VGG273581030 / US05351X1019 / US09857L1089 / US92336X1090 / US68373M1071 / US18453H1068 / US1567271093 / US89677Q1076 / US23725P2092 / US4833791035 / US92537N1081 / US6541101050 / US33813J1060 / US0090661010 / US11778X1046 / LU2314763264</td><td class="leftalignment">Melexis NV / JCDecaux SA / Borgwarner Inc / CACI International Inc / Covenant Logistics Group Inc / Equifax Inc / Halliburton Co / Lam Research Corp / Marriott International Inc / Oracle Corp / USA Truck Inc / United Parcel Service Inc / Verizon Communications Inc / Core Laboratories NV / Canadian Pacific Railway Ltd / Global Payments Inc / Telefonaktiebolaget LM Ericsson / NETGEAR Inc / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Emergent BioSolutions Inc / Teradata Corp / Westport Fuel Systems Inc / Ballard Power Systems Inc / TE Connectivity Ltd / Lear Corp / Hyatt Hotels Corp / Tesla Inc / Visteon Corp / Aptiv PLC / Expedia Group Inc / Tripadvisor Inc / XPO Logistics Inc / WEX Inc / ASML Holding NV / Intelsat SA / Plug Power Inc / Gogo Inc / Spirit Airlines Inc / Pfizer Inc / Anthem Inc / Workhorse Group Inc / Inseego Corp / Trivago NV / TFI International Inc / Hilton Worldwide Holdings Inc / Daseke Inc / argenx SE / Baker Hughes Co / Knight-Swift Transportation Holdings Inc / Boston Omaha Corp / Despegar.com Corp / Avaya Holdings Corp / Booking Holdings Inc / Veoneer Inc / Opera Ltd / Clear Channel Outdoor Holdings Inc / Cerence Inc / Trip.com Group Ltd / DarioHealth Corp / Kaleyra Inc / Vertiv Holdings Co / Nikola Corp / Fisker Inc / Airbnb Inc / BTRS Holdings Inc / Arrival SA</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / France / Luxembourg / Mexico / Netherlands / Sweden / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended April 04,2021.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Short Term Headwind - The FTC's Flawed Assumptions About Biopharma M&A</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / AMGN=US / BMY=US / GILD=US / AZN=US / GSK=US / JNJ=US / ILMN=US / VRTX=US / SNY=US / ABBV=US</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Illumina Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Day Preview, Focus On Development Strategy For '621 and '622</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Bracketing Exposure Of Big Cap Pharma To Biden Tax Reform Proposal</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">ECONOMIC REPORTS / INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">valuationLAB AG</td><td class="leftalignment">“Growing the base” Cresemba shines, cancer pipeline growing apace</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">BSLN=CH / MRK=US / LLY=US / PFE=US / 4503=JP / ROG=CH</td><td class="leftalignment">Basilea Pharmaceutica AG / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Astellas Pharma Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Bob Pooler</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Booster Shots - Charts highlighted: SWX, DPZ, WEN, CHD, GIS, AXS, CBOE, ELS, O, BAX, BSX, PFE, INGN, LMT, NOC, NEM, RGLD, SBAC, AEE, AEP, ATO, CMS, ED, ITR, LNT, SO, SRE, WEC, and XEL.</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">XEL.OQ / AEE.N / BAX.N / BSX.N / CMS.N / ED.N / LMT.N / NEM.N / NOC.N / PFE.N / WEC.N / SRE.N / ATO.N / CHD.N / SWX.N / RGLD.OQ / O.N / SBAC.OQ / DPZ.N / WEN.OQ / ITR.V / CBOE.Z / LNT.OQ / AEP.OQ</td><td class="leftalignment">Xcel Energy Inc / Ameren Corp / Baxter International Inc / Boston Scientific Corp / CMS Energy Corp / Consolidated Edison Inc / Lockheed Martin Corp / Newmont Corporation / Northrop Grumman Corp / Pfizer Inc / WEC Energy Group Inc / Sempra Energy / Atmos Energy Corp / Church & Dwight Co Inc / Southwest Gas Holdings Inc / Royal Gold Inc / Realty Income Corp / SBA Communications Corp / Domino's Pizza Inc / Wendys Co / Integra Resources Corp / Cboe Global Markets Inc / Alliant Energy Corp / American Electric Power Company Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="even"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 21 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0028241000 / US02553E1064 / US0378331005 / US0463531089 / US1101221083 / US1264081035 / US2435371073 / US25179M1036 / US28176E1082 / US2944291051 / US3377381088 / US37733W1053 / US4282911084 / US4781601046 / US5324571083 / US5398301094 / US6541061031 / US6558441084 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US87612E1064 / US9078181081 / US92532F1003 / US9311421039 / CA1363751027 / CA13645T1003 / US37940X1028 / US64110L1061 / US80105N1054 / US2533931026 / US31620M1062 / US82706C1080 / US57636Q1040 / US4103451021 / US92826C8394 / US58933Y1055 / US78454L1008 / US39304D1028 / US3390411052 / US96208T1043 / US00287Y1091 / NL0010273215 / US69327R1014 / US5764852050 / PR30040P1032 / US89400J1079 / US70450Y1038 / US8522341036 / US15136A1025 / US8760301072 / US2997341035 / US26927E1047 / US46571Y1073 / VGG312491084 / US74275G1076 / US98585X1046 / US69047Q1022 / US13123X5086 / CA67079A1021</td><td class="leftalignment">Abbott Laboratories / American Eagle Outfitters Inc / Apple Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Deckers Outdoor Corp / Devon Energy Corp / Edwards Lifesciences Corp / Equifax Inc / Fiserv Inc / GlaxoSmithKline PLC / Hexcel Corp / Johnson & Johnson / Eli Lilly and Co / Lockheed Martin Corp / Nike Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / Target Corp / Union Pacific Corp / Vertex Pharmaceuticals Inc / Walmart Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Global Payments Inc / Netflix Inc / Sanofi SA / DICK'S Sporting Goods Inc / Fidelity National Information Services Inc / Silicon Motion Technology Corp / Mastercard Inc / HanesBrands Inc / Visa Inc / Merck & Co Inc / SM Energy Co / Green Dot Corp / Fleetcor Technologies Inc / WEX Inc / Abbvie Inc / ASML Holding NV / PDC Energy Inc / Matador Resources Co / Evertec Inc / TransUnion / PayPal Holdings Inc / Block Inc / Centennial Resource Development Inc / Tapestry Inc / Evelo Biosciences Inc / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Priority Technology Holdings Inc / Yeti Holdings Inc / Ovintiv Inc / Callon Petroleum Co / Nuvei Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Netherlands / Puerto Rico / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/21/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">N=54 prescriber poll on JAK inhibitors in atopic dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : April - June 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Energy / Engineering & Construction / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale / Oil & Gas</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">Synthetic Lethality Investor Event; Reiterate OP</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">IDYA=US / PFE=US / AZN=US / GSK=US / CLVS=US / RPTX=US</td><td class="leftalignment">IDEAYA Biosciences Inc / Pfizer Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Clovis Oncology Inc / Repare Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Upcoming Biopharma Regulatory Events to Watch Given Tougher Environment</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / INCY=US / GILD=US / MOR=DE / AZN=US / GSK=US / ALKS=US / BMRN=US / ICPT=US / VRTX=US / SGEN=US / SAGE=US / PRVB=US / SNY=US / BIIB=US / ACAD=US / ALNY=US / MNKD=US / FOLD=US / IFRX=US / ASND=US / CCXI=US / FGEN=US / ABBV=US / MRTX=US / MGNX=US / ITCI=US / QURE=US / AUPH=US / BPMC=US / AXSM=US / RETA=US / BHVN=US / BBIO=US / MIRM=US / GMAB=US / TVTX=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / MorphoSys AG / AstraZeneca PLC / GlaxoSmithKline PLC / Alkermes Plc / Biomarin Pharmaceutical Inc / Intercept Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Provention Bio Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Amicus Therapeutics Inc / InflaRx NV / Ascendis Pharma A/S / ChemoCentryx Inc / FibroGen Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Aurinia Pharmaceuticals Inc / Blueprint Medicines Corp / Axsome Therapeutics Inc / Reata Pharmaceuticals Inc / Biohaven Pharmaceutical Holding Company Ltd / BridgeBio Pharma Inc / Mirum Pharmaceuticals Inc / Genmab A/S / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Germany / Denmark / France / United Kingdom / Ireland / Netherlands / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID Vax Preclinical Data Encouraging, Ph1/2 Data Expected in Q3</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US / SAN=FR / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Sanofi SA / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Germany / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer Inc. (PFE) In Allergy Treatment  Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma read across: J&J's Erleada/Zytiga P3 prostate data in context for Nubeqa (Bayer/Orion) and J&J 1Q21 read across</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4503.T / JNJ.N / PFE.N / ORNBV.HE / BAYGN.DE</td><td class="leftalignment">Astellas Pharma Inc / Johnson & Johnson / Pfizer Inc / Orion Oyj / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Finland / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">04/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IKNA: Targeted Oncology Company with Attractive Novel Therapy Candidates; Initiating with an Outperform Rating and a $30 Target Price</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">IKNA.OQ / 4502.T / 4528.T / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / AMGN.OQ / INCY.OQ / A2.MI / BAYGN.DE / MRTX.OQ</td><td class="leftalignment">Ikena Oncology Inc / Takeda Pharmaceutical Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Incyte Corp / A2A SpA / Bayer AG / Mirati Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Italy / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Can Johnson & Johnson Stock Rise Post Q1 Results?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LBPS=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / DDDD=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">4D Pharma PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / 4D Pharma PLC / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">AEP.N / AES.N / ALV.N / ANTO.L / BAC.N / BK.N / BP.L / C.N / CCI.N / CL.N / EIX.N / EL.N / ENI.MI / F.N / GM.N / JNJ.N / JPM.N / KMB.N / KO.N / MRK.N / NA / PFE.N / PNC.N / REP.MC / RIO.L / SO.N / T.N / TOTF.PA / VC.N / PEP.N / BFb.N / PG.N / CFP.TO / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / UHS.N / AAL.L / DUK.N / UNH.N / BWA.N / LEA.N / K.N / DISH.O / GS.N / CLX.N / CAG.N / GIS.N / PCG.N / XOM.N / EPC.N / SBAC.O / AMT.N / JAZZ.O / BOL.ST / CONE.O / VZ.N / STT.N / HCA.N / CYH.N / ARNA.O / STZ.N / APH.N / FISV.O / V.N / CHTR.O / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / REGN.O / ENR.N / CVX.N / NCR.N / TEL.N / CNP.N / APF.L / ENDP.O / BLU.N / CPK.N / PII.N / ST.N / GPN.N / MNST.O / CASY.O / ICPT.O / EQIX.O / ATDb.TO / 02209S103 / DLR.N / NESTE.HE / 416515104 / 427866108 / WEF.TO / WAL.N / RDSb.L / SJW.N / MS.N / FIS.N / MA.N / HOG.N / GALP.LS / 3IN.L / ATL.MI / BGS.N / PPL.TO / SLRS.MC / DAN.N / VALE.N / SPB.N / BHPB.L / NEE.N / CAML.L / PCRX.O / MTOR.N / GLEN.L / IFP.TO / MDLZ.OQ / ALLY.N / FANG.O / ABBV.N / TSLA.N / PRMW.N / TMUS.N / COTY.N / 81762P102 / CFF.TO / PTC.O / BTG.N / CFG.N / GLPG.O / TDOC.N / RACE.MI / TWLO.N / ADNT.N / VST.N / APTV.N / VNE.N / KDP.N / CWEN.N / OSMT.O / NWL.O / MORF.OQ / CRNC.OQ / 2222.SE / ETNB.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / RXT.OQ / LUMN.N / MTCR.O / TLMD.OQ / WFG.N / AFRM.O / NAPA.N / CARE.TO / OSO.N / DSEY.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Antofagasta PLC / Bank of America Corp / Bank of New York Mellon Corp / BP PLC / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / Edison International / Estee Lauder Companies Inc / Eni SpA / Ford Motor Co / General Motors Co / Johnson & Johnson / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Pfizer Inc / PNC Financial Services Group Inc / Repsol SA / Rio Tinto PLC / Southern Co / AT&T Inc / TotalEnergies SE / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Canfor Corp / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Universal Health Services Inc / Anglo American PLC / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Kellogg Co / DISH Network Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Exxon Mobil Corp / Edgewell Personal Care Co / SBA Communications Corp / American Tower Corp / Jazz Pharmaceuticals PLC / Boliden AB / CyrusOne Inc / Verizon Communications Inc / State Street Corp / HCA Healthcare Inc / Community Health Systems Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Visa Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / BELLUS Health Inc / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Global Payments Inc / Monster Beverage Corp / Caseys General Stores Inc / Intercept Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / Altria Group Inc / Digital Realty Trust Inc / Neste Oyj / Hartford Financial Services Group Inc / Hershey Co / Western Forest Products Inc / Western Alliance Bancorp / Royal Dutch Shell PLC / SJW Group / Morgan Stanley / Fidelity National Information Services Inc / Mastercard Inc / Harley-Davidson Inc / Galp Energia SGPS SA / 3I Infrastructure PLC / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Solaria Energia y Medio Ambiente SA / Dana Inc / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Nextera Energy Inc / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Interfor Corp / Mondelez International Inc / Ally Financial Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / ServiceNow Inc / Conifex Timber Inc / PTC Inc / B2Gold Corp / Citizens Financial Group Inc / Galapagos NV / Teladoc Health Inc / Ferrari NV / Twilio Inc / Adient PLC / Vistra Corp / Aptiv PLC / Veoneer Inc / Keurig Dr Pepper Inc / Clearway Energy Inc / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Morphic Holding Inc / Cerence Inc / Saudi Arabian Oil Co / 89Bio Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Rackspace Technology Inc / Lumen Technologies Inc / Metacrine Inc / Soc Telemed Inc / West Fraser Timber Co Ltd / Affirm Holdings Inc / Duckhorn Portfolio Inc / Dialogue Health Technologies Inc / Olo Inc / Diversey Holdings Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Brazil / Canada / Switzerland / Cayman Islands / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Saudi Arabia / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US09061G1013 / US0028241000 / US0079731008 / US0116591092 / US0311621009 / US0382221051 / US0463531089 / US0556221044 / US1101221083 / US1924461023 / US1925761066 / US30161Q1040 / US30231G1022 / US3755581036 / US37733W1053 / US45337C1027 / US4567881085 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US64125C1099 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91307C1027 / US91347P1057 / US92532F1003 / US1667641005 / US89151E1091 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US0042251084 / US02043Q1076 / RDSa.AS / PAP310761054 / US16115Q3083 / US3020811044 / US29089Q1058 / US92932M1018 / US01748X1028 / US2473617023 / US87874R1005 / US03152W1099 / BMG3922B1072 / CH0102993182 / IE00B4BNMY34 / US58933Y1055 / US46333X1081 / US9100471096 / US03027X1000 / US29414B1044 / US00287Y1091 / NL0010273215 / US98978V1035 / US8036071004 / US4576693075 / US6951271005 / US74587V1070 / US45845P1084 / US29428V1044 / US69366J2006 / US29664W1053 / US8485771021 / US21240E1055 / US02376R1023 / US4277461020 / US5034596040 / US90400D1081 / KYG8807B1068 / LU0974299876 / US78667J1088 / CA0089118776 / US2681582019 / US31572Q8087 / US22822V1017 / IE00BTN1Y115 / US09627Y1091 / US37890U1088 / US4622221004 / US07725L1026 / KYG4740B1059 / US2067871036 / US78410G1040 / US23355L1061 / IL0011407140 / US76243J1051 / US89854H1023 / US05351X1019 / US05455M1009 / US29260V1052 / US5904791358 / CA39342L1085 / US28414H1032 / US61775R1059 / US92537N1081 / US39813G1094 / US44891N1090 / US12769G1004 / US81181C1045 / US05875B1061</td><td class="leftalignment">Biomarin Pharmaceutical Inc / Abbott Laboratories / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Applied Materials Inc / AstraZeneca PLC / BP PLC / Bristol-Myers Squibb Co / Cognizant Technology Solutions Corp / Cohu Inc / Exelixis Inc / Exxon Mobil Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Incyte Corp / Infosys Ltd / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Neurocrine Biosciences Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / United Therapeutics Corp / Universal Display Corp / Vertex Pharmaceuticals Inc / Chevron Corp / TotalEnergies SE / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Royal Dutch Shell PLC / Copa Holdings SA / Chart Industries Inc / Exlservice Holdings Inc / Emergent BioSolutions Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / TechTarget Inc / Amicus Therapeutics Inc / Genpact Ltd / TE Connectivity Ltd / Accenture PLC / Merck & Co Inc / Ironwood Pharmaceuticals Inc / United Airlines Holdings Inc / American Tower Corp / Epam Systems Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Sarepta Therapeutics Inc / Insmed Inc / Pacira Biosciences Inc / Puma Biotechnology Inc / Intercept Pharmaceuticals Inc / Epizyme Inc / PTC Therapeutics Inc / Esperion Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Heron Therapeutics Inc / La Jolla Pharmaceutical Co / Ultragenyx Pharmaceutical Inc / Theravance Biopharma Inc / Globant SA / SAGE Therapeutics Inc / Air Canada / Dynavax Technologies Corp / FibroGen Inc / Crown Castle International Corp / Medtronic PLC / Blueprint Medicines Corp / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Ichor Holdings Ltd / Conduent Inc / SBA Communications Corp / DXC Technology Co / Urogen Pharma Ltd / Rhythm Pharmaceuticals Inc / TTEC Holdings Inc / Avaya Holdings Corp / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Morphic Holding Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / IAC/Interactivecorp / Caesars Entertainment Inc / Seagen Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / India / Ireland / Israel / Luxembourg / Mexico / Netherlands / Panama / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">PD-(L)1 Market Model: Potential Price Erosion Offset By Adjuvant Visibility</td><td class="leftalignment">English</td><td class="rightalignment">79</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US80105N1054 / US58933Y1055 / US07725L1026</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Beigene Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Michael Nedelcovych, Ph.D. / Ms. Kathleen M. Miner, R.Ph., CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AXP / 2516152 / 2000019 / 2023607 / 2065159 / 2942605 / 2219224 / 2216850 / 2270726 / 2317087 / 2670519 / 2342034 / 2689560 / 2684703 / 2048804 / 2440637 / 2402121 / 2862532 / 2857817 / B125XQ6 / B02R1L6 / B3D7K31 / B7TL820 / BYNZGK1 / BK0VHF6 / B0SDJB4 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BFWK4R7 / BZ1LFG7 / BN2R582 / BGKG6M3 / BJNQGL0 / BLBLMD5 / BMC8SQ7 / BNTB3N8 / BMFPJK6</td><td class="leftalignment">American Express Co / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / Autodesk Inc / Avista Corp / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Fiserv Inc / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nuance Communications Inc / E W Scripps Co / Netflix Inc / Portland General Electric Co / ALLETE Inc / Discovery Inc / Meta Platforms Inc / Block Inc / IDEAYA Biosciences Inc / Zealand Pharma A/S / Fox Corp / Spire Inc / ViacomCBS Inc / PagSeguro Digital Ltd / Roku Inc / Relay Therapeutics Inc / StoneCo Ltd / Rite Aid Corp / Array Technologies Inc / BTRS Holdings Inc / Vizio Holding Corp / ACV Auctions Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Denmark / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / JAZZ.O / PCRX.O</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Pacira Biosciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">BioPharma: RBC’s Rheum/Inflamm/Derm Day – Atopic Dermatitis</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N / INCY.O / ARNA.O / REGN.O / ABBV.N</td><td class="leftalignment">Pfizer Inc / Incyte Corp / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Lisa Walter / Mr. Gregory J. Renza, MD / Kennen MacKay, PHD / Daniel Busby / Mr. Luca Issi, PHD / Leonid Timashev / Steve Daddeo / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Zooming in: pharma out of favour, not out of mind</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / CH0013841017 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Lonza Group AG / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Xian Deng</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Japanese COVID-19 vaccine development status - pay attention to Shionogi data</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">4507.T / 4502.T / JNJ.N / PFE.N / AZN.L / 4552.T / 4568.T / MRNA.OQ / SVA.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / JCR Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 国内の新型コロナウイルス/COVID-19 ワクチン開発の状況-塩野義のデータに注目</td><td class="leftalignment">Japanese</td><td class="rightalignment">12</td><td class="leftalignment">4507.T / 4502.T / JNJ.N / PFE.N / AZN.L / 4552.T / 4568.T / MRNA.OQ / SVA.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / JCR Pharmaceuticals Co Ltd / Daiichi Sankyo Co Ltd / Moderna Inc / Sinovac Biotech Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations  : State of the CRO Industry: Robust Biotech Funding; CT.gov Analysis; Highlighting CRO Deal Activity</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">PFE.N / TMO.N / DGX.N / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Pfizer Inc / Thermo Fisher Scientific Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="even"><td class="leftalignment">04/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - The fifth GPO could be the largest, suggesting NHSA actively seeking savings from generics</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">1093.HK / PFE.N / AZN.L / 1177.HK / 2196.HK / 600276.SS / 002294.SZ / 2607.HK / 6600.HK</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Pfizer Inc / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Jiangsu Hengrui Pharmaceuticals Co Ltd / Shenzhen Salubris Pharmaceuticals Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / SciClone Pharmaceuticals (Holdings) Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / Hong Kong / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: TSHA now pivotal-stage; JNJ C19 safety pause</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 55</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.16.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / 81181C104 / 21900C308 / 517125100 / 04746L104 / G637AM102 / 007002108 / M47364100 / N71542109 / 45168K405 / 76200L309</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Athira Pharma Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--April 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">FSTX=US / GANX=US / MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INCY=US / CMS=US / DGX=US / NVS=US / AZN=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / UCB=BE / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ATRC=US / CHE=US / CYH=US / EW=US / ISEE=US / GEN=US / ISRG=US / PHG=US / LH=US / PRVL=US / REGN=US / USPH=US / UHS=US / VRTX=US / SGEN=US / SAGE=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / IGMS=US / BIIB=US / ISR=US / SLP=US / MRNA=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / OSCR=US / FOLD=US / EHC=US / TMDI=US / ADXN=US / SWAV=US / ADUS=US / SRNE=US / RGNX=US / ANVS=US / ACHC=US / PRTA=US / MRTX=US / MGNX=US / AERI=US / XNCR=US / TRVN=US / FLXN=US / CTRE=US / VBIV=US / WBA=US / NVTA=US / EVH=US / TDOC=US / NVCR=US / VYGR=US / MRUS=US / APVO=US / IRTC=US / CRSP=US / IOVA=US / MTEM=US / SYBX=US / NCNA=US / MDNA=US / ALLO=US / IDYA=US / BCYC=US / PSNL=US / ONCT=US / NBSE=US / DMTK=US / BNTX=US / PNTG=US / PASG=US / LYS=US / ORIC=US / INBX=US / TSHA=US / KDNY=US / SIOX=US</td><td class="leftalignment">F-Star Therapeutics Inc / Gain Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Ucb SA / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Iveric Bio Inc / General Electric Co / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Porvair PLC / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / IGM Biosciences Inc / Biogen Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Oscar Health Inc / Amicus Therapeutics Inc / Encompass Health Corp / Titan Medical Inc / Addex Therapeutics Ltd / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Regenxbio Inc / Annovis Bio Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / MacroGenics Inc / Aerie Pharmaceuticals Inc / Xencor Inc / Trevena Inc / Pacira Biosciences Inc / CareTrust REIT Inc / VBI Vaccines Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Merus NV / Aptevo Therapeutics Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Iovance Biotherapeutics Inc / Molecular Templates Inc / Synlogic Inc / NuCana PLC / Medicenna Therapeutics Corp / Allogene Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Personalis Inc / Oncternal Therapeutics Inc / NeuBase Therapeutics Inc / DermTech Inc / BioNTech SE / Pennant Group Inc / Passage Bio Inc / Lysogene SA / Oric Pharmaceuticals Inc / Inhibrx Inc / Taysha Gene Therapies Inc / Chinook Therapeutics Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Germany / France / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Updated IDE196 (Darovasertib) Data Encouraging and Derisks the Metastatic Uveal Melanoma (mUM) Opportunity; Increasing PT to $34</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703 / BCBVTX1 / BBPK0J0 / BDD1B07</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Rubius Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Next For Roche's Stock?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 9, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">Weekend Musing: The "<1x Peak Sales" Biotech Club</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US09058V1035 / US88322Q1085 / US4277461020 / US23257D1037 / CA89620X5064 / US00773J1034 / KYG108301006 / US84833T1034 / US77313F1066 / US6047491013 / US20451W1018 / US59101E1038 / US16961L1061 / US89422G1076 / US54300N1037</td><td class="leftalignment">BioCryst Pharmaceuticals Inc / TG Therapeutics Inc / Heron Therapeutics Inc / Cymabay Therapeutics Inc / Pfizer Inc / Aeglea Bio Therapeutics Inc / Beyondspring Inc / Spero Therapeutics Inc / Rocket Pharmaceuticals Inc / Mirum Pharmaceuticals Inc / Compass Pathways PLC / Metacrine Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney / Ms. Liisa A. Bayko</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">April 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">171</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">Investor Event Focusing on IDE196; Reiterate OP</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">IDYA=US / PFE=US / AZN=US / GSK=US / CLVS=US / RPTX=US</td><td class="leftalignment">IDEAYA Biosciences Inc / Pfizer Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Clovis Oncology Inc / Repare Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GB0009895292 / DE0006047004 / US4781601046 / US7170811035 / DE0006916604 / DE0005408884 / DE000WCH8881 / DE000A0S8488 / DE000A161408 / DE000A2GS5D8 / US09075V1026</td><td class="leftalignment">AstraZeneca PLC / HeidelbergCement AG / Johnson & Johnson / Pfizer Inc / Pfeiffer Vacuum Technology AG / Leoni AG / Wacker Chemie AG / Hamburger Hafen und Logistik AG / Hellofresh SE / Dermapharm Holding SE / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ACI=US / FSTX=US / AAPL=US / IBM=US / MRK=US / PFE=US / AMGN=US / BMY=US / DIS=US / INTC=US / MSFT=US / C=US / GLW=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / INCY=US / BAC=US / USB=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / NVS=US / VZ=US / URI=US / TSM=US / CCI=US / UPS=US / AZN=US / GSK=US / JNJ=US / TTWO=US / ATVI=US / PNC=US / CMCSA=US / UNH=US / DISH=US / INTU=US / NUAN=US / APPS=US / HRB=US / CTL=US / CME=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / QUIK=US / REGN=US / SBAC=US / VG=US / WSC=US / RDWR=US / SNOW=US / NET=US / CRNT=US / RHHBY=US / GME=US / FB=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / IGMS=US / RNG=US / CEVA=US / MRNA=US / GOOG=US / DLR=US / VIAC=US / INO=US / HSBC=US / DISCA=US / PDD=US / CCOI=US / LLNW=US / LUMN=US / BBVA=US / 700-HK=US / UBI-PAR=US / TSLA=US / ZNGA=US / EA=US / TMUS=US / MGNX=US / GTT=US / XNCR=US / AVYA=US / GOOGL=US / TSLX=US / FIVN=US / BABA=US / NVTA=US / MRUS=US / APVO=US / DZSI=US / TEUM=US / ATUS=US / BILI=US / HUYA=US / ZM=US / FSLY=US / ONCT=US / CMBM=US / DMTK=US / BNTX=US / DKNG=US / INBX=US / KDNY=US / CRSR=US / RXT=US / ONDS=US / PLTK=US / DOCN=US</td><td class="leftalignment">Albertsons Companies Inc / F-Star Therapeutics Inc / Apple Inc / International Business Machines Corp / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Walt Disney Co / Intel Corp / Microsoft Corp / Citigroup Inc / Corning Inc / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Incyte Corp / Bank of America Corp / US Bancorp / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / Novartis AG / Verizon Communications Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / Crown Castle International Corp / United Parcel Service Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Activision Blizzard Inc / PNC Financial Services Group Inc / Comcast Corp / UnitedHealth Group Inc / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / H & R Block Inc / Lumen Technologies Inc / CME Group Inc / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / QuickLogic Corp / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Vonage Holdings Corp / Willscot Mobile Mini Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Roche Holding AG / GameStop Corp / Meta Platforms Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / IGM Biosciences Inc / RingCentral Inc / CEVA Inc / Moderna Inc / Alphabet Inc / Digital Realty Trust Inc / ViacomCBS Inc / Inovio Pharmaceuticals Inc / HSBC Holdings PLC / Discovery Inc / Pinduoduo Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Lumen Technologies Inc / Banco Bilbao Vizcaya Argentaria SA / Tencent Holdings Ltd / Ubisoft Entertainment SA / Tesla Inc / Zynga Inc / Electronic Arts Inc / T-Mobile US Inc / MacroGenics Inc / GTT Communications Inc / Xencor Inc / Avaya Holdings Corp / Alphabet Inc / Sixth Street Specialty Lending Inc / Five9 Inc / Alibaba Group Holding Ltd / Invitae Corp / Merus NV / Aptevo Therapeutics Inc / DZS Inc / Pareteum Corp / Altice USA Inc / Bilibili Inc / HUYA Inc / Zoom Video Communications Inc / Fastly Inc / Oncternal Therapeutics Inc / Cambium Networks Corp / DermTech Inc / BioNTech SE / DraftKings Inc / Inhibrx Inc / Chinook Therapeutics Inc / Corsair Gaming Inc / Rackspace Technology Inc / Ondas Holdings Inc / Playtika Holding Corp / DigitalOcean Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / Cayman Islands / Germany / Spain / United Kingdom / Israel / Netherlands / Sweden / Taiwan / United States / Guernsey</td><td class="leftalignment">Banks / Biotechnology / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US1265011056 / US22284P1057 / US2254471012 / US2371941053 / US28176E1082 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4663671091 / US5150981018 / US5324571083 / US5370081045 / US5801351017 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7134481081 / US7170811035 / US7392761034 / US7711951043 / US7782961038 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US9029251066 / US9078181081 / US91324P1021 / US92343V1044 / US9282981086 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US00206R1023 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US64110D1046 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US95058W1009 / US9837931008 / US00287Y1091 / US98978V1035 / US8725901040 / US55405Y1001 / US69366J2006 / US8485771021 / US21240E1055 / US1220171060 / US02376R1023 / US03937C1053 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / CA1380351009 / US74624M1027 / US00938A1043 / CA87241L1094 / CA35805P1071 / CA22717L1013 / US23753F1075 / US80689H1023 / US4990491049 / US09354A1007 / CA88105E1088 / US88688T1007 / US5904791358 / CA39342L1085 / US28414H1032 / CA22587M1068 / CA89788C1041 / CA23126M1023 / CA86730L1094 / US24984K1051 / CA1973091079 / CA05156X8843 / GB00BMVP7Y09 / US07373B1098 / US56854Q2003 / ACRGau.CD / US3441741077 / US74767V1098 / US7761531083 / US03743Q1085 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / CTS Corp / Covenant Logistics Group Inc / Wolfspeed Inc / Darden Restaurants Inc / Edwards Lifesciences Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Jack in the Box Inc / Landstar System Inc / Eli Lilly and Co / Littelfuse Inc / McDonald's Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / PepsiCo Inc / Pfizer Inc / Power Integrations Inc / Roche Holding AG / Ross Stores Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Verizon Communications Inc / Vishay Intertechnology Inc / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / AT&T Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / NetApp Inc / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Wendys Co / XPO Logistics Inc / Abbvie Inc / Zoetis Inc / T-Mobile US Inc / MACOM Technology Solutions Holdings Inc / PTC Therapeutics Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / American Airlines Group Inc / ArcBest Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Canopy Growth Corp / Pure Storage Inc / Airgain Inc / TFI International Inc / Freshii Inc / Cronos Group Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Blink Charging Co / Terrascend Corp / Tilray Brands Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Elanco Animal Health Inc / Cresco Labs Inc / Trulieve Cannabis Corp / Curaleaf Holdings Inc / Sundial Growers Inc / DermTech Inc / Columbia Care Inc / Aurora Cannabis Inc / Royalty Pharma PLC / Beam Global / Marinus Pharmaceuticals Inc / Acreage Holdings Inc / Foghorn Therapeutics Inc. / Quantumscape Corp / Romeo Power Inc / APA Corp (US) / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q1:21 Results Preview</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Strong Volume Trends in Q1, but Currency and COVID Therapies Both Major Factors</td><td class="leftalignment">English</td><td class="rightalignment">101</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / GSK=US / REGN=US / VRTX=US / SNY=US / RDUS=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Sanofi SA / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / MRCG.DE / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / MRNA.OQ / ACRX.OQ / ABBV.N / MGNX.OQ / SAGE.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Moderna Inc / AcelRx Pharmaceuticals Inc / Abbvie Inc / MacroGenics Inc / SAGE Therapeutics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Biden Corporate Tax Proposals - April 2021 Update</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">BSX.N / CRM.N / JNJ.N / KO.N / PFE.N / WMT.N / PG.N / UNH.N / CAT.N / HD.N / LOW.N / RMD.N / VZ.N / COO.N / V.N / INTC.OQ / AAPL.OQ / MSFT.OQ / CTXS.OQ / AMZN.OQ / NFLX.OQ / MA.N / FSLR.OQ / HAS.OQ / FB.OQ / GOOGL.OQ / ZBH.N / PYPL.OQ / TMUS.OQ</td><td class="leftalignment">Boston Scientific Corp / Salesforce.Com Inc / Johnson & Johnson / Coca-Cola Co / Pfizer Inc / Walmart Inc / Procter & Gamble Co / UnitedHealth Group Inc / Caterpillar Inc / Home Depot Inc / Lowe's Companies Inc / Resmed Inc / Verizon Communications Inc / Cooper Companies Inc / Visa Inc / Intel Corp / Apple Inc / Microsoft Corp / Citrix Systems Inc / Amazon.com Inc / Netflix Inc / Mastercard Inc / First Solar Inc / Hasbro Inc / Meta Platforms Inc / Alphabet Inc / Zimmer Biomet Holdings Inc / PayPal Holdings Inc / T-Mobile US Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">ECONOMIC REPORTS / MARKET / COUNTRY RESEARCH / Research Digest</td><td class="leftalignment">HOLT Americas / Ron Graziano / Mr. Amit Varshney / Adrian Szumilo</td></tr>
<tr class="odd"><td class="leftalignment">04/16/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">The Long and the Short of it: Developments Down Under - cost of inaction, EV fuels copper demand, coal financing</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">AGL.AX / BHP.AX / CBA.AX / CSL.AX / HMB.ST / LLC.AX / PFE.N / RIO.AX / RIO.L / AZN.L / ORG.AX / BLK.N / ANN.AX / AMZN.OQ / BHPB.L / TSLA.OQ / EVN.AX</td><td class="leftalignment">AGL Energy Ltd / BHP Group Ltd / Commonwealth Bank of Australia / CSL Ltd / H & M Hennes & Mauritz AB / LendLease Group / Pfizer Inc / Rio Tinto Ltd / Rio Tinto PLC / AstraZeneca PLC / Origin Energy Ltd / BlackRock Inc / Ansell Ltd / Amazon.com Inc / BHP Group PLC / Tesla Inc / Evolution Mining Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / United Kingdom / Papua New Guinea / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Environmental, Social, Governance</td><td class="leftalignment">Phineas Glover / Alfred Chang</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended April 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">DLR-US -  Dividend Quality Analysis, for the period ended March 31,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / EQIX.O / FB.O</td><td class="leftalignment">Pfizer Inc / Equinix Inc / Meta Platforms Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">JNJ COVID Vax Remains Paused; Age & Gender Restrictions Seem Likely</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Danielle J. Antalffy / Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Elliott Advisors takes stake in GSK</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GSK.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / MRCG.DE / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / BMRN.OQ / VRTX.OQ / BAYGN.DE</td><td class="leftalignment">GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Bayer AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Apr 02, 2021</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">04/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - TP cut from £14 to £13 on Fx driven EPS cut & lower than consensus dividend expectations</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / HIK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Hikma Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The AdeNOvirus Debate, ACIP Meeting For Vaccine Ends With No Vote And Leaves Questions To Be Answered</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / JNJ.N</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Morning Call</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">45337C102 / 29089Q105 / 82968B103 / 01609W102 / 89620X506 / 33938J106 / 47215P106 / 09075G105 / KYG596691041 / 722304102</td><td class="leftalignment">Incyte Corp / Emergent BioSolutions Inc / Sirius XM Holdings Inc / Alibaba Group Holding Ltd / Pfizer Inc / Pacira Biosciences Inc / JD.Com Inc / Biofrontera AG / Meituan / Pinduoduo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / China / Cayman Islands / Germany / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Matthew Harrigan / Mr. Aydin Huseynov, MD / Mr. Robert M. Wasserman / Mr. Bruce D. Jackson / Ms. Fawne Jiang / Long Lin</td></tr>
<tr class="odd"><td class="leftalignment">04/14/2021</td><td class="leftalignment">The Benchmark Company LLC</td><td class="leftalignment">Best-In-Class CD47; Initiate With Buy</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Aydin Huseynov, MD</td></tr>
<tr class="even"><td class="leftalignment">04/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Drug Trend Update: Rx Volume Declines 3% Including COVID-19 Vaccine Volume Benefit</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CAH.N / JNJ.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">JNJ COVID Pause Likely to Become a Pass, Share Should Shift to mRNAs, NVAX</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / PFE=US / GSK=GB / AZN=US / GSK=US / JNJ=US / SNY=US / MRNA=US / BNTX=US</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Sanofi SA / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Danielle J. Antalffy / Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD / Dr. Andrew S. Berens, MD</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Johnson & Johnson Covid-19 Vaccine Updates: Lower Weekly Supply, Blood Clot Investigations</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Our Latest Thinking On COVID-19 Vaccine Sales for 1Q21, FY2021, And Beyond</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Our Initial Thoughts On Pause In Vaccine Rollout</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / BLD=US / DVN=US / INCY=US / TEVA=US / AMT=US / NVDA=US / APA=US / CPE=US / EOG=US / REI=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / CCI=US / MGY=US / SWN=US / MUR=US / CHRS=US / BRO=US / MRO=US / LEG=US / DISH=US / CBRL=US / CNX=US / DRI=US / EQT=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / SBAC=US / CVX=US / SAGE=US / BXS=US / MKL=US / COP=US / DIN=US / JRVR=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / CLR=US / PRPL=US / NMTR=US / TIL=US / NOG=US / IAC=US / JACK=US / TREX=US / KNSL=US / AR=US / ESTE=US / FBHS=US / ANGI=US / BCEI=US / MTDR=US / PDCE=US / FANG=US / ABBV=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / 82982L103 / CDEV=US / IRTC=US / CRSP=US / PVAC=US / JELD=US / SBOW=US / ALLO=US / LYFT=US / UBER=US / TCRR=US / RTLR=US / FERG=US / GMAB=US / OVV=US / ARQT=US / FBRX=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Crown Castle International Corp / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Brown & Brown Inc / Marathon Oil Corp / Leggett & Platt Inc / DISH Network Corp / Cracker Barrel Old Country Store Inc / CNX Resources Corp / Darden Restaurants Inc / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / SBA Communications Corp / Chevron Corp / SAGE Therapeutics Inc / Cadence Bank / Markel Corp / Conocophillips / Dine Brands Global Inc / James River Group Holdings Ltd / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / Instil Bio Inc / Northern Oil and Gas Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Kinsale Capital Group Inc / Antero Resources Corp / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Angi Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Diamondback Energy Inc / Abbvie Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / SilverBow Resources Inc / Allogene Therapeutics Inc / Lyft Inc / Uber Technologies Inc / TCR2 Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Genmab A/S / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2050832 / 2026242 / 2219224 / 2270726 / 2455965 / 2471950 / 2689560 / 2680905 / 2684703 / 2440637 / 7103065 / B00FWN1 / B125XQ6 / B3D7K31 / B3D7KG4 / B7TL820 / B3V9F12 / BYVY8G0 / BP4GNK9 / BJLT387 / BMQ5T49 / BKVDFF7 / BFMXGR0 / BYXJQG9 / BKTNTR9 / BJDX8Y8 / BJNQGL0 / BLBLMD5</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Ameren Corp / American Electric Power Company Inc / CMS Energy Corp / Walt Disney Co / Biogen Inc / Incyte Corp / PG&E Corp / PPL Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Alnylam Pharmaceuticals Inc / Portland General Electric Co / Discovery Inc / Discovery Inc / Meta Platforms Inc / PVH Corp / Alphabet Inc / SAGE Therapeutics Inc / Avantor Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Evergy Inc / Spire Inc / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Rite Aid Corp / Array Technologies Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">US Major Pharma – Assessing pipeline value and optionality</td><td class="leftalignment">English</td><td class="rightalignment">52</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / BMY=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/13/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Assessing Pipeline Value</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/13/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma  : 1Q Earnings Preview – Many Moving Pieces But Underlying Trends Remain Healthy</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">ABBV.N / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US -  Dividend Quality Analysis, for the period ended April 07,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Tracking the JAKs</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / ABBV=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Abbvie Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: 6-mo MRNA C19 data; DRNA sells ALNY royalties</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ALNY.OQ / MRNA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / RPRX=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / Royalty Pharma PLC / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FOCS=US / GANX=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / AMGN=US / CAT=US / DIS=US / MO=US / WM=US / BWA=US / MSFT=US / CL=US / MDT=US / C=US / AMZN=US / A=US / RUN=US / CG=US / CSR=US / DOX=US / GS=US / MPWR=US / TMX=US / FCEL=US / PLUG=US / AXL=US / NVS=US / SMTC=US / MET=US / VRTS=US / TSM=US / UPS=US / ENR=US / CRY=US / RAD=US / CSL=US / JCI=US / JNJ=US / UCB=BE / DE=US / FLO=US / HCC=US / NUAN=US / RSG=US / AAII=US / ALB=US / AMED=US / ECOL=US / AMSC=US / APLS=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / B=US / BL=US / CMI=US / CALM=US / CSV=US / CENX=US / CME=US / CO=US / CRVL=US / CREE=US / DAKT=US / EW=US / EXAS=US / FDS=US / FIVE=US / HTLD=US / ITRI=US / MMS=US / MRCY=US / MS=US / MCO=US / ODFL=US / PZZA=US / PRVL=US / QDEL=US / RBC=US / ROK=US / POOL=US / TRMB=US / UTL=US / VCTR=US / VRTX=US / VG=US / WDFC=US / OSUR=US / PDFS=US / CCRN=US / RHHBY=US / PYPL=US / AGR=US / ACA=US / HR=US / NEP=US / PRA=US / UFCS=US / BIO=US / O=US / SWKS=US / ICAD=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / WCN=US / NDAQ=US / BIIB=US / RNG=US / CRI=US / ISR=US / NUVA=US / PBF=US / RMR=US / ENS=US / TWIN=US / ORA=US / WTI=US / FRPT=US / MORN=US / AMRS=US / PDD=US / SPWR=US / ICE=US / ATNI=US / EHTH=US / CSIQ=US / RSI=US / EBS=US / FSLR=US / FOLD=US / MASI=US / DAN=US / WPRT=US / ADXN=US / TBK=US / KKR=US / SWAV=US / AGCO=US / SWI=US / UTZ=US / ADUS=US / SRNE=US / GNRC=US / CBOE=US / TSLA=US / MSCI=US / AMRC=US / 2454-TW=US / HZNP=US / ANVS=US / ZNGA=US / ENPH=US / PRTA=US / HASI=US / CNHI=US / FATE=US / QURE=US / GOOGL=US / DNOW=US / COUP=US / BABA=US / LOVE=US / VCEL=US / BILL=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / VYGR=US / MIME=US / NTNX=US / NGVT=US / WKHS=US / MDGL=US / IRTC=US / CRSP=US / HLNE=US / SNDR=US / IOVA=US / RDFN=US / PETQ=US / SYBX=US / ROKU=US / MDB=US / APTV=US / MDNA=US / VOW3-DE=US / SMAR=US / CWEN=US / FTDR=US / ALLO=US / ESTC=US / FVRR=US / NBSE=US / MPNGF=US / PASG=US / LYS=US / MSGS=US / MSGE=US / ORIC=US / VLDR=US / HYLN=US / SIOX=US / SHLS=US / CHPT=US / AEVA=US</td><td class="leftalignment">Focus Financial Partners Inc / Gain Therapeutics Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Walt Disney Co / Altria Group Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Colgate-Palmolive Co / Medtronic PLC / Citigroup Inc / Amazon.com Inc / Agilent Technologies Inc / Sunrun Inc / Carlyle Group Inc / Centerspace / Amdocs Ltd / Goldman Sachs Group Inc / Monolithic Power Systems Inc / Terminix Global Holdings Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Novartis AG / Semtech Corp / MetLife Inc / Virtus Investment Partners Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / CryoLife Inc / Rite Aid Corp / Carlisle Companies Inc / Johnson Controls International PLC / Johnson & Johnson / Ucb SA / Deere & Co / Flowers Foods Inc / Warrior Met Coal Inc / Nuance Communications Inc / Republic Services Inc / Alabama Aircraft Industries Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Apellis Pharmaceuticals Inc / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Barnes Group Inc / Blackline Inc / Cummins Inc / Cal-Maine Foods Inc / Carriage Services Inc / Century Aluminum Co / CME Group Inc / Global Cord Blood Corp / CorVel Corp / Wolfspeed Inc / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Factset Research Systems Inc / Five Below Inc / Heartland Express Inc / Itron Inc / Maximus Inc / Mercury Systems Inc / Morgan Stanley / Moody's Corp / Old Dominion Freight Line Inc / Papa John's International Inc / Porvair PLC / Quidel Corp / Regal Rexnord Corp / Rockwell Automation Inc / Pool Corp / Trimble Inc / Unitil Corp / Victory Capital Holdings Inc / Vertex Pharmaceuticals Inc / Vonage Holdings Corp / WD-40 Co / OraSure Technologies Inc / PDF Solutions Inc / Cross Country Healthcare Inc / Roche Holding AG / PayPal Holdings Inc / Avangrid Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / ProAssurance Corp / United Fire Group Inc / Bio Rad Laboratories Inc / Realty Income Corp / Skyworks Solutions Inc / ICAD Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / Biogen Inc / RingCentral Inc / Carter's Inc / IsoRay Inc / NuVasive Inc / PBF Energy Inc / RMR Group Inc / EnerSys / Twin Disc Inc / Ormat Technologies Inc / W&T Offshore Inc / Freshpet Inc / Morningstar Inc / Amyris Inc / Pinduoduo Inc / SunPower Corp / Intercontinental Exchange Inc / ATN International Inc / eHealth Inc / Canadian Solar Inc / Rush Street Interactive Inc / Emergent BioSolutions Inc / First Solar Inc / Amicus Therapeutics Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Addex Therapeutics Ltd / Triumph Bancorp Inc / KKR & Co Inc / Shockwave Medical Inc / AGCO Corp / SolarWinds Corp / UTZ Brands Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Generac Holdings Inc / Cboe Global Markets Inc / Tesla Inc / MSCI Inc / Ameresco Inc / MediaTek Inc / Horizon Therapeutics PLC / Annovis Bio Inc / Zynga Inc / Enphase Energy Inc / Prothena Corporation PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Fate Therapeutics Inc / Uniqure NV / Alphabet Inc / NOW Inc / Coupa Software Inc / Alibaba Group Holding Ltd / Lovesac Co / Vericel Corp / Bill.com Holdings Inc / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Voyager Therapeutics Inc / Mimecast Ltd / Nutanix Inc / Ingevity Corp / Workhorse Group Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Hamilton Lane Inc / Schneider National Inc / Iovance Biotherapeutics Inc / Redfin Corp / PetIQ Inc / Synlogic Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Medicenna Therapeutics Corp / Volkswagen AG / Smartsheet Inc / Clearway Energy Inc / Frontdoor Inc / Allogene Therapeutics Inc / Elastic NV / Fiverr International Ltd / NeuBase Therapeutics Inc / Meituan / Passage Bio Inc / Lysogene SA / Madison Square Garden Sports Corp / Madison Square Garden Entertainment Corp / Oric Pharmaceuticals Inc / Velodyne Lidar Inc / Hyliion Holdings Corp / Sio Gene Therapies Inc / Shoals Technologies Group Inc / ChargePoint Holdings Inc / Aeva Technologies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey / Guernsey</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">US0116591092 / US0231351067 / US0463531089 / US1101221083 / US37733W1053 / US45253H1014 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US37940X1028 / US4771431016 / US64110L1061 / US4198791018 / US80105N1054 / US31620M1062 / US1696561059 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US3390411052 / US30303M1027 / US96208T1043 / US00287Y1091 / US8485771021 / US60468T1051 / US21240E1055 / US5560991094 / US02376R1023 / US38000Q1022 / JE00BLG2ZQ72 / CA0089118776 / US8190471016 / US02079K1079 / US07725L1026 / IE00BY7QL619 / US83304A1060 / US8760301072 / US67022C1062 / US6085501095 / US59045L1061 / US5904791358 / KY30744W1070 / US76156B1070 / US70614W1009 / US76155X1000 / US44891N1090 / US5015751044 / US55406W1036 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Amazon.com Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / ImmunoGen Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Global Payments Inc / JetBlue Airways Corp / Netflix Inc / Hawaiian Holdings Inc / Sanofi SA / Fidelity National Information Services Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Fleetcor Technologies Inc / Meta Platforms Inc / WEX Inc / Abbvie Inc / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / MacroGenics Inc / American Airlines Group Inc / GlycoMimetics Inc / Quotient Ltd / Air Canada / Shake Shack Inc / Alphabet Inc / Beigene Ltd / Johnson Controls International PLC / Snap Inc / Tapestry Inc / NuCana PLC / Molecular Templates Inc / Mersana Therapeutics Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / Peloton Interactive Inc / Revolution Medicines Inc / IAC/Interactivecorp / Kymera Therapeutics Inc / MYT Netherlands Parent BV / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - April 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">AFL.N / AIG.N / ALV.N / AMAT.O / AMD.N / ANA.MC / CB.N / CCI.N / CRM.N / EIX.N / F.N / GM.N / LRCX.O / MMC.N / MRK.N / PB.N / PFE.N / SO.N / T.N / TRV.N / VC.N / ZION.O / CMA.N / CFP.TO / ASML.O / LPX.N / TEN.N / CMCSA.O / AMGN.O / MET.N / DUK.N / HBAN.O / BWA.N / LEA.N / NVDA.O / DISH.O / UNM.N / PCG.N / SBAC.O / AMT.N / CONE.O / ADI.O / VZ.N / VLY.N / SNV.N / EXEL.O / PACW.O / STZ.N / CINF.O / LNC.N / APH.N / FISV.O / SNPS.O / ADSK.O / V.N / AXL.N / AWK.N / NWN.N / BC.N / DB1Gn.DE / AJG.N / BMRN.O / STL.N / REGN.O / PFG.N / MU.O / PRU.N / NCR.N / TEL.N / CNP.N / ENDP.O / CFR.N / CPK.N / FRC.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / WBS.N / FCF.N / SGEN.OQ / GPN.N / PFS.N / FFBC.O / PBCT.O / SIGI.O / SIVB.O / WSBC.O / HOOK.O / CASY.O / BOKF.O / COLB.O / ACGL.O / WTFC.O / TCBI.O / ATDb.TO / FHN.N / DLR.N / 416515104 / WEF.TO / WAL.N / ALNY.O / DISCA.O / CDNS.O / FIS.N / 025676206 / ISBC.O / MA.N / HOG.N / AON.N / DAN.N / WRB.N / 759351604 / HOMB.O / NEE.N / BKU.N / PCRX.O / MTOR.N / IFP.TO / SPLK.OQ / PANW.N / FFHu.TO / NYCB.N / ABBV.N / TSLA.N / TMUS.N / VOYA.N / PRTA.O / ONB.OQ / 81762P102 / CFF.TO / XNCR.OQ / COUP.N / QURE.O / GWB.N / ASB.N / AENA.MC / RGNX.O / MESO.O / RACE.MI / ADVM.OQ / TWLO.N / KNSL.OQ / ADNT.N / UNIT.O / OKTA.OQ / CADE.N / ATUS.N / BHF.O / AY.O / APTV.N / 05971J102 / AMRX.N / EQH.N / GSHD.O / VNE.N / ESTC.N / FIXX.O / CRWD.O / GMAB.O / CRNC.OQ / IGIC.OQ / NKLA.OQ / FOUR.N / DCT.O / LUMN.N / WFG.N / NUVB.N / NAPA.N / OSO.N</td><td class="leftalignment">Aflac Inc / American International Group Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Acciona SA / Chubb Ltd / Crown Castle International Corp / Salesforce.Com Inc / Edison International / Ford Motor Co / General Motors Co / Lam Research Corp / Marsh & McLennan Companies Inc / Merck & Co Inc / Prosperity Bancshares Inc / Pfizer Inc / Southern Co / AT&T Inc / Travelers Companies Inc / Visteon Corp / Zions Bancorporation NA / Comerica Inc / Canfor Corp / ASML Holding NV / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / MetLife Inc / Duke Energy Corp / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / NVIDIA Corp / DISH Network Corp / Unum Group / PG&E Corp / SBA Communications Corp / American Tower Corp / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / Valley National Bancorp / Synovus Financial Corp / Exelixis Inc / PacWest Bancorp / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Synopsys Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Northwest Natural Holding Co / Brunswick Corp / Deutsche Boerse AG / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / Sterling Bancorp / Regeneron Pharmaceuticals Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Cullen/Frost Bankers Inc / Chesapeake Utilities Corp / First Republic Bank / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Webster Financial Corp / First Commonwealth Financial Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / First Financial Bancorp / People's United Financial Inc / Selective Insurance Group Inc / SVB Financial Group / WesBanco Inc / HOOKIPA Pharma Inc / Caseys General Stores Inc / BOK Financial Corp / Columbia Banking System Inc / Arch Capital Group Ltd / Wintrust Financial Corp / Texas Capital Bancshares Inc / Alimentation Couche-Tard Inc / First Horizon Corp / Digital Realty Trust Inc / Hartford Financial Services Group Inc / Western Forest Products Inc / Western Alliance Bancorp / Alnylam Pharmaceuticals Inc / Discovery Inc / Cadence Design Systems Inc / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Harley-Davidson Inc / Aon PLC / Dana Inc / W R Berkley Corp / Reinsurance Group of America Inc / Home BancShares Inc / Nextera Energy Inc / BankUnited Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / Splunk Inc / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / New York Community Bancorp Inc / Abbvie Inc / Tesla Inc / T-Mobile US Inc / Voya Financial Inc / Prothena Corporation PLC / Old National Bancorp / ServiceNow Inc / Conifex Timber Inc / Xencor Inc / Coupa Software Inc / Uniqure NV / Great Western Bancorp Inc / Associated Banc-Corp / Aena SME SA / Regenxbio Inc / Mesoblast Ltd / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Kinsale Capital Group Inc / Adient PLC / Uniti Group Inc / Okta Inc / Cadence Bank / Altice USA Inc / Brighthouse Financial Inc / Atlantica Sustainable Infrastructure PLC / Aptiv PLC / Cadence Bank / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Veoneer Inc / Elastic NV / Homology Medicines Inc / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Duck Creek Technologies Inc / Lumen Technologies Inc / West Fraser Timber Co Ltd / Nuvation Bio Inc / Duckhorn Portfolio Inc / Olo Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">An Emerging and Differentiated In-Silico Story; Initiating at Outperform & $30 PT</td><td class="leftalignment">English</td><td class="rightalignment">48</td><td class="leftalignment">GANX=US / LLY=US / PFE=US / NVS=US / JNJ=US / UCB=BE / PRVL=US / VRTX=US / RHHBY=US / BIIB=US / FOLD=US / ADXN=US / SRNE=US / ANVS=US / PRTA=US / VYGR=US / NBSE=US / PASG=US / LYS=US / SIOX=US</td><td class="leftalignment">Gain Therapeutics Inc / Eli Lilly and Co / Pfizer Inc / Novartis AG / Johnson & Johnson / Ucb SA / Porvair PLC / Vertex Pharmaceuticals Inc / Roche Holding AG / Biogen Inc / Amicus Therapeutics Inc / Addex Therapeutics Ltd / Sorrento Therapeutics Inc / Annovis Bio Inc / Prothena Corporation PLC / Voyager Therapeutics Inc / NeuBase Therapeutics Inc / Passage Bio Inc / Lysogene SA / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">ALN-AGT continues to show clear evidence of AGT knockdown and reductions in blood pressure</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ALNY.OQ / PFE.N</td><td class="leftalignment">Alnylam Pharmaceuticals Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Alethia R. Young / Emily Bodnar / Ms. Li W. Watsek / Ms. Emma K. Nealon, III</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Gene Therapy Day – Hemophilia</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / BMRN.O / ALNY.O / QURE.O</td><td class="leftalignment">Pfizer Inc / Biomarin Pharmaceutical Inc / Alnylam Pharmaceuticals Inc / Uniqure NV</td><td class="leftalignment"></td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Luca Issi, PHD / Kennen MacKay, PHD / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / Lisa Walter / Edwin Delfin / Leonid Timashev / David Szeto / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biopharma: Latest Short Interest for US Biopharma: Large Caps Stable; ACRX and NBIX See Moderate Increases Among SMid Caps</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">BMY.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Oncology Meeting Highlights Promising Assets; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/12/2021</td><td class="leftalignment">Sadif Analytics</td><td class="leftalignment">Will Pfizer Inc Deliver Long-Term Returns?</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research SADIF</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Potential Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual Event to Discuss How Corporate Tax Increases Could Impact Pharma, THIS THURSDAY at 2PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Healthcare Large-Cap 1Q21 Earnings Preview Conference Call on Friday, 4/16 at 2:00pm ET</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / 0715.HK / LLY.N / PFE.N / IMAB.OQ</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / China Oceanwide Holdings Ltd / Eli Lilly and Co / Pfizer Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">74</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / AYTU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / PCRX.O / ABBV.N / AMRX.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Pacira Biosciences Inc / Abbvie Inc / Amneal Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/11/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2021 Outlook Compendia: Get Your Biotech Motors Running</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US35104E1001 / US09061G1013 / US09058V1035 / US45337C1027 / US64125C1099 / US75886F1075 / US92532F1003 / US02043Q1076 / US00287Y1091 / US09609G1004 / US8036071004 / US4576693075 / US88322Q1085 / US29251M1062 / US4277461020 / US90400D1081 / NL0010696654 / KYG8807B1068 / US23257D1037 / CA89620X5064 / US04351P1012 / US37890U1088 / US4622221004 / US00773J1034 / US5588681057 / BMG637AM1024 / KYG108301006 / US24823R1059 / US5011471027 / US84833T1034 / US77313F1066 / BMG5269C1010 / KYG596651029 / US02155H2004 / US04335A1051 / US38341P1021 / US04965G1094 / US00973Y1082 / US6047491013 / CA07987C2040 / US12674W1099 / US65487U1088 / US35655L1070 / US45720L1070 / US20451W1018 / US59101E1038 / US69353Y1038 / US12529R1077 / US68236R1032 / US16961L1061 / US1920101060 / US89422G1076 / US2300311063 / US92765F1084 / US54300N1037</td><td class="leftalignment">4D Molecular Therapeutics Inc / Biomarin Pharmaceutical Inc / BioCryst Pharmaceuticals Inc / Incyte Corp / Neurocrine Biosciences Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Abbvie Inc / bluebird bio Inc / Sarepta Therapeutics Inc / Insmed Inc / TG Therapeutics Inc / Enanta Pharmaceuticals Inc / Heron Therapeutics Inc / Ultragenyx Pharmaceutical Inc / Uniqure NV / Theravance Biopharma Inc / Cymabay Therapeutics Inc / Pfizer Inc / Ascendis Pharma A/S / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Aeglea Bio Therapeutics Inc / Madrigal Pharmaceuticals Inc / Myovant Sciences Ltd / Beyondspring Inc / Denali Therapeutics Inc / Krystal Biotech Inc / Spero Therapeutics Inc / Rocket Pharmaceuticals Inc / Kiniksa Pharmaceuticals Ltd / MeiraGTx Holdings PLC / Altimmune Inc / Arvinas Inc / Gossamer Bio Inc / Atreca Inc / Akero Therapeutics Inc / Mirum Pharmaceuticals Inc / BELLUS Health Inc / Cabaletta Bio Inc / Nkarta Inc / Freeline Therapeutics Holdings PLC / Inhibrx Inc / Compass Pathways PLC / Metacrine Inc / PMV Pharmaceuticals Inc / C4 Therapeutics Inc / Oncorus Inc / Chinook Therapeutics Inc / Codiak BioSciences, Inc. / Travere Therapeutics Inc / Cullinan Oncology Inc / Viracta Therapeutics Inc / Longboard Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Liisa A. Bayko / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">04/11/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials 5% Above Pre-Pandemic Level - Week 54</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Moving At 300,000 km/sec to Advance Its Oncology Portfolio; Takeaways from Analyst and Investor Event Underscore That Franchise Is Underappreciated</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / PORTFOLIO/ASSET STRATEGIES</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 4.9.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / CPSI=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Computer Programs and Systems Inc / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Apr 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMAC=US / ONCT=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / ADCT=US / WMT=US / INCY=US / CMS=US / GILD=US / DGX=US / NVS=US / AZN=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / LH=US / LIFE=US / RKT=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / CNC=US / ACA=US / ICAD=US / ENSG=US / MD=US / SLF=US / BIIB=US / ACAD=US / GOOG=US / LHCG=US / CHNG=US / BNGO=US / TPTX=US / EHC=US / ATHX=US / TMDI=US / SWAV=US / ADUS=US / SRNE=US / IRWD=US / SLRX=US / ACHC=US / CCXI=US / TGTX=US / ABBV=US / CTRE=US / OTIC=US / VBLT=US / CLRB=US / WBA=US / SNPHY=US / NVTA=US / EVH=US / GKOS=US / BGNE=US / RETA=US / APVO=US / FLGT=US / IRTC=US / PLXP=US / CYCN=US / TMDX=US / KRTX=US / PNTG=US / NNOX=US / KDNY=US / TVTX=US / EVAX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Oncternal Therapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / ADC Therapeutics SA / Walmart Inc / Incyte Corp / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / General Electric Co / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Rocket Companies Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / ICAD Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Bionano Genomics Inc / Turning Point Therapeutics Inc / Encompass Health Corp / Athersys Inc / Titan Medical Inc / Shockwave Medical Inc / Addus Homecare Corp / Sorrento Therapeutics Inc / Ironwood Pharmaceuticals Inc / Salarius Pharmaceuticals Inc / Acadia Healthcare Company Inc / ChemoCentryx Inc / TG Therapeutics Inc / Abbvie Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Invitae Corp / Evolent Health Inc / Glaukos Corp / Beigene Ltd / Reata Pharmaceuticals Inc / Aptevo Therapeutics Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / PLx Pharma Inc / Cyclerion Therapeutics Inc / Transmedics Group Inc / Karuna Therapeutics Inc / Pennant Group Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Travere Therapeutics Inc / Evaxion Biotech A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">45337C10 / 59522J10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 81750R102 / 29604W108 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 4525EP101 / 56854Q200 / 81181C104 / 517125100 / G637AM102 / 007002108 / M47364100 / N71542109 / 45168K405 / 76200L309</td><td class="leftalignment">Incyte Corp / Mid-America Apartment Communities Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Seres Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / Larimar Therapeutics Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Rezolute Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended April 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Apr. 09, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/09/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Apr. 09, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Apr 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Daniel Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual Event to Discuss How Corporate Tax Increases Could Impact Pharma on Thursday, 4/15 at 2PM ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">DMAC May Have Unlocked Synthetic KLK1's Potential in Stroke and Chronic Kidney Disease; Initiate at Outperform</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">DMAC=US / PFE=US / BMY=US / NVS=US / BIIB=US / ATHX=US / IRWD=US / CCXI=US / RETA=US / CYCN=US / KDNY=US / TVTX=US</td><td class="leftalignment">DiaMedica Therapeutics Inc / Pfizer Inc / Bristol-Myers Squibb Co / Novartis AG / Biogen Inc / Athersys Inc / Ironwood Pharmaceuticals Inc / ChemoCentryx Inc / Reata Pharmaceuticals Inc / Cyclerion Therapeutics Inc / Chinook Therapeutics Inc / Travere Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / BMY=US / INCY=US / PEB=US / H=US / MTN=US / PXD=US / BRO=US / MAR=US / TNL=US / HLT=US / AIR=US / ATRO=US / CCL=US / CHH=US / DRH=US / DCO=US / EQT=US / AJG=US / HEI=US / HXL=US / TRIP=US / TGI=US / MKL=US / SPR=US / NFLX=US / JRVR=US / SHO=US / REX=US / TDG=US / HST=US / GPRE=US / LUMN=US / WH=US / KNSL=US / HGV=US / RLJ=US / VAC=US / RHP=US / FANG=US / ABBV=US / 00770K202 / GDDY=US / EVBG=US / PK=US / PLYA=US / OKTA=US / PLMR=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Incyte Corp / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Pioneer Natural Resources Co / Brown & Brown Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / AAR Corp / Astronics Corp / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Ducommun Inc / EQT Corp / Arthur J Gallagher & Co / HEICO Corp / Hexcel Corp / Tripadvisor Inc / Triumph Group Inc / Markel Corp / Spirit AeroSystems Holdings Inc / Netflix Inc / James River Group Holdings Ltd / Sunstone Hotel Investors Inc / REX American Resources Corp / TransDigm Group Inc / Host Hotels & Resorts Inc / Green Plains Inc / Lumen Technologies Inc / Wyndham Hotels & Resorts Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Abbvie Inc / Aemetis Inc / GoDaddy Inc / Everbridge Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Okta Inc / Palomar Holdings Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">0989529 / 2701271 / 2270726 / 2317087 / 2369174 / 2689560 / 2684703 / 2862532 / 2829601 / B1F76F9 / B121557 / 2857817 / B2R3PV1 / B3D7K31 / 2390817 / 2949758 / B7TL820 / B7VD3F2 / BFLR866 / BFH3N85 / BTN1Y44 / BYNZGK1 / BJ2Z0H2 / BFZ1K46 / BLGJ610 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BDFZSP1 / BYQHPK7 / BYWVTY5 / BZ0P3Z5 / BMC5RV6</td><td class="leftalignment">AstraZeneca PLC / Costco Wholesale Corp / Walt Disney Co / Entergy Corp / Gilead Sciences Inc / PG&E Corp / Pfizer Inc / E W Scripps Co / Southern Co / Western Union Co / Mastercard Inc / Netflix Inc / American Water Works Company Inc / Discovery Inc / Gray Television Inc / Nexstar Media Group Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Veeva Systems Inc / Walgreens Boots Alliance Inc / Block Inc / Pinterest Inc / Spotify Technology SA / Warner Music Group Corp / Spire Inc / Vistra Corp / ViacomCBS Inc / Okta Inc / Zymeworks Inc / CytomX Therapeutics Inc / Tegna Inc / Adicet Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">If You Build It, They May Not Come</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / AMRN.OQ / IMAB.OQ / HGEN.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Amarin Corporation PLC / I-Mab / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : Abrocitinib Review Extension Not Surprising; Xeljanz Label Update Represents Next Major Update for the JAK Class</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Corporate Watchdog Reports</td><td class="leftalignment">Watchdog Report: PFE - Now with Critical / Key Audit Matters</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph Burke</td></tr>
<tr class="odd"><td class="leftalignment">04/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE - Three-month PDUFA extension for abrocitinib in atopic dermatitis (AD) does not come as a surprise; follows similar competitor delays</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N / ABBV.N</td><td class="leftalignment">Pfizer Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Daniel Busby</td></tr>
<tr class="even"><td class="leftalignment">04/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">6600.HK: SciClone Pharmaceuticals - Cash cow Zadaxin supporting license-in based innovation transformation</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">6600.HK / 1093.HK / BAX.N / PFE.N / 1177.HK / NOVN.S / 600276.SS</td><td class="leftalignment">SciClone Pharmaceuticals (Holdings) Ltd / CSPC Pharmaceutical Group Ltd / Baxter International Inc / Pfizer Inc / Sino Biopharmaceutical Ltd / Novartis AG / Jiangsu Hengrui Pharmaceuticals Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / Hong Kong / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Transferring Research Coverage</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / XERS.O / AQST.O / OSMT.O / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / MCD=US / WEN=US / TEVA=US / XOM=US / CHRS=US / RCL=US / CBRL=US / CCL=US / COLL=US / DRI=US / REGI=US / SHOP=US / STRA=US / BKNG=US / DIN=US / BDSI=US / PLAY=US / DENN=US / CMG=US / REX=US / GPRE=US / AMRX=US / TAST=US / QSR=US / APEI=US / JACK=US / CLNY=US / NCLH=US / NDLS=US / 00770K202 / COUP=US / LOCO=US / NVRO=US / WBA=US / SHAK=US / WING=US / SPNE=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / McDonald's Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Exxon Mobil Corp / Coherus BioSciences Inc / Royal Caribbean Cruises Ltd / Cracker Barrel Old Country Store Inc / Carnival Corp / Collegium Pharmaceutical Inc / Darden Restaurants Inc / Renewable Energy Group Inc / Shopify Inc / Strategic Education Inc / Booking Holdings Inc / Dine Brands Global Inc / BioDelivery Sciences International Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / American Public Education Inc / Jack in the Box Inc / DigitalBridge Group Inc / Norwegian Cruise Line Holdings Ltd / Noodles & Co / Aemetis Inc / Coupa Software Inc / El Pollo Loco Holdings Inc / Nevro Corp / Walgreens Boots Alliance Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Israel / Liberia / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 5671735 / 0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2942605 / 2270726 / 2542049 / 2317087 / 2100920 / 2613990 / 2459020 / 2632003 / 2689560 / 2684703 / 2048804 / 2138158 / 7103065 / B121557 / 2713317 / B1HJLW5 / B614LY3 / B7TL820 / B4MG4Z6 / BDZCRX3 / B8DPDT7 / BFLR866 / BVVN4Q8 / BYNZGK1 / BK0VHF6 / BJFSR88 / BJ2Z0H2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BJXBP30 / BWY52P3 / BYTJZL1 / BF3N4P3 / BKF9DQ8 / BMZ9Z11 / BLR6S36 / BMG5660</td><td class="leftalignment">Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Avista Corp / Walt Disney Co / Dominion Energy Inc / Entergy Corp / FirstEnergy Corp / Illumina Inc / Intuit Inc / New York Times Co / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / Sempra Energy / Novartis AG / Mastercard Inc / ACADIA Pharmaceuticals Inc / Emergent BioSolutions Inc / Cielo SA / Meta Platforms Inc / AMC Networks Inc / RingCentral Inc / Sarepta Therapeutics Inc / Twitter Inc / Eversource Energy / Block Inc / IDEAYA Biosciences Inc / Uniqure NV / Pinterest Inc / Evergy Inc / Spire Inc / Vistra Corp / ViacomCBS Inc / Turning Point Therapeutics Inc / Blueprint Medicines Corp / Zogenix Inc / Arena Pharmaceuticals Inc / Phreesia Inc / Prometheus Biosciences Inc / Longboard Pharmaceuticals Inc / Joann Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Switzerland / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">04/06/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Takeaways from Virtual NDRs: Investor Focus on Synthetic Lethal Platform and Near-Term MAT2A, PKC Inhibitor Data</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BK0VHF6 / 2126335 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0 / BFXC911 / BDD1B07</td><td class="leftalignment">IDEAYA Biosciences Inc / Bristol-Myers Squibb Co / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Guardant Health Inc / Rubius Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Thoughts Post-Genomics Day–At the Crossroads with Micro-Dystrohpin GTx</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2684703 / B8DPDT7</td><td class="leftalignment">Pfizer Inc / Sarepta Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / Denmark / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Debjit Chattopadhyay, Ph.D. / Aaron Welch, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Guggenheim Ther Research / Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What's Happening With Johnson & Johnson's Covid-19 Vaccine Rollout?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Apr 5 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0126531013 / US01741R1023 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7237871071 / US7711951043 / US8308791024 / US8447411088 / US4771431016 / US4198791018 / US80105N1054 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US88160R1014 / US9100471096 / US00287Y1091 / US00912X3026 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US4622221004 / US26856L1035 / CA53680Q2071 / US74275G1076 / US5904791358 / US53814L1089 / US89377M1099 / US4432011082 / LU2314763264 / 120404208</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Allegheny Technologies Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Pioneer Natural Resources Co / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Tesla Inc / United Airlines Holdings Inc / Abbvie Inc / Air Lease Corp / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Ionis Pharmaceuticals Inc / elf Beauty Inc / Lithium Americas Corp / Priority Technology Holdings Inc / Mesa Air Group Inc / Livent Corp / Transmedics Group Inc / Howmet Aerospace Inc / Arrival SA / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Denmark / France / United Kingdom / Luxembourg / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">04/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRVI: Caps Off to Strong 1Q Preannouncement; CleanCap Drivers Continue</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI.OQ / PFE.N</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS FRIDAY: Please Join Our Virtual KOL Call to Discuss the Potential Role of, and Key Focus Areas for, ADCs in Oncology at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE / MRK</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas in a Podcast, Please Join Our Weekly Discussion on How Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / SIBN.MM / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Gazprom Neft' PAO / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Russian Federation / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS THURSDAY: Please Join Our Virtual KOL Call to Discuss New and Emerging Treatments in Medical Dermatology at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS.O / ARQT.O / JNJ / LLY / PFE / VYNE.O</td><td class="leftalignment">Aclaris Therapeutics Inc / Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) update for QURE in hemB; new tech for DRNA</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">UQ1.F / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / EBS=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Uniqure NV / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Emergent BioSolutions Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">04/04/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Kailash Concepts</td><td class="leftalignment">The Great Inflation:  Revisiting 1969 – 1984 and the Impact of Inflation on Equities</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABT.N / APD.N / BA.N / CCI.N / ECL.N / EOG.N / JNJ.N / KO.N / MRK.N / NEM.N / PFE.N / PM.N / SLB.N / SO.N / WMT.N / PG.N / DUK.N / DIS.N / UNH.N / D.N / CAT.N / UNP.N / MCD.N / HON.N / HD.N / UPS.N / XOM.N / AMT.N / NKE.N / LIN.N / SHW.N / VZ.N / EXC.N / V.N / PLD.N / CVX.N / COP.N / AAPL.OQ / MSFT.OQ / COST.OQ / AMZN.OQ / NVDA.OQ / EQIX.OQ / CMCSA.OQ / GOOG.OQ / DLR.N / MA.N / NEE.N / TSLA.OQ / FB.OQ / GOOGL.OQ / PEP.OQ</td><td class="leftalignment">Abbott Laboratories / Air Products and Chemicals Inc / Boeing Co / Crown Castle International Corp / Ecolab Inc / EOG Resources Inc / Johnson & Johnson / Coca-Cola Co / Merck & Co Inc / Newmont Corporation / Pfizer Inc / Philip Morris International Inc / Schlumberger NV / Southern Co / Walmart Inc / Procter & Gamble Co / Duke Energy Corp / Walt Disney Co / UnitedHealth Group Inc / Dominion Energy Inc / Caterpillar Inc / Union Pacific Corp / McDonald's Corp / Honeywell International Inc / Home Depot Inc / United Parcel Service Inc / Exxon Mobil Corp / American Tower Corp / Nike Inc / Linde PLC / Sherwin-Williams Co / Verizon Communications Inc / Exelon Corp / Visa Inc / Prologis Inc / Chevron Corp / Conocophillips / Apple Inc / Microsoft Corp / Costco Wholesale Corp / Amazon.com Inc / NVIDIA Corp / Equinix Inc / Comcast Corp / Alphabet Inc / Digital Realty Trust Inc / Mastercard Inc / Nextera Energy Inc / Tesla Inc / Meta Platforms Inc / Alphabet Inc / PepsiCo Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Ireland / United States / Curaçao</td><td class="leftalignment">Aerospace / Air Transportation / Apparel & Textiles / Automotive / Beverages & Tobacco / Broadcasting & Cable / Chemicals / Conglomerates / Defense / Healthcare / Household Products / Info. Tech./Peripheral / Info. Tech./Software / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Pharmaceuticals / Railroads / Real Estate / Retailing / Semiconductors / Technology / Telecommunications / Utilities / Oil & Gas</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Kailash Capital Kailash Capital</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">45337C10 / 09058V10 / 00422510 / 84763A108 / 29251M106 / M25722105 / 23282W605 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / RZLT / 81750R102 / 29604W108 / 462260100 / 45826J105 / 040047607 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 4525EP101 / 56854Q200 / 81181C104 / 21900C308 / 517125100 / 04746L104 / G637AM102 / 007002108 / M47364100 / N71542109 / 45168K405 / 92790C104</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Cytokinetics Inc / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Rezolute Inc / Seres Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Arena Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Immunic Inc / Marinus Pharmaceuticals Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Athira Pharma Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Idera Pharmaceuticals Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Notwithstanding JNJ, Outlook for COVID Control via Vax Increasingly Positive</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ.N / PFE=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Apr. 01, 2021 / 9:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">V / 2000019 / 2973821 / 2270726 / 2342034 / 2630513 / 2645409 / 2689560 / 2680905 / 2684703 / 2048804 / 2440637 / 2931034 / B00FWN1 / 2857817 / BJ0XLZ3 / BJ0KXV4 / BTN1Y44 / BYY8XK8 / BYVY8G0 / BYW36M8 / BD9GVY0 / BZ1LFB2 / BJLKVS6 / BFZ1K46 / BFMXGR0 / BJJMGL2 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BFFVVC1 / BQXZP64 / BN7K304 / BMDJ397</td><td class="leftalignment">Visa Inc / Amazon.com Inc / Alliant Energy Corp / Walt Disney Co / Fiserv Inc / New Jersey Resources Corp / NiSource Inc / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Vertex Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Netflix Inc / Heron Therapeutics Inc / ONE Gas Inc / Walgreens Boots Alliance Inc / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / Evergy Inc / Fox Corp / Spire Inc / Vistra Corp / ViacomCBS Inc / Bausch Health Companies Inc / Wayfair Inc / Academy Sports and Outdoors Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">04/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ / ABCL.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Pfizer Inc. (PFE) - COVID-19 vaccine sales leading to growth</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US -  Dividend Quality Analysis, for the period ended March 29,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - "Pipelines Unplugged" highlights from call #2 with head of R&D</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Three Peas In A Podcast, Please Join Our Weekly Discussion On How Catalysts and Events Could Impact Our Covered Companies</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ACRX.O / ARCS.PK / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / AYTU.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Arcis Resources Corp / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Aytu Biopharma Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Consensus for 2021 looks too low</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">US09075V1026 / US7170811035</td><td class="leftalignment">BioNTech SE / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Positive Data Means That Adolescents Could Be Vaccinated Before Start Of Next School Year</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UG-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">UG.O / ASH / IFF / JNJ / PFE / SCL / TFX</td><td class="leftalignment">United-Guardian Inc / Ashland Global Holdings Inc / International Flavors & Fragrances Inc / Johnson & Johnson / Pfizer Inc / Stepan Co / Teleflex Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/31/2021</td><td class="leftalignment">CRD Global</td><td class="leftalignment">Sustco Score Report: Pfizer Inc. MARCH 2021</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">MISCELLANEOUS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Environmental, Social, Governance</td><td class="leftalignment">CRD Global</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Bristol Myers Squibb Stock At $63?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ASND=US / VERO=US / NKE=US / CAH=US / FDX=US / AMGN=US / MO=US / TJX=US / WM=US / ETR=US / SNE=US / BLD=US / SFE=US / BAC=US / ONE=US / WB=US / PEB=US / BRKS=US / YUM=US / SO=US / PLUG=US / STM=FR / VRTS=US / CHKP=US / AIG=US / SAP=US / TTEK=US / MCK=US / EXC=US / CRY=US / SNPS=US / JCI=US / NCR=US / ETN=US / NWL=US / CMCSA=US / SRCL=US / FLWS=US / KEYS=US / ABMD=US / ATI=US / AMRN=US / ANSS=US / ADSK=US / AVNT=US / BHE=US / BL=US / BRC=US / CBRL=US / CENT=US / CSBR=US / CHH=US / CMCO=US / CYH=US / CPRT=US / CO=US / CRWS=US / DFS=US / DGII=US / DG=US / E=US / EGLE=US / EGHT=US / EXAS=US / FDS=US / FLS=US / HAE=US / ICUI=US / IDCC=US / INGN=US / JCOM=US / KVHI=US / KEX=US / LH=US / LGND=US / MVIS=US / MSA=US / MNRO=US / MCO=US / NL=US / NSSC=US / TEAM=US / NTCT=US / OSIS=US / OXM=US / PZZA=US / KWR=US / RFIL=US / RARE=US / RGEN=US / ROK=US / ROP=US / HSIC=US / SIRI=US / TDS=US / TTEC=US / TRIP=US / TRIL=US / TRMB=US / UTI=US / UG=US / UTHR=US / UTL=US / UHS=US / VRTX=US / WCC=US / WIX=US / PDFS=US / GPN=US / SYNA=US / PYPL=US / JEF=US / AOS=US / SIVB=US / ARE=US / CAC=US / HT=US / STKL=US / SF=US / TK=US / ALLE=US / NLS=US / ENSG=US / MGP=US / MGPI=US / WCN=US / GPRO=US / DKS=US / WYNN=US / ABT=CA / NDAQ=US / GLNG=US / NTGR=US / AHH=US / FLT=US / OPEN=US / CZR=US / MUSA=US / CYTK=US / ACAD=US / SFM=US / MNKD=US / ENS=US / CNS=US / DLR=US / HLF=US / VIAC=US / INO=US / DXCM=US / LHCG=US / THS=US / AMRS=US / PERI=US / IRBT=US / CLMT=US / HIMX=US / HST=US / HALO=US / MWA=US / SIX=US / ATEC=US / GPRE=US / INFI=US / TEL=US / ALLT=US / AIMC=US / CENTA=US / CPLP=US / LXRX=US / M=US / OPK=US / NWBO=US / PRPL=US / PRO=US / PZN=US / IDRA=US / GLPG=US / BEST=US / SB=US / LOPE=US / ADUS=US / FTNT=US / AVNW=US / STNG=US / CTSO=US / CBOE=US / AOSL=US / PLOW=US / MSCI=US / SAVA=US / AMRC=US / PRMW=US / WWD=US / FDUS=US / XYL=US / EA=US / ARCT=US / LXFR=US / HASI=US / CUBI=US / NDLS=US / REXR=US / MGNX=US / GLPI=US / BANX=US / ATEN=US / ARDX=US / IRMD=US / TTOO=US / BABA=US / LOVE=US / OUT=US / NVTA=US / ETSY=US / MCRB=US / BLBD=US / SPXC=US / SQ=US / IONS=US / NTLA=US / ADVM=US / WKHS=US / YUMC=US / 115450867 / ROKU=US / KRYS=US / RBBN=US / IQ=US / COCP=US / CPRI=US / XAIR=US / NLOK=US / FUBO=US / VIRX=US / 120681711</td><td class="leftalignment">Ascendis Pharma A/S / Venus Concept Inc / Nike Inc / Cardinal Health Inc / FedEx Corp / Amgen Inc / Altria Group Inc / TJX Companies Inc / Waste Management Inc / Entergy Corp / Sony Group Corp / TopBuild Corp / Safeguard Scientifics Inc / Bank of America Corp / OneSmart International Education Group Ltd / Weibo Corp / Pebblebrook Hotel Trust / Azenta Inc / Yum! Brands Inc / Southern Co / Plug Power Inc / STMicroelectronics NV / Virtus Investment Partners Inc / Check Point Software Technologies Ltd / American International Group Inc / SAP SE / Tetra Tech Inc / Mckesson Corp / Exelon Corp / CryoLife Inc / Synopsys Inc / Johnson Controls International PLC / NCR Corp / Eaton Corporation PLC / Newell Brands Inc / Comcast Corp / Stericycle Inc / 1-800-Flowers.Com Inc / Keysight Technologies Inc / ABIOMED Inc / Allegheny Technologies Inc / Amarin Corporation PLC / ANSYS Inc / Autodesk Inc / Avient Corp / Benchmark Electronics Inc / Blackline Inc / Brady Corp / Cracker Barrel Old Country Store Inc / Central Garden & Pet Co / Champions Oncology Inc / Choice Hotels International Inc / Columbus McKinnon Corp / Community Health Systems Inc / Copart Inc / Global Cord Blood Corp / Crown Crafts Inc / Discover Financial Services / Digi International Inc / Dollar General Corp / Eni SpA / Eagle Bulk Shipping Inc / 8x8 Inc / Exact Sciences Corp / Factset Research Systems Inc / Flowserve Corp / Haemonetics Corp / ICU Medical Inc / InterDigital Inc / Inogen Inc / Ziff Davis Inc / KVH Industries Inc / Kirby Corp / Laboratory Corporation of America Holdings / Ligand Pharmaceuticals Inc / MicroVision Inc / MSA Safety Inc / Monro Inc / Moody's Corp / NL Industries Inc / NAPCO Security Technologies Inc / Atlassian Corporation PLC / Netscout Systems Inc / OSI Systems Inc / Oxford Industries Inc / Papa John's International Inc / Quaker Chemical Corp / RF Industries Ltd / Ultragenyx Pharmaceutical Inc / Repligen Corp / Rockwell Automation Inc / Roper Technologies Inc / Henry Schein Inc / Sirius XM Holdings Inc / Telephone and Data Systems Inc / TTEC Holdings Inc / Tripadvisor Inc / Pfizer Inc / Trimble Inc / Universal Technical Institute Inc / United-Guardian Inc / United Therapeutics Corp / Unitil Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Wesco International Inc / Wix.Com Ltd / PDF Solutions Inc / Global Payments Inc / Synaptics Inc / PayPal Holdings Inc / Jefferies Financial Group Inc / A O Smith Corp / SVB Financial Group / Alexandria Real Estate Equities Inc / Camden National Corp / Hersha Hospitality Trust / Sunopta Inc / Stifel Financial Corp / Teekay Corp / Allegion PLC / Nautilus Inc / Ensign Group Inc / MGM Growth Properties LLC / MGP Ingredients Inc / Waste Connections Inc / GoPro Inc / DICK'S Sporting Goods Inc / Wynn Resorts Ltd / Absolute Software Corp / Nasdaq Inc / Golar LNG Ltd / NETGEAR Inc / Armada Hoffler Properties Inc / Fleetcor Technologies Inc / Opendoor Technologies Inc / Caesars Entertainment Inc / Murphy Usa Inc / Cytokinetics Inc / ACADIA Pharmaceuticals Inc / Sprouts Farmers Market Inc / MannKind Corp / EnerSys / Cohen & Steers Inc / Digital Realty Trust Inc / Herbalife Nutrition Ltd / ViacomCBS Inc / Inovio Pharmaceuticals Inc / Dexcom Inc / LHC Group Inc / TreeHouse Foods Inc / Amyris Inc / Perion Network Ltd / iRobot Corp / Calumet Specialty Products Partners LP / Himax Technologies Inc / Host Hotels & Resorts Inc / Halozyme Therapeutics Inc / Mueller Water Products Inc / Six Flags Entertainment Corp / Alphatec Holdings Inc / Green Plains Inc / Infinity Pharmaceuticals Inc / TE Connectivity Ltd / Allot Ltd / Altra Industrial Motion Corp / Central Garden & Pet Co / Capital Product Partners LP / Lexicon Pharmaceuticals Inc / Macy's Inc / OPKO Health Inc / Northwest Biotherapeutics Inc / Purple Innovation Inc / Pros Holdings Inc / Pzena Investment Management Inc / Idera Pharmaceuticals Inc / Galapagos NV / BEST Inc / Safe Bulkers Inc / Grand Canyon Education Inc / Addus Homecare Corp / Fortinet Inc / Aviat Networks Inc / Scorpio Tankers Inc / Cytosorbents Corp / Cboe Global Markets Inc / Alpha and Omega Semiconductor Ltd / Douglas Dynamics Inc / MSCI Inc / Cassava Sciences Inc / Ameresco Inc / Primo Water Corp / Woodward Inc / Fidus Investment Corp / Xylem Inc / Electronic Arts Inc / Arcturus Therapeutics Holdings Inc / Luxfer Holdings PLC / Hannon Armstrong Sustainable Infrastructure Capital Inc / Customers Bancorp Inc / Noodles & Co / Rexford Industrial Realty Inc / MacroGenics Inc / Gaming and Leisure Properties Inc / StoneCastle Financial Corp / A10 Networks Inc / Ardelyx Inc / IRadimed Corp / T2 Biosystems Inc / Alibaba Group Holding Ltd / Lovesac Co / OUTFRONT Media Inc / Invitae Corp / ETSY Inc / Seres Therapeutics Inc / Blue Bird Corp / SPX Corp / Block Inc / Ionis Pharmaceuticals Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Workhorse Group Inc / Yum China Holdings Inc / Great Elm Capital Corp / Roku Inc / Krystal Biotech Inc / Ribbon Communications Inc / iQIYI Inc / Cocrystal Pharma Inc / Capri Holdings Ltd / Beyond Air Inc / NortonLifeLock Inc / Fubotv Inc / Viracta Therapeutics Inc / Primo Water Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States / Virgin Islands, British / Marshall Islands</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Pharmaceuticals / Retailing / Semiconductors</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BDSI-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BDSI.O / JNJ / PFE / ENDP.O / MNOV.O / ACRX.O / TTNP.O</td><td class="leftalignment">BioDelivery Sciences International Inc / Johnson & Johnson / Pfizer Inc / Endo International PLC / MediciNova Inc / AcelRx Pharmaceuticals Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / BLD=US / DVN=US / TEVA=US / CMA=US / APA=US / LOW=US / PB=US / CHRS=US / EWBC=US / TRMK=US / UMPQ=US / LEG=US / ATVI=US / WTFC=US / CBRL=US / CSTR=US / CNX=US / DRI=US / FCN=US / GFF=US / IBP=US / MAS=US / MHK=US / PACW=US / WAL=US / HTH=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / AUTL=US / UCBI=US / DIN=US / PNFP=US / SBCF=US / NOMD=US / TCBI=US / TPX=US / FNB=US / EXP=US / FHN=US / BECN=US / PLAY=US / RNST=US / DENN=US / BLDR=US / GMS=US / CMG=US / PGTI=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / IBTX=US / NDLS=US / MTNB=US / LOCO=US / SHAK=US / WING=US / LOB=US / ACBI=US / ZS=US / WVE=US / NTLA=US / 82982L103 / JELD=US / ROKU=US / MBIN=US / HWC=US / OZK=US / AMTB=US / TCRR=US / CRWD=US / FERG=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / APA Corp (US) / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / East West Bancorp Inc / Trustmark Corp / Umpqua Holdings Corp / Leggett & Platt Inc / Activision Blizzard Inc / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / CNX Resources Corp / Darden Restaurants Inc / FTI Consulting Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / PacWest Bancorp / Western Alliance Bancorp / Hilltop Holdings Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Autolus Therapeutics PLC / United Community Banks Inc / Dine Brands Global Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Nomad Foods Ltd / Texas Capital Bancshares Inc / Tempur Sealy International Inc / FNB Corp / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Renasant Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / PGT Innovations Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Zscaler Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Roku Inc / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / TCR2 Therapeutics Inc / CrowdStrike Holdings Inc / Ferguson PLC / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Singapore / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">XOMA-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">XOMA.O / EBS / LLY / NVS / PFE / REGN.O / ABBV.K / TEVA.K</td><td class="leftalignment">XOMA Corp / Emergent BioSolutions Inc / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Abbvie Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">5671735 / 0989529 / 2434209 / 2126335 / 2516152 / 2000019 / 2640147 / 2026242 / 2270726 / 2689560 / 2684703 / 2440637 / 7103065 / B121557 / 2857817 / B02R1L6 / B7VD3F2 / BBGVT40 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BD8DJ71 / BJFSR88 / BZ1HM42 / BYXJQG9 / BZ8VJQ8 / BKTNTR9 / BJDX8Y8 / BP8XZL1 / BN0XTW4 / BMCC9R7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Home Depot Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Nike Inc / American Electric Power Company Inc / Walt Disney Co / PG&E Corp / Pfizer Inc / CenterPoint Energy Inc / Novartis AG / Mastercard Inc / Netflix Inc / ALLETE Inc / Duke Energy Corp / News Corp / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / Snap Inc / Uniqure NV / Adyen NV / Spire Inc / Vistra Corp / ViacomCBS Inc / Mirum Pharmaceuticals Inc / Healthequity Inc / Orphazyme A/S / SCYNEXIS Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pharmaceuticals - Introducing Berenberg DrugBank</td><td class="leftalignment">English</td><td class="rightalignment">123</td><td class="leftalignment">FR0000120578 / DE0006599905 / GB0009895292 / GB0009252882 / CH0012032048 / CH0012005267 / US1101221083 / US5324571083 / US7170811035 / US58933Y1055 / US00287Y1091 / DK0060534915</td><td class="leftalignment">Sanofi SA / Merck KGaA / AstraZeneca PLC / GlaxoSmithKline PLC / Roche Holding AG / Novartis AG / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Merck & Co Inc / Abbvie Inc / Novo Nordisk A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mrs. Luisa C. Hector, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DCPH: More Than a Gut Feeling for Second-Line GIST; Initiate with an Outperform, $78 TP</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">DCPH.OQ / PFE.N / AZN.L / ROG.S / INCY.OQ / EXEL.OQ / SGEN.OQ / CLVS.OQ / EPZM.OQ / MGNX.OQ / BPMC.OQ / BGNE.OQ / PBYI.OQ / ZLAB.OQ / 6160.HK / GMAB.CO</td><td class="leftalignment">Deciphera Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Incyte Corp / Exelixis Inc / Seagen Inc / Clovis Oncology Inc / Epizyme Inc / MacroGenics Inc / Blueprint Medicines Corp / Beigene Ltd / Puma Biotechnology Inc / Zai Lab Ltd / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / Denmark / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">EXEL: 1L RCC Stalemate Averted; Initiate with an Outperform Rating, $30 TP</td><td class="leftalignment">English</td><td class="rightalignment">61</td><td class="leftalignment">EXEL.OQ / 4523.T / BMY.N / LLY.N / MRK.N / PFE.N / ROG.S / SGEN.OQ / BAYGN.DE / ZYME.N / GMAB.CO</td><td class="leftalignment">Exelixis Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Roche Holding AG / Seagen Inc / Bayer AG / Zymeworks Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="odd"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Biotechnology: What's an Oncology Drug Worth? Data from a Decade of Oncology M&A</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">4502.T / 4503.T / BMY.N / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / NOVN.S / MRCG.DE / 4768.T / GSK.L / AMGN.OQ / GILD.OQ / SGEN.OQ / 4568.T / JAZZ.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / Otsuka Corp / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Seagen Inc / Daiichi Sankyo Co Ltd / Jazz Pharmaceuticals PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Ireland / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Bradley P. Canino</td></tr>
<tr class="even"><td class="leftalignment">03/30/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">70</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ATRS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ATRS.O / BDX / JNJ / LLY / PFE / WST / RVP / ANIP.O / TEVA.K</td><td class="leftalignment">Antares Pharma Inc / Becton Dickinson and Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / West Pharmaceutical Services Inc / Retractable Technologies Inc / ANI Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Herd Immunity Update: Vaccination Pace Encouraging, But Offset So Far By Variants/Re-Openings</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE.N / INCY.O / REGN.O</td><td class="leftalignment">Pfizer Inc / Incyte Corp / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Brian Abrahams, MD / Leonid Timashev / David Szeto / Mr. Gregory J. Renza, MD</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 29 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US3695501086 / US37733W1053 / US4433201062 / US4456581077 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US25754A2015 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US9837931008 / US00287Y1091 / US09609G1004 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US9314271084 / CA87241L1094 / US23753F1075 / US80689H1023 / US4990491049 / US80706P1030 / US5904791358 / US89377M1099 / CA23126M1023 / US65487U1088 / US75943R1023 / US6877931096</td><td class="leftalignment">Alaska Air Group Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Domino's Pizza Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / XPO Logistics Inc / Abbvie Inc / bluebird bio Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Walgreens Boots Alliance Inc / TFI International Inc / Daseke Inc / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Scholar Rock Holding Corp / Mesa Air Group Inc / Transmedics Group Inc / Curaleaf Holdings Inc / Nkarta Inc / Relay Therapeutics Inc / Oscar Health Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / China / Denmark / France / United Kingdom / Mexico / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/29/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Bristol Myers Squibb Stock Is Undervalued At $63</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">AEP.N / AES.N / ALV.N / BAC.N / BK.N / CL.N / CP.TO / EIX.N / EL.N / EOG.N / FMS.N / KMB.N / KO.N / MRK.N / NTRS.O / PFE.N / SO.N / T.N / USB.N / WFC.N / PEP.N / BFb.N / PG.N / CPB.N / TEN.N / CMCSA.O / INCY.O / DUK.N / K.N / DT.N / ADBE.O / CLX.N / CAG.N / GIS.N / PCG.N / EPC.N / AMT.N / JAZZ.O / CONE.O / VZ.N / STT.N / STZ.N / APH.N / ADSK.O / AXL.N / AWK.N / NBIX.O / CHD.N / NWN.N / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / NET.N / TEL.N / CNP.N / ENDP.O / CPK.N / ST.N / SGEN.OQ / MNST.O / BLUE.O / BIIB.O / 02209S103 / DLR.N / ACAD.O / 427866108 / MS.N / TEVA.N / ATL.MI / BGS.N / SPB.N / NEE.N / ERF.TO / ACHC.O / SPLK.OQ / PANW.N / MDLZ.OQ / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / COTY.N / PTCT.O / PRTA.O / AGIO.O / 81762P102 / LB.N / KPTI.O / ITCI.O / QURE.O / VRNS.O / AGRX.O / ANTM.N / 78667J108 / RGNX.O / WVE.OQ / IONS.O / TWLO.N / OKTA.OQ / VST.N / ATNX.O / SAIL.N / APTV.N / ZS.OQ / AMRX.N / KDP.N / XERS.O / AQST.O / MGTX.O / ESTC.N / NWL.O / NBSE.OQ / KRTX.OQ / CRWD.O / GMAB.O / PING.N / CRNC.OQ / WTRG.N / REYN.O / NKLA.OQ / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Autoliv Inc / Bank of America Corp / Bank of New York Mellon Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Fresenius Medical Care AG & Co KGaA / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Northern Trust Corp / Pfizer Inc / Southern Co / AT&T Inc / US Bancorp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Campbell Soup Co / Tenneco Inc / Comcast Corp / Incyte Corp / Duke Energy Corp / Kellogg Co / Dynatrace Inc / Adobe Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / PG&E Corp / Edgewell Personal Care Co / American Tower Corp / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / State Street Corp / Constellation Brands Inc / Amphenol Corp / Autodesk Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Cloudflare Inc / TE Connectivity Ltd / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Sensata Technologies Holding PLC / Seagen Inc / Monster Beverage Corp / bluebird bio Inc / Biogen Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / Morgan Stanley / Teva Pharmaceutical Industries Ltd / Atlantia SpA / B&G Foods Inc / Spectrum Brands Holdings Inc / Nextera Energy Inc / Enerplus Corp / Acadia Healthcare Company Inc / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Coty Inc / PTC Therapeutics Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Intra-Cellular Therapies Inc / Uniqure NV / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / SAGE Therapeutics Inc / Regenxbio Inc / WAVE Life Sciences Ltd / Ionis Pharmaceuticals Inc / Twilio Inc / Okta Inc / Vistra Corp / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / MeiraGTx Holdings PLC / Elastic NV / Newell Brands Inc / NeuBase Therapeutics Inc / Karuna Therapeutics Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / United Kingdom / Ireland / Israel / Italy / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">BLUE Blood, Ide-Cel Approval Is Positive For Heme Malignancy Drug Development</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">HGEN.O / IMAB.O / HCM.L / JNJ / LLY / MRK / PFE / US3755581036</td><td class="leftalignment">Humanigen Inc / I-Mab / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss New and Emerging Treatments in Medical Dermatology on 4/8 at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS.O / ARQT.O / JNJ / LLY / PFE / VYNE.O</td><td class="leftalignment">Aclaris Therapeutics Inc / Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / MRK</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Continue Upward Trend-Week 52</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: (+) results from PRQR & KRYS; ide-cel approved</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.26.21</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / OM=US / GNCA=US / TBPH=US / ALDX=US / ASMB=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / Assembly Biosciences Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">45337C10 / 09058V10 / 84763A108 / 89620X506 / 60468T105 / 09627Y109 / 462260100 / 019770106 / H17182108 / 483347100 / 90041T108 / 65343E108 / 24344T101 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 4525EP101 / 81181C104 / 517125100 / 04746L104 / N71542109 / 92790C104</td><td class="leftalignment">Incyte Corp / BioCryst Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Pfizer Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Iovance Biotherapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Kaleido Biosciences Inc / Turning Point Therapeutics Inc / NextCure Inc / Deciphera Pharmaceuticals Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Immunic Inc / Seagen Inc / Larimar Therapeutics Inc / Athira Pharma Inc / ProQR Therapeutics NV / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Roy Buchanan, PhD, PHD / Mr. Gobind Singh, MD, PhD</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Mar 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AdComm's Near-Unanimous "No" Delays NGFs' Timing, Lowers Probability of Success</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">PFE=US / REGN=US</td><td class="leftalignment">Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">0989529 / 2126335 / 2516152 / 2050832 / 2026242 / 2113393 / 2216850 / 2270726 / 2317087 / 2328915 / 2100920 / 2459020 / 2632003 / 2680905 / 2684703 / 2730190 / 2829601 / 2883878 / B121557 / B7TL820 / BFDV8K0 / BBGVT40 / BYVY8G0 / BYVYD43 / BYZLV46 / BMQ5T49 / BGCYWN8 / BFZ1K46 / BZ8VJQ8 / BJ9NFQ3 / BN2R582 / BN7K304</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / American Electric Power Company Inc / Boston Beer Company Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Nextera Energy Inc / FirstEnergy Corp / Intuit Inc / New York Times Co / PPL Corp / Pfizer Inc / Regeneron Pharmaceuticals Inc / Southern Co / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Meta Platforms Inc / MacroGenics Inc / News Corp / Alphabet Inc / Performance Food Group Co / InflaRx NV / Zentalis Pharmaceuticals Inc / Xencor Inc / Spotify Technology SA / Vistra Corp / Neoleukin Therapeutics Inc / Relay Therapeutics Inc / Academy Sports and Outdoors Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Israel / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Canadian Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BAER.S / BARC.L / BB.N / BNPP.PA / CBKG.DE / CSGN.S / HSBA.L / JNJ.N / LLOY.L / MRK.N / PFE.N / SAN.MC / SOGN.PA / GILD.O / TA.TO / AMGN.O / DBKGn.DE / BBVA.MC / 0989529 / CVX.N / CAGR.PA / NWG.L / INGA.AS / TEVA.N / CS.TO / 443628102 / CBRO.L / GTE.TO / PXT.TO / ABBV.N / PRGO.N / GUD.TO / ABNd.AS / UBSG.S / MTRO.L / APR_U.TO / VMUK.L / PAGPA.L</td><td class="leftalignment">Julius Baer Gruppe AG / Barclays PLC / BlackBerry Ltd / BNP Paribas SA / Commerzbank AG / Credit Suisse Group AG / HSBC Holdings PLC / Johnson & Johnson / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Banco Santander SA / Societe Generale SA / Gilead Sciences Inc / TransAlta Corp / Amgen Inc / Deutsche Bank AG / Banco Bilbao Vizcaya Argentaria SA / AstraZeneca PLC / Chevron Corp / Credit Agricole SA / Natwest Group PLC / ING Groep NV / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Hudbay Minerals Inc / Close Brothers Group PLC / Gran Tierra Energy Inc / Parex Resources Inc / Abbvie Inc / Perrigo Company PLC / Knight Therapeutics Inc / ABN Amro Bank NV / UBS Group AG / Metro Bank PLC / Automotive Properties Real Estate Investment Trust / Virgin Money UK PLC / Paragon Banking Group PLC</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / BMY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Yunhee Park / Jonathan Woo</td></tr>
<tr class="even"><td class="leftalignment">03/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: AstraZeneca BioPharma Meet Management event, March 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AZN.L / JNJ.N / LLY.N / PFE.N / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / AMGN.OQ / REGN.OQ</td><td class="leftalignment">AstraZeneca PLC / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">UK & European Research at a Glance - March 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABF.L / AEGN.AS / AHT.L / ALVG.DE / AXAF.PA / BAER.S / BARC.L / BNPP.PA / BNZL.L / BOY.L / BRW.L / CBKG.DE / CNA.L / CNE.L / CPI.L / CSGN.S / CWK.L / DANO.PA / DCC.L / DFDS.CO / DPLM.L / ECM.L / FGP.L / FOUG.PA / GOG.L / HMSO.L / HSBA.L / HSX.L / HTG.L / IMI.L / JD.L / JNJ.N / JSG.L / LAND.L / LLOY.L / MKS.L / MRK.N / MUVGn.DE / NA / NEX.L / NXT.L / OREP.PA / OXB.L / PFE.N / PFG.L / PNN.L / PRU.L / ROR.L / RPS.L / RTO.L / SAN.MC / SGC.L / SGEF.PA / SLA.L / SMWH.L / SOGN.PA / SRP.L / TLW.L / TPK.L / TTG.L / ULVR.L / VIEV.VI / WKP.L / ZURN.S / RAT.L / GILD.O / AMGN.O / DBKGn.DE / ESP.L / BBVA.MC / ENT.L / JTC.L / BYG.L / MORG.DE / DPH.L / IG.MI / 0989529 / IGG.L / FRAG.DE / CVX.N / CAGR.PA / CEY.L / ENAG.MC / AV.L / WG.L / FLS.CO / ASC.L / HAYS.L / APF.L / COA.L / NWG.L / SGSN.S / RTN.L / INGA.AS / HSV.L / NESN.S / SPI.L / BRK.L / NESTE.HE / BUCN.S / KOS.N / PFC.L / BVIC.L / DUFN.S / LRE.L / HICL.L / TEVA.N / DNLM.L / OERL.S / MARS.L / DLN.L / DWNG.DE / 3IN.L / ATL.MI / HFG.L / MONY.L / RENE.LS / CBRO.L / SLRS.MC / HOCM.L / XPS.L / BEZG.L / ABCA.L / CVSG.L / VGP1.BR / GTE.TO / INPP.L / FHZN.S / PHNX.L / SUBC.OL / CAML.L / PXT.TO / SMSS.L / BOSSn.DE / CLINC.L / DLGD.L / ABBV.N / LMPL.L / PRGO.N / MGAMM.L / UKWG.L / BOOH.L / BBOXT.L / NN.AS / DC.L / MOLN.S / FEVR.L / SNNS.L / G24N.DE / AMUN.PA / GYM.L / ABNd.AS / CMCX.L / UBSG.S / SRENH.S / MTRO.L / PAGE.L / BFIT.AS / CTEC.L / IWG.L / TCAPI.L / TKOO.PA / GREG.MC / JUSTJ.L / IHR.L / DHER.DE / GRPG.I / FERG.L / SUPR.L / WHRW.L / AFM.L / RHIM.L / SDRY.L / ENOG.L / QLT.L / HNSA.ST / TMV.DE / VMUK.L / UPR.IR / PAGPA.L / FRAS.L / JETJ.L / 001306785 / DOCS.L / TEEC.L</td><td class="leftalignment">Associated British Foods PLC / Aegon NV / Ashtead Group PLC / Allianz SE / AXA SA / Julius Baer Gruppe AG / Barclays PLC / BNP Paribas SA / Bunzl plc / Bodycote PLC / Brewin Dolphin Holdings PLC / Commerzbank AG / Centrica PLC / Capricorn Energy PLC / Capita PLC / Credit Suisse Group AG / Cranswick PLC / Danone SA / DCC PLC / DFDS AS / Diploma PLC / Electrocomponents PLC / FirstGroup PLC / Eiffage SA / Go-Ahead Group PLC / Hammerson PLC / HSBC Holdings PLC / Hiscox Ltd / Hunting PLC / IMI PLC / JD Sports Fashion PLC / Johnson & Johnson / Johnson Service Group PLC / Land Securities Group PLC / Lloyds Banking Group PLC / Marks and Spencer Group PLC / Merck & Co Inc / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / National Bank of Canada / National Express Group PLC / Next PLC / L'Oreal SA / Oxford BioMedica PLC / Pfizer Inc / Provident Financial PLC / Pennon Group PLC / Prudential PLC / Rotork PLC / RPS Group PLC / Rentokil Initial PLC / Banco Santander SA / Stagecoach Group PLC / Vinci SA / Abrdn PLC / WH Smith PLC / Societe Generale SA / Serco Group PLC / Tullow Oil PLC / Travis Perkins PLC / TT electronics PLC / Unilever PLC / Flughafen Wien AG / Workspace Group PLC / Zurich Insurance Group AG / Rathbones Group PLC / Gilead Sciences Inc / Amgen Inc / Deutsche Bank AG / Empiric Student Property PLC / Banco Bilbao Vizcaya Argentaria SA / Entain PLC / Jtc PLC / Big Yellow Group PLC / MorphoSys AG / Dechra Pharmaceuticals PLC / Italgas SpA / AstraZeneca PLC / IG Group Holdings PLC / Fraport AG Frankfurt Airport Services Worldwide / Chevron Corp / Credit Agricole SA / Centamin PLC / Enagas SA / Aviva PLC / John Wood Group PLC / FLSmidth & Co A/S / ASOS PLC / Hays PLC / Anglo Pacific Group PLC / Coats Group PLC / Natwest Group PLC / SGS SA / Restaurant Group PLC / ING Groep NV / HomeServe PLC / Nestle SA / Spire Healthcare Group PLC / Brooks Macdonald Group PLC / Neste Oyj / Bucher Industries AG / Kosmos Energy Ltd / Petrofac Ltd / Britvic PLC / Dufry AG / Lancashire Holdings Ltd / HICL Infrastructure PLC / Teva Pharmaceutical Industries Ltd / Dunelm Group PLC / OC Oerlikon Corporation AG Pfaeffikon / Marston's PLC / Derwent London PLC / Deutsche Wohnen SE / 3I Infrastructure PLC / Atlantia SpA / Hilton Food Group PLC / Moneysupermarket.Com Group PLC / Ren Redes Energeticas Nacionais SGPS SA / Close Brothers Group PLC / Solaria Energia y Medio Ambiente SA / Hochschild Mining PLC / XPS Pensions Group PLC / Beazley PLC / Abcam PLC / CVS Group PLC / VGP NV / Gran Tierra Energy Inc / International Public Partnerships Ltd / Flughafen Zuerich AG / Phoenix Group Holdings PLC / Subsea 7 SA / Central Asia Metals PLC / Parex Resources Inc / Smart Metering Systems PLC / Hugo Boss AG / Clinigen Group PLC / Direct Line Insurance Group PLC / Abbvie Inc / Londonmetric Property PLC / Perrigo Company PLC / Morgan Advanced Materials PLC / Greencoat UK Wind PLC / boohoo group plc / Tritax Big Box Reit PLC / NN Group NV / Currys PLC / Molecular Partners AG / Fevertree Drinks PLC / Sanne Group PLC / Scout24 SE / Amundi SA / GYM Group PLC / ABN Amro Bank NV / CMC Markets PLC / UBS Group AG / Swiss Re AG / Metro Bank PLC / Pagegroup PLC / Basic Fit NV / ConvaTec Group PLC / IWG Plc / TP ICAP Group PLC / Tikehau Capital SCA / Grenergy Renovables SA / Just Group PLC / Impact Healthcare REIT PLC / Delivery Hero SE / Greencoat Renewables PLC / Ferguson PLC / Supermarket Income REIT PLC / Warehouse REIT PLC / Alpha Financial Markets Consulting PLC / RHI Magnesita NV / Superdry PLC / Energean PLC / Quilter PLC / Hansa Biopharma AB / TeamViewer AG / Virgin Money UK PLC / Uniphar PLC / Paragon Banking Group PLC / Frasers Group PLC / Just Eat Takeaway.com NV / Bureau Veritas SA / Dr Martens PLC / Triple Point Energy Efficiency Infrastructure Company Plc</td><td class="leftalignment"></td><td class="leftalignment">Austria / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / Sweden / United States / Isle of Man / Jersey / Guernsey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">2021 Outlook: Chew On This</td><td class="leftalignment">English</td><td class="rightalignment">88</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Josh Schimmer / Ms. Maneka Mirchandaney</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) - 4Q Recap; ZN-c3 Initial Data at AACR; Trials Initiated as Planned</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMQ5T49 / 0989529 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE - Unfavorable FDA AdCom vote deals a blow to tanezumab's approval chances, though expectations were low to begin with</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N / TEVA.N / TEVA.TA</td><td class="leftalignment">Pfizer Inc / Teva Pharmaceutical Industries Ltd / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">DE0007100000 / DE0005190003 / DE0007664005 / DE0007010803 / AT0000969985 / DE0007297004 / US7170811035 / DE0006916604 / DE0007664039 / DE0007480204 / NL0000008977 / DE000WACK012 / DE000A0S8488 / DE000ENAG999 / DE0005111702 / DE000PAH0038 / AT0000A0E9W5 / DE000A1H8BV3 / DE000KGX8881 / NL0012059018 / DE000SHL1006 / US09075V1026</td><td class="leftalignment">Daimler AG / Bayerische Motoren Werke AG / Volkswagen AG / Rational AG / AT & S Austria Technologie & Systemtechnik AG / Suedzucker AG / Pfizer Inc / Pfeiffer Vacuum Technology AG / Volkswagen AG / Deutsche EuroShop AG / Heineken Holding NV / Wacker Neuson SE / Hamburger Hafen und Logistik AG / E.ON SE / Zooplus AG / Porsche Automobil Holding SE / S&T AG / Norma Group SE / Kion Group AG / Exor NV / Siemens Healthineers AG / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Austria / Germany / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRK=US / LSI=US / PFE=US / AMGN=US / KO=US / BLD=US / INCY=US / TEVA=US / PEB=US / H=US / MTN=US / CHRS=US / BRO=US / MAR=US / TNL=US / HLT=US / RCL=US / CCL=US / CHH=US / DRH=US / AJG=US / IBP=US / KBH=US / REGI=US / WGO=US / PSA=US / DCP=US / SBCF=US / APTX=US / EXR=US / BECN=US / SHO=US / GMS=US / HST=US / AWI=US / OC=US / WH=US / IAC=US / HGV=US / RLJ=US / VAC=US / CUBE=US / RHP=US / TILE=US / NCLH=US / NSA=US / PK=US / PLYA=US / FERG=US / OVV=US / ARQT=US / FBRX=US / BALY=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Life Storage Inc / Pfizer Inc / Amgen Inc / Coca-Cola Co / TopBuild Corp / Incyte Corp / Teva Pharmaceutical Industries Ltd / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Vail Resorts Inc / Coherus BioSciences Inc / Brown & Brown Inc / Marriott International Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Royal Caribbean Cruises Ltd / Carnival Corp / Choice Hotels International Inc / Diamondrock Hospitality Co / Arthur J Gallagher & Co / Installed Building Products Inc / KB Home / Renewable Energy Group Inc / Winnebago Industries Inc / Public Storage / DCP Midstream LP / Seacoast Banking Corporation of Florida / Aptinyx Inc / Extra Space Storage Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / GMS Inc / Host Hotels & Resorts Inc / Armstrong World Industries Inc / Owens Corning / Wyndham Hotels & Resorts Inc / IAC/Interactivecorp / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / CubeSmart / Ryman Hospitality Properties Inc / Interface Inc / Norwegian Cruise Line Holdings Ltd / National Storage Affiliates Trust / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Ferguson PLC / Ovintiv Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Israel / Liberia / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ESG Stratify™: Is Pharma at a positive ESG inflection point?</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / GILD.O / AMGN.O / 0989529 / TEVA.N / ABBV.N / PRGO.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / AstraZeneca PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Sara Mahaffy / Mr. Daniel J. Busby / Steve Daddeo / James Hong</td></tr>
<tr class="odd"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Wilson's Disease Primer</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">RARE.OQ / PFE.N / AZN.L</td><td class="leftalignment">Ultragenyx Pharmaceutical Inc / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mark Connolly / European Pharma Team / Mr. Tiago Fauth / Matthew Terwelp / Mr. Thomas Deal / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">03/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19 Vaccines: Modelling EU export controls</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">4507.T / CRDA.L / JNJ.N / PFE.N / AZN.L / SASY.PA / MRCG.DE / WCKH.BO / LONN.S / GSK.L / NVAX.OQ / SFZN.S / INO.OQ / 1099.HK / EVKN.DE / CTLT.N / CVAC.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Croda International PLC / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Merck KGaA / Wockhardt Ltd / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Siegfried Holding AG / Inovio Pharmaceuticals Inc / Sinopharm Group Co Ltd / Evonik Industries AG / Catalent Inc / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Germany / France / United Kingdom / India / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / UBX / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / COX.F / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / CKPT.O / EYPT.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / UNITY Biotechnology Inc / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Colonial Coal International Corp / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: Latest ASP data provides some insight into biosimilar price trends</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss New and Emerging Treatments in Medical Dermatology on 4/8 at 1PM ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ACRS.O / ARQT.O / JNJ / LLY / PFE / VYNE.O</td><td class="leftalignment">Aclaris Therapeutics Inc / Arcutis Biotherapeutics Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Vyne Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">RDY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">RDY / NVS / PFE / GSK / CPLFY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Dr Reddy's Laboratories Ltd / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Cipla Ltd / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / India / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">The COMIRNATY transformation</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US09075V1026 / US7170811035</td><td class="leftalignment">BioNTech SE / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Herr Daniel Wendorff</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 24 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FR0000120073 / NL0000226223 / FR0000054470 / DE0006231004 / DE0006969603 / US00724F1012 / US0079031078 / US0079731008 / US0231351067 / US0378331005 / US0382221051 / US0463531089 / US0997241064 / US1311931042 / US1727551004 / US1925761066 / US1985161066 / US2435371073 / US2546871060 / US2855121099 / US4581401001 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5184151042 / US55306N1046 / US5951121038 / US6541061031 / US67066G1040 / US7170811035 / US7392761034 / US7475251036 / US75886F1075 / US7782961038 / US8305661055 / US8610121027 / US8636671013 / US8725401090 / US8740541094 / US8807701029 / US91347P1057 / US9182041080 / US9282981086 / US9297401088 / US9581021055 / US98956P1021 / US3448491049 / US83088M1027 / US2533931026 / US1572101053 / US90385V1070 / US6098391054 / US9043111072 / US82706C1080 / US4103451021 / US5500211090 / US00507V1098 / US25470F1049 / US25470F3029 / IE00B58JVZ52 / DE000A1EWWW0 / US6936561009 / US7512121010 / US98986T1088 / NL0010273215 / US6951271005 / US55405Y1001 / KYG037AX1015 / US1220171060 / US4277461020 / US74736K1016 / US34959J1088 / KYG4740B1059 / US11135F1012 / US98585X1046 / US35137L1052 / US03828A1016 / CA16106R1091 / US50107A1043 / US72815L1070</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / STMicroelectronics NV / Ubisoft Entertainment SA / Infineon Technologies AG / Puma SE / Adobe Inc / Advanced Micro Devices Inc / Advanced Energy Industries Inc / Amazon.com Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Callaway Golf Co / Cirrus Logic Inc / Cohu Inc / Columbia Sportswear Co / Deckers Outdoor Corp / Walt Disney Co / Electronic Arts Inc / Intel Corp / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Lattice Semiconductor Corp / MKS Instruments Inc / Micron Technology Inc / Nike Inc / NVIDIA Corp / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Regeneron Pharmaceuticals Inc / Ross Stores Inc / Skechers USA Inc / STMicroelectronics NV / Stryker Corp / TJX Companies Inc / Take-Two Interactive Software Inc / Teradyne Inc / Universal Display Corp / VF Corp / Vishay Intertechnology Inc / Westinghouse Air Brake Technologies Corp / Western Digital Corp / Zimmer Biomet Holdings Inc / Foot Locker Inc / Skyworks Solutions Inc / DICK'S Sporting Goods Inc / CEVA Inc / Ultra Clean Holdings Inc / Monolithic Power Systems Inc / Under Armour Inc / Silicon Motion Technology Corp / HanesBrands Inc / Lululemon Athletica Inc / Activision Blizzard Inc / Discovery Inc / Discovery Inc / Seagate Technology Holdings PLC / Adidas AG / PVH Corp / Ralph Lauren Corp / Zynga Inc / ASML Holding NV / Pacira Biosciences Inc / MACOM Technology Solutions Holdings Inc / Ambarella Inc / Burlington Stores Inc / Heron Therapeutics Inc / Qorvo Inc / Fortive Corp / Ichor Holdings Ltd / Broadcom Inc / Yeti Holdings Inc / Fox Corp / Applied Therapeutics Inc / Charlotte's Web Holdings Inc / Kronos Bio Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Cayman Islands / Germany / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">2008154 / 2026242 / 2111955 / 2216850 / 2270726 / 2317087 / 2670519 / 2630085 / 2689560 / 2680905 / 2672689 / 2684703 / 2138158 / 7103065 / B3D7K31 / B23FN39 / B7TL820 / B4V9661 / BCBVTX1 / B7VD3F2 / B3X26D8 / B3V9F12 / BF09HX3 / BXDZ9Z0 / BK0VHF6 / BJ1N1M9 / BZ1LFB2 / BD8DJ71 / BJ1FD74 / BKVDFF7 / BLGJ610 / BZ8VJQ8 / BG31GH0 / BKTNTR9 / BHRWS81 / BJTJGC4 / BMC8SQ7</td><td class="leftalignment">Adobe Inc / American Electric Power Company Inc / Borgwarner Inc / Consolidated Edison Inc / Walt Disney Co / Entergy Corp / Exelon Corp / Neogen Corp / PG&E Corp / PPL Corp / Patterson Companies Inc / Pfizer Inc / Sempra Energy / Novartis AG / Discovery Inc / Lululemon Athletica Inc / Meta Platforms Inc / Ralph Lauren Corp / Agios Pharmaceuticals Inc / Duke Energy Corp / Pacira Biosciences Inc / PVH Corp / Tapestry Inc / Shopify Inc / IDEAYA Biosciences Inc / Capri Holdings Ltd / Deciphera Pharmaceuticals Inc / Snap Inc / Revolve Group Inc / Oric Pharmaceuticals Inc / Warner Music Group Corp / Vistra Corp / Y-mAbs Therapeutics Inc / ViacomCBS Inc / Levi Strauss & Co / Kontoor Brands Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">DCPH (BUY) - An Intriguing Entry Point? Previewing Phase III INTRIGUE Study Evaluating Qinlock in 2L Gastrointestinal Stromal Tumors (GIST)</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">BZ1LFB2 / 2684703 / BWY52P3</td><td class="leftalignment">Deciphera Pharmaceuticals Inc / Pfizer Inc / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Conference Call to Discuss the Recent FDA Regulatory Landscape on CRLs and Delays TODAY @ 10am ET</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / LLY / MRK / PFE / OMER.O / HGEN.O</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Omeros Corp / Humanigen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – 4Q Recap; ORIC-101 Ph I on Track for 2Q; 3 Addl. INDs in 2021</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">COVID-19 UPDATE: Low Dose REGN-COV2 Solid; AZN Faces Scrutiny; PFE Antiviral</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE.N / AZN.L / REGN.OQ / US0463531089 / US7170811035 / US75886F1075</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / AstraZeneca PLC / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Bermuda / Canada / Switzerland / Denmark / United Kingdom / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Yaron Werber, M.D., MD / Brendan Smith, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA (BUY) - Mgmt Discussion & Near-Term Investor Focus on MAT2A and MTAP Deletion; Earnings In-Line Heading into Multiple 2021 Milestones</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BK0VHF6 / 0925288 / 2684703 / BCBVTX1 / BBPK0J0</td><td class="leftalignment">IDEAYA Biosciences Inc / GlaxoSmithKline PLC / Pfizer Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">Multiple Upcoming Catalysts; April 20th Investor Day; PT to $32</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">IDYA=US / PFE=US / AZN=US / GSK=US / CLVS=US / RPTX=US</td><td class="leftalignment">IDEAYA Biosciences Inc / Pfizer Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Clovis Oncology Inc / Repare Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / OXY=US / RRC=US / WEN=US / T=US / BLD=US / DVN=US / TEVA=US / CMA=US / PEB=US / APA=US / CPE=US / EOG=US / REI=US / CHTR=US / H=US / MTN=US / VZ=US / XOM=US / CRK=US / LOW=US / WLL=US / PXD=US / PB=US / MGY=US / SWN=US / MUR=US / CHRS=US / MAR=US / UMPQ=US / MRO=US / LEG=US / TNL=US / HLT=US / HUM=US / CMCSA=US / DISH=US / WTFC=US / CBRL=US / ELY=US / CHH=US / CNX=US / CW=US / DRI=US / DRH=US / EQT=US / GFF=US / IBP=US / MAS=US / MRCY=US / MHK=US / REGI=US / GOLF=US / HTH=US / CVX=US / SIVB=US / ABCB=US / FBK=US / NHI=US / COP=US / DIN=US / BCO=US / TCBI=US / TPX=US / EXP=US / FHN=US / BECN=US / SHO=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / CLR=US / PRPL=US / LUMN=US / NMTR=US / WH=US / NOG=US / JACK=US / UTZ=US / TREX=US / AR=US / HGV=US / SBRA=US / PCRX=US / RLJ=US / ESTE=US / VAC=US / FBHS=US / BCEI=US / MTDR=US / PDCE=US / RHP=US / FANG=US / TILE=US / TMUS=US / NDLS=US / 00770K202 / VNOM=US / LOCO=US / SHAK=US / WING=US / SPNE=US / CABO=US / WVE=US / WLTW=US / 82982L103 / CDEV=US / IRTC=US / PK=US / PVAC=US / JELD=US / PLYA=US / SBOW=US / MBIN=US / BTAI=US / RTLR=US / FERG=US / GOCO=US / OVV=US / AZEK=US / 96758W101 / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Occidental Petroleum Corp / Range Resources Corp / Wendys Co / AT&T Inc / TopBuild Corp / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / Comerica Inc / Pebblebrook Hotel Trust / APA Corp (US) / Callon Petroleum Co / EOG Resources Inc / Ring Energy Inc / Charter Communications Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Exxon Mobil Corp / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Pioneer Natural Resources Co / Prosperity Bancshares Inc / Magnolia Oil & Gas Corp / Southwestern Energy Co / Murphy Oil Corp / Coherus BioSciences Inc / Marriott International Inc / Umpqua Holdings Corp / Marathon Oil Corp / Leggett & Platt Inc / Travel + Leisure Co / Hilton Worldwide Holdings Inc / Humana Inc / Comcast Corp / DISH Network Corp / Wintrust Financial Corp / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Choice Hotels International Inc / CNX Resources Corp / Curtiss-Wright Corp / Darden Restaurants Inc / Diamondrock Hospitality Co / EQT Corp / Griffon Corp / Installed Building Products Inc / Masco Corp / Mercury Systems Inc / Mohawk Industries Inc / Renewable Energy Group Inc / Acushnet Holdings Corp / Hilltop Holdings Inc / Chevron Corp / SVB Financial Group / Ameris Bancorp / FB Financial Corp / National Health Investors Inc / Conocophillips / Dine Brands Global Inc / Brinks Co / Texas Capital Bancshares Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Purple Innovation Inc / Lumen Technologies Inc / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / Northern Oil and Gas Inc / Jack in the Box Inc / UTZ Brands Inc / Trex Company Inc / Antero Resources Corp / Hilton Grand Vacations Inc / Sabra Health Care REIT Inc / Pacira Biosciences Inc / RLJ Lodging Trust / Earthstone Energy Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Civitas Resources Inc / Matador Resources Co / PDC Energy Inc / Ryman Hospitality Properties Inc / Diamondback Energy Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Aemetis Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Cable One Inc / WAVE Life Sciences Ltd / Willis Towers Watson PLC / SiteOne Landscape Supply Inc / Centennial Resource Development Inc / iRhythm Technologies Inc / Park Hotels & Resorts Inc / Ranger Oil Corp / JELD-WEN Holding Inc / Playa Hotels & Resorts NV / SilverBow Resources Inc / Merchants Bancorp / BioXcel Therapeutics Inc / Rattler Midstream LP / Ferguson PLC / Gohealth Inc / Ovintiv Inc / Azek Company Inc / WideOpenWest Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pfizer (PFE US) - COVID-19 profit injection</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2026242 / 2317087 / 2670519 / 2100920 / 2455965 / 2680905 / 2684703 / 2707677 / 2440637 / 2573083 / 2138158 / 7103065 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BK7Y2V9 / B0SDJB4 / BJFSR88 / BKVDFF7 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BZ1LFG7 / BMG75B4</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / American Electric Power Company Inc / Entergy Corp / Exelon Corp / FirstEnergy Corp / Biogen Inc / PPL Corp / Pfizer Inc / Public Service Enterprise Group Inc / CenterPoint Energy Inc / Sangamo Therapeutics Inc / Sempra Energy / Novartis AG / Duke Energy Corp / Eversource Energy / Alphabet Inc / Akero Therapeutics Inc / Zealand Pharma A/S / Uniqure NV / Oric Pharmaceuticals Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Roku Inc / Inventiva SA</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) - Previewing Upcoming ORIC-101 (GR Inhibitor) Phase I Data in 1H21</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BKVDFF7 / 2126335 / 2684703</td><td class="leftalignment">Oric Pharmaceuticals Inc / Bristol-Myers Squibb Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: Sumitomo Dainippon Pharma - Briefing on Sumitovant: Mix of expectations and concerns for two strategic products in US</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: 大日本住友製薬 - スミトバント説明会を開催、2つの米国戦略製品に対する期待と不安が交錯</td><td class="leftalignment">Japanese</td><td class="rightalignment">7</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Mar 12, 2021: Focus on 1Q21 trends for EU Majors</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">Quick Thoughts On Fasinumab Given Availability Of Tanezumab Briefing Docs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">881624209 / 717081103 / 532457108 / 75886F107</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Pfizer Inc / Eli Lilly and Co / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Societe Generale</td><td class="leftalignment">Pfizer (Hold, TP=$38) - 12m target downgrade - Refocusing on innovation, but more growth drivers would be welcome - F. Cespedes (6p)</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EQUITY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Florent Cespedes / Justin S. Smith / Manas Sarkar</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">FY2020 Annual Report: Pfizer profits hit by 40.9% fall</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Merck Stock Remains Significantly Undervalued At $77</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PDSB=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">PDS Biotechnology Corp / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">US0116591092 / US0126531013 / US0311621009 / US0463531089 / US1101221083 / US1264081035 / US22284P1057 / US3021301094 / US37733W1053 / US4433201062 / US4456581077 / US4581401001 / US4781601046 / US5150981018 / US5324571083 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US9029251066 / US9078181081 / US9507551086 / CA1363751027 / CA13645T1003 / AU000000LYC6 / US4771431016 / US4198791018 / US80105N1054 / US3463751087 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US45784P1012 / US58933Y1055 / US9100471096 / US92335C1062 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / US03937C1053 / CA0089118776 / US00653A1079 / CA87241L1094 / US23753F1075 / US80689H1023 / US04016X1019 / US4990491049 / CA53680Q2071 / US02083G1004 / US09354A1007 / US5904791358 / US28414H1032 / US0197701065 / US53814L1089 / US07373B1098 / US5533681012 / US74767V1098 / US7761531083 / US15961R1059</td><td class="leftalignment">Alaska Air Group Inc / Albemarle Corp / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Covenant Logistics Group Inc / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Intel Corp / Johnson & Johnson / Landstar System Inc / Eli Lilly and Co / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / USA Truck Inc / Union Pacific Corp / Werner Enterprises Inc / Canadian National Railway Co / Canadian Pacific Railway Ltd / Lynas Rare Earths Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Insulet Corp / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Air Canada / Adaptimmune Therapeutics PLC / TFI International Inc / Daseke Inc / Schneider National Inc / argenx SE / Knight-Swift Transportation Holdings Inc / Lithium Americas Corp / Alpine Immune Sciences Inc / Blink Charging Co / Mesa Air Group Inc / Elanco Animal Health Inc / Allogene Therapeutics Inc / Livent Corp / Beam Global / Mp Materials Corp / Quantumscape Corp / Romeo Power Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">Expecting Clarity on Clinical Development at R&D Day; Reiterate Buy</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee / Sean Kang</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">ALV.N / ANTO.L / BAC.N / BHP.AX / BK.N / C.N / CL.N / CP.TO / EDP.LS / EL.N / F.N / GM.N / JPM.N / KMB.N / KO.N / MRK.N / NCM.AX / NEM.N / NSC.N / PFE.N / RIO.AX / RIO.L / RSG.AX / T.N / VC.N / WFC.N / PEP.N / BFb.N / PG.N / GILD.O / FNV.N / CPB.N / TEN.N / AAL.L / CNR.TO / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / TV.TO / UNP.N / GS.N / CLX.N / CAG.N / GIS.N / EPC.N / SBM.AX / AMT.N / BOL.ST / NG.L / VZ.N / STT.N / EXEL.O / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / ACN.N / NBIX.O / CHD.N / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / VRTX.O / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / HCC.N / GPN.N / MNST.O / BLUE.O / CASY.O / BCRX.O / EQIX.O / ATDb.TO / IGO.AX / FMG.AX / GOLD.N / FM.TO / RMS.AX / NST.AX / 02209S103 / 878742204 / RRL.AX / DLR.N / WSA.AX / 427866108 / ALNY.O / 35671D857 / MS.N / FIS.N / ARWR.O / MA.N / CS.TO / HOG.N / 443628102 / 550372106 / BGS.N / NCU.TO / SLR.AX / DAN.N / EDPR.LS / OZL.AX / SFR.AX / NGD.A / OGC.TO / VALE.N / SPB.N / BHPB.L / GOR.AX / CAML.L / PCRX.O / MTOR.N / GLEN.L / EVN.AX / SPLK.OQ / PANW.N / MDLZ.OQ / 505440107 / TSLA.N / PRMW.N / TMUS.N / COTY.N / PRTA.O / AGIO.O / 81762P102 / 46579R104 / VRNS.O / CIA.TO / S32.AX / PYPL.OQ / GBT.OQ / IONS.O / RACE.MI / ADVM.OQ / TWLO.N / ADNT.N / CRSP.OQ / PBYI.OQ / OKTA.OQ / SAIL.N / APTV.N / NEXA.TO / ZS.OQ / VNE.N / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / OSMT.O / NWL.O / CRWD.O / PING.N / CRNC.OQ / REYN.O / SBSW.N / NKLA.OQ / FOUR.N / SPRB.OQ / 900435207 / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">Autoliv Inc / Antofagasta PLC / Bank of America Corp / BHP Group Ltd / Bank of New York Mellon Corp / Citigroup Inc / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Ford Motor Co / General Motors Co / JPMorgan Chase & Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Norfolk Southern Corp / Pfizer Inc / Rio Tinto Ltd / Rio Tinto PLC / Resolute Mining Ltd / AT&T Inc / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Tenneco Inc / Anglo American PLC / Canadian National Railway Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Trevali Mining Corp / Union Pacific Corp / Goldman Sachs Group Inc / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Boliden AB / National Grid PLC / Verizon Communications Inc / State Street Corp / Exelixis Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / Accenture PLC / Neurocrine Biosciences Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Warrior Met Coal Inc / Global Payments Inc / Monster Beverage Corp / bluebird bio Inc / Caseys General Stores Inc / BioCryst Pharmaceuticals Inc / Equinix Inc / Alimentation Couche-Tard Inc / IGO Ltd / Fortescue Metals Group Ltd / Barrick Gold Corp / First Quantum Minerals Ltd / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Teck Resources Ltd / Regis Resources Ltd / Digital Realty Trust Inc / Western Areas Ltd / Hershey Co / Alnylam Pharmaceuticals Inc / Freeport-McMoRan Inc / Morgan Stanley / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Mastercard Inc / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / B&G Foods Inc / Nevada Copper Corp / Silver Lake Resources Ltd / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Sandfire Resources Ltd / New Gold Inc / OceanaGold Corp / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Gold Road Resources Ltd / Central Asia Metals PLC / Pacira Biosciences Inc / Meritor Inc / Glencore PLC / Evolution Mining Ltd / Splunk Inc / Palo Alto Networks Inc / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Coty Inc / Prothena Corporation PLC / Agios Pharmaceuticals Inc / ServiceNow Inc / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / South32 Ltd / PayPal Holdings Inc / Global Blood Therapeutics Inc / Ionis Pharmaceuticals Inc / Ferrari NV / Adverum Biotechnologies Inc / Twilio Inc / Adient PLC / CRISPR Therapeutics AG / Puma Biotechnology Inc / Okta Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Nexa Resources SA / Zscaler Inc / Veoneer Inc / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Osmotica Pharmaceuticals PLC / Newell Brands Inc / CrowdStrike Holdings Inc / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / Nikola Corp / Shift4 Payments Inc / Spruce Biosciences Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Cayman Islands / Spain / United Kingdom / Ireland / Luxembourg / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">FULC: Fulcrum: Seeking Novel Solutions for Genetic Diseases; Initiate with an Outperform Rating and $26 TP</td><td class="leftalignment">English</td><td class="rightalignment">42</td><td class="leftalignment">FULC.OQ / 4502.T / BMY.N / CSL.AX / PFE.N / SASY.PA / NOVOB.CO / NOVN.S / GSK.L / BLUE.OQ / VRTX.OQ / ABBV.N / AGIO.OQ / MRTX.OQ / GBT.OQ / NTLA.OQ / IMRA.OQ / FMTX.OQ</td><td class="leftalignment">Fulcrum Therapeutics Inc / Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Pfizer Inc / Sanofi SA / Novo Nordisk A/S / Novartis AG / GlaxoSmithKline PLC / bluebird bio Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc / Global Blood Therapeutics Inc / Intellia Therapeutics Inc / Imara Inc / Forma Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Dr. Martin Auster, M.D. / Mark Connolly / Mr. Tiago Fauth / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">03/22/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">4Q20 Update – R&D Day to Set the Tone For 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Biotech: RBC’s Rare & Specialty Disease Day – Amyloidosis</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N / ALNY.O / PRTA.O / IONS.O</td><td class="leftalignment">Pfizer Inc / Alnylam Pharmaceuticals Inc / Prothena Corporation PLC / Ionis Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Luca Issi, PHD / Kennen MacKay, PHD / Lisa Walter / Edwin Delfin / Brian Abrahams, MD / Mr. Gregory J. Renza, MD / David Szeto / Leonid Timashev / Yinglu Zhang</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: SLDB makes progress in DMD</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">SLDB.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Solid Biosciences Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / PCRX.O / XERS.O / AQST.O / OSMT.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Pacira Biosciences Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / MRK</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Key Metrics Remain Above Pre-Pandemic Levels-Week 51</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Craig Hallum</td><td class="leftalignment">TRIL: TRIL Reports Annual Operating And Financial Results And Sets Date For R&D Day.</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">TRIL=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Robin Garner</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ARNA / MRNS / 45337C10 / 09058V10 / CYTK / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / RZLT / 81750R102 / 29604W108 / 462260100 / 45826J105 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 22978P106 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 03824M109 / 81181C104 / 517125100 / G637AM102 / 007002108 / M47364100 / 617760202 / N71542109</td><td class="leftalignment">Arena Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Cytokinetics Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Rezolute Inc / Seres Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Cue Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Applied Molecular Transport Inc. / Seagen Inc / Larimar Therapeutics Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / MorphoSys AG / ProQR Therapeutics NV</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Germany / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">BNGO=US / NBSE=US / MRK=US / CSII=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BAX=US / GSK=US / CRY=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / ATRC=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / EXEL=US / GEN=US / ICPT=US / LH=US / LIFE=US / NBIX=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / PRVB=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / ALPN=US / MIST=US / MD=US / SLF=US / ISR=US / SLP=US / MRNA=US / ACAD=US / MBRX=US / MNKD=US / GOOG=US / INO=US / LHCG=US / AGRX=US / CBAY=US / CHNG=US / INFI=US / TPTX=US / ORTX=US / PODD=US / EHC=US / NMTR=US / TNDM=US / SWAV=US / ASND=US / ADUS=US / ALPMY=US / ACHC=US / PRTA=US / ENTA=US / AGIO=US / FATE=US / AERI=US / TRVN=US / FLXN=US / MDWD=US / CTRE=US / ALDX=US / VBIV=US / XENT=US / AUPH=US / OTIC=US / VCEL=US / WBA=US / SNPHY=US / RLMD=US / EVH=US / GKOS=US / CFMS=US / CATB=US / IONS=US / VRAY=US / TCMD=US / AVDL=US / SRRA=US / SVRA=US / SLNO=US / URGN=US / VREX=US / IOVA=US / MTEM=US / VERU=US / KALA=US / MBIO=US / MDNA=US / MOTS=US / VCNX=US / CUE=US / MRKR=US / ORGO=US / PDSB=US / IDYA=US / BCYC=US / KRTX=US / XAIR=US / DMTK=US / ETNB=US / VERO=US / PNTG=US / AYLA=US / FMTX=US / NNOX=US / KDNY=US / VRDN=US / EVAX=US / SOBE=US</td><td class="leftalignment">Bionano Genomics Inc / NeuBase Therapeutics Inc / Merck & Co Inc / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Baxter International Inc / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / aTyr Pharma Inc / Neurocrine Biosciences Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / Alpine Immune Sciences Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Sun Life Financial Inc / IsoRay Inc / Simulations Plus Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Moleculin Biotech Inc / MannKind Corp / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Agile Therapeutics Inc / Cymabay Therapeutics Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Insulet Corp / Encompass Health Corp / 9 Meters Biopharma Inc / Tandem Diabetes Care Inc / Shockwave Medical Inc / Ascendis Pharma A/S / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Trevena Inc / Pacira Biosciences Inc / Mediwound Ltd / CareTrust REIT Inc / Aldeyra Therapeutics Inc / VBI Vaccines Inc / Intersect Ent Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Vericel Corp / Walgreens Boots Alliance Inc / Santen Pharmaceutical Co Ltd / Relmada Therapeutics Inc / Evolent Health Inc / Glaukos Corp / Conformis Inc / Astria Therapeutics Inc / Ionis Pharmaceuticals Inc / ViewRay Inc / Tactile Systems Technology Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Savara Inc / Soleno Therapeutics Inc / Urogen Pharma Ltd / Varex Imaging Corp / Iovance Biotherapeutics Inc / Molecular Templates Inc / Veru Inc / Kala Pharmaceuticals Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Motus GI Holdings Inc / Vaccinex Inc / Cue Biopharma Inc / Marker Therapeutics Inc / Organogenesis Holdings Inc / PDS Biotechnology Corp / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / Beyond Air Inc / DermTech Inc / 89Bio Inc / Venus Concept Inc / Pennant Group Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Nano-X Imaging Ltd / Chinook Therapeutics Inc / Viridian Therapeutics Inc / Evaxion Biotech A/S / AT&T Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Denmark / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Mar 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">GlobalData</td><td class="leftalignment">Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review</td><td class="leftalignment">English</td><td class="rightalignment">1134</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">GlobalData</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">FR0000120073 / US00724F1012 / US0091581068 / US00971T1016 / US02553E1064 / US09058V1035 / US1005571070 / US22160K1051 / US2546871060 / US31428X1063 / US3647601083 / US4781601046 / US5002551043 / US6549022043 / US6556641008 / US7782961038 / US8636671013 / US8725401090 / US87612E1064 / US92343V1044 / US9311421039 / US98956P1021 / US20030N1019 / US21036P1084 / US2538681030 / US19239V3024 / US2090341072 / US00206R1023 / US55616P1049 / US53261M1045 / US25470M1099 / US7181721090 / IE00B4BNMY34 / US03027X1000 / US29414B1044 / US5017971046 / US8725901040 / US8036071004 / US23283R1005 / CA89620X5064 / US22822V1017 / US29444U7000 / US12685J1051 / US16119P1084 / US36165L1089 / US78410G1040 / US91325V1089 / IL0011407140 / US02156K1034 / US65342K1051 / US87105L1044 / US02083G1004 / US6085501095 / US09354A1007 / US09857L1089 / US05455M1009 / US19626G1085 / US8693671021 / IE00BZ12WP82 / US35137L1052 / US39874R1014 / US92556H2067 / US07373B1098 / US5533681012 / US74767V1098 / US0090661010 / US7761531083 / US5502411037 / US15961R1059</td><td class="leftalignment">L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Adobe Inc / Air Products and Chemicals Inc / Akamai Technologies Inc / American Eagle Outfitters Inc / BioCryst Pharmaceuticals Inc / Boston Beer Company Inc / Costco Wholesale Corp / Walt Disney Co / FedEx Corp / Gap Inc / Johnson & Johnson / Kohls Corp / Nokia Oyj / Nordstrom Inc / Ross Stores Inc / Stryker Corp / TJX Companies Inc / Target Corp / Verizon Communications Inc / Walmart Inc / Zimmer Biomet Holdings Inc / Comcast Corp / Constellation Brands Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / AT&T Inc / Macy's Inc / Limelight Networks Inc / DISH Network Corp / Philip Morris International Inc / Accenture PLC / American Tower Corp / Epam Systems Inc / Bath & Body Works Inc / T-Mobile US Inc / Sarepta Therapeutics Inc / CyrusOne Inc / Pfizer Inc / Crown Castle International Corp / Equinix Inc / Cable One Inc / Charter Communications Inc / GDS Holdings Ltd / SBA Communications Corp / Uniti Group Inc / Urogen Pharma Ltd / Altice USA Inc / NextDecade Corp / Switch Inc / Alpine Immune Sciences Inc / Molecular Templates Inc / Blink Charging Co / Booking Holdings Inc / AVROBIO Inc / DigitalBridge Group Inc / Sutro Biopharma Inc / Linde PLC / Fox Corp / Grocery Outlet Holding Corp / ViacomCBS Inc / Beam Global / Mp Materials Corp / Quantumscape Corp / Airbnb Inc / Romeo Power Inc / Lumen Technologies Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / Finland / France / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Ladenburg Thalmann & Co. Inc.</td><td class="leftalignment">FY20 Result For A Transformative Year; R&D Day on 4/28 As Key Near-Term Catalyst</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wangzhi Li, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: 大日本住友製薬 - ラツーダ・リスクは終わっていない、株価上昇に要注意</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">03/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: Sumitomo Dainippon Pharma - Latuda risk persists, potentially limiting upside</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">R&D Day in April to Disclose Data, Clinical Development Plan, and New Trials</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Up to 5 is Better Than 1 (Number of Recognized Tumor-Associated Antigens); Initiating at OW, $6 PT</td><td class="leftalignment">English</td><td class="rightalignment">66</td><td class="leftalignment">MRKR.O / MRK / PFE / US31189P1021</td><td class="leftalignment">Marker Therapeutics Inc / Merck & Co Inc / Pfizer Inc / Fate Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call Starting in 15 mins: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Will AstraZeneca's Covid-19 Troubles Help Pfizer Stock?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">BNRGN.DE / VERB.VI / BMWG.DE / F.N / HEIG.F / PFE.N / RENA.PA / VOD.L / VOWG.DE / AZN.L / FMEG.DE / DANSKE.CO / HLAG.DE</td><td class="leftalignment">Brenntag SE / Verbund AG / Bayerische Motoren Werke AG / Ford Motor Co / HeidelbergCement AG / Pfizer Inc / Renault SA / Vodafone Group PLC / Volkswagen AG / AstraZeneca PLC / Fresenius Medical Care AG & Co KGaA / Danske Bank A/S / Hapag Lloyd AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Germany / Denmark / Finland / France / United Kingdom / Israel / Italy / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Christian Aust / Frau. Jana Schuler / Herr Sven Kreitmair, CFA / Herr Gianfranco Arcovito / Herr Jonathan Schroer / Frau Silke Stegemann / Herr Tobias Keller / Herr Natalie Tehrani Monfared / Herr. Michael Teig</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Today): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">LLY=US / PFE=US / MDT=US / PD=US / BLD=US / CMA=US / PEB=US / REI=US / H=US / MTN=US / PB=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TNL=US / VMC=US / HLT=US / MLM=US / WTFC=US / AIR=US / CHH=US / CSTR=US / DRH=US / ENDP=US / IBP=US / PACW=US / REGI=US / WAL=US / HTH=US / SAGE=US / BXS=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / BOKF=US / FBK=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / UCBI=US / PNFP=US / SBCF=US / BIIB=US / TCBI=US / FNB=US / FHN=US / SHO=US / RNST=US / BLDR=US / HST=US / CADE=US / WH=US / 45665G303 / HGV=US / RLJ=US / VAC=US / RHP=US / ABBV=US / IBTX=US / SHAK=US / SUM=US / LOB=US / ACBI=US / PK=US / PLYA=US / YEXT=US / MBIN=US / MAXR=US / HWC=US / OZK=US / AMTB=US / UBER=US / FERG=US / AHCO=US / ARQT=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Medtronic PLC / PagerDuty Inc / TopBuild Corp / Comerica Inc / Pebblebrook Hotel Trust / Ring Energy Inc / Hyatt Hotels Corp / Vail Resorts Inc / Prosperity Bancshares Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / Travel + Leisure Co / Vulcan Materials Co / Hilton Worldwide Holdings Inc / Martin Marietta Materials Inc / Wintrust Financial Corp / AAR Corp / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / Endo International PLC / Installed Building Products Inc / PacWest Bancorp / Renewable Energy Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / SAGE Therapeutics Inc / Cadence Bank / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / BOK Financial Corp / FB Financial Corp / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / Biogen Inc / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Renasant Corp / Builders FirstSource Inc / Host Hotels & Resorts Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / Infinity Pharmaceuticals Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Shake Shack Inc / Summit Materials Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Yext Inc / Merchants Bancorp / Maxar Technologies Inc / Hancock Whitney Corp / Bank Ozk / Amerant Bancorp Inc / Uber Technologies Inc / Ferguson PLC / Adapthealth Corp / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China - Wuxi Biologics: String of M&As increases capacity, suggesting high business demand . Maintain OUTPERFORM</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2269.HK / PFE.N / ICLR.OQ / IQV.N / SYNH.OQ</td><td class="leftalignment">WuXi Biologics (Cayman) Inc / Pfizer Inc / ICON PLC / IQVIA Holdings Inc / Syneos Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / Ireland / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">03/18/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">COVID-19: March 2021 Update. Vaccine rollout progress and projections</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">4507.T / JNJ.N / PFE.N / AZN.L / SASY.PA / LONN.S / GSK.L / NVAX.OQ / INO.OQ / 1099.HK / CVAC.OQ</td><td class="leftalignment">Shionogi & Co Ltd / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Inovio Pharmaceuticals Inc / Sinopharm Group Co Ltd / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / France / United Kingdom / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">ABBV, LLY, PFE: JAKs running into a brick wall, or just another bump in the road</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE.N / 00287Y109 / 532457108 / 717081103</td><td class="leftalignment">Pfizer Inc / Abbvie Inc / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on March 18th (Tomorrow): The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Rinvoq news could create a temporary overhang for Rinvoq and other JAKs</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ABBV=US / LLY=US / PFE=US / ARQT=US</td><td class="leftalignment">Abbvie Inc / Eli Lilly and Co / Pfizer Inc / Arcutis Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ABBV - Our thoughts on today's RINVOQ updates after speaking with the company; our view on approvability in AD and PsA is unchanged</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N / ABBV.N</td><td class="leftalignment">Pfizer Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AKRO=US / LOGC=US / PFE=US / DRRX=US / ICPT=US / SGMO=US / SELB=US / ALNY=US / RGNX=US / SRPT=US / PTCT=US / OPHT=US / QURE=US / AGTC=US / CLLS=US / VKTX=US / VYGR=US / EDIT=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / KRYS=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / MGTX=US / CWBR=US / NGM=US / AXLA=US / ETNB=US / PASG=US / SIGHT:FP=FR / TSHA=US</td><td class="leftalignment">Akero Therapeutics Inc / LogicBio Therapeutics Inc / Pfizer Inc / DURECT Corp / Intercept Pharmaceuticals Inc / Sangamo Therapeutics Inc / Selecta Biosciences Inc / Alnylam Pharmaceuticals Inc / Regenxbio Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Iveric Bio Inc / Uniqure NV / Applied Genetic Technologies Corp / Cellectis SA / Viking Therapeutics Inc / Voyager Therapeutics Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Krystal Biotech Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / MeiraGTx Holdings PLC / CohBar Inc / NGM Biopharmaceuticals Inc / Axcella Health Inc / 89Bio Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / France / Korea, Republic of / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Reminder: Doc Call on 18th March: The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2126335 / 2778844 / 2475833 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Johnson & Johnson / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">2367026 / 2577609 / 2936921 / 2050832 / 2026242 / 2113393 / 2542049 / 2829515 / 2328915 / 2342034 / 2100920 / 2471950 / 2684703 / 2048804 / 5531000 / B121557 / B067BM3 / B7TL820 / B7VD3F2 / BBGVT40 / BDZCRX3 / BFLR866 / BVVN4Q8 / BYVY8G0 / BYW36M8 / BDHF4K6 / BK7Y2V9 / BZBY005 / BZ8FPH3 / BZ8VJQ8 / BGSP7M9 / BP84RX0 / BK71LV3 / BGT0PL8 / BMDJ085</td><td class="leftalignment">General Mills Inc / CVS Health Corp / Walmart Inc / Ameren Corp / American Electric Power Company Inc / Boston Beer Company Inc / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Incyte Corp / Pfizer Inc / Pinnacle West Capital Corp / MorphoSys AG / Mastercard Inc / Molson Coors Beverage Co / Meta Platforms Inc / Duke Energy Corp / News Corp / RingCentral Inc / Twitter Inc / Eversource Energy / Alphabet Inc / PayPal Holdings Inc / CRISPR Therapeutics AG / Akero Therapeutics Inc / Merus NV / Editas Medicine Inc / Vistra Corp / Zoom Video Communications Inc / Townsquare Media Inc / Relmada Therapeutics Inc / DiaMedica Therapeutics Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US -  Dividend Quality Analysis, for the period ended March 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">SYN-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">SYN / ABT / MRK / PFE / AZN.O / BIIB.O / TEVA.K</td><td class="leftalignment">Synthetic Biologics Inc / Abbott Laboratories / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Biogen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">IDRA-US - Fundamental Analysis, for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">IDRA.O / ABT / JNJ / MRK / PFE / AMGN.O / AGEN.O / LGND.O / BIIB.O / DVAX.O / CLDX.O</td><td class="leftalignment">Idera Pharmaceuticals Inc / Abbott Laboratories / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / Agenus Inc / Ligand Pharmaceuticals Inc / Biogen Inc / Dynavax Technologies Corp / Celldex Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">CORT-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CORT.O / BMY / JNJ / LLY / MRK / NVS / PFE / BMRN.O / ESPR.O / MNKD.O</td><td class="leftalignment">Corcept Therapeutics Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Biomarin Pharmaceutical Inc / Esperion Therapeutics Inc / MannKind Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Annual Update - Pfizer up 0.59% from 7 week low</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Doc Call on 18th March:  The Emerging HIV Pipeline – KOL Takeaways from Recent Conferences and Market Developments</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">0925288 / 2778844 / 2369174 / 2684703</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Gilead Sciences Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Mr. Etzer Darout / Tarun Soni / Mr. Evan B. Wang / Paul Jeng, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Rethinking Pharma Merger Reviews Could Create Some Headline Risks For The Industry</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY.N / MRK.N / 0715.HK / JNJ.N / PFE.N / ZTS.N / IMAB.OQ</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">SLDB (Buy): Solid might just be fully back on track in DMD (PT +60% to $20)</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">SLDB=US / PFE=US / RGNX=US / SRPT=US / PTCT=US / QURE=US / AGTC=US / VYGR=US / EDIT=US / ADVM=US / CRSP=US / ALSEN=FR / FIXX=US / PASG=US / SIGHT:FP=FR / TSHA=US</td><td class="leftalignment">Solid Biosciences Inc / Pfizer Inc / Regenxbio Inc / Sarepta Therapeutics Inc / PTC Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Voyager Therapeutics Inc / Editas Medicine Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / Homology Medicines Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Miri, Miri on the Wall, Who's Got The Best UC Treatment Of Them All</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY / JNJ / PFE / IMAB</td><td class="leftalignment">Eli Lilly and Co / Johnson & Johnson / Pfizer Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AACR 2021 Virtual Meeting Planner</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">PFE=US / AMGN=US / INCY=US / GILD=US / SAN=FR / AZN=US / GSK=US / JNJ=US / IMGN=US / EXAS=US / ILMN=US / HOOK=US / REGN=US / NTRA=US / TPTX=US / BOLT=US / NEO=US / RCUS=US / VSTM=US / ABBV=US / MRTX=US / FATE=US / MGNX=US / KPTI=US / XNCR=US / AFMD=US / BPMC=US / BGNE=US / MRUS=US / MRSN=US / GH=US / BHC=US / REPL=US / RUBY=US / SBTX=US / TWST=US / HARP=US / TCRR=US / BNTX=US / GMAB=US / RVMD=US / ZNTL=US / ITOS=US / MOLN=DE</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Incyte Corp / Gilead Sciences Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / ImmunoGen Inc / Exact Sciences Corp / Illumina Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Natera Inc / Turning Point Therapeutics Inc / Bolt Biotherapeutics Inc / Neogenomics Inc / Arcus Biosciences Inc / Verastem Inc / Abbvie Inc / Mirati Therapeutics Inc / Fate Therapeutics Inc / MacroGenics Inc / Karyopharm Therapeutics Inc / Xencor Inc / Affimed NV / Blueprint Medicines Corp / Beigene Ltd / Merus NV / Mersana Therapeutics Inc / Guardant Health Inc / Bausch Health Companies Inc / Replimune Group Inc / Rubius Therapeutics Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / BioNTech SE / Genmab A/S / Revolution Medicines Inc / Zentalis Pharmaceuticals Inc / Iteos Therapeutics Inc / Molecular Partners AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges / Dr. Andrew S. Berens, MD / Mr. Jonathan W. Chang, PHD / Mr. Puneet Souda</td></tr>
<tr class="even"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2026242 / 2942605 / 2317087 / 2328915 / 2342034 / 2369174 / 2630513 / 2684703 / 2048804 / 2980906 / 7103065 / B121557 / B1Y9TB3 / 2857817 / B2R3PV1 / B28TS42 / B7TL820 / B7VD3F2 / BVVN4Q8 / BYVY8G0 / BF4VBS8 / BP7RS48 / BFZ1K46 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BKTNTR9 / BDD1B07 / BP8XZL1 / BFY7DC4</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Entergy Corp / Nextera Energy Inc / Fiserv Inc / Gilead Sciences Inc / New Jersey Resources Corp / Pfizer Inc / Pinnacle West Capital Corp / Foot Locker Inc / Novartis AG / Mastercard Inc / Danone SA / Netflix Inc / American Water Works Company Inc / Ulta Beauty Inc / Meta Platforms Inc / Duke Energy Corp / Eversource Energy / Alphabet Inc / BioXcel Therapeutics Inc / Intersect Ent Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / Vistra Corp / ViacomCBS Inc / Rubius Therapeutics Inc / Healthequity Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / GILD=US / AMT=US / VZ=US / LOW=US / PB=US / CHRS=US / LEG=US / DISH=US / BNL=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGN=US / REGI=US / SBAC=US / STOR=US / ABCB=US / ADC=US / BOKF=US / FFIN=US / DIN=US / BIIB=US / TPX=US / EXP=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / CMG=US / REX=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / CADE=US / TAST=US / QSR=US / PRPL=US / EPRT=US / JACK=US / TREX=US / CUBE=US / FBHS=US / TILE=US / TMUS=US / NDLS=US / CNCE=US / LOCO=US / HQY=US / SHAK=US / RLMD=US / WING=US / ZG=US / 82982L103 / ANAB=US / JELD=US / RDFN=US / BTAI=US / OPCH=US / AZEK=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / American Tower Corp / Verizon Communications Inc / Lowe's Companies Inc / Prosperity Bancshares Inc / Coherus BioSciences Inc / Leggett & Platt Inc / DISH Network Corp / Bunzl plc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / SBA Communications Corp / STORE Capital Corp / Ameris Bancorp / Agree Realty Corp / BOK Financial Corp / First Financial Bankshares Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Essential Properties Realty Trust Inc / Jack in the Box Inc / Trex Company Inc / CubeSmart / Fortune Brands Home & Security Inc / Interface Inc / T-Mobile US Inc / Noodles & Co / Concert Pharmaceuticals Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Shake Shack Inc / Relmada Therapeutics Inc / Wingstop Inc / Zillow Group Inc / SiteOne Landscape Supply Inc / AnaptysBio Inc / JELD-WEN Holding Inc / Redfin Corp / BioXcel Therapeutics Inc / Option Care Health Inc / Azek Company Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Mar 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Deep Dive: Highlighting the Knee Pain OA Market Ahead of TLC599 Phase 3 Results in 2H21E</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">PFE / US0311621009 / US75886F1075</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">EVLO=US / ADAP=US / MRK=US / LLY=US / PFE=US / BMY=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / JNJ=US / BMRN=US / BLUE=US / ISEE=US / EXAS=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NESN=US / KLDO=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / DDDD=GB / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / MCRB=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PHGE=US / PASG=US / SIGHT:FP=FR / FBRX=US / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Evelo Biosciences Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Bristol-Myers Squibb Co / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Exact Sciences Corp / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Nestle SA / Kaleido Biosciences Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / 4D Pharma PLC / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Seres Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Biomx Inc / Passage Bio Inc / Gensight Biologics SA / Forte Biosciences Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 15 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">FR0000054470 / BE0165385973 / US0079731008 / US0116591092 / US0320951017 / US0382221051 / US0463531089 / US0997241064 / US1101221083 / US1925761066 / US2371941053 / US2855121099 / US37733W1053 / US45167R1041 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6284641098 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8740541094 / US8793601050 / US8807701029 / US9021041085 / US91347P1057 / US4771431016 / US4198791018 / US80105N1054 / US0003752047 / US3463751087 / US90385V1070 / PAP310761054 / US01748X1028 / US2473617023 / US5500211090 / US00507V1098 / CA9609083097 / CA0585861085 / US58933Y1055 / US5218652049 / US88160R1014 / US9100471096 / US92839U2069 / JE00B783TY65 / US98986T1088 / US00287Y1091 / NL0010273215 / US72919P2020 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US98138J2069 / US45073V1089 / KYG4740B1059 / US05351X1019 / US92336X1090 / US5904791358 / US1567271093 / US92537N1081 / US22041X1028 / US33813J1060 / US72815L1070</td><td class="leftalignment">Ubisoft Entertainment SA / Melexis NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Amphenol Corp / Applied Materials Inc / AstraZeneca PLC / Borgwarner Inc / Bristol-Myers Squibb Co / Cohu Inc / Darden Restaurants Inc / Electronic Arts Inc / GlaxoSmithKline PLC / IDEX Corp / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Myers Industries Inc / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Take-Two Interactive Software Inc / Teledyne Technologies Inc / Teradyne Inc / II-VI Inc / Universal Display Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Abb Ltd / FormFactor Inc / Ultra Clean Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Lululemon Athletica Inc / Activision Blizzard Inc / Westport Fuel Systems Inc / Ballard Power Systems Inc / Merck & Co Inc / Lear Corp / Tesla Inc / United Airlines Holdings Inc / Visteon Corp / Aptiv PLC / Zynga Inc / Abbvie Inc / ASML Holding NV / Plug Power Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Workhorse Group Inc / ITT Inc / Ichor Holdings Ltd / Avaya Holdings Corp / Veoneer Inc / Mesa Air Group Inc / Cerence Inc / Vertiv Holdings Co / Corsair Gaming Inc / Fisker Inc / Playtika Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">ABF.L / AEP.N / ALV.N / AU.N / CAS.TO / CI.N / CL.N / CMS.N / EDP.LS / EIX.N / EL.N / F.N / FGP.L / GM.N / GOG.L / HMb.ST / IBE.MC / IP.N / JD.L / KBH.N / KMB.N / KO.N / MKS.L / MRK.N / NCM.AX / NEM.N / NXT.L / PD.N / PFE.N / PHM.N / RSG.AX / RYN.N / SO.N / T.N / TOL.N / VC.N / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / GILD.O / FNV.N / CPB.N / LPX.N / TEN.N / CMCSA.O / AMGN.O / INCY.O / DUK.N / AGI.N / BWA.N / LEA.N / PNM.N / K.N / DT.N / DISH.O / LEN.N / CLX.N / CAG.N / GIS.N / AEM.N / EPC.N / SBM.AX / AMT.N / KGC.N / NKE.N / JAZZ.O / CONE.O / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / FISV.O / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / NWN.N / BC.N / SAM.N / ITX.MC / BMRN.O / OPTN.O / REGN.O / ENR.N / JHX.AX / CEY.L / NCR.N / NET.N / TEL.N / GFI.N / ASC.L / CNP.N / ENDP.O / CPK.N / PII.N / ST.N / SEM.N / SGEN.OQ / GPN.N / MNST.O / RGLD.O / BLUE.O / CASY.O / EQIX.O / ATDb.TO / BIIB.O / GOLD.N / RMS.AX / NST.AX / 02209S103 / CWX.TO / RRL.AX / DLR.N / IAG.N / 427866108 / WEF.TO / FIS.N / ARWR.O / TEVA.N / MA.N / HOG.N / MERC.O / AUY.N / ATL.MI / BGS.N / HOCM.L / SLR.AX / ENSG.O / DAN.N / NOG.A / FRES.L / NGD.A / CLW.N / OGC.TO / ADUS.OQ / EGO.N / ADN.TO / SPB.N / NEE.N / GOR.AX / PCH.O / CFX.TO / PCRX.O / CTT.N / MTOR.N / IFP.TO / POLYP.L / EVN.AX / SPLK.OQ / RFP.N / BOSSn.DE / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / COTY.N / PRTA.O / 81762P102 / CFF.TO / LB.N / KPTI.O / XNCR.OQ / VRNS.O / BOOH.L / BTG.N / AGRX.O / RYAM.N / ZALG.DE / 03835T200 / SHOP.N / WRK.N / SGRY.O / RACE.MI / TWLO.N / OR.N / ADNT.N / CRSP.OQ / GDS.O / SAND.N / AQN.N / OKTA.OQ / VST.N / WPM.N / KL.N / ATNX.O / SAIL.N / APTV.N / EHC.N / SDRY.L / ZS.OQ / AMRX.N / ITRM.O / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / FOCS.O / ESTC.N / GMDA.OQ / OSMT.O / NWL.O / OPI.OQ / CRWD.O / GMAB.O / PING.N / APRE.OQ / CRNC.OQ / IGMS.O / FRAS.L / REYN.O / SBSW.N / IGIC.OQ / NKLA.OQ / FOUR.N / GOCO.O / ALOO.O / MAX.N / WFG.N / AG1G.DE / 120291281 / 120681711</td><td class="leftalignment">Associated British Foods PLC / American Electric Power Company Inc / Autoliv Inc / AngloGold Ashanti Ltd / Cascades Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / H & M Hennes & Mauritz AB / Iberdrola SA / International Paper Co / JD Sports Fashion PLC / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Marks and Spencer Group PLC / Merck & Co Inc / Newcrest Mining Ltd / Newmont Corporation / Next PLC / PagerDuty Inc / Pfizer Inc / Pultegroup Inc / Resolute Mining Ltd / Rayonier Inc / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Gilead Sciences Inc / Franco-Nevada Corp / Campbell Soup Co / Louisiana-Pacific Corp / Tenneco Inc / Comcast Corp / Amgen Inc / Incyte Corp / Duke Energy Corp / Alamos Gold Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Kellogg Co / Dynatrace Inc / DISH Network Corp / Lennar Corp / Clorox Co / Conagra Brands Inc / General Mills Inc / Agnico Eagle Mines Ltd / Edgewell Personal Care Co / St Barbara Ltd / American Tower Corp / Kinross Gold Corp / Nike Inc / Jazz Pharmaceuticals PLC / CyrusOne Inc / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Northwest Natural Holding Co / Brunswick Corp / Boston Beer Company Inc / Industria de Diseno Textil SA / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / James Hardie Industries PLC / Centamin PLC / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Gold Fields Ltd / ASOS PLC / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Select Medical Holdings Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Royal Gold Inc / bluebird bio Inc / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Barrick Gold Corp / Ramelius Resources Ltd / Northern Star Resources Ltd / Altria Group Inc / Doman Building Materials Group Ltd / Regis Resources Ltd / Digital Realty Trust Inc / IAMGOLD Corp / Hershey Co / Western Forest Products Inc / Fidelity National Information Services Inc / Arrowhead Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Mercer International Inc / Yamana Gold Inc / Atlantia SpA / B&G Foods Inc / Hochschild Mining PLC / Silver Lake Resources Ltd / Ensign Group Inc / Dana Inc / Northern Oil and Gas Inc / Fresnillo PLC / New Gold Inc / Clearwater Paper Corp / OceanaGold Corp / Addus Homecare Corp / Eldorado Gold Corp / Acadian Timber Corp / Spectrum Brands Holdings Inc / Nextera Energy Inc / Gold Road Resources Ltd / Potlatchdeltic Corp / Canfor Pulp Products Inc / Pacira Biosciences Inc / CatchMark Timber Trust Inc / Meritor Inc / Interfor Corp / Polymetal International PLC / Evolution Mining Ltd / Splunk Inc / Resolute Forest Products Inc / Hugo Boss AG / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / Coty Inc / Prothena Corporation PLC / ServiceNow Inc / Conifex Timber Inc / Bath & Body Works Inc / Karyopharm Therapeutics Inc / Xencor Inc / Varonis Systems Inc / boohoo group plc / B2Gold Corp / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Zalando SE / Aptose Biosciences Inc / Shopify Inc / Westrock Co / Surgery Partners Inc / Ferrari NV / Twilio Inc / Osisko Gold Royalties Ltd / Adient PLC / CRISPR Therapeutics AG / GDS Holdings Ltd / Sandstorm Gold Ltd / Algonquin Power & Utilities Corp / Okta Inc / Vistra Corp / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Encompass Health Corp / Superdry PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Iterum Therapeutics PLC / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Focus Financial Partners Inc / Elastic NV / Gamida Cell Ltd / Osmotica Pharmaceuticals PLC / Newell Brands Inc / Office Properties Income Trust / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Aprea Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / Frasers Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / Nikola Corp / Shift4 Payments Inc / Gohealth Inc / Allogene Therapeutics Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / AUTO1 Group SE / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma Feedback: GSK: Readacross from Merck/Gilead collaboration in HIV</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">GILD.OQ / GSK.L / MRK.N / 4507.T / PFE.N</td><td class="leftalignment">Gilead Sciences Inc / GlaxoSmithKline PLC / Merck & Co Inc / Shionogi & Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US -  Dividend Quality Analysis, for the period ended January 14,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / TEVA.N / PCRX.O / AGRX.O / AMRX.N / OSMT.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Osmotica Pharmaceuticals PLC</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EBS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">EBS / MRK / PFE / GSK / XOMA.O / SIGA.O / CLDX.O / CMRX.O / SNGX.O / TEVA.K</td><td class="leftalignment">Emergent BioSolutions Inc / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / XOMA Corp / SIGA Technologies Inc / Celldex Therapeutics Inc / Chimerix Inc / Soligenix Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE / MRK</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: BNTX/PFE efficacy in C19; (+) LentiGlobin news</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE.N / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / BAX=US / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Pfizer Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">03/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: New Trial Starts Continue to Increase - Week 50</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 12 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">OPT=US / VBIV=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / BMY=US / MDT=US / AMZN=US / WMT=US / INSP=US / CMS=US / GILD=US / DGX=US / BBI=US / RMD=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ISRG=US / LH=US / PHAR=US / REGN=US / USPH=US / UHS=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MRNS=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / GOOG=US / INO=US / LHCG=US / CHNG=US / EHC=US / NMTR=US / TMDI=US / SPRO=US / ASND=US / ADUS=US / ACHC=US / PRTA=US / OM=US / FLXN=US / CTRE=US / ALDX=US / XENT=US / WBA=US / EVH=US / ZBH=US / CATB=US / LIVN=US / CERC=US / AVDL=US / SRRA=US / SLNO=US / SYNH=US / FIXX=US / MRKR=US / GMDA=US / PDSB=US / TMDX=US / BCYC=US / KRTX=US / BNTX=US / PNTG=US</td><td class="leftalignment">Opthea Ltd / VBI Vaccines Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Amazon.com Inc / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Brickell Biotech Inc / Resmed Inc / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Laboratory Corporation of America Holdings / Pharming Group NV / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Marinus Pharmaceuticals Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / 9 Meters Biopharma Inc / Titan Medical Inc / Spero Therapeutics Inc / Ascendis Pharma A/S / Addus Homecare Corp / Acadia Healthcare Company Inc / Prothena Corporation PLC / Outset Medical Inc / Pacira Biosciences Inc / CareTrust REIT Inc / Aldeyra Therapeutics Inc / Intersect Ent Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Zimmer Biomet Holdings Inc / Astria Therapeutics Inc / LivaNova PLC / Avalo Therapeutics Inc / Avadel Pharmaceuticals PLC / Sierra Oncology Inc / Soleno Therapeutics Inc / Syneos Health Inc / Homology Medicines Inc / Marker Therapeutics Inc / Gamida Cell Ltd / PDS Biotechnology Corp / Transmedics Group Inc / Bicycle Therapeutics PLC / Karuna Therapeutics Inc / BioNTech SE / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.12.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / ALDX=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / Aldeyra Therapeutics Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ARNA / MRNS / 45337C10 / 09058V10 / CYTK / 00422510 / 40637H10 / IDRA / 84763A108 / ABUS / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 81750R102 / 29604W108 / 29664W105 / 462260100 / 45826J105 / 558868105 / 23306J101 / 12648L601 / 89532E109 / 603380106 / 54142F102 / 019770106 / H17182108 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / 21900C308 / 517125100 / G637AM102 / 007002108 / M47364100 / N71542109 / 206022105 / 72942A107</td><td class="leftalignment">Arena Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Cytokinetics Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Arbutus Biopharma Corp / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Seres Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Intellia Therapeutics Inc / Madrigal Pharmaceuticals Inc / DBV Technologies SA / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / LogicBio Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / CorMedix Inc / Larimar Therapeutics Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / PLx Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Portfolio Manager's Weekly - March 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">FR0000121014 / US0028241000 / US00738A1060 / US00846U1016 / US0126531013 / US02553E1064 / US0311621009 / US0463531089 / US1101221083 / US17275R1023 / US22160K1051 / US2358511028 / US30226D1063 / US3156161024 / US3377381088 / US3647601083 / US3755581036 / US37733W1053 / US4364401012 / US4523271090 / US4781601046 / US48203R1041 / US5002551043 / US5324571083 / US6245801062 / US62855J1043 / US6549022043 / US6556641008 / US66987V1098 / US6701002056 / US7140461093 / US7170811035 / US75886F1075 / US87612E1064 / US8835561023 / US9021041085 / US91307C1027 / US9311421039 / US9418481035 / US30063P1057 / US37940X1028 / AU000000LYC6 / US2948216088 / US1167941087 / US31620M1062 / US57636Q1040 / US1717793095 / US79546E1047 / US55616P1049 / US90384S3031 / US92826C8394 / US58933Y1055 / US13100M5094 / US1920051067 / US9100471096 / US69404D1081 / US92335C1062 / US98978V1035 / US5017971046 / US64051T1007 / US45845P1084 / US69366J2006 / US63009R1095 / US03823U1025 / CH0210483332 / US09062W2044 / US0404131064 / US78667J1088 / US0994061002 / IE00BTN1Y115 / US46185L1035 / US6323071042 / US70450Y1038 / US72703H1014 / US8522341036 / US26856L1035 / US74967X1037 / NL0012169213 / CA1350861060 / US03236M2008 / US8760301072 / CA53680Q2071 / US74766Q1013 / US7625441040 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / KY30744W1070 / US40131M1099 / US53814L1089 / US90184D1000 / VGG1890L1076 / US05352A1007 / US76156B1070 / US71535D1063 / US39874R1014 / US00650F1093 / US88339P1012 / US24984K1051 / US88025U1097 / US30068X1037 / US92766K1060 / US14448C1045 / US12233L1070 / US57667L1070 / US0843101017 / US07373B1098 / CA67079A1021 / US5533681012 / US74767V1098 / US81578P1066 / US65443P1021 / US7761531083 / US73739W1045 / US55406W1036 / US12047B1052 / US15961R1059</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abbott Laboratories / ADTRAN Inc / Agilent Technologies Inc / Albemarle Corp / American Eagle Outfitters Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Cisco Systems Inc / Costco Wholesale Corp / Danaher Corp / Extreme Networks Inc / F5 Inc / Fiserv Inc / Gap Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Hologic Inc / Illumina Inc / Johnson & Johnson / Juniper Networks Inc / Kohls Corp / Eli Lilly and Co / Movado Group Inc / Myriad Genetics Inc / Nokia Oyj / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PerkinElmer Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / Thermo Fisher Scientific Inc / II-VI Inc / United Therapeutics Corp / Walmart Inc / Waters Corp / Exact Sciences Corp / Global Payments Inc / Lynas Rare Earths Ltd / Telefonaktiebolaget LM Ericsson / Bruker Corp / Fidelity National Information Services Inc / Mastercard Inc / Ciena Corp / Sally Beauty Holdings Inc / Macy's Inc / Ulta Beauty Inc / Visa Inc / Merck & Co Inc / Calix Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / Vera Bradley Inc / Zoetis Inc / Bath & Body Works Inc / NeoPhotonics Corp / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Applied Optoelectronics Inc / Compagnie Financiere Richemont SA / BioLife Solutions Inc / Arista Networks Inc / SAGE Therapeutics Inc / Boot Barn Holdings Inc / Medtronic PLC / Invitae Corp / Natera Inc / PayPal Holdings Inc / Planet Fitness Inc / Block Inc / elf Beauty Inc / RH / Qiagen NV / Canada Goose Holdings Inc / Amyris Inc / Tapestry Inc / Lithium Americas Corp / Quanterix Corp / Ribbon Communications Inc / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Farfetch Ltd / Guardant Health Inc / Livent Corp / Twist Bioscience Corp / Capri Holdings Ltd / Avantor Inc / Revolve Group Inc / Personalis Inc / Grocery Outlet Holding Corp / Adaptive Biotechnologies Corp / RealReal Inc / DermTech Inc / 10X Genomics Inc / Exagen Inc / Virgin Galactic Holdings Inc / Carrier Global Corp / Burning Rock Biotech Ltd / Match Group Inc / Berkeley Lights Inc / Beam Global / Nuvei Corp / Mp Materials Corp / Quantumscape Corp / Seer Inc / 908 Devices Inc. / Romeo Power Inc / Poshmark Inc / MYT Netherlands Parent BV / Bumble Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / Denmark / Finland / France / United Kingdom / Ireland / Netherlands / Sweden / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Mar 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended March 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/12/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">UTHR-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">UTHR.O / BAX / CAH / LLY / PFE / GILD.O / GSK / CYTK.O / TEVA.K</td><td class="leftalignment">United Therapeutics Corp / Baxter International Inc / Cardinal Health Inc / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Cytokinetics Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/12/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 2021 Catalysts - How We Are Thinking About Key Updates From Here</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's The Lowdown On AACR This Year? Takeaways From Release Of Abstracts And Titles</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">LLY / MRK / JNJ / PFE / HCM.O / IMAB.O</td><td class="leftalignment">Eli Lilly and Co / Merck & Co Inc / Johnson & Johnson / Pfizer Inc / HUTCHMED (China) Ltd / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Mar. 11, 2021 / 1:15PM ET</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Pfizer Covid-19 Vaccine Updates: Will Demand Cool In 2022, Despite Growing Capacity?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Roche Looks Undervalued At $41</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">RHHBY.PK / JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Roche Holding AG / Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/11/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Not All Microdystrophin Created Equal; 1st NSAA Data to Show How SLDB Stacks Up</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">SLDB=US / PFE=US / SRPT=US</td><td class="leftalignment">Solid Biosciences Inc / Pfizer Inc / Sarepta Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Joseph P. Schwartz</td></tr>
<tr class="odd"><td class="leftalignment">03/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">IDYA - Promising & Underappreciated Synthetic Lethality Platform; Initiating Coverage with a BUY Rating and $32 Price Target</td><td class="leftalignment">English</td><td class="rightalignment">59</td><td class="leftalignment">BK0VHF6 / 0989529 / 0925288 / 2126335 / 2684703 / 7103065 / BCBVTX1 / BBPK0J0</td><td class="leftalignment">IDEAYA Biosciences Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Pfizer Inc / Novartis AG / Agios Pharmaceuticals Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Charles Zhu, Ph.D., III / Michael W. Schmidt, Ph.D., PHD / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / DRRX.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / VFF.TO / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / MRNS.OQ / CFRX.OQ / VNRX.A / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / XLY.V / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / STOK.OQ / SNDL.OQ / IMAB.OQ / ARQT.OQ / LUMO.OQ / AH.TO / PCVX.OQ / AWH.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / DURECT Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Village Farms International Inc / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / Marinus Pharmaceuticals Inc / ContraFect Corp / VolitionRX Ltd / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Auxly Cannabis Group Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Stoke Therapeutics Inc / Sundial Growers Inc / I-Mab / Arcutis Biotherapeutics Inc / Lumos Pharma Inc / Aleafia Health Inc / Vaxcyte Inc / Aspira Women's Health Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 10, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ANA.MC / KBH.N / MRK.N / PFE.N / PHM.N / TOL.N / FER.MC / EPR.N / LEN.N / XOM.N / GWW.N / NG.L / DHI.N / IG.MI / CVX.N / SRG.MI / TT.N / DKS.N / CASY.O / BIIB.O / TRN.MI / ATL.MI / GETP.PA / FTNT.O / CIO.N / PCRX.O / FANG.O / ABBV.N / TPH.N / TMHC.N / AENA.MC / 78667J108 / NTGY.MC / XERS.O / GMDA.OQ / OTRK.OQ / SHC.OQ</td><td class="leftalignment">Acciona SA / KB Home / Merck & Co Inc / Pfizer Inc / Pultegroup Inc / Toll Brothers Inc / Ferrovial SA / EPR Properties / Lennar Corp / Exxon Mobil Corp / W W Grainger Inc / National Grid PLC / D R Horton Inc / Italgas SpA / Chevron Corp / Snam SpA / Trane Technologies PLC / DICK'S Sporting Goods Inc / Caseys General Stores Inc / Biogen Inc / Terna Rete Elettrica Nazionale SpA / Atlantia SpA / Getlink SE / Fortinet Inc / City Office REIT Inc / Pacira Biosciences Inc / Diamondback Energy Inc / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Taylor Morrison Home Corp / Aena SME SA / SAGE Therapeutics Inc / Naturgy Energy Group SA / Xeris Biopharma Holdings Inc / Gamida Cell Ltd / Ontrak Inc / Sotera Health Co</td><td class="leftalignment"></td><td class="leftalignment">Spain / France / United Kingdom / Ireland / Israel / Italy / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - China healthcare policy news roundup: Basic medical insurance fund recorded near-flat growth in 2020</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / 2196.HK</td><td class="leftalignment">Pfizer Inc / Shanghai Fosun Pharmaceutical Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">03/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended March 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Short interest positioning read</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / PCRX.O / ABBV.N</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Pacira Biosciences Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.O / ACRX.O / EBS / HCM.L / JNJ / LLY / MRK / PFE / ALKS.O / JAZZ.O / CERS.O / OPTN.O / NCOX.PA / COLL.O / RMTI.O / AMRN.O / BDSI.O / BSLN.S / MNKD.O / NEOS.BO / ZTS / OMER.O / SPRO.O / ANIP.O / AXGN.O / AERI.O / HRTX.O / TRVN.O / EGRX.O / SCYX.O / ARDX.O / ALDX.O / CFRX.O / CDTX.O / SPNE.O / FBIO.O / MESO.O / VRAY.O / VERU.O / TXMD.O / CKPT.O / EYPT.O / UBX.O / EOLS.O / ARDS.O / ARAV.O / SIBN.O / ETTX.O / ARQT.O / PCVX.O / SRGA.O / VYNE.O / HGEN.O / AZYO.O / GRAY.O / IMAB.O / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / Emergent BioSolutions Inc / HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Alkermes Plc / Jazz Pharmaceuticals PLC / Cerus Corp / OptiNose Inc / Nicox SA / Collegium Pharmaceutical Inc / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Neo Corp International Ltd / Zoetis Inc / Omeros Corp / Spero Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / SCYNEXIS Inc / Ardelyx Inc / Aldeyra Therapeutics Inc / ContraFect Corp / Cidara Therapeutics Inc / SeaSpine Holdings Corp / Fortress Biotech Inc / Mesoblast Ltd / ViewRay Inc / Veru Inc / TherapeuticsMD Inc / Checkpoint Therapeutics Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Evolus Inc / Aridis Pharmaceuticals Inc / Aravive Inc / SI-BONE Inc / Entasis Therapeutics Holdings Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Vyne Therapeutics Inc / Humanigen Inc / Aziyo Biologics Inc / Graybug Vision Inc / I-Mab / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Updated; 2021 EPS And PT Raised</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US28414H1032 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Elanco Animal Health Inc / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 09 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0028241000 / US0231351067 / US0311621009 / US0463531089 / US1101221083 / US2358511028 / US3377381088 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US87612E1064 / US9021041085 / US91307C1027 / US9311421039 / US37940X1028 / US0042251084 / US0491642056 / US31620M1062 / US57636Q1040 / US92826C8394 / US00922R1059 / US58933Y1055 / US69404D1081 / US30303M1027 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US90184L1026 / US0396971071 / US78667J1088 / IE00BTN1Y115 / US81750R1023 / US6323071042 / US70450Y1038 / US8522341036 / US87164F1057 / US03236M2008 / US8760301072 / US05351X1019 / US09354A1007 / US26927E1047 / US46571Y1073 / VGG312491084 / US68373M1071 / US90184D1000 / US1255231003 / US62921N1054 / US05352A1007 / US92537N1081 / US68902V1070 / US07373B1098 / US56854Q2003 / CA67079A1021 / US74767V1098 / US21077C1071 / US7761531083 / US73739W1045 / US15961R1059</td><td class="leftalignment">Abbott Laboratories / Amazon.com Inc / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Danaher Corp / Fiserv Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / Target Corp / II-VI Inc / United Therapeutics Corp / Walmart Inc / Global Payments Inc / ACADIA Pharmaceuticals Inc / Atlas Air Worldwide Holdings Inc / Fidelity National Information Services Inc / Mastercard Inc / Visa Inc / Air Transport Services Group Inc / Merck & Co Inc / Pacific Biosciences of California Inc / Meta Platforms Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / Twitter Inc / Ardelyx Inc / SAGE Therapeutics Inc / Medtronic PLC / Seres Therapeutics Inc / Natera Inc / PayPal Holdings Inc / Block Inc / Syndax Pharmaceuticals Inc / Amyris Inc / Tapestry Inc / Avaya Holdings Corp / Blink Charging Co / EVO Payments Inc / I3 Verticals Inc / Establishment Labs Holdings Inc / Opera Ltd / Twist Bioscience Corp / Cigna Corp / NGM Biopharmaceuticals Inc / Avantor Inc / Vertiv Holdings Co / Otis Worldwide Corp / Beam Global / Marinus Pharmaceuticals Inc / Nuvei Corp / Quantumscape Corp / ContextLogic Inc / Romeo Power Inc / Poshmark Inc / ChargePoint Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / AMZN=US / BLD=US / TEVA=US / GILD=US / LOW=US / CHRS=US / LEG=US / CI=US / CBRL=US / DRI=US / GFF=US / IBP=US / MAS=US / MHK=US / REGI=US / AMSF=US / DIN=US / BIIB=US / TPX=US / EXP=US / CRD.B=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / REX=US / RPRX=US / PGTI=US / GPRE=US / EHTH=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / LOCO=US / SHAK=US / WING=US / 82982L103 / PVAC=US / ANAB=US / JELD=US / SFIX=US / GOCO=US / AZEK=US / VTRS=US / DHT.UN=CA</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Lowe's Companies Inc / Coherus BioSciences Inc / Leggett & Platt Inc / Cigna Corp / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Griffon Corp / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Renewable Energy Group Inc / Amerisafe Inc / Dine Brands Global Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Crawford & Co / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Royalty Pharma PLC / PGT Innovations Inc / Green Plains Inc / eHealth Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / El Pollo Loco Holdings Inc / Shake Shack Inc / Wingstop Inc / SiteOne Landscape Supply Inc / Ranger Oil Corp / AnaptysBio Inc / JELD-WEN Holding Inc / Stitch Fix Inc / Gohealth Inc / Azek Company Inc / Viatris Inc / Dri Healthcare Trust</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2050832 / 2026242 / 2270726 / 2328915 / 2100920 / 2369174 / 2689560 / 2672689 / 2684703 / 2048804 / 2402121 / 2980906 / 7103065 / B1F76F9 / B121557 / 2769796 / B2R3PV1 / BCZS820 / BFZNYB7 / BDHF4K6 / BMQ5T49 / BWFKZT2 / BFMXGR0 / BYXJQG9 / BZ8VJQ8 / BDRW1L7 / BZ4CHH2 / BNG3RZ7 / BMC8SQ7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Nextera Energy Inc / FirstEnergy Corp / Gilead Sciences Inc / PG&E Corp / Patterson Companies Inc / Pfizer Inc / Pinnacle West Capital Corp / Nuance Communications Inc / Foot Locker Inc / Novartis AG / Western Union Co / Mastercard Inc / Fidelity National Information Services Inc / American Water Works Company Inc / Fate Therapeutics Inc / Allogene Therapeutics Inc / CRISPR Therapeutics AG / Zentalis Pharmaceuticals Inc / Cellectis SA / Evergy Inc / Spire Inc / Vistra Corp / AnaptysBio Inc / Soleno Therapeutics Inc / Leslie's Inc / BTRS Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Indonesia Healthcare Sector - New report: Bi-weekly vaccination tracker (Feb)-Daily first/second dose rates accelerate 177%/7% WoW</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / 1177.HK / NVAX.OQ / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Novavax Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United Kingdom / Indonesia / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Khun Steven Ho</td></tr>
<tr class="even"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Indonesia Healthcare Sector: Bi-weekly vaccination tracker (Feb): Daily first/second dose rates accelerate 177%/7% WoW</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / AZN.L / NVAX.OQ / MRNA.OQ / 1099.HK</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Novavax Inc / Moderna Inc / Sinopharm Group Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / Indonesia / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Khun Steven Ho</td></tr>
<tr class="odd"><td class="leftalignment">03/09/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Cowen Health Care Conference Topical Panel Wrap-Up</td><td class="leftalignment">English</td><td class="rightalignment">217</td><td class="leftalignment">US0028241000 / US0311621009 / US0463531089 / US1101221083 / US3755581036 / US37733W1053 / US4523271090 / US4781601046 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US75886F1075 / US91307C1027 / US58933Y1055 / US69404D1081 / US98978V1035 / US45845P1084 / US69366J2006 / US63009R1095 / US78667J1088 / IE00BTN1Y115 / US03236M2008 / VGG312491084 / US90184D1000</td><td class="leftalignment">Abbott Laboratories / Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Merck & Co Inc / Pacific Biosciences of California Inc / Zoetis Inc / Intercept Pharmaceuticals Inc / PTC Therapeutics Inc / NanoString Technologies Inc / SAGE Therapeutics Inc / Medtronic PLC / Amyris Inc / Establishment Labs Holdings Inc / Twist Bioscience Corp</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / United Kingdom / Ireland / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cowen Health Care Team / Cowen Washington Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE=US / MSFT=US / EA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Microsoft Corp / Electronic Arts Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Info. Tech./Computers / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 26, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Milestone momentum for AI driven biotech, Predictive Oncology – Raising PT to $5 from $3</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS / SMALL CAPITAL / MORNING COMMENTS / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">PFE Discusses COVID-19 Vaccine Update and Key Products</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / PFE=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Pfizer Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IVA=FR / PASG=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / PRVL=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / LYS=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Inventiva SA / Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Porvair PLC / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Lysogene SA / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / REGN.OQ / AMRN.OQ / BIIB.OQ / AERI.OQ / AGTC.OQ / AKBA.OQ / ALDX.OQ / ADVM.OQ / TVTY.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Regeneron Pharmaceuticals Inc / Amarin Corporation PLC / Biogen Inc / Aerie Pharmaceuticals Inc / Applied Genetic Technologies Corp / Akebia Therapeutics Inc / Aldeyra Therapeutics Inc / Adverum Biotechnologies Inc / Tivity Health Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 08 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US0079731008 / US00846U1016 / US0116591092 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1925761066 / US22284P1057 / US2358511028 / US3021301094 / US37733W1053 / US4364401012 / US4433201062 / US4456581077 / US4523271090 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US62855J1043 / US6558441084 / US66987V1098 / US6701002056 / US6795801009 / US68389X1054 / US7140461093 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US8835561023 / US9029251066 / US9078181081 / US91347P1057 / US9418481035 / US9507551086 / CA1363751027 / US30063P1057 / CA13645T1003 / US4771431016 / US4198791018 / US80105N1054 / US1167941087 / US3463751087 / US2533931026 / US90385V1070 / US12541W2098 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US1920051067 / US9100471096 / US69404D1081 / US9837931008 / US00287Y1091 / NL0010273215 / US98978V1035 / US09609G1004 / US63009R1095 / US8485771021 / US21240E1055 / US02376R1023 / US09062W2044 / US03937C1053 / CA0089118776 / US46185L1035 / US6323071042 / KYG4740B1059 / CA87241L1094 / NL0012169213 / US23753F1075 / US80689H1023 / US6904691010 / US03236M2008 / US4990491049 / US74766Q1013 / US2575541055 / US5904791358 / US28414H1032 / US40131M1099 / US90184D1000 / US05352A1007 / US71535D1063 / US00650F1093 / US24984K1051 / US88025U1097 / US30068X1037 / US75513E1010 / US12233L1070 / US7602731025 / GB00BMVP7Y09 / US57667L1070 / US0843101017 / US86646P1030 / US6873051022 / US81578P1066 / US65443P1021 / US03783T1034 / US12047B1052 / US67080N1019</td><td class="leftalignment">Advanced Energy Industries Inc / Agilent Technologies Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cohu Inc / Covenant Logistics Group Inc / Danaher Corp / Expeditors International of Washington Inc / GlaxoSmithKline PLC / Hologic Inc / Hub Group Inc / J B Hunt Transport Services Inc / Illumina Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Myriad Genetics Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Oracle Corp / PerkinElmer Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Thermo Fisher Scientific Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / Waters Corp / Werner Enterprises Inc / Canadian National Railway Co / Exact Sciences Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Bruker Corp / FormFactor Inc / DICK'S Sporting Goods Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Codexis Inc / United Airlines Holdings Inc / Pacific Biosciences of California Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / bluebird bio Inc / NanoString Technologies Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / BioLife Solutions Inc / ArcBest Corp / Air Canada / Invitae Corp / Natera Inc / Ichor Holdings Ltd / TFI International Inc / Qiagen NV / Daseke Inc / Schneider National Inc / Ovid Therapeutics Inc / Amyris Inc / Knight-Swift Transportation Holdings Inc / Quanterix Corp / Domo Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Guardant Health Inc / Twist Bioscience Corp / Avantor Inc / Personalis Inc / Adaptive Biotechnologies Corp / DermTech Inc / 10X Genomics Inc / Exagen Inc / Raytheon Technologies Corp / Burning Rock Biotech Ltd / Repare Therapeutics Inc / Royalty Pharma PLC / Match Group Inc / Berkeley Lights Inc / Sumo Logic Inc / Orphazyme A/S / Seer Inc / 908 Devices Inc. / AppHarvest Inc / Bumble Inc / Nuvation Bio Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Life Science Tools & Diagnostics: Top Questions for Management Teams</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">4502.T / BMY.N / CI.N / CVS.N / GE.N / JPM.N / MCK.N / MRK.N / PFE.N / TMO.N / WMT.N / DGX.N / AZN.L / ROG.S / DHR.N / UNH.N / LH.N / MMM.N / CRL.N / IDXX.OQ / PDCO.OQ / XRAY.OQ / HSIC.OQ / AMZN.OQ / ALGN.OQ / STMN.S / PETS.OQ / ICLR.OQ / QGEN.N / BAYGN.DE / ZTS.N / PAHC.OQ / LNTH.OQ / ANTM.N / WBA.OQ / MEDP.OQ / FLGT.O / IQV.N / SYNH.OQ / ELAN.N / CVET.OQ / AVTR.N / CHWY.N / SDC.OQ / NVST.N / CNTG.OQ / MRVI.OQ / CERT.OQ / OCDX.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / General Electric Co / JPMorgan Chase & Co / Mckesson Corp / Merck & Co Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Walmart Inc / Quest Diagnostics Inc / AstraZeneca PLC / Roche Holding AG / Danaher Corp / UnitedHealth Group Inc / Laboratory Corporation of America Holdings / 3M Co / Charles River Laboratories International Inc / IDEXX Laboratories Inc / Patterson Companies Inc / DENTSPLY SIRONA Inc / Henry Schein Inc / Amazon.com Inc / Align Technology Inc / Straumann Holding AG / Petmed Express Inc / ICON PLC / Qiagen NV / Bayer AG / Zoetis Inc / Phibro Animal Health Corp / Lantheus Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Medpace Holdings Inc / Fulgent Genetics Inc / IQVIA Holdings Inc / Syneos Health Inc / Elanco Animal Health Inc / Covetrus Inc / Avantor Inc / Chewy Inc / SmileDirectClub Inc / Envista Holdings Corp / Centogene NV / Maravai LifeSciences Holdings Inc / Certara Inc / Ortho Clinical Diagnostics Holdings PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / Ireland / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 26, 2021: Focus on Novo GLP-1s</td><td class="leftalignment">English</td><td class="rightalignment">47</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Industrial End Market Analyser: Debating degrees of recovery and net price. Positioning for rotation to later-cycle</td><td class="leftalignment">English</td><td class="rightalignment">65</td><td class="leftalignment">BOY.L / NELES.HE / 2308.TW / 4507.T / 6501.T / ALSO.PA / ARCLK.IS / ASSAB.ST / ATCOA.ST / DAST.PA / ECM.L / ELUXB.ST / FLS.N / GE.N / GRI.L / HEXAB.ST / HLMA.L / IMI.L / IR.N / JNJ.N / MRK.N / PFE.N / PHG.AS / ROR.L / RSW.L / SAND.ST / SCHN.PA / SKFB.ST / SMIN.L / SPX.L / SWK.N / VOLVB.ST / VWS.CO / WEIR.L / ROK.N / AZN.L / TKR.N / TKAG.DE / ETN.N / WCC.N / MSM.N / ABBN.S / GEBN.S / SIEGN.DE / HON.N / MMM.N / EMR.N / WHR.N / LONN.S / PALF.VI / JCI.N / RXL.PA / RAAG.DE / GSK.L / SXS.L / NEXS.PA / NKT.CO / ANDR.VI / HUBB.N / ALFA.ST / FLS.CO / FAST.OQ / TT.N / CMCO.OQ / NVAX.OQ / AMZN.OQ / AYI.N / SUN.S / SCHP.S / FAG.ST / KNEBV.HE / CGCBV.HE / G1AG.DE / LEGD.PA / ZUMV.VI / PRY.MI / WEGE3.SA / 0656.HK / FLUI.MC / INO.OQ / WRT1V.HE / MRNA.OQ / KU2G.DE / SHLG.DE / XYL.N / MRON.L / VSVS.L / FLOW.N / PTCT.OQ / KGX.DE / 000333.SZ / ALLE.N / FCT.MI / DOKA.S / SHA_P.DE / LIGHT.AS / FTV.N / ATKR.N / AZRE.N / KCRA.HE / AVT.OQ / EPIRA.ST / KBX.DE / OTIS.N / MOCORP.HE / CVAC.OQ / ENR1N.DE</td><td class="leftalignment">Bodycote PLC / Neles Oyj / Delta Electronics Inc / Shionogi & Co Ltd / Hitachi Ltd / Alstom SA / Arcelik AS / Assa Abloy AB / Atlas Copco AB / Dassault Systemes SE / Electrocomponents PLC / Electrolux AB / Flowserve Corp / General Electric Co / Grainger PLC / Hexagon AB / Halma PLC / IMI PLC / Ingersoll Rand Inc / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Koninklijke Philips NV / Rotork PLC / Renishaw PLC / Sandvik AB / Schneider Electric SE / AB Skf / Smiths Group PLC / Spirax-Sarco Engineering PLC / Stanley Black & Decker Inc / Volvo AB / Vestas Wind Systems A/S / Weir Group PLC / Rockwell Automation Inc / AstraZeneca PLC / Timken Co / thyssenkrupp AG / Eaton Corporation PLC / Wesco International Inc / MSC Industrial Direct Co Inc / Abb Ltd / Geberit AG / Siemens AG / Honeywell International Inc / 3M Co / Emerson Electric Co / Whirlpool Corp / Lonza Group AG / Palfinger AG / Johnson Controls International PLC / Rexel SA / Rational AG / GlaxoSmithKline PLC / Spectris PLC / Nexans SA / Nkt A/S / Andritz AG / Hubbell Inc / Alfa Laval AB / FLSmidth & Co A/S / Fastenal Co / Trane Technologies PLC / Columbus McKinnon Corp / Novavax Inc / Amazon.com Inc / Acuity Brands Inc / Sulzer AG / Schindler Holding AG / Fagerhult AB / Kone Oyj / Cargotec Corp / GEA Group AG / Legrand SA / Zumtobel Group AG / Prysmian SpA / WEG SA / Fosun International Ltd / Fluidra SA / Inovio Pharmaceuticals Inc / Wartsila Oyj Abp / Moderna Inc / Kuka AG / Siemens Healthineers AG / Xylem Inc / Melrose Industries PLC / Vesuvius PLC / SPX FLOW Inc / PTC Therapeutics Inc / Kion Group AG / Midea Group Co Ltd / Allegion PLC / Fincantieri SpA / Dormakaba Holding AG / Schaeffler AG / Signify NV / Fortive Corp / Atkore Inc / Azure Power Global Ltd / Konecranes Abp / Avnet Inc / Epiroc AB / Knorr Bremse AG / Otis Worldwide Corp / Metso Outotec Corp / CureVac NV / Siemens Energy AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Brazil / Switzerland / China / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / Ireland / Italy / Japan / Mauritius / Netherlands / Sweden / Turkey / Taiwan / United States</td><td class="leftalignment">Manufacturing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Andre Kukhnin, CFA / Mr Max R. Yates / Ms. Iris Zheng / Mr. Artem Tokarenko</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Equity Strategy: Equities: Fundamentals beat rate concerns as yields head higher</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / PORTFOLIO/ASSET STRATEGIES / Investment Strategy / Equity</td><td class="leftalignment">Mr. Andrew W. Garthwaite / Mr Robert C. Griffiths / Mr Nicolas Wylenzek / Mr Mengyuan Yuan / Asim Ali / Timothy O'Sullivan</td></tr>
<tr class="even"><td class="leftalignment">03/08/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for TRIL</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">TRIL.OQ</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">03/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Big Cap Pharma Highlights From Cowen's 41st Annual Health Care Conference</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Emerging Markets Q4 update – China roars back, but EM growth still lags other geographies</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">00287Y109 / 0989529 / 5671735 / 0925288 / 7103065 / 7110388 / 717081103 / 110122108 / 532457108 / 58933Y105</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Sanofi SA / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of, And Key Focus Areas For, ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">03/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Most Key Metrics Continue To Move Favorably - Week 49</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/06/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 booster developments; 4Q20 & FY20 earnings</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Afternoon Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">CLLS=US / PFE=US / WMT=US / CMS=US / DGX=US / RAD=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / CHE=US / CYH=US / GEN=US / LH=US / PNR=US / USPH=US / UTHR=US / UHS=US / CCRN=US / CNC=US / AOS=US / ACA=US / ENSG=US / MD=US / SLF=US / GOOG=US / LHCG=US / CHNG=US / EHC=US / ADUS=US / ACHC=US / CTRE=US / WBA=US / EVH=US / IOVA=US / CLXT=US / ALLO=US / PNTG=US</td><td class="leftalignment">Cellectis SA / Pfizer Inc / Walmart Inc / CMS Energy Corp / Quest Diagnostics Inc / Rite Aid Corp / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Chemed Corp / Community Health Systems Inc / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / Pentair PLC / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Cross Country Healthcare Inc / Centene Corp / A O Smith Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Encompass Health Corp / Addus Homecare Corp / Acadia Healthcare Company Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Evolent Health Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Allogene Therapeutics Inc / Pennant Group Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / France / Ireland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Machinery</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 3.5.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / VTRS=US / GLTO=US / ABCL=US / PRTC=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Viatris Inc / Galecto Inc / Abcellera Biologics Inc / PureTech Health PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">4Q20 Review: Material Data Updates in 2021</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">CLLS=US / PFE=US / UTHR=US / IOVA=US / CLXT=US / ALLO=US</td><td class="leftalignment">Cellectis SA / Pfizer Inc / United Therapeutics Corp / Iovance Biotherapeutics Inc / Calyxt Inc / Allogene Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Mar 05 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">EVAX=US / SNSE=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / MDT=US / WMT=US / INSP=US / CMS=US / DGX=US / CRIS=US / AZN=US / GSK=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ANGN=US / APLS=US / BCRX=US / BMRN=US / CHE=US / CYH=US / COO=US / DRRX=US / EW=US / GRTS=US / GEN=US / ICPT=US / PHG=US / LH=US / NBIX=US / PHAR=US / HOOK=US / USPH=US / UTHR=US / UHS=US / PRVB=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / CMPI=US / SLF=US / ONCR=US / BIIB=US / MRNA=US / ACAD=US / GOOG=US / INO=US / LHCG=US / SNSS=US / AGRX=US / CHNG=US / TPTX=US / ORTX=US / EHC=US / CLDX=US / CVAC=US / ADUS=US / ACHC=US / SRPT=US / PRTA=US / MRTX=US / GNCA=US / CTRE=US / EKTAY=US / CLRB=US / WBA=US / NVTA=US / EVH=US / MCRB=US / CFMS=US / LIVN=US / CERC=US / IONS=US / SSKN=US / VRAY=US / SYRS=US / MDGL=US / FLGT=US / IRTC=US / AVDL=US / SLNO=US / VREX=US / ATNX=US / NCNA=US / RCKT=US / FIXX=US / ARVN=US / MRKR=US / XFOR=US / TMDX=US / BCYC=US / NEXI=US / KRTX=US / DMTK=US / BNTX=US / RCEL=US / PNTG=US / NNOX=US / TSHA=US / VIRX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Sensei Biotherapeutics Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Curis Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Angion Biomedica Corp / Apellis Pharmaceuticals Inc / BioCryst Pharmaceuticals Inc / Biomarin Pharmaceutical Inc / Chemed Corp / Community Health Systems Inc / Cooper Companies Inc / DURECT Corp / Edwards Lifesciences Corp / Gritstone bio Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / HOOKIPA Pharma Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Provention Bio Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Checkmate Pharmaceuticals Inc / Sun Life Financial Inc / Oncorus Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alphabet Inc / Inovio Pharmaceuticals Inc / LHC Group Inc / Viracta Therapeutics Inc / Agile Therapeutics Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Orchard Therapeutics PLC / Encompass Health Corp / Celldex Therapeutics Inc / CureVac NV / Addus Homecare Corp / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Prothena Corporation PLC / Mirati Therapeutics Inc / Genocea Biosciences Inc / CareTrust REIT Inc / Elekta AB (publ) / Cellectar Biosciences Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Seres Therapeutics Inc / Conformis Inc / LivaNova PLC / Avalo Therapeutics Inc / Ionis Pharmaceuticals Inc / STRATA Skin Sciences Inc / ViewRay Inc / Syros Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Avadel Pharmaceuticals PLC / Soleno Therapeutics Inc / Varex Imaging Corp / Athenex Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Arvinas Inc / Marker Therapeutics Inc / X4 Pharmaceuticals Inc / Transmedics Group Inc / Bicycle Therapeutics PLC / Neximmune Inc / Karuna Therapeutics Inc / DermTech Inc / BioNTech SE / AVITA Medical Inc / Pennant Group Inc / Nano-X Imaging Ltd / Taysha Gene Therapies Inc / Viracta Therapeutics Inc / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / United Kingdom / Ireland / Israel / Netherlands / Sweden / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Feb 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Top-read notes in February</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / TEVA.N / PCRX.O / ABBV.N / AMRX.N / XERS.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 26, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / A=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Agilent Technologies Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">SPGI=US / TRIP=US / AAPL=US / IBM=US / LSI=US / PFE=US / AMGN=US / COST=US / DIS=US / INTC=US / TWTR=US / ADI=US / MSFT=US / AMZN=US / QCOM=US / T=US / ORCL=US / VOD=US / WMT=US / TXN=US / AMT=US / DOX=US / NVDA=US / GS=US / AKAM=US / CHTR=US / NICE=US / STM=FR / VZ=US / SMTC=US / CCI=US / UPS=US / XLNX=US / SYMC=US / ASML=US / CMCSA=US / DISH=US / INTU=US / NUAN=US / APPS=US / AVGO=US / HRB=US / CTL=US / COO=US / CME=US / DRRX=US / EGAN=US / EGHT=US / EQIX=US / HEAR=US / MCHP=US / MCO=US / PHAR=US / QUIK=US / SBAC=US / SNAP=US / VG=US / RDWR=US / SNOW=US / NET=US / CRNT=US / FB=US / SWKS=US / NFLX=US / VRNT=US / TWLO=US / ERIC=US / NDAQ=US / RNG=US / OPEN=US / CEVA=US / GOOG=US / BJRI=US / DLR=US / VIAC=US / DISCA=US / CCOI=US / LLNW=US / PRPL=US / LUMN=US / 005930-KR=US / GNRC=US / TSLA=US / MSCI=US / NXPI=US / MRAAY=US / TMUS=US / GTT=US / AVYA=US / GOOGL=US / FIVN=US / EKTAY=US / QRVO=US / VRAY=US / SYRS=US / DZSI=US / FLGT=US / TEUM=US / ATUS=US / NCNA=US / RCKT=US / FOCS=US / XFOR=US / ZM=US / FSLY=US / CMBM=US / DMTK=US / RCEL=US / DKNG=US / RXT=US / ONDS=US</td><td class="leftalignment">S&P Global Inc / Tripadvisor Inc / Apple Inc / International Business Machines Corp / Life Storage Inc / Pfizer Inc / Amgen Inc / Costco Wholesale Corp / Walt Disney Co / Intel Corp / Twitter Inc / Analog Devices Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Oracle Corp / Vodafone Group PLC / Walmart Inc / Texas Instruments Inc / American Tower Corp / Amdocs Ltd / NVIDIA Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Charter Communications Inc / Nice Ltd / STMicroelectronics NV / Verizon Communications Inc / Semtech Corp / Crown Castle International Corp / United Parcel Service Inc / Xilinx Inc / NortonLifeLock Inc / ASML Holding NV / Comcast Corp / DISH Network Corp / Intuit Inc / Nuance Communications Inc / Digital Turbine Inc / Broadcom Inc / H & R Block Inc / Lumen Technologies Inc / Cooper Companies Inc / CME Group Inc / DURECT Corp / eGain Corp / 8x8 Inc / Equinix Inc / Turtle Beach Corp / Microchip Technology Inc / Moody's Corp / Pharming Group NV / QuickLogic Corp / SBA Communications Corp / Snap Inc / Vonage Holdings Corp / Radware Ltd / Snowflake Inc. / Cloudflare Inc / Ceragon Networks Ltd / Meta Platforms Inc / Skyworks Solutions Inc / Netflix Inc / Verint Systems Inc / Twilio Inc / Telefonaktiebolaget LM Ericsson / Nasdaq Inc / RingCentral Inc / Opendoor Technologies Inc / CEVA Inc / Alphabet Inc / BJ's Restaurants Inc / Digital Realty Trust Inc / ViacomCBS Inc / Discovery Inc / Cogent Communications Holdings Inc / Limelight Networks Inc / Purple Innovation Inc / Lumen Technologies Inc / Farfetch Ltd / Generac Holdings Inc / Tesla Inc / MSCI Inc / NXP Semiconductors NV / Murata Manufacturing Co Ltd / T-Mobile US Inc / GTT Communications Inc / Avaya Holdings Corp / Alphabet Inc / Five9 Inc / Elekta AB (publ) / Qorvo Inc / ViewRay Inc / Syros Pharmaceuticals Inc / DZS Inc / Fulgent Genetics Inc / Pareteum Corp / Altice USA Inc / NuCana PLC / Rocket Pharmaceuticals Inc / Focus Financial Partners Inc / X4 Pharmaceuticals Inc / Zoom Video Communications Inc / Fastly Inc / Cambium Networks Corp / DermTech Inc / AVITA Medical Inc / DraftKings Inc / Rackspace Technology Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Cayman Islands / United Kingdom / Israel / Japan / Netherlands / Sweden / United States / Guernsey</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">V / 2701271 / 2360326 / 2516152 / 2000019 / 2023607 / 2026242 / 2544960 / 2219224 / 2222631 / 2270726 / 2829515 / 2382892 / 2317087 / 2670519 / 2345022 / 2100920 / 2471950 / 2459020 / 2684703 / 2048804 / 2746711 / 2862532 / 2799351 / 2989301 / B121557 / 2212922 / B0T7YX2 / B2R3PV1 / 2390817 / 2949758 / BF311Y5 / B7VD3F2 / B7JYSG3 / B8L2798 / B424494 / BFLR866 / BYY8XK8 / BYVY8G0 / BD9GVY0 / BJ2Z0H2 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BDFZSP1 / BJVR9Y9 / BYSGPK2 / BDVLM39 / BZ0P3Z5 / BP84RX0 / BKT6B38 / BFY7DC4</td><td class="leftalignment">Visa Inc / Costco Wholesale Corp / Gap Inc / Eli Lilly and Co / Amazon.com Inc / Amgen Inc / American Electric Power Company Inc / Beasley Broadcast Group Inc / CMS Energy Corp / Cooper Companies Inc / Walt Disney Co / Edison International / Audacy Inc / Entergy Corp / Exelon Corp / Macy's Inc / FirstEnergy Corp / Incyte Corp / Intuit Inc / Pfizer Inc / Pinnacle West Capital Corp / Ross Stores Inc / E W Scripps Co / Sinclair Broadcast Group Inc / TJX Companies Inc / Mastercard Inc / NRG Energy Inc / Live Nation Entertainment Inc / American Water Works Company Inc / Gray Television Inc / Nexstar Media Group Inc / Burlington Stores Inc / Duke Energy Corp / Guidewire Software Inc / Hemisphere Media Group Inc / Splunk Inc / Twitter Inc / WEC Energy Group Inc / Alphabet Inc / Zai Lab Ltd / Pinterest Inc / Evergy Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Okta Inc / iHeartMedia Inc / ViewRay Inc / argenx SE / Tegna Inc / Townsquare Media Inc / SmileDirectClub Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">03/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Multi Industry: LEANing into the Weekend: ETN Investor Day; Energy Summit; FAST Feb Sales; Electricals Read X</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">ETN.N / FAST.OQ / ASSAB.ST / ATCOA.ST / DAST.PA / FLS.N / GE.N / IR.N / PFE.N / SCHN.PA / VNT.N / ROK.N / ABBN.S / SIEGN.DE / HON.N / MMM.N / EMR.N / LII.N / JCI.N / ADSK.OQ / TT.N / SNPS.OQ / AZPN.OQ / ANSS.OQ / AYI.N / SCHP.S / KNEBV.HE / CDNS.OQ / RXN.N / XYL.N / GTLS.N / ALLE.N / PTC.OQ / DOKA.S / LIGHT.AS / FTV.N / ATKR.N / AQUA.N / CARR.N / OTIS.N</td><td class="leftalignment">Eaton Corporation PLC / Fastenal Co / Assa Abloy AB / Atlas Copco AB / Dassault Systemes SE / Flowserve Corp / General Electric Co / Ingersoll Rand Inc / Pfizer Inc / Schneider Electric SE / Vontier Corp / Rockwell Automation Inc / Abb Ltd / Siemens AG / Honeywell International Inc / 3M Co / Emerson Electric Co / Lennox International Inc / Johnson Controls International PLC / Autodesk Inc / Trane Technologies PLC / Synopsys Inc / Aspen Technology Inc / ANSYS Inc / Acuity Brands Inc / Schindler Holding AG / Kone Oyj / Cadence Design Systems Inc / Zurn Water Solutions Corp / Xylem Inc / Chart Industries Inc / Allegion PLC / PTC Inc / Dormakaba Holding AG / Signify NV / Fortive Corp / Atkore Inc / Evoqua Water Technologies Corp / Carrier Global Corp / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Finland / France / Ireland / Netherlands / Sweden / United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. John F. Walsh, Jr / Corey Shubiak / Tamjid Chowdhury / Jing Zhang</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Travel Roaring Back and That's a Plus</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">TRIP=US / PFE=US</td><td class="leftalignment">Tripadvisor Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Leisure & Entertainment</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jason S. Helfstein</td></tr>
<tr class="even"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">China-sourced PD1s coming to a market near you!</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / China / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">03/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Credit Suisse Healthcare Conference: Day 2: Fireside discussion highlights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">4502.T / 4507.T / CSL.AX / JNJ.N / PFE.N / PHG.AS / RECI.MI / AZN.L / SASY.PA / NOVN.S / LONN.S / QIA.DE / GSK.L / UCB.BR / GN.CO / AMGN.OQ / GLPG.AS / IPN.PA / SHLG.DE / MOLN.S / SKIN.S / ARGX.OQ / IDIA.S / IQV.N / MOVE.S</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Shionogi & Co Ltd / CSL Ltd / Johnson & Johnson / Pfizer Inc / Koninklijke Philips NV / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Novartis AG / Lonza Group AG / Qiagen NV / GlaxoSmithKline PLC / Ucb SA / GN Store Nord A/S / Amgen Inc / Galapagos NV / Ipsen SA / Siemens Healthineers AG / Molecular Partners AG / Cassiopea SpA / argenx SE / Idorsia Ltd / IQVIA Holdings Inc / Medacta Group SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms. Gretel Janu / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Capital Deployment Dashboard</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / SELB.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / ARNA.OQ / RIGL.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / TGTX.OQ / ANIP.OQ / AXGN.OQ / HTBX.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / ACRS.OQ / CKPT.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / IMAB.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / NNOX.OQ / VYNE.OQ / GRAY.OQ / AZYO.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Selecta Biosciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Arena Pharmaceuticals Inc / Rigel Pharmaceuticals Inc / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / TG Therapeutics Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heat Biologics Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Aclaris Therapeutics Inc / Checkpoint Therapeutics Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / I-Mab / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Nano-X Imaging Ltd / Vyne Therapeutics Inc / Graybug Vision Inc / Aziyo Biologics Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BIIB-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BIIB.O / BIO / JNJ / PFE / GILD.O / AMGN.O / ILMN.O / ACOR.O / ABBV.K / QGEN.K / SNY.O</td><td class="leftalignment">Biogen Inc / Bio Rad Laboratories Inc / Johnson & Johnson / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Acorda Therapeutics Inc / Abbvie Inc / Qiagen NV / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Can Johnson & Johnson's Stock Benefit From Its Covid-19 Vaccine?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/03/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">GB0008220112 / MRK.N / PFE.N / SAPJ.J / TEF.MC / PIA.MI / SKG.I</td><td class="leftalignment">DS Smith PLC / Merck & Co Inc / Pfizer Inc / Sappi Ltd / Telefonica SA / Piaggio & C SpA / Smurfit Kappa Group PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Spain / United Kingdom / Ireland / Israel / Italy / United States / South Africa</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Frau. Jana Schuler / Herr Jonathan Schroer / Frau Silke Stegemann / Herr Sven Kreitmair, CFA / Herr Gianfranco Arcovito / Herr Christian Aust / Herr. Michael Teig / Herr. Stefan Kolek</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US -  Dividend Quality Analysis, for the period ended January 15,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended March 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer in bottom 1% performers of S&P 500 Index in past quarter; Institutional Ownership down 10%</td><td class="leftalignment">English</td><td class="rightalignment">51</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Pfizer, Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">46</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Infinata</td><td class="leftalignment">Trillium Therapeutics Inc. - Company Report</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EVENT CALENDAR</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Infinata</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Debates Reveal Where COVID Vaccines Are Going</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">EVAX=US / SRCL=US / AAPL=US / MRK=US / BSX=US / PFE=US / AMGN=US / BMY=US / AMD=US / TSM=US / AZN=US / GSK=US / ETN=US / ANGN=US / ACI=US / AZO=US / BCRX=US / KMX=US / GRTS=US / ICPT=US / PHG=US / ORLY=US / PHAR=US / WSC=US / RHHBY=US / BIIB=US / MRNA=US / INO=US / AGRX=US / TPTX=US / PRPL=US / CVAC=US / AMRC=US / 2454-TW=US / PRTA=US / GNCA=US / IONS=US / MDGL=US / IRTC=US / UAA=US / AVDL=US / CVNA=US / CSPR=US / ATNX=US / ZM=US / TMDX=US / BNTX=US / PHVS=US</td><td class="leftalignment">Evaxion Biotech A/S / Stericycle Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Advanced Micro Devices Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / GlaxoSmithKline PLC / Eaton Corporation PLC / Angion Biomedica Corp / Albertsons Companies Inc / Autozone Inc / BioCryst Pharmaceuticals Inc / Carmax Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / O'Reilly Automotive Inc / Pharming Group NV / Willscot Mobile Mini Holdings Corp / Roche Holding AG / Biogen Inc / Moderna Inc / Inovio Pharmaceuticals Inc / Agile Therapeutics Inc / Turning Point Therapeutics Inc / Purple Innovation Inc / CureVac NV / Ameresco Inc / MediaTek Inc / Prothena Corporation PLC / Genocea Biosciences Inc / Ionis Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / Under Armour Inc / Avadel Pharmaceuticals PLC / Carvana Co / Casper Sleep Inc / Athenex Inc / Zoom Video Communications Inc / Transmedics Group Inc / BioNTech SE / Pharvaris NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / United Kingdom / Ireland / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Pharmaceuticals / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / PFE=US / AMGN=US / HD=US / MCD=US / WEN=US / T=US / BLD=US / TEVA=US / KMI=US / AMT=US / AKAM=US / CHTR=US / CONE=US / VZ=US / LOW=US / PAA=US / CCI=US / HSII=US / CHRS=US / BYD=US / LEG=US / TNL=US / KFRC=US / MGM=US / PENN=US / CMCSA=US / DISH=US / AIR=US / KFY=US / AMN=US / CBRL=US / DRI=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MPLX=US / MHK=US / MCRI=US / ASGN=US / OKE=US / PRGO=US / REGI=US / RHI=US / SBAC=US / SGMO=US / TRGP=US / TRUE=US / VRTX=US / EPD=US / SNOW=US / SGMS=US / CCRN=US / DCP=US / DIN=US / MMP=US / TPX=US / EXP=US / CZR=US / CDLX=US / BECN=US / DLR=US / PLAY=US / DENN=US / BLDR=US / GMS=US / NSP=US / SPWR=US / SCPL=US / CMG=US / REX=US / CCOI=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / PAGP=US / JACK=US / CLNY=US / TREX=US / HGV=US / NLSN=US / APTS=US / VAC=US / FBHS=US / ENPH=US / SMLP=US / TILE=US / TMUS=US / NDLS=US / CEQP=US / ASMB=US / LOCO=US / VCEL=US / SHAK=US / WING=US / SPNE=US / AXSM=US / ADVM=US / 82982L103 / CRSP=US / PVAC=US / GDS=US / JELD=US / ATNX=US / SWCH=US / RTLR=US / LHX=US / FERGY=US / RPAY=US / AZEK=US / CRMD.US / BALY=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Home Depot Inc / McDonald's Corp / Wendys Co / AT&T Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / Kinder Morgan Inc / American Tower Corp / Akamai Technologies Inc / Charter Communications Inc / CyrusOne Inc / Verizon Communications Inc / Lowe's Companies Inc / Plains All American Pipeline LP / Crown Castle International Corp / Heidrick & Struggles International Inc / Coherus BioSciences Inc / Boyd Gaming Corp / Leggett & Platt Inc / Travel + Leisure Co / Kforce Inc / MGM Resorts International / Penn National Gaming Inc / Comcast Corp / DISH Network Corp / AAR Corp / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / MPLX LP / Mohawk Industries Inc / Monarch Casino & Resort Inc / ASGN Inc / ONEOK Inc / Perrigo Company PLC / Renewable Energy Group Inc / Robert Half International Inc / SBA Communications Corp / Sangamo Therapeutics Inc / Targa Resources Corp / TrueCar Inc / Vertex Pharmaceuticals Inc / Enterprise Products Partners LP / Snowflake Inc. / Scientific Games Corp / Cross Country Healthcare Inc / DCP Midstream LP / Dine Brands Global Inc / Magellan Midstream Partners LP / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Cardlytics Inc / Beacon Roofing Supply Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / SunPower Corp / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Cogent Communications Holdings Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Plains GP Holdings LP / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / Hilton Grand Vacations Inc / Nielsen Holdings PLC / Preferred Apartment Communities Inc / Marriott Vacations Worldwide Corp / Fortune Brands Home & Security Inc / Enphase Energy Inc / Summit Midstream Partners LP / Interface Inc / T-Mobile US Inc / Noodles & Co / Crestwood Equity Partners LP / Assembly Biosciences Inc / El Pollo Loco Holdings Inc / Vericel Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / SiteOne Landscape Supply Inc / CRISPR Therapeutics AG / Ranger Oil Corp / GDS Holdings Ltd / JELD-WEN Holding Inc / Athenex Inc / Switch Inc / Rattler Midstream LP / L3harris Technologies Inc / Ferguson PLC / Repay Holdings Corp / Azek Company Inc / CorMedix Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">The Insight Partners</td><td class="leftalignment">Pfizer Inc. (Pfe) In Anticoagulant Reversal Drugs Market, Company SWOT Analysis and Profile</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2026242 / 2065159 / 2544960 / 2229126 / 2270726 / 2382892 / 2657802 / 2684703 / 2707677 / 2862532 / 2799351 / 7103065 / B121557 / 2212922 / B1Y9TB3 / B19FQ48 / 2857817 / B2R3PV1 / 2390817 / 2949758 / B3SWPT2 / B7TL820 / B4MG4Z6 / B7VD3F2 / B8L2798 / BJ0KXV4 / BDZCRX3 / B8DPDT7 / BTN1Y11 / BVVN4Q8 / BYW36M8 / BD9GVY0 / BJFSR88 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BKTNTR9 / BK6N347 / BJVR9Y9 / BJXBP30 / BHZSB82 / BKC9SX3 / BD6JX35 / BDVLM39 / BDZ30Q0 / BZ0P3Z5 / BYNPPC6 / BP84RX0 / BMDJ397</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / Autodesk Inc / Beasley Broadcast Group Inc / Columbia Sportswear Co / Walt Disney Co / Audacy Inc / OGE Energy Corp / Pfizer Inc / Public Service Enterprise Group Inc / E W Scripps Co / Sinclair Broadcast Group Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Danone SA / Amicus Therapeutics Inc / Netflix Inc / American Water Works Company Inc / Gray Television Inc / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / AMC Networks Inc / Duke Energy Corp / Hemisphere Media Group Inc / ONE Gas Inc / RingCentral Inc / Sarepta Therapeutics Inc / Medtronic PLC / Eversource Energy / PayPal Holdings Inc / Zai Lab Ltd / Uniqure NV / Evergy Inc / Fox Corp / Vistra Corp / ViacomCBS Inc / Uber Technologies Inc / iHeartMedia Inc / Turning Point Therapeutics Inc / Covetrus Inc / Arcturus Therapeutics Holdings Inc / Krystal Biotech Inc / argenx SE / Arvinas Inc / Tegna Inc / DENTSPLY SIRONA Inc / Townsquare Media Inc / Bolt Biotherapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / Ireland / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BOLT (BUY) - Lightning Strikes Twice with Immune-Stimulating ADCs; Initiating with a BUY and $42 PT</td><td class="leftalignment">English</td><td class="rightalignment">68</td><td class="leftalignment">BMDJ397 / 5671735 / 0989529 / 2126335 / 2516152 / 2023607 / 2778844 / 2369174 / 2457864 / 2684703 / 7103065 / 2982924 / BFDV8K0 / BMQ5T49 / BKVDFF7 / BYQHPK7 / BL71K91 / BN2R582 / BG0Q4Y1 / BF3NP05</td><td class="leftalignment">Bolt Biotherapeutics Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Gilead Sciences Inc / ImmunoGen Inc / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / MacroGenics Inc / Zentalis Pharmaceuticals Inc / Oric Pharmaceuticals Inc / Zymeworks Inc / Revolution Medicines Inc / Relay Therapeutics Inc / Exicure Inc / Mersana Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Charles Zhu, Ph.D., III</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">AI-driven Oncology Story with Near-Term Catalysts: Initiate with Outperform, PT $18</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">EVAX=US / MRK=US / PFE=US / GSK=US / GRTS=US / MRNA=US / CVAC=US / GNCA=US / BNTX=US</td><td class="leftalignment">Evaxion Biotech A/S / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Gritstone bio Inc / Moderna Inc / CureVac NV / Genocea Biosciences Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Denmark / United Kingdom / Netherlands / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="odd"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRVI: 4Q Revenue, EBITDA Beat; FY21 Guide Far Exceeds Consensus with Ample CleanCap Upside Ahead</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">MRVI.OQ / PFE.N / CVAC.OQ</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Pfizer Inc / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">03/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">FLS: Flowserve Corp. - Energy Summit Update: Focus on Energy Transition</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">FLS.N / PFE.N</td><td class="leftalignment">Flowserve Corp / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Conglomerates / Manufacturing</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. John F. Walsh, Jr / Corey Shubiak / Tamjid Chowdhury / Jing Zhang</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) - Targeted Protein Degrader Pipeline Heads Towards 2H 2021 Data Updates; Maintain BUY, $100 PT</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">BDZ30Q0 / 2684703</td><td class="leftalignment">Arvinas Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Mar. 01, 2021 / 3:20PM ET</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 19, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Mr. Evan B. Wang / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">EDIT=US / MRNA=US / ADAP=US / MRK=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / DRRX=US / ISEE=US / GRTS=US / ICPT=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / ALNY=US / INO=US / AVRO=US / FOLD=US / NK=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / VKTX=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / NTLA=US / ADVM=US / MDGL=US / CRSP=US / ALSEN=FR / 199800=KR / IVA=FR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / CWBR=US / NGM=US / KOD=US / AXLA=US / STOK=US / AKRO=US / NBSE=US / ETNB=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Editas Medicine Inc / Moderna Inc / Adaptimmune Therapeutics PLC / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / DURECT Corp / Iveric Bio Inc / Gritstone bio Inc / Intercept Pharmaceuticals Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Immunitybio Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Madrigal Pharmaceuticals Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Inventiva SA / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / CohBar Inc / NGM Biopharmaceuticals Inc / Kodiak Sciences Inc / Axcella Health Inc / Stoke Therapeutics Inc / Akero Therapeutics Inc / NeuBase Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States / South Africa</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Mar 1 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">DE0006231004 / US0116591092 / US0463531089 / US09058V1035 / US1101221083 / US2254471012 / US30231G1022 / US37733W1053 / US4781601046 / US5324571083 / US5370081045 / US66987V1098 / US6701002056 / US6821891057 / US7170811035 / US7392761034 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US9021041085 / US9311421039 / US1667641005 / US4771431016 / US4198791018 / US80105N1054 / US09062X1037 / US0042251084 / US02043Q1076 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US13100M5094 / NL0009538784 / US9100471096 / US00164V1035 / US00287Y1091 / US55405Y1001 / US8485771021 / US21240E1055 / US8086251076 / US02376R1023 / US70432V1026 / US69888T2078 / US0465131078 / CA0089118776 / US74736K1016 / US00653A1079 / US05464T1043 / US00773U1088 / SE0009414576 / US5904791358 / US0197701065 / US0144421072 / US09203E1055 / US26142R1041 / CH0499880968 / US30233G2093</td><td class="leftalignment">Infineon Technologies AG / Alaska Air Group Inc / AstraZeneca PLC / BioCryst Pharmaceuticals Inc / Bristol-Myers Squibb Co / Wolfspeed Inc / Exxon Mobil Corp / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Littelfuse Inc / Novartis AG / Novo Nordisk A/S / ON Semiconductor Corp / Pfizer Inc / Power Integrations Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / II-VI Inc / Walmart Inc / Chevron Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Biogen Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / Calix Inc / NXP Semiconductors NV / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / MACOM Technology Solutions Holdings Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Science Applications International Corp / American Airlines Group Inc / Paycom Software Inc / Par Pacific Holdings Inc / Atara Biotherapeutics Inc / Air Canada / Qorvo Inc / Adaptimmune Therapeutics PLC / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Oncopeptides AB / Mesa Air Group Inc / Allogene Therapeutics Inc / Alector Inc / Black Diamond Therapeutics Inc / DraftKings Inc / ADC Therapeutics SA / EyePoint Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - March 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / ANTO.L / BAC.N / BARC.L / BCE.TO / BK.N / BNPP.PA / C.N / CCI.N / CL.N / CMS.N / COF.N / CSGN.S / DGE.L / EIX.N / EL.N / EOG.N / F.N / FITB.O / GM.N / HSBA.L / JPM.N / KEY.N / KMB.N / KO.N / L.TO / MRK.N / NEM.N / NTRS.O / PFE.N / PNC.N / RIO.L / SO.N / SOGN.PA / T.N / T.TO / USB.N / VC.N / WFC.N / PEP.N / CMA.N / BFb.N / PG.N / WY.N / CNQ.TO / GILD.O / FNV.N / ASML.O / CPB.N / TEN.N / CMCSA.O / SJRb.TO / TA.TO / RCIb.TO / AMGN.O / FER.MC / AAL.L / CNR.TO / DUK.N / QBRb.TO / HBAN.O / BWA.N / LEA.N / PNM.N / ENB.TO / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / IMO.TO / GS.N / DBKGn.DE / CLX.N / CAG.N / HON.N / MFC.TO / GIS.N / PCG.N / AEM.N / XOM.N / EPC.N / MGA.N / SBAC.O / AMT.N / BOL.ST / CONE.O / ADI.O / VZ.N / STT.N / EXEL.O / MDRX.O / ALA.TO / ARNA.O / STZ.N / APH.N / SRE.N / EXC.N / DSGX.O / FISV.O / SNPS.O / V.N / AXL.N / AWK.N / ARE.N / PLD.N / CHD.N / MTB.N / BC.N / FTS.TO / SAM.N / BMRN.O / OPTN.O / REGN.O / ENR.N / CVX.N / EMA.TO / MU.O / CAGR.PA / NCR.N / NET.N / TEL.N / RF.N / FLS.CO / CNP.N / APF.L / ENDP.O / MEOH.O / CPK.N / DOL.TO / FRC.N / PII.N / ST.N / SWN.N / WES.N / SEM.N / ADS.N / GPN.N / MNST.O / SIVB.O / CASY.O / EQIX.O / ATDb.TO / TFC.N / INGA.AS / 02209S103 / DLR.N / 427866108 / RDSb.L / BLDR.O / DISCA.O / CDNS.O / MS.N / FIS.N / CCOI.O / HICL.L / CTCa.TO / BLX.TO / MA.N / MWA.N / HOG.N / ATL.MI / BGS.N / PPL.TO / DAN.N / BIP.N / SII.TO / CLW.N / VALE.N / SPB.N / ENV.N / BHPB.L / NEE.N / NXT.AX / CAML.L / MTOR.N / GLEN.L / GEI.TO / PANW.N / MDLZ.OQ / ABBV.N / KPT.TO / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / PRTA.O / BEP.N / AGIO.O / VRNS.O / AGRX.O / CFG.N / DEA.N / SHOP.N / PYPL.OQ / SQ.N / RACE.MI / UBSG.S / ADNT.N / FRTA.OQ / GDS.O / PBYI.OQ / AQN.N / VST.N / WOW.N / ATUS.N / GRPG.I / ATNX.O / AQUA.N / AY.O / SAIL.N / APTV.N / AMRX.N / VNE.N / KDP.N / ESTC.N / NWL.O / 269796108 / ZM.O / CRWD.O / GMAB.O / PING.N / CRNC.OQ / REYN.O / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / 77311W101 / LUMN.N / PTVE.O / BSY.O / MAX.N / WFG.N / TIXT.TO / AFRM.O / ATC.N / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Antofagasta PLC / Bank of America Corp / Barclays PLC / BCE Inc / Bank of New York Mellon Corp / BNP Paribas SA / Citigroup Inc / Crown Castle International Corp / Colgate-Palmolive Co / CMS Energy Corp / Capital One Financial Corp / Credit Suisse Group AG / Diageo PLC / Edison International / Estee Lauder Companies Inc / EOG Resources Inc / Ford Motor Co / Fifth Third Bancorp / General Motors Co / HSBC Holdings PLC / JPMorgan Chase & Co / KeyCorp / Kimberly-Clark Corp / Coca-Cola Co / Loblaw Companies Ltd / Merck & Co Inc / Newmont Corporation / Northern Trust Corp / Pfizer Inc / PNC Financial Services Group Inc / Rio Tinto PLC / Southern Co / Societe Generale SA / AT&T Inc / Telus Corp / US Bancorp / Visteon Corp / Wells Fargo & Co / PepsiCo Inc / Comerica Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canadian Natural Resources Ltd / Gilead Sciences Inc / Franco-Nevada Corp / ASML Holding NV / Campbell Soup Co / Tenneco Inc / Comcast Corp / Shaw Communications Inc / TransAlta Corp / Rogers Communications Inc / Amgen Inc / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Huntington Bancshares Inc / Borgwarner Inc / Lear Corp / PNM Resources Inc / Enbridge Inc / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / Imperial Oil Ltd / Goldman Sachs Group Inc / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / Honeywell International Inc / Manulife Financial Corp / General Mills Inc / PG&E Corp / Agnico Eagle Mines Ltd / Exxon Mobil Corp / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / American Tower Corp / Boliden AB / CyrusOne Inc / Analog Devices Inc / Verizon Communications Inc / State Street Corp / Exelixis Inc / Allscripts Healthcare Solutions Inc / AltaGas Ltd / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Sempra Energy / Exelon Corp / Descartes Systems Group Inc / Fiserv Inc / Synopsys Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Alexandria Real Estate Equities Inc / Prologis Inc / Church & Dwight Co Inc / M&T Bank Corp / Brunswick Corp / Fortis Inc / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Emera Inc / Micron Technology Inc / Credit Agricole SA / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Regions Financial Corp / FLSmidth & Co A/S / CenterPoint Energy Inc / Anglo Pacific Group PLC / Endo International PLC / Methanex Corp / Chesapeake Utilities Corp / Dollarama Inc / First Republic Bank / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Western Midstream Partners LP / Select Medical Holdings Corp / Alliance Data Systems Corp / Global Payments Inc / Monster Beverage Corp / SVB Financial Group / Caseys General Stores Inc / Equinix Inc / Alimentation Couche-Tard Inc / Truist Financial Corp / ING Groep NV / Altria Group Inc / Digital Realty Trust Inc / Hershey Co / Royal Dutch Shell PLC / Builders FirstSource Inc / Discovery Inc / Cadence Design Systems Inc / Morgan Stanley / Fidelity National Information Services Inc / Cogent Communications Holdings Inc / HICL Infrastructure PLC / Canadian Tire Corporation Ltd / Boralex Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Atlantia SpA / B&G Foods Inc / Pembina Pipeline Corp / Dana Inc / Brookfield Infrastructure Partners LP / Sprott Inc / Clearwater Paper Corp / Vale SA / Spectrum Brands Holdings Inc / Envestnet Inc / BHP Group PLC / Nextera Energy Inc / NEXTDC Ltd / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Gibson Energy Inc / Palo Alto Networks Inc / Mondelez International Inc / Abbvie Inc / KP Tissue Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Prothena Corporation PLC / Brookfield Renewable Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Agile Therapeutics Inc / Citizens Financial Group Inc / Easterly Government Properties Inc / Shopify Inc / PayPal Holdings Inc / Block Inc / Ferrari NV / UBS Group AG / Adient PLC / Forterra Inc / GDS Holdings Ltd / Puma Biotechnology Inc / Algonquin Power & Utilities Corp / Vistra Corp / WideOpenWest Inc / Altice USA Inc / Greencoat Renewables PLC / Athenex Inc / Evoqua Water Technologies Corp / Atlantica Sustainable Infrastructure PLC / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Elastic NV / Newell Brands Inc / Eagle Pharmaceuticals Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Reynolds Consumer Products Inc / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rocket Companies Inc / Lumen Technologies Inc / Pactiv Evergreen Inc / Bentley Systems Inc / Mediaalpha Inc / West Fraser Timber Co Ltd / Telus International Cda Inc / Affirm Holdings Inc / Atotech Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Cayman Islands / Germany / Denmark / Spain / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MRVI: 4Q Preview; Highlighting Relevant COVID-19 Vaccine Updates</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">MRVI.OQ / PFE.N / TMO.N / CRL.N / BAYGN.DE / CTLT.N / CVAC.OQ</td><td class="leftalignment">Maravai LifeSciences Holdings Inc / Pfizer Inc / Thermo Fisher Scientific Inc / Charles River Laboratories International Inc / Bayer AG / Catalent Inc / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">03/01/2021</td><td class="leftalignment">Sadif Analytics Prime</td><td class="leftalignment">Rating Update for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">SADIF Research</td></tr>
<tr class="odd"><td class="leftalignment">02/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / OPTN.O / ENDP.O / ABBV.N / PRGO.N / AGRX.O / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / OptiNose Inc / Endo International PLC / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/28/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Optimism Doesn't Have To Be A Choice With Third EUA For COVID Vaccine Granted</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Recruiting Trials Up YoY for Most Companies- Week 48</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/27/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine boosters; BEAM acquires GuideTx</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / ASMB=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / Assembly Biosciences Inc / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">HZNP-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HZNP.O / MRK / PFE / AMGN.O / RDY / AZN.O / RDUS.O</td><td class="leftalignment">Horizon Therapeutics PLC / Merck & Co Inc / Pfizer Inc / Amgen Inc / Dr Reddy's Laboratories Ltd / AstraZeneca PLC / Radius Health Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / India / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.26.21</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / PHR=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Phreesia Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Piper Sandler Companies</td><td class="leftalignment">The Launches Keep Coming; Another Year Of EBITDA Growth On Tap</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">03168L105 / 717081103 / 031162100 / 881624209</td><td class="leftalignment">Amneal Pharmaceuticals Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David A. Amsellem / Zachary Sachar / Isaac C. Somekh</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">ARNA / MRNS / 45337C10 / 09058V10 / CYTK / 00422510 / 40637H10 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 29604W108 / 29664W105 / 462260100 / 558868105 / 12648L601 / 89532E109 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / 517125100 / G637AM102 / 007002108 / N71542109 / 206022105 / 72942A107</td><td class="leftalignment">Arena Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / Cytokinetics Inc / ACADIA Pharmaceuticals Inc / Halozyme Therapeutics Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Erytech Pharma SA / Esperion Therapeutics Inc / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Trevena Inc / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / Larimar Therapeutics Inc / Myovant Sciences Ltd / Adicet Bio Inc / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / PLx Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 26 2021</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">ICAD=US / LHCG=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / INCY=US / INSP=US / CMS=US / DGX=US / NVS=US / BWAY=US / SNN=US / RAD=US / JNJ=US / MMSI=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / APLS=US / ARNA=US / ATRC=US / BDX=US / BLUE=US / CHE=US / CYH=US / EW=US / GEN=US / ICPT=US / LH=US / NBIX=US / PHAR=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / SAGE=US / CGEN=US / CCRN=US / CNC=US / ACA=US / ENSG=US / MD=US / NKTR=US / SLF=US / BIIB=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / GOOG=US / DXCM=US / SNSS=US / CHNG=US / PODD=US / EHC=US / TNDM=US / ADUS=US / BLRX=US / ACHC=US / ALSN=US / ABBV=US / AGIO=US / FATE=US / AERI=US / MDWD=US / CTRE=US / AUPH=US / OTIC=US / EKTAY=US / VBLT=US / VCEL=US / NVRO=US / WBA=US / EVH=US / GKOS=US / TDOC=US / NVCR=US / VYGR=US / IONS=US / EDIT=US / NTLA=US / SRTS=US / TCMD=US / IRTC=US / IOVA=US / KALA=US / ATNX=US / RCKT=US / ALLO=US / TMDX=US / PSNL=US / KRTX=US / PNTG=US / ARQT=US / FBRX=US / FMTX=US / CZMWY=US / BIOVF=US / VPAHF=US</td><td class="leftalignment">ICAD Inc / LHC Group Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Incyte Corp / Inspire Medical Systems Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / Brainsway Ltd / Smith & Nephew PLC / Rite Aid Corp / Johnson & Johnson / Merit Medical Systems Inc / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / Apellis Pharmaceuticals Inc / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Laboratory Corporation of America Holdings / Neurocrine Biosciences Inc / Pharming Group NV / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / SAGE Therapeutics Inc / Compugen Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / Biogen Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Alphabet Inc / Dexcom Inc / Viracta Therapeutics Inc / Change Healthcare Inc / Insulet Corp / Encompass Health Corp / Tandem Diabetes Care Inc / Addus Homecare Corp / BioLine RX Ltd / Acadia Healthcare Company Inc / Allison Transmission Holdings Inc / Abbvie Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Aerie Pharmaceuticals Inc / Mediwound Ltd / CareTrust REIT Inc / Aurinia Pharmaceuticals Inc / Otonomy Inc / Elekta AB (publ) / Vascular Biogenics Ltd / Vericel Corp / Nevro Corp / Walgreens Boots Alliance Inc / Evolent Health Inc / Glaukos Corp / Teladoc Health Inc / Novocure Ltd / Voyager Therapeutics Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Intellia Therapeutics Inc / Sensus Healthcare Inc / Tactile Systems Technology Inc / iRhythm Technologies Inc / Iovance Biotherapeutics Inc / Kala Pharmaceuticals Inc / Athenex Inc / Rocket Pharmaceuticals Inc / Allogene Therapeutics Inc / Transmedics Group Inc / Personalis Inc / Karuna Therapeutics Inc / Pennant Group Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc / Forma Therapeutics Holdings Inc / Carl Zeiss Meditec AG / Swedish Orphan Biovitrum AB (publ) / Volpara Health Technologies Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / New Zealand / Sweden / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK.N / PFE.N / GSK.L / AMGN.OQ / COLL.OQ / CERS.OQ / MDRX.OQ / ZIOP.OQ / AGIO.OQ / AERI.OQ / ITCI.OQ / CDTX.OQ / EVH.N / GOSS.OQ / HCAT.OQ / PCVX.OQ / FMTX.OQ / HGEN.OQ</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / Amgen Inc / Collegium Pharmaceutical Inc / Cerus Corp / Allscripts Healthcare Solutions Inc / ZIOPHARM Oncology Inc / Agios Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Intra-Cellular Therapies Inc / Cidara Therapeutics Inc / Evolent Health Inc / Gossamer Bio Inc / Health Catalyst Inc / Vaxcyte Inc / Forma Therapeutics Holdings Inc / Humanigen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">33</td><td class="leftalignment">2000019 / 2094670 / 2778844 / 2026242 / 2045623 / 2065159 / 2942605 / 2544960 / 2190750 / 2270726 / 2829515 / 2382892 / 2317087 / 2576941 / 2670519 / 2345022 / 2367480 / 2457864 / 2471950 / 2459020 / 2657802 / 2689560 / 2684703 / 2048804 / 2440637 / 2862532 / 2138158 / 2799351 / 2825933 / 2829601 / B1F76F9 / 2857817 / 2951452 / B0T7YX2 / B2R3PV1 / B1XGNW4 / B3P93Y7 / 2390817 / 2949758 / B7TL820 / BFRTDG1 / BCBVTX1 / B7VD3F2 / B8L2798 / BJ0XLZ3 / B9M2WX3 / BFDV8K0 / BBPK0J0 / B3X26D8 / BCGCR79 / B8DPDT7 / BFLR866 / BFH3N85 / BFZCHN7 / BZ07BW4 / BYVY8G0 / BD3W133 / BYNZGK1 / BFZNYB7 / BK7Y2V9 / BZBY005 / BD8DJ71 / BNFWR44 / BZ00V34 / BZ8VJQ8 / BKTNTR9 / BJVR9Y9 / BFWK4R7 / BYYWPW6 / BDH65C8 / BZ1LFG7 / BK71LY6 / BKC9SX3 / BZ0P3Z5 / BJMLSD2 / BMG75B4 / BYTJZL1 / BX7RSN3 / BWY4XV3 / BRJ3GY4 / BP84RX0 / BDRW1L7 / BKLCX50 / BKT6B38 / BQXZP64 / BGDQ8B3 / BFY7DC4</td><td class="leftalignment">Amazon.com Inc / Best Buy Co Inc / Merck & Co Inc / American Electric Power Company Inc / ANSYS Inc / Autodesk Inc / Avista Corp / Beasley Broadcast Group Inc / Chesapeake Utilities Corp / Walt Disney Co / Edison International / Audacy Inc / Entergy Corp / Exelixis Inc / Exelon Corp / Macy's Inc / Genuine Parts Co / ImmunoGen Inc / Incyte Corp / Intuit Inc / OGE Energy Corp / PG&E Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Sempra Energy / Sinclair Broadcast Group Inc / South Jersey Industries Inc / Southern Co / Western Union Co / Netflix Inc / J M Smucker Co / Live Nation Entertainment Inc / American Water Works Company Inc / Insulet Corp / Anheuser Busch Inbev SA / Gray Television Inc / Nexstar Media Group Inc / Meta Platforms Inc / Aerie Pharmaceuticals Inc / Agios Pharmaceuticals Inc / Duke Energy Corp / Hemisphere Media Group Inc / Heron Therapeutics Inc / Bath & Body Works Inc / MacroGenics Inc / Mirati Therapeutics Inc / Pacira Biosciences Inc / Sprouts Farmers Market Inc / Sarepta Therapeutics Inc / Twitter Inc / Veeva Systems Inc / Wix.Com Ltd / Monster Beverage Corp / Alphabet Inc / Keurig Dr Pepper Inc / Block Inc / Allogene Therapeutics Inc / Akero Therapeutics Inc / Merus NV / Snap Inc / Worldline SA / Zscaler Inc / Vistra Corp / ViacomCBS Inc / iHeartMedia Inc / PagSeguro Digital Ltd / Beigene Ltd / PetIQ Inc / Roku Inc / WW International Inc / Arcturus Therapeutics Holdings Inc / Tegna Inc / Karuna Therapeutics Inc / Inventiva SA / Zogenix Inc / Collegium Pharmaceutical Inc / Adaptimmune Therapeutics PLC / Xenon Pharmaceuticals Inc / Townsquare Media Inc / AnaptysBio Inc / Health Catalyst Inc / SmileDirectClub Inc / Wayfair Inc / Axonics Inc / Altimmune Inc</td><td class="leftalignment"></td><td class="leftalignment">Belgium / Canada / Cayman Islands / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: FY20 earnings preview: Buy the dip as we maintain our positive view</td><td class="leftalignment">English</td><td class="rightalignment">45</td><td class="leftalignment">0867.HK / ATNX.OQ / 1066.HK / PFE.N / AZN.L / 1177.HK / 2196.HK / 000999.SZ / 1833.HK / 000538.SZ / 600196.SS / 600867.SS / 601607.SS / 300122.SZ / 300142.SZ / 2607.HK / ZLAB.OQ / 1801.HK / 1877.HK / 2142.HK</td><td class="leftalignment">China Medical System Holdings Ltd / Athenex Inc / Shandong Weigao Group Medical Polymer Co Ltd / Pfizer Inc / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / China Resources Sanjiu Medical & Pharmaceutical Co Ltd / Ping An Healthcare and Technology Co Ltd / Yunnan Baiyao Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Tonghua Dongbao Pharmaceutical Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Chongqing Zhifei Biological Products Co Ltd / Walvax Biotechnology Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Zai Lab Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Hbm Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / Cayman Islands / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu / Jing Yang</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ICAD.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BIIB.OQ / ACAD.OQ / MNKD.OQ / MSB.AX / EBS.N / SPRO.OQ / OMER.OQ / ARDX.OQ / ACRX.OQ / ZTS.N / ANIP.OQ / AXGN.OQ / FATE.OQ / AUP.TO / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / TDOC.N / SPNE.OQ / GBT.OQ / ACRS.OQ / DRIO.OQ / TVTY.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / RCUS.N / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / ICAD Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / Biogen Inc / ACADIA Pharmaceuticals Inc / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / Teladoc Health Inc / SeaSpine Holdings Corp / Global Blood Therapeutics Inc / Aclaris Therapeutics Inc / DarioHealth Corp / Tivity Health Inc / Veru Inc / TherapeuticsMD Inc / Evolus Inc / Arcus Biosciences Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Biotechnology / Consumer / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">It's On, ACIP Meeting Today Sets The Stage For The PCV Race This Year</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE / MRK / PCVX.O</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc / Vaxcyte Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Higher Value Biopharm Business, Solid Yield, Compelling Valuation Drive Outlook</td><td class="leftalignment">English</td><td class="rightalignment">99</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Pharmaceutical Industry Pulse</td><td class="leftalignment">English</td><td class="rightalignment">1138</td><td class="leftalignment">US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US00287Y1091 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Abbvie Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of And Key Focus Areas For ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: AGI, GOLD, KL, MAS, MRCY, ROP, APD, FMC, ATR, RPM, GSK, GRFS, PFE, PRGO, CHRS, CGEN, DCPH, INCY, REGN, SGEN, GMAB, SILK, STE, MKC, PEP, CHD, UL, FDS, CERN, LDOS, PDFS, SPLK, CVMK, AYX, BKI, JOBS, AKAM, CHKP, DGX, WMT, DG,</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">SBAC.OQ / APD.N / CMS.N / ED.N / FMC.N / MAS.N / PFE.N / STE.N / ULVR.L / WMT.N / DGX.N / ROP.N / HD.N / AGI.PS / FDS.N / GSK.L / RPM.N / DG.N / CHD.N / ATR.N / MKC.N / CERN.OQ / CHRS.OQ / REGN.OQ / COST.OQ / INCY.OQ / DLTR.OQ / CHKP.OQ / MRCY.OQ / AKAM.OQ / PDFS.OQ / SGEN.OQ / BSRR.OQ / JOBS.OQ / LULU.OQ / GRLS.MC / ES.N / AEE.AX / CGEN.TA / VRSK.OQ / SPLK.OQ / CONE.OQ / PRGO.N / LDOS.N / KNSL.OQ / KL.TO / AYX.N / DCPH.OQ / PEP.OQ / XEL.OQ / GOLD.TO / LNT.OQ / SILK.OQ / GMAB.CO</td><td class="leftalignment">SBA Communications Corp / Air Products and Chemicals Inc / CMS Energy Corp / Consolidated Edison Inc / FMC Corp / Masco Corp / Pfizer Inc / STERIS plc / Unilever PLC / Walmart Inc / Quest Diagnostics Inc / Roper Technologies Inc / Home Depot Inc / Alliance Global Group Inc / Factset Research Systems Inc / GlaxoSmithKline PLC / RPM International Inc / Dollar General Corp / Church & Dwight Co Inc / Aptargroup Inc / McCormick & Company Inc / Cerner Corp / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Costco Wholesale Corp / Incyte Corp / Dollar Tree Inc / Check Point Software Technologies Ltd / Mercury Systems Inc / Akamai Technologies Inc / PDF Solutions Inc / Seagen Inc / Sierra Bancorp / 51job Inc / Lululemon Athletica Inc / Grifols SA / Eversource Energy / Aura Energy Ltd / Compugen Ltd / Verisk Analytics Inc / Splunk Inc / CyrusOne Inc / Perrigo Company PLC / Leidos Holdings Inc / Kinsale Capital Group Inc / Kirkland Lake Gold Ltd / Alteryx Inc / Deciphera Pharmaceuticals Inc / PepsiCo Inc / Xcel Energy Inc / GoldMining Inc / Alliant Energy Corp / Silk Road Medical Inc / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Ireland / Israel / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AMED=US / SPXC=US / AAPL=US / BSX=US / PFE=US / AMGN=US / COST=US / INTC=US / AMD=US / GBT=US / MSFT=US / MDT=US / QCOM=US / T=US / INCY=US / TXN=US / NVDA=US / CHTR=US / NVS=US / VZ=US / SMTC=US / TSM=US / EXPE=US / CTXS=US / CMCSA=US / UNH=US / AVGO=US / CHE=US / HEAR=US / ITRI=US / Z=US / SAGE=US / CCRN=US / BKNG=US / ACA=US / HPQ=US / CLH=US / BIIB=US / ALNY=US / GOOG=US / ORA=US / DXCM=US / PODD=US / VMW=US / TNDM=US / CDXC=US / 005930-KR=US / CHWY=US / MSCI=US / NXPI=US / 2454-TW=US / TMUS=US / FATE=US / AUPH=US / LOVE=US / NVRO=US / ETSY=US / TDOC=US / HPE=US / IONS=US / NTNX=US / RDFN=US / CWEN=US / ESTC=US / FVRR=US / XPEV=US / ABNB=US / BIOVF=US</td><td class="leftalignment">Amedisys Inc / SPX Corp / Apple Inc / Boston Scientific Corp / Pfizer Inc / Amgen Inc / Costco Wholesale Corp / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Medtronic PLC / Qualcomm Inc / AT&T Inc / Incyte Corp / Texas Instruments Inc / NVIDIA Corp / Charter Communications Inc / Novartis AG / Verizon Communications Inc / Semtech Corp / Taiwan Semiconductor Manufacturing Co Ltd / Expedia Group Inc / Citrix Systems Inc / Comcast Corp / UnitedHealth Group Inc / Broadcom Inc / Chemed Corp / Turtle Beach Corp / Itron Inc / Zillow Group Inc / SAGE Therapeutics Inc / Cross Country Healthcare Inc / Booking Holdings Inc / Arcosa Inc / HP Inc / Clean Harbors Inc / Biogen Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Ormat Technologies Inc / Dexcom Inc / Insulet Corp / VMware Inc / Tandem Diabetes Care Inc / Chromadex Corp / Farfetch Ltd / Chewy Inc / MSCI Inc / NXP Semiconductors NV / MediaTek Inc / T-Mobile US Inc / Fate Therapeutics Inc / Aurinia Pharmaceuticals Inc / Lovesac Co / Nevro Corp / ETSY Inc / Teladoc Health Inc / Hewlett Packard Enterprise Co / Ionis Pharmaceuticals Inc / Nutanix Inc / Redfin Corp / Clearway Energy Inc / Elastic NV / Fiverr International Ltd / Xpeng Inc / Airbnb Inc / Swedish Orphan Biovitrum AB (publ)</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / Sweden / Taiwan / United States</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Machinery / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Inflammatory Bowel Disease - Key Takeaways from our GHC Panel</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE=US / JNJ=US / ARNA=US / ABBV=US / GOSS=US</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Arena Pharmaceuticals Inc / Abbvie Inc / Gossamer Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joseph P. Schwartz / Mr. Geoffrey Porges / Mr. Thomas J. Smith</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Refocus-and-Extend Thesis Plays Out in 2021 Guidance; Looking to ENaC Data at ATS</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">IONS=US / PFE=US / NVS=US / BIIB=US / ALNY=US / BIOVF=US</td><td class="leftalignment">Ionis Pharmaceuticals Inc / Pfizer Inc / Novartis AG / Biogen Inc / Alnylam Pharmaceuticals Inc / Swedish Orphan Biovitrum AB (publ)</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Sweden / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">31</td><td class="leftalignment">AMAT.O / CMS.N / DGE.L / EOG.N / FLS.N / FOUG.PA / MRK.N / PFE.N / TOL.N / PXD.N / GILD.O / TEN.N / AGI.N / WLK.N / NVDA.O / HON.N / MFC.TO / HD.N / LOW.N / WM.N / JAZZ.O / MTG.N / TJX.N / OKE.N / DK.N / OPTN.O / FLS.CO / SLF.TO / ENDP.O / CHE.N / HCC.N / AMED.O / STN.TO / TCW.TO / TFC.N / INGA.AS / 878742204 / ACAD.O / VIAC.O / RDSb.L / STX.O / BKD.N / TEVA.N / MWA.N / ATL.MI / GETP.PA / PCRX.O / HFC.N / XYL.N / WDC.O / ABBV.N / PRGO.N / CEQP.N / IBP.N / FLXN.O / AGRX.O / RYAM.N / AUPH.O / SUM.N / 78667J108 / TDOC.N / GBT.OQ / SITE.N / IONS.O / TRHC.OQ / NTNX.O / CDEV.O / AQUA.N / APTV.N / AMRX.N / EQH.N / XERS.O / BHC.N / AQST.O / ESTC.N / OSMT.O / 269796108 / FIXX.O / PING.N / PNTG.OQ / TFII.N</td><td class="leftalignment">Applied Materials Inc / CMS Energy Corp / Diageo PLC / EOG Resources Inc / Flowserve Corp / Eiffage SA / Merck & Co Inc / Pfizer Inc / Toll Brothers Inc / Pioneer Natural Resources Co / Gilead Sciences Inc / Tenneco Inc / Alamos Gold Inc / Westlake Chemical Corp / NVIDIA Corp / Honeywell International Inc / Manulife Financial Corp / Home Depot Inc / Lowe's Companies Inc / Waste Management Inc / Jazz Pharmaceuticals PLC / MGIC Investment Corp / TJX Companies Inc / ONEOK Inc / Delek US Holdings Inc / OptiNose Inc / FLSmidth & Co A/S / Sun Life Financial Inc / Endo International PLC / Chemed Corp / Warrior Met Coal Inc / Amedisys Inc / Stantec Inc / Trican Well Service Ltd / Truist Financial Corp / ING Groep NV / Teck Resources Ltd / ACADIA Pharmaceuticals Inc / ViacomCBS Inc / Royal Dutch Shell PLC / Seagate Technology Holdings PLC / Brookdale Senior Living Inc / Teva Pharmaceutical Industries Ltd / Mueller Water Products Inc / Atlantia SpA / Getlink SE / Pacira Biosciences Inc / HollyFrontier Corp / Xylem Inc / Western Digital Corp / Abbvie Inc / Perrigo Company PLC / Crestwood Equity Partners LP / Installed Building Products Inc / Pacira Biosciences Inc / Agile Therapeutics Inc / Rayonier Advanced Materials Inc / Aurinia Pharmaceuticals Inc / Summit Materials Inc / SAGE Therapeutics Inc / Teladoc Health Inc / Global Blood Therapeutics Inc / SiteOne Landscape Supply Inc / Ionis Pharmaceuticals Inc / Tabula Rasa HealthCare Inc / Nutanix Inc / Centennial Resource Development Inc / Evoqua Water Technologies Corp / Aptiv PLC / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Xeris Biopharma Holdings Inc / Bausch Health Companies Inc / Aquestive Therapeutics Inc / Elastic NV / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc / Homology Medicines Inc / Ping Identity Holding Corp / Pennant Group Inc / TFI International Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Denmark / France / United Kingdom / Ireland / Israel / Italy / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4502.T / JNJ.N / PFE.N / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Takeda Pharmaceutical Co Ltd / Johnson & Johnson / Pfizer Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4552.T: JCR Pharma - Coronavirus vaccine production for AstraZeneca a positive catalyst, potential share price upside; upgrading to Outperform</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">4552.T / PFE.N / AZN.L</td><td class="leftalignment">JCR Pharmaceuticals Co Ltd / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">02/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4552.T: JCRファーマ - アストラゼネカのコロナワクチン原液生産はポジティブカタリスト、株価には上昇余地ありと判断。Outperformに引き上げ</td><td class="leftalignment">Japanese</td><td class="rightalignment">10</td><td class="leftalignment">4552.T / PFE.N / AZN.L</td><td class="leftalignment">JCR Pharmaceuticals Co Ltd / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/24/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Short interest positioning read</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AGRX.O / AMRX.N / XERS.O / AQST.O / OSMT.O / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Osmotica Pharmaceuticals PLC / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/24/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Who Is Coming Up Short?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">ACRS.OQ / AERI.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / AMGN.OQ / COLL.OQ / ALKS.OQ / OPTN.OQ / GILD.OQ / CERS.OQ / RMTI.OQ / BDSI.OQ / BIIB.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / NEOS.BO / OMER.OQ / ARDX.OQ / ACRX.OQ / AMRN.NS / ZTS.N / ANIP.OQ / AXGN.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / VERU.OQ / TXMD.OQ / EOLS.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / Aerie Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Amgen Inc / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Gilead Sciences Inc / Cerus Corp / Rockwell Medical Inc / BioDelivery Sciences International Inc / Biogen Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Neo Corp International Ltd / Omeros Corp / Ardelyx Inc / AcelRx Pharmaceuticals Inc / ADF Foods Ltd / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Veru Inc / TherapeuticsMD Inc / Evolus Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / India / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / REGN.OQ / NVAX.OQ / HSTM.OQ / BIIB.OQ / CLDX.OQ / AXGN.OQ / PRQR.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novavax Inc / HealthStream Inc / Biogen Inc / Celldex Therapeutics Inc / AxoGen Inc / ProQR Therapeutics NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Acquisdata</td><td class="leftalignment">Pfizer Inc.</td><td class="leftalignment">English</td><td class="rightalignment">49</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">OPERATIONS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Acquisdata Research Team</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Pfizer Vaccine Updates: Possibly Easier Storage, Efficacy Against South African Strain</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / JNJ.N</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">February 2021 issue of "Monthly Controversies" report</td><td class="leftalignment">English</td><td class="rightalignment">165</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PANW=US / XM=US / BSX=US / LLY=US / PFE=US / ABT=US / HD=US / MDT=US / AMZN=US / QCOM=US / ORCL=US / ADBE=US / INCY=US / U=US / NVDA=US / EVER=US / CRM=US / NVS=US / EL=US / LOW=US / SAP=US / ZEN=US / RSG=US / ARNA=US / ADSK=US / BL=US / CHD=US / DOCU=US / LPSN=US / NOW=US / NDSN=US / PCTY=US / REGN=US / SHOP=US / TWOU=US / FB=US / RNG=US / SPSC=US / GOOG=US / FRPT=US / SNSS=US / PUBM=US / UTZ=US / 2454-TW=US / ALSN=US / WDAY=US / GOOGL=US / PAYC=US / COUP=US / HUBS=US / NVRO=US / BILL=US / TTD=US / YEXT=US / CNNE=US / SVMK=US / ARQT=US / FBRX=US</td><td class="leftalignment">Palo Alto Networks Inc / Qualtrics International Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Home Depot Inc / Medtronic PLC / Amazon.com Inc / Qualcomm Inc / Oracle Corp / Adobe Inc / Incyte Corp / Unity Software Inc / NVIDIA Corp / EverQuote Inc / Salesforce.Com Inc / Novartis AG / Estee Lauder Companies Inc / Lowe's Companies Inc / SAP SE / Zendesk Inc / Republic Services Inc / Arena Pharmaceuticals Inc / Autodesk Inc / Blackline Inc / Church & Dwight Co Inc / DocuSign Inc / LivePerson Inc / ServiceNow Inc / Nordson Corp / Paylocity Holding Corp / Regeneron Pharmaceuticals Inc / Shopify Inc / 2U Inc / Meta Platforms Inc / RingCentral Inc / SPS Commerce Inc / Alphabet Inc / Freshpet Inc / Viracta Therapeutics Inc / PubMatic Inc / UTZ Brands Inc / MediaTek Inc / Allison Transmission Holdings Inc / Workday Inc / Alphabet Inc / Paycom Software Inc / Coupa Software Inc / HubSpot Inc / Nevro Corp / Bill.com Holdings Inc / Trade Desk Inc / Yext Inc / Cannae Holdings Inc / Momentive Global Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / Ireland / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Retailing / Semiconductors</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / WMB=US / LLY=US / LSI=US / PFE=US / AMGN=US / MCD=US / OXY=US / WEN=US / TEVA=US / GL=US / AMT=US / REI=US / V=US / CCI=US / HSII=US / MGY=US / CHRS=US / SPOT=US / MRO=US / CVS=US / RCL=US / DISH=US / KFY=US / CBRL=US / ELY=US / DRI=US / ABG=US / OKE=US / REGI=US / SBAC=US / VRTX=US / GOLF=US / CVX=US / ADC=US / PRI=US / NHI=US / PRA=US / NLS=US / DIN=US / EXR=US / PLAY=US / DENN=US / XM=US / KBR=US / CMG=US / REX=US / MA=US / GPRE=US / AMRX=US / TAST=US / QSR=US / JACK=US / CLNY=US / HTA=US / TREX=US / GDOT=US / SBRA=US / PANW=US / FANG=US / TMUS=US / NDLS=US / FIVN=US / VNOM=US / LOCO=US / SHAK=US / SUM=US / NSA=US / BWXT=US / WING=US / ZG=US / SQ=US / FRTA=US / RDFN=US / BTAI=US / ZI=US / BIGC=US / VTRS=US / 100073616</td><td class="leftalignment">Merck & Co Inc / Williams Companies Inc / Eli Lilly and Co / Life Storage Inc / Pfizer Inc / Amgen Inc / McDonald's Corp / Occidental Petroleum Corp / Wendys Co / Teva Pharmaceutical Industries Ltd / Globe Life Inc / American Tower Corp / Ring Energy Inc / Visa Inc / Crown Castle International Corp / Heidrick & Struggles International Inc / Magnolia Oil & Gas Corp / Coherus BioSciences Inc / Spotify Technology SA / Marathon Oil Corp / CVS Health Corp / Royal Caribbean Cruises Ltd / DISH Network Corp / Korn Ferry / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Darden Restaurants Inc / Asbury Automotive Group Inc / ONEOK Inc / Renewable Energy Group Inc / SBA Communications Corp / Vertex Pharmaceuticals Inc / Acushnet Holdings Corp / Chevron Corp / Agree Realty Corp / Primerica Inc / National Health Investors Inc / ProAssurance Corp / Nautilus Inc / Dine Brands Global Inc / Extra Space Storage Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Qualtrics International Inc / KBR Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Mastercard Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Jack in the Box Inc / DigitalBridge Group Inc / Healthcare Trust Of America Inc / Trex Company Inc / Green Dot Corp / Sabra Health Care REIT Inc / Palo Alto Networks Inc / Diamondback Energy Inc / T-Mobile US Inc / Noodles & Co / Five9 Inc / Viper Energy Partners LP / El Pollo Loco Holdings Inc / Shake Shack Inc / Summit Materials Inc / National Storage Affiliates Trust / BWX Technologies Inc / Wingstop Inc / Zillow Group Inc / Block Inc / Forterra Inc / Redfin Corp / BioXcel Therapeutics Inc / ZoomInfo Technologies Inc / Bigcommerce Holdings Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Israel / Liberia / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Post-COVID Vax Opportunities for mRNA - Key Takeaways from our GHC Panel</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2486813 / 2973821 / 2050832 / 2026242 / 2270726 / 2542049 / 2345022 / 2100920 / 2367480 / 2638625 / 2645409 / 2680905 / 2684703 / 2048804 / 2730190 / 7103065 / 2971029 / B125XQ6 / B2R3PV1 / B3D7K31 / B3WNNP3 / B7254K9 / B7VD3F2 / B87ZMX0 / BFLR866 / BVVN4Q8 / BYW36M8 / BYNZGK1 / BJ5FZ74 / BFMXGR0 / BJJMGL2 / BZ8VJQ8 / BJFSR99 / BKTNTR9 / BMDCDP2 / BMDJ085</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Kellogg Co / Alliant Energy Corp / Ameren Corp / American Electric Power Company Inc / Walt Disney Co / Dominion Energy Inc / Macy's Inc / FirstEnergy Corp / Genuine Parts Co / National Beverage Corp / NiSource Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / Novartis AG / LKQ Corp / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Green Dot Corp / AxoGen Inc / Duke Energy Corp / Palo Alto Networks Inc / Twitter Inc / Eversource Energy / PayPal Holdings Inc / Block Inc / Adaptive Biotechnologies Corp / Evergy Inc / Fox Corp / Vistra Corp / Revance Therapeutics Inc / ViacomCBS Inc / Bigcommerce Holdings Inc / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/23/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Therapeutic Categories Outlook</td><td class="leftalignment">English</td><td class="rightalignment">3621</td><td class="leftalignment">US0311621009 / US0463531089 / US1101221083 / US30161Q1040 / US3755581036 / US37733W1053 / US4781601046 / US5324571083 / US66987V1098 / US7170811035 / US75886F1075 / US7711951043 / US91307C1027 / US92532F1003 / US80105N1054 / US09062X1037 / US58933Y1055 / IE00BJ3V9050</td><td class="leftalignment">Amgen Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Exelixis Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Sanofi SA / Biogen Inc / Merck & Co Inc / Endo International PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Health Care Team</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">KOL Call Takeaways: Atopic Dermatitis (Eczema)</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LLY=US / PFE=US / INCY=US / NVS=US / ARNA=US / REGN=US / ALSN=US / ARQT=US / FBRX=US</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / Incyte Corp / Novartis AG / Arena Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Allison Transmission Holdings Inc / Arcutis Biotherapeutics Inc / Forte Biosciences Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / NCOX.PA / AERI.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / HGEN.OQ / GRAY.OQ / OCUP.OQ</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Nicox SA / Aerie Pharmaceuticals Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Humanigen Inc / Graybug Vision Inc / Ocuphire Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Where We Think The Stock Could Trade On TRAILBLAZER Data At AD/PD And Key AD Updates Expected In The Next 12-18 Months</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">JNJ.N / LLY.N / PFE.N / BIIB.OQ</td><td class="leftalignment">Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Biogen Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Johnson & Johnson Covid-19 Vaccine Updates: South African Roll-out, FDA Reviews</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 12, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FR0000121014 / GB0004544929 / GB0002875804 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1912161007 / US1925761066 / US2254471012 / US37733W1053 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US6556641008 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US7711951043 / US8308791024 / US8447411088 / US8807701029 / US91347P1057 / US9182041080 / US4771431016 / US4198791018 / US80105N1054 / US02209S1033 / US3463751087 / US90385V1070 / US2538681030 / US19239V3024 / US2090341072 / PAP310761054 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US03027X1000 / US00287Y1091 / NL0010273215 / US4576693075 / US23283R1005 / US8485771021 / US21240E1055 / CH0210483332 / US02376R1023 / US3623931009 / US14862Q1004 / CA0089118776 / US22822V1017 / US29444U7000 / US36165L1089 / KYG4740B1059 / US78410G1040 / US91325V1089 / US83418M1036 / US87105L1044 / US19626G1085 / US5904791358 / KY30744W1070 / US76156B1070 / US55406W1036 / US82489W1071</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Imperial Brands PLC / British American Tobacco PLC / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Cohu Inc / Wolfspeed Inc / GlaxoSmithKline PLC / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Nordstrom Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / Teradyne Inc / Universal Display Corp / VF Corp / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Altria Group Inc / FormFactor Inc / Ultra Clean Holdings Inc / Digital Realty Trust Inc / Cogent Communications Holdings Inc / Consolidated Communications Holdings Inc / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / American Tower Corp / Abbvie Inc / ASML Holding NV / Insmed Inc / CyrusOne Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Compagnie Financiere Richemont SA / American Airlines Group Inc / GTT Communications Inc / Castlight Health Inc / Air Canada / Crown Castle International Corp / Equinix Inc / GDS Holdings Ltd / Ichor Holdings Ltd / SBA Communications Corp / Uniti Group Inc / Solaris Oilfield Infrastructure Inc / Switch Inc / DigitalBridge Group Inc / Mesa Air Group Inc / Farfetch Ltd / Revolve Group Inc / MYT Netherlands Parent BV / Shoals Technologies Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">25</td><td class="leftalignment">ALTR.O / ALV.N / AU.N / BP.L / CCI.N / CF.N / CL.N / CNA.L / CNE.L / EL.N / ENI.MI / EOG.N / F.N / FLS.N / FOUG.PA / GE.N / GM.N / KMB.N / KO.N / MRK.N / NA / NVA.TO / OXY.N / PD.TO / PFE.N / REP.MC / SGC.L / STO.AX / T.N / TLW.L / TOTF.PA / VC.N / WPL.AX / PEP.N / TRI.N / BFb.N / PG.N / PXD.N / CNQ.TO / CPB.N / TEN.N / CMCSA.O / AMGN.O / ETN.N / BWA.N / LEA.N / WCC.N / K.N / DISH.O / IMO.TO / SU.TO / BTE.TO / CLX.N / CAG.N / VLO.N / MRO.N / INTU.O / GIS.N / EMR.N / XOM.N / DVN.N / EPC.N / MGA.N / JAZZ.O / ORG.AX / CONE.O / GWW.N / VZ.N / EXEL.O / JCI.N / ARNA.O / STZ.N / APH.N / RRC.N / FISV.O / EQT.N / ADSK.O / CHTR.O / AXL.N / CHD.N / BC.N / DK.N / POU.TO / ESI.TO / SAM.N / FOG.L / BMRN.O / REGN.O / ENR.N / CVX.N / BPT.AX / SM.N / NCR.N / PSI.TO / TEL.N / COP.N / CPE.N / ENDP.O / PII.N / ST.N / SWN.N / TT.N / FCF.N / O.N / SGEN.OQ / GPN.N / MNST.O / EFX.TO / IMGN.O / CASY.O / ANSS.O / EQIX.O / ATDb.TO / FAR.AX / COE.AX / CVN.AX / TCW.TO / CFW.TO / 02209S103 / NTR.N / NVT.N / CR.TO / DLR.N / SCL.TO / NESTE.HE / 427866108 / WEF.TO / RDSb.L / KOS.N / DISCA.O / KAR.AX / FIS.N / SES.TO / ALD.AX / MWA.N / HOG.N / GALP.LS / BIR.TO / CLR.N / BGS.N / VMW.N / COI.AX / DAN.N / GTE.TO / NOG.A / PBF.N / EDPR.LS / WGO.AX / CPG.TO / AAV.TO / CEU.TO / SPB.N / ATH.TO / OAS.N / MEG.TO / VET.TO / TOU.TO / NXT.AX / ERF.TO / FRU.TO / PEY.TO / PCRX.O / MTOR.N / MPC.N / HFC.N / PXT.TO / MTDR.N / XYL.N / TVE.TO / PSX.N / PANW.N / MDLZ.OQ / FANG.O / KEL.TO / TSLA.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / CJ.TO / QTWO.N / TSLX.N / PSK.TO / LXE.V / AXTA.N / SHOP.N / GLPG.O / SQ.N / MESO.O / RACE.MI / TWLO.N / ATKR.N / PARR.N / KNSL.OQ / ATS.AX / AKERBP.OL / NTNX.O / ADNT.N / GDS.O / CDEV.O / STEP.TO / ESTE.N / ATNX.O / APTV.N / ZS.OQ / ENOG.L / DBX.O / AMRX.N / VNE.N / KDP.N / FOCS.O / VEN.AX / ESTC.N / NWL.O / PIPE.V / LSPD.TO / 269796108 / CRWD.O / GMAB.O / PING.N / CRNC.OQ / EPAC.N / 2222.SE / OVV.N / REYN.O / CARR.N / LUNE.ST / NKLA.OQ / APA.OQ / FOUR.N / RXT.OQ / IBEX.O / LUMN.N / PLTR.N / MCFE.OQ / TPZ.TO / AFRM.O / 120291281 / 120681711</td><td class="leftalignment">Altair Engineering Inc / Autoliv Inc / AngloGold Ashanti Ltd / BP PLC / Crown Castle International Corp / CF Industries Holdings Inc / Colgate-Palmolive Co / Centrica PLC / Capricorn Energy PLC / Estee Lauder Companies Inc / Eni SpA / EOG Resources Inc / Ford Motor Co / Flowserve Corp / Eiffage SA / General Electric Co / General Motors Co / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / National Bank of Canada / Nuvista Energy Ltd / Occidental Petroleum Corp / Precision Drilling Corp / Pfizer Inc / Repsol SA / Stagecoach Group PLC / Santos Ltd / AT&T Inc / Tullow Oil PLC / TotalEnergies SE / Visteon Corp / Woodside Petroleum Ltd / PepsiCo Inc / Thomson Reuters Corp / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Canadian Natural Resources Ltd / Campbell Soup Co / Tenneco Inc / Comcast Corp / Amgen Inc / Eaton Corporation PLC / Borgwarner Inc / Lear Corp / Wesco International Inc / Kellogg Co / DISH Network Corp / Imperial Oil Ltd / Suncor Energy Inc / Baytex Energy Corp / Clorox Co / Conagra Brands Inc / Valero Energy Corp / Marathon Oil Corp / Intuit Inc / General Mills Inc / Emerson Electric Co / Exxon Mobil Corp / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / Jazz Pharmaceuticals PLC / Origin Energy Ltd / CyrusOne Inc / W W Grainger Inc / Verizon Communications Inc / Exelixis Inc / Johnson Controls International PLC / Arena Pharmaceuticals Inc / Constellation Brands Inc / Amphenol Corp / Range Resources Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Church & Dwight Co Inc / Brunswick Corp / Delek US Holdings Inc / Paramount Resources Ltd / Ensign Energy Services Inc / Boston Beer Company Inc / Falcon Oil & Gas Ltd / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Chevron Corp / Beach Energy Ltd / SM Energy Co / NCR Corp / Pason Systems Inc / TE Connectivity Ltd / Conocophillips / Callon Petroleum Co / Endo International PLC / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Trane Technologies PLC / First Commonwealth Financial Corp / Realty Income Corp / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Enerflex Ltd / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Equinix Inc / Alimentation Couche-Tard Inc / FAR Ltd / Cooper Energy Ltd / Carnarvon Energy Ltd / Trican Well Service Ltd / Calfrac Well Services Ltd / Altria Group Inc / Nutrien Ltd / nVent Electric PLC / Crew Energy Inc / Digital Realty Trust Inc / Shawcor Ltd / Neste Oyj / Hershey Co / Western Forest Products Inc / Royal Dutch Shell PLC / Kosmos Energy Ltd / Discovery Inc / Karoon Energy Ltd / Fidelity National Information Services Inc / Secure Energy Services Inc / Ampol Ltd / Mueller Water Products Inc / Harley-Davidson Inc / Galp Energia SGPS SA / Birchcliff Energy Ltd / Continental Resources Inc / B&G Foods Inc / VMware Inc / Comet Ridge Ltd / Dana Inc / Gran Tierra Energy Inc / Northern Oil and Gas Inc / PBF Energy Inc / EDP Renovaveis SA / Warrego Energy Ltd / Crescent Point Energy Corp / Advantage Energy Ltd / CES Energy Solutions Corp / Spectrum Brands Holdings Inc / Athabasca Oil Corp / Oasis Petroleum Inc / MEG Energy Corp / Vermilion Energy Inc / Tourmaline Oil Corp / NEXTDC Ltd / Enerplus Corp / Freehold Royalties Ltd / Peyto Exploration & Development Corp / Pacira Biosciences Inc / Meritor Inc / Marathon Petroleum Corp / HollyFrontier Corp / Parex Resources Inc / Matador Resources Co / Xylem Inc / Tamarack Valley Energy Ltd / Phillips 66 / Palo Alto Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Kelt Exploration Ltd / Tesla Inc / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Cardinal Energy Ltd (Alberta) / Q2 Holdings Inc / Sixth Street Specialty Lending Inc / Prairiesky Royalty Ltd / Leucrotta Exploration Inc / Axalta Coating Systems Ltd / Shopify Inc / Galapagos NV / Block Inc / Mesoblast Ltd / Ferrari NV / Twilio Inc / Atkore Inc / Par Pacific Holdings Inc / Kinsale Capital Group Inc / Australis Oil & Gas Ltd / Aker BP ASA / Nutanix Inc / Adient PLC / GDS Holdings Ltd / Centennial Resource Development Inc / Step Energy Services Ltd / Earthstone Energy Inc / Athenex Inc / Aptiv PLC / Zscaler Inc / Energean PLC / Dropbox Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Keurig Dr Pepper Inc / Focus Financial Partners Inc / Vintage Energy Ltd / Elastic NV / Newell Brands Inc / Pipestone Energy Corp / Lightspeed Commerce Inc / Eagle Pharmaceuticals Inc / CrowdStrike Holdings Inc / Genmab A/S / Ping Identity Holding Corp / Cerence Inc / Enerpac Tool Group Corp / Saudi Arabian Oil Co / Ovintiv Inc / Reynolds Consumer Products Inc / Carrier Global Corp / Lundin Energy AB / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Rackspace Technology Inc / Ibex Ltd / Lumen Technologies Inc / Palantir Technologies Inc / Mcafee Corp / Topaz Energy Corp / Affirm Holdings Inc / Cenovus Energy Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Cayman Islands / Denmark / Spain / Finland / France / United Kingdom / Ireland / Italy / Netherlands / Norway / Papua New Guinea / Portugal / Saudi Arabia / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">2021 MEDACorp IBD Physician Survey Shows Novel Orals Set to Expand Market</td><td class="leftalignment">English</td><td class="rightalignment">40</td><td class="leftalignment">PFE=US / BMY=US / GILD=US / ARNA=US / NKTR=US / AMTI=US / ABBV=US / TBPH=US / PTGX=US / GOSS=US</td><td class="leftalignment">Pfizer Inc / Bristol-Myers Squibb Co / Gilead Sciences Inc / Arena Pharmaceuticals Inc / Nektar Therapeutics / Applied Molecular Transport Inc. / Abbvie Inc / Theravance Biopharma Inc / Protagonist Therapeutics Inc / Gossamer Bio Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joseph P. Schwartz / Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail: Vaccination & Hospitalization Weekly Tracker - Week 7, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">FIBRAMQ12.MX / FUNO11.MX / JNJ.N / PFE.N / AZN.L / DANHOS13.MX</td><td class="leftalignment">Macquarie Mexico Real Estate Management SA de CV / Fibra Uno Administracion SA de CV / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Concentradora Fibra Danhos SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas / Andres Ortiz</td></tr>
<tr class="even"><td class="leftalignment">02/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 12, 2021: Focus on Jan 2021 Rx volumes for branded and generic drugs</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ / MNK.N^J20</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc / Mallinckrodt PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States / Jersey</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of And Key Focus Areas For ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">MRK / PFE</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: CTP2021-ALSEN, MGTX, SIGHT; LentiGlobin BLUEs</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">MGTX.OQ / SIGHT.PA / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">MeiraGTx Holdings PLC / Gensight Biologics SA / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Key Questions for Management 2.21.21</td><td class="leftalignment">English</td><td class="rightalignment">76</td><td class="leftalignment">ADAP=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / AMGN=US / TMO=US / MDT=US / A=US / INCY=US / INSP=US / TEVA=US / GILD=US / MOR=DE / SAN=FR / GSK=GB / SYK=US / BAX=US / AZN=US / WAT=US / JNJ=US / MDRX=US / IMGN=US / NUAN=US / ABMD=US / ALKS=US / ALC=US / AMRN=US / ARNA=US / ATRC=US / BDX=US / BMRN=US / BLUE=US / CSTL=US / CALA=US / CERN=US / CNMD=US / EW=US / ENDP=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / INGN=US / ISRG=US / MYGN=US / NBIX=US / PRGO=US / PRTK=US / RARE=US / HOOK=US / REGN=US / RGEN=US / SENS=US / SIEN=US / SILK=US / TECH=US / TFX=US / VRTX=US / ALGN=US / SGEN=US / SAGE=US / OPT=US / PRVB=US / CGEN=US / ALVR=US / JAZZ=US / PHR=US / STSA=US / RNA=US / IMTX=US / MREO=US / NTRA=US / CPSI=US / NKTR=US / MRNS=US / AMTI=US / BIIB=US / ACRS=US / ARWR=US / APTX=US / NUVA=US / MRNA=US / ACAD=US / ALNY=US / MNKD=US / COGT=US / DXCM=US / CYRX=US / CBAY=US / GRAY=US / EQ=US / QTRX=US / AVRO=US / TPTX=US / AMRX=US / FOLD=US / PODD=US / TNDM=US / IFRX=US / ITRM=US / NXGN=US / FULC=US / LUN=US / ASND=US / AVEO=US / NEO=US / RCUS=US / MOLN / CTSO=US / ZGNX=US / PCRX=US / RGNX=US / CLVS=US / PBYI=US / AXGN=US / VCRA=US / CCXI=US / FGEN=US / SRPT=US / GMED=US / ABBV=US / EPZM=US / MRTX=US / AGIO=US / PINC=US / FATE=US / MGNX=US / VEEV=US / VCYT=US / KPTI=US / OM=US / ITCI=US / XNCR=US / HRTX=US / QURE=US / GNCA=US / TBPH=US / ARDX=US / RDUS=US / MASS=US / XENT=US / ASMB=US / HQY=US / TTOO=US / AUPH=US / AFMD=US / GNFT=US / DBVT=US / VCEL=US / XENE=US / NVRO=US / NVTA=US / RLMD=US / VKTX=US / BPMC=US / HTGM=US / ZBH=US / ABEO=US / TDOC=US / KURA=US / WVE=US / AXSM=US / IONS=US / BGNE=US / NTLA=US / ADVM=US / RETA=US / MDGL=US / PTGX=US / ACIU=US / TRHC=US / MYOV=US / ZYME=US / AVDL=US / OBSV=US / RCM=US / BHVN=US / MRSN=US / KALV=US / ATNX=US / SYBX=US / ZLAB=US / DCPH=US / SCPH=US / SLDB=US / GH=US / RCKT=US / EOLS=US / XERS=US / REPL=US / RUBY=US / CRNX=US / ALLK=US / SBTX=US / TWST=US / AXNX=US / MLND=US / OSMT=US / ORGO=US / HARP=US / GOSS=US / TCRR=US / IMUX=US / AXLA=US / BBIO=US / HCAT=US / BNTX=US / GMAB=US / IPHA=US / ETNB=US / PGNY=US / CNTG=US / IMVT=US / ONEM=US / RVMD=US / IMRA=US / ZNTL=US / KROS=US / FMTX=US / ACCD=US / ITOS=US / KDNY=US / GDRX=US / SPRB=US / SIOX=US / VTRS=US / ABCM=US / GLTO=US / TVTX=US / ABCL=US / KNTE=US / ELDN=US / PRTC=US / CGEM=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Amgen Inc / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Incyte Corp / Inspire Medical Systems Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / MorphoSys AG / Sanofi SA / GlaxoSmithKline PLC / Stryker Corp / Baxter International Inc / AstraZeneca PLC / Waters Corp / Johnson & Johnson / Allscripts Healthcare Solutions Inc / ImmunoGen Inc / Nuance Communications Inc / ABIOMED Inc / Alkermes Plc / Alcon AG / Amarin Corporation PLC / Arena Pharmaceuticals Inc / AtriCure Inc / Becton Dickinson and Co / Biomarin Pharmaceutical Inc / bluebird bio Inc / Castle Biosciences Inc / Calithera Biosciences Inc / Cerner Corp / Conmed Corp / Edwards Lifesciences Corp / Endo International PLC / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Inogen Inc / Intuitive Surgical Inc / Myriad Genetics Inc / Neurocrine Biosciences Inc / Perrigo Company PLC / Paratek Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Senseonics Holdings Inc / Sientra Inc / Silk Road Medical Inc / Bio-Techne Corp / Teleflex Inc / Vertex Pharmaceuticals Inc / Align Technology Inc / Seagen Inc / SAGE Therapeutics Inc / Opthea Ltd / Provention Bio Inc / Compugen Ltd / Allovir Inc / Jazz Pharmaceuticals PLC / Phreesia Inc / Satsuma Pharmaceuticals Inc / Avidity Biosciences Inc / Immatics NV / Mereo Biopharma Group PLC / Natera Inc / Computer Programs and Systems Inc / Nektar Therapeutics / Marinus Pharmaceuticals Inc / Applied Molecular Transport Inc. / Biogen Inc / Aclaris Therapeutics Inc / Arrowhead Pharmaceuticals Inc / Aptinyx Inc / NuVasive Inc / Moderna Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / MannKind Corp / Cogent Biosciences Inc / Dexcom Inc / Cryoport Inc / Cymabay Therapeutics Inc / Graybug Vision Inc / Equillium Inc / Quanterix Corp / AVROBIO Inc / Turning Point Therapeutics Inc / Amneal Pharmaceuticals Inc / Amicus Therapeutics Inc / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Iterum Therapeutics PLC / NextGen Healthcare Inc / Fulcrum Therapeutics Inc / H Lundbeck A/S / Ascendis Pharma A/S / Aveo Pharmaceuticals Inc / Neogenomics Inc / Arcus Biosciences Inc / Molecular Partners AG / Cytosorbents Corp / Zogenix Inc / Pacira Biosciences Inc / Regenxbio Inc / Clovis Oncology Inc / Puma Biotechnology Inc / AxoGen Inc / Vocera Communications Inc / ChemoCentryx Inc / FibroGen Inc / Sarepta Therapeutics Inc / Globus Medical Inc / Abbvie Inc / Epizyme Inc / Mirati Therapeutics Inc / Agios Pharmaceuticals Inc / Premier Inc / Fate Therapeutics Inc / MacroGenics Inc / Veeva Systems Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Outset Medical Inc / Intra-Cellular Therapies Inc / Xencor Inc / Heron Therapeutics Inc / Uniqure NV / Genocea Biosciences Inc / Theravance Biopharma Inc / Ardelyx Inc / Radius Health Inc / 908 Devices Inc. / Intersect Ent Inc / Assembly Biosciences Inc / Healthequity Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Affimed NV / Genfit SA / DBV Technologies SA / Vericel Corp / Xenon Pharmaceuticals Inc / Nevro Corp / Invitae Corp / Relmada Therapeutics Inc / Viking Therapeutics Inc / Blueprint Medicines Corp / HTG Molecular Diagnostics Inc / Zimmer Biomet Holdings Inc / Abeona Therapeutics Inc / Teladoc Health Inc / Kura Oncology Inc / WAVE Life Sciences Ltd / Axsome Therapeutics Inc / Ionis Pharmaceuticals Inc / Beigene Ltd / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / Reata Pharmaceuticals Inc / Madrigal Pharmaceuticals Inc / Protagonist Therapeutics Inc / AC Immune SA / Tabula Rasa HealthCare Inc / Myovant Sciences Ltd / Zymeworks Inc / Avadel Pharmaceuticals PLC / Obseva SA / R1 RCM Inc / Biohaven Pharmaceutical Holding Company Ltd / Mersana Therapeutics Inc / Kalvista Pharmaceuticals Inc / Athenex Inc / Synlogic Inc / Zai Lab Ltd / Deciphera Pharmaceuticals Inc / scPharmaceuticals Inc / Solid Biosciences Inc / Guardant Health Inc / Rocket Pharmaceuticals Inc / Evolus Inc / Xeris Biopharma Holdings Inc / Replimune Group Inc / Rubius Therapeutics Inc / Crinetics Pharmaceuticals Inc / Allakos Inc / Silverback Therapeutics Inc / Twist Bioscience Corp / Axonics Inc / Tempest Therapeutics Inc / Osmotica Pharmaceuticals PLC / Organogenesis Holdings Inc / Harpoon Therapeutics Inc / Gossamer Bio Inc / TCR2 Therapeutics Inc / Immunic Inc / Axcella Health Inc / BridgeBio Pharma Inc / Health Catalyst Inc / BioNTech SE / Genmab A/S / Innate Pharma SA / 89Bio Inc / Progyny Inc / Centogene NV / Immunovant Inc / 1Life Healthcare Inc / Revolution Medicines Inc / Imara Inc / Zentalis Pharmaceuticals Inc / Keros Therapeutics Inc / Forma Therapeutics Holdings Inc / Accolade Inc / Iteos Therapeutics Inc / Chinook Therapeutics Inc / Goodrx Holdings Inc / Spruce Biosciences Inc / Sio Gene Therapies Inc / Viatris Inc / Abcam PLC / Galecto Inc / Travere Therapeutics Inc / Abcellera Biologics Inc / Kinnate Biopharma Inc / Eledon Pharmaceuticals Inc / PureTech Health PLC / Cullinan Oncology Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Virgin Islands, British</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/21/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / ENDP.O / PCRX.O / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Endo International PLC / Pacira Biosciences Inc / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/21/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 47</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.19.21</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Validea</td><td class="leftalignment">Validea Guru Analysis Report for PFE. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others.</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">QUANTITATIVE ANALYSIS</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY REPORT</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / QUANANTITATIVE/TECH RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARNA / 45337C10 / 09058V10 / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 60468T105 / 09627Y109 / 690469101 / 558868105 / 12648L601 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 185063104 / 02155H200 / 24344T101 / 48576A100 / 03843E104 / 517125100 / 07160F107 / G637AM102 / N71542109 / 72942A107</td><td class="leftalignment">Arena Pharmaceuticals Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Mirati Therapeutics Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / Clearside Biomedical Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Aquestive Therapeutics Inc / Larimar Therapeutics Inc / Baudax Bio Inc / Myovant Sciences Ltd / ProQR Therapeutics NV / PLx Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary - Feb 19 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">UTHR=US / XAIR=US / MRK=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / BMY=US / GBT=US / MDT=US / WMT=US / TEVA=US / EPIX=US / CMS=US / DGX=US / SYK=US / IART=US / BWAY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / BLUE=US / CHE=US / CYH=US / EW=US / EXAS=US / EXEL=US / GEN=US / ICPT=US / PHG=US / LH=US / REGN=US / USPH=US / UHS=US / VRTX=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / MD=US / SLF=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / MASI=US / EHC=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / SRPT=US / AGIO=US / CTRE=US / OTIC=US / VBLT=US / WBA=US / NVTA=US / CLLS=US / VKTX=US / EVH=US / CFMS=US / CERC=US / EDIT=US / MDGL=US / IRTC=US / CRSP=US / VERU=US / MBIO=US / MDNA=US / SESN=US / ARVN=US / FREQ=US / BXRX=US / PNTG=US / TARA=US / AYLA=US / FMTX=US / MNKKQ=US / CHGCY=US</td><td class="leftalignment">United Therapeutics Corp / Beyond Air Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Bristol-Myers Squibb Co / Global Blood Therapeutics Inc / Medtronic PLC / Walmart Inc / Teva Pharmaceutical Industries Ltd / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Stryker Corp / Integra Lifesciences Holdings Corp / Brainsway Ltd / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / bluebird bio Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Exelixis Inc / Genesis Healthcare Inc / Intercept Pharmaceuticals Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / MEDNAX Inc / Sun Life Financial Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Masimo Corp / Encompass Health Corp / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / CareTrust REIT Inc / Otonomy Inc / Vascular Biogenics Ltd / Walgreens Boots Alliance Inc / Invitae Corp / Cellectis SA / Viking Therapeutics Inc / Evolent Health Inc / Conformis Inc / Avalo Therapeutics Inc / Editas Medicine Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Medicenna Therapeutics Corp / Sesen Bio Inc / Arvinas Inc / Frequency Therapeutics Inc / Baudax Bio Inc / Pennant Group Inc / Protara Therapeutics Inc / Ayala Pharmaceuticals Inc / Forma Therapeutics Holdings Inc / Mallinckrodt PLC / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / France / Ireland / Israel / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Feb 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">One Target With Potential In Many Cancers</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">CA89620X5064</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Boris Peaker, Ph.D., CFA, Ph.D. / Cynthia Chen, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Ownership Timelines & Shareholder Analytics (February 2021)</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NBIX.OQ / VRTX.OQ / PFE.N / AZN.L / ROG.S / AMGN.OQ / REGN.OQ / STSA.OQ / GILD.OQ / BIIB.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Roche Holding AG / Amgen Inc / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Biogen Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues - Website Introduction Slides</td><td class="leftalignment">English</td><td class="rightalignment">44</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Pfizer in bottom 7% performers of NYSE market in past quarter; Institutional Ownership down 10%</td><td class="leftalignment">English</td><td class="rightalignment">57</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">ALSN=US / CYH=US / AAPL=US / PFE=US / AMGN=US / INTC=US / ADI=US / AMD=US / MSFT=US / AMZN=US / QCOM=US / TXN=US / NVDA=US / GS=US / MX=US / MPWR=US / SMTC=US / TSM=US / XLNX=US / MGM=US / PENN=US / AMED=US / AVGO=US / CAKE=US / CHE=US / CRUS=US / DRI=US / ECL=US / IFX=US / ICPT=US / NOW=US / MCHP=US / QUIK=US / SHOP=US / UTHR=US / WIX=US / JEF=US / SWKS=US / TWLO=US / WCN=US / PTON=US / TCOM=US / CZR=US / MRNA=US / LHCG=US / BIDU=US / SPWR=US / RSI=US / IAC=US / JACK=US / SWAV=US / 005930-KR=US / ADUS=US / MXL=US / NXPI=US / 2454-TW=US / SRPT=US / WDAY=US / YY=US / NVTA=US / CLLS=US / GDDY=US / ETSY=US / VKTX=US / WING=US / SQ=US / MDGL=US / MDNA=US / IQ=US / TLRY=US / FSLY=US / DKNG=US / FUBO=US / AYLA=US / XPEV=US</td><td class="leftalignment">Allison Transmission Holdings Inc / Community Health Systems Inc / Apple Inc / Pfizer Inc / Amgen Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Texas Instruments Inc / NVIDIA Corp / Goldman Sachs Group Inc / MagnaChip Semiconductor Corp / Monolithic Power Systems Inc / Semtech Corp / Taiwan Semiconductor Manufacturing Co Ltd / Xilinx Inc / MGM Resorts International / Penn National Gaming Inc / Amedisys Inc / Broadcom Inc / Cheesecake Factory Inc / Chemed Corp / Cirrus Logic Inc / Darden Restaurants Inc / Ecolab Inc / Infineon Technologies AG / Intercept Pharmaceuticals Inc / ServiceNow Inc / Microchip Technology Inc / QuickLogic Corp / Shopify Inc / United Therapeutics Corp / Wix.Com Ltd / Jefferies Financial Group Inc / Skyworks Solutions Inc / Twilio Inc / Waste Connections Inc / Peloton Interactive Inc / Trip.com Group Ltd / Caesars Entertainment Inc / Moderna Inc / LHC Group Inc / Baidu Inc / SunPower Corp / Rush Street Interactive Inc / IAC/Interactivecorp / Jack in the Box Inc / Shockwave Medical Inc / Farfetch Ltd / Addus Homecare Corp / Maxlinear Inc / NXP Semiconductors NV / MediaTek Inc / Sarepta Therapeutics Inc / Workday Inc / JOYY Inc / Invitae Corp / Cellectis SA / GoDaddy Inc / ETSY Inc / Viking Therapeutics Inc / Wingstop Inc / Block Inc / Madrigal Pharmaceuticals Inc / Medicenna Therapeutics Corp / iQIYI Inc / Tilray Brands Inc / Fastly Inc / DraftKings Inc / Fubotv Inc / Ayala Pharmaceuticals Inc / Xpeng Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / Germany / France / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Info. Tech./Software / Lodging & Restaurants / Pharmaceuticals / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/18/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Despite Reassurances, PFE Vaccine Loses 60% of Immunity Vs SA Variant</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/18/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ZTS-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ZTS / LLY / MRK / PFE / ICCC.O / HSKA.O / PAHC.O / SNY.O</td><td class="leftalignment">Zoetis Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / ImmuCell Corp / Heska Corp / Phibro Animal Health Corp / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GILD-US -  Dividend Quality Analysis, for the period ended December 30,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">GILD.O / JNJ / LLY / MRK / PFE / AMGN.O / ILMN.O / VRTX.O / BIIB.O / ABBV.K</td><td class="leftalignment">Gilead Sciences Inc / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Illumina Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US -  Dividend Quality Analysis, for the period ended February 16,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Virtual RTP Day: Biotechnology Manufacturing Panel</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE=US / AMGN=US / UTHR=US / SRPT=US / CLLS=US</td><td class="leftalignment">Pfizer Inc / Amgen Inc / United Therapeutics Corp / Sarepta Therapeutics Inc / Cellectis SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Please Join Our Virtual KOL Call to Discuss The Potential Role Of And Key Focuses For ADCs In Oncology on Friday, April 9, 2021 at 1 pm ET</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">TARA=US / ULTA=US / MRK=US / PFE=US / AMGN=US / BMY=US / INTC=US / AMD=US / GBT=US / MSFT=US / QCOM=US / EPIX=US / NVDA=US / SCI=US / BWAY=US / TSM=US / EMR=US / HUM=US / BKI=US / CVS=US / BLUE=US / EXAS=US / RBC=US / UTHR=US / VRTX=US / RHHBY=US / RNG=US / CEVA=US / MNKD=US / GOOG=US / DENN=US / RXN=US / SFTBY=US / AGIO=US / SABR=US / SEDG=US / CERC=US / EDIT=US / CRSP=US / VERU=US / MBIO=US / SESN=US / ARVN=US / BXRX=US / FMTX=US / CHGCY=US</td><td class="leftalignment">Protara Therapeutics Inc / Ulta Beauty Inc / Merck & Co Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Intel Corp / Advanced Micro Devices Inc / Global Blood Therapeutics Inc / Microsoft Corp / Qualcomm Inc / ESSA Pharma Inc / NVIDIA Corp / Service Corporation International / Brainsway Ltd / Taiwan Semiconductor Manufacturing Co Ltd / Emerson Electric Co / Humana Inc / Black Knight Inc / CVS Health Corp / bluebird bio Inc / Exact Sciences Corp / Regal Rexnord Corp / United Therapeutics Corp / Vertex Pharmaceuticals Inc / Roche Holding AG / RingCentral Inc / CEVA Inc / MannKind Corp / Alphabet Inc / Denny's Corp / Zurn Water Solutions Corp / SoftBank Group Corp / Agios Pharmaceuticals Inc / Sabre Corp / Solaredge Technologies Inc / Avalo Therapeutics Inc / Editas Medicine Inc / CRISPR Therapeutics AG / Veru Inc / Mustang Bio Inc / Sesen Bio Inc / Arvinas Inc / Baudax Bio Inc / Forma Therapeutics Holdings Inc / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Israel / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Household Products / Info. Tech./Computers / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Pharmaceuticals / Semiconductors</td><td class="leftalignment">Asia / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Carefully Building an Oncology and Rare Disease Company; Initiate Outperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">TARA=US / MRK=US / PFE=US / BMY=US / RHHBY=US / CERC=US / SESN=US / CHGCY=US</td><td class="leftalignment">Protara Therapeutics Inc / Merck & Co Inc / Pfizer Inc / Bristol-Myers Squibb Co / Roche Holding AG / Avalo Therapeutics Inc / Sesen Bio Inc / Chugai Pharmaceutical Co Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">AZN's COVID Vax US Outlook, Data on Reinfections and Breakthrough Disease</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE=US / AZN=US / JNJ=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Andrew S. Berens, MD</td></tr>
<tr class="odd"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">DNB / MRK=US / LLY=US / PFE=US / HD=US / MCD=US / EFX=US / WEN=US / DVN=US / TEVA=US / TRU=US / CRK=US / LOW=US / WLL=US / DIOD=US / CHRS=US / BYD=US / MAR=US / LEG=US / VMC=US / ESS=US / MGM=US / BKI=US / EQR=US / CVS=US / STZ=US / ARCC=US / CBRL=US / CSGP=US / DRI=US / EXAS=US / MEDP=US / MHK=US / REGI=US / SGMO=US / VRTX=US / WIX=US / NET=US / UDR=US / VNO=US / DIN=US / MGP=US / MOH=US / RNG=US / TPX=US / KAR=US / AINV=US / PLAY=US / DENN=US / CMG=US / REX=US / FIS=US / GPRE=US / AMRX=US / TAST=US / QSR=US / CLR=US / PNNT=US / PRPL=US / IAA=US / JACK=US / ZTS=US / SBRA=US / FBHS=US / PANW=US / NDLS=US / NMIH=US / 70806A106 / LOCO=US / SHAK=US / NXRT=US / GSBD=US / CHCT=US / WING=US / CRSP=US / PVAC=US / JELD=US / IMVT=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Home Depot Inc / McDonald's Corp / Equifax Inc / Wendys Co / Devon Energy Corp / Teva Pharmaceutical Industries Ltd / TransUnion / Comstock Resources Inc / Lowe's Companies Inc / Whiting Petroleum Corp / Diodes Inc / Coherus BioSciences Inc / Boyd Gaming Corp / Marriott International Inc / Leggett & Platt Inc / Vulcan Materials Co / Essex Property Trust Inc / MGM Resorts International / Black Knight Inc / Equity Residential / CVS Health Corp / Constellation Brands Inc / Ares Capital Corp / Cracker Barrel Old Country Store Inc / CoStar Group Inc / Darden Restaurants Inc / Exact Sciences Corp / Medpace Holdings Inc / Mohawk Industries Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Wix.Com Ltd / Cloudflare Inc / UDR Inc / Vornado Realty Trust / Dine Brands Global Inc / MGM Growth Properties LLC / Molina Healthcare Inc / RingCentral Inc / Tempur Sealy International Inc / KAR Auction Services Inc / Apollo Investment Corp / Dave & Buster's Entertainment Inc / Denny's Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / Green Plains Inc / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Continental Resources Inc / Pennantpark Investment Corp / Purple Innovation Inc / IAA Inc / Jack in the Box Inc / Zoetis Inc / Sabra Health Care REIT Inc / Fortune Brands Home & Security Inc / Palo Alto Networks Inc / Noodles & Co / NMI Holdings Inc / PennantPark Floating Rate Capital Ltd / El Pollo Loco Holdings Inc / Shake Shack Inc / NexPoint Residential Trust Inc / Goldman Sachs BDC Inc / Community Healthcare Trust Inc / Wingstop Inc / CRISPR Therapeutics AG / Ranger Oil Corp / JELD-WEN Holding Inc / Immunovant Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/17/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">5671735 / 0989529 / 2367026 / 2577609 / 2126335 / 2516152 / 2778844 / 2026242 / 2208073 / 2280220 / 2270726 / 2542049 / 2100920 / 2415204 / 2459020 / 2684703 / 7103065 / 2822019 / B121557 / 2857817 / B2R3PV1 / B4Y1MH7 / BBFL7S1 / B7VD3F2 / B8CKK03 / BFZCHN7 / B95WG16 / BYRY499 / BYY8XK8 / BYVFC94 / BJF8Q81 / BDHF4K6 / BZ1HM42 / BLGJ610 / BFMXGR0 / BZ8VJQ8 / BGT3960 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / General Mills Inc / CVS Health Corp / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / American Electric Power Company Inc / Copart Inc / DTE Energy Co / Walt Disney Co / Dominion Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Intuit Inc / Pfizer Inc / Novartis AG / Advance Auto Parts Inc / Mastercard Inc / Netflix Inc / American Water Works Company Inc / KAR Auction Services Inc / bluebird bio Inc / Duke Energy Corp / Mondelez International Inc / Wix.Com Ltd / Zoetis Inc / Kraft Heinz Co / WEC Energy Group Inc / US Foods Holding Corp / IAA Inc / CRISPR Therapeutics AG / Adyen NV / Warner Music Group Corp / Evergy Inc / Vistra Corp / Orchard Therapeutics PLC / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Feb 05, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">VNDA-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">VNDA.O / BMY / JNJ / LLY / MRK / NVS / PFE / TTNP.O</td><td class="leftalignment">Vanda Pharmaceuticals Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Titan Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ALSEN=FR / MGTX=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / 199800=KR / IOVA=US / CLXT=US / SYBX=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / SIGHT=US / FIXX=US / GNPX=US / XCUR=US / REPL=US / KOD=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Sensorion SA / MeiraGTx Holdings PLC / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Synlogic Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Gensight Biologics SA / Homology Medicines Inc / Genprex Inc / Exicure Inc / Replimune Group Inc / Kodiak Sciences Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AIMC=US / MCO=US / AAPL=US / BSX=US / CSII=US / LLY=US / PFE=US / SBUX=US / ABT=US / CAT=US / COST=US / INTC=US / AMD=US / WM=US / BWA=US / MSFT=US / MDT=US / JNPR=US / AMZN=US / QCOM=US / WMT=US / TXN=US / TEVA=US / RUN=US / NVDA=US / MPWR=US / FCEL=US / PLUG=US / CRM=US / SCI=US / EL=US / SMTC=US / BJ=US / DAL=US / TSM=US / HELE=US / CTAS=US / JCI=US / JNJ=US / TTWO=US / LSTR=US / DE=US / HUM=US / LECO=US / UNH=US / INTU=US / RSG=US / ALB=US / AMSC=US / ARRY=US / AVNT=US / AVGO=US / CMI=US / CHE=US / CREE=US / DHI=US / DG=US / EW=US / EGAN=US / EXEL=US / ITRI=US / PHG=US / MS=US / TEAM=US / PZZA=US / REGN=US / ROK=US / SNAP=US / TRMB=US / TYL=US / UTHR=US / VG=US / WIX=US / RDWR=US / NET=US / ACA=US / FB=US / NEP=US / JBLU=US / NFLX=US / VRNT=US / BE=US / CLH=US / WCN=US / NDAQ=US / RNG=US / MRNA=US / MNKD=US / ENS=US / GOOG=US / TWIN=US / ORA=US / OLED=US / FRPT=US / LHCG=US / AMRS=US / SPWR=US / AXON=US / XPO=US / ELF=US / TEL=US / CSIQ=US / FSLR=US / LULU=US / MASI=US / ULTA=US / TNDM=US / DAN=US / SPGI=US / WPRT=US / KKR=US / AGCO=US / ADUS=US / TCEHY=US / TSLA=US / AMRC=US / ENPH=US / WDAY=US / HASI=US / CNHI=US / COUP=US / OTIC=US / VBLT=US / QRVO=US / NVTA=US / ETSY=US / SEDG=US / AQMS=US / WKHS=US / TTD=US / EVBG=US / IRTC=US / CRSP=US / OKTA=US / IOVA=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / FOCS=US / CWEN=US / FTDR=US / ESTC=US / UBER=US / CRWD=US / DKNG=US / VLDR=US</td><td class="leftalignment">Altra Industrial Motion Corp / Moody's Corp / Apple Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Starbucks Corp / Abbott Laboratories / Caterpillar Inc / Costco Wholesale Corp / Intel Corp / Advanced Micro Devices Inc / Waste Management Inc / Borgwarner Inc / Microsoft Corp / Medtronic PLC / Juniper Networks Inc / Amazon.com Inc / Qualcomm Inc / Walmart Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Sunrun Inc / NVIDIA Corp / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / Salesforce.Com Inc / Service Corporation International / Estee Lauder Companies Inc / Semtech Corp / BJ's Wholesale Club Holdings Inc / Delta Air Lines Inc / Taiwan Semiconductor Manufacturing Co Ltd / Helen of Troy Ltd / Cintas Corp / Johnson Controls International PLC / Johnson & Johnson / Take-Two Interactive Software Inc / Landstar System Inc / Deere & Co / Humana Inc / Lincoln Electric Holdings Inc / UnitedHealth Group Inc / Intuit Inc / Republic Services Inc / Albemarle Corp / American Superconductor Corp / Array Technologies Inc / Avient Corp / Broadcom Inc / Cummins Inc / Chemed Corp / Wolfspeed Inc / D R Horton Inc / Dollar General Corp / Edwards Lifesciences Corp / eGain Corp / Exelixis Inc / Itron Inc / Koninklijke Philips NV / Morgan Stanley / Atlassian Corporation PLC / Papa John's International Inc / Regeneron Pharmaceuticals Inc / Rockwell Automation Inc / Snap Inc / Trimble Inc / Tyler Technologies Inc / United Therapeutics Corp / Vonage Holdings Corp / Wix.Com Ltd / Radware Ltd / Cloudflare Inc / Arcosa Inc / Meta Platforms Inc / Nextera Energy Partners LP / JetBlue Airways Corp / Netflix Inc / Verint Systems Inc / Bloom Energy Corp / Clean Harbors Inc / Waste Connections Inc / Nasdaq Inc / RingCentral Inc / Moderna Inc / MannKind Corp / EnerSys / Alphabet Inc / Twin Disc Inc / Ormat Technologies Inc / Universal Display Corp / Freshpet Inc / LHC Group Inc / Amyris Inc / SunPower Corp / Axon Enterprise Inc / XPO Logistics Inc / elf Beauty Inc / TE Connectivity Ltd / Canadian Solar Inc / First Solar Inc / Lululemon Athletica Inc / Masimo Corp / Ulta Beauty Inc / Tandem Diabetes Care Inc / Dana Inc / S&P Global Inc / Westport Fuel Systems Inc / KKR & Co Inc / AGCO Corp / Addus Homecare Corp / Tencent Holdings Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / Workday Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Coupa Software Inc / Otonomy Inc / Vascular Biogenics Ltd / Qorvo Inc / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Aqua Metals Inc / Workhorse Group Inc / Trade Desk Inc / Everbridge Inc / iRhythm Technologies Inc / CRISPR Therapeutics AG / Okta Inc / Iovance Biotherapeutics Inc / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / Focus Financial Partners Inc / Clearway Energy Inc / Frontdoor Inc / Elastic NV / Uber Technologies Inc / CrowdStrike Holdings Inc / DraftKings Inc / Velodyne Lidar Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Pharmaceuticals / Retailing / Semiconductors / Services / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 16 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">US0116591092 / US0382221051 / US0463531089 / US0530151036 / US0997241064 / US1101221083 / US1311931042 / US30161Q1040 / US3614481030 / US3647601083 / US37733W1053 / US4234521015 / US4663671091 / US5324571083 / US66987V1098 / US6701002056 / US7043261079 / US7170811035 / US75886F1075 / US7711951043 / US7782961038 / US8308791024 / US8447411088 / US8552441094 / US8725401090 / US87612E1064 / US9311421039 / US3448491049 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US2533931026 / US25754A2015 / US0491642056 / US1696561059 / PAP310761054 / US79546E1047 / US01748X1028 / US2473617023 / US90384S3031 / US00922R1059 / US58933Y1055 / US9100471096 / US92335C1062 / US00287Y1091 / US5017971046 / IE00B4Q5ZN47 / US55345K1034 / US8485771021 / US21240E1055 / US1220171060 / CA05156V1022 / US02376R1023 / US70438V1061 / US70432V1026 / US0404131064 / US67576A1007 / IE00BQPVQZ61 / US0994061002 / CA0089118776 / US12685J1051 / US26856L1035 / US01345P1066 / CA1350861060 / US8760301072 / US15677J1088 / US5904791358 / CA39342L1085 / CA23126M1023 / US81181C1045 / US55406W1036</td><td class="leftalignment">Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Automatic Data Processing Inc / Borgwarner Inc / Bristol-Myers Squibb Co / Callaway Golf Co / Exelixis Inc / GATX Corp / Gap Inc / GlaxoSmithKline PLC / Helmerich and Payne Inc / Jack in the Box Inc / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Paychex Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / Ross Stores Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / TJX Companies Inc / Target Corp / Walmart Inc / Foot Locker Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / DICK'S Sporting Goods Inc / Domino's Pizza Inc / Atlas Air Worldwide Holdings Inc / Chipotle Mexican Grill Inc / Copa Holdings SA / Sally Beauty Holdings Inc / Allegiant Travel Co / Delta Air Lines Inc / Ulta Beauty Inc / Air Transport Services Group Inc / Merck & Co Inc / United Airlines Holdings Inc / Vera Bradley Inc / Abbvie Inc / Bath & Body Works Inc / Jazz Pharmaceuticals PLC / MRC Global Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / Burlington Stores Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / Paylocity Holding Corp / Paycom Software Inc / Arista Networks Inc / Ocular Therapeutix Inc / Horizon Therapeutics PLC / Boot Barn Holdings Inc / Air Canada / Cable One Inc / elf Beauty Inc / Albireo Pharma Inc / Canada Goose Holdings Inc / Tapestry Inc / Ceridian HCM Holding Inc / Mesa Air Group Inc / Green Thumb Industries Inc / Curaleaf Holdings Inc / Seagen Inc / MYT Netherlands Parent BV</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Denmark / France / United Kingdom / Ireland / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">02/16/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Reports 4Q; Litigation Uncertainty Remains Key Overhang</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">TEVA=US / LLY=US / PFE=US / REGN=US</td><td class="leftalignment">Teva Pharmaceutical Industries Ltd / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/16/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 16, 2021</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">AC.TO / ALV.N / ANTO.L / BAER.S / BARC.L / BBDb.TO / BCE.TO / BHP.AX / BNPP.PA / CC.N / CI.N / CL.N / CP.TO / CSGN.S / EDP.LS / EL.N / ELE.MC / F.N / GM.N / HSBA.L / IBE.MC / IP.N / KBH.N / KMB.N / KO.N / LLOY.L / MRK.N / PFE.N / PHM.N / RIO.AX / RIO.L / RWEG.DE / SAN.MC / SOGN.PA / T.N / T.TO / TOL.N / VC.N / SSE.L / PEP.N / BFb.N / PG.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / SJRb.TO / RCIb.TO / AMGN.O / THC.N / FER.MC / AAL.L / CNR.TO / QBRb.TO / UNH.N / BWA.N / LEA.N / CCA.TO / REE.MC / ENB.TO / K.N / DISH.O / LEN.N / TV.TO / DBKGn.DE / CLX.N / CAG.N / GIS.N / EPC.N / MGA.N / SBAC.O / BBVA.MC / JAZZ.O / ADI.O / NG.L / VZ.N / EXEL.O / DHI.N / STZ.N / APH.N / DVA.N / FISV.O / SNPS.O / CHTR.O / AXL.N / PLD.N / CHD.N / ATA.TO / BC.N / ARCC.O / SAM.N / FRAG.DE / REGN.O / ENR.N / VRTX.O / SWIR.O / FTT.TO / CAGR.PA / MHK.N / NCR.N / NET.N / TEL.N / APF.L / PII.N / ST.N / TYL.N / HCC.N / SGEN.OQ / GPN.N / MNST.O / NWG.L / CCLb.TO / IMGN.O / CASY.O / STN.TO / ATDb.TO / IGO.AX / TIH.TO / SNC.TO / FM.TO / INGA.AS / 02209S103 / 878742204 / DLR.N / HUN.N / 427866108 / 35671D857 / FIS.N / TEVA.N / CS.TO / HOG.N / 443628102 / 550372106 / ATL.MI / BGS.N / CBRO.L / DAN.N / EDPR.LS / OZL.AX / ABI.BR / SFR.AX / VALE.N / SPB.N / BHPB.L / CAML.L / MTOR.N / GLEN.L / TRL.TO / QLYS.O / FFHu.TO / MDLZ.OQ / 505440107 / TPH.N / TSLA.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / PRTA.O / 46579R104 / VRNS.O / CIA.TO / PAYC.N / RYAM.N / HUBS.N / ANTM.N / CIGI.O / PYPL.OQ / WRK.N / RPD.O / ABNd.AS / MESO.O / RACE.MI / UBSG.S / MTRO.L / MP1.AX / ADNT.N / GRPG.I / ATNX.O / ORSTED.CO / APTV.N / NEXA.TO / VNE.N / NTGY.MC / KDP.N / XERS.O / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / VMUK.L / PEAK.N / PAGPA.L / REYN.O / SBSW.N / TFII.N / SLQT.N / NKLA.OQ / FOUR.N / LUMN.N / 900435207 / AFRM.O / 120681711</td><td class="leftalignment">Air Canada / Autoliv Inc / Antofagasta PLC / Julius Baer Gruppe AG / Barclays PLC / Bombardier Inc / BCE Inc / BHP Group Ltd / BNP Paribas SA / Chemours Co / Cigna Corp / Colgate-Palmolive Co / Canadian Pacific Railway Ltd / Credit Suisse Group AG / EDP Energias de Portugal SA / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Iberdrola SA / International Paper Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / Merck & Co Inc / Pfizer Inc / Pultegroup Inc / Rio Tinto Ltd / Rio Tinto PLC / Rwe AG / Banco Santander SA / Societe Generale SA / AT&T Inc / Telus Corp / Toll Brothers Inc / Visteon Corp / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Shaw Communications Inc / Rogers Communications Inc / Amgen Inc / Tenet Healthcare Corp / Ferrovial SA / Anglo American PLC / Canadian National Railway Co / Quebecor Inc / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / Cogeco Communications Inc / Red Electrica Corporacion SA / Enbridge Inc / Kellogg Co / DISH Network Corp / Lennar Corp / Trevali Mining Corp / Deutsche Bank AG / Clorox Co / Conagra Brands Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Banco Bilbao Vizcaya Argentaria SA / Jazz Pharmaceuticals PLC / Analog Devices Inc / National Grid PLC / Verizon Communications Inc / Exelixis Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / DaVita Inc / Fiserv Inc / Synopsys Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / Prologis Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Ares Capital Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Vertex Pharmaceuticals Inc / Sierra Wireless Inc / Finning International Inc / Credit Agricole SA / Mohawk Industries Inc / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Anglo Pacific Group PLC / Polaris Inc / Sensata Technologies Holding PLC / Tyler Technologies Inc / Warrior Met Coal Inc / Seagen Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / CCL Industries Inc / ImmunoGen Inc / Caseys General Stores Inc / Stantec Inc / Alimentation Couche-Tard Inc / IGO Ltd / Toromont Industries Ltd / SNC-Lavalin Group Inc / First Quantum Minerals Ltd / ING Groep NV / Altria Group Inc / Teck Resources Ltd / Digital Realty Trust Inc / Huntsman Corp / Hershey Co / Freeport-McMoRan Inc / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Capstone Mining Corp / Harley-Davidson Inc / Hudbay Minerals Inc / Lundin Mining Corp / Atlantia SpA / B&G Foods Inc / Close Brothers Group PLC / Dana Inc / EDP Renovaveis SA / OZ Minerals Ltd / Anheuser Busch Inbev SA / Sandfire Resources Ltd / Vale SA / Spectrum Brands Holdings Inc / BHP Group PLC / Central Asia Metals PLC / Meritor Inc / Glencore PLC / Trilogy International Partners Inc / Qualys Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Labrador Iron Ore Royalty Corp / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Prothena Corporation PLC / Ivanhoe Mines Ltd / Varonis Systems Inc / Champion Iron Ltd / Paycom Software Inc / Rayonier Advanced Materials Inc / HubSpot Inc / Anthem Inc / Colliers International Group Inc / PayPal Holdings Inc / Westrock Co / Rapid7 Inc / ABN Amro Bank NV / Mesoblast Ltd / Ferrari NV / UBS Group AG / Metro Bank PLC / Megaport Ltd / Adient PLC / Greencoat Renewables PLC / Athenex Inc / Orsted A/S / Aptiv PLC / Nexa Resources SA / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / Virgin Money UK PLC / Healthpeak Properties Inc / Paragon Banking Group PLC / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / TFI International Inc / SelectQuote Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Turquoise Hill Resources Ltd / Affirm Holdings Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Brazil / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Luxembourg / Netherlands / Portugal / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 46</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Updated Takeaways from ASCO GU & KOL Panel: Competitor Clearly Potent but Likely More Toxic Than CM-9ER</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2576941 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused next week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / JAZZ.O / TEVA.N / XERS.O</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Xeris Biopharma Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Are Covid-19 Vaccine Stocks Still Worth Investing In?</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">EXEL-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">EXEL.O / BMY / JNJ / MRK / PFE / AMGN.O / GSK / CRIS.O / AVEO.O / SNY.O</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Curis Inc / Aveo Pharmaceuticals Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AZN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AZN.O / ABT / BMY / JNJ / LLY / MRK / NVS / PFE / GSK / BIIB.O / SNY.O</td><td class="leftalignment">AstraZeneca PLC / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Biogen Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">DANHOS13.MX: Fibra Danhos - Quality Matters - Initiating with Outperform</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">DANHOS13.MX / FUNO11.MX / PFE.N / SPG.N / AZN.L / MAC.N / BFS.N / RPT.N / PEI.N / SKT.N / UBA.N / BRML3.SA / ROIC.OQ / BRPR3.SA / FIBRAMQ12.MX / TERRA13.MX / GOOGL.OQ / FIBRAPL14.MX / UE.N / REG.OQ / 100073616</td><td class="leftalignment">Concentradora Fibra Danhos SA de CV / Fibra Uno Administracion SA de CV / Pfizer Inc / Simon Property Group Inc / AstraZeneca PLC / Macerich Co / Saul Centers Inc / RPT Realty / Pennsylvania Real Estate Investment Trust / Tanger Factory Outlet Centers Inc / Urstadt Biddle Properties Inc / BR Malls Participacoes SA / Retail Opportunity Investments Corp / BR Properties SA / Macquarie Mexico Real Estate Management SA de CV / CI Banco SA Institucion de Banca Multiple FF/00939 / Alphabet Inc / Prologis Property Mexico SA de CV / Urban Edge Properties / Regency Centers Corp / Kimco Realty Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Fibra Danhos Initiation</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">DANHOS13.MX / FUNO11.MX / PFE.N / SPG.N / AZN.L / LIVEPOLC1.MX / MAC.N / BFS.N / RPT.N / PEI.N / SKT.N / UBA.N / BRML3.SA / ROIC.OQ / BRPR3.SA / FIBRAMQ12.MX / TERRA13.MX / GOOGL.OQ / FIBRAPL14.MX / UE.N / GICSAB.MX / REG.OQ / 100073616</td><td class="leftalignment">Concentradora Fibra Danhos SA de CV / Fibra Uno Administracion SA de CV / Pfizer Inc / Simon Property Group Inc / AstraZeneca PLC / El Puerto de Liverpool SAB de CV / Macerich Co / Saul Centers Inc / RPT Realty / Pennsylvania Real Estate Investment Trust / Tanger Factory Outlet Centers Inc / Urstadt Biddle Properties Inc / BR Malls Participacoes SA / Retail Opportunity Investments Corp / BR Properties SA / Macquarie Mexico Real Estate Management SA de CV / CI Banco SA Institucion de Banca Multiple FF/00939 / Alphabet Inc / Prologis Property Mexico SA de CV / Urban Edge Properties / Grupo Gicsa SAB de CV / Regency Centers Corp / Kimco Realty Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Brazil / United Kingdom / Mexico / United States</td><td class="leftalignment">Consumer / Financial Services / Healthcare / Pharmaceuticals / Real Estate / Retailing / Telecommunications</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas</td></tr>
<tr class="even"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail: Vaccination & Hospitalization Weekly Tracker - Week 6, 2021</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">FIBRAMQ12.MX / FUNO11.MX / PFE.N</td><td class="leftalignment">Macquarie Mexico Real Estate Management SA de CV / Fibra Uno Administracion SA de CV / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas / Andres Ortiz</td></tr>
<tr class="odd"><td class="leftalignment">02/15/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IQVIA (IMS) Tracker: For the Week Ended Feb 05, 2021: Focus on Dupixent's resilience</td><td class="leftalignment">English</td><td class="rightalignment">41</td><td class="leftalignment">4502.T / 4503.T / BAX.N / BMY.N / CI.N / CVS.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / LUN.CO / SUN.BO / NOVOB.CO / NOVN.S / RB.L / GSK.L / UCB.BR / ABC.N / AMPH.OQ / AMGN.OQ / CHRS.OQ / REGN.OQ / GILD.OQ / INCY.OQ / ARNA.OQ / ESPR.OQ / BDSI.OQ / GLPG.AS / TEVA.N / BAYGN.DE / IRWD.OQ / 4578.T / ABBV.N / PRGO.N / INDV.L / CRVS.OQ</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Baxter International Inc / Bristol-Myers Squibb Co / Cigna Corp / CVS Health Corp / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / H Lundbeck A/S / Sun Pharmaceutical Industries Ltd / Novo Nordisk A/S / Novartis AG / Reckitt Benckiser Group PLC / GlaxoSmithKline PLC / Ucb SA / Amerisourcebergen Corp / Amphastar Pharmaceuticals Inc / Amgen Inc / Coherus BioSciences Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / BioDelivery Sciences International Inc / Galapagos NV / Teva Pharmaceutical Industries Ltd / Bayer AG / Ironwood Pharmaceuticals Inc / Otsuka Holdings Co Ltd / Abbvie Inc / Perrigo Company PLC / Indivior PLC / Corvus Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / Denmark / France / United Kingdom / India / Ireland / Israel / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Evan D. Seigerman</td></tr>
<tr class="even"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Faricimab Competitive On Efficacy, Safety, But More Convenient; Model Updated</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">US7711951043 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Roche Holding AG / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/14/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Keytruda + Lenvima adds incremental challenge for Cabometyx in 1L RCC</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IPN.PA / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Ipsen SA / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: Ex vivo GT sees positive readouts</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/13/2021</td><td class="leftalignment">Wright Reports</td><td class="leftalignment">Wright Investors Service Comprehensive Report for Trillium Therapeutics Inc</td><td class="leftalignment">English</td><td class="rightalignment">67</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">RESEARCH SUMMARY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Wright Reports</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">BuySellSignals Research</td><td class="leftalignment">Trillium Therapeutics accelerates rise, up 899% in 2 years</td><td class="leftalignment">English</td><td class="rightalignment">32</td><td class="leftalignment">TRIL.TO</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Team</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.12.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / GNCA=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Genocea Biosciences Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARNA / MRNS / 45337C10 / 09058V10 / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / RZLT / 29604W108 / 462260100 / 558868105 / 12648L601 / 89532E109 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 87184Q107 / 185063104 / 869367102 / 22978P106 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / 517125100 / G637AM102 / 007002108 / M47364100 / N71542109 / 72942A107</td><td class="leftalignment">Arena Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Rezolute Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Trevena Inc / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Cue Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / Larimar Therapeutics Inc / Myovant Sciences Ltd / Adicet Bio Inc / Gamida Cell Ltd / ProQR Therapeutics NV / PLx Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ZNTL (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: ZN-c5 Updates & ZN-c3 Initial Data in 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BMQ5T49 / 5671735 / 0989529 / 2516152 / 2684703</td><td class="leftalignment">Zentalis Pharmaceuticals Inc / Sanofi SA / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TPTX (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Validation of Best-In-Class TKIs</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BJXBP30 / 2516152 / 2684703 / BD9GVY0 / BWY52P3</td><td class="leftalignment">Turning Point Therapeutics Inc / Eli Lilly and Co / Pfizer Inc / Zai Lab Ltd / Blueprint Medicines Corp</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--February 12, 2021</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">BNGO=US / INO=US / AAPL=US / MRK=US / BSX=US / CSII=US / PFE=US / ABT=US / BMY=US / MDT=US / WMT=US / INCY=US / EPIX=US / CMS=US / DGX=US / NVS=US / AZN=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CHE=US / CYH=US / EW=US / EXEL=US / GEN=US / LH=US / NVAX=US / REGN=US / SILK=US / USPH=US / UTHR=US / UHS=US / VRTX=US / SGEN=US / CCRN=US / RHHBY=US / CNC=US / ACA=US / ENSG=US / SNY=US / MD=US / SLF=US / BIIB=US / ISR=US / MRNA=US / ALNY=US / GOOG=US / DXCM=US / LHCG=US / CHNG=US / INFI=US / ORTX=US / EHC=US / BAYRY=US / SPRO=US / SWAV=US / ADUS=US / ALPMY=US / ACHC=US / ARCT=US / ABBV=US / PRTA=US / ENTA=US / CTRE=US / WBA=US / NVTA=US / EVH=US / ZBH=US / IONS=US / EDIT=US / AVDL=US / MTEM=US / VERU=US / GMDA=US / NBSE=US / FREQ=US / RCEL=US / PNTG=US / TSHA=US / SIOX=US</td><td class="leftalignment">Bionano Genomics Inc / Inovio Pharmaceuticals Inc / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Medtronic PLC / Walmart Inc / Incyte Corp / ESSA Pharma Inc / CMS Energy Corp / Quest Diagnostics Inc / Novartis AG / AstraZeneca PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exelixis Inc / Genesis Healthcare Inc / Laboratory Corporation of America Holdings / Novavax Inc / Regeneron Pharmaceuticals Inc / Silk Road Medical Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Seagen Inc / Cross Country Healthcare Inc / Roche Holding AG / Centene Corp / Arcosa Inc / Ensign Group Inc / Sanofi SA / MEDNAX Inc / Sun Life Financial Inc / Biogen Inc / IsoRay Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Alphabet Inc / Dexcom Inc / LHC Group Inc / Change Healthcare Inc / Infinity Pharmaceuticals Inc / Orchard Therapeutics PLC / Encompass Health Corp / Bayer AG / Spero Therapeutics Inc / Shockwave Medical Inc / Addus Homecare Corp / Astellas Pharma Inc / Acadia Healthcare Company Inc / Arcturus Therapeutics Holdings Inc / Abbvie Inc / Prothena Corporation PLC / Enanta Pharmaceuticals Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Evolent Health Inc / Zimmer Biomet Holdings Inc / Ionis Pharmaceuticals Inc / Editas Medicine Inc / Avadel Pharmaceuticals PLC / Molecular Templates Inc / Veru Inc / Gamida Cell Ltd / NeuBase Therapeutics Inc / Frequency Therapeutics Inc / AVITA Medical Inc / Pennant Group Inc / Taysha Gene Therapies Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Ireland / Israel / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Feb 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended February 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Morning Bite Flash</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">SE0000114837 / CH0011075394 / US7170811035 / DE0005773303 / DE0005936124 / ES0127797019 / DE000EVNK013 / NL0006294274 / DE000A13SX22 / NL0012169213 / US09075V1026</td><td class="leftalignment">Trelleborg AB / Zurich Insurance Group AG / Pfizer Inc / Fraport AG Frankfurt Airport Services Worldwide / OHB SE / EDP Renovaveis SA / Evonik Industries AG / Euronext NV / HELLA GmbH & Co KGaA / Qiagen NV / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Spain / Netherlands / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Herr. Ingo-Martin Schachel, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">INO=US / TWOU=US / AAPL=US / MRK=US / WSM=US / NKE=US / PFE=US / BMY=US / HD=US / INTC=US / ADI=US / AMD=US / BWA=US / MSFT=US / AMZN=US / QCOM=US / BBY=US / TXN=US / EPIX=US / MPWR=US / NVS=US / SMTC=US / LOW=US / TSM=US / AZN=US / CRY=US / XLNX=US / EXPE=US / JNJ=US / UNH=US / ARCC=US / AVGO=US / BL=US / CRUS=US / IFX=US / FROG=US / MCHP=US / NVAX=US / REGN=US / TSCO=US / UTHR=US / VCTR=US / WTS=US / SGEN=US / RHHBY=US / PYPL=US / SWKS=US / ARES=US / DKS=US / BIIB=US / MRNA=US / ALNY=US / ENS=US / GOOG=US / BJRI=US / PBH=US / DXCM=US / XPO=US / LULU=US / GNRC=US / MXL=US / NXPI=US / ARCT=US / PRTA=US / VRNS=US / GDDY=US / UAA=US / CARG=US / DDOG=US / RCEL=US / SIOX=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / 2U Inc / Apple Inc / Merck & Co Inc / Williams-Sonoma Inc / Nike Inc / Pfizer Inc / Bristol-Myers Squibb Co / Home Depot Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Borgwarner Inc / Microsoft Corp / Amazon.com Inc / Qualcomm Inc / Best Buy Co Inc / Texas Instruments Inc / ESSA Pharma Inc / Monolithic Power Systems Inc / Novartis AG / Semtech Corp / Lowe's Companies Inc / Taiwan Semiconductor Manufacturing Co Ltd / AstraZeneca PLC / CryoLife Inc / Xilinx Inc / Expedia Group Inc / Johnson & Johnson / UnitedHealth Group Inc / Ares Capital Corp / Broadcom Inc / Blackline Inc / Cirrus Logic Inc / Infineon Technologies AG / Jfrog Ltd / Microchip Technology Inc / Novavax Inc / Regeneron Pharmaceuticals Inc / Tractor Supply Co / United Therapeutics Corp / Victory Capital Holdings Inc / Watts Water Technologies Inc / Seagen Inc / Roche Holding AG / PayPal Holdings Inc / Skyworks Solutions Inc / Ares Management Corp / DICK'S Sporting Goods Inc / Biogen Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / EnerSys / Alphabet Inc / BJ's Restaurants Inc / Prestige Consumer Healthcare Inc / Dexcom Inc / XPO Logistics Inc / Lululemon Athletica Inc / Generac Holdings Inc / Maxlinear Inc / NXP Semiconductors NV / Arcturus Therapeutics Holdings Inc / Prothena Corporation PLC / Varonis Systems Inc / GoDaddy Inc / Under Armour Inc / CarGurus Inc / Datadog Inc / AVITA Medical Inc / Sio Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Germany / United Kingdom / Ireland / Israel / Netherlands / Taiwan / United States</td><td class="leftalignment">Biotechnology / Conglomerates / Consumer / Electrical / Financial Services / Healthcare / Info. Tech./Software / Leisure & Entertainment / Lodging & Restaurants / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- Happy Lunar New Year!</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / LLY.N / MRK.N / PFE.N / SASY.PA / ROG.S / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / MRNA.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Sanofi SA / Roche Holding AG / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Moderna Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/12/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Learning the ABCs of ADCs, Part 2</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ARVN (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt – Year of Clinical Data for Lead Programs</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BDZ30Q0 / 2684703 / B6RS2B3</td><td class="leftalignment">Arvinas Inc / Pfizer Inc / Clovis Oncology Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">MINKABU THE INOFONOID, Inc.</td><td class="leftalignment">Equity Quarterly Update - Pfizer down 4.9% from 1 week high</td><td class="leftalignment">English</td><td class="rightalignment">36</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">STUDY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">A DNA Medicines Disruptor Gaining Steam; Initiate at Outperform with $35 PT</td><td class="leftalignment">English</td><td class="rightalignment">93</td><td class="leftalignment">INO=US / MRK=US / PFE=US / AZN=US / JNJ=US / NVAX=US / REGN=US / UTHR=US / MRNA=US / ALNY=US / ARCT=US</td><td class="leftalignment">Inovio Pharmaceuticals Inc / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Regeneron Pharmaceuticals Inc / United Therapeutics Corp / Moderna Inc / Alnylam Pharmaceuticals Inc / Arcturus Therapeutics Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">ORIC (BUY) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt – ORIC-101 Initial PoC Data On Track in 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BKVDFF7 / 0989529 / 2126335 / 2516152 / 2684703 / 7103065 / 2982924 / BBPK0J0</td><td class="leftalignment">Oric Pharmaceuticals Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Novartis AG / Spectrum Pharmaceuticals Inc / Mirati Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Movers & Shakers: Our Thoughts on Potential Upcoming Catalysts</td><td class="leftalignment">English</td><td class="rightalignment">69</td><td class="leftalignment">ACRS.OQ / ACRX.OQ / 0715.HK / JNJ.N / LLY.N / MRK.N / PFE.N / NCOX.PA / COLL.OQ / ALKS.OQ / OPTN.OQ / CERS.OQ / RMTI.OQ / AMRN.OQ / BDSI.OQ / BSLN.S / MNKD.OQ / MSB.AX / EBS.N / JAZZ.OQ / SPRO.OQ / OMER.OQ / ARDX.OQ / ABBV.N / ZTS.N / ANIP.OQ / AXGN.OQ / AERI.OQ / HRTX.OQ / TRVN.OQ / EGRX.OQ / ALDX.OQ / SCYX.OQ / CFRX.OQ / VRAY.OQ / CDTX.OQ / FBIO.OQ / SPNE.OQ / CKPT.OQ / VERU.OQ / EOLS.OQ / EYPT.OQ / UBX.OQ / ARDS.OQ / ETTX.OQ / ARAV.OQ / SIBN.OQ / ARQT.OQ / PCVX.OQ / SRGA.OQ / HGEN.OQ / VYNE.OQ / GRAY.OQ / 120551486</td><td class="leftalignment">Aclaris Therapeutics Inc / AcelRx Pharmaceuticals Inc / China Oceanwide Holdings Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Nicox SA / Collegium Pharmaceutical Inc / Alkermes Plc / OptiNose Inc / Cerus Corp / Rockwell Medical Inc / Amarin Corporation PLC / BioDelivery Sciences International Inc / Basilea Pharmaceutica AG / MannKind Corp / Mesoblast Ltd / Emergent BioSolutions Inc / Jazz Pharmaceuticals PLC / Spero Therapeutics Inc / Omeros Corp / Ardelyx Inc / Abbvie Inc / Zoetis Inc / ANI Pharmaceuticals Inc / AxoGen Inc / Aerie Pharmaceuticals Inc / Heron Therapeutics Inc / Trevena Inc / Eagle Pharmaceuticals Inc / Aldeyra Therapeutics Inc / SCYNEXIS Inc / ContraFect Corp / ViewRay Inc / Cidara Therapeutics Inc / Fortress Biotech Inc / SeaSpine Holdings Corp / Checkpoint Therapeutics Inc / Veru Inc / Evolus Inc / EyePoint Pharmaceuticals Inc / UNITY Biotechnology Inc / Aridis Pharmaceuticals Inc / Entasis Therapeutics Holdings Inc / Aravive Inc / SI-BONE Inc / Arcutis Biotherapeutics Inc / Vaxcyte Inc / Surgalign Holdings Inc / Humanigen Inc / Vyne Therapeutics Inc / Graybug Vision Inc / Opiant Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Here's Why Merck Is A Better Pick Over Johnson & Johnson Stock</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Continued Near & Long-Term Growth</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">DCPH (BUY) - Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Multiple Key Milestones Through 2021</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BZ1LFB2 / 2778844 / 2684703 / BBPK0J0 / BD9GVY0</td><td class="leftalignment">Deciphera Pharmaceuticals Inc / Merck & Co Inc / Pfizer Inc / Mirati Therapeutics Inc / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Commerzbank Corporate Clients</td><td class="leftalignment">Expanding lipid production for BioNTECH vaccine, accelerating growth in H&C</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">DE000EVNK013 / US7170811035 / US09075V1026</td><td class="leftalignment">Evonik Industries AG / Pfizer Inc / BioNTech SE</td><td class="leftalignment"></td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Industrial Materials</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Fabian Sémon / Michael Schäfer</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: BTG, GOLD, HYLN, ROP, APD, FMC, AZN, BMY, MRK, PFE, BLUE, IMVT, REGN, VRTX, MDLZ, KO, PEP, CLX, PG, UL, WCN, FDS, DNB, CHKP, HUM, FMS, CHTR, LNT, AEP, PNW, XEL, UWMC, CNNE, PGR, SBAC, T, and VZ.</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">VZ.N / APD.N / BMY.N / FMC.N / KO.N / MRK.N / PFE.N / ULVR.L / PG.N / HUM.N / ROP.N / CLX.N / FDS.N / DNB.N / REGN.OQ / CHKP.OQ / CHTR.OQ / BLUE.OQ / VRTX.OQ / WCN.AX / BLHI.PK / AZN.V / MDLZ.OQ / CNNE.N / PEP.OQ / XEL.OQ / LNT.OQ / IMVT.OQ / HYLN.N / UWMC.N</td><td class="leftalignment">Verizon Communications Inc / Air Products and Chemicals Inc / Bristol-Myers Squibb Co / FMC Corp / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Unilever PLC / Procter & Gamble Co / Humana Inc / Roper Technologies Inc / Clorox Co / Factset Research Systems Inc / Dun & Bradstreet Holdings Inc / Regeneron Pharmaceuticals Inc / Check Point Software Technologies Ltd / Charter Communications Inc / bluebird bio Inc / Vertex Pharmaceuticals Inc / White Cliff Minerals Ltd / Blue Holdings Inc / AZN Capital Corp / Mondelez International Inc / Cannae Holdings Inc / PepsiCo Inc / Xcel Energy Inc / Alliant Energy Corp / Immunovant Inc / Hyliion Holdings Corp / UWM Holdings Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">MRTX (NEUTRAL) – Takeaways from Guggenheim Oncology Day Fireside Chat with Mgmt: Confidence Across KRAS & Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BBPK0J0 / 0989529 / 2516152 / 2023607 / 2778844 / 2684703 / 7103065</td><td class="leftalignment">Mirati Therapeutics Inc / AstraZeneca PLC / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Pfizer Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/11/2021</td><td class="leftalignment">Argus Research Corporation</td><td class="leftalignment">Argus Analyst Report, PFE</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / COMPANY REPORT / ESTIMATE CHANGES</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. David H. Toung / Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/11/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">EDF.PA / VWS.CO / AEGN.AS / GM.N / PFE.N / RWEG.DE / SCHN.PA / AZN.L / SASY.PA / EUFI.PA / CAGR.PA / EBKG.DE / CAIV.VI / TNET.BE</td><td class="leftalignment">Electricite de France SA / Vestas Wind Systems A/S / Aegon NV / General Motors Co / Pfizer Inc / Rwe AG / Schneider Electric SE / AstraZeneca PLC / Sanofi SA / Eurofins Scientific SE / Credit Agricole SA / EnBW Energie Baden Wuerttemberg AG / CA Immobilien Anlagen AG / Telenet Group Holding NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Israel / Luxembourg / Netherlands / Russian Federation / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr Christian Aust / Herr. Ulrich Scholz, CFA / Frau Silke Stegemann / Frau. Jana Schuler / Herr Sven Kreitmair, CFA / Herr Jonathan Schroer / Sergey Bolshakov / Herr Tobias Keller / Herr Natalie Tehrani Monfared / Herr. Stefan Kolek</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">BMY-US -  Dividend Quality Analysis, for the period ended February 01,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BMY / JNJ / LLY / MRK / NVS / PFE / AMGN.O / AZN.O / BIIB.O / ABBV.K / SNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / AstraZeneca PLC / Biogen Inc / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US -  Dividend Quality Analysis, for the period ended December 08,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABBV-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABBV.K / BMY / LLY / PFE / GILD.O / AMGN.O / GSK / NBIX.O / AZN.O / BIIB.O</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / GlaxoSmithKline PLC / Neurocrine Biosciences Inc / AstraZeneca PLC / Biogen Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Intraday vs Overnight Returns 2016-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Sector Flash - Health Care: COVID-19 - many question marks surrounding herd immunity</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">AZN.L / PFE.N / MRCG.DE</td><td class="leftalignment">AstraZeneca PLC / Pfizer Inc / Merck KGaA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / United Kingdom / United States</td><td class="leftalignment">Aerospace / Air Transportation / Biotechnology / Conglomerates / Defense / Electrical / Engineering & Construction / Environmental Services / Healthcare / Industrial Materials / Machinery / Pharmaceuticals / Railroads / Shipping & Shipbuilding / Transportation</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CREDIT</td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Frau Silke Stegemann</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2936921 / 2126335 / 2516152 / 2000019 / 2026242 / 2219224 / 2216850 / 2270726 / 2542049 / 2829515 / 2328915 / 2342034 / 2100920 / 2471950 / 2689560 / 2684703 / 2138158 / 5531000 / 7103065 / 2712013 / B17HG57 / B121557 / 2769796 / 2857817 / B2R3PV1 / B7VD3F2 / BFLR866 / BFZCHN7 / BVVN4Q8 / BYY8XK8 / BYVY8G0 / BXDZ9Z0 / BJT1RW7 / BZ1LFB2 / BD8DJ71 / BJ2Z0H2 / BJJMGL2 / BFXC911 / BKTNTR9 / BGT3960 / BMDCDP2 / BJRFSB7 / 021513106</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / American Electric Power Company Inc / CMS Energy Corp / Consolidated Edison Inc / Walt Disney Co / Dominion Energy Inc / Edison International / Nextera Energy Inc / Fiserv Inc / FirstEnergy Corp / Incyte Corp / PG&E Corp / Pfizer Inc / Sempra Energy / MorphoSys AG / Novartis AG / Global Payments Inc / Cardiovascular Systems Inc / Mastercard Inc / Fidelity National Information Services Inc / Netflix Inc / American Water Works Company Inc / Duke Energy Corp / Twitter Inc / Wix.Com Ltd / Eversource Energy / WEC Energy Group Inc / Alphabet Inc / Shopify Inc / Lyft Inc / Deciphera Pharmaceuticals Inc / Snap Inc / Pinterest Inc / Fox Corp / Guardant Health Inc / ViacomCBS Inc / Orchard Therapeutics PLC / Bigcommerce Holdings Inc / Immunovant Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">H.C. Wainwright & Co., LLC</td><td class="leftalignment">A CD47 Player Leading the Fight Against Solid Tumors; Initiate With Buy and a $100 PT</td><td class="leftalignment">English</td><td class="rightalignment">29</td><td class="leftalignment">ALXO.OQ / 89620X506 / 98985W102 / IMAB.OQ / BWBSJ10</td><td class="leftalignment">ALX Oncology Holdings Inc / Pfizer Inc / Zymeworks Inc / I-Mab / OSE Immunotherapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Cayman Islands / France / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Swayampakula Ramakanth, Ph.D. / Arthur He, Ph.D. / Sean Lee / Sean Kang</td></tr>
<tr class="odd"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: EU approves export of first batch of vaccines to Japan</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">02/10/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナウイルス：EUがワクチン第1便の日本への輸出を承認</td><td class="leftalignment">Japanese</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">DCPH (BUY) - Good Qinlock Quarter as Company Heads Towards 2H 2021 Data for 2L GIST & Early Pipeline</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BZ1LFB2 / 2684703 / 7103065 / BD9GVY0</td><td class="leftalignment">Deciphera Pharmaceuticals Inc / Pfizer Inc / Novartis AG / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin / Yige Guo, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 29, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">IBK Securities</td><td class="leftalignment">Pfizer-코로나19 백신 & 항암제/희귀의약품 성장-02/09/2021</td><td class="leftalignment">Korean</td><td class="rightalignment">8</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Mr. Gyeongjun Moon</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">DNB / FISV=US / MRK=US / BSX=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / ADI=US / WEN=US / AMZN=US / BLD=US / TEVA=US / NVDA=US / SLG=US / LOW=US / ENR=US / DIOD=US / IGT=US / CHRS=US / BYD=US / TTWO=US / LEG=US / TTMI=US / ATVI=US / KFRC=US / MGM=US / HUM=US / PENN=US / BKI=US / AVGO=US / CBRL=US / DRI=US / EXEL=US / GFF=US / HAS=US / IBP=US / MAS=US / MHK=US / MCRI=US / REGI=US / SGMO=US / SPG=US / SGMS=US / GPN=US / AUTL=US / DIN=US / ECPG=US / PRAA=US / RRR=US / BIIB=US / TPX=US / EXP=US / CZR=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SCPL=US / CMG=US / REX=US / FIS=US / PGTI=US / GPRE=US / SAIA=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / JACK=US / CLNY=US / TREX=US / NXPI=US / FBHS=US / ZNGA=US / EA=US / ENPH=US / TILE=US / NDLS=US / VRNS=US / GOOGL=US / LOCO=US / HQY=US / OSH=US / SHAK=US / WING=US / TDOC=US / EDIT=US / 82982L103 / IRTC=US / JELD=US / MPWR-US / CARG=US / BTAI=US / ALLO=US / HARP=US / TCRR=US / FERGY=US / OPCH=US / DKNG=US / AZEK=US / BALY=US / VTRS=US</td><td class="leftalignment">Dun & Bradstreet Holdings Inc / Fiserv Inc / Merck & Co Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Analog Devices Inc / Wendys Co / Amazon.com Inc / TopBuild Corp / Teva Pharmaceutical Industries Ltd / NVIDIA Corp / SL Green Realty Corp / Lowe's Companies Inc / Energizer Holdings Inc / Diodes Inc / International Game Technology PLC / Coherus BioSciences Inc / Boyd Gaming Corp / Take-Two Interactive Software Inc / Leggett & Platt Inc / TTM Technologies Inc / Activision Blizzard Inc / Kforce Inc / MGM Resorts International / Humana Inc / Penn National Gaming Inc / Black Knight Inc / Broadcom Inc / Cracker Barrel Old Country Store Inc / Darden Restaurants Inc / Exelixis Inc / Griffon Corp / Hasbro Inc / Installed Building Products Inc / Masco Corp / Mohawk Industries Inc / Monarch Casino & Resort Inc / Renewable Energy Group Inc / Sangamo Therapeutics Inc / Simon Property Group Inc / Scientific Games Corp / Global Payments Inc / Autolus Therapeutics PLC / Dine Brands Global Inc / Encore Capital Group Inc / PRA Group Inc / Red Rock Resorts Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / Caesars Entertainment Inc / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / Sciplay Corp / Chipotle Mexican Grill Inc / REX American Resources Corp / Fidelity National Information Services Inc / PGT Innovations Inc / Green Plains Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Jack in the Box Inc / DigitalBridge Group Inc / Trex Company Inc / NXP Semiconductors NV / Fortune Brands Home & Security Inc / Zynga Inc / Electronic Arts Inc / Enphase Energy Inc / Interface Inc / Noodles & Co / Varonis Systems Inc / Alphabet Inc / El Pollo Loco Holdings Inc / Healthequity Inc / Oak Street Health Inc / Shake Shack Inc / Wingstop Inc / Teladoc Health Inc / Editas Medicine Inc / SiteOne Landscape Supply Inc / iRhythm Technologies Inc / JELD-WEN Holding Inc / Monolithic Power Systems Inc / CarGurus Inc / BioXcel Therapeutics Inc / Allogene Therapeutics Inc / Harpoon Therapeutics Inc / TCR2 Therapeutics Inc / Ferguson PLC / Option Care Health Inc / DraftKings Inc / Azek Company Inc / Bally's Corp / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / United Kingdom / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">2126335 / 2778844 / 2026242 / 2942605 / 2175672 / 2542049 / 2576941 / 2684703 / 2048804 / 2440637 / 2402121 / 2883878 / 2931034 / 2795393 / 2712013 / B121557 / B02R1L6 / B2R3PV1 / B3D7K31 / 2679204 / B3SWPT2 / B7TL820 / B7VD3F2 / BJ3V905 / BVVN4Q8 / BYY8XK8 / BQPVQZ6 / BYW36M8 / BDHF4K6 / BJFSR88 / BKTHM05 / BFMXGR0 / BKTNTR9 / BZ1LFG7 / BP8XZL1 / BN4NJG4</td><td class="leftalignment">Bristol-Myers Squibb Co / Merck & Co Inc / American Electric Power Company Inc / Avista Corp / Cardinal Health Inc / Dominion Energy Inc / Exelixis Inc / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Nuance Communications Inc / Teva Pharmaceutical Industries Ltd / Vertex Pharmaceuticals Inc / Amerisourcebergen Corp / Global Payments Inc / Mastercard Inc / ALLETE Inc / American Water Works Company Inc / Discovery Inc / Align Technology Inc / Ameresco Inc / Meta Platforms Inc / Duke Energy Corp / Endo International PLC / Eversource Energy / WEC Energy Group Inc / Horizon Therapeutics PLC / PayPal Holdings Inc / CRISPR Therapeutics AG / Uniqure NV / Passage Bio Inc / Evergy Inc / ViacomCBS Inc / Roku Inc / Healthequity Inc / Freeline Therapeutics Holdings PLC</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">IPN.PA: Ipsen - Cabometyx readacross: Keynote-581 data mixed at upcoming ASCO GU</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">IPN.PA / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Ipsen SA / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: Sumitomo Dainippon Pharma - Preliminary report: Phase 3 trial of anticancer agent napabucasin fails to meet primary endpoints</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">02/09/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: 大日本住友製薬 - 速報：抗がん剤ナパブカシンのフェーズ3、主要評価項目を未達</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Valuation Landscape 2006-2021</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Marktfeld</td><td class="leftalignment">Pfizer Inc: Information Content of Earnings Releases 2015-2020</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michail Paraskevopoulos</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">IDE397 to Begin Phase 1 Study in 1Q21; Hosting Call Tomorrow</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">IDYA=US / PFE=US / AZN=US / GSK=US / CLVS=US / RPTX=US</td><td class="leftalignment">IDEAYA Biosciences Inc / Pfizer Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Clovis Oncology Inc / Repare Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: VYGR deal termination; big pharma engages GRTS</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">GRTS.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / RNA=US / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Avidity Biosciences Inc / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 8 2021</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">NL0000226223 / US0079731008 / US0116591092 / US0382221051 / US0463531089 / US1005571070 / US1101221083 / US1156372096 / US1266501006 / US14149Y1082 / US1912161007 / US1925761066 / US2546871060 / US37733W1053 / US4781601046 / US4824801009 / US5012421013 / US5128071082 / US5324571083 / US55306N1046 / US66987V1098 / US6701002056 / US7134481081 / US7170811035 / US75886F1075 / US7711951043 / US8308791024 / US8447411088 / US8610121027 / US8807701029 / US9021041085 / US9029251066 / US91347P1057 / US03073E1055 / US98956P1021 / US4771431016 / US4198791018 / US80105N1054 / US21036P1084 / US3463751087 / US60855R1005 / US90385V1070 / US60871R2094 / US15135B1017 / RDSa.AS / PAP310761054 / US01748X1028 / US2473617023 / US25470F1049 / US58933Y1055 / US25470F3029 / US9100471096 / US00164V1035 / US00287Y1091 / NL0010273215 / US98978V1035 / US8485771021 / US21240E1055 / US02376R1023 / CA0089118776 / US61174X1090 / US87918A1051 / KYG4740B1059 / LGFb / LGFa / US53115L1044 / US05351X1019 / US49271V1008 / US5904791358 / US28414H1032 / US1255231003 / US35137L1052 / US92556H2067 / US92537N1081 / US6833731044 / US03044L1052 / US62955J1034 / US73739W1045 / 120175706 / 120404208</td><td class="leftalignment">STMicroelectronics NV / Advanced Energy Industries Inc / Alaska Air Group Inc / Applied Materials Inc / AstraZeneca PLC / Boston Beer Company Inc / Bristol-Myers Squibb Co / Brown-Forman Corp / CVS Health Corp / Cardinal Health Inc / Coca-Cola Co / Cohu Inc / Walt Disney Co / GlaxoSmithKline PLC / Johnson & Johnson / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Eli Lilly and Co / MKS Instruments Inc / Novartis AG / Novo Nordisk A/S / PepsiCo Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Roche Holding AG / SkyWest Inc / Southwest Airlines Co / STMicroelectronics NV / Teradyne Inc / II-VI Inc / USA Truck Inc / Universal Display Corp / Amerisourcebergen Corp / Zimmer Biomet Holdings Inc / JetBlue Airways Corp / Hawaiian Holdings Inc / Sanofi SA / Constellation Brands Inc / FormFactor Inc / Molina Healthcare Inc / Ultra Clean Holdings Inc / Molson Coors Beverage Co / Centene Corp / Royal Dutch Shell PLC / Copa Holdings SA / Allegiant Travel Co / Delta Air Lines Inc / Discovery Inc / Merck & Co Inc / Discovery Inc / United Airlines Holdings Inc / AMC Networks Inc / Abbvie Inc / ASML Holding NV / Zoetis Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / Air Canada / Monster Beverage Corp / Teladoc Health Inc / Ichor Holdings Ltd / Lions Gate Entertainment Corp / Lions Gate Entertainment Corp / Liberty Oilfield Services Inc / Avaya Holdings Corp / Keurig Dr Pepper Inc / Mesa Air Group Inc / Elanco Animal Health Inc / Cigna Corp / Fox Corp / ViacomCBS Inc / Vertiv Holdings Co / Ontrak Inc / American Well Corp / Nov Inc / Poshmark Inc / Cisco Systems Inc / MedAvail Holdings Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Mexico / Netherlands / Panama / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NBIX-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NBIX.O / LLY / PFE / PTN / RGEN.O / RPRX.O / ATHX.O / ANIP.O / ABBV.K / CASI.O</td><td class="leftalignment">Neurocrine Biosciences Inc / Eli Lilly and Co / Pfizer Inc / Palatin Technologies Inc / Repligen Corp / Royalty Pharma PLC / Athersys Inc / ANI Pharmaceuticals Inc / Abbvie Inc / CASI Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 8, 2021</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">AEP.N / AES.N / AFL.N / ALV.N / CB.N / CI.N / CL.N / CMS.N / CP.TO / EIX.N / EL.N / EMN.N / EOG.N / F.N / GM.N / IBE.MC / IP.N / JNJ.N / KMB.N / KO.N / MRK.N / NSC.N / PEG.N / PFE.N / RWEG.DE / SO.N / T.N / VC.N / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CAE.TO / CHKP.O / AMGN.O / AAPL.O / MET.N / FLEX.O / CNR.TO / DUK.N / DIS.N / BWA.N / LEA.N / K.N / DT.N / DISH.O / CSX.N / UNP.N / CLX.N / CAG.N / UNM.N / GIS.N / EPC.N / MGA.N / SBAC.O / JAZZ.O / NG.L / VZ.N / HCA.N / EXEL.O / ARNA.O / STZ.N / LNC.N / APH.N / FISV.O / CHTR.O / AXL.N / AWK.N / CHD.N / ATA.TO / BC.N / SAM.N / BMRN.O / REGN.O / ENR.N / PRU.N / NCR.N / TEL.N / CNP.N / CPK.N / MKL.N / PII.N / RLI.N / ST.N / SR.N / TT.N / SGEN.OQ / GPN.N / MNST.O / CCLb.TO / CASY.O / ORLY.O / ACGL.O / PCTY.O / ATDb.TO / 02209S103 / AINV.O / DLR.N / VIAC.O / 416515104 / 427866108 / DISCA.O / SJW.N / FIS.N / TEVA.N / HOG.N / AON.N / BGS.N / TDC.N / ENSG.O / DAN.N / VALE.N / FTNT.O / SPB.N / CHNG.O / CJT.TO / PCRX.O / MTOR.N / IFP.TO / AMCX.O / MDLZ.OQ / FANG.O / ABBV.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / DOO.TO / COTY.N / FOXA.OQ / PRTA.O / RYAM.N / SHOP.N / PYPL.OQ / WRK.N / MIME.OQ / RACE.MI / MP1.AX / BBU.N / ADNT.N / LGFB.N / TFII.TO / WOW.N / ATUS.N / ORSTED.CO / APTV.N / EAF.N / VNE.N / NTGY.MC / KDP.N / NWL.O / GMAB.O / DDOG.O / CRNC.OQ / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / FOUR.N / LUMN.N / AFRM.O / TEEC.L / 120681711</td><td class="leftalignment">American Electric Power Company Inc / AES Corp / Aflac Inc / Autoliv Inc / Chubb Ltd / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Canadian Pacific Railway Ltd / Edison International / Estee Lauder Companies Inc / Eastman Chemical Co / EOG Resources Inc / Ford Motor Co / General Motors Co / Iberdrola SA / International Paper Co / Johnson & Johnson / Kimberly-Clark Corp / Coca-Cola Co / Merck & Co Inc / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Rwe AG / Southern Co / AT&T Inc / Visteon Corp / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / CAE Inc / Check Point Software Technologies Ltd / Amgen Inc / Apple Inc / MetLife Inc / Flex Ltd / Canadian National Railway Co / Duke Energy Corp / Walt Disney Co / Borgwarner Inc / Lear Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Union Pacific Corp / Clorox Co / Conagra Brands Inc / Unum Group / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / SBA Communications Corp / Jazz Pharmaceuticals PLC / National Grid PLC / Verizon Communications Inc / HCA Healthcare Inc / Exelixis Inc / Arena Pharmaceuticals Inc / Constellation Brands Inc / Lincoln National Corp / Amphenol Corp / Fiserv Inc / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Brunswick Corp / Boston Beer Company Inc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Prudential Financial Inc / NCR Corp / TE Connectivity Ltd / CenterPoint Energy Inc / Chesapeake Utilities Corp / Markel Corp / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Spire Inc / Trane Technologies PLC / Seagen Inc / Global Payments Inc / Monster Beverage Corp / CCL Industries Inc / Caseys General Stores Inc / O'Reilly Automotive Inc / Arch Capital Group Ltd / Paylocity Holding Corp / Alimentation Couche-Tard Inc / Altria Group Inc / Apollo Investment Corp / Digital Realty Trust Inc / ViacomCBS Inc / Hartford Financial Services Group Inc / Hershey Co / Discovery Inc / SJW Group / Fidelity National Information Services Inc / Teva Pharmaceutical Industries Ltd / Harley-Davidson Inc / Aon PLC / B&G Foods Inc / Teradata Corp / Ensign Group Inc / Dana Inc / Vale SA / Fortinet Inc / Spectrum Brands Holdings Inc / Change Healthcare Inc / Cargojet Inc / Pacira Biosciences Inc / Meritor Inc / Interfor Corp / AMC Networks Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / BRP Inc / Coty Inc / Fox Corp / Prothena Corporation PLC / Rayonier Advanced Materials Inc / Shopify Inc / PayPal Holdings Inc / Westrock Co / Mimecast Ltd / Ferrari NV / Megaport Ltd / Brookfield Business Partners LP / Adient PLC / Lions Gate Entertainment Corp / TFI International Inc / WideOpenWest Inc / Altice USA Inc / Orsted A/S / Aptiv PLC / GrafTech International Ltd / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Newell Brands Inc / Genmab A/S / Datadog Inc / Cerence Inc / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Affirm Holdings Inc / Triple Point Energy Efficiency Infrastructure Company Plc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Brazil / Canada / Switzerland / Germany / Denmark / Spain / United Kingdom / Ireland / Israel / Netherlands / Singapore / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Australia Research</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">GSK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">GSK / MRK / NVS / PFE / AZN.O / DVAX.O / TEVA.K / SNY.O</td><td class="leftalignment">GlaxoSmithKline PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / AstraZeneca PLC / Dynavax Technologies Corp / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVO-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NVO / BMY / LLY / PFE / SNY.O</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Denmark / France / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">AMGN-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">AMGN.O / BMY / JNJ / LLY / PFE / GILD.O / GSK / ILMN.O / BIIB.O / ABBV.K</td><td class="leftalignment">Amgen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / GlaxoSmithKline PLC / Illumina Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Major Pharmaceuticals : 4Q Earnings Season Takeaways - Solid Results, Mixed Stock Performance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / ABBV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - New report: China's vaccination roadmap-deep-dive into clinical data and market potential</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / 2196.HK / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Shanghai Fosun Pharmaceutical Group Co Ltd / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">China / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="even"><td class="leftalignment">02/08/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Healthcare Sector: China's vaccination roadmap: Deep-dive into clinical data and market potential</td><td class="leftalignment">English</td><td class="rightalignment">60</td><td class="leftalignment">2196.HK / 600196.SS / JNJ.N / MRK.N / PFE.N / AZN.L / SASY.PA / LONN.S / GSK.L / NVAX.OQ / MRNA.OQ / SVA.OQ / 300122.SZ / 300142.SZ / CVAC.OQ</td><td class="leftalignment">Shanghai Fosun Pharmaceutical Group Co Ltd / Shanghai Fosun Pharmaceutical Group Co Ltd / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Lonza Group AG / GlaxoSmithKline PLC / Novavax Inc / Moderna Inc / Sinovac Biotech Ltd / Chongqing Zhifei Biological Products Co Ltd / Walvax Biotechnology Co Ltd / CureVac NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Switzerland / China / France / United Kingdom / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">02/07/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / JAZZ.O / TEVA.N / ABBV.N</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Jazz Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">India / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company Detailed Pipeline Report</td><td class="leftalignment">English</td><td class="rightalignment">35</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="odd"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Clarivate Analytics</td><td class="leftalignment">Trillium Therapeutics Inc - Cortellis Company and Pipeline Overview Report</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">114525350</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Clarivate Analytics</td></tr>
<tr class="even"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Positive - Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/07/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail: Vaccination & Hospitalization Weekly Tracker - Week 5, 2021</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">JNJ.N / PFE.N / AZN.L / FUNO11.MX / FIBRAMQ12.MX</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / AstraZeneca PLC / Fibra Uno Administracion SA de CV / Macquarie Mexico Real Estate Management SA de CV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Financial Services / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas / Andres Ortiz</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 2.5.21</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Stephens Inc.</td><td class="leftalignment">4Q20 Wrap: With Occupancy Decline De-Risked, Focus Turns to Recovery; TP to $93</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">B1YWPP8 / PFE</td><td class="leftalignment">Ensign Group Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Scott J. Fidel / Caleb Ezell</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ARNA / MRNS / 45337C10 / 03116210 / 09058V10 / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 29604W108 / 462260100 / 558868105 / 12648L601 / 89532E109 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / G637AM102 / 007002108 / N71542109 / 206022105 / 72942A107 / 92790C104</td><td class="leftalignment">Arena Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Incyte Corp / Amgen Inc / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Trevena Inc / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / Myovant Sciences Ltd / Adicet Bio Inc / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / PLx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Jan 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">AMGN.OQ / BIIB.OQ / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / GLPG.AS / ACRX.OQ / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">Amgen Inc / Biogen Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Galapagos NV / AcelRx Pharmaceuticals Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">02/05/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">The long and the short of it: APAC ESG Digest: AGL, Remediation, Hydrogen, China Antitrust, APT</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AGL.AX / APT.AX / 1093.HK / 2317.TW / 7201.T / 7267.T / BHP.AX / BP.L / DBSM.SI / GE.N / ICT.PS / OML.AX / PFE.N / QAN.AX / RIO.AX / RIO.L / SE.N / STEG.SI / STO.AX / VENM.SI / WBC.AX / WOW.AX / WPL.AX / 1088.HK / AZN.L / NOVN.S / RMD.AX / SATS.SI / GME.N / NIO.N / AAPL.OQ / MSFT.OQ / TAMO.BO / NHC.AX / LYC.AX / FMG.AX / 2338.HK / 600521.SS / 0700.HK / 600733.SS / 600885.SS / KKR.N / 000338.SZ / WHC.AX / 601088.SS / MQG.AX / VALE.N / BHPB.L / 2238.HK / 601238.SS / AZJ.AX / GOOGL.OQ / 2186.HK / BABA.N / KEPE.SI / FB.PS / DQ.ZY / 9988.HK / LI.OQ / XPEV.N / ENR1N.DE / NANO.SI</td><td class="leftalignment">AGL Energy Ltd / Afterpay Ltd / CSPC Pharmaceutical Group Ltd / Hon Hai Precision Industry Co Ltd / Nissan Motor Co Ltd / Honda Motor Co Ltd / BHP Group Ltd / BP PLC / DBS Group Holdings Ltd / General Electric Co / International Container Terminal Services Inc / Ooh!Media Ltd / Pfizer Inc / Qantas Airways Ltd / Rio Tinto Ltd / Rio Tinto PLC / Sea Ltd / Singapore Technologies Engineering Ltd / Santos Ltd / Venture Corporation Ltd / Westpac Banking Corp / Woolworths Group Ltd / Woodside Petroleum Ltd / China Shenhua Energy Co Ltd / AstraZeneca PLC / Novartis AG / Resmed Inc / SATS Ltd / GameStop Corp / NIO Inc / Apple Inc / Microsoft Corp / Tata Motors Ltd / New Hope Corporation Ltd / Lynas Rare Earths Ltd / Fortescue Metals Group Ltd / Weichai Power Co Ltd / Zhejiang Huahai Pharmaceutical Co Ltd / Tencent Holdings Ltd / BAIC BluePark New Energy Technology Co Ltd / Hongfa Technology Co Ltd / KKR & Co Inc / Weichai Power Co Ltd / Whitehaven Coal Ltd / China Shenhua Energy Co Ltd / Macquarie Group Ltd / Vale SA / BHP Group PLC / Guangzhou Automobile Group Co Ltd / Guangzhou Automobile Group Co Ltd / Aurizon Holdings Ltd / Alphabet Inc / Luye Pharma Group Ltd / Alibaba Group Holding Ltd / Keppel DC REIT / San Miguel Food and Beverage Inc / Daqo New Energy Corp / Alibaba Group Holding Ltd / Li Auto Inc / Xpeng Inc / Siemens Energy AG / Nanofilm Technologies International Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Brazil / Switzerland / China / Cayman Islands / Germany / United Kingdom / Hong Kong / India / Japan / Philippines / Papua New Guinea / Singapore / Taiwan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Phineas Glover</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Vermilion Technical Research</td><td class="leftalignment">Short Shots - Charts highlighted: BTG, GOLD, NEM, NDSN, NEM, NDSN, ROP, LMT, ADCT, GSK, MRK, PFE, SGEN, VRTX, PG, BAH, FDS, JKHY, HUM, DG, CHRW, AEE, ETR, XEL, ATO, PGR, KNSL, BRO, and VZ</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">PFE.N / ADCT.N / CHRW.OQ / FDS.N / JKHY.OQ / KNSL.OQ / LMT.N / NDSN.OQ / NEM.N / ROP.N / SGEN.OQ / VRTX.OQ / VZ.N / XEL.OQ / ABX.TO / GOLD.TO / BTG.NH</td><td class="leftalignment">Pfizer Inc / ADC Therapeutics SA / CH Robinson Worldwide Inc / Factset Research Systems Inc / Jack Henry & Associates Inc / Kinsale Capital Group Inc / Lockheed Martin Corp / Nordson Corp / Newmont Corporation / Roper Technologies Inc / Seagen Inc / Vertex Pharmaceuticals Inc / Verizon Communications Inc / Xcel Energy Inc / Barrick Gold Corp / GoldMining Inc / Beroni Group Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / Latin America / North America / Australasia</td><td class="leftalignment">STRATEGY / TECHNICAL ANALYSIS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">David P. Nicoski, CMT</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">UnivDatos Market Insights (UMI)</td><td class="leftalignment">Global Nanotechnology in Drug Delivery Market: Current Analysis and Forecast (2020-2027)</td><td class="leftalignment">English</td><td class="rightalignment">241</td><td class="leftalignment">NANO=FR / MRK=US / PFE=US / NOVN=CH / SPL=AU / SELB=US / null / 500672=IN / 4571=JP / BAYN=DE</td><td class="leftalignment">Nanobiotix SA / Merck & Co Inc / Pfizer Inc / Novartis AG / Starpharma Holdings Ltd / Selecta Biosciences Inc / One 97 Communications Ltd / Novartis India Ltd / NanoCarrier Co Ltd / Bayer AG</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / China / Germany / Spain / France / United Kingdom / India / Italy / Japan / Korea, Republic of / Taiwan / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE / INDUSTRY OVERVIEW / MERGER/ACQUISITION/DIVESTITURE / OPERATIONS / OPERATING RESULTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">univdatos Co / UMI Team</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Updating PT to $106 as COVID-19 Vaccine Market Continues to Evolve</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BNTX=US / PFE=US</td><td class="leftalignment">BioNTech SE / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BSX=US / PFE=US / AMGN=US / AVB=US / AMZN=US / DT=US / EBAY=US / GL=US / CMA=US / PEB=US / H=US / V=US / MTN=US / CHKP=US / PB=US / VRM=US / EWBC=US / TRMK=US / MAR=US / UMPQ=US / TTMI=US / HLT=US / HUM=US / WTFC=US / FUN=US / CENT=US / CHH=US / CSTR=US / DRH=US / FCN=US / PACW=US / SMG=US / TGI=US / WAL=US / HTH=US / EPD=US / BXS=US / PYPL=US / CFB=US / CFR=US / FMBI=US / SNV=US / ZION=US / SIVB=US / ABCB=US / AVTR=US / BOKF=US / FBK=US / JAZZ=US / MKL=US / MTCH=US / MAA=US / ASB=US / SSB=US / RF=US / CATY=US / FFIN=US / GBCI=US / SBSI=US / ENSG=US / UCBI=US / PNFP=US / SBCF=US / JRVR=US / TCBI=US / FNB=US / FHN=US / SHO=US / WMG=US / RNST=US / HST=US / MA=US / SIX=US / ELF=US / ICFI=US / CADE=US / WH=US / SEAS=US / NXGN=US / WYND=US / IAC=US / KNSL=US / HGV=US / RLJ=US / VAC=US / ANGI=US / RHP=US / ABBV=US / IBTX=US / PINC=US / VCYT=US / LOB=US / ACBI=US / SQ=US / MIME=US / ADVM=US / VVV=US / CRSP=US / PK=US / PLYA=US / CVNA=US / MBIN=US / HWC=US / OZK=US / FOCS=US / AMTB=US / UBER=US / PLMR=US / FERGY=US / IMVT=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Amgen Inc / Avalonbay Communities Inc / Amazon.com Inc / Dynatrace Inc / eBay Inc / Globe Life Inc / Comerica Inc / Pebblebrook Hotel Trust / Hyatt Hotels Corp / Visa Inc / Vail Resorts Inc / Check Point Software Technologies Ltd / Prosperity Bancshares Inc / Vroom Inc / East West Bancorp Inc / Trustmark Corp / Marriott International Inc / Umpqua Holdings Corp / TTM Technologies Inc / Hilton Worldwide Holdings Inc / Humana Inc / Wintrust Financial Corp / Cedar Fair LP / Central Garden & Pet Co / Choice Hotels International Inc / CapStar Financial Holdings Inc / Diamondrock Hospitality Co / FTI Consulting Inc / PacWest Bancorp / Scotts Miracle-Gro Co / Triumph Group Inc / Western Alliance Bancorp / Hilltop Holdings Inc / Enterprise Products Partners LP / Cadence Bank / PayPal Holdings Inc / Crossfirst Bankshares Inc / Cullen/Frost Bankers Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Zions Bancorporation NA / SVB Financial Group / Ameris Bancorp / Avantor Inc / BOK Financial Corp / FB Financial Corp / Jazz Pharmaceuticals PLC / Markel Corp / Match Group Inc / Mid-America Apartment Communities Inc / Associated Banc-Corp / SouthState Corp / Regions Financial Corp / Cathay General Bancorp / First Financial Bankshares Inc / Glacier Bancorp Inc / Southside Bancshares Inc / Ensign Group Inc / United Community Banks Inc / Pinnacle Financial Partners Inc / Seacoast Banking Corporation of Florida / James River Group Holdings Ltd / Texas Capital Bancshares Inc / FNB Corp / First Horizon Corp / Sunstone Hotel Investors Inc / Warner Music Group Corp / Renasant Corp / Host Hotels & Resorts Inc / Mastercard Inc / Six Flags Entertainment Corp / elf Beauty Inc / ICF International Inc / Cadence Bank / Wyndham Hotels & Resorts Inc / SeaWorld Entertainment Inc / NextGen Healthcare Inc / Travel + Leisure Co / IAC/Interactivecorp / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Angi Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Independent Bank Group Inc / Premier Inc / Veracyte Inc / Live Oak Bancshares Inc / Atlantic Capital Bancshares Inc / Block Inc / Mimecast Ltd / Adverum Biotechnologies Inc / Valvoline Inc / CRISPR Therapeutics AG / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / Carvana Co / Merchants Bancorp / Hancock Whitney Corp / Bank Ozk / Focus Financial Partners Inc / Amerant Bancorp Inc / Uber Technologies Inc / Palomar Holdings Inc / Ferguson PLC / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Ireland / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: Philippine Market Strategy - Philippine Vaccination: A govt-private sector alliance - key takeaways</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Ms. Hazel Tanedo / Mr. Justin J. Cimafranca</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">PFE-US -  Dividend Quality Analysis, for the period ended December 01,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">PFE / ABT / BMY / JNJ / LLY / MRK / NVS / AMGN.O / GSK / AZN.O</td><td class="leftalignment">Pfizer Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Novartis AG / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">MRK-US -  Dividend Quality Analysis, for the period ended January 08,2021.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">MRK / ABT / BMY / JNJ / LLY / NVS / PFE / AMGN.O / GSK / TEVA.K / SNY.O</td><td class="leftalignment">Merck & Co Inc / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US -  Dividend Quality Analysis, for the period ended November 16,2020.</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">SMALL CAPITAL</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">02/04/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ARE-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">BMY / LLY / PFE / GILD.O / AMGN.O / ILMN.O / ALNY.O</td><td class="leftalignment">Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Illumina Inc / Alnylam Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Egypt / Turkey / United States</td><td class="leftalignment">Real Estate</td><td class="leftalignment">Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Solid Q and outlook; PT to $115; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">ABBV=US / PFE=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">What To Expect From Bristol Myers Squibb's Q4?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Merck Q4 Earnings Preview: Keytruda And Gardasil In Focus</td><td class="leftalignment">English</td><td class="rightalignment">2</td><td class="leftalignment">MRK.N / BMY.N / JNJ.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Merck & Co Inc / Bristol-Myers Squibb Co / Johnson & Johnson / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N / AMGN.OQ / NVAX.OQ / DRRX.OQ / EVGN.TA / PRTA.OQ / VYGR.OQ / CVSI.PK / WEED.TO / GTII.CD / CWEB.TO / CURA.CD / TRUL.CD / SAVA.OQ / YCBD.A / OCGN.OQ / 120346301</td><td class="leftalignment">Pfizer Inc / Amgen Inc / Novavax Inc / DURECT Corp / Evogene Ltd / Prothena Corporation PLC / Voyager Therapeutics Inc / CV Sciences Inc / Canopy Growth Corp / Green Thumb Industries Inc / Charlotte's Web Holdings Inc / Curaleaf Holdings Inc / Trulieve Cannabis Corp / Cassava Sciences Inc / cbdMD Inc / Ocugen Inc / Ayr Wellness Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Ireland / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary of 141 page Covid-19 Multilateralism Agility and Innovation TLSD Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">22UAy.DE / GSK.L / 4507.T / JNJ / LLY / PFE / AZN.L / BAVA.CO / REGN.O / 4563.T / IMM.L / CADI.NS / NVAX.O / SYNG.L / MRNA.O / 1099.HK / SVA.O / 4142.TW / ARCT.O / VBIV.O / ALT.O / VXRT.O / POLX.L / BNTX.O / VIR.O / 688185.SS</td><td class="leftalignment">BioNTech SE / GlaxoSmithKline PLC / Shionogi & Co Ltd / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Bavarian Nordic A/S / Regeneron Pharmaceuticals Inc / AnGes Inc / ImmuPharma PLC / Cadila Healthcare Ltd / Novavax Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Adimmune Corp / Arcturus Therapeutics Holdings Inc / VBI Vaccines Inc / Altimmune Inc / Vaxart Inc / Polarean Imaging PLC / BioNTech SE / Vir Biotechnology Inc / CanSino Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Antigua and Barbuda / Canada / China / Germany / Denmark / United Kingdom / India / Japan / Taiwan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / CORPORATE SUMMARY / STRATEGY / STRATEGIC ANALYSIS / EQUITY</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Trimming EPS and PT to $43 on higher spending; Maintain Buy</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">BP.L / SIEGn.DE / PFE.N / PUBP.PA / SAN.MC / SAPJ.J / SHBA.ST / VOLVB.ST / VOWG.DE / RACE.MI</td><td class="leftalignment">BP PLC / Siemens AG / Pfizer Inc / Publicis Groupe SA / Banco Santander SA / Sappi Ltd / Svenska Handelsbanken AB / Volvo AB / Volkswagen AG / Ferrari NV</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / Spain / France / United Kingdom / Italy / Netherlands / Sweden / United States / South Africa</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Conglomerates / Consumer / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Financial Services / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr Christian Aust / Frau. Jana Schuler / Herr Sven Kreitmair, CFA / Herr Jonathan Schroer / Frau Silke Stegemann / Herr Tobias Keller / Holger Kapitza</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">COVID Vaccine Windfall Offers One-Time Offset to Core Business Challenges</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">MRK=US / PFE=US / OXY=US / PLD=US / AMZN=US / BR=US / XOM=US / CHRS=US / HCA=US / MANH=US / CSGP=US / ABG=US / MAN=US / MPLX=US / MRCY=US / RHI=US / ST=US / VRTX=US / CVX=US / BDN=US / MTCH=US / DRE=US / COP=US / MMP=US / CMG=US / NXPI=US / ESTE=US / FBHS=US / EA=US / FEYE=US / GOOGL=US / ARCB=US / BABA=US / ARGX=US / WVE=US / VRNA=US / TENB=US / HARP=US / IMVT=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Occidental Petroleum Corp / Prologis Inc / Amazon.com Inc / Broadridge Financial Solutions Inc / Exxon Mobil Corp / Coherus BioSciences Inc / HCA Healthcare Inc / Manhattan Associates Inc / CoStar Group Inc / Asbury Automotive Group Inc / ManpowerGroup Inc / MPLX LP / Mercury Systems Inc / Robert Half International Inc / Sensata Technologies Holding PLC / Vertex Pharmaceuticals Inc / Chevron Corp / Brandywine Realty Trust / Match Group Inc / Duke Realty Corp / Conocophillips / Magellan Midstream Partners LP / Chipotle Mexican Grill Inc / NXP Semiconductors NV / Earthstone Energy Inc / Fortune Brands Home & Security Inc / Electronic Arts Inc / Mandiant Inc / Alphabet Inc / ArcBest Corp / Alibaba Group Holding Ltd / argenx SE / WAVE Life Sciences Ltd / Verona Pharma PLC / Tenable Holdings Inc / Harpoon Therapeutics Inc / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United Kingdom / Netherlands / Singapore / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">BP.L / EL.N / F.N / FLS.N / GE.N / GM.N / IBE.MC / PFE.N / WMT.N / SSE.L / AMGN.O / FER.MC / ETN.N / DHR.N / WCC.N / DOV.N / IEX.N / ROP.N / HON.N / MMM.N / EMR.N / HCA.N / JCI.N / EPAY.O / AME.N / APT.AX / VRTX.O / GGG.N / MKL.N / PNR.N / ST.N / SKY.N / TT.N / ICPT.O / MMP.N / BIIB.O / NVT.N / HOG.N / EHTH.O / AEO.N / SPB.N / PCH.O / PCRX.O / STAG.N / MPC.N / FBHS.N / XYL.N / MPLX.N / BPY.N / AGIO.O / VRNS.O / CTLT.N / GBT.OQ / RPD.O / TRHC.OQ / ATKR.N / ICHR.O / GOOS.TO / ESTE.N / ORSTED.CO / AQUA.N / SAIL.N / Z1P.AX / GSHD.O / NTGY.MC / NBSE.OQ / CRNC.OQ / IGMS.O / SLQT.N / FOUR.N / RXT.OQ / JAMF.O</td><td class="leftalignment">BP PLC / Estee Lauder Companies Inc / Ford Motor Co / Flowserve Corp / General Electric Co / General Motors Co / Iberdrola SA / Pfizer Inc / Walmart Inc / SSE PLC / Amgen Inc / Ferrovial SA / Eaton Corporation PLC / Danaher Corp / Wesco International Inc / Dover Corp / IDEX Corp / Roper Technologies Inc / Honeywell International Inc / 3M Co / Emerson Electric Co / HCA Healthcare Inc / Johnson Controls International PLC / Bottomline Technologies Inc / AMETEK Inc / Afterpay Ltd / Vertex Pharmaceuticals Inc / Graco Inc / Markel Corp / Pentair PLC / Sensata Technologies Holding PLC / Skyline Champion Corp / Trane Technologies PLC / Intercept Pharmaceuticals Inc / Magellan Midstream Partners LP / Biogen Inc / nVent Electric PLC / Harley-Davidson Inc / eHealth Inc / American Eagle Outfitters Inc / Spectrum Brands Holdings Inc / Potlatchdeltic Corp / Pacira Biosciences Inc / STAG Industrial Inc / Marathon Petroleum Corp / Fortune Brands Home & Security Inc / Xylem Inc / MPLX LP / Brookfield Property Partners LP / Agios Pharmaceuticals Inc / Varonis Systems Inc / Catalent Inc / Global Blood Therapeutics Inc / Rapid7 Inc / Tabula Rasa HealthCare Inc / Atkore Inc / Ichor Holdings Ltd / Canada Goose Holdings Inc / Earthstone Energy Inc / Orsted A/S / Evoqua Water Technologies Corp / SailPoint Technologies Holdings Inc / Zip Co Ltd / Goosehead Insurance Inc / Naturgy Energy Group SA / NeuBase Therapeutics Inc / Cerence Inc / IGM Biosciences Inc / SelectQuote Inc / Shift4 Payments Inc / Rackspace Technology Inc / Jamf Holding Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Cayman Islands / Denmark / Spain / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Asian Daily: China Healthcare Sector - Fourth round GPO tendering completed; results in line with previous rounds as expected</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">1093.HK / PFE.N / AZN.L / 1177.HK / NOVN.S / 2196.HK / 600521.SS / 600276.SS / 002294.SZ / 2607.HK / 2186.HK</td><td class="leftalignment">CSPC Pharmaceutical Group Ltd / Pfizer Inc / AstraZeneca PLC / Sino Biopharmaceutical Ltd / Novartis AG / Shanghai Fosun Pharmaceutical Group Co Ltd / Zhejiang Huahai Pharmaceutical Co Ltd / Jiangsu Hengrui Pharmaceuticals Co Ltd / Shenzhen Salubris Pharmaceuticals Co Ltd / Shanghai Pharmaceuticals Holding Co Ltd / Luye Pharma Group Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Switzerland / China / Cayman Islands / United Kingdom / Hong Kong / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / CNC.N / EL.N / GM.N / KO.N / MRK.N / PFE.N / PM.N / HUM.N / FE.N / ITW.N / XOM.N / LIN.N / TWTR.N / AMGN.OQ / FISV.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / EQIX.OQ / GPN.N / FIS.N / TDG.N / CME.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / IQV.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Centene Corp / Estee Lauder Companies Inc / General Motors Co / Coca-Cola Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Humana Inc / FirstEnergy Corp / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Twitter Inc / Amgen Inc / Fiserv Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Equinix Inc / Global Payments Inc / Fidelity National Information Services Inc / TransDigm Group Inc / CME Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / IQVIA Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">European Pharma: 2021 Catalysts & NPV sensitivity analysis</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / SASY.PA / ROG.S / LUN.CO / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / IPN.PA / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / ABBV.N / VIFN.S / ARGX.OQ / GMAB.CO</td><td class="leftalignment">Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Ipsen SA / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Abbvie Inc / Vifor Pharma AG / argenx SE / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Italy / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">02/03/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : Core Business Performing Well, BNT-162 Est. Appear Conservative (But Unlikely To Drive Shares Higher) - Model Update</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/03/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - PFE 4Q20 Postview</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Vaccine focus high but Biopharma mixed and more important to the stock, our outlook is unchanged</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">PFE - PFE 4Q20 Conference Call Recap</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">PFE Commits to mRNA Long-Term as COVID Sales Balloon</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Still Like PFE Post Mixed 4Q20 Results And Ahead Of Positive Outlook for 2021+, Street Is Missing Strength Of Its R&D Engine</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">Pfizer Inc. : 2021 Guidance Modestly Ahead Of Expectations On Core Biz; Vaccine Targets Leave Room For Upside</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">EVERCORE ISI</td><td class="leftalignment">parsing through covid vaccine #s & FY21 guidance</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Umer Raffat</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 EPS Light, Sales Beat; '21 Guidance Includes Vaccine But Upside Seems Likely</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Decent Q and outlook; stock reaction seems overdone</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Zephirin Group, Inc.</td><td class="leftalignment">Zephirin Group View: The Dating Game - Key Quarterly Earnings on Feb 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / BP.L / BR.N / IBM.N / MCK.N / SLB.N / STE.N / WAT.N / BEN.N / HAL.N / ETN.N / IMO.TO / SYY.N / UPS.N / EMR.N / XOM.N / GWW.N / PKI.N / HCA.N / ATO.N / COP.N / AMGN.OQ / AAPL.OQ / MSFT.OQ / TECH.OQ / SBUX.OQ / IDXX.OQ / GL.N / AMZN.OQ / MTCH.OQ / 0700.HK / RDSa.L / CMG.N / 9999.HK / MPC.N / BKR.N / FBHS.N / EA.OQ / GOOGL.OQ / CTLT.N / LYFT.OQ / CB.BN / PINS.N / BYND.OQ / UBER.N / ZM.OQ / AMCR.N / 9988.HK / 9618.HK / ABNB.OQ</td><td class="leftalignment">Pfizer Inc / BP PLC / Broadridge Financial Solutions Inc / International Business Machines Corp / Mckesson Corp / Schlumberger NV / STERIS plc / Waters Corp / Franklin Resources Inc / Halliburton Co / Eaton Corporation PLC / Imperial Oil Ltd / Sysco Corp / United Parcel Service Inc / Emerson Electric Co / Exxon Mobil Corp / W W Grainger Inc / PerkinElmer Inc / HCA Healthcare Inc / Atmos Energy Corp / Conocophillips / Amgen Inc / Apple Inc / Microsoft Corp / Bio-Techne Corp / Starbucks Corp / IDEXX Laboratories Inc / Globe Life Inc / Amazon.com Inc / Match Group Inc / Tencent Holdings Ltd / Royal Dutch Shell PLC / Chipotle Mexican Grill Inc / NetEase Inc / Marathon Petroleum Corp / Baker Hughes Co / Fortune Brands Home & Security Inc / Electronic Arts Inc / Alphabet Inc / Catalent Inc / Lyft Inc / Chubb Ltd / Pinterest Inc / Beyond Meat Inc / Uber Technologies Inc / Zoom Video Communications Inc / Amcor PLC / Alibaba Group Holding Ltd / JD.Com Inc / Airbnb Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / United States / Jersey / Curaçao</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment">INVESTMENT STRATEGY / CAPITALIZATION / GOVERNMENT RELATIONS/REGULATIONS / MISCELLANEOUS / SMALL CAPITAL / GOVERNMENTS / RELATIVE VALUE / TRADING / GROWTH / INDEX / PORTFOLIO STRATEGY</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Longdley Zephirin</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Brief of Pfizer Inc conference call, Feb. 02, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">26</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Refinitiv StreetEvents</td><td class="leftalignment">PFE.N - Event Transcript of Pfizer Inc conference call, Feb. 02, 2021 / 10:00AM ET</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">PFE reports a mixed 4Q with several moving parts; here's where to focus for the 10AM ET call</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Johnson & Johnson Vaccine's 66% Efficacy Figure Is Better Than It Looks</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4 EPS Miss Despite Rev Beat; 2021 EPS Guidance Below, But Many Moving Parts</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">First Look at Mixed 4Q20 Results and More Color on 2021 Guidance</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Northland Securities</td><td class="leftalignment">Hosting Management Call on Tuesday, Feb.9; Synthetic Lethality Play</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">IDYA=US / PFE=US / AZN=US / GSK=US / CLVS=US / RPTX=US</td><td class="leftalignment">IDEAYA Biosciences Inc / Pfizer Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Clovis Oncology Inc / Repare Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Timothy Chiang</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / HD=US / MCD=US / WEN=US / BLD=US / EBAY=US / TXN=US / TEVA=US / GILD=US / PEB=US / CONE=US / LOW=US / FMS=US / HSII=US / DIOD=US / CHRS=US / TTWO=US / LEG=US / ATVI=US / KFRC=US / MAC=US / KFY=US / AMN=US / CBRL=US / CSTR=US / DRI=US / DRH=US / EQIX=US / GFF=US / IBP=US / MAN=US / MAS=US / MHK=US / ASGN=US / REGN=US / REGI=US / RHI=US / ROLL=US / SKY=US / THO=US / CCRN=US / MTCH=US / VNO=US / FFIN=US / GBCI=US / DIN=US / PTON=US / RPD=US / TPX=US / EXP=US / BECN=US / SHO=US / DLR=US / PLAY=US / BAH=US / WMG=US / DENN=US / BLDR=US / GMS=US / NSP=US / CMG=US / REX=US / HST=US / PGTI=US / GPRE=US / AWI=US / OC=US / AMRX=US / TAST=US / QSR=US / PRPL=US / EHC=US / NMTR=US / IAC=US / JACK=US / RCUS=US / TREX=US / NXPI=US / WWD=US / RLJ=US / FBHS=US / ANGI=US / EA=US / RHP=US / TILE=US / IBTX=US / NDLS=US / PINC=US / CNCE=US / MTNB=US / LOCO=US / ANTM=US / WBA=US / SHAK=US / ON=US / WING=US / ARGX=US / 82982L103 / PK=US / GDS=US / JELD=US / SWCH=US / FERGY=US / ARQT=US / AZEK=US / CRMD.US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / eBay Inc / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Pebblebrook Hotel Trust / CyrusOne Inc / Lowe's Companies Inc / Fresenius Medical Care AG & Co KGaA / Heidrick & Struggles International Inc / Diodes Inc / Coherus BioSciences Inc / Take-Two Interactive Software Inc / Leggett & Platt Inc / Activision Blizzard Inc / Kforce Inc / Macerich Co / Korn Ferry / AMN Healthcare Services Inc / Cracker Barrel Old Country Store Inc / CapStar Financial Holdings Inc / Darden Restaurants Inc / Diamondrock Hospitality Co / Equinix Inc / Griffon Corp / Installed Building Products Inc / ManpowerGroup Inc / Masco Corp / Mohawk Industries Inc / ASGN Inc / Regeneron Pharmaceuticals Inc / Renewable Energy Group Inc / Robert Half International Inc / RBC Bearings Inc / Skyline Champion Corp / Thor Industries Inc / Cross Country Healthcare Inc / Match Group Inc / Vornado Realty Trust / First Financial Bankshares Inc / Glacier Bancorp Inc / Dine Brands Global Inc / Peloton Interactive Inc / Rapid7 Inc / Tempur Sealy International Inc / Eagle Materials Inc / Beacon Roofing Supply Inc / Sunstone Hotel Investors Inc / Digital Realty Trust Inc / Dave & Buster's Entertainment Inc / Booz Allen Hamilton Holding Corp / Warner Music Group Corp / Denny's Corp / Builders FirstSource Inc / GMS Inc / Insperity Inc / Chipotle Mexican Grill Inc / REX American Resources Corp / Host Hotels & Resorts Inc / PGT Innovations Inc / Green Plains Inc / Armstrong World Industries Inc / Owens Corning / Amneal Pharmaceuticals Inc / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / Encompass Health Corp / 9 Meters Biopharma Inc / IAC/Interactivecorp / Jack in the Box Inc / Arcus Biosciences Inc / Trex Company Inc / NXP Semiconductors NV / Woodward Inc / RLJ Lodging Trust / Fortune Brands Home & Security Inc / Angi Inc / Electronic Arts Inc / Ryman Hospitality Properties Inc / Interface Inc / Independent Bank Group Inc / Noodles & Co / Premier Inc / Concert Pharmaceuticals Inc / Matinas BioPharma Holdings Inc / El Pollo Loco Holdings Inc / Anthem Inc / Walgreens Boots Alliance Inc / Shake Shack Inc / ON Semiconductor Corp / Wingstop Inc / argenx SE / SiteOne Landscape Supply Inc / Park Hotels & Resorts Inc / GDS Holdings Ltd / JELD-WEN Holding Inc / Switch Inc / Ferguson PLC / Arcutis Biotherapeutics Inc / Azek Company Inc / CorMedix Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / Cayman Islands / Germany / Israel / Netherlands / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">22</td><td class="leftalignment">5671735 / 0989529 / 2126335 / 2516152 / 2000019 / 2778844 / 2050832 / 2026242 / 2942605 / 2270726 / 2542049 / 2576941 / 2328915 / 2100920 / 2415204 / 2684703 / 2048804 / 2931034 / 7103065 / B121557 / 2212922 / 2857817 / B125XQ6 / B2R3PV1 / B3D7K31 / B1HJLW5 / 2390817 / B7TL820 / B7VD3F2 / BJ0XLZ3 / BH65L93 / BFLR866 / BYY8XK8 / BQPVQZ6 / BFNF1D6 / BJLKVS6 / BFZ1K46 / BLGJ610 / BFMXGR0 / BKTNTR9 / BKX9VD3 / BDVLM39 / BJRFSB7</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amazon.com Inc / Merck & Co Inc / Ameren Corp / American Electric Power Company Inc / Avista Corp / Walt Disney Co / Dominion Energy Inc / Exelixis Inc / Nextera Energy Inc / FirstEnergy Corp / Hawaiian Electric Industries Inc / Pfizer Inc / Pinnacle West Capital Corp / Vertex Pharmaceuticals Inc / Novartis AG / Mastercard Inc / NRG Energy Inc / Netflix Inc / Portland General Electric Co / American Water Works Company Inc / Discovery Inc / Emergent BioSolutions Inc / Gray Television Inc / Meta Platforms Inc / Duke Energy Corp / Heron Therapeutics Inc / Seacoast Banking Corporation of Florida / Twitter Inc / WEC Energy Group Inc / Horizon Therapeutics PLC / Amneal Pharmaceuticals Inc / Phathom Pharmaceuticals Inc / Spotify Technology SA / Warner Music Group Corp / Evergy Inc / ViacomCBS Inc / Arcutis Biotherapeutics Inc / argenx SE / Immunovant Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Luxembourg / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - Competitor Data at ASCO GU 2021; Phase III CLEAR/KN-581 Regimen Likely Active, but CM-9ER Sets High Bar</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703 / 7103065</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Seamus Fernandez</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">MCK: Q&A Our Way: Shots in Arms & a Strong FY3Q Drive FY21 Outlook Higher</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MCK.N / CAH.N / PFE.N / ABC.N / MRNA.OQ / WBA.OQ</td><td class="leftalignment">Mckesson Corp / Cardinal Health Inc / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc / Walgreens Boots Alliance Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner</td></tr>
<tr class="odd"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">SASY.PA: Sanofi - 4Q20 and CMD Preview</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">SASY.PA / PFE.N / REGN.OQ</td><td class="leftalignment">Sanofi SA / Pfizer Inc / Regeneron Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh</td></tr>
<tr class="even"><td class="leftalignment">02/02/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 2, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BDX.N / BMY.N / BSX.N / CI.N / EL.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / HD.N / ITW.N / XOM.N / LIN.N / ARE.N / AMGN.OQ / JKHY.OQ / ATVI.OQ / REGN.OQ / TT.N / QCOM.OQ / GILD.OQ / AMZN.OQ / TTWO.OQ / GPN.N / VRTX.OQ / ICE.N / TDG.N / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Becton Dickinson and Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Home Depot Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Amgen Inc / Jack Henry & Associates Inc / Activision Blizzard Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Intercontinental Exchange Inc / TransDigm Group Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / GILD.OQ / AMRN.OQ / BSLN.S / AXSM.OQ / BHVN.N / ARAV.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Amarin Corporation PLC / Basilea Pharmaceutica AG / Axsome Therapeutics Inc / Biohaven Pharmaceutical Holding Company Ltd / Aravive Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Cayman Islands / United Kingdom / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">The Life Sciences Division Ltd</td><td class="leftalignment">Executive Summary Covid-19 Multilateralism Agility and Innovation The Life Sciences Division Industry Update Equities Research 1 February 2021</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">AZN.L / NVAX.OQ / JNJ.N / LLY.N / PFE.N / GSK.L / IMM.L / REGN.OQ / SYNG.L / MRNA.OQ / 1099.HK / SVA.OQ / ARCT.OQ / POLX.L / 6185.HK / VIR.OQ</td><td class="leftalignment">AstraZeneca PLC / Novavax Inc / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / GlaxoSmithKline PLC / ImmuPharma PLC / Regeneron Pharmaceuticals Inc / Synairgen PLC / Moderna Inc / Sinopharm Group Co Ltd / Sinovac Biotech Ltd / Arcturus Therapeutics Holdings Inc / Polarean Imaging PLC / CanSino Biologics Inc / Vir Biotechnology Inc</td><td class="leftalignment">RESEARCH OVERVIEW - INVESTMENT STRATEGY</td><td class="leftalignment">Antigua and Barbuda / China / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / Latin America / North America</td><td class="leftalignment">COMPANY / INDUSTRY / INVESTMENT STRATEGY / MARKET ANALYSIS / COMPANY UPDATE / CORPORATE SUMMARY / COMPANY REPORT</td><td class="leftalignment">INDUSTRY REPORTS / Investment Strategy / Equity</td><td class="leftalignment">Mr. Navid Malik, Ph.D. / Ms. Alia Minhas, MBA</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">TARO-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">TARO.K / JNJ / MRK / NVS / PFE / GSK / TEVA.K</td><td class="leftalignment">Taro Pharmaceutical Industries Ltd / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / Teva Pharmaceutical Industries Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">LLY-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">LLY / BMY / JNJ / MRK / NVS / PFE / AMGN.O / GSK / AZN.O / ABBV.K / SNY.O</td><td class="leftalignment">Eli Lilly and Co / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Novartis AG / Pfizer Inc / Amgen Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Abbvie Inc / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 22, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Litchfield Hills Research, LLC</td><td class="leftalignment">Initiating coverage – Patient-centric drug development, Predictive Oncology Inc.– Buy rating and $3 PT</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">POAI.OQ / 4502.T / MRK.N / PFE.N / SNY.N / AZN.L / AZN.N / ROG.S / SYK.N / GSK.L / GSK.N / DXR.A / QBIO.PK / MYGN.OQ / BAYGN.DE / ZBH.N / CODX.OQ / DE000BAY0199 / ANPC.OQ</td><td class="leftalignment">Predictive Oncology Inc / Takeda Pharmaceutical Co Ltd / Merck & Co Inc / Pfizer Inc / Sanofi SA / AstraZeneca PLC / AstraZeneca PLC / Roche Holding AG / Stryker Corp / GlaxoSmithKline PLC / GlaxoSmithKline PLC / Daxor Corp / Q BioMed Inc / Myriad Genetics Inc / Bayer AG / Zimmer Biomet Holdings Inc / Co-Diagnostics Inc / Bayer AG / AnPac Bio-Medical Science Co Ltd</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Japan / United States / Virgin Islands, British</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">SMALL CAPITAL / MORNING COMMENTS / GROWTH</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Theodore R. O'Neill</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">State of MRNA Debate After an Eventful Week</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">MRNA=US / PFE=US / JNJ=US / BNTX=US</td><td class="leftalignment">Moderna Inc / Pfizer Inc / Johnson & Johnson / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Feb 01 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">MOGa / US0079731008 / US0116591092 / US0311621009 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US14149Y1082 / US1925761066 / US22284P1057 / US2910111044 / US3021301094 / US3695501086 / US37733W1053 / US4385161066 / US4433201062 / US4448591028 / US4456581077 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US58155Q1031 / US6558441084 / US6668071029 / US66987V1098 / US6701002056 / US6795801009 / US7170811035 / US7711951043 / US7766961061 / US8308791024 / US8447411088 / US8552441094 / US87612E1064 / US8807701029 / US9029251066 / US9078181081 / US91324P1021 / US91347P1057 / US9311421039 / US9507551086 / CA1363751027 / US03073E1055 / CA13645T1003 / US4771431016 / US4198791018 / US2948216088 / US80105N1054 / US3463751087 / US09062X1037 / US90385V1070 / US25754A2015 / US0042251084 / US02043Q1076 / US15135B1017 / US12541W2098 / ACOR.OQ / US1696561059 / US78709Y1055 / PAP310761054 / US75025X1000 / US01748X1028 / US2473617023 / US58933Y1055 / US9100471096 / US30303M1027 / US9837931008 / US00287Y1091 / NL0010273215 / US8485771021 / US60468T1051 / US21240E1055 / US02376R1023 / US03937C1053 / US0465131078 / CA0089118776 / US00653A1079 / US9741551033 / US70450Y1038 / US40434L1052 / US05464T1043 / US00773U1088 / US16119P1084 / IE00BY7QL619 / KYG4740B1059 / CA87241L1094 / US23753F1075 / US80689H1023 / US02156K1034 / US4990491049 / US1010441053 / US05351X1019 / US5904791358 / US0197701065 / US1255231003 / US8740602052 / US24703L2025 / US0144421072 / US55087P1049 / US90353T1007 / US18453H1068 / US70614W1009 / US09203E1055 / US4432011082 / CH0499880968</td><td class="leftalignment">Moog Inc / Advanced Energy Industries Inc / Alaska Air Group Inc / Amgen Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cardinal Health Inc / Cohu Inc / Covenant Logistics Group Inc / Emerson Electric Co / Expeditors International of Washington Inc / General Dynamics Corp / GlaxoSmithKline PLC / Honeywell International Inc / Hub Group Inc / Humana Inc / J B Hunt Transport Services Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / Mckesson Corp / Norfolk Southern Corp / Northrop Grumman Corp / Novartis AG / Novo Nordisk A/S / Old Dominion Freight Line Inc / Pfizer Inc / Roche Holding AG / Roper Technologies Inc / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Target Corp / Teradyne Inc / USA Truck Inc / Union Pacific Corp / UnitedHealth Group Inc / Universal Display Corp / Walmart Inc / Werner Enterprises Inc / Canadian National Railway Co / Amerisourcebergen Corp / Canadian Pacific Railway Ltd / JetBlue Airways Corp / Hawaiian Holdings Inc / Telefonaktiebolaget LM Ericsson / Sanofi SA / FormFactor Inc / Biogen Inc / Ultra Clean Holdings Inc / Domino's Pizza Inc / ACADIA Pharmaceuticals Inc / Alnylam Pharmaceuticals Inc / Centene Corp / CH Robinson Worldwide Inc / Acorda Therapeutics Inc / Chipotle Mexican Grill Inc / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Allegiant Travel Co / Delta Air Lines Inc / Merck & Co Inc / United Airlines Holdings Inc / Meta Platforms Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Spirit Airlines Inc / Mirati Therapeutics Inc / Controladora Vuela Compania de Aviacion SAB de CV / American Airlines Group Inc / ArcBest Corp / Atara Biotherapeutics Inc / Air Canada / Adaptimmune Therapeutics PLC / Wingstop Inc / PayPal Holdings Inc / HP Inc / Axsome Therapeutics Inc / Adverum Biotechnologies Inc / Charter Communications Inc / Johnson Controls International PLC / Ichor Holdings Ltd / TFI International Inc / Daseke Inc / Schneider National Inc / Altice USA Inc / Knight-Swift Transportation Holdings Inc / Boston Omaha Corp / Avaya Holdings Corp / Mesa Air Group Inc / Allogene Therapeutics Inc / Cigna Corp / Takeda Pharmaceutical Co Ltd / Dell Technologies Inc / Alector Inc / Lyft Inc / Uber Technologies Inc / Clear Channel Outdoor Holdings Inc / Peloton Interactive Inc / Black Diamond Therapeutics Inc / Howmet Aerospace Inc / ADC Therapeutics SA</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / Japan / Mexico / Netherlands / Panama / Sweden / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Berenberg</td><td class="leftalignment">Pfizer (PFE US) - Biopharma emerges with a vaccine booster</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kerry A. Holford, CFA</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">AOS=US / PNR=US / AAPL=US / MRK=US / BSX=US / PFE=US / ABT=US / AMGN=US / CAT=US / INTC=US / CHRW=US / WM=US / BWA=US / MDT=US / GLW=US / QCOM=US / RUN=US / MPWR=US / FCEL=US / PLUG=US / AXL=US / SBH=US / CRM=US / SMTC=US / UMC=US / VRTS=US / URI=US / TSM=US / UPS=US / ENR=US / CHRS=US / JCI=US / JNJ=US / LSTR=US / DE=US / DOV=US / FLO=US / RSG=US / ALB=US / AMED=US / ECOL=US / AMSC=US / ARRY=US / ATRC=US / AVNT=US / AVT=US / BOX=US / CMI=US / CALM=US / CENX=US / CREE=US / CYBR=US / DAKT=US / EW=US / EXAS=US / FIVE=US / HTLD=US / ITRI=US / LGND=US / MTRX=US / MMS=US / NVAX=US / ODFL=US / PZZA=US / RBC=US / ROK=US / ROP=US / POOL=US / TRMB=US / TYL=US / VG=US / WDFC=US / SGEN=US / CCRN=US / ACA=US / HR=US / NEP=US / UFCS=US / BIO=US / OSTK=US / ENSG=US / BE=US / AMSF=US / ARES=US / CLH=US / PETS=US / WCN=US / TCOM=US / RNG=US / CRI=US / NUVA=US / MRNA=US / DPZ=US / BDC=US / PBF=US / ENS=US / GOOG=US / TWIN=US / MKTX=US / ORA=US / FRPT=US / PBH=US / MORN=US / BIDU=US / AMRS=US / SPWR=US / ATNI=US / TPTX=US / TEL=US / CSIQ=US / EBS=US / FSLR=US / TRIT=US / MASI=US / DAN=US / WPRT=US / TBK=US / AGCO=US / 005930-KR=US / GNRC=US / RRTS=US / TSLA=US / AMRC=US / ENPH=US / YY=US / HASI=US / CNHI=US / QURE=US / DNOW=US / COUP=US / SYF=US / VCEL=US / NVTA=US / ETSY=US / SEDG=US / WING=US / TDOC=US / AQMS=US / WKHS=US / TRHC=US / FLGT=US / IRTC=US / HLNE=US / RDFN=US / ROKU=US / MDB=US / APTV=US / VOW3-DE=US / IQ=US / VNE=US / FOCS=US / CWEN=US / ZM=US / VLDR=US / 120376391</td><td class="leftalignment">A O Smith Corp / Pentair PLC / Apple Inc / Merck & Co Inc / Boston Scientific Corp / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Intel Corp / CH Robinson Worldwide Inc / Waste Management Inc / Borgwarner Inc / Medtronic PLC / Corning Inc / Qualcomm Inc / Sunrun Inc / Monolithic Power Systems Inc / Fuelcell Energy Inc / Plug Power Inc / American Axle & Manufacturing Holdings Inc / Sally Beauty Holdings Inc / Salesforce.Com Inc / Semtech Corp / United Microelectronics Corp / Virtus Investment Partners Inc / United Rentals Inc / Taiwan Semiconductor Manufacturing Co Ltd / United Parcel Service Inc / Energizer Holdings Inc / Coherus BioSciences Inc / Johnson Controls International PLC / Johnson & Johnson / Landstar System Inc / Deere & Co / Dover Corp / Flowers Foods Inc / Republic Services Inc / Albemarle Corp / Amedisys Inc / US Ecology Inc / American Superconductor Corp / Array Technologies Inc / AtriCure Inc / Avient Corp / Avnet Inc / Box Inc / Cummins Inc / Cal-Maine Foods Inc / Century Aluminum Co / Wolfspeed Inc / Cyberark Software Ltd / Daktronics Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Five Below Inc / Heartland Express Inc / Itron Inc / Ligand Pharmaceuticals Inc / Matrix Service Co / Maximus Inc / Novavax Inc / Old Dominion Freight Line Inc / Papa John's International Inc / Regal Rexnord Corp / Rockwell Automation Inc / Roper Technologies Inc / Pool Corp / Trimble Inc / Tyler Technologies Inc / Vonage Holdings Corp / WD-40 Co / Seagen Inc / Cross Country Healthcare Inc / Arcosa Inc / Healthcare Realty Trust Inc / Nextera Energy Partners LP / United Fire Group Inc / Bio Rad Laboratories Inc / Overstock.com Inc / Ensign Group Inc / Bloom Energy Corp / Amerisafe Inc / Ares Management Corp / Clean Harbors Inc / Petmed Express Inc / Waste Connections Inc / Trip.com Group Ltd / RingCentral Inc / Carter's Inc / NuVasive Inc / Moderna Inc / Domino's Pizza Inc / Belden Inc / PBF Energy Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Marketaxess Holdings Inc / Ormat Technologies Inc / Freshpet Inc / Prestige Consumer Healthcare Inc / Morningstar Inc / Baidu Inc / Amyris Inc / SunPower Corp / ATN International Inc / Turning Point Therapeutics Inc / TE Connectivity Ltd / Canadian Solar Inc / Emergent BioSolutions Inc / First Solar Inc / Triterras Inc / Masimo Corp / Dana Inc / Westport Fuel Systems Inc / Triumph Bancorp Inc / AGCO Corp / Farfetch Ltd / Generac Holdings Inc / Roadrunner Transportation Systems Inc / Tesla Inc / Ameresco Inc / Enphase Energy Inc / JOYY Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / CNH Industrial NV / Uniqure NV / NOW Inc / Coupa Software Inc / Synchrony Financial / Vericel Corp / Invitae Corp / ETSY Inc / Solaredge Technologies Inc / Wingstop Inc / Teladoc Health Inc / Aqua Metals Inc / Workhorse Group Inc / Tabula Rasa HealthCare Inc / Fulgent Genetics Inc / iRhythm Technologies Inc / Hamilton Lane Inc / Redfin Corp / Roku Inc / MongoDB Inc / Aptiv PLC / Volkswagen AG / iQIYI Inc / Veoneer Inc / Focus Financial Partners Inc / Clearway Energy Inc / Zoom Video Communications Inc / Velodyne Lidar Inc / Proterra Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Ireland / Israel / Netherlands / Taiwan / United States / Jersey</td><td class="leftalignment">Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Info. Tech./Computers / Machinery / Retailing / Semiconductors / Services</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Downgrade To Market Perform Pending Greater Clarity On Outlook</td><td class="leftalignment">English</td><td class="rightalignment">23</td><td class="leftalignment">US66987V1098 / US0463531089 / US5324571083 / US7170811035</td><td class="leftalignment">Novartis AG / AstraZeneca PLC / Eli Lilly and Co / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">37</td><td class="leftalignment">AEP.N / AFL.N / AIG.N / ALV.N / AMAT.O / AMD.N / ANA.MC / AU.N / BBDb.TO / BCE.TO / CB.N / CCI.N / CE.N / CL.N / CMS.N / CNA.L / CP.TO / DFDS.CO / EIX.N / EL.N / ELE.MC / F.N / FLT.N / GM.N / INTC.O / KMB.N / KO.N / MMC.N / MSFT.O / MUVGn.DE / NSC.N / PEG.N / PFE.N / SCOR.PA / SO.N / STO.AX / PEP.N / BFb.N / PG.N / WY.N / CFP.TO / CNQ.TO / ASML.O / CPB.N / CMCSA.O / SJRb.TO / RCIb.TO / CHKP.O / AMGN.O / MET.N / CNR.TO / DUK.N / QBRb.TO / DIS.N / BWA.N / LEA.N / ROP.N / DRI.N / NVDA.O / K.N / DT.N / DISH.O / CSX.N / LNR.TO / SU.TO / NICE.O / CLX.N / EAT.N / MCD.N / CAG.N / HON.N / GIS.N / EPC.N / MGA.N / AMT.N / JAZZ.O / BOL.ST / CONE.O / OLN.N / ADI.O / VLY.N / EXEL.O / SBUX.O / JCI.N / STZ.N / CINF.O / LNC.N / HNRGn.DE / APH.N / FISV.O / EQT.N / SNPS.O / ADSK.O / EPD.N / CHTR.O / AXL.N / AWK.N / CHD.N / ATA.TO / EPAY.O / BC.N / SAM.N / CTSH.O / AJG.N / BMRN.O / OPTN.O / REGN.O / ENR.N / PFG.N / MU.O / PRU.N / CEY.L / SM.N / NCR.N / NET.N / GFI.N / COP.N / CNP.N / ENDP.O / CPK.N / MKL.N / BRO.N / PII.N / RLI.N / ST.N / SR.N / LNG.A / NTCT.OQ / ADS.N / SGEN.OQ / GPN.N / PFS.N / MNST.O / EFX.TO / FFBC.O / IMGN.O / SIGI.O / CASY.O / ACGL.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / MRE.TO / 02209S103 / DPZ.N / DLR.N / SCL.TO / 416515104 / 427866108 / RDSb.L / DISCA.O / CDNS.O / SJW.N / DRX.L / CMG.N / FIS.N / 025676206 / ISBC.O / MA.N / MWA.N / HOG.N / CVLT.O / EHTH.O / AON.N / BGS.N / PPL.TO / HOCM.L / GETP.PA / DAN.N / FRES.L / 759351604 / ACQ.TO / SPB.N / LYB.N / CFX.TO / FRU.TO / FHI.N / MTOR.N / NGL.N / PXT.TO / BKR.N / AMCX.O / POLYP.L / SPLK.OQ / PSX.N / PANW.N / FFHu.TO / MDLZ.OQ / ABBV.N / PRGO.N / PRMW.N / DOO.TO / COTY.N / FOXA.OQ / PSXP.N / AGIO.O / 81762P102 / PTC.O / QTWO.N / AGRX.O / SYF.N / QSR.N / EVA.N / PYPL.OQ / BYD.TO / RPD.O / MIME.OQ / RACE.MI / SRENH.S / KNSL.OQ / AKERBP.OL / NTNX.O / ADNT.N / LGFB.N / PBYI.OQ / DXC.N / ATUS.N / BHF.O / ATNX.O / SAIL.N / APTV.N / AMRX.N / EQH.N / GSHD.O / NTGY.MC / KDP.N / AQST.O / ESTC.N / NWL.O / RTLR.O / CRWD.O / GMAB.O / CRNC.OQ / ETNB.O / REYN.O / SBSW.N / IGIC.OQ / GFL.N / NKLA.OQ / FOUR.N / LUMN.N / MTCR.O / SUMO.O / 120681711</td><td class="leftalignment">American Electric Power Company Inc / Aflac Inc / American International Group Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Acciona SA / AngloGold Ashanti Ltd / Bombardier Inc / BCE Inc / Chubb Ltd / Crown Castle International Corp / Celanese Corp / Colgate-Palmolive Co / CMS Energy Corp / Centrica PLC / Canadian Pacific Railway Ltd / DFDS AS / Edison International / Estee Lauder Companies Inc / Endesa SA / Ford Motor Co / Fleetcor Technologies Inc / General Motors Co / Intel Corp / Kimberly-Clark Corp / Coca-Cola Co / Marsh & McLennan Companies Inc / Microsoft Corp / Muenchener Rueckversicherungs Gesellschaft in Muenchen AG / Norfolk Southern Corp / Public Service Enterprise Group Inc / Pfizer Inc / Scor SE / Southern Co / Santos Ltd / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Weyerhaeuser Co / Canfor Corp / Canadian Natural Resources Ltd / ASML Holding NV / Campbell Soup Co / Comcast Corp / Shaw Communications Inc / Rogers Communications Inc / Check Point Software Technologies Ltd / Amgen Inc / MetLife Inc / Canadian National Railway Co / Duke Energy Corp / Quebecor Inc / Walt Disney Co / Borgwarner Inc / Lear Corp / Roper Technologies Inc / Darden Restaurants Inc / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / CSX Corp / Linamar Corp / Suncor Energy Inc / Nice Ltd / Clorox Co / Brinker International Inc / McDonald's Corp / Conagra Brands Inc / Honeywell International Inc / General Mills Inc / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Boliden AB / CyrusOne Inc / Olin Corp / Analog Devices Inc / Valley National Bancorp / Exelixis Inc / Starbucks Corp / Johnson Controls International PLC / Constellation Brands Inc / Cincinnati Financial Corp / Lincoln National Corp / Hannover Rueck SE / Amphenol Corp / Fiserv Inc / EQT Corp / Synopsys Inc / Autodesk Inc / Enterprise Products Partners LP / Charter Communications Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / ATS Automation Tooling Systems Inc / Bottomline Technologies Inc / Brunswick Corp / Boston Beer Company Inc / Cognizant Technology Solutions Corp / Arthur J Gallagher & Co / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Principal Financial Group Inc / Micron Technology Inc / Prudential Financial Inc / Centamin PLC / SM Energy Co / NCR Corp / Cloudflare Inc / Gold Fields Ltd / Conocophillips / CenterPoint Energy Inc / Endo International PLC / Chesapeake Utilities Corp / Markel Corp / Brown & Brown Inc / Polaris Inc / Rli Corp / Sensata Technologies Holding PLC / Spire Inc / Cheniere Energy Inc / Netscout Systems Inc / Alliance Data Systems Corp / Seagen Inc / Global Payments Inc / Provident Financial Services Inc / Monster Beverage Corp / Enerflex Ltd / First Financial Bancorp / ImmunoGen Inc / Selective Insurance Group Inc / Caseys General Stores Inc / Arch Capital Group Ltd / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Martinrea International Inc / Altria Group Inc / Domino's Pizza Inc / Digital Realty Trust Inc / Shawcor Ltd / Hartford Financial Services Group Inc / Hershey Co / Royal Dutch Shell PLC / Discovery Inc / Cadence Design Systems Inc / SJW Group / Drax Group PLC / Chipotle Mexican Grill Inc / Fidelity National Information Services Inc / American Equity Investment Life Holding Co / Investors Bancorp Inc / Mastercard Inc / Mueller Water Products Inc / Harley-Davidson Inc / Commvault Systems Inc / eHealth Inc / Aon PLC / B&G Foods Inc / Pembina Pipeline Corp / Hochschild Mining PLC / Getlink SE / Dana Inc / Fresnillo PLC / Reinsurance Group of America Inc / AutoCanada Inc / Spectrum Brands Holdings Inc / LyondellBasell Industries NV / Canfor Pulp Products Inc / Freehold Royalties Ltd / Federated Hermes Inc / Meritor Inc / NGL Energy Partners LP / Parex Resources Inc / Baker Hughes Co / AMC Networks Inc / Polymetal International PLC / Splunk Inc / Phillips 66 / Palo Alto Networks Inc / Fairfax Financial Holdings Ltd / Mondelez International Inc / Abbvie Inc / Perrigo Company PLC / Primo Water Corp / BRP Inc / Coty Inc / Fox Corp / Phillips 66 Partners LP / Agios Pharmaceuticals Inc / ServiceNow Inc / PTC Inc / Q2 Holdings Inc / Agile Therapeutics Inc / Synchrony Financial / Restaurant Brands International Inc / Enviva Inc / PayPal Holdings Inc / Boyd Group Services Inc / Rapid7 Inc / Mimecast Ltd / Ferrari NV / Swiss Re AG / Kinsale Capital Group Inc / Aker BP ASA / Nutanix Inc / Adient PLC / Lions Gate Entertainment Corp / Puma Biotechnology Inc / DXC Technology Co / Altice USA Inc / Brighthouse Financial Inc / Athenex Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Amneal Pharmaceuticals Inc / Equitable Holdings Inc / Goosehead Insurance Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Aquestive Therapeutics Inc / Elastic NV / Newell Brands Inc / Rattler Midstream LP / CrowdStrike Holdings Inc / Genmab A/S / Cerence Inc / 89Bio Inc / Reynolds Consumer Products Inc / Sibanye Stillwater Ltd / International General Insurance Holdings Ltd / GFL Environmental Inc / Nikola Corp / Shift4 Payments Inc / Lumen Technologies Inc / Metacrine Inc / Sumo Logic Inc / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Netherlands / Norway / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Our thoughts on the 4Q set-up, what to watch for and outlook from here</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ABBV/PFE: Atopic derm deep-dive follow-up</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE.N / ABBV.N</td><td class="leftalignment">Pfizer Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused this week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">MRK.N / PFE.N / ENDP.O / TEVA.N / ABBV.N / AMRX.N / 269796108</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Amneal Pharmaceuticals Inc / Eagle Pharmaceuticals Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Distribution: Quick Thoughts Heading Into the Week of Distributors' Earnings</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">CAH.N / MCK.N / PFE.N / ABC.N / MRNA.OQ</td><td class="leftalignment">Cardinal Health Inc / Mckesson Corp / Pfizer Inc / Amerisourcebergen Corp / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner / Carlos Consuegra</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: February 1, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / FE.N / CAT.N / HON.N / ITW.N / XOM.N / LIN.N / ARE.N / CVX.N / AMGN.OQ / JKHY.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / TTWO.OQ / CHTR.OQ / GPN.N / VRTX.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / SPG.NZ / OTIS.N</td><td class="leftalignment">Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / FirstEnergy Corp / Caterpillar Inc / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Jack Henry & Associates Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Take-Two Interactive Software Inc / Charter Communications Inc / Global Payments Inc / Vertex Pharmaceuticals Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Stride Property Ltd / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / New Zealand / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">02/01/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma 4Q Earnings Season : What to Watch for the Week Ahead (ABBV, BMY, MRK, PFE)</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / ABBV.N / BMY.N / MRK.N / LLY.N</td><td class="leftalignment">Pfizer Inc / Abbvie Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Eli Lilly and Co</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Christopher T. Schott, CFA / Xiling Chen / Christopher Neyor / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">02/01/2021</td><td class="leftalignment">ValuEngine, Inc</td><td class="leftalignment">ValuEngine Rating and Forecast Report for PFE</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Paul Henneman</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Still the Premium Player Among COVID-19 Vaccines; PT to $206</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">MRNA=US / MRK=US / PFE=US / JNJ=US / NVAX=US</td><td class="leftalignment">Moderna Inc / Merck & Co Inc / Pfizer Inc / Johnson & Johnson / Novavax Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccines vs variants; IND cleared for PASG</td><td class="leftalignment">English</td><td class="rightalignment">38</td><td class="leftalignment">PASG.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / SNY=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Passage Bio Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Sanofi SA / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">What's New At WCLC This Year; Takeaways Keep Us Positive on MRK, JNJ and HCM</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">JNJ / MRK / HCM.L / LLY / PFE / AMGN.O / BSLN.S / ARAV.O / IMAB.O</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / HUTCHMED (China) Ltd / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Basilea Pharmaceutica AG / Aravive Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 45</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/31/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology: 4Q20 Biotech Earnings Consensus Cheat Sheet for VRTX, AMGN, BIIB, GILD, NBIX, and REGN</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">LLY.N / PFE.N / AZN.L / NOVN.S / GSK.L / AMGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ABBV.N</td><td class="leftalignment">Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Novartis AG / GlaxoSmithKline PLC / Amgen Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Crispidea</td><td class="leftalignment">Merck vs Pfizer - Relative Performance of the Two Pharmaceutical Giants</td><td class="leftalignment">English</td><td class="rightalignment">128</td><td class="leftalignment">PFE.N / MRK.N</td><td class="leftalignment">Pfizer Inc / Merck & Co Inc</td><td class="leftalignment">RESEARCH OVERVIEW</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">INVESTMENT STRATEGY / ASSET MANAGEMENT / CAPITALIZATION / EARNINGS/FINANCIAL STATEMENTS / MERGER/ACQUISITION/DIVESTITURE / MISCELLANEOUS / CHANGE IN RECOMMENDATION / GROWTH</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Rimi Murarka / Ms. Shejal Ajmera</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">SVB Leerink COVID-19 Research Round-Up 1.29.21</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">MRK=US / BSX=US / CSII=US / LLY=US / PFE=US / ABT=US / TMO=US / MDT=US / A=US / GILD=US / SAN=FR / GSK=GB / BAX=US / AZN=US / GSK=US / JNJ=US / HUM=US / CVS=US / HOLX=US / ABMD=US / ALC=US / ATRC=US / BDX=US / EW=US / EXAS=US / ILMN=US / INSM=US / ICPT=US / ISRG=US / HOOK=US / REGN=US / RGEN=US / SIEN=US / TECH=US / TFX=US / ALGN=US / PRVB=US / MREO=US / SNY=US / BRKR=US / MOH=US / ACRS=US / MRNA=US / DXCM=US / CYRX=US / CHNG=US / EQ=US / QTRX=US / PODD=US / TNDM=US / IFRX=US / FULC=US / NEO=US / CTSO=US / PCRX=US / SRPT=US / FATE=US / VCYT=US / KPTI=US / TBPH=US / TTOO=US / AUPH=US / GNFT=US / VCEL=US / NVRO=US / BGNE=US / GH=US / TWST=US / AXNX=US / IMUX=US / BNTX=US / IPHA=US / ETNB=US / CNTG=US / ONEM=US / MOLN=DE / GLTO=US / ABCL=US</td><td class="leftalignment">Merck & Co Inc / Boston Scientific Corp / Cardiovascular Systems Inc / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Thermo Fisher Scientific Inc / Medtronic PLC / Agilent Technologies Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Baxter International Inc / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Humana Inc / CVS Health Corp / Hologic Inc / ABIOMED Inc / Alcon AG / AtriCure Inc / Becton Dickinson and Co / Edwards Lifesciences Corp / Exact Sciences Corp / Illumina Inc / Insmed Inc / Intercept Pharmaceuticals Inc / Intuitive Surgical Inc / HOOKIPA Pharma Inc / Regeneron Pharmaceuticals Inc / Repligen Corp / Sientra Inc / Bio-Techne Corp / Teleflex Inc / Align Technology Inc / Provention Bio Inc / Mereo Biopharma Group PLC / Sanofi SA / Bruker Corp / Molina Healthcare Inc / Aclaris Therapeutics Inc / Moderna Inc / Dexcom Inc / Cryoport Inc / Change Healthcare Inc / Equillium Inc / Quanterix Corp / Insulet Corp / Tandem Diabetes Care Inc / InflaRx NV / Fulcrum Therapeutics Inc / Neogenomics Inc / Cytosorbents Corp / Pacira Biosciences Inc / Sarepta Therapeutics Inc / Fate Therapeutics Inc / Veracyte Inc / Karyopharm Therapeutics Inc / Theravance Biopharma Inc / T2 Biosystems Inc / Aurinia Pharmaceuticals Inc / Genfit SA / Vericel Corp / Nevro Corp / Beigene Ltd / Guardant Health Inc / Twist Bioscience Corp / Axonics Inc / Immunic Inc / BioNTech SE / Innate Pharma SA / 89Bio Inc / Centogene NV / 1Life Healthcare Inc / Molecular Partners AG / Galecto Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Germany / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">ARNA / MRNS / 45337C10 / 09058V10 / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 29604W108 / 462260100 / 558868105 / 12648L601 / 89532E109 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 22053A107 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / G637AM102 / 007002108 / N71542109 / 206022105 / 72942A107</td><td class="leftalignment">Arena Pharmaceuticals Inc / Marinus Pharmaceuticals Inc / Incyte Corp / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Trevena Inc / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Cortexyme Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / Myovant Sciences Ltd / Adicet Bio Inc / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / PLx Pharma Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Workhorse Vaccine For The Pandemic</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">JNJ / PFE / NVAX.O</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc / Novavax Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung / Wayne Wu</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Jan 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">TPTX (BUY) - Interim Repotrectinib Update Reinforces Its Best-In-Class Profile in Front-Line ROS1 NSCLC</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">BJXBP30 / 2684703 / BD9GVY0</td><td class="leftalignment">Turning Point Therapeutics Inc / Pfizer Inc / Zai Lab Ltd</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">JNJ COVID-19 vaccine results disappoint but there are some important (positive) aspects to it; our initial take and positive read to PFE/others</td><td class="leftalignment">English</td><td class="rightalignment">1</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">ABT-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">ABT / BMY / JNJ / MDT / NVS / PFE / GSK / AZN.O / HOLX.O</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Medtronic PLC / Novartis AG / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Hologic Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / Turkey / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">NVS-US Company reports financial results for the quarter ended December 31,2020.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">NVS / ABT / BMY / JNJ / MRK / PFE / GSK / AZN.O / BAYRY.PK / TEVA.K / SNY.O</td><td class="leftalignment">Novartis AG / Abbott Laboratories / Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / GlaxoSmithKline PLC / AstraZeneca PLC / Bayer AG / Teva Pharmaceutical Industries Ltd / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / France / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">CapitalCube</td><td class="leftalignment">JNJ-US Company reports financial results for the quarter ended January 03,2021.</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ / ABT / LLY / MDT / MRK / NVS / PFE / SYK / GILD.O / GSK / SNY.O</td><td class="leftalignment">Johnson & Johnson / Abbott Laboratories / Eli Lilly and Co / Medtronic PLC / Merck & Co Inc / Novartis AG / Pfizer Inc / Stryker Corp / Gilead Sciences Inc / GlaxoSmithKline PLC / Sanofi SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / France / United Kingdom / Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">AnalytixInsight</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / BMY=US / TEVA=US / GILD=US / SAN=FR / NVS=US / GSK=GB / AZN=US / GSK=US / JNJ=US / EXEL=US / ICPT=US / NVO=US / REGN=US / RHHBY=US / INVA=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / Novartis AG / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Exelixis Inc / Intercept Pharmaceuticals Inc / Novo Nordisk A/S / Regeneron Pharmaceuticals Inc / Roche Holding AG / Innoviva Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">GALP.LS / AKZO.AS / CBKG.DE / ERICb.ST / PFE.N / SAN.MC / VOD.L / AZN.L / SASY.PA / BBVA.MC / US20030N1019 / CABK.MC</td><td class="leftalignment">Galp Energia SGPS SA / Akzo Nobel NV / Commerzbank AG / Telefonaktiebolaget LM Ericsson / Pfizer Inc / Banco Santander SA / Vodafone Group PLC / AstraZeneca PLC / Sanofi SA / Banco Bilbao Vizcaya Argentaria SA / Comcast Corp / Caixabank SA</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Spain / France / United Kingdom / Italy / Netherlands / Portugal / Russian Federation / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Shipping & Shipbuilding / Technology / Telecommunications / Tire & Rubber / Transportation / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr Christian Aust / Sergey Bolshakov / Herr Sven Kreitmair, CFA / Herr Jonathan Schroer / Herr Gianfranco Arcovito / Frau Silke Stegemann / Frau. Jana Schuler / Herr Tobias Keller / Herr. Michael Teig / Holger Kapitza</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">NVAX Trial Results - There's Some Good News and Then Some Very Bad News</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">NVAX.OQ / PFE=US / SAN=FR / GSK=GB / AZN=US / JNJ=US / NVAX=US / MRNA=US / BNTX=US</td><td class="leftalignment">Novavax Inc / Pfizer Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / Johnson & Johnson / Novavax Inc / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / France / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">V / 2023607 / 2002305 / 2003698 / 2050832 / 2026242 / 2542049 / 2670519 / 2645409 / 2684703 / 2048804 / 2440637 / 2138158 / 2900335 / 2980906 / B121557 / 2212922 / B2R3PV1 / B5B1S13 / 2949758 / B3SWPT2 / B7TL820 / B7VD3F2 / B8CKK03 / BBPK0J0 / B95N910 / BDZCRX3 / BFLR866 / BYY8XK8 / BYVY8G0 / BYW36M8 / BZ8VJQ8 / BKTNTR9 / BMH0MR7 / BYTJZL1 / 021513106</td><td class="leftalignment">Visa Inc / Amgen Inc / Abbott Laboratories / ABIOMED Inc / Ameren Corp / American Electric Power Company Inc / Dominion Energy Inc / Exelon Corp / NiSource Inc / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / Sempra Energy / Tractor Supply Co / Foot Locker Inc / Mastercard Inc / NRG Energy Inc / American Water Works Company Inc / Dollar General Corp / Nexstar Media Group Inc / Ameresco Inc / Meta Platforms Inc / Duke Energy Corp / Mondelez International Inc / Mirati Therapeutics Inc / PTC Inc / RingCentral Inc / Twitter Inc / WEC Energy Group Inc / Alphabet Inc / PayPal Holdings Inc / Vistra Corp / ViacomCBS Inc / Zendesk Inc / Zogenix Inc / Alto Ingredients Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology - Evan's Weekly Dose of Targeted Therapy & Video Update- 4Q20 Earnings Preview Edition</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">ACRX.OQ / AMGN.OQ / 4523.T / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / GSK.L / REGN.OQ / STSA.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / BAYGN.DE / ABBV.N / MRTX.OQ / MGNX.OQ / GRTX.OQ</td><td class="leftalignment">AcelRx Pharmaceuticals Inc / Amgen Inc / Eisai Co Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Satsuma Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Bayer AG / Abbvie Inc / Mirati Therapeutics Inc / MacroGenics Inc / Galera Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Switzerland / Germany / France / United Kingdom / Japan / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Ms. Judah C. Frommer / Jonathan Woo / Yunhee Park</td></tr>
<tr class="odd"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 29, 2021</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">BA.N / BMY.N / BSX.N / CI.N / EL.N / LLY.N / MRK.N / PFE.N / PM.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / ITW.N / XOM.N / LIN.N / V.N / ARE.N / CVX.N / AMGN.OQ / REGN.OQ / TT.N / QCOM.OQ / AMZN.OQ / CHTR.OQ / EXPE.OQ / VRTX.OQ / CMCSA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / TMUS.OQ / BKNG.OQ / OTIS.N</td><td class="leftalignment">Boeing Co / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Estee Lauder Companies Inc / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Illinois Tool Works Inc / Exxon Mobil Corp / Linde PLC / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Regeneron Pharmaceuticals Inc / Trane Technologies PLC / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Expedia Group Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / T-Mobile US Inc / Booking Holdings Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Ireland / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Jonathan N. Golub, CFA / Mr. Manish G. Bangard / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/29/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">The long and short of it: APAC ESG Digest: Renewables rush, tailings, Big Tech regulation, China anti-trust</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">7201.T / AIRP.PA / BANPU.BK / BMWG.DE / CBA.AX / CSL.AX / HSBA.L / KPJH.KL / NAB.AX / PFE.N / PTT.BK / RELI.BO / TOTF.PA / VOWG.DE / WBC.AX / WOW.AX / WPL.AX / AZN.L / ILU.AX / GS.N / 0241.HK / BLK.N / IVN.TO / TPGC.KL / 1211.HK / NIO.N / AMZN.OQ / 051910.KS / LYC.AX / KRIB.KL / NESN.S / 0700.HK / LUN.TO / RDSA.L / SGM.AX / MQG.AX / HTHB.KL / VRSK.OQ / TSLA.OQ / 002594.SZ / IHHH.KL / GOOGL.OQ / TDOC.N / 300750.SZ / DQ.ZY / LI.OQ / XPEV.N</td><td class="leftalignment">Nissan Motor Co Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Banpu PCL / Bayerische Motoren Werke AG / Commonwealth Bank of Australia / CSL Ltd / HSBC Holdings PLC / KPJ Healthcare Bhd / National Australia Bank Ltd / Pfizer Inc / PTT PCL / Reliance Industries Ltd / TotalEnergies SE / Volkswagen AG / Westpac Banking Corp / Woolworths Group Ltd / Woodside Petroleum Ltd / AstraZeneca PLC / Iluka Resources Ltd / Goldman Sachs Group Inc / Alibaba Health Information Technology Ltd / BlackRock Inc / Ivanhoe Mines Ltd / Top Glove Corporation Bhd / BYD Co Ltd / NIO Inc / Amazon.com Inc / LG Chem Ltd / Lynas Rare Earths Ltd / Kossan Rubber Industries Bhd / Nestle SA / Tencent Holdings Ltd / Lundin Mining Corp / Royal Dutch Shell PLC / Sims Ltd / Macquarie Group Ltd / Hartalega Holdings Bhd / Verisk Analytics Inc / Tesla Inc / BYD Co Ltd / IHH Healthcare Bhd / Alphabet Inc / Teladoc Health Inc / Contemporary Amperex Technology Co Ltd / Daqo New Energy Corp / Li Auto Inc / Xpeng Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Bermuda / Canada / Switzerland / China / Cayman Islands / Germany / France / United Kingdom / India / Japan / Korea, Republic of / Malaysia / Thailand / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Phineas Glover</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Model Updated In Advance Of Q4 Results</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">CACI=US / PEP=US / PFE=US / AMGN=US / BMY=US / KO=US / AMD=US / CL=US / T=US / PEB=US / SLG=US / PLUG=US / H=US / MTN=US / VZ=US / SYK=US / CCI=US / ENR=US / PB=US / SWN=US / XLNX=US / BRO=US / MAR=US / LSTR=US / HLT=US / NWL=US / RCL=US / FLO=US / APH=US / ARW=US / AVT=US / CCL=US / CENT=US / CHH=US / CHD=US / DRH=US / EPC=US / EXAS=US / AJG=US / HAIN=US / NOW=US / MNRO=US / REGN=US / SMG=US / POST=US / R=US / FB=US / FBK=US / MKL=US / DRE=US / SBSI=US / NTRA=US / MGPI=US / MNST=US / JRVR=US / NOMD=US / STRO=US / SHO=US / FRPT=US / THS=US / HST=US / XPO=US / ELF=US / SAIA=US / TEL=US / NMTR=US / WH=US / NXGN=US / WYND=US / ATSG=US / NEO=US / AAN=US / KNSL=US / HGV=US / NXPI=US / RLJ=US / VAC=US / BCEI=US / RHP=US / ABBV=US / NCLH=US / VCYT=US / ARCB=US / LOB=US / WLTW=US / PK=US / PLYA=US / PETQ=US / KDP=US / HARP=US / PLMR=US / PSNL=US / BRBR=US / REYN=US / HYFM=US</td><td class="leftalignment">CACI International Inc / PepsiCo Inc / Pfizer Inc / Amgen Inc / Bristol-Myers Squibb Co / Coca-Cola Co / Advanced Micro Devices Inc / Colgate-Palmolive Co / AT&T Inc / Pebblebrook Hotel Trust / SL Green Realty Corp / Plug Power Inc / Hyatt Hotels Corp / Vail Resorts Inc / Verizon Communications Inc / Stryker Corp / Crown Castle International Corp / Energizer Holdings Inc / Prosperity Bancshares Inc / Southwestern Energy Co / Xilinx Inc / Brown & Brown Inc / Marriott International Inc / Landstar System Inc / Hilton Worldwide Holdings Inc / Newell Brands Inc / Royal Caribbean Cruises Ltd / Flowers Foods Inc / Amphenol Corp / Arrow Electronics Inc / Avnet Inc / Carnival Corp / Central Garden & Pet Co / Choice Hotels International Inc / Church & Dwight Co Inc / Diamondrock Hospitality Co / Edgewell Personal Care Co / Exact Sciences Corp / Arthur J Gallagher & Co / Hain Celestial Group Inc / ServiceNow Inc / Monro Inc / Regeneron Pharmaceuticals Inc / Scotts Miracle-Gro Co / Post Holdings Inc / Ryder System Inc / Meta Platforms Inc / FB Financial Corp / Markel Corp / Duke Realty Corp / Southside Bancshares Inc / Natera Inc / MGP Ingredients Inc / Monster Beverage Corp / James River Group Holdings Ltd / Nomad Foods Ltd / Sutro Biopharma Inc / Sunstone Hotel Investors Inc / Freshpet Inc / TreeHouse Foods Inc / Host Hotels & Resorts Inc / XPO Logistics Inc / elf Beauty Inc / Saia Inc / TE Connectivity Ltd / 9 Meters Biopharma Inc / Wyndham Hotels & Resorts Inc / NextGen Healthcare Inc / Travel + Leisure Co / Air Transport Services Group Inc / Neogenomics Inc / Aaron's Company Inc / Kinsale Capital Group Inc / Hilton Grand Vacations Inc / NXP Semiconductors NV / RLJ Lodging Trust / Marriott Vacations Worldwide Corp / Civitas Resources Inc / Ryman Hospitality Properties Inc / Abbvie Inc / Norwegian Cruise Line Holdings Ltd / Veracyte Inc / ArcBest Corp / Live Oak Bancshares Inc / Willis Towers Watson PLC / Park Hotels & Resorts Inc / Playa Hotels & Resorts NV / PetIQ Inc / Keurig Dr Pepper Inc / Harpoon Therapeutics Inc / Palomar Holdings Inc / Personalis Inc / Bellring Brands Inc / Reynolds Consumer Products Inc / Hydrofarm Holdings Group Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Switzerland / Ireland / Liberia / Luxembourg / Netherlands / Panama / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Africa / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Pulse Call: 10 Insights from REGN Infectious Diseases Guru About COVID Variants</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">REGN=US / PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Regeneron Pharmaceuticals Inc / Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">ACIP Highlights: mRNA Vaccines Maintain Safety Profile, Adeno Efficacy Up Next</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE=US / AZN=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United Kingdom / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Major Pharma : 4Q Earnings Preview – 2021 Shaping Up To Be A Solid Year For The Group</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">ABBV.N / BMY.N / MRK.N / PFE.N</td><td class="leftalignment">Abbvie Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">AXP / 2259101 / 2000019 / 2023607 / 2002305 / 2026242 / 2216850 / 2542049 / 2567116 / 2328915 / 2600088 / 2680905 / 2684703 / 2048804 / 2440637 / 2862532 / 2138158 / 2853688 / 2928683 / B121557 / 2769796 / 2713317 / B2R3PV1 / B614LY3 / B7TL820 / B7VD3F2 / B95N910 / BVVN4Q8 / BYY8XK8 / BNGY4Q0 / BLGJ610 / BFMXGR0 / BYXJQG9 / BHRWS81 / BYQHPK7 / BZ1LFG7</td><td class="leftalignment">American Express Co / Target Corp / Amazon.com Inc / Amgen Inc / Abbott Laboratories / American Electric Power Company Inc / Consolidated Edison Inc / Dominion Energy Inc / Edwards Lifesciences Corp / Nextera Energy Inc / Monro Inc / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / CenterPoint Energy Inc / E W Scripps Co / Sempra Energy / Stryker Corp / VF Corp / Mastercard Inc / Fidelity National Information Services Inc / ACADIA Pharmaceuticals Inc / American Water Works Company Inc / Cielo SA / Meta Platforms Inc / Duke Energy Corp / PTC Inc / Eversource Energy / WEC Energy Group Inc / Nextera Energy Partners LP / Warner Music Group Corp / Evergy Inc / Spire Inc / Levi Strauss & Co / Zymeworks Inc / Roku Inc</td><td class="leftalignment"></td><td class="leftalignment">Brazil / Canada / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">More Data on Potential Impact of SARS-COV-2 Variants on BNT162b2 Protection</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">BNTX=US / PFE=US / MRNA=US</td><td class="leftalignment">BioNTech SE / Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">CCK.N / CP.TO / FGP.L / LRCX.O / NCM.AX / NEX.L / NSC.N / PB.N / PFE.N / T.N / CMCSA.O / AAPL.O / FER.MC / CLS.N / DIS.N / DISH.O / CSX.N / GIBa.TO / BLL.N / VZ.N / VFC.N / APH.N / CHTR.O / SLGN.O / TEL.N / MEOH.O / RLI.N / VIAC.O / EDF.PA / DISCA.O / CVLT.O / 3IN.L / AGNC.O / AMCX.O / BERY.N / NYCB.N / ABBV.N / TSLA.N / UKWG.L / FOXA.OQ / 81762P102 / PTC.O / CIA.TO / GWB.N / ANTM.N / CRBP.OQ / IONS.O / LGFB.N / GREG.MC / WOW.N / ATUS.N / EHC.N / NTGY.MC / NXGN.O / TLMD.OQ</td><td class="leftalignment">Crown Holdings Inc / Canadian Pacific Railway Ltd / FirstGroup PLC / Lam Research Corp / Newcrest Mining Ltd / National Express Group PLC / Norfolk Southern Corp / Prosperity Bancshares Inc / Pfizer Inc / AT&T Inc / Comcast Corp / Apple Inc / Ferrovial SA / Celestica Inc / Walt Disney Co / DISH Network Corp / CSX Corp / CGI Inc / Ball Corp / Verizon Communications Inc / VF Corp / Amphenol Corp / Charter Communications Inc / Silgan Holdings Inc / TE Connectivity Ltd / Methanex Corp / Rli Corp / ViacomCBS Inc / Electricite de France SA / Discovery Inc / Commvault Systems Inc / 3I Infrastructure PLC / AGNC Investment Corp / AMC Networks Inc / Berry Global Group Inc / New York Community Bancorp Inc / Abbvie Inc / Tesla Inc / Greencoat UK Wind PLC / Fox Corp / ServiceNow Inc / PTC Inc / Champion Iron Ltd / Great Western Bancorp Inc / Anthem Inc / Corbus Pharmaceuticals Holdings Inc / Ionis Pharmaceuticals Inc / Lions Gate Entertainment Corp / Grenergy Renovables SA / WideOpenWest Inc / Altice USA Inc / Encompass Health Corp / Naturgy Energy Group SA / NextGen Healthcare Inc / Soc Telemed Inc</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / Switzerland / Spain / France / United Kingdom / Luxembourg / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">ABBV/PFE: Atopic derm deep dive and new survey</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">PFE.N / ABBV.N</td><td class="leftalignment">Pfizer Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: Sumitomo Dainippon Pharma - 3Q FY3/21 results: Substantially ahead in 3Q, but guidance revisions pending events in 4Q</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 28, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BMY.N / BSX.N / CI.N / LLY.N / MRK.N / PFE.N / PM.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / QCOM.OQ / GILD.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / CMCSA.OQ / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Bristol-Myers Squibb Co / Boston Scientific Corp / Cigna Corp / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Philip Morris International Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Qualcomm Inc / Gilead Sciences Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Comcast Corp / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">4506.T: 大日本住友製薬 - 3Q決算：3Q大幅過達だが4Qイベントを理由に業績修正を見送る</td><td class="leftalignment">Japanese</td><td class="rightalignment">6</td><td class="leftalignment">4506.T / PFE.N</td><td class="leftalignment">Sumitomo Dainippon Pharma Co Ltd / Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccinations of seniors to start from 1 April at the earliest</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">01/28/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナウイルス：高齢者のワクチン接種は最短でも4月1日以降に</td><td class="leftalignment">Japanese</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">01/28/2021</td><td class="leftalignment">The Business Research Company</td><td class="leftalignment">Pfizer Inc. (Pfizer) Company Briefing</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America / Global</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Department of Research</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Pharma : PFE/ABBV: Quick Thoughts on Xeljanz Safety Study Update</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">PFE.N / ABBV.N</td><td class="leftalignment">Pfizer Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Christopher T. Schott, CFA / Christopher Neyor / Xiling Chen / Ms. Ekaterina V. Knyazkova</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">MACE And Malignancy Risk In Xeljanz CV Safety Study A Risk For JAK Class</td><td class="leftalignment">English</td><td class="rightalignment">5</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Updating PFE Model to Present Continuing Ops Ex-Upjohn; Q4 EPS Estimate $0.54</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Bristol Myers Squibb Stock Can Offer Better Returns Over Eli Lilly</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">BMY.N / JNJ.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Bristol-Myers Squibb Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Sanofi To Help Manufacture BioNTech's BNT162b2. Collaboration With TBIO Still Intact</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Joon Lee, MD / Les Sulewski</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">ACE.MI / SEVI.PA / ALV.N / BP.L / ENI.MI / KPN.AS / LVMH.PA / OMVV.VI / PFE.N / REP.MC / TOTF.PA / SASY.PA / US64110L1061 / LXSG.DE / RDSa.L / SY1G.DE / SKG.I / HLAG.DE</td><td class="leftalignment">Acea SpA / Suez SA / Autoliv Inc / BP PLC / Eni SpA / Koninklijke KPN NV / LVMH Moet Hennessy Louis Vuitton SE / OMV AG / Pfizer Inc / Repsol SA / TotalEnergies SE / Sanofi SA / Netflix Inc / Lanxess AG / Royal Dutch Shell PLC / Symrise AG / Smurfit Kappa Group PLC / Hapag Lloyd AG</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Austria / Switzerland / Germany / Spain / France / United Kingdom / Ireland / Italy / Netherlands / Sweden / United States</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Services / Shipping & Shipbuilding / Telecommunications / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Herr Christian Aust / Herr Sven Kreitmair, CFA / Herr Jonathan Schroer / Herr Gianfranco Arcovito / Frau Silke Stegemann / Frau. Jana Schuler / Herr Tobias Keller</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">KOLs' Views of Emerging SARS-CoV-2 Strains: Regulatory & Clinical Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">PFE=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">FISV=US / PFE=US / AMGN=US / INTC=US / ADI=US / AMD=US / BXP=US / PLD=US / T=US / DVN=US / INCY=US / TXN=US / TEVA=US / AMT=US / NVDA=US / EOG=US / BC=US / PLUG=US / H=US / VZ=US / WLL=US / CHKP=US / CCI=US / MGY=US / XLNX=US / BRO=US / MRO=US / DISH=US / DHI=US / ENDP=US / HXL=US / HZO=US / PACW=US / PRGO=US / PII=US / REGN=US / SBAC=US / ST=US / BXS=US / NET=US / GPN=US / FMBI=US / SNV=US / LCI=US / MKL=US / RPD=US / BIIB=US / FIS=US / TEL=US / AMRX=US / CLR=US / EHC=US / NOG=US / SWI=US / NXPI=US / PCRX=US / VAC=US / PANW=US / FANG=US / ABBV=US / TMUS=US / PTCT=US / FEYE=US / MBUU=US / VRNS=US / AJRD=US / MCFT=US / EVRI=US / ZS=US / OKTA=US / SAIL=US / BHC=US / TENB=US / PLMR=US / CRWD=US / ONEW=US / VTRS=US / 100073616</td><td class="leftalignment">Fiserv Inc / Pfizer Inc / Amgen Inc / Intel Corp / Analog Devices Inc / Advanced Micro Devices Inc / Boston Properties Inc / Prologis Inc / AT&T Inc / Devon Energy Corp / Incyte Corp / Texas Instruments Inc / Teva Pharmaceutical Industries Ltd / American Tower Corp / NVIDIA Corp / EOG Resources Inc / Brunswick Corp / Plug Power Inc / Hyatt Hotels Corp / Verizon Communications Inc / Whiting Petroleum Corp / Check Point Software Technologies Ltd / Crown Castle International Corp / Magnolia Oil & Gas Corp / Xilinx Inc / Brown & Brown Inc / Marathon Oil Corp / DISH Network Corp / D R Horton Inc / Endo International PLC / Hexcel Corp / MarineMax Inc / PacWest Bancorp / Perrigo Company PLC / Polaris Inc / Regeneron Pharmaceuticals Inc / SBA Communications Corp / Sensata Technologies Holding PLC / Cadence Bank / Cloudflare Inc / Global Payments Inc / First Midwest Bancorp Inc / Synovus Financial Corp / Lannett Company Inc / Markel Corp / Rapid7 Inc / Biogen Inc / Fidelity National Information Services Inc / TE Connectivity Ltd / Amneal Pharmaceuticals Inc / Continental Resources Inc / Encompass Health Corp / Northern Oil and Gas Inc / SolarWinds Corp / NXP Semiconductors NV / Pacira Biosciences Inc / Marriott Vacations Worldwide Corp / Palo Alto Networks Inc / Diamondback Energy Inc / Abbvie Inc / T-Mobile US Inc / PTC Therapeutics Inc / Mandiant Inc / Malibu Boats Inc / Varonis Systems Inc / Aerojet Rocketdyne Holdings Inc / Mastercraft Boat Holdings Inc / Everi Holdings Inc / Zscaler Inc / Okta Inc / SailPoint Technologies Holdings Inc / Bausch Health Companies Inc / Tenable Holdings Inc / Palomar Holdings Inc / CrowdStrike Holdings Inc / OneWater Marine Inc / Viatris Inc / Kimco Realty Corp</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">20</td><td class="leftalignment">AXP / V / 5671735 / 0989529 / 2126335 / 2516152 / 2270726 / 2542049 / 2829515 / 2382892 / 2670519 / 2328915 / 2459020 / 2689560 / 2680905 / 2684703 / 2048804 / 2730190 / 2862532 / 2138158 / 2503529 / 4595739 / 5531000 / 7103065 / B121557 / B2R3PV1 / B7TL820 / BCBVTX1 / B7VD3F2 / BFLR866 / B76LYJ2 / BTN1Y44 / BYY8XK8 / BNGY4Q0 / BF5L3T2 / BYNZGK1 / BFZ1K46 / BJJMGL2 / BYXJQG9 / BKTNTR9 / BKLCX50</td><td class="leftalignment">American Express Co / Visa Inc / Sanofi SA / AstraZeneca PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Walt Disney Co / Dominion Energy Inc / Edison International / Audacy Inc / Exelon Corp / Nextera Energy Inc / Intuit Inc / PG&E Corp / PPL Corp / Pfizer Inc / Pinnacle West Capital Corp / Regeneron Pharmaceuticals Inc / E W Scripps Co / Sempra Energy / World Wrestling Entertainment Inc / Genmab A/S / MorphoSys AG / Novartis AG / Mastercard Inc / American Water Works Company Inc / Meta Platforms Inc / Agios Pharmaceuticals Inc / Duke Energy Corp / Twitter Inc / Vocera Communications Inc / Walgreens Boots Alliance Inc / WEC Energy Group Inc / Nextera Energy Partners LP / Elanco Animal Health Inc / Block Inc / Spotify Technology SA / Fox Corp / Spire Inc / ViacomCBS Inc / Health Catalyst Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Luxembourg / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">India Healthcare Sector: Digital health in India: Who benefits and who gets impacted?</td><td class="leftalignment">English</td><td class="rightalignment">58</td><td class="leftalignment">APLH.NS / METP.BO / AIG.N / AXAF.PA / HDBK.BO / MRK.N / PFE.N / RELI.BO / SASY.PA / TORP.BO / 0241.HK / AMZN.OQ / 2318.HK / 601318.SS / JD.OQ / BABA.N / TDOC.N / 9988.HK / TACN.BO / 9618.HK / AMWL.N</td><td class="leftalignment">Apollo Hospitals Enterprise Ltd / Metropolis Healthcare Ltd / American International Group Inc / AXA SA / HDFC Bank Ltd / Merck & Co Inc / Pfizer Inc / Reliance Industries Ltd / Sanofi SA / Torrent Pharmaceuticals Ltd / Alibaba Health Information Technology Ltd / Amazon.com Inc / Ping An Insurance Group Co of China Ltd / Ping An Insurance Group Co of China Ltd / JD.Com Inc / Alibaba Group Holding Ltd / Teladoc Health Inc / Alibaba Group Holding Ltd / Tata Consumer Products Ltd / JD.Com Inc / American Well Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Bermuda / China / Cayman Islands / France / India / United States</td><td class="leftalignment">Consumer / Leisure & Entertainment / Lodging & Restaurants</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Mr. Anubhav Aggarwal / Sayantan Maji</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Earnings Brief: January 27, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">ABT.N / BSX.N / JNJ.N / LLY.N / PFE.N / T.N / TMO.N / HUM.N / DHR.N / CAT.N / MCD.N / HON.N / XOM.N / VZ.N / V.N / ARE.N / CVX.N / AMGN.OQ / AAPL.OQ / MSFT.OQ / QCOM.OQ / AMZN.OQ / CHTR.OQ / VRTX.OQ / TXN.OQ / CMCSA.OQ / NEE.N / TSLA.OQ / EA.OQ / MDLZ.OQ / ABBV.N / GOOGL.OQ / PYPL.OQ / FB.PS / OTIS.N</td><td class="leftalignment">Abbott Laboratories / Boston Scientific Corp / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AT&T Inc / Thermo Fisher Scientific Inc / Humana Inc / Danaher Corp / Caterpillar Inc / McDonald's Corp / Honeywell International Inc / Exxon Mobil Corp / Verizon Communications Inc / Visa Inc / Alexandria Real Estate Equities Inc / Chevron Corp / Amgen Inc / Apple Inc / Microsoft Corp / Qualcomm Inc / Amazon.com Inc / Charter Communications Inc / Vertex Pharmaceuticals Inc / Texas Instruments Inc / Comcast Corp / Nextera Energy Inc / Tesla Inc / Electronic Arts Inc / Mondelez International Inc / Abbvie Inc / Alphabet Inc / PayPal Holdings Inc / San Miguel Food and Beverage Inc / Otis Worldwide Corp</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Philippines / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Investment Strategy / Equity</td><td class="leftalignment">Mr. Manish G. Bangard / Mr. Jonathan N. Golub, CFA / Chandni Chellappa / Katherine Zhou</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">U.S. Biotechnology 4Q20 Preview: More of the same? Large Cap lethargy, SMid-Cap enthusiasm, against the continuing pandemic backdrop</td><td class="leftalignment">English</td><td class="rightalignment">72</td><td class="leftalignment">AMGN.OQ / GILD.OQ / BMY.N / LLY.N / PFE.N / REGN.OQ / RARE.OQ / INCY.OQ / NBIX.OQ / ICPT.OQ / UTHR.OQ / BMRN.OQ / INSM.OQ / ARNA.OQ / ESPR.OQ / VRTX.OQ / BIIB.OQ / CRTX.OQ / GLPG.AS / IRWD.OQ / SRPT.OQ / ABBV.N / PTCT.OQ / RNA.OQ / QURE.OQ / FLXN.OQ / ASND.OQ / ANAB.OQ / APLS.OQ / KURA.OQ / NTLA.OQ / ARGX.OQ / IFRX.OQ / SRRK.OQ / CYCN.OQ / ISEE.OQ / STOK.OQ / INBX.OQ / IMVT.OQ / FMTX.OQ / ALXO.OQ / CVAC.OQ / SPRB.OQ / GLTO.OQ / BCAB.OQ / ABCL.OQ</td><td class="leftalignment">Amgen Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Pfizer Inc / Regeneron Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / Incyte Corp / Neurocrine Biosciences Inc / Intercept Pharmaceuticals Inc / United Therapeutics Corp / Biomarin Pharmaceutical Inc / Insmed Inc / Arena Pharmaceuticals Inc / Esperion Therapeutics Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Cortexyme Inc / Galapagos NV / Ironwood Pharmaceuticals Inc / Sarepta Therapeutics Inc / Abbvie Inc / PTC Therapeutics Inc / Avidity Biosciences Inc / Uniqure NV / Pacira Biosciences Inc / Ascendis Pharma A/S / AnaptysBio Inc / Apellis Pharmaceuticals Inc / Kura Oncology Inc / Intellia Therapeutics Inc / argenx SE / InflaRx NV / Scholar Rock Holding Corp / Cyclerion Therapeutics Inc / Iveric Bio Inc / Stoke Therapeutics Inc / Inhibrx Inc / Immunovant Inc / Forma Therapeutics Holdings Inc / ALX Oncology Holdings Inc / CureVac NV / Spruce Biosciences Inc / Galecto Inc / Bioatla Inc / Abcellera Biologics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Denmark / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Evan D. Seigerman / Dr. Martin Auster, M.D. / Ms. Judah C. Frommer / Mr. Tiago Fauth / Mark Connolly / Jonathan Woo / Yunhee Park / Mr. Thomas Deal / Matthew Terwelp / Roger Xu</td></tr>
<tr class="even"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Retailing sector: COVID-19: Vaccinations from end-February, seniors from late March</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="odd"><td class="leftalignment">01/27/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">小売りセクター: 新型コロナウイルス：ワクチン接種は2月末からスタート、高齢者は3月下旬から</td><td class="leftalignment">Japanese</td><td class="rightalignment">5</td><td class="leftalignment">PFE.N / AZN.L / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / AstraZeneca PLC / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Japan / United States</td><td class="leftalignment">Consumer / Retailing</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Takahiro Kazahaya / Koki Yamada</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">PriceTarget Research</td><td class="leftalignment">Pfizer Inc Investment Status Report</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">US7170811035</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">EARNINGS/FINANCIAL STATEMENTS</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">John Lafferty</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">MRK.N / PFE.N / GILD.OQ / AMRN.OQ / EHTH.OQ / OMER.OQ / EVGN.TA / AUP.TO / AKTX.OQ / APLS.OQ / IAN.CD / GTII.CD / MMEN.CD / CURA.CD / TRUL.CD / CL.CD / CCHW.NLB / PHGE.A / SLQT.N / GOCO.OQ / ACRGau.CD / 120346301</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Amarin Corporation PLC / eHealth Inc / Omeros Corp / Evogene Ltd / Aurinia Pharmaceuticals Inc / Akari Therapeutics PLC / Apellis Pharmaceuticals Inc / Ianthus Capital Holdings Inc / Green Thumb Industries Inc / Medmen Enterprises Inc / Curaleaf Holdings Inc / Trulieve Cannabis Corp / Cresco Labs Inc / Columbia Care Inc / Biomx Inc / SelectQuote Inc / Gohealth Inc / Acreage Holdings Inc / Ayr Wellness Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / United Kingdom / Israel / United States</td><td class="leftalignment"></td><td class="leftalignment">Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Access to Medicine Foundation</td><td class="leftalignment">2021 Access to Medicine Index (26 Jan 2021)</td><td class="leftalignment">English</td><td class="rightalignment">237</td><td class="leftalignment">4502.T / 4503.T / 4523.T / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOb.CO / NOVN.S / MRCG.DE / GSK.L / GILD.OQ / 4568.T / BAYGn.DE / ABBV.N</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Eisai Co Ltd / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Gilead Sciences Inc / Daiichi Sankyo Co Ltd / Bayer AG / Abbvie Inc</td><td class="leftalignment">INDUSTRY OVERVIEW</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / Japan / United States</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Team Index</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 15, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharma/generic read from NVS 4Q "kick-off" results</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">PFE.N / TEVA.N / ABBV.N</td><td class="leftalignment">Pfizer Inc / Teva Pharmaceutical Industries Ltd / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">China / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">UniCredit Research</td><td class="leftalignment">Daily Credit Briefing</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">IBE.MC / NLMK.MM / MRK.N / PFE.N / CONG.DE / AZN.L / TKAG.DE / DBKGn.DE / SAPG.DE / CHMF.RTS / EUFI.PA / IM00B7S9G985</td><td class="leftalignment">Iberdrola SA / Novolipetsk Steel PAO / Merck & Co Inc / Pfizer Inc / Continental AG / AstraZeneca PLC / thyssenkrupp AG / Deutsche Bank AG / SAP SE / Severstal' PAO / Eurofins Scientific SE / Playtech PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Spain / United Kingdom / Italy / Luxembourg / Russian Federation / Ukraine / United States / Isle of Man</td><td class="leftalignment">Advertising / Aerospace / Agriculture / Air Transportation / Apparel & Textiles / Appliances / Automotive / Banks / Beverages & Tobacco / Biotechnology / Broadcasting & Cable / Building & Building Materials / Chemicals / Communications / Conglomerates / Consumer / Containers & Packing / Cosmetics & Personal Care / Defense / Electrical / Electronics / Energy / Engineering & Construction / Environmental Services / Fertilizers / Financial Services / Food / Healthcare / Household Products / Industrial Materials / Info. Tech./Computers / Info. Tech./Peripheral / Info. Tech./Software / Insurance / Leisure & Entertainment / Lodging & Restaurants / Machinery / Media / Metals & Minerals / Office Equipment / Paper & Forest Products / Pharmaceuticals / Photography / Publishing / Railroads / Real Estate / Retailing / Semiconductors / Services / Shipping & Shipbuilding / Technology / Tire & Rubber / Transportation / Utilities / Oil & Gas / Internet / Marketing</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION / MORNING COMMENTS / CREDIT</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Herr. Ulrich Scholz, CFA / Sergey Bolshakov / Herr Christian Aust / Herr Sven Kreitmair, CFA / Herr Gianfranco Arcovito / Frau Silke Stegemann / Frau. Jana Schuler / Herr. Michael Teig / Holger Kapitza</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">"Fahrenheit 351" - COVID Vaccine Alarm Bells Go Off Again</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE=US / JNJ=US / MRNA=US / BNTX=US</td><td class="leftalignment">Pfizer Inc / Johnson & Johnson / Moderna Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Geoffrey Porges / Dr. Daina Graybosch, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Emerging Viral Strains Reopen Debates on Vaccine Efficacy & Endpoints</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">MRNA=US / PFE=US / BNTX=US</td><td class="leftalignment">Moderna Inc / Pfizer Inc / BioNTech SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Germany / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Dr. Daina Graybosch, PHD / Mr. Geoffrey Porges</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Truist Securities Daily Spotlight</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">BSX=US / PFE=US / HD=US / MCD=US / WEN=US / BLD=US / RUN=US / GILD=US / BC=US / LOW=US / IART=US / MUR=US / BRO=US / LEG=US / MANH=US / CBRL=US / ELY=US / FUN=US / KIDS=US / DRI=US / GFF=US / HAS=US / HXL=US / IBP=US / HZO=US / MAS=US / MAT=US / MHK=US / PII=US / REGN=US / SGMO=US / STRA=US / THO=US / WW=US / WGO=US / GOLF=US / OPT=US / BXS=US / FBK=US / NLS=US / DIN=US / MGPI=US / BIIB=US / TPX=US / EXP=US / FHN=US / BECN=US / PLAY=US / DENN=US / BLDR=US / GMS=US / SIBN=US / CMG=US / SIX=US / XPO=US / PGTI=US / SAIA=US / AWI=US / OC=US / CADE=US / TAST=US / QSR=US / PRPL=US / NMTR=US / SEAS=US / CWH=US / IAC=US / JACK=US / TREX=US / FBHS=US / TILE=US / NDLS=US / FOXF=US / MBUU=US / ARCB=US / LOCO=US / VCEL=US / NVRO=US / SHAK=US / WING=US / SPNE=US / TDOC=US / MCFT=US / ACBI=US / 82982L103 / JELD=US / FNKO=US / AXNX=US / KOD=US / FERGY=US / BRBR=US / ONEM=US / ONEW=US / AZEK=US / BALY=US</td><td class="leftalignment">Boston Scientific Corp / Pfizer Inc / Home Depot Inc / McDonald's Corp / Wendys Co / TopBuild Corp / Sunrun Inc / Gilead Sciences Inc / Brunswick Corp / Lowe's Companies Inc / Integra Lifesciences Holdings Corp / Murphy Oil Corp / Brown & Brown Inc / Leggett & Platt Inc / Manhattan Associates Inc / Cracker Barrel Old Country Store Inc / Callaway Golf Co / Cedar Fair LP / OrthoPediatrics Corp / Darden Restaurants Inc / Griffon Corp / Hasbro Inc / Hexcel Corp / Installed Building Products Inc / MarineMax Inc / Masco Corp / Mattel Inc / Mohawk Industries Inc / Polaris Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Strategic Education Inc / Thor Industries Inc / WW International Inc / Winnebago Industries Inc / Acushnet Holdings Corp / Opthea Ltd / Cadence Bank / FB Financial Corp / Nautilus Inc / Dine Brands Global Inc / MGP Ingredients Inc / Biogen Inc / Tempur Sealy International Inc / Eagle Materials Inc / First Horizon Corp / Beacon Roofing Supply Inc / Dave & Buster's Entertainment Inc / Denny's Corp / Builders FirstSource Inc / GMS Inc / SI-BONE Inc / Chipotle Mexican Grill Inc / Six Flags Entertainment Corp / XPO Logistics Inc / PGT Innovations Inc / Saia Inc / Armstrong World Industries Inc / Owens Corning / Cadence Bank / Carrols Restaurant Group Inc / Restaurant Brands International Inc / Purple Innovation Inc / 9 Meters Biopharma Inc / SeaWorld Entertainment Inc / Camping World Holdings Inc / IAC/Interactivecorp / Jack in the Box Inc / Trex Company Inc / Fortune Brands Home & Security Inc / Interface Inc / Noodles & Co / Fox Factory Holding Corp / Malibu Boats Inc / ArcBest Corp / El Pollo Loco Holdings Inc / Vericel Corp / Nevro Corp / Shake Shack Inc / Wingstop Inc / SeaSpine Holdings Corp / Teladoc Health Inc / Mastercraft Boat Holdings Inc / Atlantic Capital Bancshares Inc / SiteOne Landscape Supply Inc / JELD-WEN Holding Inc / Funko Inc / Axonics Inc / Kodiak Sciences Inc / Ferguson PLC / Bellring Brands Inc / 1Life Healthcare Inc / OneWater Marine Inc / Azek Company Inc / Bally's Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Canada / United Kingdom / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Malaysia Healthcare Sector: Riding through the waves</td><td class="leftalignment">English</td><td class="rightalignment">14</td><td class="leftalignment">IHHH.KL / TPGC.KL / KPJH.KL / PFE.N / AZN.L / KRIB.KL / HTHB.KL</td><td class="leftalignment">IHH Healthcare Bhd / Top Glove Corporation Bhd / KPJ Healthcare Bhd / Pfizer Inc / AstraZeneca PLC / Kossan Rubber Industries Bhd / Hartalega Holdings Bhd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Malaysia / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / INDUSTRY REPORTS / Equity</td><td class="leftalignment">Ms. Amanda Foo / Cik Joanna Cheah</td></tr>
<tr class="odd"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharma - Consumer survey suggests COVID-19 vaccine adoption, pandemic resolution will take time</td><td class="leftalignment">English</td><td class="rightalignment">21</td><td class="leftalignment">PFE=US / ZTS=US</td><td class="leftalignment">Pfizer Inc / Zoetis Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/26/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Consumer survey suggests COVID-19 vaccine adoption, pandemic resolution will take time</td><td class="leftalignment">English</td><td class="rightalignment">19</td><td class="leftalignment">PFE=US</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Microbiome Deep Dive: Key Players, Themes and Events for 2021</td><td class="leftalignment">English</td><td class="rightalignment">87</td><td class="leftalignment">EVGN.O / PHGE.K / MRK / PFE / GILD.O</td><td class="leftalignment">Evogene Ltd / Biomx Inc / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Johnson & Johnson's Vaccine Updates: When Will The Shot Be Available For Use?</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / PFE.N</td><td class="leftalignment">Johnson & Johnson / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Stock Traders Daily Research</td><td class="leftalignment">Comprehensive Technical and Fundamental Analysis for PFE.  This reports includes The Investment Rate, a macroeconomic leading indicator, and Market Analysis.</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">PFE.N</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Utilities</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Thomas Kee</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">PFE Model Update To Remove Upjohn Contributions In 2020, And Lowering 2020 Contributions From Comirnaty</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">PFE</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Wolfe Research</td><td class="leftalignment">Wolfe Pharma & Biotech* 4Q20 EPS Preview - Model Changes and Updated Perspectives</td><td class="leftalignment">English</td><td class="rightalignment">89</td><td class="leftalignment">031162100 / 09062X103 / 5671735 / 0989529 / 0925288 / 7103065 / 7110388 / 717081103 / 375558103 / 110122108 / 532457108 / 75886F107 / 58933Y105 / 00287Y109</td><td class="leftalignment">Amgen Inc / Biogen Inc / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Novartis AG / Roche Holding AG / Pfizer Inc / Gilead Sciences Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Regeneron Pharmaceuticals Inc / Merck & Co Inc / Abbvie Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Dr. Tim M. Anderson, MD / Mr. Andrew Galler / Nicole Maher / Brian Tsang / Salma Buddaseth</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Trefis</td><td class="leftalignment">Should You Buy Johnson & Johnson Stock At $160?</td><td class="leftalignment">English</td><td class="rightalignment">3</td><td class="leftalignment">JNJ.N / BMY.N / MRK.N / PFE.N / RHHBY.PK</td><td class="leftalignment">Johnson & Johnson / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Roche Holding AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment">INVESTMENT STRATEGY</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Research Department</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">7</td><td class="leftalignment">LJPC=US / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">La Jolla Pharmaceutical Co / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - January 25, 2021</td><td class="leftalignment">English</td><td class="rightalignment">13</td><td class="leftalignment">NL0000226223 / DE0006231004 / US0079731008 / US0116591092 / US0378331005 / US0382221051 / US0463531089 / US1101221083 / US1264081035 / US1727551004 / US1924461023 / US1925761066 / US2017231034 / US22284P1057 / US2371941053 / US2829141009 / US3021301094 / US3156161024 / US37733W1053 / US4433201062 / US4456581077 / US4567881085 / US4581401001 / US4663671091 / US4824801009 / US5012421013 / US5128071082 / US5150981018 / US5324571083 / US55306N1046 / US5801351017 / US5949181045 / US5951121038 / US6558441084 / US66987V1098 / US6701002056 / US6703461052 / US6795801009 / US7170811035 / US7392761034 / US7475251036 / US7595091023 / US7711951043 / AN8068571086 / US8068821060 / US8168501018 / US8308791024 / US8447411088 / US8552441094 / US8581191009 / US8610121027 / US8807701029 / US9029251066 / US9078181081 / US91347P1057 / US9182041080 / US9507551086 / US9581021055 / CA1363751027 / CA13645T1003 / US9129091081 / US87157D1090 / US9884981013 / US4771431016 / US83088M1027 / US4198791018 / US80105N1054 / US3463751087 / US1572101053 / US90385V1070 / US12541W2098 / US1696561059 / US82706C1080 / US78709Y1055 / PAP310761054 / US75025X1000 / US3020811044 / US92932M1018 / US01748X1028 / US2473617023 / BMG3922B1072 / IE00B4BNMY34 / US58933Y1055 / US9100471096 / US95058W1009 / US03027X1000 / US29414B1044 / US9837931008 / US00287Y1091 / NL0010273215 / US45845P1084 / US8485771021 / US21240E1055 / US76680R2067 / CA05156V1022 / US02376R1023 / US03937C1053 / US8873991033 / LU0974299876 / CA0089118776 / US22822V1017 / CA76131D1033 / US74736K1016 / US8190471016 / US9741551033 / US5588681057 / US01345P1066 / KYG4740B1059 / US2067871036 / CA87241L1094 / US78410G1040 / CA35805P1071 / US23753F1075 / US23355L1061 / US80689H1023 / US4990491049 / US1858991011 / US30057T1051 / US89854H1023 / US05351X1019 / US11135F1012 / US05455M1009 / US29260V1052 / US5904791358 / US62921N1054 / CA59935V1076 / US4833791035 / US92537N1081 / US39813G1094 / 120175706</td><td class="leftalignment">STMicroelectronics NV / Infineon Technologies AG / Advanced Energy Industries Inc / Alaska Air Group Inc / Apple Inc / Applied Materials Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / CSX Corp / Cirrus Logic Inc / Cognizant Technology Solutions Corp / Cohu Inc / Commercial Metals Co / Covenant Logistics Group Inc / Darden Restaurants Inc / 8x8 Inc / Expeditors International of Washington Inc / F5 Inc / GlaxoSmithKline PLC / Hub Group Inc / J B Hunt Transport Services Inc / Infosys Ltd / Intel Corp / Jack in the Box Inc / KLA Corp / Kulicke and Soffa Industries Inc / Lam Research Corp / Landstar System Inc / Eli Lilly and Co / MKS Instruments Inc / McDonald's Corp / Microsoft Corp / Micron Technology Inc / Norfolk Southern Corp / Novartis AG / Novo Nordisk A/S / Nucor Corp / Old Dominion Freight Line Inc / Pfizer Inc / Power Integrations Inc / Qualcomm Inc / Reliance Steel & Aluminum Co / Roche Holding AG / Schlumberger NV / Schnitzer Steel Industries Inc / Semtech Corp / SkyWest Inc / Southwest Airlines Co / Starbucks Corp / Steel Dynamics Inc / STMicroelectronics NV / Teradyne Inc / USA Truck Inc / Union Pacific Corp / Universal Display Corp / VF Corp / Werner Enterprises Inc / Western Digital Corp / Canadian National Railway Co / Canadian Pacific Railway Ltd / United States Steel Corp / Synaptics Inc / Yum! Brands Inc / JetBlue Airways Corp / Skyworks Solutions Inc / Hawaiian Holdings Inc / Sanofi SA / FormFactor Inc / CEVA Inc / Ultra Clean Holdings Inc / CH Robinson Worldwide Inc / Chipotle Mexican Grill Inc / Silicon Motion Technology Corp / Saia Inc / Copa Holdings SA / Radiant Logistics Inc / Exlservice Holdings Inc / WNS (Holdings) Ltd / Allegiant Travel Co / Delta Air Lines Inc / Genpact Ltd / Accenture PLC / Merck & Co Inc / United Airlines Holdings Inc / Wendys Co / American Tower Corp / Epam Systems Inc / XPO Logistics Inc / Abbvie Inc / ASML Holding NV / Intercept Pharmaceuticals Inc / Spirit Airlines Inc / Controladora Vuela Compania de Aviacion SAB de CV / RingCentral Inc / Aurinia Pharmaceuticals Inc / American Airlines Group Inc / ArcBest Corp / TimkenSteel Corp / Globant SA / Air Canada / Crown Castle International Corp / Restaurant Brands International Inc / Qorvo Inc / Shake Shack Inc / Wingstop Inc / Madrigal Pharmaceuticals Inc / Albireo Pharma Inc / Ichor Holdings Ltd / Conduent Inc / TFI International Inc / SBA Communications Corp / Freshii Inc / Daseke Inc / DXC Technology Co / Schneider National Inc / Knight-Swift Transportation Holdings Inc / Cleveland-Cliffs Inc / Evoqua Water Technologies Corp / TTEC Holdings Inc / Avaya Holdings Corp / Broadcom Inc / AVROBIO Inc / Endava PLC / Mesa Air Group Inc / NGM Biopharmaceuticals Inc / Milestone Pharmaceuticals Inc / Kaleyra Inc / Vertiv Holdings Co / Grid Dynamics Holdings Inc / Cisco Systems Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / Switzerland / Cayman Islands / Germany / Denmark / France / United Kingdom / India / Ireland / Luxembourg / Mexico / Netherlands / Panama / United States / Jersey / Curaçao</td><td class="leftalignment"></td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">PharmaValues 2021 Strategic Conclusions. Summary slides</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / China / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Ms Jo Walton / Mr Matthew J. Weston / Mr. Trung Huynh / Elizabeth Walton / Mr. Dominic Lunn</td></tr>
<tr class="odd"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Pharmaceutical sector: Weekly review/outlook (from 25 Jan): Reporting results this week - Sumitomo Dainippon, JCR, Daiichi Sankyo, Astellas, M3</td><td class="leftalignment">English</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4506.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">M3 Inc / Sumitomo Dainippon Pharma Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="even"><td class="leftalignment">01/25/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">医薬品セクター: 週間レビューと見通し（1月25日～）: 今週の決算発表‐大日本住友、JCRファーマ、第一三共、アステラス、M3</td><td class="leftalignment">Japanese</td><td class="rightalignment">9</td><td class="leftalignment">2413.T / 4506.T / 4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / 4543.T / PFE.N / 4516.T / 4536.T / ROG.S / 4151.T / 4552.T / 4553.T / 4540.T / 6869.T / 4541.T / 4568.T / 4578.T / 4581.T / 4587.T</td><td class="leftalignment">M3 Inc / Sumitomo Dainippon Pharma Co Ltd / Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Terumo Corp / Pfizer Inc / Nippon Shinyaku Co Ltd / Santen Pharmaceutical Co Ltd / Roche Holding AG / Kyowa Kirin Co Ltd / JCR Pharmaceuticals Co Ltd / Towa Pharmaceutical Co Ltd / Tsumura & Co / Sysmex Corp / Nichi-Iko Pharmaceutical Co Ltd / Daiichi Sankyo Co Ltd / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / PeptiDream Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Japan / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Mr. Fumiyoshi Sakai</td></tr>
<tr class="odd"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Viral News in Genetic Medicines: C19 vaccine from GRTS; TSHA designations</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">GRTS.OQ / TSHA.OQ / ADAP=US / LLY=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / GRTS=US / LOGC=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / ONCS=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / KRYS=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US / VRDN=US</td><td class="leftalignment">Gritstone bio Inc / Taysha Gene Therapies Inc / Adaptimmune Therapeutics PLC / Eli Lilly and Co / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / Gritstone bio Inc / LogicBio Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / OncoSec Medical Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Krystal Biotech Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">INDUSTRY / INDUSTRY OVERVIEW</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">DR. Gbola B. Amusa,  MD, CFA, CFA / Geulah Livshits, PhD, PHD / Mr. Keay T. Nakae, CFA</td></tr>
<tr class="even"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Clinical Trial Monitor: Trial Activity Remains Above Jan 2020 Baseline- Week 44</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="odd"><td class="leftalignment">01/24/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Mexican Properties and Retail: Vaccination & Hospitalization Weekly Tracker - Week 3, 2021</td><td class="leftalignment">English</td><td class="rightalignment">12</td><td class="leftalignment">FIBRAMQ12.MX / FUNO11.MX / JNJ.N / PFE.N / AZN.L</td><td class="leftalignment">Macquarie Mexico Real Estate Management SA de CV / Fibra Uno Administracion SA de CV / Johnson & Johnson / Pfizer Inc / AstraZeneca PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / Mexico / United States</td><td class="leftalignment">Beverages & Tobacco / Consumer / Financial Services / Food / Real Estate</td><td class="leftalignment">Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS / Research Digest</td><td class="leftalignment">Ms. Vanessa Quiroga, CFA / Sr. Alejandro Chavelas / Andres Ortiz</td></tr>
<tr class="even"><td class="leftalignment">01/23/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Top of the Charts - A review of the week's best reads</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">ANTO.L / AVMD.PA / BARC.L / BHP.AX / BNPP.PA / CRH.I / ERICB.ST / HEIN.AS / HSBA.L / JNJ.N / KGF.L / LLY.N / MRK.N / NHY.OL / PFE.N / PRU.L / RIO.AX / SAPJ.J / SHBA.ST / SOGN.PA / SOLB.BR / VOD.L / SASY.PA / ROG.S / DBKGN.F / NOVOB.CO / NOVN.S / BOL.ST / CARLB.CO / GSK.L / NWG.L / MAERSKB.CO / NKELYQ.L / ASOS.L / ABI.BR / 0486.HK / BNRGN.DE / BASFN.DE / 1299.HK / SHLG.DE / GLEN.L / ABBV.N / FBK.MI / IMB.L / UBSG.S / DHER.DE / TEPRF.PA</td><td class="leftalignment">Antofagasta PLC / Dassault Aviation SA / Barclays PLC / BHP Group Ltd / BNP Paribas SA / CRH PLC / Telefonaktiebolaget LM Ericsson / Heineken NV / HSBC Holdings PLC / Johnson & Johnson / Kingfisher PLC / Eli Lilly and Co / Merck & Co Inc / Norsk Hydro ASA / Pfizer Inc / Prudential PLC / Rio Tinto Ltd / Sappi Ltd / Svenska Handelsbanken AB / Societe Generale SA / Solvay SA / Vodafone Group PLC / Sanofi SA / Roche Holding AG / Deutsche Bank AG / Novo Nordisk A/S / Novartis AG / Boliden AB / Carlsberg A/S / GlaxoSmithKline PLC / Natwest Group PLC / AP Moeller - Maersk A/S / GMK Noril'skiy Nikel' PAO / ASOS PLC / Anheuser Busch Inbev SA / OK Rusal MKPAO / Brenntag SE / BASF SE / AIA Group Ltd / Siemens Healthineers AG / Glencore PLC / Abbvie Inc / FinecoBank Banca Fineco SpA / Imperial Brands PLC / UBS Group AG / Delivery Hero SE / Teleperformance SE</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Germany / Denmark / France / United Kingdom / Hong Kong / Ireland / Italy / Netherlands / Norway / Russian Federation / Sweden / United States / South Africa / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Africa / Asia / Euroland / Europe / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Joelle Anamooto Natzkoff / Mr. Richard A. Kersley / Samuel Burgess</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / AMGN.OQ / REGN.OQ / GILD.OQ / INCY.OQ / VRTX.OQ / BIIB.OQ / ACB.TO / IBIO.A / ZTS.N / WEED.TO / TLRY.OQ / OGI.TO / XGN.OQ / IMAB.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Amgen Inc / Regeneron Pharmaceuticals Inc / Gilead Sciences Inc / Incyte Corp / Vertex Pharmaceuticals Inc / Biogen Inc / Aurora Cannabis Inc / Ibio Inc / Zoetis Inc / Canopy Growth Corp / Tilray Brands Inc / OrganiGram Holdings Inc / Exagen Inc / I-Mab</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Canada / Cayman Islands / United States</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals: Where we are focused next week</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">JNJ.N / MRK.N / PFE.N / ENDP.O / TEVA.N / PCRX.O / ABBV.N / PRGO.N / FLXN.O / AMRX.N / AQST.O</td><td class="leftalignment">Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Pacira Biosciences Inc / Abbvie Inc / Perrigo Company PLC / Pacira Biosciences Inc / Amneal Pharmaceuticals Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">EXEL (BUY) - FDA Approval in 1L Kidney Cancer as Expected & Should Represent Tailwind for Further Cabo TRx Growth</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">2576941 / 2126335 / 2778844 / 2684703</td><td class="leftalignment">Exelixis Inc / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Mr. Charles Zhu, Ph.D., III / Yige Guo, Ph.D. / Kelsey Goodwin / Mr. Seamus Fernandez</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">The Weekender</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">45337C10 / 03116210 / 09058V10 / 00422510 / IDRA / 84763A108 / 29251M106 / M25722105 / 89620X506 / 98978L204 / 60468T105 / 45845P108 / 09627Y109 / 690469101 / 29604W108 / 462260100 / 558868105 / 12648L601 / 89532E109 / 603380106 / 019770106 / 67576A100 / 483347100 / 299734103 / 90041T108 / 50127T109 / 04016X101 / 87184Q107 / 185063104 / 869367102 / 65343E108 / 22978P106 / 02155H200 / 24344T101 / 48576A100 / 75943R102 / 03843E104 / 43906K100 / 81181C104 / G637AM102 / 007002108 / N71542109 / 206022105 / 72942A107 / 92790C104</td><td class="leftalignment">Incyte Corp / Amgen Inc / BioCryst Pharmaceuticals Inc / ACADIA Pharmaceuticals Inc / Idera Pharmaceuticals Inc / Spectrum Pharmaceuticals Inc / Enanta Pharmaceuticals Inc / Compugen Ltd / Pfizer Inc / Zogenix Inc / Mirati Therapeutics Inc / Intercept Pharmaceuticals Inc / Blueprint Medicines Corp / Ovid Therapeutics Inc / Erytech Pharma SA / Iovance Biotherapeutics Inc / Madrigal Pharmaceuticals Inc / CTI Biopharma Corp / Trevena Inc / Minerva Neurosciences Inc / Allogene Therapeutics Inc / Ocular Therapeutix Inc / Kaleido Biosciences Inc / Evelo Biosciences Inc / Turning Point Therapeutics Inc / Kura Oncology Inc / argenx SE / Syros Pharmaceuticals Inc / Clearside Biomedical Inc / Sutro Biopharma Inc / NextCure Inc / Cue Biopharma Inc / Altimmune Inc / Deciphera Pharmaceuticals Inc / Karuna Therapeutics Inc / Relay Therapeutics Inc / Aquestive Therapeutics Inc / HOOKIPA Pharma Inc / Seagen Inc / Myovant Sciences Ltd / Adicet Bio Inc / ProQR Therapeutics NV / Concert Pharmaceuticals Inc / PLx Pharma Inc / Viridian Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Bermuda / Canada / France / Ireland / Israel / Netherlands / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD / Mr. Jason N. N. Butler, PhD, PHD / Mr. Silvan Tuerkcan / Mr. Jonathan P. Wolleben / Mr. Gobind Singh, MD, PhD / Mr. Roy Buchanan, PhD, PHD</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Healthcare Weekly Summary--January 22, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">DMTK=US / VERU=US / BSX=US / LLY=US / PFE=US / ABT=US / AMGN=US / GBT=US / MDT=US / DYN=US / WMT=US / CMS=US / GILD=US / DGX=US / NVS=US / GSK=US / CRY=US / RAD=US / JNJ=US / HCA=US / HUM=US / CVS=US / CI=US / UNH=US / AMED=US / AMN=US / ATRC=US / CSTL=US / CHE=US / CYH=US / EW=US / EXAS=US / GEN=US / ISRG=US / PHG=US / LH=US / REGN=US / USPH=US / UTHR=US / UHS=US / VRTX=US / OPT=US / CCRN=US / CNC=US / ACA=US / STSA=US / NTRA=US / ENSG=US / MIST=US / MD=US / NKTR=US / SLF=US / IGMS=US / AMTI=US / MRNA=US / CRTX=US / MNKD=US / GOOG=US / LHCG=US / CHNG=US / TPTX=US / IVA=US / EHC=US / NEO=US / ADUS=US / BEAM=US / ACHC=US / SRPT=US / AGIO=US / FATE=US / VCYT=US / CTRE=US / WBA=US / NVTA=US / VKTX=US / EVH=US / VRAY=US / MDGL=US / IRTC=US / NCNA=US / GH=US / ARVN=US / ALLO=US / ANCN=US / MITO=US / INMB=US / DTIL=US / BCDA=US / APLT=US / IDYA=US / BCYC=US / BCEL=US / KRTX=US / FREQ=US / ETNB=US / CABA=US / CNTG=US / GRTX=US / PNTG=US / PASG=US / ORIC=US / AYLA=US / LTRN=US / FMTX=US / PCVX=US / INBX=US / TSHA=US</td><td class="leftalignment">DermTech Inc / Veru Inc / Boston Scientific Corp / Eli Lilly and Co / Pfizer Inc / Abbott Laboratories / Amgen Inc / Global Blood Therapeutics Inc / Medtronic PLC / Dyne Therapeutics Inc / Walmart Inc / CMS Energy Corp / Gilead Sciences Inc / Quest Diagnostics Inc / Novartis AG / GlaxoSmithKline PLC / CryoLife Inc / Rite Aid Corp / Johnson & Johnson / HCA Healthcare Inc / Humana Inc / CVS Health Corp / Cigna Corp / UnitedHealth Group Inc / Amedisys Inc / AMN Healthcare Services Inc / AtriCure Inc / Castle Biosciences Inc / Chemed Corp / Community Health Systems Inc / Edwards Lifesciences Corp / Exact Sciences Corp / Genesis Healthcare Inc / Intuitive Surgical Inc / Koninklijke Philips NV / Laboratory Corporation of America Holdings / Regeneron Pharmaceuticals Inc / US Physical Therapy Inc / United Therapeutics Corp / Universal Health Services Inc / Vertex Pharmaceuticals Inc / Opthea Ltd / Cross Country Healthcare Inc / Centene Corp / Arcosa Inc / Satsuma Pharmaceuticals Inc / Natera Inc / Ensign Group Inc / Milestone Pharmaceuticals Inc / MEDNAX Inc / Nektar Therapeutics / Sun Life Financial Inc / IGM Biosciences Inc / Applied Molecular Transport Inc. / Moderna Inc / Cortexyme Inc / MannKind Corp / Alphabet Inc / LHC Group Inc / Change Healthcare Inc / Turning Point Therapeutics Inc / Inventiva SA / Encompass Health Corp / Neogenomics Inc / Addus Homecare Corp / Beam Therapeutics Inc / Acadia Healthcare Company Inc / Sarepta Therapeutics Inc / Agios Pharmaceuticals Inc / Fate Therapeutics Inc / Veracyte Inc / CareTrust REIT Inc / Walgreens Boots Alliance Inc / Invitae Corp / Viking Therapeutics Inc / Evolent Health Inc / ViewRay Inc / Madrigal Pharmaceuticals Inc / iRhythm Technologies Inc / NuCana PLC / Guardant Health Inc / Arvinas Inc / Allogene Therapeutics Inc / Chemomab Therapeutics Ltd / Stealth BioTherapeutics Corp / INmune Bio Inc / Precision BioSciences Inc / BioCardia Inc / Applied Therapeutics Inc / IDEAYA Biosciences Inc / Bicycle Therapeutics PLC / Atreca Inc / Karuna Therapeutics Inc / Frequency Therapeutics Inc / 89Bio Inc / Cabaletta Bio Inc / Centogene NV / Galera Therapeutics Inc / Pennant Group Inc / Passage Bio Inc / Oric Pharmaceuticals Inc / Ayala Pharmaceuticals Inc / Lantern Pharma Inc. / Forma Therapeutics Holdings Inc / Vaxcyte Inc / Inhibrx Inc / Taysha Gene Therapies Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / Netherlands / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Henry Capellan</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">CALL STARTING SOON: Cantor Research Call - Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM.L / LLY / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">HUTCHMED (China) Ltd / Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">IQVIA Script Trends for the Week Ended January 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">96</td><td class="leftalignment">MRK=US / PFE=US / AMGN=US / TEVA=US / GILD=US / SAN=FR / GSK=GB / AZN=US / GSK=US / JNJ=US / ICPT=US / REGN=US / BIIB=US / ABBV=US</td><td class="leftalignment">Merck & Co Inc / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / AstraZeneca PLC / GlaxoSmithKline PLC / Johnson & Johnson / Intercept Pharmaceuticals Inc / Regeneron Pharmaceuticals Inc / Biogen Inc / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / Israel / United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">Pharmaceuticals Rx: Week ending Jan 15, 2021</td><td class="leftalignment">English</td><td class="rightalignment">17</td><td class="leftalignment">PFE.N / JAZZ.O / OPTN.O / ENDP.O / TEVA.N / ABBV.N / PRGO.N / AGRX.O / AMRX.N / XERS.O / AQST.O</td><td class="leftalignment">Pfizer Inc / Jazz Pharmaceuticals PLC / OptiNose Inc / Endo International PLC / Teva Pharmaceutical Industries Ltd / Abbvie Inc / Perrigo Company PLC / Agile Therapeutics Inc / Amneal Pharmaceuticals Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc</td><td class="leftalignment"></td><td class="leftalignment">Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Randall S. Stanicky, CFA / Mr. Daniel J. Busby / Steve Daddeo</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Zacks Equity Research</td><td class="leftalignment">Pfizer Inc.(PFE) Zacks Company Report</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">717081103</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Morning Call - Jan 22 2021</td><td class="leftalignment">English</td><td class="rightalignment">15</td><td class="leftalignment">FR0000121014 / CH0012221716 / US0028962076 / US02553E1064 / US0311001004 / US0320951017 / US0378331005 / US0463531089 / US0530151036 / US1011371077 / US1101221083 / US1264081035 / US1271903049 / US1924221039 / US22160K1051 / US2310211063 / US28176E1082 / US34354P1057 / US3647601083 / US37733W1053 / US45167R1041 / US4581401001 / US4698141078 / US5324571083 / US5949181045 / US66987V1098 / US6701002056 / US7010941042 / US7043261079 / US7170811035 / US7711951043 / US7739031091 / US7766961061 / US7782961038 / US8636671013 / US8725401090 / US87612E1064 / US8793601050 / US9078181081 / US9297401088 / US9311421039 / US9427491025 / US5645631046 / US80105N1054 / US0003752047 / US2538681030 / US6247581084 / US48242W1062 / US92932M1018 / US90384S3031 / US0231112063 / US1940141062 / CA0585861085 / CH0102993182 / US58933Y1055 / IE00B58JVZ52 / US9100471096 / US0995021062 / US7512121010 / US98419M1009 / US00287Y1091 / US98978V1035 / US81762P1021 / US72919P2020 / US23283R1005 / US8086251076 / US5253271028 / CH0210483332 / US70438V1061 / US70432V1026 / US98936J1016 / IE00BLS09M33 / US0994061002 / US29444U7000 / US72703H1014 / GB00BZ09BD16 / US45073V1089 / US34959J1088 / US90138F1021 / US36165L1089 / US74967X1037 / CA1350861060 / US05722G1004 / US87105L1044 / US8760301072 / US30057T1051 / GB00BFMBMT84 / US15677J1088 / US2575541055 / US0937121079 / US28414H1032 / KY30744W1070 / VGG1890L1076 / US70202L1026 / US35952H6018 / US76156B1070 / US88339P1012 / US30068X1037 / US6541101050 / GB00BMVP7Y09 / US6873051022</td><td class="leftalignment">LVMH Moet Hennessy Louis Vuitton SE / Abb Ltd / Abercrombie & Fitch Co / American Eagle Outfitters Inc / AMETEK Inc / Amphenol Corp / Apple Inc / AstraZeneca PLC / Automatic Data Processing Inc / Boston Scientific Corp / Bristol-Myers Squibb Co / CSX Corp / CACI International Inc / Cognex Corp / Costco Wholesale Corp / Cummins Inc / Edwards Lifesciences Corp / Flowserve Corp / Gap Inc / GlaxoSmithKline PLC / IDEX Corp / Intel Corp / Jacobs Engineering Group Inc / Eli Lilly and Co / Microsoft Corp / Novartis AG / Novo Nordisk A/S / Parker-Hannifin Corp / Paychex Inc / Pfizer Inc / Roche Holding AG / Rockwell Automation Inc / Roper Technologies Inc / Ross Stores Inc / Stryker Corp / TJX Companies Inc / Target Corp / Teledyne Technologies Inc / Union Pacific Corp / Westinghouse Air Brake Technologies Corp / Walmart Inc / Watts Water Technologies Inc / ManTech International Corp / Sanofi SA / Abb Ltd / Digital Realty Trust Inc / Mueller Water Products Inc / KBR Inc / WNS (Holdings) Ltd / Ulta Beauty Inc / Amarin Corporation PLC / Colfax Corp / Ballard Power Systems Inc / TE Connectivity Ltd / Merck & Co Inc / Seagate Technology Holdings PLC / United Airlines Holdings Inc / Booz Allen Hamilton Holding Corp / Ralph Lauren Corp / Xylem Inc / Abbvie Inc / Zoetis Inc / ServiceNow Inc / Plug Power Inc / CyrusOne Inc / Science Applications International Corp / Leidos Holdings Inc / Compagnie Financiere Richemont SA / Paylocity Holding Corp / Paycom Software Inc / Zendesk Inc / Pentair PLC / Boot Barn Holdings Inc / Equinix Inc / Planet Fitness Inc / Atlassian Corporation PLC / ITT Inc / Fortive Corp / Twilio Inc / GDS Holdings Ltd / RH / Canada Goose Holdings Inc / Baker Hughes Co / Switch Inc / Tapestry Inc / Evoqua Water Technologies Corp / Sensata Technologies Holding PLC / Ceridian HCM Holding Inc / Domo Inc / Bloom Energy Corp / Elanco Animal Health Inc / Farfetch Ltd / Capri Holdings Ltd / Parsons Corp / Fuelcell Energy Inc / Revolve Group Inc / RealReal Inc / Exagen Inc / Nikola Corp / Royalty Pharma PLC / Orphazyme A/S</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Ireland / United States / Virgin Islands, British / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">Cowen Research</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Healthcare Technology & Distribution: COVID Vaccine Distribution Tracker</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">PFE.N / MRNA.OQ</td><td class="leftalignment">Pfizer Inc / Moderna Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United States</td><td class="leftalignment">Healthcare</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Jailendra P. Singh / Jermaine Brown / Adam Heussner</td></tr>
<tr class="even"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">China Biotech Sector: Pipeline updates and recent license-out deals accentuate LT potential of high-flying biotechs</td><td class="leftalignment">English</td><td class="rightalignment">34</td><td class="leftalignment">1952.HK / BGNE.OQ / BMY.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / GILD.OQ / INCY.OQ / MGNX.OQ / TPB.N / ZLAB.OQ / 6160.HK / 1801.HK / 1877.HK / GTH.OQ</td><td class="leftalignment">Everest Medicines Ltd / Beigene Ltd / Bristol-Myers Squibb Co / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Gilead Sciences Inc / Incyte Corp / MacroGenics Inc / Turning Point Brands Inc / Zai Lab Ltd / Beigene Ltd / Innovent Biologics Inc / Shanghai Junshi Biosciences Co Ltd / Genetron Holdings Ltd</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / China / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Yang Huang / Mr. Jason Liu</td></tr>
<tr class="odd"><td class="leftalignment">01/22/2021</td><td class="leftalignment">Cowen and Company</td><td class="leftalignment">Q4:20 Results Preview/2021 Outlook</td><td class="leftalignment">English</td><td class="rightalignment">39</td><td class="leftalignment">US00287Y1091 / US0463531089 / US1101221083 / US37733W1053 / US5324571083 / US66987V1098 / US6701002056 / US7170811035 / US7711951043 / US80105N1054 / US58933Y1055 / US98978V1035 / US28414H1032 / GB00BMVP7Y09</td><td class="leftalignment">Abbvie Inc / AstraZeneca PLC / Bristol-Myers Squibb Co / GlaxoSmithKline PLC / Eli Lilly and Co / Novartis AG / Novo Nordisk A/S / Pfizer Inc / Roche Holding AG / Sanofi SA / Merck & Co Inc / Zoetis Inc / Elanco Animal Health Inc / Royalty Pharma PLC</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Steve M. Scala, R.Ph., CFA, CFA / Ms. Kathleen M. Miner, R.Ph., CFA / Michael Nedelcovych, Ph.D.</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">BGNE (NEUTRAL) - Model Update Post NOVN Collaboration; Incremental Updates on 2021 Key Milestones; Maintain NEUTRAL</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">BYYWPW6 / 5671735 / 0989529 / 0925288 / 2126335 / 2778844 / 2684703 / 2730190 / 7103065</td><td class="leftalignment">Beigene Ltd / Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Merck & Co Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Novartis AG</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / Cayman Islands / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Michael W. Schmidt, Ph.D., PHD / Yige Guo, Ph.D. / Mr. Charles Zhu, Ph.D., III / Kelsey Goodwin</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">The Scope of iBio's Opportunities Is Only Just Beginning to Sprout; Initiating at OW, $3 PT</td><td class="leftalignment">English</td><td class="rightalignment">55</td><td class="leftalignment">IBIO.K / PFE</td><td class="leftalignment">Ibio Inc / Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Ms. Kristen Kluska</td></tr>
<tr class="even"><td class="leftalignment">01/21/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">TOMORROW AM: Cantor Research Call - Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM.O / LLY / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">HUTCHMED (China) Ltd / Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/21/2021</td><td class="leftalignment">JMP Securities</td><td class="leftalignment">2021 Outlook – Moving Forward With the Right Combinations</td><td class="leftalignment">English</td><td class="rightalignment">6</td><td class="leftalignment">89620X506</td><td class="leftalignment">Pfizer Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada</td><td class="leftalignment"></td><td class="leftalignment">North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Mr. Reni J. J. Benjamin, PhD, PHD</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">Morning Summary</td><td class="leftalignment">English</td><td class="rightalignment">18</td><td class="leftalignment">5671735 / 0989529 / 2936921 / 2126335 / 2516152 / 2050832 / 2270726 / 2542049 / 2415204 / 2455965 / 2657802 / 2684703 / 2048804 / 7103065 / B1F76F9 / B121557 / 2857817 / B02R1L6 / B2R3PV1 / 2679204 / B7TL820 / B7VD3F2 / BFLR866 / BVVN4Q8 / BYY8XK8 / BYW36M8 / BD8DJ71 / BJ2Z0H2 / BLGJ610 / BFMXGR0 / BKC9SX3 / BYTJZL1 / BKT6B38</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / Walmart Inc / Bristol-Myers Squibb Co / Eli Lilly and Co / Ameren Corp / Walt Disney Co / Dominion Energy Inc / Hawaiian Electric Industries Inc / Biogen Inc / OGE Energy Corp / Pfizer Inc / Pinnacle West Capital Corp / Novartis AG / Western Union Co / Mastercard Inc / Netflix Inc / ALLETE Inc / American Water Works Company Inc / Align Technology Inc / Meta Platforms Inc / Duke Energy Corp / Twitter Inc / Eversource Energy / WEC Energy Group Inc / PayPal Holdings Inc / Snap Inc / Pinterest Inc / Warner Music Group Corp / Evergy Inc / Arcturus Therapeutics Holdings Inc / Zogenix Inc / SmileDirectClub Inc</td><td class="leftalignment"></td><td class="leftalignment">Switzerland / France / United Kingdom / United States</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Guggenheim Secu Research</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">HOLT Novo Nordisk: Concerns over sustainability of returns overdone</td><td class="leftalignment">English</td><td class="rightalignment">11</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / MRCG.DE / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Sophia Graeff Buhl-Nielsen / HOLT Europe / Selim Gogus</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">GSK.L: GlaxoSmithKline plc - Downgrade to Underperform</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">GSK.L / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVOB.CO / NOVN.S / GILD.OQ / BAYGN.DE / ABBV.N</td><td class="leftalignment">GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novo Nordisk A/S / Novartis AG / Gilead Sciences Inc / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Global Pharmaceuticals: PharmaValues 2021 strategic conclusions</td><td class="leftalignment">English</td><td class="rightalignment">110</td><td class="leftalignment">4502.T / 4503.T / 4507.T / 4519.T / 4523.T / 4528.T / BMY.N / CSL.AX / JNJ.N / LLY.N / MRK.N / PFE.N / RECI.MI / AZN.L / 4506.T / 4536.T / SASY.PA / ROG.S / LUN.CO / 4151.T / NOVOB.CO / NOVN.S / MRCG.DE / GSK.L / UCB.BR / AMGN.OQ / REGN.OQ / ALKS.OQ / GILD.OQ / INCY.OQ / NBIX.OQ / BMRN.OQ / VRTX.OQ / BIIB.OQ / GLPG.AS / 4568.T / IPN.PA / HIK.L / TEVA.N / ORNBV.HE / ALM.MC / GRLS.MC / BAYGN.DE / 4578.T / 4581.T / SRPT.OQ / ABBV.N / QURE.OQ / BGNE.OQ / VIFN.S / 6160.HK / GMAB.CO</td><td class="leftalignment">Takeda Pharmaceutical Co Ltd / Astellas Pharma Inc / Shionogi & Co Ltd / Chugai Pharmaceutical Co Ltd / Eisai Co Ltd / Ono Pharmaceutical Co Ltd / Bristol-Myers Squibb Co / CSL Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Recordati Industria Chimica e Farmaceutica SpA / AstraZeneca PLC / Sumitomo Dainippon Pharma Co Ltd / Santen Pharmaceutical Co Ltd / Sanofi SA / Roche Holding AG / H Lundbeck A/S / Kyowa Kirin Co Ltd / Novo Nordisk A/S / Novartis AG / Merck KGaA / GlaxoSmithKline PLC / Ucb SA / Amgen Inc / Regeneron Pharmaceuticals Inc / Alkermes Plc / Gilead Sciences Inc / Incyte Corp / Neurocrine Biosciences Inc / Biomarin Pharmaceutical Inc / Vertex Pharmaceuticals Inc / Biogen Inc / Galapagos NV / Daiichi Sankyo Co Ltd / Ipsen SA / Hikma Pharmaceuticals PLC / Teva Pharmaceutical Industries Ltd / Orion Oyj / Almirall SA / Grifols SA / Bayer AG / Otsuka Holdings Co Ltd / Taisho Pharmaceutical Holdings Co Ltd / Sarepta Therapeutics Inc / Abbvie Inc / Uniqure NV / Beigene Ltd / Vifor Pharma AG / Beigene Ltd / Genmab A/S</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Belgium / Switzerland / Cayman Islands / Germany / Denmark / Spain / Finland / France / United Kingdom / Ireland / Israel / Italy / Japan / Netherlands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia / Global</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Ms. Gretel Janu / Mr. Dominic Lunn / Mr. Matt S. Miksic / Mr. Fumiyoshi Sakai / Mr. Evan D. Seigerman / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="even"><td class="leftalignment">01/20/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">NOVOb.CO: Novo Nordisk A/S - Downgrading to Neutral; Reiterate DKK470/share Price Target</td><td class="leftalignment">English</td><td class="rightalignment">30</td><td class="leftalignment">NOVOB.CO / BMY.N / JNJ.N / LLY.N / MRK.N / PFE.N / AZN.L / SASY.PA / ROG.S / NOVN.S / GSK.L / BAYGN.DE / ABBV.N</td><td class="leftalignment">Novo Nordisk A/S / Bristol-Myers Squibb Co / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / AstraZeneca PLC / Sanofi SA / Roche Holding AG / Novartis AG / GlaxoSmithKline PLC / Bayer AG / Abbvie Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Germany / Denmark / France / United Kingdom / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">CHANGE IN RECOMMENDATION</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">European Pharma Team / Mr. Trung Huynh / Mr. Dominic Lunn / Elizabeth Walton / Ms Jo Walton / Mr Matthew J. Weston</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Guggenheim Securities LLC</td><td class="leftalignment">GPH/BIO: This Week's IQVIA Rx Tracker (Week Ending Jan 8, 2021)</td><td class="leftalignment">English</td><td class="rightalignment">108</td><td class="leftalignment">5671735 / 0989529 / 0925288 / 2126335 / 2516152 / 2023607 / 2778844 / 2576941 / 2369174 / 2455965 / 2623911 / 2684703 / 2730190 / 2883878 / 7103065 / B6WXT12 / BQPVQZ6 / BZ1LFB2 / BYYWPW6 / BWY52P3 / BFFVVC1</td><td class="leftalignment">Sanofi SA / AstraZeneca PLC / GlaxoSmithKline PLC / Bristol-Myers Squibb Co / Eli Lilly and Co / Amgen Inc / Merck & Co Inc / Exelixis Inc / Gilead Sciences Inc / Biogen Inc / Neurocrine Biosciences Inc / Pfizer Inc / Regeneron Pharmaceuticals Inc / Teva Pharmaceutical Industries Ltd / Novartis AG / TherapeuticsMD Inc / Horizon Therapeutics PLC / Deciphera Pharmaceuticals Inc / Beigene Ltd / Blueprint Medicines Corp / Bausch Health Companies Inc</td><td class="leftalignment"></td><td class="leftalignment">Canada / Switzerland / Cayman Islands / France / United Kingdom / Ireland / Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Investment Strategy / Equity</td><td class="leftalignment">Mr. Seamus Fernandez / Tarun Soni / Kushal Patel / Guggenheim Ther Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">Cantor Daily Research Highlights</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">HCM.L / JNJ.N / LLY.N / MRK.N / PFE.N / GILD.OQ / MSB.AX / ARDX.OQ / ZTS.N / BHVN.N / XELA.OQ / XGN.OQ / IMAB.OQ / ALXO.OQ</td><td class="leftalignment">HUTCHMED (China) Ltd / Johnson & Johnson / Eli Lilly and Co / Merck & Co Inc / Pfizer Inc / Gilead Sciences Inc / Mesoblast Ltd / Ardelyx Inc / Zoetis Inc / Biohaven Pharmaceutical Holding Company Ltd / Exela Technologies Inc / Exagen Inc / I-Mab / ALX Oncology Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Cayman Islands / United States / Virgin Islands, British</td><td class="leftalignment"></td><td class="leftalignment">Latin America / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH</td><td class="leftalignment">Cantor Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Truist Securities</td><td class="leftalignment">Pharmaceuticals: US Biosimilars Tracker</td><td class="leftalignment">English</td><td class="rightalignment">24</td><td class="leftalignment">MRK=US / LLY=US / PFE=US / AMGN=US / TEVA=US / CHRS=US / AMRX=US / VTRS=US</td><td class="leftalignment">Merck & Co Inc / Eli Lilly and Co / Pfizer Inc / Amgen Inc / Teva Pharmaceutical Industries Ltd / Coherus BioSciences Inc / Amneal Pharmaceuticals Inc / Viatris Inc</td><td class="leftalignment"></td><td class="leftalignment">Israel / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Middle East / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Research Digest / Equity</td><td class="leftalignment">Mr. Gregg Gilbert / Mr. Gregory D. Fraser / Tyler Knisley</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Chardan Capital Markets</td><td class="leftalignment">Chardan Global Insights</td><td class="leftalignment">English</td><td class="rightalignment">8</td><td class="leftalignment">KRYS=US / ADAP=US / PFE=US / XON=US / GILD=US / NVS=US / ROG=CH / AZN=US / GSK=US / BMRN=US / BLUE=US / ISEE=US / LOGC=US / MGEN=US / NVAX=US / NVO=US / RARE=US / REGN=US / SGMO=US / VRTX=US / LYS=FR / CYAD=US / IMTX=US / AUTL=US / BIIB=US / ARWR=US / MRNA=US / ALNY=US / INO=US / AVRO=US / FOLD=US / RGNX=US / ARCT=US / SRPT=US / RGLS=US / FATE=US / QURE=US / AGTC=US / PRQR=US / VBLT=US / NVTA=US / CLLS=US / ABEO=US / ABUS=US / VYGR=US / WVE=US / EDIT=US / NTLA=US / ADVM=US / CRSP=US / ALSEN=FR / 199800=KR / IOVA=US / CLXT=US / MBIO=US / SLDB=US / RCKT=US / FIXX=US / GNPX=US / XCUR=US / MGTX=US / REPL=US / STOK=US / NBSE=US / CABA=US / OCGN=US / PASG=US / SIGHT:FP=FR / TSHA=US / SIOX=US / FDMT=US / VINC=US</td><td class="leftalignment">Krystal Biotech Inc / Adaptimmune Therapeutics PLC / Pfizer Inc / Precigen Inc / Gilead Sciences Inc / Novartis AG / Roche Holding AG / AstraZeneca PLC / GlaxoSmithKline PLC / Biomarin Pharmaceutical Inc / bluebird bio Inc / Iveric Bio Inc / LogicBio Therapeutics Inc / Viridian Therapeutics Inc / Novavax Inc / Novo Nordisk A/S / Ultragenyx Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Sangamo Therapeutics Inc / Vertex Pharmaceuticals Inc / Lysogene SA / Celyad Oncology SA / Immatics NV / Autolus Therapeutics PLC / Biogen Inc / Arrowhead Pharmaceuticals Inc / Moderna Inc / Alnylam Pharmaceuticals Inc / Inovio Pharmaceuticals Inc / AVROBIO Inc / Amicus Therapeutics Inc / Regenxbio Inc / Arcturus Therapeutics Holdings Inc / Sarepta Therapeutics Inc / Regulus Therapeutics Inc / Fate Therapeutics Inc / Uniqure NV / Applied Genetic Technologies Corp / ProQR Therapeutics NV / Vascular Biogenics Ltd / Invitae Corp / Cellectis SA / Abeona Therapeutics Inc / Arbutus Biopharma Corp / Voyager Therapeutics Inc / WAVE Life Sciences Ltd / Editas Medicine Inc / Intellia Therapeutics Inc / Adverum Biotechnologies Inc / CRISPR Therapeutics AG / Sensorion SA / ToolGen Inc / Iovance Biotherapeutics Inc / Calyxt Inc / Mustang Bio Inc / Solid Biosciences Inc / Rocket Pharmaceuticals Inc / Homology Medicines Inc / Genprex Inc / Exicure Inc / MeiraGTx Holdings PLC / Replimune Group Inc / Stoke Therapeutics Inc / NeuBase Therapeutics Inc / Cabaletta Bio Inc / Ocugen Inc / Passage Bio Inc / Gensight Biologics SA / Taysha Gene Therapies Inc / Sio Gene Therapies Inc / 4D Molecular Therapeutics Inc / Vincerx Pharma Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Belgium / Canada / Switzerland / Cayman Islands / Denmark / France / United Kingdom / Israel / Korea, Republic of / Netherlands / Singapore / United States</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / Middle East / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Chardan Research</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Morning Research Summary</td><td class="leftalignment">English</td><td class="rightalignment">16</td><td class="leftalignment">GE=US / VZ=US / NEM=US / X=US / BSX=US / FDX=US / PFE=US / ABT=US / AMGN=US / CAT=US / DIS=US / INTC=US / WM=US / BWA=US / GBT=US / MSFT=US / MDT=US / C=US / AA=US / FCX=US / KGC=US / AMZN=US / QCOM=US / T=US / AEM=US / RUN=US / BAC=US / USB=US / WFC=US / AMT=US / GS=US / AKAM=US / GGB=US / JPM=US / FCEL=US / PLUG=US / CHTR=US / NVS=US / GOLD=US / CCI=US / GSK=US / CRY=US / SPOT=US / JCI=US / PNC=US / HL=US / DE=US / CMCSA=US / BHP=US / COF=US / RGLD=US / DISH=US / RSG=US / ALB=US / ATI=US / AMSC=US / APPS=US / ARRY=US / AVNT=US / CMI=US / CRS=US / CENX=US / CLF=US / CDE=US / CMC=US / CREE=US / EW=US / EGHT=US / EQIX=US / ISRG=US / ITRI=US / MS=US / NUE=US / ZEUS=US / PKX=US / RS=US / ROK=US / SBAC=US / SCHN=US / SCCO=US / STLD=US / SYNL=US / TECH=US / TRMB=US / VALE=US / VG=US / WOR=US / PAAS=US / MTCH=US / NEP=US / RIO=US / NFLX=US / BE=US / TWLO=US / CLH=US / WCN=US / ERIC=US / BBL=US / RNG=US / ENS=US / GOOG=US / TWIN=US / DLR=US / ORA=US / MT=US / VIAC=US / BIDU=US / AMRS=US / SPWR=US / CCOI=US / KALU=US / CSIQ=US / FSLR=US / HAYN=US / LLNW=US / LUMN=US / DAN=US / MTRN=US / KLR=US / WPRT=US / AGCO=US / 005930-KR=US / FNV=US / TCEHY=US / TSLA=US / AMRC=US / ENPH=US / YY=US / TMUS=US / HASI=US / AGIO=US / CNHI=US / TME=US / TMST=US / MOMO=US / SEDG=US / VKTX=US / AQMS=US / VRAY=US / WKHS=US / MDGL=US / ATUS=US / SSRM=US / WPM=US / KL=US / NCNA=US / APTV=US / IQ=US / BILI=US / HUYA=US / CWEN=US / ARVN=US / UBER=US / ZM=US / FSLY=US / IDYA=US / DOYU=US / VLDR=US / ONDS=US</td><td class="leftalignment">General Electric Co / Verizon Communications Inc / Newmont Corporation / United States Steel Corp / Boston Scientific Corp / FedEx Corp / Pfizer Inc / Abbott Laboratories / Amgen Inc / Caterpillar Inc / Walt Disney Co / Intel Corp / Waste Management Inc / Borgwarner Inc / Global Blood Therapeutics Inc / Microsoft Corp / Medtronic PLC / Citigroup Inc / Alcoa Corp / Freeport-McMoRan Inc / Kinross Gold Corp / Amazon.com Inc / Qualcomm Inc / AT&T Inc / Agnico Eagle Mines Ltd / Sunrun Inc / Bank of America Corp / US Bancorp / Wells Fargo & Co / American Tower Corp / Goldman Sachs Group Inc / Akamai Technologies Inc / Gerdau SA / JPMorgan Chase & Co / Fuelcell Energy Inc / Plug Power Inc / Charter Communications Inc / Novartis AG / Barrick Gold Corp / Crown Castle International Corp / GlaxoSmithKline PLC / CryoLife Inc / Spotify Technology SA / Johnson Controls International PLC / PNC Financial Services Group Inc / Hecla Mining Co / Deere & Co / Comcast Corp / BHP Group Ltd / Capital One Financial Corp / Royal Gold Inc / DISH Network Corp / Republic Services Inc / Albemarle Corp / Allegheny Technologies Inc / American Superconductor Corp / Digital Turbine Inc / Array Technologies Inc / Avient Corp / Cummins Inc / Carpenter Technology Corp / Century Aluminum Co / Cleveland-Cliffs Inc / Coeur Mining Inc / Commercial Metals Co / Wolfspeed Inc / Edwards Lifesciences Corp / 8x8 Inc / Equinix Inc / Intuitive Surgical Inc / Itron Inc / Morgan Stanley / Nucor Corp / Olympic Steel Inc / Posco / Reliance Steel & Aluminum Co / Rockwell Automation Inc / SBA Communications Corp / Schnitzer Steel Industries Inc / Southern Copper Corp / Steel Dynamics Inc / Synalloy Corp / Bio-Techne Corp / Trimble Inc / Vale SA / Vonage Holdings Corp / Worthington Industries Inc / Pan American Silver Corp / Match Group Inc / Nextera Energy Partners LP / Rio Tinto PLC / Netflix Inc / Bloom Energy Corp / Twilio Inc / Clean Harbors Inc / Waste Connections Inc / Telefonaktiebolaget LM Ericsson / BHP Group PLC / RingCentral Inc / EnerSys / Alphabet Inc / Twin Disc Inc / Digital Realty Trust Inc / Ormat Technologies Inc / ArcelorMittal SA / ViacomCBS Inc / Baidu Inc / Amyris Inc / SunPower Corp / Cogent Communications Holdings Inc / Kaiser Aluminum Corp / Canadian Solar Inc / First Solar Inc / Haynes International Inc / Limelight Networks Inc / Lumen Technologies Inc / Dana Inc / Materion Corp / Kaleyra Inc / Westport Fuel Systems Inc / AGCO Corp / Farfetch Ltd / Franco-Nevada Corp / Tencent Holdings Ltd / Tesla Inc / Ameresco Inc / Enphase Energy Inc / JOYY Inc / T-Mobile US Inc / Hannon Armstrong Sustainable Infrastructure Capital Inc / Agios Pharmaceuticals Inc / CNH Industrial NV / Tencent Music Entertainment Group / TimkenSteel Corp / Hello Group Inc / Solaredge Technologies Inc / Viking Therapeutics Inc / Aqua Metals Inc / ViewRay Inc / Workhorse Group Inc / Madrigal Pharmaceuticals Inc / Altice USA Inc / SSR Mining Inc / Wheaton Precious Metals Corp / Kirkland Lake Gold Ltd / NuCana PLC / Aptiv PLC / iQIYI Inc / Bilibili Inc / HUYA Inc / Clearway Energy Inc / Arvinas Inc / Uber Technologies Inc / Zoom Video Communications Inc / Fastly Inc / IDEAYA Biosciences Inc / Douyu International Holdings Ltd / Velodyne Lidar Inc / Ondas Holdings Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Australia / Brazil / Canada / Switzerland / Cayman Islands / United Kingdom / Ireland / Korea, Republic of / Luxembourg / Netherlands / Sweden / United States / Jersey</td><td class="leftalignment">Banks / Biotechnology / Conglomerates / Electrical / Financial Services / Healthcare / Pharmaceuticals / Retailing / Semiconductors / Telecommunications</td><td class="leftalignment">Asia / Euroland / Europe / Latin America / North America / Australasia</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment"></td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">SVB Leerink</td><td class="leftalignment">Normally Q4 is Solid, but COVID & Currency Cloud Outlook</td><td class="leftalignment">English</td><td class="rightalignment">118</td><td class="leftalignment">ABBV=US / PFE=US / AMGN=US / GILD=US / SAN=FR / GSK=GB / REGN=US / VRTX=US</td><td class="leftalignment">Abbvie Inc / Pfizer Inc / Amgen Inc / Gilead Sciences Inc / Sanofi SA / GlaxoSmithKline PLC / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">France / United Kingdom / United States</td><td class="leftalignment">Biotechnology / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Mr. Geoffrey Porges</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">RBC Capital Markets</td><td class="leftalignment">US Research at a Glance - January 19, 2021</td><td class="leftalignment">English</td><td class="rightalignment">27</td><td class="leftalignment">AC.TO / AEP.N / ALTR.O / ALV.N / AMAT.O / AMD.N / BARC.L / BBDb.TO / C.N / CI.N / CL.N / CMS.N / CNA.L / CP.TO / CVS.N / EDP.LS / EIX.N / EL.N / ELE.MC / EOG.N / F.N / GM.N / HSBA.L / HSX.L / INTC.O / IP.N / JPM.N / KBH.N / KMB.N / KO.N / LLOY.L / PD.N / PEG.N / PFE.N / PHM.N / PNC.N / SAN.MC / SGEF.PA / SO.N / T.N / TOL.N / VC.N / WFC.N / SSE.L / PEP.N / BFb.N / PG.N / PXD.N / HUM.N / CPB.N / TEN.N / CMCSA.O / CHKP.O / AMGN.O / INCY.O / THC.N / CNR.TO / DUK.N / UNH.N / BWA.N / LEA.N / TRP.TO / NVDA.O / K.N / DT.N / DISH.O / EPR.N / LEN.N / CTXS.O / CLX.N / CAG.N / MRO.N / GIS.N / DVN.N / EPC.N / MGA.N / AMT.N / JAZZ.O / VZ.N / EXEL.O / CYH.N / DHI.N / STZ.N / APH.N / FISV.O / EQT.N / ADSK.O / V.N / AXL.N / AWK.N / CHD.N / BC.N / SAM.N / FRAG.DE / BMRN.O / OPTN.O / REGN.O / ENR.N / MU.O / SM.N / NCR.N / NET.N / TEL.N / COP.N / CNP.N / CPE.N / ENDP.O / CPK.N / PII.N / ST.N / SWN.N / SR.N / NTCT.OQ / GPN.N / MNST.O / NWG.L / IMGN.O / CASY.O / ANSS.O / ICPT.O / FFIV.O / EQIX.O / ATDb.TO / BIIB.O / CHR.TO / 02209S103 / DLR.N / ACAD.O / 427866108 / SJW.N / BKD.N / FIS.N / HICL.L / ADP.PA / TEVA.N / MA.N / HOG.N / CVLT.O / ATL.MI / BGS.N / VMW.N / TDC.N / INO.OQ / DAN.N / EDPR.LS / SWI.N / EIF.TO / FTNT.O / SPB.N / FHZN.S / PCRX.O / MSP.N / MTOR.N / MTDR.N / SPLK.OQ / WDC.O / PANW.N / QLYS.O / MDLZ.OQ / FANG.O / ABBV.N / TPH.N / TSLA.N / PRGO.N / PRMW.N / TMUS.N / TMHC.N / DOO.TO / COTY.N / AGIO.O / PTC.O / VRNS.O / AGRX.O / ANTM.N / AENA.MC / SHOP.N / GLPG.O / WRK.N / RPD.O / SGRY.O / MIME.OQ / MESO.O / RACE.MI / MTRO.L / SCWX.O / TWLO.N / ADNT.N / PBYI.OQ / OKTA.OQ / CDEV.O / ESTE.N / SAIL.N / APTV.N / ZS.OQ / AMRX.N / VNE.N / NTGY.MC / KDP.N / XERS.O / AQST.O / PRVB.O / ESTC.N / NWL.O / ZM.O / CRWD.O / GMAB.O / DOCU.N / PING.N / DDOG.O / CRNC.OQ / VMUK.L / NLOK.O / WTRG.N / REYN.O / NKLA.OQ / APA.OQ / FOUR.N / JAMF.O / PLTR.N / ASAN.N / MTCR.O / SUMO.O / BSY.O / MCFE.OQ / 900435207 / 120681711</td><td class="leftalignment">Air Canada / American Electric Power Company Inc / Altair Engineering Inc / Autoliv Inc / Applied Materials Inc / Advanced Micro Devices Inc / Barclays PLC / Bombardier Inc / Citigroup Inc / Cigna Corp / Colgate-Palmolive Co / CMS Energy Corp / Centrica PLC / Canadian Pacific Railway Ltd / CVS Health Corp / EDP Energias de Portugal SA / Edison International / Estee Lauder Companies Inc / Endesa SA / EOG Resources Inc / Ford Motor Co / General Motors Co / HSBC Holdings PLC / Hiscox Ltd / Intel Corp / International Paper Co / JPMorgan Chase & Co / KB Home / Kimberly-Clark Corp / Coca-Cola Co / Lloyds Banking Group PLC / PagerDuty Inc / Public Service Enterprise Group Inc / Pfizer Inc / Pultegroup Inc / PNC Financial Services Group Inc / Banco Santander SA / Vinci SA / Southern Co / AT&T Inc / Toll Brothers Inc / Visteon Corp / Wells Fargo & Co / SSE PLC / PepsiCo Inc / Brown-Forman Corp / Procter & Gamble Co / Pioneer Natural Resources Co / Humana Inc / Campbell Soup Co / Tenneco Inc / Comcast Corp / Check Point Software Technologies Ltd / Amgen Inc / Incyte Corp / Tenet Healthcare Corp / Canadian National Railway Co / Duke Energy Corp / UnitedHealth Group Inc / Borgwarner Inc / Lear Corp / TC Energy Corp / NVIDIA Corp / Kellogg Co / Dynatrace Inc / DISH Network Corp / EPR Properties / Lennar Corp / Citrix Systems Inc / Clorox Co / Conagra Brands Inc / Marathon Oil Corp / General Mills Inc / Devon Energy Corp / Edgewell Personal Care Co / Magna International Inc / American Tower Corp / Jazz Pharmaceuticals PLC / Verizon Communications Inc / Exelixis Inc / Community Health Systems Inc / D R Horton Inc / Constellation Brands Inc / Amphenol Corp / Fiserv Inc / EQT Corp / Autodesk Inc / Visa Inc / American Axle & Manufacturing Holdings Inc / American Water Works Company Inc / Church & Dwight Co Inc / Brunswick Corp / Boston Beer Company Inc / Fraport AG Frankfurt Airport Services Worldwide / Biomarin Pharmaceutical Inc / OptiNose Inc / Regeneron Pharmaceuticals Inc / Energizer Holdings Inc / Micron Technology Inc / SM Energy Co / NCR Corp / Cloudflare Inc / TE Connectivity Ltd / Conocophillips / CenterPoint Energy Inc / Callon Petroleum Co / Endo International PLC / Chesapeake Utilities Corp / Polaris Inc / Sensata Technologies Holding PLC / Southwestern Energy Co / Spire Inc / Netscout Systems Inc / Global Payments Inc / Monster Beverage Corp / Natwest Group PLC / ImmunoGen Inc / Caseys General Stores Inc / ANSYS Inc / Intercept Pharmaceuticals Inc / F5 Inc / Equinix Inc / Alimentation Couche-Tard Inc / Biogen Inc / Chorus Aviation Inc / Altria Group Inc / Digital Realty Trust Inc / ACADIA Pharmaceuticals Inc / Hershey Co / SJW Group / Brookdale Senior Living Inc / Fidelity National Information Services Inc / HICL Infrastructure PLC / Aeroports de Paris SA / Teva Pharmaceutical Industries Ltd / Mastercard Inc / Harley-Davidson Inc / Commvault Systems Inc / Atlantia SpA / B&G Foods Inc / VMware Inc / Teradata Corp / Inovio Pharmaceuticals Inc / Dana Inc / EDP Renovaveis SA / SolarWinds Corp / Exchange Income Corp / Fortinet Inc / Spectrum Brands Holdings Inc / Flughafen Zuerich AG / Pacira Biosciences Inc / Datto Holding Corp / Meritor Inc / Matador Resources Co / Splunk Inc / Western Digital Corp / Palo Alto Networks Inc / Qualys Inc / Mondelez International Inc / Diamondback Energy Inc / Abbvie Inc / Tri Pointe Homes Inc (Delaware) / Tesla Inc / Perrigo Company PLC / Primo Water Corp / T-Mobile US Inc / Taylor Morrison Home Corp / BRP Inc / Coty Inc / Agios Pharmaceuticals Inc / PTC Inc / Varonis Systems Inc / Agile Therapeutics Inc / Anthem Inc / Aena SME SA / Shopify Inc / Galapagos NV / Westrock Co / Rapid7 Inc / Surgery Partners Inc / Mimecast Ltd / Mesoblast Ltd / Ferrari NV / Metro Bank PLC / SecureWorks Corp / Twilio Inc / Adient PLC / Puma Biotechnology Inc / Okta Inc / Centennial Resource Development Inc / Earthstone Energy Inc / SailPoint Technologies Holdings Inc / Aptiv PLC / Zscaler Inc / Amneal Pharmaceuticals Inc / Veoneer Inc / Naturgy Energy Group SA / Keurig Dr Pepper Inc / Xeris Biopharma Holdings Inc / Aquestive Therapeutics Inc / Provention Bio Inc / Elastic NV / Newell Brands Inc / Zoom Video Communications Inc / CrowdStrike Holdings Inc / Genmab A/S / DocuSign Inc / Ping Identity Holding Corp / Datadog Inc / Cerence Inc / Virgin Money UK PLC / NortonLifeLock Inc / Essential Utilities Inc / Reynolds Consumer Products Inc / Nikola Corp / APA Corp (US) / Shift4 Payments Inc / Jamf Holding Corp / Palantir Technologies Inc / Asana Inc / Metacrine Inc / Sumo Logic Inc / Bentley Systems Inc / Mcafee Corp / Turquoise Hill Resources Ltd / Primo Water Corp</td><td class="leftalignment"></td><td class="leftalignment">Australia / Belgium / Bermuda / Canada / Switzerland / Germany / Denmark / Spain / France / United Kingdom / Ireland / Israel / Italy / Netherlands / Portugal / United States / Jersey</td><td class="leftalignment"></td><td class="leftalignment">Euroland / Europe / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">MARKET / COUNTRY RESEARCH / Research Digest / Equity</td><td class="leftalignment">RBCCM Global Research</td></tr>
<tr class="even"><td class="leftalignment">01/19/2021</td><td class="leftalignment">JPMorgan</td><td class="leftalignment">US Biotechnology : Putting a Wrap on The 2021 Healthcare Conference</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">CVS.N / JNJ.N / MCK.N / PFE.N / GILD.O / AMGN.O / INCY.O / ALKS.O / BMRN.O / REGN.O / VRTX.O / RARE.O / BLUE.O / NVAX.O / SGEN.O / BIIB.O / ACAD.O / MRNA.O / CLVS.O / SAGE.O / GBT.O / NVCR.O / EDIT.O / PBYI.O / JNCE.O / ALLO.O / BNTX.O / LEGN.O / BCAB.O</td><td class="leftalignment">CVS Health Corp / Johnson & Johnson / Mckesson Corp / Pfizer Inc / Gilead Sciences Inc / Amgen Inc / Incyte Corp / Alkermes Plc / Biomarin Pharmaceutical Inc / Regeneron Pharmaceuticals Inc / Vertex Pharmaceuticals Inc / Ultragenyx Pharmaceutical Inc / bluebird bio Inc / Novavax Inc / Seagen Inc / Biogen Inc / ACADIA Pharmaceuticals Inc / Moderna Inc / Clovis Oncology Inc / SAGE Therapeutics Inc / Global Blood Therapeutics Inc / Novocure Ltd / Editas Medicine Inc / Puma Biotechnology Inc / Jounce Therapeutics Inc / Allogene Therapeutics Inc / BioNTech SE / Legend Biotech Corp / Bioatla Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Cayman Islands / Germany / United Kingdom / Ireland / United States / Jersey</td><td class="leftalignment">Biotechnology / Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS / Equity</td><td class="leftalignment">Cory W. Kasimov / James Scott / Mr. Matthew T. Holt, P.Eng / Mr. Turner Kufe</td></tr>
<tr class="odd"><td class="leftalignment">01/19/2021</td><td class="leftalignment">Credit Suisse</td><td class="leftalignment">Contract Research Organizations : State of the CRO Industry: Biotech Funding Remains Robust; CT.gov Analysis</td><td class="leftalignment">English</td><td class="rightalignment">28</td><td class="leftalignment">PFE.N / DGX.N / LH.N / LONN.S / WST.N / CRL.N / ICLR.OQ / CTLT.N / MEDP.OQ / IQV.N / SYNH.OQ / CERT.OQ</td><td class="leftalignment">Pfizer Inc / Quest Diagnostics Inc / Laboratory Corporation of America Holdings / Lonza Group AG / West Pharmaceutical Services Inc / Charles River Laboratories International Inc / ICON PLC / Catalent Inc / Medpace Holdings Inc / IQVIA Holdings Inc / Syneos Health Inc / Certara Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">Switzerland / Ireland / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Euroland / Europe / North America</td><td class="leftalignment"></td><td class="leftalignment">INDUSTRY REPORTS</td><td class="leftalignment">Ms. Erin E. Wright / Ms. Katie A. Tryhane / Haley Christofides / Matthew Urbik</td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Cantor Fitzgerald</td><td class="leftalignment">THIS FRIDAY: Cantor Research Call- Healthcare Large Cap 4Q20 Preview</td><td class="leftalignment">English</td><td class="rightalignment">4</td><td class="leftalignment">HCM.O / LLY / JNJ / MRK / PFE / ZTS / IMAB.O</td><td class="leftalignment">HUTCHMED (China) Ltd / Eli Lilly and Co / Johnson & Johnson / Merck & Co Inc / Pfizer Inc / Zoetis Inc / I-Mab</td><td class="leftalignment"></td><td class="leftalignment">Cayman Islands / United States</td><td class="leftalignment">Healthcare / Pharmaceuticals</td><td class="leftalignment">Latin America / North America</td><td class="leftalignment"></td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Louise Chen / Brandon Folkes, CFA / Ms. Jennifer M. Kim / Mr. Carvey Leung</td></tr>
<tr class="odd"><td class="leftalignment">01/18/2021</td><td class="leftalignment">Oppenheimer & Co., Inc.</td><td class="leftalignment">Takeaways from Management and KOL Calls: MAT2A and PARG Are Well Differentiated</td><td class="leftalignment">English</td><td class="rightalignment">10</td><td class="leftalignment">IDYA=US / PFE=US / GSK=US / AGIO=US</td><td class="leftalignment">IDEAYA Biosciences Inc / Pfizer Inc / GlaxoSmithKline PLC / Agios Pharmaceuticals Inc</td><td class="leftalignment">EQUITY</td><td class="leftalignment">United Kingdom / United States</td><td class="leftalignment">Biotechnology</td><td class="leftalignment">Europe / North America</td><td class="leftalignment">COMPANY UPDATE</td><td class="leftalignment">COMPANY (EQUITY) REPORTS</td><td class="leftalignment">Kevin M. DeGeeter</td></tr>
<tr class="even"><td class="leftalignment">01/18/2021</td><td class="leftalignment">JPMorgan Econ & FI</td><td class="leftalignment">Autos, Basic Resources, Healthcare & Transport Calendar : January - April 2020</td><td class="leftalignment">English</td><td class="rightalignment">43</td><td class="leftalignment">ACF / AIRP.PA / BAX.N / BDX.N / BHP.AX / BMWG.DE / BMY.N / CC.N / CCK.N / CCL.N / CE.N / CRH.I / DSMN.AS / EPED.PA / F.N / FGP.L / GM.N / GOG.L / HEIG.DE / JNJ.N / LHAG.DE / LLY.N / MCK.N / MRK.N / MWDP.PA / NEX.L / PFE.N / PLOF.PA / RENA.PA / RIO.AX / RR.L / RYA.I / SAPJ.J / SAS.ST / SCAb.ST / SCHN.PA / SGC.L / SGOB.PA / SMIN.L / SOLB.BR / SYD.AX / TCFP.PA / TMO.N / VLLP.PA / VOLVb.ST / VOWG.DE / WBSV.VI / STERV.HE / AIRF.PA / CONG.DE / AZN.L / AMGN.O / AAL.L / SASY.PA / TKAG.DE / ROG.S / SIEGn.F / HON.N / NOVN.S / MG.TO / FMEG.DE / BZU.MI / MRCG.DE / MGA.N / PSHG_p.DE / OI.N / BLL.N / GLAX.NS / PKI.N / FREG.DE / RXL.PA / EZJ.L / SUP.N / GSK.L / ESI.N / CC@US / MHK.N / TAMO.BO / FLWS.O / VOES.VI / MT.N / LXSG.DE / HUN.N / SAF.PA / TUIGn.DE / LEGD.PA / TEVA.N / SKG.I / MNDI.L / DAIGn.DE / BAES.L / BAYGn.DE / BASFn.DE / GLEN.L / CAR.O / SDFGn.DE / METSB.HE / LKQ.O / XPO.N / GT.O / ABBV.N / GEST.MC / CSTM.N / EVKn.F / CTLT.N / EUCAR.PA / ZBH.N / 1COV.DE / HLAG.DE / NVGR.LS / ADNT.N / BHC.N / 114556048 / VTRS.O</td><td class="leftalignment">Acrow Formwork and Construction Services Ltd / L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes George / Baxter International Inc / Becton Dickinson and Co / BHP Group Ltd / Bayerische Motoren Werke AG / Bristol-Myers Squibb Co / Chemours Co / Crown Holdings Inc / Carnival Corp / Celanese Corp / CRH PLC / Koninklijke DSM NV / Faurecia SE / Ford Motor Co / FirstGroup PLC / General Motors Co / Go-Ahead Group PLC / HeidelbergCement AG / Johnson & Johnson / Deutsche Lufthansa AG / Eli Lilly and Co / Mckesson Corp / Merck & Co Inc / Wendel SE / National Express Group PLC / Pfizer Inc / Compagnie Plastic Omnium SE / Renault SA / Rio Tinto Ltd / Rolls-Royce Holdings PLC / Ryanair Holdings PLC / Sappi Ltd / SAS AB / Svenska Cellulosa SCA AB / Schneider Electric SE / Stagecoach Group PLC / Compagnie de Saint Gobain SA / Smiths Group PLC / Solvay SA / Sydney Airport / Thales SA / Thermo Fisher Scientific Inc / Vallourec SA / Volvo AB / Volkswagen AG / Wienerberger AG / Stora Enso Oyj / Air France KLM SA / Continental AG / AstraZeneca PLC / Amgen Inc / Anglo American PLC / Sanofi SA / thyssenkrupp AG / Roche Holding AG / Siemens AG / Honeywell International Inc / Novartis AG / Magna International Inc / Fresenius Medical Care AG & Co KGaA / Buzzi Unicem SpA / Merck KGaA / Magna International Inc / Porsche Automobil Holding SE / O-I Glass Inc / Ball Corp / GlaxoSmithKline Pharmaceuticals Ltd / PerkinElmer Inc / Fresenius SE & Co KGaA / Rexel SA / Easyjet PLC / Superior Industries International Inc / GlaxoSmithKline PLC / Element Solutions Inc / Chemours Co / Mohawk Industries Inc / Tata Motors Ltd / 1-800-Flowers.Com Inc / voestalpine AG / ArcelorMittal SA / Lanxess AG / Huntsman Corp / Safran SA / TUI AG / Legrand SA / Teva Pharmaceutical Industries Ltd / Smurfit Kappa Group PLC / Mondi PLC / Daimler AG / BAE Systems PLC / Bayer AG / BASF SE / Glencore PLC / Avis Budget Group Inc / K&S AG / Metsa Board Oyj / LKQ Corp / XPO Logistics Inc / Goodyear Tire & Rubber Co / Abbvie Inc / Gestamp Automocion SA / Constellium SE / Evonik Industries AG / Catalent Inc / Europcar Mobility Group SA / Zimmer Biomet Holdings Inc / Covestro AG / Hapag Lloyd AG / Navigator Company SA / Adient PLC / Bausch Health Companies Inc / Stellantis NV / Viatris Inc</td><td class="leftalignment">CREDIT RESEARCH</td><td class="leftalignment">Australia / Austria / Belgium / Canada / Switzerland / Germany / Denmark / Spain / Finland / France / United Kingdom / Hong Kong / India / Ireland / Israel / Italy / Luxembourg / Netherlands / Norway / Panama / Portugal / Sweden / United States / South Africa / Jersey</td><td class="leftalignment">Aerospace / Air Transportation / Automotive / Biotechnology / Building & Building Materials / Chemicals / Conglomerates / Consumer / Containers & Packing / Defense / Electrical / Financial Services / Healthcare / Household Products / Industrial Materials / Leisure & Entertainment / Lodging & Restaurants / Machinery / Manufacturing / Metals & Minerals / Paper & Forest Products / Pharmaceuticals / Railroads / Retailing / Shipping & Shipbuilding / Tire & Rubber / Transportation / Wholesale</td><td class="leftalignment">Africa / Asia / Euroland / Europe / Latin America / Middle East / North America / Australasia</td><td class="leftalignment"></td><td class="leftalignment">FIXED INCOME/DEBT RESEARCH / MARKET / COUNTRY RESEARCH / Equity</td><td class="leftalignment">Danielle Ward / Benjamin Defay / Stephanie Vincent / Mr. William W. Wade / Jemma Permalloo / Ed McGuinness / Mr. Adam Bodor</td></tr>
</tbody></table>
</body>
</html>